Citrus Sinensis ID: 046609
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 399 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.924 | 0.809 | 0.632 | 1e-138 | |
| Q9SFT7 | 414 | Serine/threonine-protein | no | no | 0.887 | 0.855 | 0.632 | 1e-128 | |
| Q9LQQ8 | 423 | Probable serine/threonine | no | no | 0.744 | 0.702 | 0.673 | 1e-123 | |
| Q9LFP7 | 493 | Probable receptor-like pr | no | no | 0.804 | 0.651 | 0.524 | 5e-95 | |
| Q9SRH7 | 490 | Receptor-like serine/thre | no | no | 0.736 | 0.6 | 0.551 | 1e-92 | |
| O49840 | 426 | Protein kinase 2B, chloro | no | no | 0.734 | 0.687 | 0.557 | 1e-92 | |
| O49839 | 426 | Protein kinase 2A, chloro | no | no | 0.802 | 0.751 | 0.526 | 2e-90 | |
| Q9FM85 | 408 | Probable receptor-like pr | no | no | 0.771 | 0.754 | 0.522 | 2e-89 | |
| Q8GXZ3 | 410 | Serine/threonine-protein | no | no | 0.744 | 0.724 | 0.525 | 6e-88 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.781 | 0.802 | 0.504 | 2e-87 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 490 bits (1262), Expect = e-138, Method: Compositional matrix adjust.
Identities = 238/376 (63%), Positives = 284/376 (75%), Gaps = 7/376 (1%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISF------KTESSRHRYITEEL 54
MGCF C + + + +S G ++ NIS K S + EL
Sbjct: 1 MGCFS-CFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKREL 59
Query: 55 RKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR 114
G I A F++REL AT NF+PD LGEGGFGRVY+G+L+ T Q VAVKQLDR
Sbjct: 60 LLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 115 NGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNR 174
NG QGNREFLVEVLMLS+L +P LVNL+GYC DGDQR+LVYE+MP GSLEDHL DLPP++
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 175 KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
+ALDWN RMKIA GAA+GLE+LH+ A PPVIYRDFK+SN+LLD+ F+PKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294
TGDKSHVSTRVMGTYGYCAPEYA+TGQLT KSDVYSFGVVFLE+ITGR+ ID+ P EQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354
NLV WA PLF DRRKF +ADP L+G +P + LYQALAVA+MC+QE+A TRP+++DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 355 IEYLAHSKEEACIEDS 370
+ YLA+ + +DS
Sbjct: 360 LSYLANQAYDPSKDDS 375
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SFT7|Y3707_ARATH Serine/threonine-protein kinase At3g07070 OS=Arabidopsis thaliana GN=At3g07070 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 229/362 (63%), Positives = 271/362 (74%), Gaps = 8/362 (2%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
M CF C EK +K + S YR + N KT + + E+ + +
Sbjct: 1 MNCFS-CFYFHEK--KKVPRDSDNSYRRNGEVTGRDN--NKTHPENPKTVNEQNKNNDED 55
Query: 61 K---NNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF 117
K NNI A+ FS+REL AT NF + L+GEGGFGRVY+GKLE T VAVKQLDRNG
Sbjct: 56 KEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGL 115
Query: 118 QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKAL 177
QGN+EF+VEVLMLS+L + +LVNL+GYC DGDQR+LVYEYM GSLEDHLLDL P++ L
Sbjct: 116 QGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPL 175
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237
DW+TR++IA GAA GLEYLH+ A PPVIYRD KA+N+LLD +FN KLSDFGLAKLGP GD
Sbjct: 176 DWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGD 235
Query: 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
K HVS+RVMGTYGYCAPEY TGQLT KSDVYSFGVV LE+ITGRRVID +RP +EQNLV
Sbjct: 236 KQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLV 295
Query: 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357
TWA P+FK+ +F +ADP LEG +P K L QA+AVAAMCLQEEA RP+MSDVVTA+ +
Sbjct: 296 TWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGF 355
Query: 358 LA 359
L
Sbjct: 356 LG 357
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LQQ8|RLCK7_ARATH Probable serine/threonine-protein kinase RLCKVII OS=Arabidopsis thaliana GN=At1g07870 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 200/297 (67%), Positives = 245/297 (82%)
Query: 66 AKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV 125
A+ F+++EL AT NF D LGEGGFG+V++G +E +Q VA+KQLDRNG QG REF+V
Sbjct: 88 AQTFTFQELAEATGNFRSDCFLGEGGFGKVFKGTIEKLDQVVAIKQLDRNGVQGIREFVV 147
Query: 126 EVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKI 185
EVL LS+ +P LV L+G+C +GDQR+LVYEYMP GSLEDHL LP +K LDWNTRMKI
Sbjct: 148 EVLTLSLADHPNLVKLIGFCAEGDQRLLVYEYMPQGSLEDHLHVLPSGKKPLDWNTRMKI 207
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
A GAARGLEYLH+ PPVIYRD K SN+LL +D+ PKLSDFGLAK+GP+GDK+HVSTRV
Sbjct: 208 AAGAARGLEYLHDRMTPPVIYRDLKCSNILLGEDYQPKLSDFGLAKVGPSGDKTHVSTRV 267
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305
MGTYGYCAP+YA+TGQLT KSD+YSFGVV LE+ITGR+ IDN++ ++QNLV WA PLFK
Sbjct: 268 MGTYGYCAPDYAMTGQLTFKSDIYSFGVVLLELITGRKAIDNTKTRKDQNLVGWARPLFK 327
Query: 306 DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362
DRR F M DPLL+G YP++GLYQALA++AMC+QE+ RP++SDVV A+ +LA SK
Sbjct: 328 DRRNFPKMVDPLLQGQYPVRGLYQALAISAMCVQEQPTMRPVVSDVVLALNFLASSK 384
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 348 bits (892), Expect = 5e-95, Method: Compositional matrix adjust.
Identities = 182/347 (52%), Positives = 233/347 (67%), Gaps = 26/347 (7%)
Query: 32 LASFANISFKTESSRHRYITEELRKIGKGKNNITAKI--FSYRELCVATTNFNPDNLLGE 89
++S S SS I+EEL NI++ + F++ +L ++T NF P++LLGE
Sbjct: 99 VSSTTTTSNAESSSSTPVISEEL--------NISSHLRKFTFNDLKLSTRNFRPESLLGE 150
Query: 90 GGFGRVYRGKLE---------GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVN 140
GGFG V++G +E GT VAVK L+ +G QG++E+L E+ L L +P LV
Sbjct: 151 GGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLVK 210
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLL--DLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
LVGYC++ DQR+LVYE+MP GSLE+HL LP L W+ RMKIA GAA+GL +LHE
Sbjct: 211 LVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP-----LPWSIRMKIALGAAKGLSFLHE 265
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
A PVIYRDFK SN+LLD D+N KLSDFGLAK P K+HVSTRVMGTYGY APEY +
Sbjct: 266 EALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVM 325
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318
TG LT+KSDVYSFGVV LE++TGRR +D +RP E NLV WA P D+R+F + DP L
Sbjct: 326 TGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRL 385
Query: 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365
EG++ IKG + +AA CL + RP MSDVV A++ L H K+ A
Sbjct: 386 EGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKDMA 432
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (873), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 171/310 (55%), Positives = 218/310 (70%), Gaps = 16/310 (5%)
Query: 67 KIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLE---------GTNQDVAVKQLDRNGF 117
K FS+ +L +AT NF P++LLGEGGFG V++G +E GT VAVK L+ +G
Sbjct: 122 KKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGL 181
Query: 118 QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLL--DLPPNRK 175
QG++E+L E+ L L +P LV LVGYC++ DQR+LVYE+MP GSLE+HL LP
Sbjct: 182 QGHKEWLAEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRSLP---- 237
Query: 176 ALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235
L W+ RMKIA GAA+GL +LHE A PVIYRDFK SN+LLD ++N KLSDFGLAK P
Sbjct: 238 -LPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPD 296
Query: 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN 295
K+HVSTRVMGTYGY APEY +TG LT+KSDVYSFGVV LE++TGRR +D +RP E N
Sbjct: 297 EGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHN 356
Query: 296 LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355
LV WA P D+R+F + DP LEG++ +KG + +AA CL ++ RP MS+VV +
Sbjct: 357 LVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVL 416
Query: 356 EYLAHSKEEA 365
+ L H K+ A
Sbjct: 417 KPLPHLKDMA 426
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1 | Back alignment and function description |
|---|
Score = 340 bits (871), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 170/305 (55%), Positives = 217/305 (71%), Gaps = 12/305 (3%)
Query: 67 KIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQD---------VAVKQLDRNGF 117
K F++ EL AT NF PD+LLGEGGFG V++G ++GT VAVK+L G+
Sbjct: 69 KAFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGY 128
Query: 118 QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKAL 177
QG++E+L EV L LS+P LV LVGYCV+G+ R+LVYE+MP GSLE+HL + L
Sbjct: 129 QGHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRR--GAQPL 186
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237
W RMK+A GAA+GL +LH+ A+ VIYRDFKA+N+LLD +FN KLSDFGLAK GPTGD
Sbjct: 187 TWAIRMKVAIGAAKGLTFLHD-AKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGD 245
Query: 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
K+HVST+VMGT+GY APEY TG+LTAKSDVYSFGVV LE+++GRR +D S+ EQ+LV
Sbjct: 246 KTHVSTQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLV 305
Query: 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357
WATP D+RK + D L G YP KG Y A ++A CL +A RP MS+V+ ++
Sbjct: 306 DWATPYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQ 365
Query: 358 LAHSK 362
L +K
Sbjct: 366 LESTK 370
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1 | Back alignment and function description |
|---|
Score = 332 bits (852), Expect = 2e-90, Method: Compositional matrix adjust.
Identities = 176/334 (52%), Positives = 222/334 (66%), Gaps = 14/334 (4%)
Query: 54 LRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLE---------GTN 104
LR G+ ++ K F++ EL AT NF DNLLGEGGFG V++G ++ G+
Sbjct: 59 LRTEGEILSSPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPGSG 118
Query: 105 QDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLE 164
VAVKQL GFQG++E+L EV L LS+P LV LVGYC +G+ R+LVYE+MP GSLE
Sbjct: 119 IVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAEGENRLLVYEFMPKGSLE 178
Query: 165 DHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224
+HL + L W RMK+A GAA+GL +LHE A+ VIYRDFKA+N+LLD DFN KL
Sbjct: 179 NHLFRR--GAQPLTWAIRMKVAVGAAKGLTFLHE-AKSQVIYRDFKAANILLDADFNAKL 235
Query: 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRV 284
SDFGLAK GPTGD +HVST+V+GT+GY APEY TG+LTAKSDVYSFGVV LE+I+GRR
Sbjct: 236 SDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGRRA 295
Query: 285 IDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT 344
+DNS E +LV WATP D+RK + D L G YP KG + A +A CL +A
Sbjct: 296 MDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDAKL 355
Query: 345 RPMMSDVVTAIEYLAHSKEEACIEDSLDS--CHH 376
RP MS+V+ +E L + ++S HH
Sbjct: 356 RPKMSEVLVTLEQLESVAKPGTKHTQMESPRFHH 389
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (844), Expect = 2e-89, Method: Compositional matrix adjust.
Identities = 172/329 (52%), Positives = 221/329 (67%), Gaps = 21/329 (6%)
Query: 51 TEELRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQD---- 106
E+LR+ N + A F+Y EL T+NF D +LG GGFG VY+G ++ D
Sbjct: 49 VEDLRR-DSAANPLIA--FTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVP 105
Query: 107 ----VAVKQLD-RNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161
VAVK D N FQG+RE+L EV+ L LS+P LV L+GYC + + R+L+YEYM G
Sbjct: 106 EPLPVAVKVHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARG 165
Query: 162 SLEDHLLD---LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218
S+E++L LP L W RMKIA GAA+GL +LHE A+ PVIYRDFK SN+LLD
Sbjct: 166 SVENNLFSRVLLP-----LSWAIRMKIAFGAAKGLAFLHE-AKKPVIYRDFKTSNILLDM 219
Query: 219 DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEI 278
D+N KLSDFGLAK GP GDKSHVSTR+MGTYGY APEY +TG LT SDVYSFGVV LE+
Sbjct: 220 DYNAKLSDFGLAKDGPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLEL 279
Query: 279 ITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCL 338
+TGR+ +D SRPT EQNL+ WA PL K+++K + DP + YP+K + +A +A CL
Sbjct: 280 LTGRKSLDKSRPTREQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCL 339
Query: 339 QEEAGTRPMMSDVVTAIEYLAHSKEEACI 367
RP+M D+V ++E L ++EEA +
Sbjct: 340 NRNPKARPLMRDIVDSLEPLQATEEEALL 368
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 6e-88, Method: Compositional matrix adjust.
Identities = 164/312 (52%), Positives = 210/312 (67%), Gaps = 15/312 (4%)
Query: 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGT------NQDVAVKQLDRNGFQGNRE 122
F+ EL T +F PD +LGEGGFG VY+G ++ + VAVK L++ G QG+RE
Sbjct: 57 FTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKEGLQGHRE 116
Query: 123 FLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTR 182
+L EV L L +P LV L+GYC + D R+LVYE+M GSLE+HL L W+ R
Sbjct: 117 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFR--KTTAPLSWSRR 174
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
M IA GAA+GL +LH +A+ PVIYRDFK SN+LLD D+ KLSDFGLAK GP GD++HVS
Sbjct: 175 MMIALGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 233
Query: 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302
TRVMGTYGY APEY +TG LTA+SDVYSFGVV LE++TGR+ +D +RP++EQNLV WA P
Sbjct: 234 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVDWARP 293
Query: 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362
D+RK + DP LE Y ++ +A ++A CL + RP+MSDVV +E L
Sbjct: 294 KLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL---- 349
Query: 363 EEACIEDSLDSC 374
C D+L C
Sbjct: 350 --QCTGDALIPC 359
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 322 bits (826), Expect = 2e-87, Method: Compositional matrix adjust.
Identities = 163/323 (50%), Positives = 219/323 (67%), Gaps = 11/323 (3%)
Query: 55 RKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLE---------GTNQ 105
R G+ N K FS EL AT NF PD+++GEGGFG V++G ++ GT
Sbjct: 42 RTEGEILQNANLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGI 101
Query: 106 DVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLED 165
+AVK+L++ GFQG+RE+L E+ L L +P LV L+GYC++ + R+LVYE+M GSLE+
Sbjct: 102 VIAVKRLNQEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLEN 161
Query: 166 HLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLS 225
HL + L WNTR+++A GAARGL +LH +AQP VIYRDFKASN+LLD ++N KLS
Sbjct: 162 HLFRRGTFYQPLSWNTRVRMALGAARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLS 220
Query: 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVI 285
DFGLA+ GP GD SHVSTRVMGT GY APEY TG L+ KSDVYSFGVV LE+++GRR I
Sbjct: 221 DFGLARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAI 280
Query: 286 DNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTR 345
D ++P E NLV WA P ++R+ + DP L+G Y + + +A C+ +A +R
Sbjct: 281 DKNQPVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSR 340
Query: 346 PMMSDVVTAIEYLAHSKEEACIE 368
P M+++V +E L H ++EA E
Sbjct: 341 PTMNEIVKTMEEL-HIQKEASKE 362
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 399 | ||||||
| 224126397 | 357 | predicted protein [Populus trichocarpa] | 0.892 | 0.997 | 0.818 | 1e-175 | |
| 255563977 | 385 | receptor serine-threonine protein kinase | 0.907 | 0.940 | 0.782 | 1e-171 | |
| 449470433 | 406 | PREDICTED: serine/threonine-protein kina | 0.899 | 0.884 | 0.779 | 1e-169 | |
| 449513479 | 406 | PREDICTED: LOW QUALITY PROTEIN: serine/t | 0.899 | 0.884 | 0.779 | 1e-168 | |
| 356524244 | 412 | PREDICTED: serine/threonine-protein kina | 0.932 | 0.902 | 0.740 | 1e-166 | |
| 224117484 | 372 | predicted protein [Populus trichocarpa] | 0.899 | 0.965 | 0.765 | 1e-165 | |
| 302142869 | 911 | unnamed protein product [Vitis vinifera] | 0.924 | 0.405 | 0.755 | 1e-164 | |
| 147822535 | 427 | hypothetical protein VITISV_021095 [Viti | 0.899 | 0.840 | 0.770 | 1e-164 | |
| 357459493 | 544 | Protein kinase-like protein [Medicago tr | 0.904 | 0.663 | 0.711 | 1e-162 | |
| 11994140 | 377 | receptor protein kinase-like protein [Ar | 0.879 | 0.931 | 0.780 | 1e-162 |
| >gi|224126397|ref|XP_002319828.1| predicted protein [Populus trichocarpa] gi|222858204|gb|EEE95751.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 622 bits (1603), Expect = e-175, Method: Compositional matrix adjust.
Identities = 294/359 (81%), Positives = 331/359 (92%), Gaps = 3/359 (0%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
MGCF CC++KE+ +KS+KKSIK Y +A++LASFANISFKT+SSR RYI EE+R+IGKG
Sbjct: 1 MGCFK-CCISKERLCKKSLKKSIKEYHDARTLASFANISFKTDSSRKRYIAEEIRQIGKG 59
Query: 61 KNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN 120
NI+A IF++R+L AT NFN +NL+GEGGFGRVY+G ++ T Q VAVKQLDRNGFQGN
Sbjct: 60 --NISADIFTFRDLTTATKNFNHENLIGEGGFGRVYKGIIQKTKQVVAVKQLDRNGFQGN 117
Query: 121 REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
REFLVEVLMLS+L +P LV+LVGYC DGDQRILVYEYM NGSLEDHLL+L P++K LDWN
Sbjct: 118 REFLVEVLMLSLLHHPNLVSLVGYCADGDQRILVYEYMINGSLEDHLLELAPDKKPLDWN 177
Query: 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
TRMKIA GAARGLEYLHESA PPVIYRDFKASNVLLD++FNPKLSDFGLAKLGPTGDK+H
Sbjct: 178 TRMKIAEGAARGLEYLHESANPPVIYRDFKASNVLLDENFNPKLSDFGLAKLGPTGDKTH 237
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300
VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLE+ITGRRVIDNSRPTEEQNLV+WA
Sbjct: 238 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLELITGRRVIDNSRPTEEQNLVSWA 297
Query: 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359
TPLFKDRRKFT+MADPLL+GNYP+KGLYQALAVAAMCLQEEA TRP+MSDVVTA+E+LA
Sbjct: 298 TPLFKDRRKFTLMADPLLQGNYPLKGLYQALAVAAMCLQEEASTRPLMSDVVTALEFLA 356
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255563977|ref|XP_002522988.1| receptor serine-threonine protein kinase, putative [Ricinus communis] gi|223537800|gb|EEF39418.1| receptor serine-threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1567), Expect = e-171, Method: Compositional matrix adjust.
Identities = 292/373 (78%), Positives = 326/373 (87%), Gaps = 11/373 (2%)
Query: 9 VAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKGKNNITAKI 68
++++K RKS+K+SIK Y + K+LASFANISFK++SSR RYI +E++KIGKG NI+A I
Sbjct: 1 MSEQKLSRKSLKESIKEYHDTKTLASFANISFKSDSSRRRYIADEIKKIGKG--NISADI 58
Query: 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVL 128
F++REL AT NFNPDNL+GEGGFGRVY+G++E TNQ VAVKQLDRNGFQGNREFLVEVL
Sbjct: 59 FTFRELSSATKNFNPDNLIGEGGFGRVYKGQMEKTNQVVAVKQLDRNGFQGNREFLVEVL 118
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG 188
MLS+L +P LVNLVGYC DGDQRILVY+YMPNGSLEDHLLDL P +K LDW TRMKIA G
Sbjct: 119 MLSLLHHPNLVNLVGYCADGDQRILVYDYMPNGSLEDHLLDLAPGKKPLDWKTRMKIAEG 178
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
AARGLEYLHESA PPVIYRDFKASN+LLD+DFNPKLSDFGLAKLGPTGDK+HVSTRVMGT
Sbjct: 179 AARGLEYLHESANPPVIYRDFKASNILLDEDFNPKLSDFGLAKLGPTGDKTHVSTRVMGT 238
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW--------- 299
YGYCAPEYALTGQLT+KSDVYSFGVVFLEIITGRRVIDNSR TEEQNLV W
Sbjct: 239 YGYCAPEYALTGQLTSKSDVYSFGVVFLEIITGRRVIDNSRTTEEQNLVIWASLKHQAQN 298
Query: 300 ATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359
ATPLFKD++KF +MADPLLEG YP+K LYQALAVAAMCLQEEA TRP+MSDVVTA+EYLA
Sbjct: 299 ATPLFKDKKKFILMADPLLEGKYPLKSLYQALAVAAMCLQEEAATRPLMSDVVTALEYLA 358
Query: 360 HSKEEACIEDSLD 372
K E ED D
Sbjct: 359 VKKGELDHEDMDD 371
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470433|ref|XP_004152921.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 599 bits (1545), Expect = e-169, Method: Compositional matrix adjust.
Identities = 282/362 (77%), Positives = 321/362 (88%), Gaps = 3/362 (0%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
M CF CC ++EK ++KS+KKSIK + E K+L SFANISFK+++SR RYITEE++K+GKG
Sbjct: 1 MNCFQ-CCGSEEKVNKKSLKKSIKEFEETKTLTSFANISFKSDASRRRYITEEIKKLGKG 59
Query: 61 KNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN 120
NITA+IF++ EL AT NFN +NLLGEGGFGRVY+G +E T Q AVKQLDRNGFQGN
Sbjct: 60 --NITAQIFTFDELSTATNNFNHENLLGEGGFGRVYKGIIESTKQVTAVKQLDRNGFQGN 117
Query: 121 REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
+EFLVEVLMLS+L +P LVNLVGYC DGDQRILVYEYM GSLEDHLLD+ ++ LDW
Sbjct: 118 KEFLVEVLMLSLLHHPNLVNLVGYCADGDQRILVYEYMAKGSLEDHLLDIASDKPPLDWK 177
Query: 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
TRMKIA GAA+GLEYLHE+A PPVIYRDFKASN+LLD++FNPKLSDFGLAKLGPTGDKSH
Sbjct: 178 TRMKIAEGAAKGLEYLHETANPPVIYRDFKASNILLDEEFNPKLSDFGLAKLGPTGDKSH 237
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300
VSTRVMGTYGYCAPEYALTGQLT KSDVYSFGVVFLEIITGRRVIDN+RPT EQNL+TWA
Sbjct: 238 VSTRVMGTYGYCAPEYALTGQLTTKSDVYSFGVVFLEIITGRRVIDNARPTAEQNLITWA 297
Query: 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
PLFKDRRKFT+MADP LEG+YP+K LYQALAVAAMCLQEEA TRP++SDVVTA+EYLA
Sbjct: 298 QPLFKDRRKFTLMADPKLEGDYPVKALYQALAVAAMCLQEEANTRPLISDVVTALEYLAA 357
Query: 361 SK 362
+K
Sbjct: 358 NK 359
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449513479|ref|XP_004164336.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase PBS1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 598 bits (1541), Expect = e-168, Method: Compositional matrix adjust.
Identities = 282/362 (77%), Positives = 320/362 (88%), Gaps = 3/362 (0%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
M CF CC ++EK ++KS+KKSIK + E K+L SFANISFK+++SR RYITEE +K+GKG
Sbjct: 1 MNCFQ-CCGSEEKVNKKSLKKSIKEFEETKTLTSFANISFKSDASRRRYITEEXKKLGKG 59
Query: 61 KNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN 120
NITA+IF++ EL AT NFN +NLLGEGGFGRVY+G +E T Q AVKQLDRNGFQGN
Sbjct: 60 --NITAQIFTFDELSTATNNFNHENLLGEGGFGRVYKGIIESTKQVTAVKQLDRNGFQGN 117
Query: 121 REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
+EFLVEVLMLS+L +P LVNLVGYC DGDQRILVYEYM GSLEDHLLD+ ++ LDW
Sbjct: 118 KEFLVEVLMLSLLHHPNLVNLVGYCADGDQRILVYEYMAKGSLEDHLLDIASDKPPLDWK 177
Query: 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
TRMKIA GAA+GLEYLHE+A PPVIYRDFKASN+LLD++FNPKLSDFGLAKLGPTGDKSH
Sbjct: 178 TRMKIAEGAAKGLEYLHETANPPVIYRDFKASNILLDEEFNPKLSDFGLAKLGPTGDKSH 237
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300
VSTRVMGTYGYCAPEYALTGQLT KSDVYSFGVVFLEIITGRRVIDN+RPT EQNL+TWA
Sbjct: 238 VSTRVMGTYGYCAPEYALTGQLTTKSDVYSFGVVFLEIITGRRVIDNARPTAEQNLITWA 297
Query: 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
PLFKDRRKFT+MADP LEG+YP+K LYQALAVAAMCLQEEA TRP++SDVVTA+EYLA
Sbjct: 298 QPLFKDRRKFTLMADPKLEGDYPVKALYQALAVAAMCLQEEANTRPLISDVVTALEYLAA 357
Query: 361 SK 362
+K
Sbjct: 358 NK 359
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356524244|ref|XP_003530740.1| PREDICTED: serine/threonine-protein kinase PBS1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 286/386 (74%), Positives = 324/386 (83%), Gaps = 14/386 (3%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
M CF CC ++E+ ++KS+KKSIK Y E K LASFANIS KT+S + IT EL K+GKG
Sbjct: 1 MSCFP-CCTSQERINKKSLKKSIKEYHEEKILASFANISVKTDSGKRNLITNELAKLGKG 59
Query: 61 KNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN 120
NIT+KIF YRELCVAT NFNP N++GEGGFGRVY+G L+ TNQ VAVKQLDRNGFQGN
Sbjct: 60 --NITSKIFPYRELCVATQNFNPANMIGEGGFGRVYKGHLKSTNQVVAVKQLDRNGFQGN 117
Query: 121 REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
REFLVEVL+LS+L +P LVNLVGYC +G+ RILVYEYM NGSLEDHLL++ P+RK LDW
Sbjct: 118 REFLVEVLILSLLHHPNLVNLVGYCAEGEHRILVYEYMINGSLEDHLLEITPDRKPLDWQ 177
Query: 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
TRMKIA GAA+GLE LHE A PPVIYRDFKASN+LLD++FNPKLSDFGLAKLGPTGDK+H
Sbjct: 178 TRMKIAEGAAKGLECLHEQANPPVIYRDFKASNILLDENFNPKLSDFGLAKLGPTGDKTH 237
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300
VSTRVMGTYGYCAPEYA TGQLT+KSDVYSFGVVFLE+ITGRRVIDN+RP+EEQNLV WA
Sbjct: 238 VSTRVMGTYGYCAPEYASTGQLTSKSDVYSFGVVFLEMITGRRVIDNARPSEEQNLVLWA 297
Query: 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA- 359
PL +DR KFT MADPLLE NYPIK LYQALAVAAMCLQEEA TRP++SDVVTAIE+LA
Sbjct: 298 QPLLRDRMKFTQMADPLLEDNYPIKSLYQALAVAAMCLQEEADTRPLISDVVTAIEFLAR 357
Query: 360 ---------HSKEEACIEDSLDSCHH 376
H+KE + +D DS H
Sbjct: 358 KKVEVDEPRHTKETSSTQDG-DSSEH 382
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117484|ref|XP_002317587.1| predicted protein [Populus trichocarpa] gi|222860652|gb|EEE98199.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 588 bits (1515), Expect = e-165, Method: Compositional matrix adjust.
Identities = 278/363 (76%), Positives = 327/363 (90%), Gaps = 4/363 (1%)
Query: 9 VAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKGKNNITAKI 68
+++E+ RK++KKSIK YR+A++LAS+ANISFKT+SSR R+ITEE++KIGKG NI+A I
Sbjct: 1 MSEERLGRKALKKSIKEYRDAETLASYANISFKTDSSRKRFITEEIKKIGKG--NISADI 58
Query: 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVL 128
F+ REL ATTNFN +NL+GEGGFGRVY+G + TNQ VAVKQLDRNGFQGNREFLVEVL
Sbjct: 59 FTCRELATATTNFNNENLIGEGGFGRVYKGLIAKTNQVVAVKQLDRNGFQGNREFLVEVL 118
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG 188
MLS+L +P LVN+VGYC DGDQRILVYE+M NGSLEDHLLDL P++ LDWNTR+KIA G
Sbjct: 119 MLSLLHHPNLVNMVGYCADGDQRILVYEFMVNGSLEDHLLDLTPDKNPLDWNTRIKIAEG 178
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
AARGLEYLHESA PPVIYRDFKASNVLLD++FNPKLSDFGLAKLGPTGDK+HVSTRVMGT
Sbjct: 179 AARGLEYLHESADPPVIYRDFKASNVLLDENFNPKLSDFGLAKLGPTGDKTHVSTRVMGT 238
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308
YGYCAPEYALTGQLTAKSDVYSFGVVFLE+ITGRRVID+SRP E+NLV+WATPLFKD++
Sbjct: 239 YGYCAPEYALTGQLTAKSDVYSFGVVFLEMITGRRVIDSSRPAGEKNLVSWATPLFKDKK 298
Query: 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA--HSKEEAC 366
K ++ADPLL+GNYP++GLYQALAVA MCLQEEA TRP+M+DVVTA+++LA + EE
Sbjct: 299 KLALIADPLLKGNYPLRGLYQALAVANMCLQEEALTRPLMADVVTALKFLAVNDAPEETA 358
Query: 367 IED 369
++D
Sbjct: 359 VDD 361
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142869|emb|CBI20164.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 584 bits (1506), Expect = e-164, Method: Compositional matrix adjust.
Identities = 281/372 (75%), Positives = 312/372 (83%), Gaps = 3/372 (0%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
MGCF CC++ KS+KKSIK Y +AK LASF NISFK++ S+ RYI EE+ K+GKG
Sbjct: 484 MGCF-ACCMSDPNVGSKSLKKSIKEYGDAKRLASFVNISFKSDGSKRRYIAEEIAKMGKG 542
Query: 61 KNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN 120
+I A +F+ EL AT NFN + L+GEGGFGRVY+G +E TN VAVK+LDRNGFQGN
Sbjct: 543 --SIPAHVFTIGELSAATNNFNHEALIGEGGFGRVYKGHVEKTNNSVAVKRLDRNGFQGN 600
Query: 121 REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
REFLVEV MLS+L + LVN+VGYC DGDQRILVYEYM NGSLEDHLLDL PN+K LDW
Sbjct: 601 REFLVEVFMLSLLHHTNLVNMVGYCCDGDQRILVYEYMANGSLEDHLLDLAPNKKPLDWK 660
Query: 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
TRMKIA GAARGLEYLH++A PPVIYRDFKASN+LLD+DFNPKLSDFGLAKLGPTGDK+H
Sbjct: 661 TRMKIAEGAARGLEYLHDTANPPVIYRDFKASNILLDEDFNPKLSDFGLAKLGPTGDKTH 720
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300
VSTRVMGTYGYCAPEYALTGQLT SDVYSFGVV LEIITGRRVIDNSRPTEEQNLVTWA
Sbjct: 721 VSTRVMGTYGYCAPEYALTGQLTTMSDVYSFGVVLLEIITGRRVIDNSRPTEEQNLVTWA 780
Query: 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
PL KDRRKFT+MADPLLEGNYPIKGLYQALAVAAMCLQEEA RP+MSDVV A+EYL+
Sbjct: 781 QPLLKDRRKFTLMADPLLEGNYPIKGLYQALAVAAMCLQEEATIRPLMSDVVMALEYLSD 840
Query: 361 SKEEACIEDSLD 372
+ D D
Sbjct: 841 KRAAGVDGDEED 852
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147822535|emb|CAN68395.1| hypothetical protein VITISV_021095 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1502), Expect = e-164, Method: Compositional matrix adjust.
Identities = 279/362 (77%), Positives = 309/362 (85%), Gaps = 3/362 (0%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
MGCF CC++ KS+KKSIK Y +AK LASF NISFK++ S+ RYI EE+ K+GKG
Sbjct: 1 MGCFA-CCMSDPNVGNKSLKKSIKEYGDAKRLASFVNISFKSDGSKRRYIAEEIAKMGKG 59
Query: 61 KNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN 120
+I A +F+ EL AT NFN + L+GEGGFGRVY+G E TN VAVK+LDRNGFQGN
Sbjct: 60 --SIPAHVFTIGELSAATNNFNHEALIGEGGFGRVYKGHXEKTNNSVAVKRLDRNGFQGN 117
Query: 121 REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
REFLVEV MLS+L + LVN+VGYC DGDQRILVYEYM NGSLEDHLLDL PN+K LDW
Sbjct: 118 REFLVEVFMLSLLHHTNLVNMVGYCCDGDQRILVYEYMANGSLEDHLLDLAPNKKPLDWK 177
Query: 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
TRMKIA GAARGLEYLH++A PPVIYRDFKASN+LLD+DFNPKLSDFGLAKLGPTGDK+H
Sbjct: 178 TRMKIAEGAARGLEYLHDTANPPVIYRDFKASNILLDEDFNPKLSDFGLAKLGPTGDKTH 237
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300
VSTRVMGTYGYCAPEYALTGQLT SDVYSFGVV LEIITGRRVIDNSRPTEEQNLVTWA
Sbjct: 238 VSTRVMGTYGYCAPEYALTGQLTTMSDVYSFGVVLLEIITGRRVIDNSRPTEEQNLVTWA 297
Query: 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
PL KDRRKFT+MADPLLEGNYPIKGLYQALAVAAMCLQEEA RP+MSDVV A+EYL+
Sbjct: 298 QPLLKDRRKFTLMADPLLEGNYPIKGLYQALAVAAMCLQEEASIRPLMSDVVMALEYLSD 357
Query: 361 SK 362
+
Sbjct: 358 KR 359
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357459493|ref|XP_003600027.1| Protein kinase-like protein [Medicago truncatula] gi|355489075|gb|AES70278.1| Protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1487), Expect = e-162, Method: Compositional matrix adjust.
Identities = 276/388 (71%), Positives = 317/388 (81%), Gaps = 27/388 (6%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKT------------------ 42
M CF CC ++E+ ++S+KKSIK Y +AK L SF NISFKT
Sbjct: 1 MSCFP-CCTSEERIKKRSLKKSIKQYHDAKVLTSFTNISFKTGFINSYFLNDESTFVKNL 59
Query: 43 ------ESSRHRYITEELRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVY 96
+S + R+I EEL K+GKG N+T+KIF+YRELCVAT NF P N++GEGGFGRVY
Sbjct: 60 NTFYIVDSGKRRFIAEELAKLGKG--NVTSKIFTYRELCVATENFQPTNMIGEGGFGRVY 117
Query: 97 RGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156
+G ++ TNQ VAVK LDRNGFQGNREFLVEVL+LS+L +P LVNLVGYC +GDQR+LVYE
Sbjct: 118 KGTIKNTNQIVAVKALDRNGFQGNREFLVEVLILSLLHHPNLVNLVGYCAEGDQRVLVYE 177
Query: 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216
YM NG LE+HLLDL P RK LDW TRMKIA GAA+GLEYLHE A PPVIYRDFKASN+LL
Sbjct: 178 YMANGCLEEHLLDLAPGRKPLDWKTRMKIAEGAAKGLEYLHEEANPPVIYRDFKASNILL 237
Query: 217 DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFL 276
D+++NPKLSDFGLAKLGPTG+K HVSTRVMGTYGYCAPEYA TGQL+ KSDVYSFGVVFL
Sbjct: 238 DENYNPKLSDFGLAKLGPTGEKEHVSTRVMGTYGYCAPEYASTGQLSTKSDVYSFGVVFL 297
Query: 277 EIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAM 336
EIITGRRVIDNSRP+EEQNLV WA PL +DR+KFT MADPLLE YPIKGLYQALA+AAM
Sbjct: 298 EIITGRRVIDNSRPSEEQNLVLWAQPLLRDRKKFTQMADPLLEDKYPIKGLYQALAIAAM 357
Query: 337 CLQEEAGTRPMMSDVVTAIEYLAHSKEE 364
CLQEEA TRP++SDVVTA+E+LA+ KEE
Sbjct: 358 CLQEEADTRPLISDVVTALEFLANKKEE 385
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|11994140|dbj|BAB01161.1| receptor protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 577 bits (1487), Expect = e-162, Method: Compositional matrix adjust.
Identities = 278/356 (78%), Positives = 319/356 (89%), Gaps = 5/356 (1%)
Query: 12 EKFHRKSI-KKSIKGYREAKS-LASFANISFKTESSRHRYITEELRKIGKGKNNITAKIF 69
E+F+R+S ++SIK +AK+ + +F NISFKT+SSR RYI+EE+ K+GKG NI+A IF
Sbjct: 4 ERFNRRSSSRQSIKDCIDAKNNITTFDNISFKTDSSRRRYISEEIAKLGKG--NISAHIF 61
Query: 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM 129
++RELCVAT NFNPDN LGEGGFGRVY+G++E Q VAVKQLDRNG+QGNREFLVEV+M
Sbjct: 62 TFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQGNREFLVEVMM 121
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA-LDWNTRMKIAHG 188
LS+L + LVNLVGYC DGDQRILVYEYM NGSLEDHLL+L N+K LDW+TRMK+A G
Sbjct: 122 LSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPLDWDTRMKVAAG 181
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
AARGLEYLHE+A PPVIYRDFKASN+LLD++FNPKLSDFGLAK+GPTG ++HVSTRVMGT
Sbjct: 182 AARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGGETHVSTRVMGT 241
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308
YGYCAPEYALTGQLT KSDVYSFGVVFLE+ITGRRVID ++PTEEQNLVTWA+PLFKDRR
Sbjct: 242 YGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLVTWASPLFKDRR 301
Query: 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364
KFT+MADPLLEG YPIKGLYQALAVAAMCLQEEA TRPMMSDVVTA+EYLA +K E
Sbjct: 302 KFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEYLAVTKTE 357
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 399 | ||||||
| TAIR|locus:2085720 | 386 | AT3G20530 [Arabidopsis thalian | 0.904 | 0.935 | 0.762 | 2.3e-149 | |
| TAIR|locus:2179857 | 456 | PBS1 "avrPphB susceptible 1" [ | 0.924 | 0.809 | 0.632 | 6.3e-124 | |
| TAIR|locus:2183018 | 513 | AT5G18610 [Arabidopsis thalian | 0.892 | 0.693 | 0.662 | 1.3e-123 | |
| TAIR|locus:2036818 | 389 | AT1G61860 [Arabidopsis thalian | 0.857 | 0.879 | 0.664 | 7.2e-123 | |
| TAIR|locus:2151191 | 378 | CDL1 "CDG1-like 1" [Arabidopsi | 0.799 | 0.843 | 0.697 | 9.5e-121 | |
| TAIR|locus:2098580 | 414 | AT3G07070 [Arabidopsis thalian | 0.884 | 0.852 | 0.634 | 3.4e-116 | |
| TAIR|locus:2087263 | 363 | AT3G24790 [Arabidopsis thalian | 0.817 | 0.898 | 0.660 | 9.4e-114 | |
| TAIR|locus:2119350 | 389 | AT4G13190 [Arabidopsis thalian | 0.832 | 0.853 | 0.618 | 1.9e-108 | |
| TAIR|locus:2056613 | 424 | AT2G28590 [Arabidopsis thalian | 0.829 | 0.780 | 0.605 | 8.1e-108 | |
| TAIR|locus:2034344 | 381 | ASG5 "ALTERED SEED GERMINATION | 0.807 | 0.845 | 0.608 | 9.5e-105 |
| TAIR|locus:2085720 AT3G20530 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1458 (518.3 bits), Expect = 2.3e-149, P = 2.3e-149
Identities = 280/367 (76%), Positives = 325/367 (88%)
Query: 1 MGCFHYCCVAKEKFHRKSI-KKSIKGYREAKS-LASFANISFKTESSRHRYITEELRKIG 58
+ C +CC++ +F+R+S ++SIK +AK+ + +F NISFKT+SSR RYI+EE+ K+G
Sbjct: 3 INCL-FCCMSHRRFNRRSSSRQSIKDCIDAKNNITTFDNISFKTDSSRRRYISEEIAKLG 61
Query: 59 KGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ 118
KG NI+A IF++RELCVAT NFNPDN LGEGGFGRVY+G++E Q VAVKQLDRNG+Q
Sbjct: 62 KG--NISAHIFTFRELCVATKNFNPDNQLGEGGFGRVYKGQIETPEQVVAVKQLDRNGYQ 119
Query: 119 GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA-L 177
GNREFLVEV+MLS+L + LVNLVGYC DGDQRILVYEYM NGSLEDHLL+L N+K L
Sbjct: 120 GNREFLVEVMMLSLLHHQNLVNLVGYCADGDQRILVYEYMQNGSLEDHLLELARNKKKPL 179
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237
DW+TRMK+A GAARGLEYLHE+A PPVIYRDFKASN+LLD++FNPKLSDFGLAK+GPTG
Sbjct: 180 DWDTRMKVAAGAARGLEYLHETADPPVIYRDFKASNILLDEEFNPKLSDFGLAKVGPTGG 239
Query: 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
++HVSTRVMGTYGYCAPEYALTGQLT KSDVYSFGVVFLE+ITGRRVID ++PTEEQNLV
Sbjct: 240 ETHVSTRVMGTYGYCAPEYALTGQLTVKSDVYSFGVVFLEMITGRRVIDTTKPTEEQNLV 299
Query: 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357
TWA+PLFKDRRKFT+MADPLLEG YPIKGLYQALAVAAMCLQEEA TRPMMSDVVTA+EY
Sbjct: 300 TWASPLFKDRRKFTLMADPLLEGKYPIKGLYQALAVAAMCLQEEAATRPMMSDVVTALEY 359
Query: 358 LAHSKEE 364
LA +K E
Sbjct: 360 LAVTKTE 366
|
|
| TAIR|locus:2179857 PBS1 "avrPphB susceptible 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1218 (433.8 bits), Expect = 6.3e-124, P = 6.3e-124
Identities = 238/376 (63%), Positives = 284/376 (75%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISF------KTESSRHRYITEEL 54
MGCF C + + + +S G ++ NIS K S + EL
Sbjct: 1 MGCFS-CFDSSDDEKLNPVDESNHGQKKQSQPTVSNNISGLPSGGEKLSSKTNGGSKREL 59
Query: 55 RKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR 114
G I A F++REL AT NF+PD LGEGGFGRVY+G+L+ T Q VAVKQLDR
Sbjct: 60 LLPRDGLGQIAAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDR 119
Query: 115 NGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNR 174
NG QGNREFLVEVLMLS+L +P LVNL+GYC DGDQR+LVYE+MP GSLEDHL DLPP++
Sbjct: 120 NGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDK 179
Query: 175 KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
+ALDWN RMKIA GAA+GLE+LH+ A PPVIYRDFK+SN+LLD+ F+PKLSDFGLAKLGP
Sbjct: 180 EALDWNMRMKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGP 239
Query: 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294
TGDKSHVSTRVMGTYGYCAPEYA+TGQLT KSDVYSFGVVFLE+ITGR+ ID+ P EQ
Sbjct: 240 TGDKSHVSTRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQ 299
Query: 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354
NLV WA PLF DRRKF +ADP L+G +P + LYQALAVA+MC+QE+A TRP+++DVVTA
Sbjct: 300 NLVAWARPLFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTA 359
Query: 355 IEYLAHSKEEACIEDS 370
+ YLA+ + +DS
Sbjct: 360 LSYLANQAYDPSKDDS 375
|
|
| TAIR|locus:2183018 AT5G18610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1215 (432.8 bits), Expect = 1.3e-123, P = 1.3e-123
Identities = 239/361 (66%), Positives = 285/361 (78%)
Query: 2 GCFH-YCCVAKEKFHRKSIKKSIKGYREAKSLASFANISF-KTESSRHRYITEELRKIGK 59
GC + AK+ + S+KK + ++ S+ +IS K++S R +EL +
Sbjct: 3 GCLPCFGSSAKDAASKDSVKKELSA-KDG-SVTQSHHISLDKSKSRRGPEQKKELTAPKE 60
Query: 60 GKN-NITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ 118
G +I A+ F++REL AT NF P+ LLGEGGFGRVY+G+LE T Q VAVKQLDRNG Q
Sbjct: 61 GPTAHIAAQTFTFRELAAATKNFRPECLLGEGGFGRVYKGRLETTGQIVAVKQLDRNGLQ 120
Query: 119 GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALD 178
GNREFLVEVLMLS+L +P LVNL+GYC DGDQR+LVYEYMP GSLEDHL DLPP+++ LD
Sbjct: 121 GNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLGSLEDHLHDLPPDKEPLD 180
Query: 179 WNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238
W+TRM IA GAA+GLEYLH+ A PPVIYRD K+SN+LL ++PKLSDFGLAKLGP GDK
Sbjct: 181 WSTRMTIAAGAAKGLEYLHDKANPPVIYRDLKSSNILLGDGYHPKLSDFGLAKLGPVGDK 240
Query: 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298
+HVSTRVMGTYGYCAPEYA+TGQLT KSDVYSFGVVFLE+ITGR+ IDN+R E NLV
Sbjct: 241 THVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVFLELITGRKAIDNARAPGEHNLVA 300
Query: 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358
WA PLFKDRRKF MADP L+G YP++GLYQALAVAAMCLQE+A TRP++ DVVTA+ YL
Sbjct: 301 WARPLFKDRRKFPKMADPSLQGRYPMRGLYQALAVAAMCLQEQAATRPLIGDVVTALTYL 360
Query: 359 A 359
A
Sbjct: 361 A 361
|
|
| TAIR|locus:2036818 AT1G61860 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
Identities = 230/346 (66%), Positives = 271/346 (78%)
Query: 16 RKSIKKSIKGYR--EAKSLASFANISFKTESSRHRYITEELRKIGKGKNNITAKIFSYRE 73
R S + + YR K A F S + S R +YITEE++K G KN +IF ++E
Sbjct: 20 RDSFDEGLTAYRGHSRKLFALFTFRSHRKGSCRQKYITEEIKKYGNVKN--CGRIFKFKE 77
Query: 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML 133
L AT NF+ D ++GEGGFGRVY+G L NQ VAVK+LDRNG QG REF EV++LS+
Sbjct: 78 LIAATDNFSMDCMIGEGGFGRVYKGFLTSLNQVVAVKRLDRNGLQGTREFFAEVMVLSLA 137
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
+P LVNL+GYCV+ +QR+LVYE+MPNGSLEDHL DLP +LDW TRM+I HGAA+GL
Sbjct: 138 QHPNLVNLIGYCVEDEQRVLVYEFMPNGSLEDHLFDLPEGSPSLDWFTRMRIVHGAAKGL 197
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
EYLH+ A PPVIYRDFKASN+LL DFN KLSDFGLA+LGPT K HVSTRVMGTYGYCA
Sbjct: 198 EYLHDYADPPVIYRDFKASNILLQSDFNSKLSDFGLARLGPTEGKDHVSTRVMGTYGYCA 257
Query: 254 PEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313
PEYA+TGQLTAKSDVYSFGVV LEII+GRR ID RPTEEQNL++WA PL KDRR F +
Sbjct: 258 PEYAMTGQLTAKSDVYSFGVVLLEIISGRRAIDGDRPTEEQNLISWAEPLLKDRRMFAQI 317
Query: 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359
DP L+GNYP+KGL+QALA+AAMCLQEEA TRP+M DVVTA+E+LA
Sbjct: 318 VDPNLDGNYPVKGLHQALAIAAMCLQEEAETRPLMGDVVTALEFLA 363
|
|
| TAIR|locus:2151191 CDL1 "CDG1-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1188 (423.3 bits), Expect = 9.5e-121, P = 9.5e-121
Identities = 224/321 (69%), Positives = 261/321 (81%)
Query: 42 TESSRHRYITEELRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLE 101
+E SR + E + KG ++I A+ F++ EL AT NF + L+GEGGFGRVY+G L
Sbjct: 36 SEKSRAKSSLSESKS--KGSDHIVAQTFTFSELATATRNFRKECLIGEGGFGRVYKGYLA 93
Query: 102 GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161
T+Q A+KQLD NG QGNREFLVEVLMLS+L +P LVNL+GYC DGDQR+LVYEYMP G
Sbjct: 94 STSQTAAIKQLDHNGLQGNREFLVEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEYMPLG 153
Query: 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221
SLEDHL D+ P ++ LDWNTRMKIA GAA+GLEYLH+ PPVIYRD K SN+LLD D+
Sbjct: 154 SLEDHLHDISPGKQPLDWNTRMKIAAGAAKGLEYLHDKTMPPVIYRDLKCSNILLDDDYF 213
Query: 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITG 281
PKLSDFGLAKLGP GDKSHVSTRVMGTYGYCAPEYA+TGQLT KSDVYSFGVV LEIITG
Sbjct: 214 PKLSDFGLAKLGPVGDKSHVSTRVMGTYGYCAPEYAMTGQLTLKSDVYSFGVVLLEIITG 273
Query: 282 RRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEE 341
R+ ID+SR T EQNLV WA PLFKDRRKF+ MADP+L+G YP +GLYQALAVAAMC+QE+
Sbjct: 274 RKAIDSSRSTGEQNLVAWARPLFKDRRKFSQMADPMLQGQYPPRGLYQALAVAAMCVQEQ 333
Query: 342 AGTRPMMSDVVTAIEYLAHSK 362
RP+++DVVTA+ YLA K
Sbjct: 334 PNLRPLIADVVTALSYLASQK 354
|
|
| TAIR|locus:2098580 AT3G07070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1145 (408.1 bits), Expect = 3.4e-116, P = 3.4e-116
Identities = 229/361 (63%), Positives = 271/361 (75%)
Query: 1 MGCFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKG 60
M CF C EK +K + S YR + N KT + + E+ + +
Sbjct: 1 MNCFS-CFYFHEK--KKVPRDSDNSYRRNGEVTGRDNN--KTHPENPKTVNEQNKNNDED 55
Query: 61 K---NNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF 117
K NNI A+ FS+REL AT NF + L+GEGGFGRVY+GKLE T VAVKQLDRNG
Sbjct: 56 KEVTNNIAAQTFSFRELATATKNFRQECLIGEGGFGRVYKGKLEKTGMIVAVKQLDRNGL 115
Query: 118 QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKAL 177
QGN+EF+VEVLMLS+L + +LVNL+GYC DGDQR+LVYEYM GSLEDHLLDL P++ L
Sbjct: 116 QGNKEFIVEVLMLSLLHHKHLVNLIGYCADGDQRLLVYEYMSRGSLEDHLLDLTPDQIPL 175
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237
DW+TR++IA GAA GLEYLH+ A PPVIYRD KA+N+LLD +FN KLSDFGLAKLGP GD
Sbjct: 176 DWDTRIRIALGAAMGLEYLHDKANPPVIYRDLKAANILLDGEFNAKLSDFGLAKLGPVGD 235
Query: 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
K HVS+RVMGTYGYCAPEY TGQLT KSDVYSFGVV LE+ITGRRVID +RP +EQNLV
Sbjct: 236 KQHVSSRVMGTYGYCAPEYQRTGQLTTKSDVYSFGVVLLELITGRRVIDTTRPKDEQNLV 295
Query: 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357
TWA P+FK+ +F +ADP LEG +P K L QA+AVAAMCLQEEA RP+MSDVVTA+ +
Sbjct: 296 TWAQPVFKEPSRFPELADPSLEGVFPEKALNQAVAVAAMCLQEEATVRPLMSDVVTALGF 355
Query: 358 L 358
L
Sbjct: 356 L 356
|
|
| TAIR|locus:2087263 AT3G24790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1122 (400.0 bits), Expect = 9.4e-114, P = 9.4e-114
Identities = 216/327 (66%), Positives = 255/327 (77%)
Query: 40 FKTESSRHRYITEELRKIGKG-KNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRG 98
+K +S R E + K G NN+ A+IF++REL AT NF + L+GEGGFGRVY+G
Sbjct: 5 YKQPNSPKRTTGEVVAKNANGPSNNMGARIFTFRELATATKNFRQECLIGEGGFGRVYKG 64
Query: 99 KLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158
KLE Q VAVKQLDRNG QG REFLVEVLMLS+L + LVNL+GYC DGDQR+LVYEYM
Sbjct: 65 KLENPAQVVAVKQLDRNGLQGQREFLVEVLMLSLLHHRNLVNLIGYCADGDQRLLVYEYM 124
Query: 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218
P GSLEDHLLDL P +K LDWNTR+KIA GAA+G+EYLH+ A PPVIYRD K+SN+LLD
Sbjct: 125 PLGSLEDHLLDLEPGQKPLDWNTRIKIALGAAKGIEYLHDEADPPVIYRDLKSSNILLDP 184
Query: 219 DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEI 278
++ KLSDFGLAKLGP GD HVS+RVMGTYGYCAPEY TG LT KSDVYSFGVV LE+
Sbjct: 185 EYVAKLSDFGLAKLGPVGDTLHVSSRVMGTYGYCAPEYQRTGYLTNKSDVYSFGVVLLEL 244
Query: 279 ITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCL 338
I+GRRVID RP+ EQNLVTWA P+F+D ++ +ADPLL G+YP K L QA+AVAAMCL
Sbjct: 245 ISGRRVIDTMRPSHEQNLVTWALPIFRDPTRYWQLADPLLRGDYPEKSLNQAIAVAAMCL 304
Query: 339 QEEAGTRPMMSDVVTAIEYLAHSKEEA 365
EE RP+MSDV+TA+ +L S +
Sbjct: 305 HEEPTVRPLMSDVITALSFLGASSNSS 331
|
|
| TAIR|locus:2119350 AT4G13190 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1072 (382.4 bits), Expect = 1.9e-108, P = 1.9e-108
Identities = 206/333 (61%), Positives = 256/333 (76%)
Query: 28 EAKSLASFANISFKTESSRHRYITEELRKIGK-GKNNITAKIFSYRELCVATTNFNPDNL 86
E S+A+ + R + T E K NI AK F +REL AT +F + L
Sbjct: 17 EGSSMAAPYEQQNLPRNDRRQITTWEAVGTNKESPKNIKAKSFKFRELATATNSFRQEFL 76
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+GEGGFGRVY+GK+E T Q VAVKQLDRNG QGNREFLVE+ LS+L +P L NL+GYC+
Sbjct: 77 IGEGGFGRVYKGKMEKTGQVVAVKQLDRNGLQGNREFLVEIFRLSLLHHPNLANLIGYCL 136
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
DGDQR+LV+E+MP GSLEDHLLD+ ++ LDWN+R++IA GAA+GLEYLHE A PPVIY
Sbjct: 137 DGDQRLLVHEFMPLGSLEDHLLDVVVGQQPLDWNSRIRIALGAAKGLEYLHEKANPPVIY 196
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKS 266
RDFK+SN+LL+ DF+ KLSDFGLAKLG GD +VS+RV+GTYGYCAPEY TGQLT KS
Sbjct: 197 RDFKSSNILLNVDFDAKLSDFGLAKLGSVGDTQNVSSRVVGTYGYCAPEYHKTGQLTVKS 256
Query: 267 DVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKG 326
DVYSFGVV LE+ITG+RVID +RP EQNLVTWA P+F++ +F +ADPLL+G +P K
Sbjct: 257 DVYSFGVVLLELITGKRVIDTTRPCHEQNLVTWAQPIFREPNRFPELADPLLQGEFPEKS 316
Query: 327 LYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359
L QA+A+AAMCLQEE RP++SDVVTA+ +++
Sbjct: 317 LNQAVAIAAMCLQEEPIVRPLISDVVTALSFMS 349
|
|
| TAIR|locus:2056613 AT2G28590 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
Identities = 201/332 (60%), Positives = 254/332 (76%)
Query: 66 AKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV 125
A+ F++ EL V+T NF D LGEGGFG+VY+G +E NQ VA+KQLDRNG QG REF+V
Sbjct: 83 AQTFTFEELSVSTGNFKSDCFLGEGGFGKVYKGFIEKINQVVAIKQLDRNGAQGIREFVV 142
Query: 126 EVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKI 185
EVL LS+ +P LV L+G+C +G QR+LVYEYMP GSL++HL DLP + L WNTRMKI
Sbjct: 143 EVLTLSLADHPNLVKLIGFCAEGVQRLLVYEYMPLGSLDNHLHDLPSGKNPLAWNTRMKI 202
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
A GAARGLEYLH++ +PPVIYRD K SN+L+D+ ++ KLSDFGLAK+GP G ++HVSTRV
Sbjct: 203 AAGAARGLEYLHDTMKPPVIYRDLKCSNILIDEGYHAKLSDFGLAKVGPRGSETHVSTRV 262
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305
MGTYGYCAP+YALTGQLT KSDVYSFGVV LE+ITGR+ DN+R Q+LV WA PLFK
Sbjct: 263 MGTYGYCAPDYALTGQLTFKSDVYSFGVVLLELITGRKAYDNTRTRNHQSLVEWANPLFK 322
Query: 306 DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365
DR+ F M DPLLEG+YP++GLYQALA+AAMC+QE+ RP+++DVV A+++LA SK +
Sbjct: 323 DRKNFKKMVDPLLEGDYPVRGLYQALAIAAMCVQEQPSMRPVIADVVMALDHLASSKYDR 382
Query: 366 CIEDSLDSCHHGRNSQEPTAAARGSTVLMDRK 397
D+ + +E T S V ++ K
Sbjct: 383 SHRQKQDNVTETKVDEEKTLTTE-SNVCVEEK 413
|
|
| TAIR|locus:2034344 ASG5 "ALTERED SEED GERMINATION 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1037 (370.1 bits), Expect = 9.5e-105, P = 9.5e-105
Identities = 202/332 (60%), Positives = 250/332 (75%)
Query: 37 NISFKTESSRHRYITEELRKIG----KGKNNIT-----AKIFSYRELCVATTNFNPDNLL 87
N ++T+SS H T I GK N A+ F+++EL AT NF NLL
Sbjct: 25 NSRYQTDSSVHGSDTTGTESISGILVNGKVNSPIPGGGARSFTFKELAAATRNFREVNLL 84
Query: 88 GEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD 147
GEGGFGRVY+G+L+ + Q VA+KQL+ +G QGNREF+VEVLMLS+L +P LV L+GYC
Sbjct: 85 GEGGFGRVYKGRLD-SGQVVAIKQLNPDGLQGNREFIVEVLMLSLLHHPNLVTLIGYCTS 143
Query: 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYR 207
GDQR+LVYEYMP GSLEDHL DL N++ L WNTRMKIA GAARG+EYLH +A PPVIYR
Sbjct: 144 GDQRLLVYEYMPMGSLEDHLFDLESNQEPLSWNTRMKIAVGAARGIEYLHCTANPPVIYR 203
Query: 208 DFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSD 267
D K++N+LLD++F+PKLSDFGLAKLGP GD++HVSTRVMGTYGYCAPEYA++G+LT KSD
Sbjct: 204 DLKSANILLDKEFSPKLSDFGLAKLGPVGDRTHVSTRVMGTYGYCAPEYAMSGKLTVKSD 263
Query: 268 VYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGL 327
+Y FGVV LE+ITGR+ ID + EQNLVTW+ P KD++KF + DP L G YP + L
Sbjct: 264 IYCFGVVLLELITGRKAIDLGQKQGEQNLVTWSRPYLKDQKKFGHLVDPSLRGKYPRRCL 323
Query: 328 YQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359
A+A+ AMCL EEA RP + D+V A+EYLA
Sbjct: 324 NYAIAIIAMCLNEEAHYRPFIGDIVVALEYLA 355
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XIII.2950.1 | hypothetical protein (357 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 399 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-56 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-49 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 9e-49 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-48 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-38 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-30 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-29 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-28 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-28 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 6e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-27 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-26 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-25 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-24 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-23 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-23 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-23 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-23 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-22 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-22 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 4e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-21 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-21 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-21 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-21 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 7e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-20 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-20 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-20 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-20 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 7e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-19 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 4e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-19 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-19 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-19 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-18 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-18 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-18 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 6e-18 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 7e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-17 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 7e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 8e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 9e-17 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-16 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-16 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 8e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 8e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 9e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-15 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-15 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-15 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-15 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-15 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-14 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 5e-14 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-14 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 6e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 9e-14 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 9e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-13 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-13 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-13 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-13 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-12 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-12 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 4e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 7e-12 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-11 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-11 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-11 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-11 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-11 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-11 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 7e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 8e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-11 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-10 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-10 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-10 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-10 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-08 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-08 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-07 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 5e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-07 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-06 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 8e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-05 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 3e-56
Identities = 76/215 (35%), Positives = 110/215 (51%), Gaps = 18/215 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLVNLVGYC 145
LGEGGFG VY + + T + VA+K + + E L E+ +L L++P +V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
D + LV EY GSL+D L + N L + ++I GLEYLH + +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE---NEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 206 YRDFKASNVLLDQD-FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLT 263
+RD K N+LLD D KL+DFGL+KL + ++GT Y APE L G +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKL--LTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 264 AKSDVYSFGVVFLEIITGRRVID-------NSRPT 291
KSD++S GV+ E+ + +I RP+
Sbjct: 173 EKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPS 207
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-50
Identities = 74/200 (37%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 87 LGEGGFGRVYRGKLEGTN----QDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG VY+GKL+G +VAVK L + Q EFL E ++ L +P +V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+G C + + +V EYM G L +L NR L + + A ARG+EYL
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRK---NRPKLSLSDLLSFALQIARGMEYLESK-- 121
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD-KSHVSTRVMGTYGYCAPEYALTG 260
I+RD A N L+ ++ K+SDFGL++ D ++ + APE G
Sbjct: 122 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL--PIRWMAPESLKEG 178
Query: 261 QLTAKSDVYSFGVVFLEIIT 280
+ T+KSDV+SFGV+ EI T
Sbjct: 179 KFTSKSDVWSFGVLLWEIFT 198
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 80/286 (27%), Positives = 120/286 (41%), Gaps = 41/286 (14%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLV 139
+ LGEG FG+VY + + T + VA+K + + + +RE L E+ +L L +P +V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L D D+ LV EY G L D L R L + LEYLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSK 116
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
+++RD K N+LLD+D + KL+DFGLA+ ++T V GT Y APE L
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQ--LDPGEKLTTFV-GTPEYMAPEVLLG 170
Query: 260 GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319
D++S GV+ E++TG+ P F + + + +
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK-------------------PPFPGDDQLLELFKKIGK 211
Query: 320 GNYPIKGLYQALAVAAM-----CLQEEAGTRPMMSDVVTAIEYLAH 360
P ++ A L ++ R TA E L H
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL------TAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 6e-49
Identities = 74/200 (37%), Positives = 105/200 (52%), Gaps = 13/200 (6%)
Query: 87 LGEGGFGRVYRGKLEGTN----QDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG VY+G L+G +VAVK L + Q EFL E ++ L +P +V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+G C + + ++V EYMP G L D+L P L + + A ARG+EYL
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE--LSLSDLLSFALQIARGMEYLESK-- 122
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD-KSHVSTRVMGTYGYCAPEYALTG 260
I+RD A N L+ ++ K+SDFGL++ D ++ + APE G
Sbjct: 123 -NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL--PIRWMAPESLKEG 179
Query: 261 QLTAKSDVYSFGVVFLEIIT 280
+ T+KSDV+SFGV+ EI T
Sbjct: 180 KFTSKSDVWSFGVLLWEIFT 199
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 9e-49
Identities = 78/199 (39%), Positives = 106/199 (53%), Gaps = 12/199 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
LG G FG VY+ K +GT + VAVK L + ++ E+ +L LS+P +V L+
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
D D LV EY G L D+L L + KIA RGLEYLH + +
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSNG---I 119
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL-T 263
I+RD K N+LLD++ K++DFGLAK S ++T V GT Y APE L G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177
Query: 264 AKSDVYSFGVVFLEIITGR 282
K DV+S GV+ E++TG+
Sbjct: 178 PKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-48
Identities = 88/285 (30%), Positives = 128/285 (44%), Gaps = 36/285 (12%)
Query: 85 NLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVN 140
LGEG FG VY+GKL+ G +VAVK L + + R +FL E ++ L +P +V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLD-----LPPNRKALDWNTRMKIAHGAARGLEY 195
L+G C + + LV EYM G L D+L P + L + A A+G+EY
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
L ++RD A N L+ +D K+SDFGL++ D T + APE
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRRV----IDNSRPTEEQNLVTWATPLFKDRRKFT 311
G T+KSDV+SFGV+ EI T + N + + RK
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------------VLEYLRKGY 224
Query: 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
+ P P + LY+ + C Q + RP S++V +E
Sbjct: 225 RLPKPE---YCPDE-LYE---LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-48
Identities = 74/200 (37%), Positives = 103/200 (51%), Gaps = 11/200 (5%)
Query: 87 LGEGGFGRVYRGKL----EGTNQDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG VY+G L EGT VAVK L + EFL E ++ LS+P +V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+G C G+ +V EYMP G L D L + + L +++A A+G+EYL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRK---HGEKLTLKDLLQMALQIAKGMEYLESK-- 121
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++RD A N L+ ++ K+SDFGL++ D + APE G+
Sbjct: 122 -NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180
Query: 262 LTAKSDVYSFGVVFLEIITG 281
T+KSDV+SFGV+ EI T
Sbjct: 181 FTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-38
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQ--LDRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
LLG G FG VY + T + +AVK L + + E+ +LS L +P +V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 143 GYCVDGDQR-ILVY-EYMPNGSLEDHLLDLPPNRKALDWN-----TRMKIAHGAARGLEY 195
G D ++ + ++ EY+ GSL L L TR + GL Y
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPVIRKYTRQIL-----EGLAY 116
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
LH + +++RD K +N+L+D D KL+DFG AK + + V GT + APE
Sbjct: 117 LHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRRV 284
+ +D++S G +E+ TG+
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 2e-31
Identities = 71/202 (35%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
+G+G FG V G G Q VAVK L + + FL E +++ L +P LV L+G
Sbjct: 13 TIGKGEFGDVMLGDYRG--QKVAVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ G+ +V EYM GSL D+L R + ++ A G+EYL E +
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRS--RGRAVITLAQQLGFALDVCEGMEYL-EEKN--FV 124
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAK---LGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
+RD A NVL+ +D K+SDFGLAK G K V + APE +
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKKF 176
Query: 263 TAKSDVYSFGVVFLEIITGRRV 284
+ KSDV+SFG++ EI + RV
Sbjct: 177 STKSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-31
Identities = 65/217 (29%), Positives = 110/217 (50%), Gaps = 13/217 (5%)
Query: 87 LGEGGFGRVYRG----KLEGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LG G FG VY+G + E VA+K L + + N+E L E +++ + +P++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+G C+ Q L+ + MP G L D++ + ++ + + A+G+ YL E
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR- 129
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+++RD A NVL+ + K++DFGLAKL +K + + + A E L
Sbjct: 130 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI 187
Query: 262 LTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLV 297
T KSDV+S+GV E++T G + + E +L+
Sbjct: 188 YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-30
Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 85 NLLGEGGFGRVYRGKLE----GTNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLV 139
LGEG FG+V + + T + VAVK L+ +G Q +F E+ +L L + +V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 140 NLVGYCVDGDQRI--LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
G C R L+ EY+P+GSL D+L +R ++ + + +G++YL
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYL---QRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST--RVMGTYGYCAPE 255
I+RD A N+L++ + K+SDFGLAK+ P + + Y APE
Sbjct: 127 SQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APE 182
Query: 256 YALTGQLTAKSDVYSFGVVFLEIIT 280
T + ++ SDV+SFGV E+ T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 3e-29
Identities = 72/217 (33%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV----EVLMLSMLS- 134
++ LGEG FG VY + + VA+K L + + + E+ +L+ L+
Sbjct: 1 SYRILRKLGEGSFGEVYLARD---RKLVALKVL-AKKLESKSKEVERFLREIQILASLNH 56
Query: 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
P +V L + D LV EY+ GSLED LL + L + + I LE
Sbjct: 57 PPNIVKLYDFFQDEGSLYLVMEYVDGGSLED-LLKKIGRKGPLSESEALFILAQILSALE 115
Query: 195 YLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAK-LGPTGDKSHV---STRVMGTY 249
YLH +I+RD K N+LLD+D KL DFGLAK L G S + + +GT
Sbjct: 116 YLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 250 GYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRR 283
GY APE L ++ SD++S G+ E++TG
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 58/202 (28%), Positives = 99/202 (49%), Gaps = 21/202 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G+GGFG VY+ + + T ++VA+K + + + + E+ +L +P +V G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK------IAHGAARGLEYLHESA 200
D+ +V E+ GSL+D LL N + + +GLEYLH +
Sbjct: 68 KKDELWIVMEFCSGGSLKD-LLK--------STNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
+I+RD KA+N+LL D KL DFGL+ + ++GT + APE
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGK 172
Query: 261 QLTAKSDVYSFGVVFLEIITGR 282
K+D++S G+ +E+ G+
Sbjct: 173 PYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 67/210 (31%), Positives = 100/210 (47%), Gaps = 19/210 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
LGEG FG+V+ G+ + VAVK L + ++F E +L+ + +V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHL---------LDLPPNRKA-LDWNTRMKIAHGAA 190
G C +GD I+V+EYM +G L L L P + L + ++IA A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
G+ YL ++Q V +RD N L+ D K+ DFG+++ T D V M
Sbjct: 133 SGMVYL--ASQHFV-HRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ PE + + T +SDV+SFGVV EI T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 69/210 (32%), Positives = 109/210 (51%), Gaps = 21/210 (10%)
Query: 87 LGEGGFGRVYRGKLEGTN-----QDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVN 140
LGEG FG+VY+G+L G N VA+K L N + EF E ++S L +P +V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN------------RKALDWNTRMKIAHG 188
L+G C +++EY+ +G L + L+ P+ + +LD + + IA
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
A G+EYL + ++RD A N L+ + K+SDFGL++ + D V ++ +
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEI 278
+ PE L G+ T +SD++SFGVV EI
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 6e-28
Identities = 65/200 (32%), Positives = 102/200 (51%), Gaps = 8/200 (4%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVN 140
F + LG G FG V+ G + + VA+K L + ++F EV L L + +L++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L C G+ ++ E M GSL L P + L + + +A A G+ YL E
Sbjct: 67 LFAVCSVGEPVYIITELMEKGSLLAFLRS--PEGQVLPVASLIDMACQVAEGMAYLEEQN 124
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
I+RD A N+L+ +D K++DFGLA+L + ++S+ Y + APE A G
Sbjct: 125 ---SIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPEAASHG 179
Query: 261 QLTAKSDVYSFGVVFLEIIT 280
+ KSDV+SFG++ E+ T
Sbjct: 180 TFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-27
Identities = 74/201 (36%), Positives = 102/201 (50%), Gaps = 14/201 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+ G GT + VAVK L + G FL E ++ L + LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTK-VAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+ + +V EYM GSL D L K L + +A A G+ YL ES I+
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKS--GEGKKLRLPQLVDMAAQIAEGMAYL-ESRN--YIH 126
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYALTGQLT 263
RD A N+L+ ++ K++DFGLA+L + + R G + APE A G+ T
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI---EDDEYTAR-EGAKFPIKWTAPEAANYGRFT 182
Query: 264 AKSDVYSFGVVFLEIITGRRV 284
KSDV+SFG++ EI+T RV
Sbjct: 183 IKSDVWSFGILLTEIVTYGRV 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 19/209 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPY 137
N+ +L+G G FG VY+G T VA+KQ+ + + + E+ +L L +P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLED---HLLDLPPNRKALDWNTRMKIAHGAARGLE 194
+V +G D ++ EY NGSL P + A + +GL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-------VYVYQVLQGLA 113
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCA 253
YLHE VI+RD KA+N+L +D KL+DFG+A KL V+GT + A
Sbjct: 114 YLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS---VVGTPYWMA 167
Query: 254 PEYALTGQLTAKSDVYSFGVVFLEIITGR 282
PE + SD++S G +E++TG
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 4e-27
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 27/204 (13%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+GEG G VY+ T ++VA+K++ + N+E ++ E+L++ +P +V+
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLR--KQNKELIINEILIMKDCKHPNIVDYYDSY 84
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN-TRMKIAHGAA------RGLEYLHE 198
+ GD+ +V EYM GSL D + N RM A +GLEYLH
Sbjct: 85 LVGDELWVVMEYMDGGSLTD----------IITQNFVRMNEPQIAYVCREVLQGLEYLH- 133
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
VI+RD K+ N+LL +D + KL+DFG A+L K + V+GT + APE
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN---SVVGTPYWMAPEVI 188
Query: 258 LTGQLTAKSDVYSFGVVFLEIITG 281
K D++S G++ +E+ G
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 77/279 (27%), Positives = 126/279 (45%), Gaps = 36/279 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVG-Y 144
LG+G G VY+ + + T + A+K++ +G + R+ L+ E+ L +PY+V G +
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRM--KIAHGAARGLEYLHESAQP 202
+G+ I V EYM GSL D L +K + IA +GL+YLH
Sbjct: 69 YKEGEISI-VLEYMDGGSLADLL------KKVGKIPEPVLAYIARQILKGLDYLHTKRH- 120
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+I+RD K SN+L++ K++DFG++K L T D+ + T V GT Y +PE
Sbjct: 121 -IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN--TFV-GTVTYMSPERIQGES 176
Query: 262 LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321
+ +D++S G+ LE G+ P ++ + + P L
Sbjct: 177 YSYAADIWSLGLTLLECALGK------FPFLPPGQPSFFELM----QAICDGPPPSLPAE 226
Query: 322 YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+ + CLQ++ RP +A E L H
Sbjct: 227 EFSPEFRDFI---SACLQKDPKKRP------SAAELLQH 256
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 63/197 (31%), Positives = 99/197 (50%), Gaps = 8/197 (4%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLVNLVGY 144
+G+G FG VY+G L+G N +VAVK + FL E +L +P +V L+G
Sbjct: 2 KIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
CV +V E +P GSL L + L ++++ AA G+EYL ES
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYL-ESKN--C 114
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
I+RD A N L+ ++ K+SDFG+++ G + + APE G+ T+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 265 KSDVYSFGVVFLEIITG 281
+SDV+S+G++ E +
Sbjct: 175 ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-25
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
+GEG +G+VY+ + + T + VA+K++ ++ GF + E+ +L L +P +V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFP--ITAIREIKLLQKLRHPNIVRLK 64
Query: 143 GYCVDGDQR--ILVYEYMP---NGSLEDHLLDL-PPNRKALDWNTRMKIAHGAARGLEYL 196
+ +V+EYM G L+ + K GL+YL
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC--------YMKQLLEGLQYL 116
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H + +++RD K SN+L++ D KL+DFGLA+ T S T + T Y PE
Sbjct: 117 HSNG---ILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRPPEL 172
Query: 257 ALTG--QLTAKSDVYSFGVVFLEIITGR 282
L G + + D++S G + E+ G+
Sbjct: 173 -LLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 68/209 (32%), Positives = 98/209 (46%), Gaps = 32/209 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLVG 143
LG+G FG+V + + T + A+K L + +E L E +LS +++P++V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-- 58
Query: 144 YCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR--------GL 193
+ + LV EY P G L HL + + + AR L
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHL------------SKEGRFSEERARFYAAEIVLAL 106
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
EYLH +IYRD K N+LLD D + KL+DFGLAK + S +T GT Y A
Sbjct: 107 EYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC-GTPEYLA 161
Query: 254 PEYALTGQLTAKSDVYSFGVVFLEIITGR 282
PE L D +S GV+ E++TG+
Sbjct: 162 PEVLLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-25
Identities = 66/205 (32%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 87 LGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGN-REFLVEVLMLSMLSNPYLVNLV 142
LG G FG V +G G +VAVK L + +EFL E +++ L +P +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESA 200
G C G+ +LV E P G L +L P + AH A G+ YL
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESKH 115
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG-----YCAPE 255
++RD A NVLL K+SDFG+++ G + +T T G + APE
Sbjct: 116 ---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYAPE 168
Query: 256 YALTGQLTAKSDVYSFGVVFLEIIT 280
G+ ++KSDV+S+GV E +
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 24/208 (11%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQ---DVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYL 138
+ ++G G FG V RG+L+ + DVA+K L + G +FL E ++ +P +
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNI 67
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+ L G +++ EYM NGSL+ L + N + + G A G++YL E
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSE 124
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG------YC 252
++RD A N+L++ + K+SDFGL++ D T T G +
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRR--LEDSEATYT----TKGGKIPIRWT 175
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIIT 280
APE + T+ SDV+SFG+V E+++
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-24
Identities = 84/284 (29%), Positives = 127/284 (44%), Gaps = 36/284 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G G VY N+ VA+K++D Q + + L EV +S ++P +V
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
V GD+ LV Y+ GSL D ++ R LD + +GLEYLH + Q I
Sbjct: 69 VVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---I 124
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSH-VSTRVMGTYGYCAPEYALTGQ-L 262
+RD KA N+LL +D + K++DFG+ A L GD++ V +GT + APE
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 263 TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM----ADPLL 318
K+D++SFG+ +E+ TG P K M+ P L
Sbjct: 185 DFKADIWSFGITAIELATGAAPYSKYPPM-----------------KVLMLTLQNDPPSL 227
Query: 319 EGNYPIKGLYQAL-AVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361
E K ++ + ++CLQ++ RP TA E L H
Sbjct: 228 ETGADYKKYSKSFRKMISLCLQKDPSKRP------TAEELLKHK 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 18/202 (8%)
Query: 90 GGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLVGYCV 146
G +GRV+ K + T A+K + + + L E +LS +PY+V L Y
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62
Query: 147 DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
G + + LV EY+P G L LL+ N +LD + LEYLH + +I
Sbjct: 63 QGKKNLYLVMEYLPGGDLA-SLLE---NVGSLDEDVARIYIAEIVLALEYLHSNG---II 115
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS------TRVMGTYGYCAPEYALT 259
+RD K N+L+D + + KL+DFGL+K+G + +++ R++GT Y APE L
Sbjct: 116 HRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILG 175
Query: 260 GQLTAKSDVYSFGVVFLEIITG 281
+ D +S G + E + G
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 15/198 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+ GK G DVA+K + R G +F+ E ++ LS+P LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRG-KIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+V EYM NG L ++L + + L + + +EYL + I+
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRE---RKGKLGTEWLLDMCSDVCEAMEYLESNG---FIH 123
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYALTGQLT 263
RD A N L+ +D K+SDFGLA+ D + S+ GT + PE + +
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSS--QGTKFPVKWAPPEVFDYSRFS 179
Query: 264 AKSDVYSFGVVFLEIITG 281
+KSDV+SFGV+ E+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 63/229 (27%), Positives = 101/229 (44%), Gaps = 37/229 (16%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-----FLVEVLMLSMLS 134
+F ++GEG F V K + TN++ A+K LD+ Q +E +E +L+ L+
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLN 59
Query: 135 -NPYLVNLVGYCVDGDQRIL--VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
+P ++ L Y D+ L V EY PNG L ++ +LD A
Sbjct: 60 GHPGIIKL--YYTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILL 113
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM----- 246
LEYLH +I+RD K N+LLD+D + K++DFG AK+ +
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 247 -------------GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
GT Y +PE SD+++ G + +++TG+
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 99 bits (249), Expect = 6e-24
Identities = 71/202 (35%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 87 LGEGGFGRV----YRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLVNL 141
LGEG FG+V Y +GT + VAVK L R Q N + E+ +L L + +V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 142 VGYCVDGDQRI--LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G C + + L+ EY+P GSL D+L P ++ L + A G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNL--AQLLLFAQQICEGMAYLHSQ 126
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH-VSTRVMGTYGYCAPEYAL 258
I+RD A NVLLD D K+ DFGLAK P G + + V + A E
Sbjct: 127 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183
Query: 259 TGQLTAKSDVYSFGVVFLEIIT 280
+ + SDV+SFGV E++T
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 8e-24
Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 19/210 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG+V+ + + VAVK L ++F E +L++L + ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALD-----------WNTRMKIAHGAA 190
G C +G ++V+EYM +G L L P+ K L + IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
G+ YL A ++RD N L+ Q K+ DFG+++ + D V R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ PE L + T +SD++SFGVV EI T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 9e-24
Identities = 60/214 (28%), Positives = 98/214 (45%), Gaps = 33/214 (15%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLV-EVLMLSMLSNPYLVNLV 142
+G+G FG+VY + + + +K++D N + RE + EV +L L++P ++
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLD------LPPNRKALDWNTRMKIAHGAARGLEYL 196
+ + +V EY G L + P + LDW ++ +A L+YL
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------LKYL 119
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPE 255
H +++RD K N+ L + KL DFG++K L T D + T V GT Y +PE
Sbjct: 120 HSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--KTVV-GTPYYLSPE 173
Query: 256 ------YALTGQLTAKSDVYSFGVVFLEIITGRR 283
Y KSD++S G V E+ T +
Sbjct: 174 LCQNKPY------NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-23
Identities = 66/198 (33%), Positives = 100/198 (50%), Gaps = 11/198 (5%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+ G T VAVK L + G ++FL E ++ L +P L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTP-VAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+ +V E M GSL ++L +AL + +A A G+ YL I+
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YIH 126
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGD-KSHVSTRVMGTYGYCAPEYALTGQLTAK 265
RD A NVL+ ++ K++DFGLA++ ++ + + APE AL + + K
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRFSIK 184
Query: 266 SDVYSFGVVFLEIIT-GR 282
SDV+SFG++ EI+T GR
Sbjct: 185 SDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 3e-23
Identities = 69/232 (29%), Positives = 110/232 (47%), Gaps = 15/232 (6%)
Query: 82 NPDNL-----LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP 136
+P L +G G FG V+ G + VA+K + R G +F+ E ++ LS+P
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHP 59
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
LV L G C + LV+E+M +G L D+ L R T + + G+ YL
Sbjct: 60 KLVQLYGVCTERSPICLVFEFMEHGCLSDY---LRAQRGKFSQETLLGMCLDVCEGMAYL 116
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
S VI+RD A N L+ ++ K+SDFG+ + D+ ST + +PE
Sbjct: 117 ESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEV 172
Query: 257 ALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDR 307
+ ++KSDV+SFGV+ E+ + G+ +N +E + L+K R
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPR 224
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 3e-23
Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 86 LLGEGGFGRV----YRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LG+G FG V Y + T + VAVK+L + + R+F E+ +L L + +V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70
Query: 142 VGYCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G C +R LV EY+P GSL D+L +R+ LD + A +G+EYL
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYL--- 124
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG---TYGYCAPEY 256
++RD N+L++ + K+ DFGL K+ P DK + R G + Y APE
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ-DKEYYKVREPGESPIFWY-APES 182
Query: 257 ALTGQLTAKSDVYSFGVVFLEIIT 280
+ + SDV+SFGVV E+ T
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 4e-23
Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 12/198 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYC 145
LG G G V + T + +AVK + + ++ ++ L + N PY+V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ + EYM GSL+ L + + KIA +GL YLHE + +I
Sbjct: 69 YNNGDISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHK--II 123
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD K SN+L++ KL DFG++ +L + K+ V GT Y APE +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPERIQGNDYSV 178
Query: 265 KSDVYSFGVVFLEIITGR 282
KSD++S G+ +E+ TGR
Sbjct: 179 KSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 4e-23
Identities = 71/224 (31%), Positives = 111/224 (49%), Gaps = 27/224 (12%)
Query: 66 AKIFSYRELCVATTNFNPDNLLGEGGFGRVYRG----KLEGTNQDVAVKQL-DRNGFQGN 120
A+I EL LLG G FG V++G + + VA+K + DR+G Q
Sbjct: 1 ARILKETEL-------RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 121 REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLL----DLPPNRKA 176
+E +L + L + Y+V L+G C G LV + P GSL DH+ L P R
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQR-L 111
Query: 177 LDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236
L+W ++ A+G+ YL E +++R+ A N+LL D +++DFG+A L
Sbjct: 112 LNWCVQI------AKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162
Query: 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
DK + + + A E L G+ T +SDV+S+GV E+++
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 5e-23
Identities = 85/299 (28%), Positives = 138/299 (46%), Gaps = 47/299 (15%)
Query: 87 LGEGGFGRVYRGKLE----------------GTNQDVAVKQLDRNGFQGNR-EFLVEVLM 129
LGEG FG V+ ++ G VAVK L + + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLED-----HLLD--------LPPNRK- 175
LS L +P ++ L+G CVD D ++ EYM NG L HL D +PP
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 176 -ALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
A+ +++ + +A A G++YL + ++RD N L+ ++ K++DFG+++
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294
GD + R + + A E L G+ T SDV++FGV EI+ + T+EQ
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249
Query: 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPI--KGLYQALAVAAMCLQEEAGTRPMMSDV 351
++ A F+D+ + + P P +GLY+ + C + RP SD+
Sbjct: 250 -VIENAGEFFRDQGRQVYLFRP------PPCPQGLYELM---LQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 5e-23
Identities = 74/236 (31%), Positives = 111/236 (47%), Gaps = 29/236 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGY 144
+G+G FG VY+ + TNQ VA+K +D + E + E+ LS +PY+ G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+ G + ++ EY GS D LL LD I GLEYLHE
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLD-LLKPGK----LDETYIAFILREVLLGLEYLHEEG---K 119
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
I+RD KA+N+LL ++ + KL+DFG++ +L T K + T V GT + APE
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN--TFV-GTPFWMAPEVIKQSGYD 176
Query: 264 AKSDVYSFGVVFLEIITG-------------RRVIDNSRPTEEQNLVTWATPLFKD 306
K+D++S G+ +E+ G + N+ P+ E N + FKD
Sbjct: 177 EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKP---FKD 229
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 9e-23
Identities = 70/228 (30%), Positives = 117/228 (51%), Gaps = 15/228 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G G VY T Q+VA+KQ++ Q +E ++ E+L++ +P +VN +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ GD+ +V EY+ GSL D + + +D + + LE+LH + VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VI 137
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD K+ N+LL D + KL+DFG A++ P ++S ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKDRRKFT 311
K D++S G++ +E++ G N P L+ T TP ++ K +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 63/230 (27%), Positives = 96/230 (41%), Gaps = 46/230 (20%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLM 129
+ + LG+G FG VY G +G + VA+K + + + EFL E +
Sbjct: 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL------------LDLPPNRKAL 177
+ + ++V L+G G ++V E M G L+ +L L P +K +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL----- 232
A A G+ YL ++RD A N ++ +D K+ DFG+ +
Sbjct: 123 QM------AAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETD 173
Query: 233 --GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
G K + R M APE G T KSDV+SFGVV E+ T
Sbjct: 174 YYRKGG-KGLLPVRWM------APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-22
Identities = 81/289 (28%), Positives = 132/289 (45%), Gaps = 32/289 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G FG V++G T + VA+K +D + E + E+ +LS +PY+ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ + ++ EY+ GS D LL+ P LD I +GL+YLH + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALD-LLEPGP----LDETQIATILREILKGLDYLHSEKK---I 123
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
+RD KA+NVLL + KL+DFG+A G D +GT + APE +K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSK 181
Query: 266 SDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNY--P 323
+D++S G+ +E+ G P + L+ P P LEGNY P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP-------------PTLEGNYSKP 228
Query: 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDSLD 372
+K +A CL +E RP +++ + +K+ + + + +D
Sbjct: 229 LKEFVEA------CLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 69/201 (34%), Positives = 103/201 (51%), Gaps = 15/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+ G G + VA+K L + G FL E ++ L +P LV L Y V
Sbjct: 14 LGAGQFGEVWMGYYNG-HTKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 147 DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ I ++ EYM NGSL D L P L N + +A A G+ ++ I
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKT--PEGIKLTINKLIDMAAQIAEGMAFIERKNY---I 124
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYALTGQLT 263
+RD +A+N+L+ + K++DFGLA+L + + + R + + APE G T
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFT 181
Query: 264 AKSDVYSFGVVFLEIITGRRV 284
KSDV+SFG++ EI+T R+
Sbjct: 182 IKSDVWSFGILLTEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-22
Identities = 71/271 (26%), Positives = 115/271 (42%), Gaps = 30/271 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPY 137
+F N +G+G FG V++ + + A+KQ+D + E + E +L+ L + Y
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
++ +D + +V EY NG L L D R I GL +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQ--ILLGLAHLH 118
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+++RD K+ N+ LD N K+ D G+AKL D ++ + ++GT Y +PE
Sbjct: 119 SKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPELC 173
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317
KSDV++ GVV E TG+ P + N + +
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGK------HPFDANNQGALILKIIRGVFP-------- 219
Query: 318 LEGNYPIKGLY-QALA-VAAMCLQEEAGTRP 346
P+ +Y Q LA + CL ++ RP
Sbjct: 220 -----PVSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-22
Identities = 84/281 (29%), Positives = 129/281 (45%), Gaps = 33/281 (11%)
Query: 85 NLLGEGGFGRVYRGKL---EGTNQDVAVKQLDR-NGFQGNREFLVEVLMLSMLSNPYLVN 140
++G+G FG VY G L +G AVK L+R + +FL E +++ S+P +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 141 LVGYCVDGDQRILV-YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG--AARGLEYLH 197
L+G C+ + LV YM +G L + + N D I G A+G+EYL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL-----IGFGLQVAKGMEYL- 114
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK--LGPTGDKSHVSTRVMGTYGYCAPE 255
A ++RD A N +LD+ F K++DFGLA+ H T + A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315
T + T KSDV+SFGV+ E++T + P + + L + RR
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT-----RGAPPYPDVDSFDITVYLLQGRR------- 220
Query: 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
LL+ Y LY+ V C + RP S++V+ IE
Sbjct: 221 -LLQPEYCPDPLYE---VMLSCWHPKPEMRPTFSELVSRIE 257
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-22
Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 11/199 (5%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVG 143
LG+GGFG V +++ T + A K+LD+ +G + L E +L +S+ ++V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
D LV M G L+ H+ ++ + A GLE+LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
++YRD K NVLLD N ++SD GLA G K GT GY APE
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGEVYD 172
Query: 264 AKSDVYSFGVVFLEIITGR 282
D ++ G E+I GR
Sbjct: 173 FSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-22
Identities = 64/211 (30%), Positives = 95/211 (45%), Gaps = 24/211 (11%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-----EVLMLSMLSNPYLV 139
N +G G FG+VY T + +AVK++ Q N + E+ +L +L +P LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIR---IQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G V ++ + EY G+LE+ L + + LD + GL YLH
Sbjct: 63 KYYGVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSH 118
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRV---MGTYGYCAPE 255
+++RD K +N+ LD + KL DFG A L V GT Y APE
Sbjct: 119 G---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG--EEVQSLAGTPAYMAPE 173
Query: 256 YALTGQLTAK---SDVYSFGVVFLEIITGRR 283
G+ +D++S G V LE+ TG+R
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 3e-22
Identities = 73/258 (28%), Positives = 119/258 (46%), Gaps = 28/258 (10%)
Query: 87 LGEGGFGRVYRGKLEG---------TNQD-----VAVKQLDRNGFQGNR-EFLVEVLMLS 131
LGEG FG V+ + EG D VAVK L + + R +FL E+ ++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 132 MLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL--------LDLPPNRKALDWNTRM 183
L NP ++ L+G CV D ++ EYM NG L L N ++ +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 184 KIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243
+A A G++YL A ++RD N L+ + K++DFG+++ +GD +
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303
R + + A E L G+ T SDV++FGV E+ T + S ++EQ ++
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-VIENTGEF 248
Query: 304 FKDR-RKFTMMADPLLEG 320
F+++ R+ + PL
Sbjct: 249 FRNQGRQIYLSQTPLCPS 266
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 4e-22
Identities = 66/204 (32%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVN 140
F+ LGEG +G VY+ + T Q VA+K + +E + E+ +L +PY+V
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 141 LVG-YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G Y + D I V EY GS+ D ++ + K L I + +GLEYLH +
Sbjct: 63 YYGSYFKNTDLWI-VMEYCGAGSVSD-IMKI--TNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
I+RD KA N+LL+++ KL+DFG++ +L T K + V+GT + APE
Sbjct: 119 K---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT---VIGTPFWMAPEVIQ 172
Query: 259 TGQLTAKSDVYSFGVVFLEIITGR 282
K+D++S G+ +E+ G+
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-22
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
+ LG G +G VY G + + VAVK L + + EFL E ++ + +P LV L+G
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
C ++ E+M G+L D+L + NR+ ++ + +A + +EYL +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
I+RD A N L+ ++ K++DFGL++L TGD + APE + +
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 184
Query: 265 KSDVYSFGVVFLEIIT 280
KSDV++FGV+ EI T
Sbjct: 185 KSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 67/216 (31%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 84 DNLLGEGGFGRVYRGKLEGTN-----QDVAVKQLDRNGFQGN-REFLVEVLMLSML-SNP 136
LGEG FG+V + + G + VAVK L + + + + + E+ M+ M+ +
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 76
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHL------------LDLPPNRKALDWNTRMK 184
++NL+G C +V EY +G+L D L D P + L +
Sbjct: 77 NIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVS 136
Query: 185 IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR 244
A+ ARG+E+L A I+RD A NVL+ +D K++DFGLA+ D +T
Sbjct: 137 FAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193
Query: 245 VMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE T +SDV+SFGV+ EI T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-22
Identities = 71/201 (35%), Positives = 105/201 (52%), Gaps = 15/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+ G G + VAVK L + G FL E ++ L + LV L Y V
Sbjct: 14 LGNGQFGEVWMGTWNGNTK-VAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 147 DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
++ I +V EYM GSL D L D +AL + +A A G+ Y+ I
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKD--GEGRALKLPNLVDMAAQVAAGMAYIERMN---YI 124
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYALTGQLT 263
+RD +++N+L+ K++DFGLA+L + + + R + + APE AL G+ T
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 264 AKSDVYSFGVVFLEIITGRRV 284
KSDV+SFG++ E++T RV
Sbjct: 182 IKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-22
Identities = 65/211 (30%), Positives = 98/211 (46%), Gaps = 20/211 (9%)
Query: 87 LGEGGFGRVYRGK---LEGTNQD--VAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG+V+ + L T VAVK L ++F E +L+ L + ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN------------RKALDWNTRMKIAHGA 189
G C DGD I+V+EYM +G L L P+ + L + + IA
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
A G+ YL A ++RD N L+ + K+ DFG+++ + D V M
Sbjct: 133 ASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ PE + + T +SDV+SFGV+ EI T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 1e-21
Identities = 68/230 (29%), Positives = 116/230 (50%), Gaps = 15/230 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G G VY T Q+VA++Q++ Q +E ++ E+L++ NP +VN +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ GD+ +V EY+ GSL D + + +D + + LE+LH + VI
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VI 138
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD K+ N+LL D + KL+DFG A++ P K + ++GT + APE
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK---RSTMVGTPYWMAPEVVTRKAYGP 195
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKDRRKFTMM 313
K D++S G++ +E+I G N P L+ T TP ++ K + +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-21
Identities = 72/228 (31%), Positives = 118/228 (51%), Gaps = 15/228 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G G V+ T Q+VA+KQ++ Q +E ++ E+L++ L NP +VN +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ GD+ +V EY+ GSL D + + +D + + LE+LH + VI
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VI 137
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD K+ NVLL D + KL+DFG A++ P ++S ST V GT + APE
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKDRRKFT 311
K D++S G++ +E++ G N P L+ T TP ++ K +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 2e-21
Identities = 74/278 (26%), Positives = 123/278 (44%), Gaps = 24/278 (8%)
Query: 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
+N++ G G Y+GK VK++ D N + E+ + L +P +V
Sbjct: 693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS-----EIADMGKLQHPNIVK 747
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L+G C L++EY+ +L + L +L W R KIA G A+ L +LH
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRNL-------SWERRRKIAIGIAKALRFLHCRC 800
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
P V+ + +++D P L L L T K +S+ Y APE T
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETK 853
Query: 261 QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320
+T KSD+Y FG++ +E++TG+ D ++V WA + D M DP + G
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCH-LDMWIDPSIRG 911
Query: 321 NYPI--KGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
+ + + + + +A C + RP +DV+ +E
Sbjct: 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 63/211 (29%), Positives = 100/211 (47%), Gaps = 22/211 (10%)
Query: 86 LLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVN 140
+LGEG FG V G+L +G+ VAVK + + + EFL E + +P ++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 141 LVGYCVDGDQR------ILVYEYMPNGSLEDHLLD--LPPNRKALDWNTRMKIAHGAARG 192
L+G C + +++ +M +G L LL L + L T +K A G
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD---KSHVSTRVMGTY 249
+EYL + I+RD A N +L +D ++DFGL+K +GD + ++ +
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV--- 179
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ A E T+KSDV++FGV EI T
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-21
Identities = 66/197 (33%), Positives = 101/197 (51%), Gaps = 15/197 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V GK G DVA+K + + G EF+ E ++ LS+ LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+V EYM NG L ++L + + K + +++ G+ YL ES Q I+
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYL-ESKQ--FIH 123
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYALTGQLT 263
RD A N L+D K+SDFGL++ D + S+ +G+ + PE L + +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEVLLYSKFS 179
Query: 264 AKSDVYSFGVVFLEIIT 280
+KSDV++FGV+ E+ +
Sbjct: 180 SKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-21
Identities = 63/204 (30%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQD---VAVKQLDRNGFQGN-REFLVEVLMLSMLSNPYLVNL 141
LG+G FG V RG+ + VAVK L + +FL E ++ L + L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLD--LPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G + ++V E P GSL D L L + + ++IA G+ YL
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLE-- 114
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST---RVMGTYGYCAPEY 256
I+RD A N+LL D K+ DFGL + P + +V +V + +CAPE
Sbjct: 115 -SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 257 ALTGQLTAKSDVYSFGVVFLEIIT 280
T + SDV+ FGV E+ T
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 4e-21
Identities = 70/214 (32%), Positives = 105/214 (49%), Gaps = 25/214 (11%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNRE---FLVEVLMLSML 133
TN+ LLG+G FGRVY T +++AVKQ+ D + + +E E+ +L L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 134 SNPYLVNLVGYCVDGDQRILVY-EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARG 192
+ +V G C+ D+ + ++ EYMP GS++D L AL K G
Sbjct: 62 QHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEG 116
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK------LGPTGDKSHVSTRVM 246
+EYLH + +++RD K +N+L D N KL DFG +K TG KS V
Sbjct: 117 VEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-----VT 168
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
GT + +PE K+DV+S G +E++T
Sbjct: 169 GTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 4e-21
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLV-GYC 145
LG+G FG+VY+ + + T A K + + +F+VE+ +LS +P +V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ IL+ E+ G+L+ +L+L + L + L +LH VI
Sbjct: 73 YENKLWILI-EFCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VI 125
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT- 263
+RD KA N+LL D + KL+DFG+ AK T K +GT + APE
Sbjct: 126 HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT---FIGTPYWMAPEVVACETFKD 182
Query: 264 ----AKSDVYSFGVVFLEIITGR 282
K+D++S G+ +E+
Sbjct: 183 NPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 5e-21
Identities = 66/218 (30%), Positives = 98/218 (44%), Gaps = 38/218 (17%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGY 144
++GEG +G+VY+ + + T Q VA+K +D E E +L SN P N+ +
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHP---NIATF 68
Query: 145 ---------CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK------IAHGA 189
+ DQ LV E GS+ D + + R+K I
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV------KGLRKKGKRLKEEWIAYILRET 122
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGT 248
RGL YLHE+ VI+RD K N+LL ++ KL DFG+ A+L T + + GT
Sbjct: 123 LRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GT 176
Query: 249 YGYCAPE-----YALTGQLTAKSDVYSFGVVFLEIITG 281
+ APE A+SDV+S G+ +E+ G
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 6e-21
Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 32/280 (11%)
Query: 82 NPDNL-----LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP 136
NP L LG G FG V+ GK + VA+K + G +F+ E ++ LS+P
Sbjct: 2 NPSELTFMKELGSGQFGVVHLGKWRAQIK-VAIKAI-NEGAMSEEDFIEEAKVMMKLSHP 59
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
LV L G C +V E+M NG L ++L + L + + + G+EYL
Sbjct: 60 KLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYL 116
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
++ I+RD A N L+ K+SDFG+ + D+ S+ + PE
Sbjct: 117 ERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEV 172
Query: 257 ALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315
+ ++KSDV+SFGV+ E+ T G+ + E +++ L++
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---------- 222
Query: 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355
P L + +Y C E+ RP ++++ AI
Sbjct: 223 PKLASMTVYEVMY-------SCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 7e-21
Identities = 68/254 (26%), Positives = 123/254 (48%), Gaps = 28/254 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQD----------------VAVKQLDRNGFQGNR-EFLVEVLM 129
LGEG FG V+ + EG + VAVK L + + R +FL E+ +
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPP-------NRKALDWNTR 182
+S L +P ++ L+ C+ D ++ EYM NG L L P + + ++T
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
+ +A A G++YL + ++RD N L+ +++ K++DFG+++ +GD +
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302
R + + + E L G+ T SDV++FGV EI+T + S+ ++EQ ++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGE 248
Query: 303 LFKDRRKFTMMADP 316
F+D+ + + P
Sbjct: 249 FFRDQGRQVYLPKP 262
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 7e-21
Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGNREFLV--EVLMLSMLSNPYLVNLVG 143
LG GGFGRV K++ N+ A+K + + + ++ + E +L ++P++V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALD-WNTRMKIAHGAARGLEYLHESAQP 202
D ++ EY G L L D R D + R IA EYLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD----RGLFDEYTARFYIA-CVVLAFEYLHNRG-- 113
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
+IYRD K N+LLD + KL DFG AK +G K+ GT Y APE L
Sbjct: 114 -IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIILNKGY 169
Query: 263 TAKSDVYSFGVVFLEIITGR 282
D +S G++ E++TGR
Sbjct: 170 DFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 8e-21
Identities = 69/228 (30%), Positives = 117/228 (51%), Gaps = 15/228 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G G VY T Q+VA+KQ++ Q +E ++ E+L++ NP +VN +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ GD+ +V EY+ GSL D + + +D + + L++LH + VI
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VI 137
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD K+ N+LL D + KL+DFG A++ P ++S ST V GT + APE
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV-GTPYWMAPEVVTRKAYGP 194
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKDRRKFT 311
K D++S G++ +E++ G N P L+ T TP ++ + +
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS 242
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-20
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 15/197 (7%)
Query: 87 LGEGGFGRVYRG--KLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLVG 143
LG G FG V +G K+ DVA+K L + R E + E ++ L NPY+V ++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
C + + +LV E G L L + + + +++ H + G++YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTY--GYCAPEYALTG 260
++RD A NVLL K+SDFGL+K LG D S+ R G + + APE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALG--ADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 261 QLTAKSDVYSFGVVFLE 277
+ +++SDV+S+G+ E
Sbjct: 174 KFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 38/277 (13%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G FG VY+G T + VA+K +D + E + E+ +LS +PY+ G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ G + ++ EY+ GS D L P L+ I +GL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLKPGP-----LEETYIATILREILKGLDYLHSERK---I 123
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
+RD KA+NVLL + + KL+DFG+A G D +GT + APE K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFK 181
Query: 266 SDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNY--P 323
+D++S G+ +E+ G + P L+ +P P LEG Y P
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQYSKP 228
Query: 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
K +A CL ++ RP TA E L H
Sbjct: 229 FKEFVEA------CLNKDPRFRP------TAKELLKH 253
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 1e-20
Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN---GFQGNREFLVEVLMLSMLSNPYLVNL 141
++G+G FG+V + T + A+K +++ R L E +L L++P+LVNL
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
D + LV + + G L HL K + + I LEYLH
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHLSQ---KVKFSEEQVKFWICE-IVLALEYLHSKG- 120
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+I+RD K N+LLD+ + ++DF +A +T GT GY APE
Sbjct: 121 --IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPEVLCRQG 175
Query: 262 LTAKSDVYSFGVVFLEIITGRRVID-NSRPTEEQ 294
+ D +S GV E + G+R +SR +Q
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 18/210 (8%)
Query: 79 TNFNPDNLLGEGGFGRVYRG----KLEGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSML 133
T F +LG G FG VY+G + E VA+K+L + + N+E L E +++ +
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 66
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN---RKALDWNTRMKIAHGAA 190
NP++ L+G C+ + L+ + MP G L D++ + N + L+W ++ A
Sbjct: 67 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------A 119
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
+G+ YL E +++RD A NVL+ + K++DFGLAKL +K + +
Sbjct: 120 KGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176
Query: 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ A E L T +SDV+S+GV E++T
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 66/213 (30%), Positives = 97/213 (45%), Gaps = 36/213 (16%)
Query: 86 LLGEGGFGRVYRGKLEGTNQD----VAVKQ--LDRNGFQGN---REFLVEVLMLSMLSNP 136
LLG G FG VY EG N D AVK+ L +G G ++ E+ +LS L +P
Sbjct: 7 LLGSGSFGSVY----EGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN-TRMKIAHGAARGLEY 195
+V +G + D + E +P GSL L + + TR + GLEY
Sbjct: 63 NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEY 117
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-----GTYG 250
LH+ ++RD K +N+L+D + KL+DFG+AK V G+
Sbjct: 118 LHDRN---TVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPY 166
Query: 251 YCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
+ APE G +D++S G LE+ TG+
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 65/208 (31%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 87 LGEGGFGRVYRGKLEG--TNQD---VAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG+V+ + QD VAVK L ++F E +L+ L + ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNR---------KALDWNTRMKIAHGAARG 192
G CV+GD I+V+EYM +G L L P+ L + + IA A G
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252
+ YL A ++RD N L+ ++ K+ DFG+++ + D V M +
Sbjct: 133 MVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIIT 280
PE + + T +SDV+S GVV EI T
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 68/207 (32%), Positives = 95/207 (45%), Gaps = 33/207 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLVG 143
LG G FGRV + +G+ + A+K L + ++ L E +L + +P+LVNL G
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG---AAR---GLEYLH 197
D LV EY+P G L HL RK + R AA+ LEYLH
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL------RK----SGRFPEPVARFYAAQVVLALEYLH 118
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM---GTYGYCAP 254
++YRD K N+LLD D K++DFG AK V R GT Y AP
Sbjct: 119 SLD---IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLAP 167
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITG 281
E L+ D ++ G++ E++ G
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-20
Identities = 70/201 (34%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG+G FG V+ G GT + VA+K L + G FL E ++ L + LV L Y V
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 147 DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
++ I +V EYM GSL D L K L + +A A G+ Y+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YV 124
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYALTGQLT 263
+RD +A+N+L+ ++ K++DFGLA+L + + + R + + APE AL G+ T
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 264 AKSDVYSFGVVFLEIITGRRV 284
KSDV+SFG++ E+ T RV
Sbjct: 182 IKSDVWSFGILLTELTTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 2e-20
Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 15/197 (7%)
Query: 87 LGEGGFGRVYRG--KLEGTNQDVAVKQL--DRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
LG G FG V +G K++ + + VAVK L D N E L E ++ L NPY+V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G C + + +LV E G L L N+ + N ++ H + G++YL E+
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNI-TELVHQVSMGMKYLEETN-- 115
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYALTG 260
++RD A NVLL K+SDFGL+K D+++ + G + + APE
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 261 QLTAKSDVYSFGVVFLE 277
+ ++KSDV+SFGV+ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 2e-20
Identities = 71/211 (33%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 85 NLLGEGGFGRVYRGKL-----EGTN-QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPY 137
N LG G FG VY G G+ VAVK L + Q +EFL E ++S ++P
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA---LDWNTRMKIAHGAARGLE 194
+V L+G C+ + + ++ E M G L +L D R L + I A+G
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 195 YLHESAQPPVIYRDFKASNVLL-----DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
YL Q I+RD A N L+ D D K+ DFGLA+ D +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE L G+ T +SDV+SFGV+ EI+T
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 3e-20
Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 43/288 (14%)
Query: 87 LGEGGFGRVYRGKLEGTNQD----------------VAVKQLDRNGFQGNR-EFLVEVLM 129
LGEG FG V+ + +G VAVK L + R +FL EV +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL-------LDLPPNRKALDWNTR 182
LS LS+P + L+G C ++ EYM NG L L L N K+L ++T
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
+ +A A G+ YL ++RD N L+ +++ K++DFG+++ + D V
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEE---QNLVT 298
R + A E L G+ T KSDV++FGV EI+T R +P E Q ++
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCRE-----QPYEHLTDQQVIE 244
Query: 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP 346
A F+D + + P N P K +Y+ + C + + RP
Sbjct: 245 NAGHFFRDDGRQIYLPRP---PNCP-KDIYE---LMLECWRRDEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 4e-20
Identities = 61/205 (29%), Positives = 106/205 (51%), Gaps = 9/205 (4%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLV-EVLMLSMLSNPY 137
+F LG+G +G VY+ K NQ A+K++D + Q RE V E+ +L+ +++P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+++ +DG++ +V EY P G L + RK + +I RGL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
E +++RD K++N+LL + K+ D G++K+ K +++ +GT Y APE
Sbjct: 121 EQK---ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGR 282
+ KSD++S G + E+ T
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVG 143
+GEG +G VY+ + + T + VA+K++ F+ + L E+ +L L++P ++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKL-RFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
LV+E+M D + ++ L + + +GL + H
Sbjct: 66 VFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG--- 118
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGD--KSHVSTRVMGTYGYCAPEYALT- 259
+++RD K N+L++ + KL+DFGLA+ G +V TR Y APE L
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPELLLGD 173
Query: 260 GQLTAKSDVYSFGVVFLEIITGR 282
+ D++S G +F E+++ R
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-20
Identities = 70/201 (34%), Positives = 108/201 (53%), Gaps = 15/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG+G FG V+ G GT + VA+K L + G FL E ++ L + LV L Y V
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 147 DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
++ I +V E+M GSL D L + + K L + +A A G+ Y+ I
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKE--GDGKYLKLPQLVDMAAQIADGMAYIERMN---YI 124
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYALTGQLT 263
+RD +A+N+L+ + K++DFGLA+L + + + R + + APE AL G+ T
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 264 AKSDVYSFGVVFLEIITGRRV 284
KSDV+SFG++ E++T RV
Sbjct: 182 IKSDVWSFGILLTELVTKGRV 202
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 6e-20
Identities = 82/287 (28%), Positives = 121/287 (42%), Gaps = 35/287 (12%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYL 138
LG G FG VY G G + D VAVK L + Q +FL+E L++S ++ +
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRK---ALDWNTRMKIAHGAARGLEY 195
V L+G + R ++ E M G L+ L + P + +L + A A+G +Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNP----KLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
L E+ I+RD A N LL P K++DFG+A+ R M +
Sbjct: 132 LEENH---FIHRDIAARNCLLTCK-GPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKW 187
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310
PE L G T+K+DV+SFGV+ EI + G E VT L
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL------- 240
Query: 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357
DP P+ Y+ + C Q RP + ++ I+Y
Sbjct: 241 ----DPPKGCPGPV---YR---IMTDCWQHTPEDRPNFATILERIQY 277
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 6e-20
Identities = 62/207 (29%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSNP 136
+ LGEG +G VY+ + + T + VA+K++ + G L E+ +L L +P
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA--LREISLLKELKHP 58
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+V L+ + LV+EY L+ LD L N I + RGL Y
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLK-KYLDK--RPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H +++RD K N+L+++D KL+DFGLA+ +++ + V+ T Y APE
Sbjct: 115 H---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TLWYRAPEI 169
Query: 257 ALTGQLTAKS-DVYSFGVVFLEIITGR 282
L + + + D++S G +F E+ITG+
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-20
Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 21/212 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQD----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LGE FG++Y+G L D VA+K L D N Q EF E +++ L +P +V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN-------------RKALDWNTRMKIAHG 188
+G +++EY+ G L + L+ P+ + +LD + IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
A G+EYL + +++D A N+L+ + + K+SD GL++ + D V + +
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ PE + G+ ++ SD++SFGVV EI +
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 8e-20
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 15/213 (7%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLD-RNGFQGNREFLVEVLMLSM 132
+N LG G FG V+ K EG V VK L EF E+ M
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRK 64
Query: 133 LSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLL-----DLPPNRKALDWNTRMKIAH 187
LS+ +V L+G C + + ++ EY G L+ L D L ++ +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG 247
A G+++L + ++RD A N L+ K+S L+K + + +
Sbjct: 125 QIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSK-DVYNSEYYKLRNALI 180
Query: 248 TYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE + KSDV+SFGV+ E+ T
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 1e-19
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 13/200 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVG 143
LG+GGFG V +++ T + A K+LD+ + G + L+E +L +++P++VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 144 YCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
Y + + LV M G L+ H+ ++ + L+ + + G+ +LH
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD-- 115
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
++YRD K NVLLD N +LSD GLA G T+ GT GY APE
Sbjct: 116 -IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPY 171
Query: 263 TAKSDVYSFGVVFLEIITGR 282
+ D ++ G E++ GR
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 62/201 (30%), Positives = 100/201 (49%), Gaps = 13/201 (6%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSML-SNPYLVNL 141
+LG+G FG+V +L+G + AVK L ++ + + +VE +L++ NP+L +L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+ V E++ G L H+ D + D A GL++LH
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG- 116
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+IYRD K NV+LD+D + K++DFG+ K GD ++ GT Y APE +
Sbjct: 117 --IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAPEILQGLK 172
Query: 262 LTAKSDVYSFGVVFLEIITGR 282
T D +SFGV+ E++ G+
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 67/208 (32%), Positives = 106/208 (50%), Gaps = 27/208 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSML-SNPYLVNL 141
+LG+G FG+V+ +L+GTNQ A+K L ++ + + +VE +LS+ +P+L +L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 142 VGYCV--DGDQRILVYEYMPNGSLEDHL-----LDLPPNRKALDWNTRMKIAHGAARGLE 194
YC + V EY+ G L H+ DLP +A + + GL+
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLP---RATFYAAEIIC------GLQ 110
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
+LH ++YRD K N+LLD D + K++DFG+ K GD + GT Y AP
Sbjct: 111 FLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAP 165
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGR 282
E L + D +SFGV+ E++ G+
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 18/203 (8%)
Query: 86 LLGEGGFGRVYRG----KLEGTNQDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLVN 140
+LG G FG VY+G + E VA+K L+ G + N EF+ E L+++ + +P+LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN---RKALDWNTRMKIAHGAARGLEYLH 197
L+G C+ + LV + MP+G L D++ + N + L+W ++ A+G+ YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
E +++RD A NVL+ + K++DFGLA+L +K + + + A E
Sbjct: 127 ERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT 280
+ T +SDV+S+GV E++T
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 62/202 (30%), Positives = 99/202 (49%), Gaps = 17/202 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQG-NREFLVEVLMLSMLSNPYLVNLVGY 144
+GEG G V++ K T + VA+K++ R G + L E+ L +PY+V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDL--PPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G +LV EYMP L + L D P + RM + +G+ Y+H +
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLL-----KGVAYMHANG-- 119
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ- 261
+++RD K +N+L+ D K++DFGLA+L + S +V T Y APE L G
Sbjct: 120 -IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LYGAR 176
Query: 262 -LTAKSDVYSFGVVFLEIITGR 282
D+++ G +F E++ G
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 63/203 (31%), Positives = 105/203 (51%), Gaps = 18/203 (8%)
Query: 86 LLGEGGFGRVYRGKL----EGTNQDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLVN 140
+LG G FG VY+G E VA+K L N + N+E L E +++ + +PY+
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLL---DLPPNRKALDWNTRMKIAHGAARGLEYLH 197
L+G C+ + LV + MP G L D++ D ++ L+W ++ A+G+ YL
Sbjct: 74 LLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMSYLE 126
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
E +++RD A NVL+ + K++DFGLA+L + + + + A E
Sbjct: 127 EVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT 280
L + T +SDV+S+GV E++T
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-19
Identities = 65/200 (32%), Positives = 98/200 (49%), Gaps = 17/200 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G+G FG V G G VAVK + + + FL E +++ L + LV L+G V
Sbjct: 14 IGKGEFGDVMLGDYRGNK--VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 147 DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ + +V EYM GSL D+L R L + +K + +EYL + +
Sbjct: 70 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEANN---FV 124
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD A NVL+ +D K+SDFGL K T D + + + APE + +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKKFST 178
Query: 265 KSDVYSFGVVFLEIITGRRV 284
KSDV+SFG++ EI + RV
Sbjct: 179 KSDVWSFGILLWEIYSFGRV 198
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 70/198 (35%), Positives = 101/198 (51%), Gaps = 19/198 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVG 143
+G G FG VY + TN+ VA+K++ +G Q N ++ + EV L L +P + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ LV EY GS D +L++ ++K L I HGA +GL YLH +
Sbjct: 83 CYLREHTAWLVMEYCL-GSASD-ILEV--HKKPLQEVEIAAICHGALQGLAYLHSHER-- 136
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT---G 260
I+RD KA N+LL + KL+DFG A L S ++ V GT + APE L G
Sbjct: 137 -IHRDIKAGNILLTEPGTVKLADFGSASL-----VSPANSFV-GTPYWMAPEVILAMDEG 189
Query: 261 QLTAKSDVYSFGVVFLEI 278
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 5e-19
Identities = 67/198 (33%), Positives = 106/198 (53%), Gaps = 18/198 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+GEG FG V +G E T Q VAVK + + + FL E +++ L + LV L+G +
Sbjct: 14 IGEGEFGAVLQG--EYTGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
I V E M G+L + L R + ++ + A G+EYL ES + +++
Sbjct: 70 HNGLYI-VMELMSKGNLVNFLRT--RGRALVSVIQLLQFSLDVAEGMEYL-ESKK--LVH 123
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTG-DKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
RD A N+L+ +D K+SDFGLA++G G D S + + + APE + ++K
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSSK 177
Query: 266 SDVYSFGVVFLEIIT-GR 282
SDV+S+GV+ E+ + GR
Sbjct: 178 SDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 71/198 (35%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVG 143
+G G FG VY TN+ VAVK++ +G Q N ++ + EV L L +P + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ LV EY GS D LL++ ++K L I HGA +GL YLH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASD-LLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT---G 260
+I+RD KA N+LL + KL+DFG A KS + +GT + APE L G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSAS------KSSPANSFVGTPYWMAPEVILAMDEG 195
Query: 261 QLTAKSDVYSFGVVFLEI 278
Q K DV+S G+ +E+
Sbjct: 196 QYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 6e-19
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 19/204 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLS-NPYLVNL 141
+LG+G FG+V +L+GTN+ A+K L ++ + + +VE +L++ +P+L +L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 142 VGYCV--DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
+C + V EY+ G L H+ D A GL++LH+
Sbjct: 62 --FCTFQTKEHLFFVMEYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK 115
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
+IYRD K NVLLD+D + K++DFG+ K G+ ++ GT Y APE L
Sbjct: 116 G---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDYIAPE-ILK 169
Query: 260 GQLTAKS-DVYSFGVVFLEIITGR 282
GQ +S D +SFGV+ E++ G+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 8e-19
Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 26/214 (12%)
Query: 85 NLLGEGGFGRVYRG--KLEGTNQDVAVKQLDRNGFQGN-REFLVEVLMLSMLSN-PYLVN 140
+++GEG FG+V + K +G D A+K++ + + R+F E+ +L L + P ++N
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHL-----LDLPP-------NRKALDWNTRMKIAHG 188
L+G C L EY P+G+L D L L+ P L + A
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
ARG++YL + I+RD A N+L+ +++ K++DFGL++ G + +V + MG
Sbjct: 121 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGR 172
Query: 249 YG--YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ A E T SDV+S+GV+ EI++
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 1e-18
Identities = 70/217 (32%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNRE---FLVEVLMLSML 133
TN+ LLG+G FGRVY T +++AVKQ+ D + ++E E+ +L L
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL 61
Query: 134 SNPYLVNLVGYCVDGDQRIL--VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
+ +V G D +R L E+MP GS++D L + AL N K
Sbjct: 62 LHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILE 117
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK------LGPTGDKSHVSTRV 245
G+ YLH + +++RD K +N+L D N KL DFG +K L TG KS V
Sbjct: 118 GVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-----V 169
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
GT + +PE K+D++S G +E++T +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 1e-18
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 24/206 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQ-LDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
LGEG G V + +L+ T A+K ++ L E+ + +PY+V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 146 VD-GDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRM------KIAHGAARGLEYLH 197
+D I + EY GSL+ +K R+ KIA +GL YLH
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIY------KKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEY 256
+I+RD K SN+LL + KL DFG++ +L + + GT Y APE
Sbjct: 123 SRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPER 174
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGR 282
+ SDV+S G+ LE+ R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 1e-18
Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 29/227 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRG---KLEGTN--QDVAVKQLDRNGFQGN-REFLVEVLMLSML 133
N LGEG FG+V + +L+G VAVK L N R+ L E +L +
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL--------------------LDLPPN 173
++P+++ L G C +L+ EY GSL L P+
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 174 RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233
+AL + A +RG++YL E +++RD A NVL+ + K+SDFGL++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
D ++ + A E T +SDV+SFGV+ EI+T
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 75/289 (25%), Positives = 127/289 (43%), Gaps = 32/289 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G FG V++G T Q VA+K +D + E + E+ +LS +PY+ G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ G + ++ EY+ GS D L P D + +GL+YLH + I
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGP-----FDEFQIATMLKEILKGLDYLHSEKK---I 123
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
+RD KA+NVLL + + KL+DFG+A G D +GT + APE +K
Sbjct: 124 HRDIKAANVLLSEQGDVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSK 181
Query: 266 SDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP-- 323
+D++S G+ +E+ G + P V + P P L G +
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIPKNN---------PPTLTGEFSKP 228
Query: 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDSLD 372
K A CL ++ RP +++ + ++K+ + + + +D
Sbjct: 229 FKEFIDA------CLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-18
Identities = 62/206 (30%), Positives = 99/206 (48%), Gaps = 15/206 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVN 140
LG+G FG VY G +G +D VA+K ++ R EFL E ++ + ++V
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRK-----ALDWNTRM-KIAHGAARGLE 194
L+G G +++ E M G L+ +L L P + A +M ++A A G+
Sbjct: 74 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
YL+ + ++RD A N ++ +DF K+ DFG+ + D + + + +P
Sbjct: 134 YLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIIT 280
E G T SDV+SFGVV EI T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 71/299 (23%), Positives = 112/299 (37%), Gaps = 45/299 (15%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-------FLVEVLMLSMLSNPYL 138
++GEG +G V + + + T + VA+K F+ + + L EV +L L + +
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIK-----KFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
VNL + LV+EY+ LE LL+ P L + + + Y H
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPG--GLPPDAVRSYIWQLLQAIAYCH- 117
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+I+RD K N+L+ + KL DFG A+ S ++ V T Y APE +
Sbjct: 118 --SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLV 174
Query: 259 TGQLTAKS-DVYSFGVVFLEIITGR----------------RVIDNSRPTEEQNLVTWAT 301
K DV++ G + E++ G + + + +
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPL--PPSHQELFSSN 232
Query: 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
P F LE YP K AL CL+ + R T E L H
Sbjct: 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL------TCDELLQH 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 3e-18
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
+G+G FGRV++ + G VAVK L + +F E +++ +P +V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPP------------------NRKALDWNTR 182
L+G C G L++EYM G L + L P N L +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
+ IA A G+ YL E ++RD N L+ ++ K++DFGL++ + D S
Sbjct: 133 LCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ PE + T +SDV+++GVV EI +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 66/207 (31%), Positives = 97/207 (46%), Gaps = 19/207 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN---GFQGNREFLVEVLMLSMLSNP 136
+F LG G FGRV K +GT + A+K L + + + E +L LS+P
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDW-NTRMKIAHG-AARGLE 194
++VN++ D ++ + E++ G L HL RKA + N K H E
Sbjct: 79 FIVNMMCSFQDENRVYFLLEFVVGGELFTHL------RKAGRFPNDVAKFYHAELVLAFE 132
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
YLH +IYRD K N+LLD + K++DFG AK P D++ + GT Y AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAP 184
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITG 281
E + D ++ GV+ E I G
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 66/205 (32%), Positives = 100/205 (48%), Gaps = 21/205 (10%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM-----LSMLSN-PYLV 139
+LG+G FG+V +L+GT++ AVK L ++ + + VE M L++ P+L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDD--VECTMTEKRVLALAGKHPFLT 59
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L D+ V EY+ G L H+ D A GL++LHE
Sbjct: 60 QLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER 115
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYGYCAPEYAL 258
+IYRD K NVLLD + + K++DFG+ K G G V+T GT Y APE L
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTSTFCGTPDYIAPE-IL 168
Query: 259 TGQLTAKS-DVYSFGVVFLEIITGR 282
+ Q + D ++ GV+ E++ G+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 3e-18
Identities = 65/214 (30%), Positives = 114/214 (53%), Gaps = 26/214 (12%)
Query: 85 NLLGEGGFGRVYRGKL--EGTNQDVAVKQLDRNGFQGN-REFLVEVLMLSMLS-NPYLVN 140
+++GEG FG+V + ++ +G D A+K++ + + R+F E+ +L L +P ++N
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHL-----LDLPP-----NRKALDWNTRMKIAHGA- 189
L+G C L EY P+G+L D L L+ P N A +++ + A
Sbjct: 73 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132
Query: 190 -ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
ARG++YL +Q I+RD A N+L+ +++ K++DFGL++ G + +V + MG
Sbjct: 133 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KTMGR 184
Query: 249 YG--YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ A E T SDV+S+GV+ EI++
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 70/282 (24%), Positives = 138/282 (48%), Gaps = 40/282 (14%)
Query: 80 NFNPDNLLGEGGFGR--VYRGKLEGTNQDVAVKQLD--RNGFQGNREFLVEVLMLSMLSN 135
++ P +LG+G FG +YR + + V K+++ R + R+ L E+++LS+L +
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTED--DSLVVWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAH--GAARGL 193
P ++ + +D + ++ EY G+L D ++ +K + M + + +
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIV----RQKGQLFEEEMVLWYLFQIVSAV 114
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
Y+H++ +++RD K N+ L + KL DFG++K+ + + S T V+GT Y +
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGS-EYSMAET-VVGTPYYMS 169
Query: 254 PEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313
PE + KSD+++ G V E++T +R D + P NLV
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV--------------- 211
Query: 314 ADPLLEGNY-PIKGLYQA--LAVAAMCLQEEAGTRPMMSDVV 352
+++GNY P+ +Y + +++ LQ++ RP +V+
Sbjct: 212 --KIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 5e-18
Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVG 143
++G G FG V+ + + + V +KQ+ + E +L +LS+P ++
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLD----LPPNRKALDWNTRMKIAHGAARGLEYLHES 199
++ ++V EY P G+L +++ L L + ++ +A LH
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---------LHHV 117
Query: 200 AQPPVIYRDFKASNVLLDQDFNP-KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+++RD K N+LLD+ K+ DFG++K+ KS T V+GT Y +PE
Sbjct: 118 HTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPCYISPELCE 174
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVID 286
KSD+++ G V E+ + +R +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 6e-18
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 25/227 (11%)
Query: 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEGT-----NQDVAVKQL-DRNGFQGNREFLVE 126
E+ ++T F + LGE FG+VY+G L GT Q VA+K L D+ EF E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 127 VLMLSMLSNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPN------------ 173
+M S L +P +V L+G V +Q + +++ Y + L + L+ P+
Sbjct: 59 AMMRSRLQHPNIVCLLG-VVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 174 RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233
+ L+ + I A G+E+L + V+++D NVL+ N K+SD GL +
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
D + + + +PE + G+ + SD++S+GVV E+ +
Sbjct: 175 YAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 6e-18
Identities = 59/198 (29%), Positives = 84/198 (42%), Gaps = 17/198 (8%)
Query: 90 GGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSMLSNPYLVNLVGYC 145
G FG VY K T A+K L ++ + +M+ +PY+ L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
D LV EY+ G + L DW + IA G+E LH Q +I
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLIKTLGG--LPEDW-AKQYIAE-VVLGVEDLH---QRGII 119
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
+RD K N+L+DQ + KL+DFGL++ G + + +GT Y APE L
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKM 173
Query: 266 SDVYSFGVVFLEIITGRR 283
SD +S G V E + G
Sbjct: 174 SDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 6e-18
Identities = 65/205 (31%), Positives = 93/205 (45%), Gaps = 24/205 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM--------LSMLSNPYL 138
LG G FG+V + + T + A+K L + E VE LM + +P+L
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANSERHPFL 64
Query: 139 VNLVGYCVDGDQRI-LVYEYMPNGSLEDHL-LDLPPNRKALDWNTRMKIAHGAARGLEYL 196
VNL C + + V EY G L H+ D+ +A + A GL+YL
Sbjct: 65 VNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA------VFYAACVVLGLQYL 117
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
HE+ ++YRD K N+LLD + K++DFGL K G G ST GT + APE
Sbjct: 118 HENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG-MGFGDRTST-FCGTPEFLAPEV 172
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITG 281
T D + GV+ E++ G
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 7e-18
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 84 DNLLGEGGFGRVYRG--KLEGTNQDVAVKQLDRNGFQGN-REFLVEVLMLSMLS-NPYLV 139
++++GEG FG+V R K +G + A+K L + + R+F E+ +L L +P ++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHL-----LDLPP-------NRKALDWNTRMKIAH 187
NL+G C + + EY P G+L D L L+ P L ++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG 247
A G++YL E I+RD A NVL+ ++ K++DFGL++ G++ +V + MG
Sbjct: 127 DVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KTMG 178
Query: 248 TYG--YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ A E T KSDV+SFGV+ EI++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-------VAVKQLDRNGFQGNREFLV-EVLMLSML-SNPY 137
LGEG FG+V + G ++D VAVK L + + LV E+ M+ M+ +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHL-LDLPPN-----------RKALDWNTRMKI 185
++NL+G C ++ EY G+L ++L PP + L + +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
A+ ARG+EYL A I+RD A NVL+ +D K++DFGLA+ D +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE T +SDV+SFGV+ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 9e-18
Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 16/203 (7%)
Query: 87 LGEGGFGRV----YRGKLEGTNQDVAVKQLD-RNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG+V Y + + T + VAVK L +G + E+ +L L + +V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 142 VGYCV-DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G C DG I L+ E++P+GSL+++L P N+ ++ ++K A +G++YL
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL--- 125
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR--VMGTYGYCAPEYA 257
++RD A NVL++ + K+ DFGL K T DK + + + + + APE
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDLDSPVFWYAPECL 184
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT 280
+ + SDV+SFGV E++T
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-17
Identities = 60/193 (31%), Positives = 91/193 (47%), Gaps = 9/193 (4%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGY 144
+G G FG V+ G+L N VAVK R + +FL E +L S+P +V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
C +V E + G L P K +++ AA G+EYL ES
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPRLKV---KELIQMVENAAAGMEYL-ESKH--C 115
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
I+RD A N L+ + K+SDFG+++ G + + APE G+ ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 265 KSDVYSFGVVFLE 277
+SDV+SFG++ E
Sbjct: 176 ESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLD------RNGFQGNREFLVEVLMLSMLSNPYLVN 140
LG+GGFG V ++ T + A K+L+ R G++G +VE +L+ + + ++V+
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGA---MVEKRILAKVHSRFIVS 57
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L LV M G L H+ ++ GLE+LH
Sbjct: 58 LAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH--- 114
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLA---KLGPTGDKSHVSTRVMGTYGYCAPEYA 257
Q +IYRD K NVLLD D N ++SD GLA K G + K + GT G+ APE
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA-----GTPGFMAPELL 169
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGR 282
+ D ++ GV E+I R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-17
Identities = 68/220 (30%), Positives = 106/220 (48%), Gaps = 34/220 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-------VAVKQLDRNGFQGN-REFLVEVLMLSML-SNPY 137
LGEG FG+V + G +++ VAVK L + + + + + E+ M+ M+ +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHL-LDLPPN-----------RKALDWNTRMKI 185
++NL+G C ++ EY G+L ++L PP + L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
A+ ARG+EYL A I+RD A NVL+ +D K++DFGLA+ D H+
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-----DIHHIDYYK 197
Query: 246 MGTYG-----YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
T G + APE T +SDV+SFGV+ EI T
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 64/203 (31%), Positives = 101/203 (49%), Gaps = 26/203 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+ G + + VAVK L + G + FL E ++ L + LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTK-VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 147 DGDQRILVYEYMPNGSLEDHL-------LDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
+ ++ EYM GSL D L + LP K +D++ ++ A G+ Y+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLP---KLIDFSAQI------AEGMAYIERK 122
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYA 257
I+RD +A+NVL+ + K++DFGLA++ + + + R + + APE
Sbjct: 123 N---YIHRDLRAANVLVSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAI 176
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT 280
G T KSDV+SFG++ EI+T
Sbjct: 177 NFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 72/280 (25%), Positives = 128/280 (45%), Gaps = 31/280 (11%)
Query: 86 LLGEGGFGRVYRG--KLEGTNQD-VAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNL 141
++G G FG V+RG K+ G + VA+K L + R +FL E ++ S+ ++ L
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
G +++ EYM NG+L+ +L D + + + G A G++YL +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQL---VGMLRGIAAGMKYLSDMN- 127
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKL---GPTGDKSHVSTRVMGTYGYCAPEYAL 258
++RD A N+L++ + K+SDFGL+++ P G + ++ + APE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIA 183
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318
+ T+ SDV+SFG+V E+++ RP + + + R M P
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSF-----GERPYWDMSNHEVMKAINDGFRLPAPMDCP-- 236
Query: 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358
+YQ + C Q++ RP D+V ++ L
Sbjct: 237 ------SAVYQLM---LQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLD---RNGFQGNREFLV---EVLMLSMLSNPYL 138
+LG+G +G VY G L Q +AVKQ++ N +E+ EV +L L + +
Sbjct: 6 EVLGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
V +G C+D + + E++P GS+ L P + + +I G A YLH
Sbjct: 65 VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVA----YLHN 120
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK----LGPTGDKSHVSTRVMGTYGYCAP 254
+ V++RD K +NV+L + KL DFG A+ +G G S++ + GT + AP
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGR 282
E KSD++S G E+ TG+
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-17
Identities = 60/209 (28%), Positives = 106/209 (50%), Gaps = 16/209 (7%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQD---VAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYL 138
+ ++G G FG V RG+L+ + VA+K L ++G+ + R+FL E ++ +P +
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
++L G +++ E+M NG+L D L N + + G A G++YL E
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGAL-DSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLSE 124
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG---TYGYCAPE 255
++RD A N+L++ + K+SDFGL++ T +G + APE
Sbjct: 125 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
Query: 256 YALTGQLTAKSDVYSFGVVFLEIIT-GRR 283
+ T+ SDV+S+G+V E+++ G R
Sbjct: 182 AIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 3e-17
Identities = 67/198 (33%), Positives = 99/198 (50%), Gaps = 19/198 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVG 143
+G G FG VY + TN+ VA+K++ +G Q N ++ + EV L + +P + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ LV EY GS D LL++ ++K L I HGA +GL YLH
Sbjct: 93 CYLREHTAWLVMEYCL-GSASD-LLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT---G 260
+I+RD KA N+LL + KL+DFG A + + +GT + APE L G
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPEVILAMDEG 199
Query: 261 QLTAKSDVYSFGVVFLEI 278
Q K DV+S G+ +E+
Sbjct: 200 QYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 3e-17
Identities = 61/199 (30%), Positives = 108/199 (54%), Gaps = 17/199 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVG-YC 145
LG+G FG+VY+ K + T A K ++ + +++VE+ +L+ ++PY+V L+G +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
DG I++ E+ P G+++ +L+L +R + ++ I L+YLH +I
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIMLEL--DRGLTEPQIQV-ICRQMLEALQYLHSMK---II 132
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD KA NVLL D + KL+DFG+ AK T + +GT + APE + +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR---RDSFIGTPYWMAPEVVMCETMKD 189
Query: 265 -----KSDVYSFGVVFLEI 278
K+D++S G+ +E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE----------FLVEVLMLSMLSN 135
L+G+G +GRVY T + +AVKQ++ R E+ L L +
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
+V +G+ + + EY+P GS+ L + L R GL Y
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL---VRF-FTEQVLEGLAY 123
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
LH +++RD KA N+L+D D K+SDFG++K + + + G+ + APE
Sbjct: 124 LHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 256 YALTGQ--LTAKSDVYSFGVVFLEIITGRR 283
+ +AK D++S G V LE+ GRR
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-17
Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLD--RNGFQGNREFLVEVL-----MLSMLSNPYL 138
LG G F Y+ + T +AVKQ+ RN +E +VE L +++ L++P++
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT-SSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 139 VNLVG-YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+ ++G C D + V E+M GS+ L ++A+ + RGL YLH
Sbjct: 66 IRMLGATCEDSHFNLFV-EWMAGGSVSHLLSKYGAFKEAV----IINYTEQLLRGLSYLH 120
Query: 198 ESAQPPVIYRDFKASNVLLD---QDFNPKLSDFGLA-KLGPTGDKS-HVSTRVMGTYGYC 252
E+ +I+RD K +N+L+D Q +++DFG A +L G + +++GT +
Sbjct: 121 ENQ---IIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175
Query: 253 APEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
APE L G+ +S DV+S G V +E+ T +
Sbjct: 176 APE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 24/215 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-------VAVKQLDRNGFQGNREFLV-EVLMLSMLS-NPY 137
LGEG FG+V + G ++D VAVK L + + + LV E+ M+ M+ +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPP---------NR---KALDWNTRMKI 185
++NL+G C ++ EY G+L ++L P R + + + +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
+ ARG+EYL A I+RD A NVL+ ++ K++DFGLA+ D +T
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE T +SDV+SFGV+ EI T
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 6e-17
Identities = 63/200 (31%), Positives = 108/200 (54%), Gaps = 13/200 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
LGEG + VY+G+ T + VA+K++ + +G + E+ ++ L + +V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
++ +LV+EYM + L+ ++ D R ALD NT + +G+ + HE+ V+
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYM-DTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAK-LG-PTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
+RD K N+L+++ KL+DFGLA+ G P + S V+ T Y AP+ L +
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPV---NTFSNEVV-TLWYRAPDVLLGSRTY 178
Query: 264 AKS-DVYSFGVVFLEIITGR 282
+ S D++S G + E+ITGR
Sbjct: 179 STSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 7e-17
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 37/220 (16%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-----NREFLVEVLMLSMLS 134
+ LGEG + VY+ + + T + VA+K++ + N L E+ +L L
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 135 NPYLVNLVG-YCVDGDQRI-LVYEYMPNGSLE----DHLLDL-PPNRKALDWNTRMKIAH 187
+P ++ L+ + I LV+E+M LE D + L P + K+ T
Sbjct: 61 HPNIIGLLDVFGHK--SNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMT------ 111
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG 247
RGLEYLH + +++RD K +N+L+ D KL+DFGLA+ + ++ +V+
Sbjct: 112 --LRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS-PNRKMTHQVV- 164
Query: 248 TYGYCAPEYALTGQLTAKS-----DVYSFGVVFLEIITGR 282
T Y APE L G A+ D++S G +F E++
Sbjct: 165 TRWYRAPEL-LFG---ARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-17
Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-------VAVKQLDRNGFQGNREFLVEV--LMLSMLSNPY 137
LGEG FG+V R + G ++ VAVK L N + L+ LM + +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHL-------LDLPPN-----RKALDWNTRMKI 185
++NL+G C ++ EY G+L + L D + + L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
A+ ARG+EYL ES + I+RD A NVL+ +D K++DFGLA+ D ++
Sbjct: 140 AYQVARGMEYL-ESRR--CIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE T +SDV+SFG++ EI T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 8e-17
Identities = 65/198 (32%), Positives = 97/198 (48%), Gaps = 19/198 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVG 143
+G G FG VY + ++ VA+K++ +G Q N ++ + EV L L +P + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ LV EY GS D LL++ ++K L + HGA +GL YLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASD-LLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT---G 260
+I+RD KA N+LL + KL DFG A + + +GT + APE L G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX------FVGTPYWMAPEVILAMDEG 189
Query: 261 QLTAKSDVYSFGVVFLEI 278
Q K DV+S G+ +E+
Sbjct: 190 QYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 9e-17
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQD---------VAVKQLDRNGFQGNR-EFLVEVLMLSMLSNP 136
LG+G FG VY EG +D VAVK ++ + R EFL E ++ +
Sbjct: 14 LGQGSFGMVY----EGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCH 69
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDL------PPNRKALDWNTRMKIAHGAA 190
++V L+G G ++V E M +G L+ +L L P R +++A A
Sbjct: 70 HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
G+ YL+ ++RD A N ++ DF K+ DFG+ + D + +
Sbjct: 130 DGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE G T SD++SFGVV EI +
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 9e-17
Identities = 63/196 (32%), Positives = 99/196 (50%), Gaps = 9/196 (4%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLVGY 144
LLG+G FG V++G L+ VAVK + Q + +FL E +L +P +V L+G
Sbjct: 2 LLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
C +V E +P G D L L + L +K A AA G+ YL ES
Sbjct: 61 CTQRQPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYL-ESKN--C 114
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
I+RD A N L+ ++ K+SDFG+++ G S + + + APE G+ ++
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALNYGRYSS 173
Query: 265 KSDVYSFGVVFLEIIT 280
+SDV+S+G++ E +
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-16
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQ--LDRNGFQG---NREFLV----EVLMLSMLSNP 136
L+G G FG VY G + + +AVKQ L R L E+ +L L +
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+V +G +D D + EY+P GS+ L + + L N +I +GL YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQIL----KGLNYL 122
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-----LGPTGDKSHVSTRVMGTYGY 251
H +I+RD K +N+L+D K+SDFG++K T + + G+ +
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFW 178
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
APE T K+D++S G + +E++TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 1e-16
Identities = 69/217 (31%), Positives = 100/217 (46%), Gaps = 43/217 (19%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM---LSMLSN--PYLVN 140
+G G G+VY+ + + T +AVKQ+ R GN+E +LM + + S+ PY+V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVKQMRRT---GNKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 141 LVGYCV-DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRM----------KIAHGA 189
GY + D D I + E M + D LL R+ K+
Sbjct: 79 CYGYFITDSDVFICM-ELM--STCLDKLL------------KRIQGPIPEDILGKMTVAI 123
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
+ L YL E VI+RD K SN+LLD N KL DFG++ G D S TR G
Sbjct: 124 VKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGIS--GRLVD-SKAKTRSAGCA 178
Query: 250 GYCAPEY----ALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE + ++DV+S G+ +E+ TG+
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNREFLV-EVLM 129
F +NL LG G FG+V G ++ VAVK L RE L+ E+ +
Sbjct: 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91
Query: 130 LSMLSNPY-LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA---LDWNTRMKI 185
+S L N +VNL+G C G +++ EY G L + L RK L +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-----RRKRESFLTLEDLLSF 146
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV---S 242
++ A+G+ +L A I+RD A NVLL K+ DFGLA+ D ++V +
Sbjct: 147 SYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGN 202
Query: 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
R+ + APE T +SDV+S+G++ EI +
Sbjct: 203 ARL--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 2e-16
Identities = 66/211 (31%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNRE---FLVEVLMLSMLS 134
N+ LLG+G FGRVY T +++A KQ+ D + ++E E+ +L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 135 NPYLVNLVGYCVDGDQRILV--YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARG 192
+ +V G D ++ L EYMP GS++D L AL + K G
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILEG 118
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR-VMGTYGY 251
+ YLH + +++RD K +N+L D N KL DFG +K T S R V GT +
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYW 175
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
+PE K+DV+S G +E++T +
Sbjct: 176 MSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 41/235 (17%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLML 130
C ++ LGEG FG VY+ + T + VA+K++ +++GF L E+ +L
Sbjct: 4 CSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITA--LREIKIL 61
Query: 131 SMLSNPYLVNLVGYCVD-----GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKI 185
L +P +V L+ V+ +R VY P DH DL L N +K+
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP---YMDH--DL----SGLLENPSVKL 112
Query: 186 AHGAAR--------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL----- 232
+ G+ YLHE+ +++RD KA+N+L+D K++DFGLA+
Sbjct: 113 TESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 233 ----GPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
G G + T ++ T Y PE L + T D++ G VF E+ T R
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 3e-16
Identities = 59/201 (29%), Positives = 98/201 (48%), Gaps = 13/201 (6%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN-PYLVNL 141
+LG+G FG+V +L+GT++ A+K L ++ + + + E +L++ + P+L L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
D+ V EY+ G L + + +RK + +R A L +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG- 116
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
VIYRD K N+LLD + + KL+DFG+ K G +T GT Y APE +
Sbjct: 117 --VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQELE 172
Query: 262 LTAKSDVYSFGVVFLEIITGR 282
D ++ GV+ E++ G+
Sbjct: 173 YGPSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-16
Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNRE---FLVEVLMLSMLS 134
N+ LLG G FG VY T +++AVKQ+ D + + ++E E+ +L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 135 NPYLVNLVGYCVDGDQRIL--VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARG 192
+ +V G D +++ L EYMP GS++D L AL N + +G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQG 118
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK------LGPTGDKSHVSTRVM 246
+ YLH + +++RD K +N+L D N KL DFG +K + TG KS V
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-----VT 170
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
GT + +PE K+DV+S +E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 77/284 (27%), Positives = 133/284 (46%), Gaps = 27/284 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQ-LDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVG 143
L+GEG +G V + K + T Q VA+K+ L+ + ++ + E+ ML L + LVNL+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ LV+E++ + L+D L+ PN LD + K RG+E+ H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDD--LEKYPN--GLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
+I+RD K N+L+ Q KL DFG A+ L G+ V T + T Y APE +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTK 177
Query: 263 TAKS-DVYSFGVVFLEIITGRRVIDNSRPTEE--------QNLVTWATPLFKDRRKFTMM 313
++ D+++ G + E++TG + ++ NL+ +F+ F M
Sbjct: 178 YGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 314 ADPLLEGNYPIKGLY-----QALAVAAMCLQEEAGTRPMMSDVV 352
P ++ P++ + L +A CL+ + RP S ++
Sbjct: 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 4e-16
Identities = 66/215 (30%), Positives = 98/215 (45%), Gaps = 33/215 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQLD-----RNGFQGNREFLVEVLMLSMLSNP 136
LGEG FG V G+L NQD VAVK + R+ + +FL E + + +P
Sbjct: 7 LGEGEFGSVMEGQL---NQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHP 60
Query: 137 YLVNLVGYCVDGDQR------ILVYEYMPNGSLEDHLL-----DLPPNRKALDWNTRMKI 185
++ L+G C+ + +++ +M +G L LL D P + L +K
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP---QYLPTQMLVKF 117
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
A G+EYL + I+RD A N +L+++ N ++DFGL+K GD
Sbjct: 118 MTDIASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIA 174
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ A E T KSDV+SFGV EI T
Sbjct: 175 KMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-16
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPY 137
F +LG+GGFG V ++ T + A K+L++ + G L E +L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+VNL D LV M G L+ H+ ++ + + A GLE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLH 119
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+ +YRD K N+LLD + ++SD GLA P G+ + RV GT GY APE
Sbjct: 120 ---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGR 282
+ T D + G + E+I G+
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 24/218 (11%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLML 130
C + T F N +GEG +G VYR + + + VA+K++ +R+G + L E+ +L
Sbjct: 3 CRSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISS--LREITLL 60
Query: 131 SMLSNPYLVNLVGYCVDGDQR---ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK-IA 186
L +P +V L V G LV EY E L L N +++K +
Sbjct: 61 LNLRHPNIVELK-EVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFSESQVKCLM 114
Query: 187 HGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM 246
RGL+YLHE+ +I+RD K SN+LL K++DFGLA+ G + T +
Sbjct: 115 LQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPKV 169
Query: 247 GTYGYCAPEYAL--TGQLTAKSDVYSFGVVFLEIITGR 282
T Y APE L T TA D+++ G + E++ +
Sbjct: 170 VTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 6e-16
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 14/202 (6%)
Query: 83 PDNLLGEGGFGRVYRG---KLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYL 138
+GEG FG VY+G E VAVK RE FL E ++ +P++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
V L+G + + +V E P G L +L N+ +LD + + ++ + L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYLES 125
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV-STRVMGTYGYCAPEYA 257
++RD A NVL+ KL DFGL++ D+S+ +++ + APE
Sbjct: 126 KR---FVHRDIAARNVLVSSPDCVKLGDFGLSRY--LEDESYYKASKGKLPIKWMAPESI 180
Query: 258 LTGQLTAKSDVYSFGVVFLEII 279
+ T+ SDV+ FGV EI+
Sbjct: 181 NFRRFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 8e-16
Identities = 59/206 (28%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQD---VAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYL 138
+ ++G G FG V G+L+ + VA+K L + G+ + R+FL E ++ +P +
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNI 67
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIA---HGAARGLEY 195
++L G ++V EYM NGSL+ L RK T +++ G A G++Y
Sbjct: 68 IHLEGVVTKSKPVMIVTEYMENGSLDAFL------RKHDGQFTVIQLVGMLRGIASGMKY 121
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAP 254
L + ++RD A N+L++ + K+SDFGL++ L + ++ + + AP
Sbjct: 122 LSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIIT 280
E + T+ SDV+S+G+V E+++
Sbjct: 179 EAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
+LG+G +G VY + T +A+K++ + + E+ + S L + +V +G
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 146 VDGDQRILVYEYMPNGSLEDHLLD----LPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+ + E +P GSL L L N + + + T+ + GL+YLH++
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLHDNQ- 128
Query: 202 PPVIYRDFKASNVLLDQDFNP-KLSDFG----LAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+++RD K NVL++ K+SDFG LA + P + GT Y APE
Sbjct: 129 --IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMAPEV 180
Query: 257 ALTGQ--LTAKSDVYSFGVVFLEIITGR 282
G A +D++S G +E+ TG+
Sbjct: 181 IDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 9e-16
Identities = 61/214 (28%), Positives = 93/214 (43%), Gaps = 32/214 (14%)
Query: 87 LGEGGFGRVYRGKL-EGTNQ-DVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNLVG 143
+G G FG+V G+ G ++ V VK+L FL EV L++P ++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKAL----DWNTRMKIAHGAARGLEYLHES 199
C++ +LV E+ P G L+++L NR + + ++A A GL +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRS---NRGMVAQMAQKDVLQRMACEVASGLLWLH-- 117
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLA------KLGPTGDKSHVSTRVMGTYGYCA 253
Q I+ D N L D + K+ D+GLA T D V R + A
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR------WLA 170
Query: 254 PEYA-------LTGQLTAKSDVYSFGVVFLEIIT 280
PE L T KS+++S GV E+ T
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 37/204 (18%)
Query: 103 TNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL-VYEYM 158
T +VA+K L + + + F E + + L +P +V L+ + V+EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 159 PNGSLEDHLLD---LPPNR------KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDF 209
P +L + L LP + LD +A +G +++RD
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLD-----ALACAHNQG-----------IVHRDL 105
Query: 210 KASNVLL---DQDFNPKLSDFGLAKLGP-TGDKSHV----STRVMGTYGYCAPEYALTGQ 261
K N+++ + K+ DFG+ L P D +T V+GT YCAPE
Sbjct: 106 KPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEP 165
Query: 262 LTAKSDVYSFGVVFLEIITGRRVI 285
+T SD+Y++G++FLE +TG+RV+
Sbjct: 166 VTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 66/202 (32%), Positives = 97/202 (48%), Gaps = 17/202 (8%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVK--QLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVG 143
L+G G +G VYRGK T + VA+K LD + + EV +LS L N+
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVS-DIQREVALLSQLRQSQPPNITK 66
Query: 144 Y--C-VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
Y + G + ++ EY GS+ + P K + R + L+Y+H+
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLV-----ALKYIHKV- 120
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
VI+RD KA+N+L+ N KL DFG+A L S ST V GT + APE G
Sbjct: 121 --GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQN-SSKRSTFV-GTPYWMAPEVITEG 176
Query: 261 QL-TAKSDVYSFGVVFLEIITG 281
+ K+D++S G+ E+ TG
Sbjct: 177 KYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 63/214 (29%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNP 136
+FN +LG+G FG+V + +GT++ A+K L ++ + + +VE +L++ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 137 -YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA------ 189
+L L D+ V EY+ G L H+ + + K H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV----------GKFKEPHAVFYAAEI 110
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
A GL +LH +IYRD K NV+LD + + K++DFG+ K G K +TR GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGT 164
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE D ++FGV+ E++ G+
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 1e-15
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLV-EVLMLSMLSNPYLVNLVGY 144
+G+G FG V + + + + + K++D N + ++ LV EV +L L +P N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHP---NIVRY 64
Query: 145 C---VDGDQRIL--VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH-- 197
+D + L V EY G L + RK ++ +I L H
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD---KSHVSTRVMGTYGYCAP 254
V++RD K +N+ LD + N KL DFGLAK+ K++V GT Y +P
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSP 179
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGR 282
E KSD++S G + E+
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALS 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 34/209 (16%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-------EVLMLSMLSNPYLV 139
+GEG +G V++ + T Q VA+K+ F + + V E+ ML L +P LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK-----FVESEDDPVIKKIALREIRMLKQLKHPNLV 63
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDH--LLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
NL+ + LV+EY DH L +L N + + + KI + + + H
Sbjct: 64 NLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKS-HVSTRVMGTYGYCAP 254
+ I+RD K N+L+ + KL DFG A++ GP D + +V+TR Y AP
Sbjct: 118 KHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WYRAP 169
Query: 255 EYALTG--QLTAKSDVYSFGVVFLEIITG 281
E L G Q DV++ G VF E++TG
Sbjct: 170 EL-LVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 2e-15
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSN---PYLV 139
++G GGFG VY + T + A+K LD+ QG L E +MLS++S P++V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKI-AHGAARGLEYLHE 198
+ D+ + + M G L HL ++ + M+ A GLE++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEAEMRFYAAEIILGLEHMHN 115
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
V+YRD K +N+LLD+ + ++SD GLA + K H S +GT+GY APE
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 259 TG-QLTAKSDVYSFGVVFLEIITG 281
G + +D +S G + +++ G
Sbjct: 169 KGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 70/235 (29%), Positives = 106/235 (45%), Gaps = 26/235 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGN--REFLVEVLMLSMLSNPYLVNLVG 143
+G+GG+G+V+ K + T + VA+K++ ++ F+ N R L E +L+ + +LV L+
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 144 YCVDGDQRI-LVYEYMPNGSLEDHL--LDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
Y D+ + L EY+P G L L + A + M A A L Y+H
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIH--- 124
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
RD K N L+D + KL+DFGL+K T S V+G+ Y APE
Sbjct: 125 ------RDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-----VVGSPDYMAPEVLRGK 173
Query: 261 QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEE-QNLVTWAT----PLFKDRRKF 310
D +S G + E + G S P E +NL W P++ D R
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFN 228
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSN---PYLV 139
++G GGFG VY + T + A+K LD+ QG L E +MLS++S P++V
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKI-AHGAARGLEYLHE 198
+ D+ + + M G L HL ++ + M+ A GLE++H
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL-----SQHGVFSEKEMRFYATEIILGLEHMHN 115
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
V+YRD K +N+LLD+ + ++SD GLA + K H S +GT+GY APE
Sbjct: 116 RF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVLQ 168
Query: 259 TGQ-LTAKSDVYSFGVVFLEIITG 281
G + +D +S G + +++ G
Sbjct: 169 KGTAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 3e-15
Identities = 71/222 (31%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN--PYLVNLVGY 144
LG G +G V + + T +AVK++ ++ L+ L +SM S PY V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 145 CV-DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRM------KIAHGAARGLEYLH 197
+GD I + E M + SL+ +K D + KIA + LEYLH
Sbjct: 69 LFREGDVWICM-EVM-DTSLDKFY------KKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+ VI+RD K SNVL++++ KL DFG++ G D S T G Y APE
Sbjct: 121 S--KLSVIHRDVKPSNVLINRNGQVKLCDFGIS--GYLVD-SVAKTIDAGCKPYMAPE-R 174
Query: 258 LTGQLTA-----KSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294
+ +L KSDV+S G+ +E+ TGR D+ + +Q
Sbjct: 175 INPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 11/205 (5%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPY 137
F +LG+GGFG V ++ T + A K+L++ + G L E +L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V+L D LV M G L+ H+ + + + A GLE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
Q ++YRD K N+LLD + ++SD GLA P G + RV GT GY APE
Sbjct: 120 ---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPEVV 173
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGR 282
+ T D ++ G + E+I G+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 62/209 (29%), Positives = 105/209 (50%), Gaps = 26/209 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQ----LDRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
LG+G +G VY+ T +A+K+ LD + F + ++E+ +L +PY+V+
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFY 65
Query: 143 G-YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
G + ++G + + EYM GSL D L + + + +I + +GL++L E
Sbjct: 66 GAFFIEGAVYMCM-EYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD--KSHVSTRVMGTYGYCAPEYALT 259
+I+RD K +NVL++ + KL DFG+ +G+ S T + G Y APE +
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGV-----SGNLVASLAKTNI-GCQSYMAPERIKS 175
Query: 260 GQLTA------KSDVYSFGVVFLEIITGR 282
G +SDV+S G+ LE+ GR
Sbjct: 176 GGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 1e-14
Identities = 57/201 (28%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
+GEG +G VY+G+ + T Q VA+K++ + G + E+ +L L +P +V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IREISLLKELQHPNIVCLQ 65
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
+ + L++E++ + L+ +L LP + +D + +G+ + H
Sbjct: 66 DVLMQESRLYLIFEFL-SMDLKKYLDSLPKG-QYMDAELVKSYLYQILQGILFCH---SR 120
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
V++RD K N+L+D KL+DFGLA+ G V T + T Y APE L
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR--AFGIPVRVYTHEVVTLWYRAPEVLLGSPR 178
Query: 263 TAKS-DVYSFGVVFLEIITGR 282
+ D++S G +F E+ T +
Sbjct: 179 YSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 56/198 (28%), Positives = 95/198 (47%), Gaps = 13/198 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLVGYC 145
LG G G V + K T +A K + R + L E+ ++ +PY+V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
++ + + E+M GSL+ P + KIA GL YL+ + ++
Sbjct: 73 LNENNICMCMEFMDCGSLDRIYKKGGP----IPVEILGKIAVAVVEGLTYLYNVHR--IM 126
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK-SHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD K SN+L++ KL DFG+ +G+ + ++ +GT Y +PE G+ T
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGV-----SGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 265 KSDVYSFGVVFLEIITGR 282
KSDV+S G+ +E+ G+
Sbjct: 182 KSDVWSLGISIIELALGK 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 65/244 (26%), Positives = 115/244 (47%), Gaps = 33/244 (13%)
Query: 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVL 128
+ CV F+ +GEG +G+VY+ + + T + VA+K++ ++ GF + E+
Sbjct: 3 KRCV--DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITA--IREIK 58
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRI----------LVYEYMPN---GSLEDHLLDLPPNRK 175
+L L++ +VNL D + LV+EYM + G LE L+ +
Sbjct: 59 ILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHI 118
Query: 176 ALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235
+ MK GL Y H+ ++RD K SN+LL+ KL+DFGLA+L +
Sbjct: 119 K----SFMK---QLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGRRVIDNSRPTEEQ 294
+ + +V+ T Y PE L + + DV+S G + E+ T + + ++ +
Sbjct: 169 EESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL 227
Query: 295 NLVT 298
L++
Sbjct: 228 ELIS 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 19/206 (9%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVG 143
+ LG G FG V+ + VAVK + + G FL E ++ L + LV L
Sbjct: 11 EKKLGAGQFGEVWMATYN-KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNR----KALDWNTRMKIAHGAARGLEYLHES 199
V + ++ E+M GSL D L ++ K +D++ ++ A G+ ++
Sbjct: 69 -VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIE-- 119
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR-VMGTYGYCAPEYAL 258
Q I+RD +A+N+L+ K++DFGLA++ D + + + APE
Sbjct: 120 -QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRV 284
G T KSDV+SFG++ +EI+T R+
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRI 202
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLV--EVLMLSMLSNPYLVNLV 142
+G G FGRV+ + + A+K + + +E V E +L +S+P+++ L
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL- 66
Query: 143 GYCVDGDQRIL--VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA--ARGLEYLHE 198
+ + DQR L + EY+P G L +L R + ++ + + + LEYLH
Sbjct: 67 -FWTEHDQRFLYMLMEYVPGGELFSYL------RNSGRFSNSTGLFYASEIVCALEYLHS 119
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYGYCAPE-Y 256
++YRD K N+LLD++ + KL+DFG AK K T + GT Y APE
Sbjct: 120 KE---IVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLAPEVI 170
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITG 281
G A D ++ G++ E++ G
Sbjct: 171 QSKGHNKA-VDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-14
Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 16/208 (7%)
Query: 86 LLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVN 140
+LG+G FG V +L +G+ Q VAVK L + F + EFL E + +P ++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 141 LVGYCVDGDQR------ILVYEYMPNGSLEDHLL--DLPPNRKALDWNTRMKIAHGAARG 192
L+G + + +++ +M +G L LL + L T ++ A G
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252
+EYL + I+RD A N +L+++ ++DFGL+K +GD +
Sbjct: 126 MEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIIT 280
A E T SDV++FGV EI+T
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 32/212 (15%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-F----LVEVLMLSMLSNPYLV 139
N + EG +G VYR + + T + VA+K+L + +E F L E+ +L L +P +V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLK---MEKEKEGFPITSLREINILLKLQHPNIV 67
Query: 140 NL----VGYCVDGDQRILVYEYMPNG--SLEDHLLD--LPPNRKALDWNTRMKIAHGAAR 191
+ VG + D+ +V EY+ + SL + + L K L
Sbjct: 68 TVKEVVVG--SNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCL--------MLQLLS 117
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
G+ +LH++ +++RD K SN+LL+ K+ DFGLA+ G T+++ T Y
Sbjct: 118 GVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWY 172
Query: 252 CAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
APE L + + D++S G +F E++T +
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 64/208 (30%), Positives = 98/208 (47%), Gaps = 19/208 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSMLSNPYLVNL 141
++G G + +V +L+ +Q A+K + + + + + + SNP+LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 142 VGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
C R+ LV EY+ G L H+ RK + + R A L +LHE
Sbjct: 62 HS-CFQTTSRLFLVIEYVNGGDLMFHM---QRQRKLPEEHARFYAAE-ICIALNFLHERG 116
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAK--LGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+IYRD K NVLLD D + KL+D+G+ K LGP GD ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD---TTSTFCGTPNYIAPEILR 169
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVID 286
+ D ++ GV+ E++ GR D
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-14
Identities = 66/212 (31%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 84 DNLLGEGGFGRVYRG--KLEGTNQ-DVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYL 138
+ +LG G FG + RG KL + VA+ L R G R FL E L L + +
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRK---ALDWNTRMKIAHGAARGLEY 195
V L G G+ ++V EYM NG+L+ L RK L M + G A G++Y
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFL------RKHEGQLVAGQLMGMLPGLASGMKY 122
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG---YC 252
L E +++ A VL++ D K+S F + DKS M +
Sbjct: 123 LSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQ----EDKSEAIYTTMSGKSPVLWA 175
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIIT-GRR 283
APE ++ SDV+SFG+V E+++ G R
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.9 bits (177), Expect = 5e-14
Identities = 64/242 (26%), Positives = 95/242 (39%), Gaps = 55/242 (22%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVL----MLSMLSNP 136
F LLG+G GRV+ +L+GT + A+K LD+ R + VL +L+ L +P
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMI-KRNKVKRVLTEQEILATLDHP 61
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR----- 191
+L L LV +Y P G L LL P + + AR
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGK-------CLSEEV--ARFYAAE 111
Query: 192 ---GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK-----SHVST 243
LEYLH ++YRD K N+LL + + LSDF L+K +
Sbjct: 112 VLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 244 RVM----------------------GTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIIT 280
R GT Y APE ++G + D ++ G++ E++
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEMLY 227
Query: 281 GR 282
G
Sbjct: 228 GT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 5e-14
Identities = 54/198 (27%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLV-GYC 145
LG+G FG+VY+ + + T A K +D + +++VE+ +L+ +P +V L+ +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ + IL+ E+ G+++ +L+L + L + L YLHE+ +I
Sbjct: 73 YENNLWILI-EFCAGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---II 125
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ---- 261
+RD KA N+L D + KL+DFG++ + S +GT + APE +
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDR 183
Query: 262 -LTAKSDVYSFGVVFLEI 278
K+DV+S G+ +E+
Sbjct: 184 PYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLV 142
+LG+GGFG V ++ T + A K+L++ + G L E +L +++ ++V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
D LV M G L+ H+ ++ D + A GLE LH
Sbjct: 67 YAYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHRER-- 122
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
++YRD K N+LLD + ++SD GLA P G+ + RV GT GY APE +
Sbjct: 123 -IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPEVVKNERY 178
Query: 263 TAKSDVYSFGVVFLEIITGR 282
T D + G + E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLV 142
LLG+G FG+V + + + + A+K L + E L E +L +P+L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA--ARGLEYLHESA 200
D+ V EY+ G L HL +R+ + R + +GA L+YLH
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRF-YGAEIVSALDYLHSGK 115
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
++YRD K N++LD+D + K++DFGL K G T D + + T GT Y APE
Sbjct: 116 ---IVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKT-FCGTPEYLAPEVLEDN 170
Query: 261 QLTAKSDVYSFGVVFLEIITGR 282
D + GVV E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 6e-14
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 33/205 (16%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLSNPYLVNLVG 143
+G G +G VY+ + T + VA+K + + F E+ ML +P +V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF---EIIQQEISMLKECRHPNIVAYFG 67
Query: 144 YCVDGDQRILVYEYMPNGSLED--HLLDLPPNRKALDWNTRMKIAH---GAARGLEYLHE 198
+ D+ +V EY GSL+D + P + +IA+ +GL YLHE
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSEL--------QIAYVCRETLKGLAYLHE 119
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTR--VMGTYGYCAPE 255
+ I+RD K +N+LL +D + KL+DFG+ A+L T ++ R +GT + APE
Sbjct: 120 TG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-----IAKRKSFIGTPYWMAPE 171
Query: 256 YA---LTGQLTAKSDVYSFGVVFLE 277
A G K D+++ G+ +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 7e-14
Identities = 66/202 (32%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLV 142
LLG+G FG+V K + T + A+K L + E L E +L +P+L L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA--ARGLEYLHESA 200
D+ V EY G L HL +R+ + R + +GA L+YLH +
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARF-YGAEIVSALDYLH--S 113
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
+ V+YRD K N++LD+D + K++DFGL K G D + + T GT Y APE
Sbjct: 114 EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG-IKDGATMKT-FCGTPEYLAPEVLEDN 171
Query: 261 QLTAKSDVYSFGVVFLEIITGR 282
D + GVV E++ GR
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGR 193
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 7e-14
Identities = 60/212 (28%), Positives = 106/212 (50%), Gaps = 25/212 (11%)
Query: 85 NLLGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLV 139
+LL EG FGR++ G L G ++V VK + + + L E +L LS+ ++
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71
Query: 140 NLVGYCV-DGDQRILVYEYMPNGSLEDHLLD--LPPNRKALDWNTR--MKIAHGAARGLE 194
++ C+ DG+ ++Y YM G+L+ L L +T+ + +A A G+
Sbjct: 72 PILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS 131
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPT-----GDKSHVSTRVMGT 248
YLH+ VI++D A N ++D++ K++D L++ L P GD + + M
Sbjct: 132 YLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM-- 186
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
A E + + ++ SDV+SFGV+ E++T
Sbjct: 187 ----ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 7e-14
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 31/210 (14%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-----FLVEVLMLSMLSN---P 136
+GEG +G VY+ + T + VA+K++ + E L E+ +L L + P
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVR---VPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 137 YLVNLVGYC--VDGDQRI---LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
+V L+ C D+ + LV+E++ + L +L P L T + R
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPK--PGLPPETIKDLMRQLLR 118
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS-TRVMGTYG 250
G+++LH +++RD K N+L+ D K++DFGLA++ ++ T V+ T
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY----SFEMALTSVVVTLW 171
Query: 251 YCAPEYALTGQLTAKS--DVYSFGVVFLEI 278
Y APE L Q + + D++S G +F E+
Sbjct: 172 YRAPEVLL--QSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 9e-14
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLV 142
+LG+GGFG V ++ T + A K+L++ + G L E +L +++ ++V+L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
D LV M G L+ H+ ++ D + A GLE L
Sbjct: 67 YAYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER-- 122
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
++YRD K N+LLD + ++SD GLA P G+ V RV GT GY APE +
Sbjct: 123 -IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYMAPEVINNEKY 178
Query: 263 TAKSDVYSFGVVFLEIITGR 282
T D + G + E+I G+
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNP 136
+FN +LG+G FG+V + +GT++ A+K L ++ + + +VE +L++ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 137 YLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
+ + C R+ V EY+ G L H+ + ++ + A + GL +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP----QAVFYAAEISVGLFF 116
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYGYCAP 254
LH +IYRD K NV+LD + + K++DFG+ K V+TR GT Y AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAP 170
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292
E D +++GV+ E++ G+ D E
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 1e-13
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 28/206 (13%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
++GEG FGR + ++Q A+K++ + + +R+ E ++L+ + +P N+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK---EAVLLAKMKHP---NI 60
Query: 142 VGY--CVDGDQRI-LVYEYMPNGSLEDHLLD----LPPNRKALDWNTRMKIAHGAARGLE 194
V + + D + +V EY G L + L P L W +M + G++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQ 114
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
++HE V++RD K+ N+ L Q+ KL DFG A+L T ++ T V GT Y P
Sbjct: 115 HIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARL-LTSPGAYACTYV-GTPYYVPP 169
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIIT 280
E KSD++S G + E+ T
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 20/210 (9%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLS 134
T + +G G FG V + + T Q+VA+K++ F + E+ +L L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKLLKHLR 67
Query: 135 NPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
+ +++L + + I V E + G+ LL P L+ + RGL
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRP----LEKQFIQYFLYQILRGL 121
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
+Y+H + V++RD K SN+L++++ + K+ DFGLA++ +VSTR Y A
Sbjct: 122 KYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRA 173
Query: 254 PEYALTGQ-LTAKSDVYSFGVVFLEIITGR 282
PE LT Q + D++S G +F E++ G+
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 1e-13
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQL-DRNGFQGNREFL--VEVLMLSMLSN-PYLVNL 141
+G G FG V + + + +AVK++ + + L ++V+M S S+ PY+V
Sbjct: 11 EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS--SDCPYIVKF 68
Query: 142 VGYCV-DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRM--KIAHGAARGLEYLHE 198
G +GD I + E M + SL D + KIA + L YL E
Sbjct: 69 YGALFREGDCWICM-ELM-DISL-DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE 125
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+ +I+RD K SN+LLD++ N KL DFG++ G D S TR G Y APE
Sbjct: 126 ELK--IIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVD-SIAKTRDAGCRPYMAPERID 180
Query: 259 TGQLTA---KSDVYSFGVVFLEIITGR 282
+SDV+S G+ E+ TG+
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 1e-13
Identities = 62/208 (29%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---------GNREFLVEVLMLSMLSNPY 137
+G+G FG+VY+ + + T + A+K L + G R LV + +P+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRT---LLDESPF 57
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGAARGLE 194
+V L LV +YM G L HL +R + IA LE
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDR------AKFYIAE-LVLALE 110
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
+LH+ ++YRD K N+LLD + L DFGL+K T +K+ + GT Y AP
Sbjct: 111 HLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAP 165
Query: 255 EYALTGQ-LTAKSDVYSFGVVFLEIITG 281
E L + T D +S GV+ E+ G
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLV 142
LLG+G FG+V + + T + A+K L + E + E +L +P+L L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA--ARGLEYLHESA 200
D+ V EY G L HL +R+ + R + +GA LEYLH
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARF-YGAEIVSALEYLHSRD 115
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
V+YRD K N++LD+D + K++DFGL K G + D + + T GT Y APE
Sbjct: 116 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLAPEVLEDN 170
Query: 261 QLTAKSDVYSFGVVFLEIITGR 282
D + GVV E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 1e-13
Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPY 137
NF +GEG G V + T + VAVK++D Q RE L EV+++ +P
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPN 77
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK------IAHGAAR 191
+V + + GD+ +V E++ G+L D + +TRM + +
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVT-----------HTRMNEEQIATVCLAVLK 126
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
L +LH VI+RD K+ ++LL D KLSDFG + ++GT +
Sbjct: 127 ALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYW 181
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEIITG 281
APE + D++S G++ +E++ G
Sbjct: 182 MAPEVISRLPYGTEVDIWSLGIMVIEMVDG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-13
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 33/211 (15%)
Query: 87 LGEGGFGRVYRG--------KLEGTNQDVAV--KQLDRNGFQGNREFLVEVLMLSMLSNP 136
LG+G F +Y+G + G Q+V+V K L + + + F ++S LS+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH-RDSLAFFETASLMSQLSHK 61
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+LV L G CV D+ I+V EY+ G L D L N +L W ++ +A A L YL
Sbjct: 62 HLVKLYGVCV-RDENIMVEEYVKFGPL-DVFLHREKNNVSLHW--KLDVAKQLASALHYL 117
Query: 197 HESAQPPVIYRDFKASNVLLDQD-----FNP--KLSDFGLAKLGPTGDKSHVSTRVMGTY 249
+ +++ + N+L+ + + P KLSD G+ + R+
Sbjct: 118 EDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI--TVLSREERVERI---- 168
Query: 250 GYCAPEYALTGQ--LTAKSDVYSFGVVFLEI 278
+ APE GQ LT +D +SFG LEI
Sbjct: 169 PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 21/219 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN-PYLVNL 141
++G G + +V +L+ T + A+K + + + + E + SN P+LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 142 VGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
C + R+ V E++ G L H+ RK + + R A + L +LHE
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHM---QRQRKLPEEHARFYSAE-ISLALNFLHERG 116
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAK--LGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+IYRD K NVLLD + + KL+D+G+ K + P GD ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GD---TTSTFCGTPNYIAPEILR 169
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVID--NSRPTEEQN 295
D ++ GV+ E++ GR D +QN
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 3e-13
Identities = 59/201 (29%), Positives = 94/201 (46%), Gaps = 15/201 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN-PYLVNL 141
+LG+G FG+V +L+ + + AVK L ++ + + + E +LS+ N P+L L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 142 VGYCVDGDQRIL-VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
C R+ V E++ G L H+ + D A L +LH+
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDLMFHI----QKSRRFDEARARFYAAEITSALMFLHDKG 116
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
+IYRD K NVLLD + + KL+DFG+ K G K+ ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEM 171
Query: 261 QLTAKSDVYSFGVVFLEIITG 281
D ++ GV+ E++ G
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 4e-13
Identities = 56/162 (34%), Positives = 87/162 (53%), Gaps = 20/162 (12%)
Query: 126 EVLMLSMLSNPYLVNLVG-YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA--LDWNTR 182
E+ +L ++PY+V G + DG+ I + E+M GSL D +L +KA + N
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSL-DQVL-----KKAGRIPENIL 101
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHV 241
KI+ RGL YL E + +++RD K SN+L++ KL DFG++ +L + S V
Sbjct: 102 GKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159
Query: 242 STRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGR 282
TR Y +PE L G T +SD++S G+ +E+ GR
Sbjct: 160 GTR-----SYMSPE-RLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 5e-13
Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 22/209 (10%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-----PYLVN 140
L+G G +G+VY+G+ T Q A+K +D G + E E+ ML S+ Y
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGA 71
Query: 141 LVGYCVDG--DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+ G DQ LV E+ GS+ D + + N +W I RGL +LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLH- 128
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
Q VI+RD K NVLL ++ KL DFG+ A+L T + + +GT + APE
Sbjct: 129 --QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVI 183
Query: 258 LTGQ-----LTAKSDVYSFGVVFLEIITG 281
+ KSD++S G+ +E+ G
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 6e-13
Identities = 65/202 (32%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLV 142
LLG+G FG+V + + T + A+K L + E L E +L +P+L L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA--ARGLEYLHESA 200
D+ V EY G L HL +R+ + R + +GA L YLH
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARF-YGAEIVSALGYLHSCD 115
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
V+YRD K N++LD+D + K++DFGL K G + D + + T GT Y APE
Sbjct: 116 ---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLAPEVLEDN 170
Query: 261 QLTAKSDVYSFGVVFLEIITGR 282
D + GVV E++ GR
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN-PYLVNL 141
++G G + +V +L+ T + A+K + + + + E + SN P+LV L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 142 VGYCVDGDQRIL-VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
C + R+ V EY+ G L H+ RK + + R A + L YLHE
Sbjct: 62 HS-CFQTESRLFFVIEYVNGGDLMFHM---QRQRKLPEEHARFYSAE-ISLALNYLHERG 116
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG-PTGDKSHVSTRVMGTYGYCAPEYALT 259
+IYRD K NVLLD + + KL+D+G+ K G GD ++ GT Y APE
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGTPNYIAPEILRG 170
Query: 260 GQLTAKSDVYSFGVVFLEIITGRRVID--NSRPTEEQN 295
D ++ GV+ E++ GR D S +QN
Sbjct: 171 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 208
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+GEG G V + T + VAVK++D Q RE L EV+++ + +V++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ GD+ +V E++ G+L D + N + + + R L YLH VI
Sbjct: 89 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQG---VI 140
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV------MGTYGYCAPEYALT 259
+RD K+ ++LL D KLSDFG + VS V +GT + APE
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFC--------AQVSKEVPKRKSLVGTPYWMAPEVISR 192
Query: 260 GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292
+ D++S G++ +E+I G N P +
Sbjct: 193 LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 30/204 (14%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVK--QLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
LG G G VY+ T + +AVK LD + ++ + E+ +L +PY++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 145 CVDGDQRILVYEYMPNGSLE------DHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
++ + E+M GSL+ +H+L +IA +GL YL
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRKIPEHVLG--------------RIAVAVVKGLTYLWS 113
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+++RD K SN+L++ KL DFG++ T + ++ +GT Y APE
Sbjct: 114 LK---ILHRDVKPSNMLVNTRGQVKLCDFGVS----TQLVNSIAKTYVGTNAYMAPERIS 166
Query: 259 TGQLTAKSDVYSFGVVFLEIITGR 282
Q SDV+S G+ F+E+ GR
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 11/206 (5%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQ--LDRNGFQGNREFLVEVLMLSMLSNPY 137
NF +GEG +G VY+ + + T + VA+K+ LD + E+ +L L++P
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V L+ ++ LV+E++ + L+ + P + L +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKSYLFQLLQGLAFCH 117
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
V++RD K N+L++ + KL+DFGLA+ G T + T Y APE
Sbjct: 118 SHR---VLHRDLKPQNLLINTEGAIKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEIL 172
Query: 258 LTGQLTAKS-DVYSFGVVFLEIITGR 282
L + + + D++S G +F E++T R
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 50/154 (32%), Positives = 75/154 (48%), Gaps = 18/154 (11%)
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWN-TRMKIAHGAAR 191
P+LV L Y D ++ L+ +Y+ G L HL R+ + R+ IA
Sbjct: 63 RCPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLY----QREHFTESEVRVYIAE-IVL 116
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK--LGPTGDKSHVSTRVMGTY 249
L++LH Q +IYRD K N+LLD + + L+DFGL+K L ++++ GT
Sbjct: 117 ALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTI 170
Query: 250 GYCAPEYALTGQLTAKS--DVYSFGVVFLEIITG 281
Y APE G D +S GV+ E++TG
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 29/215 (13%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNP 136
+FN +LG+G FG+V + +GT++ A+K L ++ + + +VE +L++ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 137 YLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA------ 189
+ + C R+ V EY+ G L + + R K H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV----------GRFKEPHAVFYAAEI 110
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
A GL +LH +IYRD K NV+LD + + K++DFG+ K V+T+ GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 165 PDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 59/235 (25%), Positives = 104/235 (44%), Gaps = 15/235 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+GEG G V ++ + + VAVK++D Q RE L EV+++ + +V +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ GD+ +V E++ G+L D + N + + + + L LH VI
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQG---VI 138
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
+RD K+ ++LL D KLSDFG + ++GT + APE +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 266 SDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320
D++S G++ +E++ G N P + ++ P + K P L+G
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---PKLKNLHKVSPSLKG 248
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 62/224 (27%), Positives = 98/224 (43%), Gaps = 43/224 (19%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ----GNREFLVEVLMLSMLSNP 136
+ +G G +G V + T + VA+K++ N F R L E+ +L L +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI-SNVFDDLIDAKR-ILREIKLLRHLRHE 59
Query: 137 YLVNLVGYCVDGDQR-----ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA- 190
++ L+ +V E M DL K + + H
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELME--------TDL---HKVIKSPQPLTDDHIQYF 108
Query: 191 -----RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKS----- 239
RGL+YLH SA VI+RD K SN+L++ + + K+ DFGLA+ + P D+
Sbjct: 109 LYQILRGLKYLH-SAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 240 HVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITGR 282
+V TR Y APE L+ T D++S G +F E++T +
Sbjct: 166 YVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 58/199 (29%), Positives = 89/199 (44%), Gaps = 14/199 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLVG 143
+G+G FG+V + + T + A+K + + E L E +L+ ++ P++V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR-GLEYLHESAQP 202
++ LV ++ G L HL R+ +R + LE LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHL-----QREGRFDLSRARFYTAELLCALENLHKFN-- 113
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
VIYRD K N+LLD + L DFGL KL + GT Y APE L
Sbjct: 114 -VIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 263 TAKSDVYSFGVVFLEIITG 281
T D ++ GV+ E++TG
Sbjct: 171 TKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 76/272 (27%), Positives = 116/272 (42%), Gaps = 30/272 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNP 136
+F+ +L+G G FG V + + T A+K + ++ F E +LS+ ++P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
++ L D D LV EY P G L L NR ++ M A + +
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-----NRYEDQFDEDM-AQFYLAELVLAI 115
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFG-LAKLGPTGDKSHVSTRVMGTYGYCAPE 255
H Q ++RD K NVL+D+ + KL+DFG A+L T +K S +GT Y APE
Sbjct: 116 HSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARL--TANKMVNSKLPVGTPDYIAPE 173
Query: 256 YALTGQLTAKS------DVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309
T K D +S GV+ E+I GR P E + +R
Sbjct: 174 VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR------SPFHEGTSAKTYNNIMNFQRF 227
Query: 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEE 341
DP + ++ L Q+L +C Q+E
Sbjct: 228 LKFPEDPKVSSDF--LDLIQSL----LCGQKE 253
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 4e-12
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 16/205 (7%)
Query: 87 LGEGGFGRVYRGK-------LEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
LG+G F ++++G E +V +K LD++ + F M+S LS+ +LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G CV GD+ I+V EY+ GSL+ + L N+ ++ + ++++A A L +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTY---LKKNKNLINISWKLEVAKQLAWALHFLEDK 119
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT--YGYCAPEYA 257
+ + + A NVLL ++ + K + KL G V + + + PE
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECI 176
Query: 258 LTGQ-LTAKSDVYSFGVVFLEIITG 281
Q L+ +D +SFG EI +G
Sbjct: 177 ENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 5e-12
Identities = 60/199 (30%), Positives = 87/199 (43%), Gaps = 13/199 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVE-VLMLSMLSNPYLVNLV 142
+G+G FG+V K + + AVK L + +E + E ++L + +P+LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
D+ V +Y+ G L HL R + R A A L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHL---QRERSFPEPRARFYAAE-IASALGYLHSLN-- 116
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
+IYRD K N+LLD + L+DFGL K G K+ ++ GT Y APE
Sbjct: 117 -IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPEVLRKQPY 173
Query: 263 TAKSDVYSFGVVFLEIITG 281
D + G V E++ G
Sbjct: 174 DRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-12
Identities = 72/255 (28%), Positives = 112/255 (43%), Gaps = 26/255 (10%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-----PYLVN 140
++G G +G+VY+G+ T Q A+K +D + E +E+ ML S+ Y
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE-EEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 141 LVGYCVDG--DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+ G DQ LV E+ GS+ D + + N DW I RGL +LH
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGLAHLHA 139
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
VI+RD K NVLL ++ KL DFG+ A+L T + + +GT + APE
Sbjct: 140 HK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPEVI 193
Query: 258 LTGQ-----LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW-ATPLFKDR---R 308
+ +SD++S G+ +E+ G + + P L+ P K + +
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253
Query: 309 KFTMMADPLLEGNYP 323
KF + L NY
Sbjct: 254 KFIDFIEGCLVKNYL 268
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 32/210 (15%)
Query: 86 LLGEGGFGRVYR-GKLEGT--NQDVAVKQL--------DRNGFQGNREFLVEVLMLSMLS 134
+LG+G FG+V+ K+ G Q A+K L DR + R+ L EV +
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------N 56
Query: 135 NPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKAL--DWNTRMKIAHGAAR 191
+P++V L Y + ++ L+ +++ G L L +++ + + + + +A A
Sbjct: 57 HPFIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL-----SKEVMFTEEDVKFYLAE-LAL 109
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
L++LH +IYRD K N+LLD++ + KL+DFGL+K +K S GT Y
Sbjct: 110 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEY 164
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEIITG 281
APE T +D +SFGV+ E++TG
Sbjct: 165 MAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 13/208 (6%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYL 138
+F + LG G G V + + + + +A K + R + + E+ +L ++PY+
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 139 VNLVG-YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
V G + DG+ I + E+M GSL+ L + K + K++ RGL YL
Sbjct: 66 VGFYGAFYSDGEISICM-EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLR 120
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
E Q +++RD K SN+L++ KL DFG++ G D ++ +GT Y +PE
Sbjct: 121 EKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERL 174
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGRRVI 285
+ +SD++S G+ +E+ GR I
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 26/211 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTN-QDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN 135
+FN LG G FGRV + + VA+K+ +++ ++ E +L+ +++
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL-- 193
P+ VNL G D LV E++ G L R+ + + + A L
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFL------RRNKRFPNDVGCFYAAQIVLIF 144
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR---VMGTYG 250
EYL ++YRD K N+LLD+D K++DFG AK+ V TR + GT
Sbjct: 145 EYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPE 193
Query: 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIITG 281
Y APE L +D ++ G+ EI+ G
Sbjct: 194 YIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 1e-11
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVG-- 143
+G+G +G+VY+ + AVK LD + E E +L L N P +V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 144 YCVD---GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
Y D G Q LV E GS+ + + L + LD I +GA GL++LH +
Sbjct: 89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR 148
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
+I+RD K +N+LL + KL DFG+ A+L T + + S +GT + APE
Sbjct: 149 ---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 202
Query: 260 GQ-----LTAKSDVYSFGVVFLEIITG 281
Q A+ DV+S G+ +E+ G
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDG 229
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 38/110 (34%), Positives = 64/110 (58%), Gaps = 7/110 (6%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
RGL+YLH SA +++RD K N+L++ + K+ DFGLA++ + H++ V+ Y
Sbjct: 114 RGLKYLH-SAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY- 169
Query: 251 YCAPEYALTG--QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298
Y APE L G T+ D++S G +F E++ R + P ++ +L+T
Sbjct: 170 YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 64/238 (26%), Positives = 95/238 (39%), Gaps = 49/238 (20%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLD-----RNGFQGNREFLVEVLMLSMLS 134
+F ++G G FG V+ + + T Q A+K L + + E +L+
Sbjct: 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH--VRAERDILADAD 59
Query: 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGAAR 191
+P++V L D + LV EYMP G L + L+ P + R IA
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE-----ET-ARFYIAELVL- 112
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK------------------LG 233
L+ +H+ I+RD K N+L+D D + KL+DFGL K L
Sbjct: 113 ALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169
Query: 234 PTGDKSHVS----TRVM-----GTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITG 281
RV GT Y APE L G + D +S GV+ E++ G
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 36/94 (38%), Positives = 57/94 (60%), Gaps = 5/94 (5%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG-PTGDKSHVSTRVMGTY 249
RGL+Y+H SA V++RD K SN+LL+ + + K+ DFGLA++ P D + T + T
Sbjct: 117 RGLKYIH-SAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 250 GYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L + K+ D++S G + E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 2e-11
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 39/219 (17%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ----GNREFLVEVLMLSMLSNP 136
+ + +G G +G+V T + VA+K+L R FQ R + E+ +L + +
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRP-FQSAIHAKRTYR-ELRLLKHMDHE 74
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLED--------HLLDLPPNR----KALDWNTRMK 184
N++G L+ + P SLED HL+ N + L +
Sbjct: 75 ---NVIG---------LLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF 122
Query: 185 IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR 244
+ + RGL+Y+H SA +I+RD K SN+ +++D K+ DFGLA+ +V+TR
Sbjct: 123 LVYQILRGLKYIH-SAG--IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR 179
Query: 245 VMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGR 282
Y APE L D++S G + E++TG+
Sbjct: 180 -----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 35/224 (15%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF----QGNREFLVEVLMLSMLSN 135
+F L+ G +G VY + + T Q A+K++++ Q + F VE +L+ N
Sbjct: 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVF-VERDILTFAEN 60
Query: 136 PYLVNLVGYCVDGDQRIL--VYEYMPNG---SLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
P++V++ +C +R L V EY+ G +L ++ LP + RM A
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDM------ARMYFAE-TV 111
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG-------------PTGD 237
LEYLH +++RD K N+L+ + KL+DFGL+K+G
Sbjct: 112 LALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDT 168
Query: 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITG 281
+ + +V GT Y APE L D ++ G++ E + G
Sbjct: 169 REFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 37/96 (38%), Positives = 57/96 (59%), Gaps = 7/96 (7%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH--VSTRVMGT 248
RGL+Y+H SA VI+RD K SN+L+++D ++ DFG+A+ + H T + T
Sbjct: 118 RGLKYIH-SAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 249 YGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRR 283
Y APE L+ + T D++S G +F E++ GRR
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 49/208 (23%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLD--RNGFQGNREFLVEVLMLSMLSNPY 137
+ +GEG FG++Y K + ++ +K++D + + EV++L+ + +P
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLD----LPPNRKALDWNTRMKIAHGAARGL 193
+V + + +V EY G L + L + L W ++ + GL
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252
+++H+ +++RD K+ N+ L ++ KL DFG+A+ D ++ +GT Y
Sbjct: 115 KHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYL 169
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIIT 280
+PE K+D++S G V E+ T
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 19/207 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGY- 144
+G+G +G+V++ + AVK LD + E E +L LS+ P +V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 145 ----CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
+GDQ LV E GS+ D + + ++ I H A GL++LH +
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEY-AL 258
I+RD K +N+LL + KL DFG+ A+L T + + S +GT + APE A
Sbjct: 145 ---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS---VGTPFWMAPEVIAC 198
Query: 259 TGQL----TAKSDVYSFGVVFLEIITG 281
QL A+ DV+S G+ +E+ G
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDG 225
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 15/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
+GEG +G VY+ + + T + VA+K++ + G + E+ +L L++P +V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IREISLLKELNHPNIVRLL 64
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
++ LV+E++ + L+ ++ P LD + +G+ Y H
Sbjct: 65 DVVHSENKLYLVFEFL-DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCH---SH 118
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-Q 261
V++RD K N+L+D++ KL+DFGLA+ G T + T Y APE L Q
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLAR--AFGVPVRTYTHEVVTLWYRAPEILLGSRQ 176
Query: 262 LTAKSDVYSFGVVFLEIITGR 282
+ D++S G +F E++ R
Sbjct: 177 YSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 27/212 (12%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-----EVLMLSMLS- 134
+ P +G G +G VY+ + + VA+K + Q N + L EV +L L
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVR---VQTNEDGLPLSTVREVALLKRLEA 58
Query: 135 --NPYLVNLVGYCVDG--DQRI---LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAH 187
+P +V L+ C D+ LV+E++ + L +L +PP L T +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPP--PGLPAETIKDLMR 115
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS-TRVM 246
RGL++LH + +++RD K N+L+ KL+DFGLA++ ++ T V+
Sbjct: 116 QFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVV 168
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEI 278
T Y APE L D++S G +F E+
Sbjct: 169 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 70/286 (24%), Positives = 124/286 (43%), Gaps = 41/286 (14%)
Query: 86 LLGEGGFGRVYRGKLEGTNQD-VAVKQLD-RNGFQGN---------REFLVEVLML-SML 133
LG G FG VY+ + + Q+ +A+K+++ N G + + EV ++ L
Sbjct: 7 HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALD----WNTRMKIAHGA 189
+P +V ++ D+ +V + + L +H L ++ WN +++
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMV--- 123
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
L YLH+ + +++RD +N++L +D ++DFGLAK K T V+GT
Sbjct: 124 -LALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESK---LTSVVGTI 177
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309
Y PE K+DV++FG + ++ T P N+++ AT + +
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYSTNMLSLATKIVE---- 227
Query: 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355
+ +PL EG Y V CL +A RP + V I
Sbjct: 228 --AVYEPLPEGMYS----EDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+GEG G V + + + + VAVK +D Q RE L EV+++ + +V +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ G++ ++ E++ G+L D + N + + + + L YLH VI
Sbjct: 88 LVGEELWVLMEFLQGGALTDIVSQTRLNEEQI-----ATVCESVLQALCYLHSQG---VI 139
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD K+ ++LL D KLSDFG A++ K ++GT + APE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGT 196
Query: 265 KSDVYSFGVVFLEIITG 281
+ D++S G++ +E++ G
Sbjct: 197 EVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLVGYC 145
LGEG + VY+G+ + T+ VA+K++ +G + EV +L L + +V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
LV+EY+ + L+ +L D +++ + RGL Y H V+
Sbjct: 74 HTEKSLTLVFEYL-DKDLKQYLDDCG---NSINMHNVKLFLFQLLRGLNYCHRRK---VL 126
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTA 264
+RD K N+L+++ KL+DFGLA+ K++ + V T Y P+ L + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYST 184
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
+ D++ G +F E+ TGR + S E+ + +
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 55/222 (24%), Positives = 99/222 (44%), Gaps = 48/222 (21%)
Query: 88 GEGGFGRVYRGKLE--GTNQDVAVKQLDRNGFQGNREFLV--------EVLMLSMLSNPY 137
G G +GRVY+ K + ++ A+K+ F+G++E E+ +L L +
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKK-----FKGDKEQYTGISQSACREIALLRELKHEN 63
Query: 138 LVNLVGYCV-DGDQRI-LVYEYMPNGSLEDHLLDL-----PPNRKALDWNTRMKIAHGAA 190
+V+LV + D+ + L+++Y E L + R ++ + +
Sbjct: 64 VVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNP----KLSDFGLAKL--GP-----TGDKS 239
G+ YLH + V++RD K +N+L+ + K+ D GLA+L P D
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP- 174
Query: 240 HVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIIT 280
V+ T Y APE L + T D+++ G +F E++T
Sbjct: 175 -----VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 4e-11
Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 18/150 (12%)
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGL 193
P +V L Y V D LV ++ G L H+ P W M +A L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVA------L 98
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG-LAKLGPTGDKSHVSTRVMGTYGYC 252
+ LH ++ RD +N+LLD + +L+ F +++ + D V YC
Sbjct: 99 DALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YC 149
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIITGR 282
APE + T D +S G + E++TG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-11
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 50/218 (22%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF--------LVEVLML-SMLSNPY 137
LG+G FG VY + + T + VA+K++ ++F L EV L + +P
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM-------KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR------ 191
+V L + D+ V+EYM E +L L +RK + R
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRK------GKPFSESVIRSIIYQI 108
Query: 192 --GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK----SHVSTRV 245
GL ++H+ +RD K N+L+ K++DFGLA+ + +VSTR
Sbjct: 109 LQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYTDYVSTR- 162
Query: 246 MGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
Y APE L + ++ D+++ G + E+ T R
Sbjct: 163 ----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 6e-11
Identities = 53/232 (22%), Positives = 96/232 (41%), Gaps = 47/232 (20%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLD----RNGFQGNREF----------LVEVLM 129
LGEG +G+V + T + VA+K++ N +R+ L E+ +
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
++ + + ++ LV V+GD LV + M + DL +K +D R+ +
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMDIMAS--------DL---KKVVDRKIRLTESQVK 122
Query: 190 A------RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-------LGPTG 236
GL LH+ ++RD +N+ ++ K++DFGLA+
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179
Query: 237 DKSHVSTRVMGTYG-----YCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
+ R T Y APE + + D++S G +F E++TG+
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 46/204 (22%), Positives = 90/204 (44%), Gaps = 8/204 (3%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLS 134
NF + +G+G F VY+ + VA+K++ + + ++ L E+ +L L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
+P ++ + ++ ++ +V E G L + ++ + T K LE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
++H +++RD K +NV + KL D GL + K+ + ++GT Y +P
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSP 175
Query: 255 EYALTGQLTAKSDVYSFGVVFLEI 278
E KSD++S G + E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 59/203 (29%), Positives = 102/203 (50%), Gaps = 18/203 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQ--LDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
+GEG +G VY+ + TN+ +A+K+ L++ + E+ +L + + +V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD- 68
Query: 145 CVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRM--KIAHGAARGLEYLHESAQ 201
V ++R+ LV+EY+ + L+ H+ P K N R+ + RG+ Y H
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAK----NPRLIKTYLYQILRGIAYCHSHR- 122
Query: 202 PPVIYRDFKASNVLLDQDFNP-KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-T 259
V++RD K N+L+D+ N KL+DFGLA+ G T + T Y APE L +
Sbjct: 123 --VLHRDLKPQNLLIDRRTNALKLADFGLAR--AFGIPVRTFTHEVVTLWYRAPEILLGS 178
Query: 260 GQLTAKSDVYSFGVVFLEIITGR 282
+ D++S G +F E++ +
Sbjct: 179 RHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 62.2 bits (152), Expect = 8e-11
Identities = 67/215 (31%), Positives = 102/215 (47%), Gaps = 38/215 (17%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL-D--RNGFQGNREFLVEVLMLSMLSN-PYLVNLV 142
LG+G +G V++ T + VA+K++ D RN R F E++ L L + P +V L+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL 73
Query: 143 G-YCVDGDQRI-LVYEYMPN--------GSLED-HLLDLPPNRKALDWNTRMKIAHGAAR 191
+ D+ I LV+EYM LED H + I + +
Sbjct: 74 NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH---------------KRYIMYQLLK 118
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL---GPTGDKSHVSTRVMGT 248
L+Y+H S VI+RD K SN+LL+ D KL+DFGLA+ ++ V T + T
Sbjct: 119 ALKYIH-SGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L K D++S G + E++ G+
Sbjct: 176 RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 9e-11
Identities = 60/211 (28%), Positives = 96/211 (45%), Gaps = 33/211 (15%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV------EVLMLSMLSNPYL 138
N +G G G VY+ T + A+K + GN E V E+ +L +++P +
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-----YGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 139 VNLVG-YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
V + +G+ ++L+ E+M GSLE D +A G+ YLH
Sbjct: 135 VKCHDMFDHNGEIQVLL-EFMDGGSLE--------GTHIADEQFLADVARQILSGIAYLH 185
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEY 256
+++RD K SN+L++ N K++DFG+++ L T D + S +GT Y +PE
Sbjct: 186 RRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS---VGTIAYMSPER 239
Query: 257 ALTGQLTAK-----SDVYSFGVVFLEIITGR 282
T D++S GV LE GR
Sbjct: 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 56/213 (26%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLVGYC 145
LGEG + V++G+ + T VA+K++ +G + EV +L L + +V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
LV+EY+ + L+ ++ D + + + RGL Y H V+
Sbjct: 74 HTDKSLTLVFEYL-DKDLKQYMDDCG---NIMSMHNVKIFLYQILRGLAYCHRRK---VL 126
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTA 264
+RD K N+L+++ KL+DFGLA+ K++ + V T Y P+ L + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYST 184
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
+ D++ G +F E+ +GR + S +E +L+
Sbjct: 185 QIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.5 bits (150), Expect = 1e-10
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF--LVEVLMLSMLS-NPYLVNLVG 143
+GEG F V + + T + A+K + + F+ + L E+ L LS +P ++ L+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 144 YCVDGDQRI-----LVYEYMPNGSLEDHLLDLPPNRK-ALDWNTRMKIAHGAARGLEYLH 197
D R LV+E M + +L +L RK L + + L+++H
Sbjct: 66 VLFD---RKTGRLALVFELM-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH 117
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH------VSTRVMGTYGY 251
+ + +RD K N+L+ D KL+DFG + G S +STR Y
Sbjct: 118 RNG---IFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTR-----WY 164
Query: 252 CAPEYALT-GQLTAKSDVYSFGVVFLEIIT 280
APE LT G K D+++ G VF EI++
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 21/202 (10%)
Query: 87 LGEGGFGRVY--------RGKLEGTNQDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPY 137
LG+G FG VY + +++ V +L+ N Q N E +LS L +P
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQAN----QEAQLLSKLDHPA 63
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V ++ D ++ EY L+ L +L K L N + G+ Y+H
Sbjct: 64 IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+ +++RD KA N+ L + K+ DFG+++L ++T GT Y +PE A
Sbjct: 124 QRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPE-A 176
Query: 258 LTGQ-LTAKSDVYSFGVVFLEI 278
L Q +KSD++S G + E+
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 39/239 (16%)
Query: 67 KIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN-----R 121
K+ +Y++L LGEG + VY+G+ + T Q VA+K++ +G R
Sbjct: 3 KLETYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR 52
Query: 122 EFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG---SLEDHLLDLPPNRKALD 178
E +L L + +V L LV+EY+ ++D L +
Sbjct: 53 E----ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH----- 103
Query: 179 WNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL--AKLGPTG 236
N R+ RGL Y H Q V++RD K N+L+ + KL+DFGL AK P+
Sbjct: 104 -NVRL-FLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158
Query: 237 DKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294
S+ V+ T Y P+ L + + + D++ G +F E+ TGR + S E+Q
Sbjct: 159 TYSN---EVV-TLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 61/228 (26%), Positives = 94/228 (41%), Gaps = 43/228 (18%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN----REFLVEVLMLSMLSNPYLVNL 141
L+G+GG G VY ++ VA+K++ R N + FL E + + L +P +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAADLIHPGIVPV 67
Query: 142 VGYCVDGDQRILVYEYMP--NGSLEDHLL-------DLPPNRKALDWNTRMK----IAHG 188
C DGD VY MP G LL L K L T + I H
Sbjct: 68 YSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLS---KELAEKTSVGAFLSIFHK 121
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-------------KLGPT 235
+EY+H V++RD K N+LL + D+G A +
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178
Query: 236 GDKSHVST---RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
T +++GT Y APE L + +D+Y+ GV+ +++T
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 37/93 (39%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
RGL+Y+H SA V++RD K SN+LL+ + + K+ DFGLA+ T +K T + T
Sbjct: 119 RGLKYIH-SAN--VLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRW 173
Query: 251 YCAPEYALT-GQLTAKSDVYSFGVVFLEIITGR 282
Y APE L + T DV+S G +F E++ +
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 22/200 (11%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAK-LGPTGDKSHVSTRVMG- 247
RGL+Y+H SA V++RD K +NV ++ D K+ DFGLA+ + P SH G
Sbjct: 125 RGLKYIH-SAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDP--HYSHKGYLSEGL 179
Query: 248 -TYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305
T Y +P L+ T D+++ G +F E++TG+ + + E+ L+ + P+ +
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR 239
Query: 306 DR-RKFTMMADPLLEGNY------PIKGLYQALAVAAMCLQEEAGT-RPMMSDVVTAIEY 357
+ R + P N P++ L + A+ E+ T PM D +TA E
Sbjct: 240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPM--DRLTAEEA 297
Query: 358 LAHS--KEEACIEDSLDSCH 375
L H +C D S H
Sbjct: 298 LMHPYMSCYSCPFDEPVSLH 317
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-10
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 23/209 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVK----QLDRNGFQGNREFLVEVLMLSMLS-NPYLVNL 141
+GEG +G+VY+ + + T + VA+K ++D G L E+ +L MLS + Y+V L
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIYIVRL 66
Query: 142 VGYCVD------GDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
+ V+ G + LV+EY+ + + + + L T + +G+
Sbjct: 67 L--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVA 124
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNP-KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
+ H+ V++RD K N+L+D+ K++D GL + KS+ T + T Y A
Sbjct: 125 HCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTLWYRA 179
Query: 254 PEYALTG-QLTAKSDVYSFGVVFLEIITG 281
PE L + D++S G +F E+
Sbjct: 180 PEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-10
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 13/200 (6%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEV-LMLSMLSNPYLVNL 141
++G+G FG+V K + AVK L + +E + E ++L L +P+LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
++ V +Y+ G L HL R L+ R A A + YLH
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHL---QRERCFLEPRARFYAAE-VASAIGYLHSLN- 116
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+IYRD K N+LLD + L+DFGL K G + ++ GT Y APE
Sbjct: 117 --IIYRDLKPENILLDSQGHVVLTDFGLCKEGV--EPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 262 LTAKSDVYSFGVVFLEIITG 281
D + G V E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 59/204 (28%), Positives = 99/204 (48%), Gaps = 18/204 (8%)
Query: 86 LLGEGGFGRVYR-GKLEGTN--QDVAVKQLDRNGFQGNRE----FLVEVLMLSMLSNPYL 138
+LG+GG+G+V++ K+ G + + A+K L + N++ E +L + +P++
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDW-NTRMKIAHGAARGLEYLH 197
V+L+ G + L+ EY+ G L HL R+ + +T + LE+LH
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALEHLH 117
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+ +IYRD K N+LLD + KL+DFGL K V+ GT Y APE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEIL 172
Query: 258 LTGQLTAKSDVYSFGVVFLEIITG 281
+ D +S G + +++TG
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 13/200 (6%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEV-LMLSMLSNPYLVNL 141
++G+G FG+V K + + AVK L + +E + E ++L + +P+LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
++ V +++ G L HL R + R A A L YLH
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHL---QRERSFPEPRARFYAAE-IASALGYLHSIN- 116
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++YRD K N+LLD + L+DFGL K G +S +T GT Y APE
Sbjct: 117 --IVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 262 LTAKSDVYSFGVVFLEIITG 281
D + G V E++ G
Sbjct: 173 YDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 58/236 (24%), Positives = 112/236 (47%), Gaps = 25/236 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV---EVLMLSMLSNPYLVNLVG 143
+G G +G VY+ + T + A+K + + +F V E++M+ + +V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 144 YCVDGDQRILVYEYMPNGSLED-HLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
+ D+ + E+ GSL+D + + P + + + +R + +GL YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK- 127
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-- 259
++RD K +N+LL + + KL+DFG+ A++ T K +GT + APE A
Sbjct: 128 --MHRDIKGANILLTDNGHVKLADFGVSAQITATIAK---RKSFIGTPYWMAPEVAAVER 182
Query: 260 -GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT---WATPLFKDRRKFT 311
G D+++ G+ +E+ + + + P L+T + P KD+ K++
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 4e-10
Identities = 46/203 (22%), Positives = 91/203 (44%), Gaps = 8/203 (3%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLSN 135
NF + +G G F VYR + VA+K++ + + ++ + E+ +L L++
Sbjct: 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH 61
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
P ++ + ++ ++ +V E G L + ++ + T K +E+
Sbjct: 62 PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
+H V++RD K +NV + KL D GL + + K+ + ++GT Y +PE
Sbjct: 122 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPE 176
Query: 256 YALTGQLTAKSDVYSFGVVFLEI 278
KSD++S G + E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-10
Identities = 58/213 (27%), Positives = 103/213 (48%), Gaps = 11/213 (5%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLVGYC 145
LGEG + V++G+ + T VA+K++ +G + EV +L L + +V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
LV+EY+ + LD N ++ N ++ + RGL Y H+ ++
Sbjct: 73 HTERCLTLVFEYLDSDL--KQYLDNCGNLMSMH-NVKIFMFQ-LLRGLSYCHKRK---IL 125
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTA 264
+RD K N+L+++ KL+DFGLA+ K++ + V T Y P+ L + + +
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYST 183
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
D++ G + E+ TGR + S EE +L+
Sbjct: 184 PIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 6e-10
Identities = 59/206 (28%), Positives = 90/206 (43%), Gaps = 20/206 (9%)
Query: 87 LGEGGFGRVYRGKLEG--TNQDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLVNLVG 143
+G G FG+V G++ T V VK+L + Q +FL E L + L+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA----LDWNTRMKIAHGAARGLEYLHES 199
C + +LV E+ P G L+ + L RKA D T ++A A GL +LH++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGY---LRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA-- 257
I+ D N LL D K+ D+GL+ D ++ + APE
Sbjct: 120 N---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDE 176
Query: 258 -----LTGQLTAKSDVYSFGVVFLEI 278
L T +S+V+S GV E+
Sbjct: 177 VHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 7e-10
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 81 FNPDNLLGEGGFGRVYRGK-LEGTNQDVAVK----QLDRNGFQGNREFLVEVL-MLSMLS 134
+ +GEG +G+V++ + L+ + VA+K Q G + V VL L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 135 NPYLVNLVGYCV----DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
+P +V L C D + ++ LV+E++ + L +L +P + T +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVP--EPGVPTETIKDMMFQL 119
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
RGL++LH V++RD K N+L+ KL+DFGLA++ T V+ T
Sbjct: 120 LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTL 173
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE L D++S G +F E+ +
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 8e-10
Identities = 48/164 (29%), Positives = 86/164 (52%), Gaps = 16/164 (9%)
Query: 122 EFLVEVLMLSMLSNPYLVNLVG-YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
+ + E+ +L ++PY+V G + DG+ I + E+M GSL+ L +KA
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMDGGSLDQVL------KKAGRIP 101
Query: 181 TRM--KIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238
++ K++ +GL YL E + +++RD K SN+L++ KL DFG++ G D
Sbjct: 102 EQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS 157
Query: 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
++ +GT Y +PE + +SD++S G+ +E+ GR
Sbjct: 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEV-LMLSMLSNPYLVNL 141
++G+G FG+V + + + AVK L + +E + E ++L + +P+LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
D+ V +Y+ G L HL R L+ R A A L YLH
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAE-IASALGYLHSLN- 116
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAK--LGPTGDKSHVSTRVMGTYGYCAPEYALT 259
++YRD K N+LLD + L+DFGL K + G ++ GT Y APE
Sbjct: 117 --IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG----TTSTFCGTPEYLAPEVLHK 170
Query: 260 GQLTAKSDVYSFGVVFLEIITG 281
D + G V E++ G
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 26/228 (11%)
Query: 66 AKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE--- 122
+L + +F+ ++G G FG V + + + Q A+K L + +
Sbjct: 30 KAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAF 89
Query: 123 FLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL--VYEYMPNGSLEDHL--LDLPPNRKALD 178
F E +++ ++ ++V L + D + L V EYMP G L + + D+P
Sbjct: 90 FWEERDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-----K 142
Query: 179 WNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGD 237
W R A L+ +H I+RD K N+LLD+ + KL+DFG K+ G
Sbjct: 143 W-ARFYTAE-VVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG- 196
Query: 238 KSHVSTRVMGTYGYCAPEYALT----GQLTAKSDVYSFGVVFLEIITG 281
T V GT Y +PE + G + D +S GV E++ G
Sbjct: 197 MVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 52/203 (25%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGY 144
+GEG FG+ K + + +K+++ + E EV +LS + +P N+V Y
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHP---NIVQY 64
Query: 145 CVDGDQR---ILVYEYMPNGSLEDHLLD----LPPNRKALDWNTRMKIAHGAARGLEYLH 197
++ +V +Y G L + L P + LDW ++ +A L+++H
Sbjct: 65 QESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVH 118
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+ +++RD K+ N+ L +D KL DFG+A++ ++ +GT Y +PE
Sbjct: 119 DRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLSPEIC 173
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT 280
KSD+++ G V E+ T
Sbjct: 174 ENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 48/202 (23%), Positives = 88/202 (43%), Gaps = 8/202 (3%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLSNP 136
NF + +G G F VYR VA+K++ D + + + E+ +L L++P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
++ ++ ++ +V E G L + ++ + T K LE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H V++RD K +NV + KL D GL + + K+ + ++GT Y +PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 177
Query: 257 ALTGQLTAKSDVYSFGVVFLEI 278
KSD++S G + E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 14/201 (6%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSMLSNPYLVNL 141
++GEG +G V + + + T + VA+K+ + + N E L E+ ML L +V L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDS--EENEEVKETTLRELKMLRTLKQENIVEL 65
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+ LV+EY+ LE LL+ PN + K+ + ++ +H +
Sbjct: 66 KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPE-----KVRSYIYQLIKAIHWCHK 118
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+++RD K N+L+ + KL DFG A+ G ++ T + T Y +PE L
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAP 177
Query: 262 LTAKSDVYSFGVVFLEIITGR 282
D++S G + E+ G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 62/236 (26%), Positives = 107/236 (45%), Gaps = 39/236 (16%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
N++G G FG VY T++ VA+K++ ++ NRE L+ + L++ ++ L Y
Sbjct: 72 NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNHINIIFLKDY 127
Query: 145 ----CVDGDQRIL----VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
C +++ + V E++P ++ ++ N AL ++ R L Y+
Sbjct: 128 YYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNP-KLSDFGLAK--LGPTGDKSHVSTRVMGTYGYCA 253
H + +RD K N+L+D + + KL DFG AK L S++ +R Y A
Sbjct: 187 HSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRA 238
Query: 254 PEYAL-TGQLTAKSDVYSFGVVFLEII------TGRRVIDN--------SRPTEEQ 294
PE L T D++S G + E+I +G+ +D PTE+Q
Sbjct: 239 PELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQ 294
|
Length = 440 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-09
Identities = 69/265 (26%), Positives = 113/265 (42%), Gaps = 42/265 (15%)
Query: 80 NFNPDNLLGEGGFGRVYR-GKLEG--TNQDVAVKQLDRNGF----QGNREFLVEVLMLSM 132
NF +LG G +G+V+ K+ G + + A+K L + + E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 133 L-SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
+ +P+LV L Y D ++ L+ +Y+ G L HL R+ +
Sbjct: 61 IRQSPFLVTL-HYAFQTDTKLHLILDYINGGELFTHLS----QRERFKEQEVQIYSGEIV 115
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
LE+LH+ +IYRD K N+LLD + + L+DFGL+K D+ + GT
Sbjct: 116 LALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIE 171
Query: 251 YCAPEYALTGQLTAKS--DVYSFGVVFLEIITG-----------------RRVIDNSRPT 291
Y AP+ G D +S GV+ E++TG RR++ + P
Sbjct: 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 231
Query: 292 EEQNLVTWATPLFKDRRKFTMMADP 316
++ + L KD + +M DP
Sbjct: 232 PQE-----MSALAKDIIQRLLMKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 3e-09
Identities = 70/264 (26%), Positives = 113/264 (42%), Gaps = 42/264 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLVGYC 145
LGEG + VY+GK + + VA+K + +G + E +L L + +V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 146 VDGDQRILVYEYMPNG---SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
+ LV+EY+ ++ H L P N ++ + RGL Y+H Q
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPE------NVKLFLFQ-LLRGLSYIH---QR 122
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQ 261
+++RD K N+L+ KL+DFGLA+ SH + + T Y P+ L + +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 262 LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ-----------NLVTW----ATPLFKD 306
+ D++ G +F+E+I G + ++Q N TW + P FK
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKP 240
Query: 307 RRKFTMMADPLLEGNYPIKGLYQA 330
R FT+ Y K L QA
Sbjct: 241 ER-FTL---------YSPKNLRQA 254
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 3e-09
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVL 128
R+L + +++ ++G G FG V + + + + A+K L + + F E
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRIL--VYEYMPNGSLEDHLLDLP-PNRKALDWNTRMKI 185
+++ ++P++V L +C D + L V EYMP G L + + + P + A + + +
Sbjct: 96 IMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL 153
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTR 244
A L+ +H +I+RD K N+LLD+ + KL+DFG K+ TG T
Sbjct: 154 A------LDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-MVRCDTA 203
Query: 245 VMGTYGYCAPEYALT----GQLTAKSDVYSFGVVFLEIITG 281
V GT Y +PE + G + D +S GV E++ G
Sbjct: 204 V-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 51/236 (21%), Positives = 103/236 (43%), Gaps = 28/236 (11%)
Query: 75 CVATTNFNPDN--LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-----EV 127
C+ + + + L+ E +Y+G N++V ++ + F + L+ E+
Sbjct: 14 CIESDDIDKYTSVLIKENDQNSIYKGIFN--NKEVIIRTFKK--FHKGHKVLIDITENEI 69
Query: 128 LMLSMLSNPYLVNLVGYCVDGDQR----ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRM 183
L + + ++ + G+ +D L+ EY G L + L K L + T++
Sbjct: 70 KNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD----KEKDLSFKTKL 125
Query: 184 KIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243
+A +GL L++ P Y++ + + L+ +++ K+ GL K+ + +V+
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183
Query: 244 RVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
V Y + + + T K D+YS GVV EI TG+ +N E +L+
Sbjct: 184 MV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI 234
|
Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLV 142
++G+G +G V T + VA+K++ + F+ + L E+ +L +L +P +V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPDIVEIK 65
Query: 143 GYCVDGDQR-----ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK---IAHGAARGLE 194
+ +R +V+E M + DL KA D T + R L+
Sbjct: 66 HIMLPPSRREFKDIYVVFELMES--------DLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL----GPTGD--KSHVSTRVMGT 248
Y+H + V +RD K N+L + D K+ DFGLA++ PT +V+TR
Sbjct: 118 YIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR---- 170
Query: 249 YGYCAPEY--ALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE + + T D++S G +F E++TG+
Sbjct: 171 -WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 5e-09
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 37/212 (17%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVG 143
+G G +G V Q VAVK+L R FQ R E+ +L + + N++G
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRP-FQSLIHARRTYRELRLLKHMKHE---NVIG 78
Query: 144 YCVDGDQRILVYEYMPNGSLED-HLLDLPPNRKALDWNTRMK-----------IAHGAAR 191
L+ + P S+E+ + + L N D N +K + + R
Sbjct: 79 ---------LLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
GL+Y+H + +I+RD K SNV +++D ++ DFGLA+ +V+TR Y
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 252 CAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
APE L ++ D++S G + E++ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 7e-09
Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 16/222 (7%)
Query: 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN 135
VA+ + L G GRV+ G V +K G +G L+E ++L +++
Sbjct: 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKI----GQKGTT--LIEAMLLQNVNH 116
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
P ++ + V G +V +P+ S D L + L + + I GL Y
Sbjct: 117 PSVIRMKDTLVSGAITCMV---LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
LH +I+RD K N+ ++ + D G A+ P + + + GT APE
Sbjct: 173 LH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLG--LAGTVETNAPE 226
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
+ +K+D++S G+V E++ I P+ + V
Sbjct: 227 VLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYV 268
|
Length = 357 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 69/264 (26%), Positives = 101/264 (38%), Gaps = 56/264 (21%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDR-NGFQGNREFLV--EVLMLSMLSNPYLVNLVG 143
+G G FG V + TN A+K L + + N+ V E +L+ N ++V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYY 68
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
D D V +Y+P G + L+ L A R IA +E +H+
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-----RFYIAE-LTCAIESVHKMG- 121
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGL---------AKLGPTGDKSHVS---------- 242
I+RD K N+L+D+D + KL+DFGL +K GD
Sbjct: 122 --FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 243 -----------------TRVM-----GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
R + GT Y APE L T D +S GV+ E++
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 281 GRRVIDNSRPTEEQ-NLVTWATPL 303
G+ P E Q ++ W T L
Sbjct: 240 GQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 36/224 (16%)
Query: 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSM 132
E+ N +P +G G +G V T VAVK+L R FQ L +
Sbjct: 14 EVPERYQNLSP---VGSGAYGSVCAAFDTKTGLRVAVKKLSRP-FQSIIHAKRTYRELRL 69
Query: 133 LSNPYLVNLVGYCVDGDQRILVYEYMPNGSLED--------HLLDLPPN-----RKALDW 179
L + N++G L+ + P SLE+ HL+ N +K D
Sbjct: 70 LKHMKHENVIG---------LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 120
Query: 180 NTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239
+ + I + RGL+Y+H + +I+RD K SN+ +++D K+ DFGLA+
Sbjct: 121 HVQFLI-YQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTG 176
Query: 240 HVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGR 282
+V+TR Y APE L D++S G + E++TGR
Sbjct: 177 YVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 52/210 (24%), Positives = 97/210 (46%), Gaps = 36/210 (17%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFL-VEVLMLSMLSNPYLVN---- 140
+G+G +G V + + +K+L+ RN + R+ E +LS L +P +V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 141 ----------LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
++G+C GD +Y L++ L P + ++W ++ +A
Sbjct: 68 WEGEDGLLYIVMGFCEGGD----LYH-----KLKEQKGKLLPENQVVEWFVQIAMA---- 114
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
L+YLHE +++RD K NV L + K+ D G+A++ ++ +++ ++GT
Sbjct: 115 --LQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIGTPY 167
Query: 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
Y +PE KSDV++ G E+ T
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 3e-08
Identities = 67/272 (24%), Positives = 103/272 (37%), Gaps = 68/272 (25%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---------QGNREFLVEVLMLSMLSNPY 137
LG G FG V + T A+K L + + R+ L E N +
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA------DNEW 62
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V L D D V +Y+P G + L+ + + L R IA +E +H
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIAELTC-AVESVH 118
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL---------AKLGPTGD----------- 237
+ I+RD K N+L+D+D + KL+DFGL +K +GD
Sbjct: 119 KMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSN 175
Query: 238 ----------------------KSH---VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFG 272
+ H ++ ++GT Y APE L T D +S G
Sbjct: 176 EWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235
Query: 273 VVFLEIITGRRVIDNSRPTEEQ-NLVTWATPL 303
V+ E++ G+ P E Q ++ W T L
Sbjct: 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 3e-08
Identities = 61/222 (27%), Positives = 99/222 (44%), Gaps = 39/222 (17%)
Query: 80 NFNPDNLLGEGGFGRVYR-GKLEG--TNQDVAVKQLDRNGFQGNREFLVE-------VLM 129
NF +LG G +G+V+ K+ G T + A+K L + + VE VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALV-QKAKTVEHTRTERNVLE 59
Query: 130 LSMLSNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG 188
+ +P+LV L Y + ++ L+ +Y+ G + HL R +
Sbjct: 60 H-VRQSPFLVTL-HYAFQTEAKLHLILDYVSGGEMFTHLYQ------------RDNFSED 105
Query: 189 AAR--------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
R LE+LH+ ++YRD K N+LLD + + L+DFGL+K + +K
Sbjct: 106 EVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITG 281
+ GT Y APE K+ D +S G++ E++TG
Sbjct: 163 TYS-FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 13/216 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYC 145
LGEG + VY+G Q VA+K + +G + E +L L + +V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ V+EYM + L +++ P +N R+ + RGL Y+H ++
Sbjct: 73 HTKETLTFVFEYM-HTDLAQYMIQHPGGLHP--YNVRLFMFQ-LLRGLAYIHGQH---IL 125
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
+RD K N+L+ KL+DFGLA+ +++ S V T Y P+ L G
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPD-VLLGATDYS 182
Query: 266 S--DVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW 299
S D++ G +F+E++ G+ EQ W
Sbjct: 183 SALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 37/193 (19%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
+G+G FG V++ + + T Q VA+K++ ++ GF L E+ +L +L + +VNL+
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITA--LREIKILQLLKHENVVNLI 77
Query: 143 GYCV--------DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA---- 190
C LV+E+ E L L N+ N + ++
Sbjct: 78 EICRTKATPYNRYKGSFYLVFEF-----CEHDLAGLLSNK-----NVKFTLSEIKKVMKM 127
Query: 191 --RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK---LGPTGDKSHVSTRV 245
GL Y+H + +++RD KA+N+L+ +D KL+DFGLA+ L + + RV
Sbjct: 128 LLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 246 MGTYGYCAPEYAL 258
+ T Y PE L
Sbjct: 185 V-TLWYRPPELLL 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 68/269 (25%), Positives = 105/269 (39%), Gaps = 62/269 (23%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVL----MLSMLSNPYLVNLV 142
LG G FG V T+ A+K L + NR + V +L+ N ++V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVL-NRNQVAHVKAERDILAEADNEWVVKLY 67
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESA 200
D D V +Y+P G + L+ + P A + + +A +E +H+
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLA------IESVHKMG 121
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLA---------------------KLGPT---- 235
I+RD K N+L+D D + KL+DFGL + P+
Sbjct: 122 ---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWD 178
Query: 236 -------GD----------KSH---VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVF 275
GD K H ++ ++GT Y APE L T D +S GV+
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238
Query: 276 LEIITGRRVIDNSRPTEEQ-NLVTWATPL 303
E++ G+ PTE Q ++ W L
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 6e-08
Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 20/199 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGY 144
+G G +G VY+ + T + AVK + G+ L+ E+ M+ + +V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLE--PGDDFSLIQQEIFMVKECKHCNIVAYFGS 74
Query: 145 CVDGDQRILVYEYMPNGSLED-HLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ ++ + EY GSL+D + + P + + + R + +GL YLH +
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK-- 127
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYAL---T 259
++RD K +N+LL + + KL+DFG+ AK+ T K +GT + APE A
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAK---RKSFIGTPYWMAPEVAAVEKN 183
Query: 260 GQLTAKSDVYSFGVVFLEI 278
G D+++ G+ +E+
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
+GEG +G V++ K T++ VA+K++ D G + L E+ +L L + +V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA--LREICLLKELKHKNIVRLY 65
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA--------RGLE 194
+ LV+EY DL +K D + I +GL
Sbjct: 66 DVLHSDKKLTLVFEYCDQ--------DL---KKYFD-SCNGDIDPEIVKSFMFQLLKGLA 113
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
+ H V++RD K N+L++++ KL+DFGLA+ + + S V+ T Y P
Sbjct: 114 FCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY-SAEVV-TLWYRPP 168
Query: 255 EYALTGQLTAKS-DVYSFGVVFLEIITGRR 283
+ +L + S D++S G +F E+ R
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 1e-07
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 33/212 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVA---VKQLDRN-GFQGNREFLVEVLMLSMLSNPYLVNLV 142
+G G FG+V ++ T+ VA VK+L N + EFL + +L +P ++ +
Sbjct: 3 IGNGWFGKVLLSEIY-TDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G CV+ +LV+EY G L+ +L +R+ ++A A G+ ++H+
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN-- 119
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP---------TGDKSHVSTRVMGTYGYCA 253
++ D N L D K+ D+G +GP T D V R + A
Sbjct: 120 -FLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKEDYIETEDDKCVPLR------WLA 169
Query: 254 PEYA-------LTGQLTAKSDVYSFGVVFLEI 278
PE +T + T S+V++ GV E+
Sbjct: 170 PELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 31/93 (33%), Positives = 51/93 (54%), Gaps = 9/93 (9%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
+GL+Y+H + +I+RD K N+ +++D K+ DFGLA+ + +V TR
Sbjct: 129 KGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----W 180
Query: 251 YCAPEYALTG-QLTAKSDVYSFGVVFLEIITGR 282
Y APE L T D++S G + E++TG+
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 43/199 (21%)
Query: 103 TNQDVAVKQLDRNGFQGN-------REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155
T Q+VA+K+L R FQ RE VLM + N++G L+
Sbjct: 40 TGQNVAIKKLSRP-FQNVTHAKRAYREL---VLMKLVNHK----NIIG---------LLN 82
Query: 156 EYMPNGSLEDHLLDLPPNRKALDWN----TRMKIAHGAAR--------GLEYLHESAQPP 203
+ P SLE+ D+ + +D N +M + H G+++LH +
Sbjct: 83 VFTPQKSLEE-FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG--- 138
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
+I+RD K SN+++ D K+ DFGLA+ T S + T + T Y APE L
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYYRAPEVILGMGYK 195
Query: 264 AKSDVYSFGVVFLEIITGR 282
D++S G + E+I G
Sbjct: 196 ENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 18/218 (8%)
Query: 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVL 128
R+L + ++ ++G G FG V + + T + A+K L + + F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLP-PNRKALDWNTRMKIAH 187
+++ ++P++V L D +V EYMP G L + + + P + A + + +A
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG 247
A + ++H RD K N+LLD+ + KL+DFG T V G
Sbjct: 156 DAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-G 205
Query: 248 TYGYCAPEYALT----GQLTAKSDVYSFGVVFLEIITG 281
T Y +PE + G + D +S GV E++ G
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV---STRVM 246
ARG+E+L A I+RD A N+LL ++ K+ DFGLA+ D +V S R+
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGSARL- 238
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE T +SDV+SFGV+ EI +
Sbjct: 239 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 64/254 (25%), Positives = 97/254 (38%), Gaps = 72/254 (28%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---------QGNREFLVEVLML 130
+F ++G G FG V + + T A+K+L ++ + R+ L E
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA--- 58
Query: 131 SMLSNPYLVNLVGYCV--DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN-TRMKIAH 187
NP++V L Y D + L+ EY+P G + L+ + TR IA
Sbjct: 59 ---DNPWVVKL--YYSFQDENYLYLIMEYLPGGDMMTLLM----KKDTFTEEETRFYIAE 109
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG-DKSHVST--- 243
++ +H + I+RD K N+LLD + KLSDFGL TG KSH +
Sbjct: 110 -TILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLC----TGLKKSHRTEFYR 161
Query: 244 -------------------------------RVM-----GTYGYCAPEYALTGQLTAKSD 267
R + GT Y APE L + D
Sbjct: 162 ILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECD 221
Query: 268 VYSFGVVFLEIITG 281
+S GV+ E++ G
Sbjct: 222 WWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
GL+Y+H + +I+RD K N+ +++D K+ DFGLA+ +V TR
Sbjct: 128 CGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----W 179
Query: 251 YCAPEYALTG-QLTAKSDVYSFGVVFLEIITGR 282
Y APE L D++S G + E++TG+
Sbjct: 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-07
Identities = 33/151 (21%), Positives = 55/151 (36%), Gaps = 17/151 (11%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLV-NLVG 143
LL G RVY L ++D +K +RE EV +L +L V ++
Sbjct: 5 LLKGGLTNRVYL--LGTKDEDYVLKINPSREKGADRER--EVAILQLLARKGLPVPKVLA 60
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
L+ E++ +L++ + IA A L LH+
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKE-----------DIAEQLAELLAKLHQLPLLV 109
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
+ + D N+L+D + D+ A GP
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 30/91 (32%), Positives = 47/91 (51%)
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
+H +I+RD K++N+LL + KL DFG +K+ V GT Y APE
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRRVID 286
+ K+D++S GV+ E++T +R D
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 35/98 (35%), Positives = 54/98 (55%), Gaps = 8/98 (8%)
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK---LGPTGDKSHVSTRVMG 247
GL+Y+H SA V++RD K N+L++ D K+ DFGLA+ P + + T +
Sbjct: 116 CGLKYIH-SAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171
Query: 248 TYGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGRRV 284
T Y APE L+ Q K+ DV+S G + E++ + V
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 35/94 (37%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV---STRVM 246
ARG+E+L A I+RD A N+LL ++ K+ DFGLA+ D +V R+
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 237
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE T +SDV+SFGV+ EI +
Sbjct: 238 -PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 6e-07
Identities = 38/127 (29%), Positives = 60/127 (47%), Gaps = 7/127 (5%)
Query: 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214
Y+ + +++ L D + L + + ARG+E+L A ++RD A NV
Sbjct: 214 YKGSNDSEVKNLLSD--DGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 215 LLDQDFNPKLSDFGLAKLGPTGDKSHVST-RVMGTYGYCAPEYALTGQLTAKSDVYSFGV 273
LL Q K+ DFGLA+ D ++VS + APE T SDV+S+G+
Sbjct: 269 LLAQGKIVKICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 274 VFLEIIT 280
+ EI +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 29/217 (13%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNP 136
+F ++G G FG V KL+ ++ A+K L++ E F E +L N
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSL-------EDHLLDLPPNRKALDWNTRMKIAHGA 189
++ L D + LV +Y G L ED L P A + M IA +
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL----PEDMARFYLAEMVIAIDS 117
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
L Y+H RD K N+L+D + + +L+DFG + L D + S+ +GT
Sbjct: 118 VHQLHYVH---------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTP 167
Query: 250 GYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITG 281
Y +PE G+ + D +S GV E++ G
Sbjct: 168 DYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 41/223 (18%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR---------NGFQGNREFLVE---- 126
+F ++G G FG V K++ T + A+K L++ F+ R LV
Sbjct: 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61
Query: 127 ---VLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRM 183
L + YL ++ Y V GD L+ ++ ED L P A + M
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYIAEM 111
Query: 184 KIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243
+A + L Y+H RD K NVLLD + + +L+DFG + L D + S+
Sbjct: 112 VLAIHSIHQLHYVH---------RDIKPDNVLLDMNGHIRLADFG-SCLKMNQDGTVQSS 161
Query: 244 RVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITG 281
+GT Y +PE G+ + D +S GV E++ G
Sbjct: 162 VAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 6/106 (5%)
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
G+++LH + +I+RD K SN+++ D K+ DFGLA+ T + + T + T Y
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TACTNFMMTPYVVTRYY 188
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
APE L D++S G + E++ G + + ++ N V
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 12/109 (11%)
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
G+++LH + +I+RD K SN+++ D K+ DFGLA+ T S + T + T Y
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEII------TGRRVIDNSRPTEEQ 294
APE L D++S G + E++ GR ID EQ
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 3e-06
Identities = 63/222 (28%), Positives = 96/222 (43%), Gaps = 46/222 (20%)
Query: 80 NFNPDNLLGEGGFGRV---YRGKLEGTNQDVAVKQLDR---NGFQGNREFLVEVLMLSML 133
N P +G G G V Y LE ++VA+K+L R N R + VLM
Sbjct: 28 NLKP---IGSGAQGIVCAAYDAILE---RNVAIKKLSRPFQNQTHAKRAYRELVLM---- 77
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWN----TRMKIAHG 188
CV+ I L+ + P SLE+ D+ + +D N +M++ H
Sbjct: 78 ----------KCVNHKNIIGLLNVFTPQKSLEE-FQDVYIVMELMDANLCQVIQMELDHE 126
Query: 189 AAR--------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
G+++LH + +I+RD K SN+++ D K+ DFGLA+ T S
Sbjct: 127 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSF 180
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
+ T + T Y APE L D++S G + E+I G
Sbjct: 181 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 5e-06
Identities = 32/105 (30%), Positives = 43/105 (40%), Gaps = 5/105 (4%)
Query: 180 NTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDK 238
+ I L YLH +I+RD K N+ LD+ N L DFG A KL D
Sbjct: 185 EQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT 241
Query: 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRR 283
GT +PE AK+D++S G+V E+
Sbjct: 242 PQCYGWS-GTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285
|
Length = 392 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 5e-06
Identities = 32/105 (30%), Positives = 49/105 (46%), Gaps = 3/105 (2%)
Query: 176 ALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235
ALD + ++ A+G+ +L A I+RD A N+LL K+ DFGLA+
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
V + APE T +SDV+S+G++ EI +
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 9/94 (9%)
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV---STRVM 246
A+G+E+L A I+RD A N+LL ++ K+ DFGLA+ D +V R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKDPDYVRKGDARL- 243
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ APE T +SDV+SFGV+ EI +
Sbjct: 244 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-06
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 41/217 (18%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDR---------NGFQGNREFLVE-------VLM 129
++G G FG V K++ T Q A+K L++ F+ R+ LV L
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
+ L ++ Y V GD L+ ++ ED L P A + M +A +
Sbjct: 68 YAFQDENNLYLVMDYYVGGDLLTLLSKF------EDRL----PEDMARFYLAEMVLAIDS 117
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
L Y+H RD K NVLLD++ + +L+DFG + L D + S +GT
Sbjct: 118 VHQLGYVH---------RDIKPDNVLLDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTP 167
Query: 250 GYCAPEY--AL---TGQLTAKSDVYSFGVVFLEIITG 281
Y +PE A+ G+ + D +S GV E++ G
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 38/123 (30%), Positives = 60/123 (48%), Gaps = 8/123 (6%)
Query: 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218
P + D L++ P AL + + ++ A G+E+L A ++RD A NVL+ +
Sbjct: 221 PERTRRDTLINESP---ALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICE 274
Query: 219 DFNPKLSDFGLAKLGPTGDKSHVST-RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLE 277
K+ DFGLA+ D +++S + APE T SDV+SFG++ E
Sbjct: 275 GKLVKICDFGLAR-DIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWE 333
Query: 278 IIT 280
I T
Sbjct: 334 IFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 11/108 (10%)
Query: 177 LDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236
LD + ++ + A+G+++L A I+RD A NVLL K+ DFGLA+
Sbjct: 209 LDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMN 264
Query: 237 DKSHVSTRVMGT----YGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
D ++V V G + APE T +SDV+S+G++ EI +
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 16/149 (10%)
Query: 90 GGFGRVYRGKLEGTNQDVAVK------QLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVG 143
G FG+VY G+ + ++ AVK +++N + E L++ +P++V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVH---QVQAERDALALSKSPFIVHLYY 71
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ LV EY+ G ++ LL + D +K A L+YLH +
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKS-LLHI---YGYFDEEMAVKYISEVALALDYLH---RHG 124
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKL 232
+I+RD K N+L+ + + KL+DFGL+K+
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 26/80 (32%), Positives = 43/80 (53%)
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
+++RD K++N+ L KL DFG +K V++ GT Y APE + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249
Query: 264 AKSDVYSFGVVFLEIITGRR 283
K+D++S GV+ E++T R
Sbjct: 250 KKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 40/109 (36%), Positives = 54/109 (49%), Gaps = 18/109 (16%)
Query: 185 IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG-LAKLGPTGDKSHV-- 241
I GA RGL YLH++ I+R+ KAS++L+ D LS L L G K+ V
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 242 -----STRVMGTYGYCAPEYA---LTGQLTAKSDVYSFGVVFLEIITGR 282
ST V+ + +PE L G KSD+YS G+ E+ TGR
Sbjct: 163 DFPQFSTSVLP---WLSPELLRQDLYG-YNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 1e-04
Identities = 58/225 (25%), Positives = 95/225 (42%), Gaps = 36/225 (16%)
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG 188
++S +S+ +L + G CV G + I+V E++ +G L D L R + W ++ +A
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAW--KITVAQQ 125
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVL-----LDQDFNP--KLSDFGLAKLGPTGDKSHV 241
A L YL + +++ + A N+L L + +P KLSD G++ + V
Sbjct: 126 LASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERV 181
Query: 242 STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301
R+ C P L+ +D +SFG LEI D P +E+ T
Sbjct: 182 E-RIPWIAPECVPG---GNSLSTAADKWSFGTTLLEI-----CFDGEVPLKER------T 226
Query: 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP 346
P K+R F L E + + + + CL E RP
Sbjct: 227 PSEKER--FYEKKHRLPEPSCK-----ELATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 43/183 (23%), Positives = 71/183 (38%), Gaps = 21/183 (11%)
Query: 103 TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGS 162
T + V +K R G E +L +++P ++ L G Y
Sbjct: 116 TCEHVVIKAGQRGGT------ATEAHILRAINHPSIIQLKG--------TFTYNKFTCLI 161
Query: 163 LEDHLLDL---PPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD 219
L + DL ++ + + I R ++YLHE+ +I+RD KA N+ ++
Sbjct: 162 LPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHP 218
Query: 220 FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEII 279
+ L DFG A P ++ GT APE D++S G+V E+
Sbjct: 219 GDVCLGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277
Query: 280 TGR 282
T
Sbjct: 278 TCH 280
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 3e-04
Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 22/160 (13%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---------QGNREFLVEVLML 130
+F+ ++G+G FG V + + T + A+K L ++ + R+ L E
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES--- 58
Query: 131 SMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
+P++V+L D L+ E++P G L L+ + + TR +A
Sbjct: 59 ---DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV---TRFYMAE-CV 111
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230
+E +H+ I+RD K N+L+D+ + KLSDFGL+
Sbjct: 112 LAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 4e-04
Identities = 60/267 (22%), Positives = 97/267 (36%), Gaps = 56/267 (20%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---------QGNREFLVEVLML 130
+F ++G G FG V + + T A+K L + + R+ LVE
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA--- 58
Query: 131 SMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
++V + D L+ E++P G D + L + T+ IA
Sbjct: 59 ---DGAWVVKMFYSFQDKRNLYLIMEFLPGG---DMMTLLMKKDTLSEEATQFYIAE-TV 111
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA---------------KLGPT 235
++ +H Q I+RD K N+LLD + KLSDFGL P
Sbjct: 112 LAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPP 168
Query: 236 GD------------------KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLE 277
D + ++ +GT Y APE + D +S GV+ E
Sbjct: 169 SDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYE 228
Query: 278 IITGRRVIDNSRPTEE-QNLVTWATPL 303
++ G + P E + ++ W L
Sbjct: 229 MLIGYPPFCSETPQETYRKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 53/220 (24%), Positives = 85/220 (38%), Gaps = 38/220 (17%)
Query: 84 DNLLGEGGFGR--VYRGKLEGTNQDVAVKQLDRNGFQGNREFLV---EVLMLSMLSNPYL 138
L+G+ V+ K + TN VAVK+++ + + + E++ L +P +
Sbjct: 3 LTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNI 61
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLD------LPPNRKALDWNTRMKIAHGAARG 192
+ V + + +V M GS ED LL LP A I
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCED-LLKTHFPEGLPELAIAF-------ILKDVLNA 113
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA--------KLGPTGDKSHVSTR 244
L+Y+H I+R KAS++LL D LS + + D S +
Sbjct: 114 LDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170
Query: 245 VMGTYGYCAPEY---ALTGQLTAKSDVYSFGVVFLEIITG 281
+ + +PE L G KSD+YS G+ E+ G
Sbjct: 171 NL---PWLSPEVLQQNLQG-YNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 5e-04
Identities = 61/271 (22%), Positives = 99/271 (36%), Gaps = 64/271 (23%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR---------NGFQGNREFLVEVLML 130
+F ++G G FG V + + T A+K L + + R+ LVE L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 131 SMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
++V + D L+ E++P G D + L + T+ IA
Sbjct: 62 ------WVVKMFYSFQDKLNLYLIMEFLPGG---DMMTLLMKKDTLTEEETQFYIAE-TV 111
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG-------------- 236
++ +H Q I+RD K N+LLD + KLSDFGL TG
Sbjct: 112 LAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLC----TGLKKAHRTEFYRNLN 164
Query: 237 -----------------------DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGV 273
++ ++ +GT Y APE + D +S GV
Sbjct: 165 HSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 274 VFLEIITGRRVIDNSRPTEE-QNLVTWATPL 303
+ E++ G + P E + ++ W L
Sbjct: 225 IMYEMLIGYPPFCSETPQETYKKVMNWKETL 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 29/88 (32%), Positives = 39/88 (44%), Gaps = 7/88 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL--V 139
LG G FGRV G + VAVK L ++ L+ L + P+L V
Sbjct: 45 LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHL 167
NL+G C G ++ EY G L D+L
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYL 132
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.002
Identities = 57/216 (26%), Positives = 92/216 (42%), Gaps = 40/216 (18%)
Query: 87 LGEGGFGRVYRGKLE----------GTNQDVAV--KQLDRNGFQGNREFLVEVLMLSMLS 134
LG G ++Y G L +++ V K LD + + F M+ +S
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNT--RMKIAHGAARG 192
+ ++V L G CV + I+V E++ G LDL +RK+ T + K+A A
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGP-----LDLFMHRKSDVLTTPWKFKVAKQLASA 117
Query: 193 LEYLHESAQPPVIYRDFKASNVLL-----DQDFNP--KLSDFGLAKLGPTGDKSHVSTR- 244
L YL + +++ + N+LL D + P KLSD G+ P V +R
Sbjct: 118 LSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI----PIT----VLSRQ 166
Query: 245 -VMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEI 278
+ + APE + L+ +D +SFG EI
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.004
Identities = 34/99 (34%), Positives = 47/99 (47%), Gaps = 12/99 (12%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNREFLV-EVLM 129
F DNL LG G FG+V G ++ VAVK L + RE L+ E+ +
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKI 94
Query: 130 LSMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL 167
LS L +VNL+G C G +++ EY G L + L
Sbjct: 95 LSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFL 133
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 399 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.79 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.59 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.5 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.45 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.98 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.92 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.85 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.83 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.7 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.67 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.65 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.65 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.44 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.38 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.33 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.3 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.15 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.02 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.01 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.97 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.89 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.79 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.78 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.65 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.64 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.61 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.56 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.51 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.4 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.28 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.26 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.25 | |
| PLN02236 | 344 | choline kinase | 97.21 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.17 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.92 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.82 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.68 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.67 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.59 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.55 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.27 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.23 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.09 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.82 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 95.72 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.56 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.5 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.44 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=408.22 Aligned_cols=292 Identities=58% Similarity=0.959 Sum_probs=255.9
Q ss_pred ccccccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEE
Q 046609 65 TAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144 (399)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~ 144 (399)
..+.|++.++..+|++|...++||+|+||.||+|...+ +..||||.+.........+|.+|+.++.+++|||+|+|+|+
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy 139 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY 139 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence 56779999999999999999999999999999999986 48899998876543314569999999999999999999999
Q ss_pred EeeCC-eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 145 CVDGD-QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 145 ~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
|.+.+ ..+||+||+++|+|.++|...... +++|..+++|+.++|.||+|||....++||||||||+|||+|+++++|
T Consensus 140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred EecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 99998 599999999999999999873222 899999999999999999999998888899999999999999999999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
|+|||+|+..+.. .........||.+|+|||++..+..+.++||||||++|.||+||+.|.+...+.....+..|+.+.
T Consensus 218 lsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~ 296 (361)
T KOG1187|consen 218 LSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL 296 (361)
T ss_pred ccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence 9999999765441 111111117999999999999999999999999999999999999999987766777799999887
Q ss_pred hhccchhhhccCCccC-CCCCH-HHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 304 FKDRRKFTMMADPLLE-GNYPI-KGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
+.+. .+.+++|+.+. ..++. .....+..++.+|++.+|.+||+|.+|++.|+.+...
T Consensus 297 ~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 297 LEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 7775 89999999987 66664 6788899999999999999999999999999666544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=396.99 Aligned_cols=249 Identities=26% Similarity=0.404 Sum_probs=216.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.+|...++||+|||+.||.+++..+|+.||+|++.+... ...+.+.+|++|.+.|+|||||+++++|++.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 568999999999999999999988999999999986433 33466889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|+|..++|..++++ .+++++.+++.++.||+.||.|||+++ |+|||||..|+|++++.++||+|||+|.....
T Consensus 98 ELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 99999999999986 678999999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. .....+.||||.|+|||++....++..+||||+||+||.||.|++||+.....+..+.+....
T Consensus 171 ~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~-------------- 234 (592)
T KOG0575|consen 171 D--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE-------------- 234 (592)
T ss_pred c--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC--------------
Confidence 3 234456899999999999999999999999999999999999999999865433222221110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
-..|...+....+||.++|+.||.+|||+.+|+.+
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01234555678899999999999999999999977
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=374.16 Aligned_cols=252 Identities=27% Similarity=0.394 Sum_probs=211.6
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe-eEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ-RILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~e~ 157 (399)
+.+..+.||+|..|+||++.++.+++.+|+|.+..... ...+++.+|+++++..+|||||.+|+.|..+.. ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 55566899999999999999999999999999954432 345789999999999999999999999999984 9999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++|+|..++.. .+.+++...-.|+.++++||.|||+ ++ ||||||||+||||+..|.+||||||.+......
T Consensus 160 MDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS 232 (364)
T KOG0581|consen 160 MDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS 232 (364)
T ss_pred cCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence 999999999987 4679999999999999999999996 77 999999999999999999999999999864433
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
......||..|||||.+.+..|+.++||||||++++|+.+|+.||....+.... .... +..+++.
T Consensus 233 ----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-~~~L----------l~~Iv~~ 297 (364)
T KOG0581|consen 233 ----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-IFEL----------LCAIVDE 297 (364)
T ss_pred ----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-HHHH----------HHHHhcC
Confidence 445578999999999999999999999999999999999999999885221111 1111 1111111
Q ss_pred ccCCCCCHH-HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIK-GLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. .+..|.. .+.++.+|+..||++||.+||++.+++++
T Consensus 298 p-pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 298 P-PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred C-CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 1122333 66689999999999999999999999887
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=378.93 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=209.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-------chHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
.+.|.+.+.||+|+||.|-+|..+.+++.||||++++.... ....+.+|+++|++++|||||+++++|...+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 35678889999999999999999999999999999754322 22346799999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC---CCeeEecc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD---FNPKLSDF 227 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Df 227 (399)
.||||||+.||+|.+++.. ++.+.+.....++.|++.|+.|||+.| |+||||||+|||++.+ ..+||+||
T Consensus 251 ~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred eEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999987 677888999999999999999999999 9999999999999766 67999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCC---CchhhHHHHHHHHHHHHcCCCCCCCCCCcc-cchhhHhhhhh
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL---TAKSDVYSFGVVFLEIITGRRVIDNSRPTE-EQNLVTWATPL 303 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~---~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~~ 303 (399)
|+|+... ......+.|||+.|.|||++.++.+ ..+.|+||+||+||-+|+|.+||....... ...++......
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~ 400 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA 400 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc
Confidence 9999754 3345566899999999999976543 347899999999999999999999765432 11111111110
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+ .| ..-.....+.++||.+||..||++|||+.|++.+
T Consensus 401 f----------~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 401 F----------GP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred c----------cC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 0 11 1123455688899999999999999999999765
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=369.15 Aligned_cols=251 Identities=25% Similarity=0.354 Sum_probs=211.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.++++||+|+||+||+++.+++++.+|+|++++...- +.+....|..+|..++||+||+++..|++.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 46899999999999999999999999999999999865433 235578899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
+||+.||.|..+|++ .+.+++..++.++..|+.||.|||+++ ||||||||+|||+|.+|+++|+|||+++..-
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999986 577999999999999999999999999 9999999999999999999999999998532
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. ......++||+.|||||++.+..|+..+|+||||+++|+|++|.+||...+.......+ ....
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I------~~~k------- 241 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI------LKGK------- 241 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH------hcCc-------
Confidence 22 23334489999999999999999999999999999999999999999987643222111 1111
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCC----ChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP----MMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~ 354 (399)
....+.-......+++.++|+.||.+|- .+.+|-.+
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H 281 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH 281 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence 0111222345788999999999999995 45555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-51 Score=368.85 Aligned_cols=206 Identities=30% Similarity=0.492 Sum_probs=186.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
..+|.+.+.||.|+||+||+|+++.++..||||.+.+... ...+.+..|+.+|+.++|||||.+++++.+++..||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3578888999999999999999999999999999987743 33455789999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC------CCeeEecccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD------FNPKLSDFGL 229 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~------~~~kl~Dfg~ 229 (399)
|||.||+|.+|++. .+.+++..++.++.||+.||++||+++ ||||||||+||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999987 568999999999999999999999999 9999999999999765 4589999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEE 293 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 293 (399)
|+.... .......+|++-|||||++...+|+.|+|+||+|+++|+|++|++||....+.+.
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL 222 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL 222 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence 997653 3345568999999999999999999999999999999999999999997766543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-50 Score=375.05 Aligned_cols=262 Identities=33% Similarity=0.533 Sum_probs=216.5
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCC-eeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGD-QRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~e~ 157 (399)
..+.+.||.|+||+||+|.+.++ ..||||++....... .+.|.+|+.+|.+++|||||+++|++.+.. ..++||||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34446699999999999999953 239999998654333 458999999999999999999999999888 79999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~ 236 (399)
+++|+|.+++... ....+++..++.++.||+.|+.|||+.+. ||||||||+|||++.++ ++||+|||+++.....
T Consensus 122 ~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 9999999999873 35789999999999999999999998874 89999999999999998 9999999999864332
Q ss_pred CCcccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYAL--TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
. ...+...||+.|||||++. ...|+.++||||||+++|||+||+.||....+... ...++
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~----------------~~~v~ 259 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV----------------ASAVV 259 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH----------------HHHHH
Confidence 2 2233367999999999999 56999999999999999999999999998875211 11111
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccc
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~ 365 (399)
....+...+......+..++.+||..||..||++.+|+..|+.+.......
T Consensus 260 ~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 260 VGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred hcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 112223334446668889999999999999999999999999998755543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-52 Score=360.87 Aligned_cols=259 Identities=20% Similarity=0.286 Sum_probs=213.1
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEE-EEeeCCe-eEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVG-YCVDGDQ-RILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~-~~~~~~~-~~lv~ 155 (399)
+|.++++||+|.||.||+++...++..+|.|.++..... ..+....|+.+|++|+|||||++++ .+.+++. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 577789999999999999999999999999999854332 3356889999999999999999999 5655555 89999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-CCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA-QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||.+|+|...++...+..+.+++..+|+++.|++.||..+|+.- ...|+||||||.|||++.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999999988778889999999999999999999999832 1239999999999999999999999999999754
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... ......+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||.+..- .....++ ..-
T Consensus 180 s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~L~~KI-------~qg- 243 (375)
T KOG0591|consen 180 SKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LSLCKKI-------EQG- 243 (375)
T ss_pred chh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HHHHHHH-------HcC-
Confidence 433 334457899999999999999999999999999999999999999998632 2211111 111
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
....-....++.+|..+|..|+.+||..||+...++..+.
T Consensus 244 --d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 244 --DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred --CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1111112567789999999999999999998655554444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=371.23 Aligned_cols=255 Identities=25% Similarity=0.350 Sum_probs=216.1
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCe
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 150 (399)
....++|.+.+.||+|+|++|++|+.+.+++.||||++.+... ...+.+..|-.+|.+| .||.|++|+..|+++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 3456799999999999999999999999999999999976432 2235577788999999 79999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
+|+|+||+++|+|.++|.. -+.+++..++.++.+|+.||+|||++| ||||||||+|||+|.||++||+|||.|
T Consensus 149 LYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 9999999999999999987 477999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCc---------cc--cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh
Q 046609 231 KLGPTGDKS---------HV--STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW 299 (399)
Q Consensus 231 ~~~~~~~~~---------~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 299 (399)
+........ .. ...++||..|.+||++.++..++.+|+|+|||+||+|+.|.+||.+.++--....+
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI-- 299 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI-- 299 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH--
Confidence 875443222 11 24588999999999999999999999999999999999999999987653211111
Q ss_pred hhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 300 ATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+. +.=.++...+..+.+|+.+.|..||.+|++..+|.++
T Consensus 300 --------------~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 300 --------------QA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred --------------HH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 11 0112333444678899999999999999999999876
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=346.99 Aligned_cols=267 Identities=24% Similarity=0.296 Sum_probs=220.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+.|+.+.++|+|+||+||++++++||+.||||++-.... .-.+-.++|+.+|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457788999999999999999999999999999965432 223557899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
||+. ++.+-|... ...++...+.+++.|++.|+.|+|+++ +|||||||+||||+.+|.+||||||.|+....
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 9954 676677663 456999999999999999999999999 99999999999999999999999999997553
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH--------hhhhhhhcc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT--------WATPLFKDR 307 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~--------~~~~~~~~~ 307 (399)
+....+..+.|..|.|||++.+ .+|+..+||||+||++.||++|.+.|.+....++...+. .-..+|...
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 3344556678999999999887 689999999999999999999999999887666554432 333344444
Q ss_pred chhhhccCCccCCC-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGN-----YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+.+..+.-|..... -.+..+.-+++|+..||+.||.+|++-++++.+
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 55554444433321 122344588999999999999999999999865
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=364.12 Aligned_cols=256 Identities=31% Similarity=0.448 Sum_probs=217.1
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+...+.||+|.||.||.|.+++ ...||+|.+.... .....|.+|+.+|++|+|+|||+++++|..+..++|||||++.
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~ 285 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPK 285 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEeccc
Confidence 3445889999999999999986 4579999997653 3346788999999999999999999999998899999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|.+||+. ..+..+...+.+.++.||++|++||++++ +|||||...||||+++..+||+|||+++...+. ...
T Consensus 286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~ 359 (468)
T KOG0197|consen 286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYT 359 (468)
T ss_pred CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCC-cee
Confidence 999999987 45678999999999999999999999999 999999999999999999999999999943322 233
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
......-+..|.|||.+..+.++.+||||||||+||||+| |+.||..+...+....+ ....+
T Consensus 360 ~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~l-----------------e~GyR 422 (468)
T KOG0197|consen 360 ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELL-----------------ERGYR 422 (468)
T ss_pred ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHH-----------------hccCc
Confidence 3333456789999999999999999999999999999999 99999987754332222 22222
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
-..|..++..+.+++..||+.+|++|||++.+...|+.+...
T Consensus 423 lp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 423 LPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred CCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 233555677899999999999999999999999999988654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=360.96 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=212.6
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
.....++|.++++||+|+||.||+|+.+.||..+|+|++++...... ..+..|..+|....+|+||++|..|++.++
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 34567899999999999999999999999999999999987655443 446789999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
+||||||++||++-.+|.. .+.|+++.++.++.+++.|++.||..| +|||||||+|+|||..|++||+|||||
T Consensus 216 LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred eEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeecccccc
Confidence 9999999999999999987 678999999999999999999999999 999999999999999999999999998
Q ss_pred cCCCC----------------------CCCcc----c-------------------cccccccccccccccccCCCCCch
Q 046609 231 KLGPT----------------------GDKSH----V-------------------STRVMGTYGYCAPEYALTGQLTAK 265 (399)
Q Consensus 231 ~~~~~----------------------~~~~~----~-------------------~~~~~g~~~y~aPE~~~~~~~~~~ 265 (399)
..... .+... . ....+|||.|+|||++.+..|+..
T Consensus 289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~ 368 (550)
T KOG0605|consen 289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE 368 (550)
T ss_pred chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence 52111 00000 0 011479999999999999999999
Q ss_pred hhHHHHHHHHHHHHcCCCCCCCCCCcccch-hhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCC
Q 046609 266 SDVYSFGVVFLEIITGRRVIDNSRPTEEQN-LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT 344 (399)
Q Consensus 266 ~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~ 344 (399)
+|+||||||+||||.|.+||...++.+.-. +..|-..+ ..+. .........+||.+||. ||.+
T Consensus 369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-~fP~--------------~~~~s~eA~DLI~rll~-d~~~ 432 (550)
T KOG0605|consen 369 CDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-KFPE--------------EVDLSDEAKDLITRLLC-DPEN 432 (550)
T ss_pred ccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-cCCC--------------cCcccHHHHHHHHHHhc-CHHH
Confidence 999999999999999999999988865443 33332211 1100 11112578899999999 9999
Q ss_pred CCC---hHHHHHH
Q 046609 345 RPM---MSDVVTA 354 (399)
Q Consensus 345 RPs---~~eil~~ 354 (399)
|-. +.||.++
T Consensus 433 RLG~~G~~EIK~H 445 (550)
T KOG0605|consen 433 RLGSKGAEEIKKH 445 (550)
T ss_pred hcCcccHHHHhcC
Confidence 964 6666554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=335.57 Aligned_cols=237 Identities=28% Similarity=0.380 Sum_probs=206.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.+|+..+.||.|+||.|.+++.+.++..+|+|++++...-.. +...+|..+|+.+.||+++++++.+.+.+.++|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 578889999999999999999999999999999987644333 34678999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||.|..+++. .+++++..++.++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+....
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999987 567999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ..+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||...++... ..++....-
T Consensus 197 r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y~KI~~~~v------- 258 (355)
T KOG0616|consen 197 R-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------YEKILEGKV------- 258 (355)
T ss_pred c-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------HHHHHhCcc-------
Confidence 2 4458999999999999999999999999999999999999999998776321 111121111
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCC
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTR 345 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 345 (399)
.+|.-...++.+|+.+.|+.|-.+|
T Consensus 259 -----~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 -----KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred -----cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 3455556688999999999999999
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=353.42 Aligned_cols=257 Identities=28% Similarity=0.406 Sum_probs=208.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC--eeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD--QRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~e 156 (399)
.+|...+.||+|+||.||++.+..++...|||.+........+.+.+|+.+|.+++|||||+.+|...... .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45777899999999999999999889999999997653333567899999999999999999999854444 6899999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~ 235 (399)
|+++|+|.+++... +..|++..+..+..|+++||.|||+++ ||||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999873 227999999999999999999999999 999999999999999 79999999999986443
Q ss_pred -CCCccccccccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCC-CCcccchhhHhhhhhhhccchhhh
Q 046609 236 -GDKSHVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITGRRVIDNS-RPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 -~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
...........||+.|||||++.++. ...++|||||||++.||+||.+||... .... +. +..
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~------~~---------~~i 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE------AL---------LLI 235 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH------HH---------HHH
Confidence 12222233477999999999998643 345999999999999999999999974 2111 00 001
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
.... ..+.+|...+..+.+|+.+|++.+|.+|||+.+++++..-
T Consensus 236 g~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~ 279 (313)
T KOG0198|consen 236 GRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL 279 (313)
T ss_pred hccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence 1111 1123445566688999999999999999999999988543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=359.47 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=212.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC----CC-cchHHHHHHHHHHHccC-CCceeeEEEEEeeCCe
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN----GF-QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~ 150 (399)
...+|.+.+.||+|+||+|++|.+..++..||||+++.. .. ...+.+.+|+.+++.++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 456899999999999999999999999999999987764 11 23355678999999999 9999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-CCeeEecccC
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGL 229 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~ 229 (399)
.++||||+.||+|.+++.. .+++.+..+..++.|++.|++|||++| |+||||||+|||++.+ +++||+|||+
T Consensus 95 ~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred EEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999987 577999999999999999999999999 9999999999999999 9999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCC-CC-chhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ-LT-AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
+.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||........ ...+....
T Consensus 168 s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l------~~ki~~~~ 239 (370)
T KOG0583|consen 168 SAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL------YRKIRKGE 239 (370)
T ss_pred ccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH------HHHHhcCC
Confidence 98753 2333445678999999999999877 86 689999999999999999999998443211 11111111
Q ss_pred chhhhccCCccCCCCCHHH-HHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 308 RKFTMMADPLLEGNYPIKG-LYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
-.+ |... ..++.+|+.+||..||.+|+++.+|+ .-.-++
T Consensus 240 ~~~------------p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~ 279 (370)
T KOG0583|consen 240 FKI------------PSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQ 279 (370)
T ss_pred ccC------------CCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhc
Confidence 111 2222 55788999999999999999999998 334343
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=325.90 Aligned_cols=266 Identities=24% Similarity=0.341 Sum_probs=218.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.+|...++||+|.||.||+|++..+|+.||||++...... ......+|+..|+.++|+||+.++++|...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4677789999999999999999999999999999765433 23568899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++ .+|...+++ ....++..++..++.+++.||+|||++. |+||||||+|+||+.+|.+||+|||+++.+...
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 995 599999987 5678999999999999999999999999 999999999999999999999999999986655
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-----------hh
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-----------LF 304 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----------~~ 304 (399)
.... +..+.|..|.|||++.| ..|+...|+||.||++.||+-|.+-|.+....++...+-.+.. .+
T Consensus 155 ~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Cccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 4333 23368999999999886 5799999999999999999999999998776554433322111 11
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+...+.....+.+.. .-.....++++|+.++|..||.+|+++.+.+++
T Consensus 233 pdY~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccHHHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1222223223333332 344556677999999999999999999999987
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=352.43 Aligned_cols=286 Identities=23% Similarity=0.319 Sum_probs=221.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l 153 (399)
.+.|..+++||+|+||.||+|++..+++.||+|++..... .......+||.||++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457778999999999999999999999999999987653 2335578899999999999999999998876 68999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
|+|||+. +|.-++.. ..-.+++.++..++.||+.||+|||+++ |+|||||.+|||||.+|.+||+|||+|+++
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999965 89888876 3457999999999999999999999999 999999999999999999999999999976
Q ss_pred CCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh-hhhhhccchhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA-TPLFKDRRKFT 311 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~ 311 (399)
.... ....+..+.|..|.|||+++|. .|+.++|+||.||||.||++|++.|++..+.++...+--. ...-.+.+...
T Consensus 269 ~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 5443 3335667789999999999875 7999999999999999999999999998876655443211 11111111111
Q ss_pred hccCC-ccC--CCC-------CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccccccccccCc
Q 046609 312 MMADP-LLE--GNY-------PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDSLDS 373 (399)
Q Consensus 312 ~~~~~-~l~--~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~ 373 (399)
.+... .+. ..+ ....+...++|+..+|..||.+|.|+.+++.. +.+ ...+.++-+..+..
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s-eyF-~t~p~~~~p~~Lp~ 417 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS-EYF-TTEPLPCDPSSLPK 417 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC-ccc-ccCCCCCCcccCCC
Confidence 11110 000 011 11234577889999999999999999999865 333 33333344444433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=343.10 Aligned_cols=266 Identities=24% Similarity=0.348 Sum_probs=218.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch-HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN-REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
...++|.+.++||.|..++||+|+...+++.||||+++...-... +.+.+|+..++.++||||++++..|..+..+|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 345789999999999999999999999999999999986654433 7889999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|+||.+|++.+.++... ...+++..+..|+.+++.||.|||.+| .||||||+.||||+.+|.+||+|||.+....
T Consensus 103 mpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred ehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999998754 345999999999999999999999999 9999999999999999999999999886433
Q ss_pred CCCC-cccc-cccccccccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 235 TGDK-SHVS-TRVMGTYGYCAPEYAL--TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 235 ~~~~-~~~~-~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.... .... ....||+.|||||++. ...|+.|+||||||++..||.+|+.||....|....-.. +-.. +
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~t-----Lqn~-p-- 249 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLT-----LQND-P-- 249 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHH-----hcCC-C--
Confidence 3221 1111 4578999999999965 357999999999999999999999999998775432111 1111 1
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....-..+..+........+.+++..||+.||.+|||+++++++
T Consensus 250 p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 250 PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 11111112222233445688899999999999999999999976
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=357.78 Aligned_cols=265 Identities=26% Similarity=0.392 Sum_probs=225.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
..|.....||+|+-|.||.|....+++.||||.+........+-+.+|+.+|+..+|+|||.+++.|..++.+|+||||+
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45777889999999999999999999999999999887777788999999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+||+|.+.+.. ..+++.++..|+.+++.||+|||.++ |+|||||.+|||++.+|.+||+|||++........
T Consensus 353 ~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred CCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999976 45999999999999999999999999 99999999999999999999999999986544432
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......||+.|||||++....|+++.||||||++++||+-|++||-..++.....++.-. ...
T Consensus 425 --KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n---------------g~P 487 (550)
T KOG0578|consen 425 --KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN---------------GTP 487 (550)
T ss_pred --ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc---------------CCC
Confidence 445578999999999999999999999999999999999999999986664433332111 111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccccccc
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIED 369 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~~~~ 369 (399)
.-..+...+..+.+|+.+||+.|+.+||++.|+|++ ..|+...++.+|.+
T Consensus 488 ~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H-pFl~~a~p~ssL~p 537 (550)
T KOG0578|consen 488 KLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH-PFLKMAKPESSLNP 537 (550)
T ss_pred CcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC-hhhhhcCCHHHhHH
Confidence 122344556689999999999999999999999987 33444444444433
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=357.91 Aligned_cols=248 Identities=27% Similarity=0.386 Sum_probs=216.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|+.+.+.+.||+|.+.+....+ .+.+.+|++|++.++|||||.++++|++..+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999999999999999998765433 3568899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+.| +|..+|.+ ++.++++.+..++.|++.||.|||+++ |+|||+||.|||++.+|++|+||||+++....
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9965 99999987 678999999999999999999999999 99999999999999999999999999997443
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.....+...|||-|||||++.+.+|+..+|+||+||++|||++|++||.... +...+..+..++.
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~d~v-------- 217 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILKDPV-------- 217 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhcCCC--------
Confidence 4455667889999999999999999999999999999999999999998643 2222222222211
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+|......+..|+...|.+||..|.+..+++.+
T Consensus 218 ----~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 ----KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred ----CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 3455667788999999999999999999999876
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=353.54 Aligned_cols=265 Identities=23% Similarity=0.328 Sum_probs=216.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHH--HHHHHHHHHccC-CCceeeEEEEEeeCC-eeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE--FLVEVLMLSMLS-NPYLVNLVGYCVDGD-QRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l~-hpnIv~l~~~~~~~~-~~~l 153 (399)
.++|.+.+.||.|+||.||+|+...++..||||.+.+.-.. .++ -.+|+..|++++ |||||++.+++.+.+ .+++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 46788899999999999999999999999999999765433 333 467999999999 999999999999888 9999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||| ..+|+++++. .++.+++..++.|+.||++||+|+|.+| +.|||+||+|||+.....+||+|||+|+..
T Consensus 88 VfE~M-d~NLYqLmK~---R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKD---RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eHHhh-hhhHHHHHhh---cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 99999 5699999998 3678999999999999999999999999 999999999999999999999999999965
Q ss_pred CCCCCcccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc-----
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR----- 307 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----- 307 (399)
.... ..+..+.|..|.|||++. .+-|+.+.|+||+||+++|+.+-++.|.+.++.++...+.-+.+.....
T Consensus 161 ~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 RSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred ccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 4333 345567899999999875 6789999999999999999999999999987765554443322211110
Q ss_pred --------chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 --------RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 --------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
-.+.......+..-.+ ..+.++.+++.+|+.+||++|||+.+.+++
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 1111111222222222 366788999999999999999999999886
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=351.03 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=216.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
..|...+.||+|.||.||+|.+..+++.||+|++....... ..++.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 45777799999999999999999999999999998765443 36688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
|.||++.+.|+. +..+.+..+..++.+++.||.|||..+ .+|||||+.|||+..+|.+||+|||++.......
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999976 455688888999999999999999999 9999999999999999999999999997654433
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. ....++||+.|||||++....|+.++||||||++.+||++|.+|+....|.....++ ..-..|.
T Consensus 166 ~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------------pk~~PP~ 230 (467)
T KOG0201|consen 166 K--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------------PKSAPPR 230 (467)
T ss_pred h--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------------cCCCCCc
Confidence 2 235688999999999999889999999999999999999999999998884332222 1122333
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+.+ .....+.+|+..||+.||+.||++.+++++
T Consensus 231 L~~----~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 231 LDG----DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccc----ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 433 444578999999999999999999999987
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=353.03 Aligned_cols=265 Identities=25% Similarity=0.378 Sum_probs=207.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 149 (399)
..++|.+.++||+|+||.||+|.+. .++..||||++..... .....+.+|+.++..+ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 4468999999999999999999752 3356899999875432 2335688999999999 8999999999887644
Q ss_pred -eeEEEEEecCCCChHHhhccCCC--------------------------------------------------------
Q 046609 150 -QRILVYEYMPNGSLEDHLLDLPP-------------------------------------------------------- 172 (399)
Q Consensus 150 -~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 172 (399)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 57899999999999999875221
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcccccccccccc
Q 046609 173 --NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250 (399)
Q Consensus 173 --~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~ 250 (399)
....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...............++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0235888899999999999999999999 99999999999999999999999999975433222222223446788
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHH
Q 046609 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQ 329 (399)
Q Consensus 251 y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 329 (399)
|+|||++.+..++.++|||||||++|||++ |..||......+. ... ...... . ...+...+..
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~~----~~~~~~------~----~~~~~~~~~~ 305 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FCQ----RLKDGT------R----MRAPENATPE 305 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HHH----HHhcCC------C----CCCCCCCCHH
Confidence 999999999999999999999999999997 9999987543211 000 001100 0 0112233457
Q ss_pred HHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 330 ALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 330 l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8899999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=357.36 Aligned_cols=247 Identities=27% Similarity=0.426 Sum_probs=211.3
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccC-CCceeeEEEEEeeCC
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLS-NPYLVNLVGYCVDGD 149 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~ 149 (399)
......+|.++++||+|+||+|+++..+++++.+|||.+++...-. .+..+.|..|+.... ||.++.++..|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3455678999999999999999999999999999999998765433 355677888888775 999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
++++||||+.||++..+.+ .+.+++..+..++..|+.||.|||+++ |||||||.+|||+|.+|++||+|||+
T Consensus 443 ~l~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGl 514 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGL 514 (694)
T ss_pred eEEEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccc
Confidence 9999999999999655444 367999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
++... .......+++||+.|+|||++.+..|+.++|+|||||+|||||.|+.||.+.++.+...
T Consensus 515 cKe~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd-------------- 578 (694)
T KOG0694|consen 515 CKEGM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD-------------- 578 (694)
T ss_pred ccccC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--------------
Confidence 98632 23445677999999999999999999999999999999999999999999877644221
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM 348 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 348 (399)
.++.. ...||.-.+.+.+.+++++|..+|.+|-.+
T Consensus 579 --sI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 --SIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --HHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11111 124566667788999999999999999865
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=355.59 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=211.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.-|.+.+.||.|+-|.|-+|++..||+.+|||++.+... .....+.+|+.||+.+.||||+++|+++++..++|+|+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457888999999999999999999999999999976522 12245788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||.|++++.. .+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|+|..+++||+|||.|..-..
T Consensus 92 Eyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 99999999999987 688999999999999999999999999 99999999999999999999999999976333
Q ss_pred CCCccccccccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLT-AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
+ ....+-||.+.|.+||++.|.+|+ .++||||.|||||.||+|+.||++.+- .....+.-. +.+
T Consensus 165 g---klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi------r~LLlKV~~--G~f---- 229 (786)
T KOG0588|consen 165 G---KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI------RVLLLKVQR--GVF---- 229 (786)
T ss_pred C---ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH------HHHHHHHHc--Ccc----
Confidence 3 334456899999999999999986 589999999999999999999996432 111111100 111
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
+.|...+.++.+|+.+||.+||.+|.|+++|+++--
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 123344567889999999999999999999988743
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=339.59 Aligned_cols=266 Identities=24% Similarity=0.288 Sum_probs=210.7
Q ss_pred ccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--------------cchHHHHHHHHHHHccC
Q 046609 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--------------QGNREFLVEVLMLSMLS 134 (399)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~ 134 (399)
+...+-+...+.|.+.+.||+|.||.|-+|.+..+++.||||++.+... ...+.+.+|+.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 3344455566899999999999999999999999999999999965322 12246889999999999
Q ss_pred CCceeeEEEEEeeC--CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046609 135 NPYLVNLVGYCVDG--DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKAS 212 (399)
Q Consensus 135 hpnIv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~ 212 (399)
|||||+|+.+..+. +..|||+|||..|.+...--+ ...+++.+++.++.+++.||+|||.++ ||||||||+
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d----~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs 239 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD----KPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS 239 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCC----cccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence 99999999999764 578999999999887543322 333999999999999999999999999 999999999
Q ss_pred ceEECCCCCeeEecccCccCCCCCC---CccccccccccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCC
Q 046609 213 NVLLDQDFNPKLSDFGLAKLGPTGD---KSHVSTRVMGTYGYCAPEYALTGQ----LTAKSDVYSFGVVFLEIITGRRVI 285 (399)
Q Consensus 213 NIll~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf 285 (399)
|+||+.+|++||+|||.+..++.+. .........||+.|+|||...++. .+.+.||||+||+||.|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 9999999999999999998654432 122223367999999999887632 345789999999999999999999
Q ss_pred CCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 286 DNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
.+....+ .. ..++...+.-....++...+.+||.++|++||..|.++.+|..+..-
T Consensus 320 ~~~~~~~------l~----------~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 320 FDDFELE------LF----------DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ccchHHH------HH----------HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 9754322 11 12222222222222455688999999999999999999999877543
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=331.84 Aligned_cols=255 Identities=26% Similarity=0.332 Sum_probs=211.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.+|++++.||+|.-|+||++...+++..+|+|++.+...... .+...|-+||..++||.++.||+.|+.+...|++|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456667999999999999999999999999999987655433 44677999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|||+||+|...++.+ .++.+++..++.++.+++-||+|||..| ||+|||||+||||.++|++.|+||.++.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999999874 5678999999999999999999999999 99999999999999999999999988753211
Q ss_pred C---------------------------------CCc---------------------cccccccccccccccccccCCC
Q 046609 236 G---------------------------------DKS---------------------HVSTRVMGTYGYCAPEYALTGQ 261 (399)
Q Consensus 236 ~---------------------------------~~~---------------------~~~~~~~g~~~y~aPE~~~~~~ 261 (399)
. ... ..+..++||-.|+|||++.|..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 0 000 0112367999999999999999
Q ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccC
Q 046609 262 LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEE 341 (399)
Q Consensus 262 ~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~d 341 (399)
.+.++|+|+|||++|||+.|..||.+.+..+.. ..++...+.-.-....+..+.+||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl----------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL----------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH----------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999999997754322 1111111111111245568899999999999
Q ss_pred CCCCCC----hHHHHHH
Q 046609 342 AGTRPM----MSDVVTA 354 (399)
Q Consensus 342 p~~RPs----~~eil~~ 354 (399)
|.+|.. +.||.++
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999998 8888765
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=363.74 Aligned_cols=266 Identities=29% Similarity=0.454 Sum_probs=225.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
..+....+.||+|.||+||+|+.. .....||||.++..... ...+|.+|++++..++|||||+++|+|.+++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345566789999999999999863 34578999999876655 568899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCC------C----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC
Q 046609 152 ILVYEYMPNGSLEDHLLDLPP------N----RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~ 221 (399)
++|+|||..|+|.+||+.... . ..+|+..+.+.|+.|||.|++||-++. +|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence 999999999999999986321 1 234889999999999999999999999 999999999999999999
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (399)
+||+|||+++.....+.......-.-+.+|||||.+..+.|+.+||||||||+|||+++ |+.||.+...++....+
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i--- 718 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI--- 718 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH---
Confidence 99999999997666655544444456789999999999999999999999999999999 99999987765432222
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
....+ -..|...+..+.+|+..||+.+|.+||+++||-..|+......+
T Consensus 719 -------------~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~ 767 (774)
T KOG1026|consen 719 -------------RAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP 767 (774)
T ss_pred -------------HcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence 11112 23466677799999999999999999999999999998766544
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=316.08 Aligned_cols=271 Identities=23% Similarity=0.290 Sum_probs=220.8
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC----
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD---- 149 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~---- 149 (399)
+.++.++|.+.+.||+|||+.||+++...++..||+|++........+..++|++..++++||||++++++...+.
T Consensus 16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence 4566789999999999999999999999999999999998887777788999999999999999999998875444
Q ss_pred -eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 150 -QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 150 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
..||+++|...|+|.+.+......+..+++.+++.|+.++.+||++||+.. +++.||||||.|||+...+.++|.|||
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence 489999999999999999887666778999999999999999999999886 569999999999999999999999999
Q ss_pred CccCCCCCCCcc-------cccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH
Q 046609 229 LAKLGPTGDKSH-------VSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298 (399)
Q Consensus 229 ~~~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 298 (399)
.+...+..-... .-.....|..|.|||++. +...+.++|||||||+||+|+.|..||+..-....
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg----- 249 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG----- 249 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC-----
Confidence 987543322111 112245789999999885 45678899999999999999999999985432111
Q ss_pred hhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
.-...+..+.+........+..+.+++++||+.||.+||++.+++..++.+-
T Consensus 250 ---------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 ---------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 0111111111211112236678999999999999999999999999998763
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=335.43 Aligned_cols=248 Identities=22% Similarity=0.367 Sum_probs=211.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHH---HHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.+|.+.+.||+|+||+|-+|.....|..||||.++++.....++ +.+|++||..|+||||+.+|.+|++.+..++||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 46888899999999999999998899999999998876655544 678999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||..+|.|++|+.. .+.|++.+++.++.||+.|+.|+|.++ ++|||||.+|||+|.|+++||+|||++..+..
T Consensus 133 EYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999987 577999999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCccccccccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLT-AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
+.. ...+||++-|.+||++.|.+|. +..|-||||++||.|+.|..||++.+-.. ++.. +-
T Consensus 206 ~kf---LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lvrQ-------------Is 266 (668)
T KOG0611|consen 206 KKF---LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LVRQ-------------IS 266 (668)
T ss_pred ccH---HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HHHH-------------hh
Confidence 543 3458899999999999999885 68999999999999999999999865321 1111 11
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
..... .+..+.+..-||++||.+||.+|.|+.+|..+-
T Consensus 267 ~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 267 RGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 11000 111223566799999999999999999998874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=332.84 Aligned_cols=246 Identities=20% Similarity=0.340 Sum_probs=201.0
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEee----CCeeEEEEEe
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVD----GDQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~e~ 157 (399)
..||+|++|.||+|... ++.||||.+....... .+.+.+|+.++++++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIFN--NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEEC--CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 67999999999999984 7899999997654333 3567799999999999999999999876 3467899999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
+++|+|.+++.. ...+++.....++.|++.||.|||+. + ++||||||+||+++.++.+||+|||++......
T Consensus 104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999976 45689999999999999999999985 7 889999999999999999999999998754322
Q ss_pred CCccccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
. ....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ...
T Consensus 177 ~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~-------- 237 (283)
T PHA02988 177 P-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INK-------- 237 (283)
T ss_pred c-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hhc--------
Confidence 1 12457899999999876 68999999999999999999999999876432211110 000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
......+...+..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus 238 --~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 238 --NNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 00111222345578899999999999999999999999998864
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=334.00 Aligned_cols=252 Identities=27% Similarity=0.393 Sum_probs=204.7
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
|...+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 66779999999999999999989999999998754322 224577899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999888652 2346899999999999999999999999 9999999999999999999999999997543222
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||............. .. +..
T Consensus 157 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~~----------~~~-- 219 (285)
T cd05631 157 ---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RR----------VKE-- 219 (285)
T ss_pred ---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH--HH----------hhc--
Confidence 1223468999999999999999999999999999999999999998755422111110 00 000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
....++...+..+.+|+.+||+.||.+||+ +++++++
T Consensus 220 ~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 011223334557889999999999999997 7888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=328.85 Aligned_cols=279 Identities=22% Similarity=0.305 Sum_probs=221.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEc--cCCCcchHHHHHHHHHHHccCCCceeeEEEEEee-----CC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLD--RNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD-----GD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-----~~ 149 (399)
....|...+.||.|+||.|..+.+..+++.||||++. .......++..+|+.+|+.++|+||+.+++++.. -+
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3456777899999999999999999999999999997 3344455778999999999999999999999865 45
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..|+|+|+| +.+|...++. +..|+...+..++.|++.||.|+|+.+ |+||||||.|+|++.+..+||+|||+
T Consensus 100 DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred eeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 789999999 6799999976 556999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCcccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
|+...........+....|..|.|||++. ...|+.+.||||.|||+.||++|++.|.+.+...+..++....+...+ .
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~-e 250 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE-E 250 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH-H
Confidence 99754433333445677899999999875 568999999999999999999999999998876665555433222211 1
Q ss_pred hhhhcc---------------CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--HHHhhhccccc
Q 046609 309 KFTMMA---------------DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA--IEYLAHSKEEA 365 (399)
Q Consensus 309 ~~~~~~---------------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~l~~~~~~~ 365 (399)
.+..+. ...+...++ ......++|+.+||..||.+|+|++|.+++ |+.+.....|+
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence 111111 001111112 344578899999999999999999999876 44444444444
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=334.79 Aligned_cols=268 Identities=20% Similarity=0.251 Sum_probs=206.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|++..++..||+|++..... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468899999999999999999999999999999875432 233567889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 9988766554432 356999999999999999999999999 999999999999999999999999999764332
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh--------hhccc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL--------FKDRR 308 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--------~~~~~ 308 (399)
... ......|++.|+|||++.+..++.++|||||||++|+|++|++||......+....+...... +....
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred ccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 211 122356899999999999889999999999999999999999999876543221111111000 00000
Q ss_pred hhhhccCCccC------CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLE------GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.......+... ..+....+..+.+|+.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000001100 01111234578999999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=344.51 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=208.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368889999999999999999998999999999975422 23356788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999975 456899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
......|++.|+|||++.+..++.++|||||||++|+|++|..||......+....+......+ ..
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------~~ 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL---------QR 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc---------cC
Confidence 2234569999999999999999999999999999999999999998765433211111000000 00
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+.. ..........+.+++.+||..+|.+||++.+++.+
T Consensus 220 ~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 220 PVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 100 00012334578899999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=338.45 Aligned_cols=246 Identities=24% Similarity=0.314 Sum_probs=205.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 368889999999999999999998999999999865322 23355788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999976 456899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. .....|++.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ....
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~-------- 214 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LAGK-------- 214 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC--------
Confidence 1 12346899999999999889999999999999999999999999875432211110 0000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
..++......+.+++.+||+.||.+||+ +.+++++
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1122233457889999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=333.44 Aligned_cols=267 Identities=22% Similarity=0.293 Sum_probs=205.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 578999999999999999999999999999999975432 2234677899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDN---CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 96 599998875 2345889999999999999999999999 9999999999999999999999999987533222
Q ss_pred CccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh--------hhhccc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP--------LFKDRR 308 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~~ 308 (399)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|++||......+....+..... ......
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 11223468899999998865 5689999999999999999999999987654332222111100 000000
Q ss_pred hhhhccCCccCCC----CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGN----YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.....+..... ........+.+|+.+||+.||.+|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 1111111110000 011223567899999999999999999999754
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=335.70 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=205.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECC----------------CCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEG----------------TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNL 141 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l 141 (399)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578889999999999999998642 3457999998764322 23568899999999999999999
Q ss_pred EEEEeeCCeeEEEEEecCCCChHHhhccCC---------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046609 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLP---------------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206 (399)
Q Consensus 142 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH 206 (399)
++++.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999986521 11235788899999999999999999999 999
Q ss_pred cCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCC
Q 046609 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT--GRRV 284 (399)
Q Consensus 207 ~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~p 284 (399)
|||||+|||++.++.+||+|||++................++..|+|||++.++.++.++||||||+++|+|++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999975443332222333456789999999988899999999999999999986 5677
Q ss_pred CCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 285 IDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 285 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
|....... ........+...... .....+...+..+.+++.+||+.+|.+|||+.+|...|+
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTDEQ---VIENAGEFFRDQGRQ-------VYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCHHH---HHHHHHHHhhhcccc-------ccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 87654322 111111111110000 000112233457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=342.24 Aligned_cols=243 Identities=27% Similarity=0.363 Sum_probs=200.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
++||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345778999999999999999999999999999999999999
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccc
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV 241 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 241 (399)
+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~--~~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GAT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC--CCc
Confidence 99999876 457899999999999999999999999 999999999999999999999999998742211 122
Q ss_pred cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCC
Q 046609 242 STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321 (399)
Q Consensus 242 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 321 (399)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ ... . ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~--------~----~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME--------E----IR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------HcC--------C----CC
Confidence 23456999999999999999999999999999999999999999764432111100 000 0 11
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 322 YPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
++......+.+++.+||+.||.+|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2233455788999999999999999 79998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=342.02 Aligned_cols=246 Identities=28% Similarity=0.377 Sum_probs=204.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 578889999999999999999999999999999975422 23356788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999976 456899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. ....|++.|+|||++.+..++.++|||||||++|+|++|+.||....+.... .......
T Consensus 171 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~-------- 231 (329)
T PTZ00263 171 RT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------EKILAGR-------- 231 (329)
T ss_pred Cc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH------HHHhcCC--------
Confidence 21 2356999999999999999999999999999999999999999865432111 0111100
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
..++......+.+|+.+||+.||.+||+ +.+++.+
T Consensus 232 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 ----LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred ----cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 0112223346789999999999999997 6888765
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=345.16 Aligned_cols=262 Identities=25% Similarity=0.366 Sum_probs=206.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEE-----CCCCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 150 (399)
.++|.+.+.||+|+||.||+|.+ ..++..||||++..... .....+.+|+.++..+ +||||+++++++.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45788899999999999999974 34567899999875432 2345688899999999 89999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCC----------------------------------------------------------
Q 046609 151 RILVYEYMPNGSLEDHLLDLPP---------------------------------------------------------- 172 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 172 (399)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999865211
Q ss_pred -------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 173 -------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 173 -------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1235788999999999999999999999 999999999999999999999999999754333222
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... ...... ... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~----~~~----------~ 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI----KEG----------Y 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH----HhC----------c
Confidence 22222345678999999999999999999999999999998 889997654321 111111 100 0
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
....+...+..+.+++.+||+.||++||++.+|++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0001112234788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=321.31 Aligned_cols=271 Identities=24% Similarity=0.306 Sum_probs=214.2
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch--HHHHHHHHHHHccCCCceeeEEEEEee--CCe
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGYCVD--GDQ 150 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~ 150 (399)
|...++|+.++.|++|+||.||+|+++.+++.||+|+++....... -.-.+|+.+|.+.+|||||.+-.+... -+.
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~ 151 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDK 151 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccce
Confidence 4556789999999999999999999999999999999986542221 346789999999999999999888763 457
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.|+|||||+. +|...+... ..++...++..++.|++.|++|||.+. |+||||||+|+|++..|.+||+|||+|
T Consensus 152 iy~VMe~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLA 224 (419)
T KOG0663|consen 152 IYIVMEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLA 224 (419)
T ss_pred eeeeHHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchh
Confidence 8999999954 999999874 357999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh--------
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT-------- 301 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------- 301 (399)
+.+... ....+..+.|..|.|||++.+ ..|+.+.|+||+|||+.||+++++.|.+....++.+.+-...
T Consensus 225 R~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iw 302 (419)
T KOG0663|consen 225 REYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIW 302 (419)
T ss_pred hhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccC
Confidence 975444 333455778999999999987 479999999999999999999999999987655444332111
Q ss_pred hhhhccchh-----hhccCCccCCCCCHH-HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 302 PLFKDRRKF-----TMMADPLLEGNYPIK-GLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 302 ~~~~~~~~~-----~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+-+.....+ ..-.-..++..+... ....-.+|+..+|..||.+|.|+.+.|++
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 111111100 000111122222222 33567889999999999999999999876
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=310.34 Aligned_cols=251 Identities=27% Similarity=0.373 Sum_probs=215.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
+.++|++.+.||+|.||.||+|+.+.++-.||+|++.+... ....++.+|++|...|+||||+++|++|.+....||
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34689999999999999999999999999999999876432 334678899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
++||.++|+|...|+.. ....+++.....++.|++.||.|+|..+ ++||||||+|+|++.+|.+||+|||-+...
T Consensus 100 ilEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999863 2566899999999999999999999999 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
+ .......+||..|.|||...+..++..+|+|++|++.||++.|.+||......+....+ ...+.
T Consensus 175 p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI----------~k~~~- 239 (281)
T KOG0580|consen 175 P----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI----------RKVDL- 239 (281)
T ss_pred C----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH----------HHccc-
Confidence 3 33445688999999999999999999999999999999999999999976532211111 11111
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+|...+..+.++|.+|+..+|.+|.+..+++++
T Consensus 240 -------~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 -------KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -------cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 2234455688899999999999999999999876
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=344.05 Aligned_cols=267 Identities=27% Similarity=0.442 Sum_probs=216.2
Q ss_pred HHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCC
Q 046609 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD 149 (399)
Q Consensus 72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 149 (399)
.+..+..+...+...||.|.||+||+|.+.+ .||||+++..... ..+.|.+|+.++++-+|.||+-++|+|..+.
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 4555666777888999999999999999986 3999999865543 3477999999999999999999999999887
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
. .+|..+|+|.+|+.+|+.. ...+...+.+.|+.|+++|+.|||.++ |||||||..|||+.++++|||+|||+
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccc
Confidence 7 9999999999999999973 466899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
+................|...|||||+++. .+|+..+||||||+++|||++|..||.....+. +-|. .
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq----Iifm-----V 605 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIFM-----V 605 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh----eEEE-----e
Confidence 975443333333344568889999999964 589999999999999999999999999433221 1110 0
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.. -....+. .........++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 606 Gr-G~l~pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 GR-GYLMPDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cc-cccCccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 00 0000010 011234556889999999999999999999999999888764
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=345.11 Aligned_cols=263 Identities=26% Similarity=0.382 Sum_probs=206.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 150 (399)
.++|.+.+.||+|+||.||+|.+.. +...||+|.+...... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4578899999999999999998643 3457999999754322 235678899999999 89999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCC-----------------------------------------------------------
Q 046609 151 RILVYEYMPNGSLEDHLLDLP----------------------------------------------------------- 171 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~----------------------------------------------------------- 171 (399)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999986421
Q ss_pred -------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcccccc
Q 046609 172 -------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR 244 (399)
Q Consensus 172 -------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 244 (399)
....++++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++..............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 01235788999999999999999999999 99999999999999999999999999875433322222223
Q ss_pred ccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 245 VMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 245 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
..++..|+|||++.+..++.++|||||||++|+|++ |+.||........ ..... .. ......+
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~~~~----~~----------~~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FYKMV----KR----------GYQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HHHHH----Hc----------ccCccCC
Confidence 345678999999988999999999999999999997 9999986543211 00000 00 0000111
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
...+..+.+++.+||+.||.+||++.+|++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 122357889999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=329.89 Aligned_cols=259 Identities=31% Similarity=0.494 Sum_probs=209.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCC-----eEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTN-----QDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|.+.+.||+|+||.||+|.....+ ..||+|.+...... ....+.+|+.++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 47888999999999999999876544 67999998754322 2356889999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC
Q 046609 153 LVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF 220 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~ 220 (399)
++|||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999976321 1156889999999999999999999999 99999999999999999
Q ss_pred CeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHh
Q 046609 221 NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTW 299 (399)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 299 (399)
.++|+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||......+....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i-- 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMI-- 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999975433332223333456889999999988899999999999999999998 99999875543211110
Q ss_pred hhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 300 ATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
.. ......+...+..+.+|+.+||+.||.+||++.+|+++|+.
T Consensus 240 -----~~----------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 240 -----RS----------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -----Hc----------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 00 00111233445688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=336.95 Aligned_cols=266 Identities=21% Similarity=0.282 Sum_probs=208.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||++.+..++..+|+|.+..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4689999999999999999999999999999999875432 223568899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQ---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 9999999999976 45689999999999999999999985 5 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc--------
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR-------- 307 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------- 307 (399)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...+..+...... .......
T Consensus 157 ~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPVVDGEEGEPHSIS 230 (331)
T ss_pred c----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccccccccCCccccC
Confidence 2 1223468999999999998899999999999999999999999997654322111100 0000000
Q ss_pred ------------------------chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 308 ------------------------RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 308 ------------------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
.....+................+.+|+.+||+.||++|||+.+++++--
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~ 303 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF 303 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence 0000000000000001123457899999999999999999999998743
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=354.23 Aligned_cols=255 Identities=19% Similarity=0.215 Sum_probs=208.3
Q ss_pred CCCCCCeeccCCcEEEEEEEECCC-CeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGT-NQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.|.+.+.||+|++|.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 488899999999999999998776 7889999876554444456788999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988654334567899999999999999999999999 99999999999999999999999999986544332
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......+... ..... ...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~~~~~------~~~--- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------QVLYG------KYD--- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhC------CCC---
Confidence 223344679999999999999999999999999999999999999997644321110 00000 000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+......+.+++.+||+.+|++||++.+++.+
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1122334578899999999999999999999754
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=326.32 Aligned_cols=257 Identities=26% Similarity=0.388 Sum_probs=205.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+. ..+..||+|.+..... .....+.+|+.++.+++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 457888999999999999999864 3467899999876532 223568899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++++|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999976 2356899999999999999999999999 999999999999999999999999987643
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.... ........++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .... ...
T Consensus 158 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----~~~----- 224 (266)
T cd05064 158 KSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IKAV----EDG----- 224 (266)
T ss_pred cccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH----HCC-----
Confidence 2211 111112335678999999999999999999999999999775 9999987654221 1110 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.. ...+...+..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 225 -~~----~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 -FR----LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred -CC----CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00 011223445788999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=333.23 Aligned_cols=262 Identities=27% Similarity=0.431 Sum_probs=208.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCe----EEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQ----DVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
..+|++.+.||+|+||.||+|.+..++. .||+|.+..... .....+..|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3578999999999999999998765544 489999875432 3346788899999999999999999999865 568
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 85 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred eeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccc
Confidence 99999999999999986 2346889999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..............++..|+|||++.+..++.++||||||+++|+|++ |..||........... .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~-------~~~~~--- 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGE--- 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------HhCCC---
Confidence 544333222222335678999999999999999999999999999998 9999986543221110 11100
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
....+......+.+++.+||+.+|.+||++.+++..|..+.....
T Consensus 229 -------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~ 273 (316)
T cd05108 229 -------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 273 (316)
T ss_pred -------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCc
Confidence 001112233468899999999999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=336.50 Aligned_cols=243 Identities=26% Similarity=0.373 Sum_probs=200.5
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
++||+|+||.||++.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 23356788999999999999999999999999999999999999
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccc
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV 241 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 241 (399)
+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AAT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccc
Confidence 99998875 456999999999999999999999999 999999999999999999999999998743221 112
Q ss_pred cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCC
Q 046609 242 STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321 (399)
Q Consensus 242 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 321 (399)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ ... . ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~~--------~----~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME--------D----IK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------ccC--------C----cc
Confidence 23356999999999999899999999999999999999999999865432211110 000 0 11
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 322 YPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
++......+.+++.+||+.||.+|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2233445788999999999999997 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=330.59 Aligned_cols=266 Identities=21% Similarity=0.292 Sum_probs=201.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|....+++.||||++..... .....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 4689999999999999999999998899999999875432 223457789999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+ .++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YV-HTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CC-CcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99 4688888865 2456899999999999999999999999 999999999999999999999999998643222
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc--cchh---
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD--RRKF--- 310 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~--- 310 (399)
. .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||........ ........... ...+
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccch
Confidence 1 12233568999999998865 4588899999999999999999999987543211 11000000000 0000
Q ss_pred ---hhc--------cCCccCCCC-CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 ---TMM--------ADPLLEGNY-PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ---~~~--------~~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ....+...+ .......+.+|+.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 000 000000000 00122467899999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=336.66 Aligned_cols=243 Identities=27% Similarity=0.356 Sum_probs=199.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
++||+|+||.||++.+..++..||+|++..... .....+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345678999999999999999999999999999999999999
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccc
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV 241 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 241 (399)
+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988875 456899999999999999999999999 9999999999999999999999999987422211 12
Q ss_pred cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCC
Q 046609 242 STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321 (399)
Q Consensus 242 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 321 (399)
.....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+........ .... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~~------------~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEE------------IR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC------------CC
Confidence 23356999999999999999999999999999999999999999865432211110 0000 01
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 322 YPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
++......+.+++.+||+.||.+|| ++.+++++
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2223445788999999999999998 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-45 Score=340.82 Aligned_cols=247 Identities=25% Similarity=0.399 Sum_probs=209.4
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
...++-||.|+.|.||+|+.+ ++.||||+++.- -..+|.-|++|+||||+.+.|+|.....+|||||||+.
T Consensus 126 IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhhccCcccceeeeecc--CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 344678999999999999998 688999998532 23478899999999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|.|.+.|+. ...++......+..+|+.|+.|||.+. |||||||.-||||+.+..+||+|||-++..... .
T Consensus 197 GqL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S 266 (904)
T KOG4721|consen 197 GQLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S 266 (904)
T ss_pred ccHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence 999999987 678999999999999999999999999 999999999999999999999999998753222 3
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
....++||..|||||++.+.+.+.|+|||||||+|||||||..||.+.+.... .|... ...+.-
T Consensus 267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----IwGVG------------sNsL~L 330 (904)
T KOG4721|consen 267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IWGVG------------SNSLHL 330 (904)
T ss_pred hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EEecc------------CCcccc
Confidence 44558899999999999999999999999999999999999999997654321 11111 111222
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
..|..++..+.-|+++||+-.|.+||++.+|+.+|+-+...-
T Consensus 331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 345667778999999999999999999999999998655433
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=327.44 Aligned_cols=264 Identities=28% Similarity=0.409 Sum_probs=211.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEE-----CCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
..+|.+.+.||+|+||.||++.. ..++..+|+|.+..........+.+|+.++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 35788889999999999999985 3345679999987655445567899999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 153 LVYEYMPNGSLEDHLLDLP---------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
+||||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999997532 12235899999999999999999999999 99999999999999999999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhh
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 302 (399)
|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |.+||...........+
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i----- 235 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----- 235 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----
Confidence 999999875433322222223345778999999988899999999999999999998 99999765532211000
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
... . ... .+...+..+.+++.+||+.+|.+|||+.++++.|+++...
T Consensus 236 -~~~-~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 236 -TQG-R------VLQ----RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -HcC-C------cCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 000 0 000 1112334689999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=321.69 Aligned_cols=262 Identities=20% Similarity=0.290 Sum_probs=212.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||.|+||.||+|....++..||||.+..... .....+.+|+.+++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 578999999999999999999998899999998864322 22345788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.........+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988754444566899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... ....... .....
T Consensus 159 ~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~----------~~~~~ 225 (267)
T cd08228 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI----------EQCDY 225 (267)
T ss_pred hh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH----------hcCCC
Confidence 22 11223458889999999988889999999999999999999999997543211 0111100 00000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
+ ...+......+.+++.+||+.+|.+||++.+|++.|++++
T Consensus 226 ~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 P---PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C---CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 1112234467889999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=352.69 Aligned_cols=262 Identities=22% Similarity=0.251 Sum_probs=211.6
Q ss_pred HHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCC-
Q 046609 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD- 149 (399)
Q Consensus 73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~- 149 (399)
+.....++|.+.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.++..++|+||++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 3344568999999999999999999999989999999999765432 2355788999999999999999988775432
Q ss_pred -------eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 150 -------QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 150 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 367999999999999999765445567999999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. ...
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHH
Confidence 99999999765433333333446799999999999999999999999999999999999999986543211 111
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... .. ...+...+..+.+++.+||+.||.+||++.+++.+
T Consensus 257 ~~~~------~~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TLAG------RY-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HhcC------CC-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0000 00 01223344578899999999999999999999865
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=334.99 Aligned_cols=241 Identities=26% Similarity=0.339 Sum_probs=197.2
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||+|+||.||+|.+..+++.||+|.+.... ......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999999999999999986532 22335577899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999976 456899999999999999999999999 9999999999999999999999999987532221 2223
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......... ..++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~~~~------------~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKILQEP------------LRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCC------------CCCC
Confidence 4569999999999999999999999999999999999999998654221 111111110 0122
Q ss_pred HHHHHHHHHHHhhccccCCCCCCC---hHHHHHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRPM---MSDVVTA 354 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~ 354 (399)
......+.+++.+||+.||.+||+ +.+++.+
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 234457889999999999999985 5565544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=339.66 Aligned_cols=268 Identities=31% Similarity=0.427 Sum_probs=217.6
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCC----eEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEe
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTN----QDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~ 146 (399)
.....++..+.++||+|+||.||+|.....+ ..||||...... .....++.+|++++++++|||||++||++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3344566677799999999999999885432 238999987532 334477999999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
....+++|||+|+||+|.++|+.. ...++..+...++.+.+.||+|||+++ ++||||..+|+|++.++.+||+|
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISD 305 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISD 305 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCc
Confidence 999999999999999999999983 346999999999999999999999999 99999999999999999999999
Q ss_pred ccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhh
Q 046609 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFK 305 (399)
Q Consensus 227 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 305 (399)
||+++... ..........-+..|+|||.+..+.|+.++|||||||++||+++ |..||.+.........+.
T Consensus 306 FGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------- 376 (474)
T KOG0194|consen 306 FGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------- 376 (474)
T ss_pred cccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH-------
Confidence 99998533 11111112346789999999999999999999999999999999 888999876543221110
Q ss_pred ccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccc
Q 046609 306 DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365 (399)
Q Consensus 306 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~ 365 (399)
....+...+...+..+..++.+||..+|++||+|.++.+.|+.+.......
T Consensus 377 ---------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~ 427 (474)
T KOG0194|consen 377 ---------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF 427 (474)
T ss_pred ---------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence 111111223344567778899999999999999999999999998876643
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=325.93 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=207.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
.+|.+.+.||+|+||.||+|.+.. ++..||||.+...... ....+.+|+.+++.++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998743 3578999999765443 3467899999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCC----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 153 LVYEYMPNGSLEDHLLDLP----------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
+||||+++++|.+++.... .....+++..+..++.|++.||.|||+++ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997531 22345889999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (399)
+|+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~---~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI---T 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H
Confidence 9999999875332222222223346788999999999999999999999999999998 99999765432211111 0
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
... ....+...+..+.+++.+||+.||++||++.+|++.|+
T Consensus 239 -------------~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 -------------QGR-LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred -------------cCC-cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 000 00112234457889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=321.36 Aligned_cols=258 Identities=26% Similarity=0.443 Sum_probs=208.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+..+ ...||||.+...... ....+..|+.++++++||||+++++++...+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 35788999999999999999998643 467999998754322 23568889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
+|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 83 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 83 ITEYMENGSLDKFLRE---NDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 9999999999999976 2347899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.............++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~~~~~~~-------- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IKAVEDGY-------- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HHHHHcCC--------
Confidence 42222222222345678999999988899999999999999999998 9999976543211 11110000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
....+...+..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus 226 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ------RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0011223345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=319.20 Aligned_cols=249 Identities=26% Similarity=0.405 Sum_probs=199.8
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
+.||+|+||.||+|.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 469999999999999988899999998864432 2335688999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
.+++.. ....+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999975 2346899999999999999999999999 9999999999999999999999999987533221111111
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNY 322 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 322 (399)
....+..|+|||.+.++.++.++||||||+++|+|++ |..||............. . ......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------~----------~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------Q----------GVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------c----------CCCCCC
Confidence 1223567999999988899999999999999999997 889997654321111000 0 001111
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 323 PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-45 Score=324.55 Aligned_cols=271 Identities=24% Similarity=0.321 Sum_probs=211.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC-----eeEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD-----QRILV 154 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv 154 (399)
.|...+++|.|+||.||+|....+++.||||++-.+.. .-.+|+.+|+.+.|||||++..+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 35567999999999999999999999999999865432 2335899999999999999999886432 34589
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-CCeeEecccCccCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAKLG 233 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~ 233 (399)
|||++. +|.+.++.....+..++.-.+.-+..||++||.|||+.+ |+||||||.|+|+|.+ |.+||||||.|+..
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999964 999999865555778999999999999999999999999 9999999999999976 99999999999976
Q ss_pred CCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc-----
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR----- 307 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----- 307 (399)
..+... .....|..|.|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+...+...+..+.+...+.
T Consensus 177 ~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m 253 (364)
T KOG0658|consen 177 VKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM 253 (364)
T ss_pred ccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence 655544 234578899999999874 79999999999999999999999999976554443332222211111
Q ss_pred ------chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--HHHhhhc
Q 046609 308 ------RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA--IEYLAHS 361 (399)
Q Consensus 308 ------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~l~~~ 361 (399)
..+..+....+..-+......++.+|+.++|+.+|.+|.++.+++.+ ++.++..
T Consensus 254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 11111111111112344556789999999999999999999999865 5555444
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=338.49 Aligned_cols=247 Identities=26% Similarity=0.339 Sum_probs=203.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC-eEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN-QDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+..++ ..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 357899999999999999999876554 6899999865322 233567889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999976 456999999999999999999999999 999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...++......+ ....
T Consensus 182 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i------~~~~------ 244 (340)
T PTZ00426 182 DTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKI------LEGI------ 244 (340)
T ss_pred CCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHH------hcCC------
Confidence 321 12356999999999999888999999999999999999999999875442211111 0000
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
..++......+.+++.+||+.||.+|+ ++++++++
T Consensus 245 ------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 011222334678999999999999995 89988776
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=320.95 Aligned_cols=256 Identities=27% Similarity=0.409 Sum_probs=208.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|.+.+.||+|++|.||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999999889999999987543 33467889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999752 2346899999999999999999999999 99999999999999999999999999876433221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. ......++..|+|||.+.+..++.++|||||||++|+|++ |..||......+..... .. .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~----------~ 221 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------EK----------G 221 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HC----------C
Confidence 1 1111234568999999988999999999999999999998 99999765432211000 00 0
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11112233445788999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=318.19 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=209.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCc-eeeEEEEEeeCC------e
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPY-LVNLVGYCVDGD------Q 150 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~------~ 150 (399)
.|...++||+|+||+||+|+...+|+.||+|+++..... .-....+|+.+++.++|+| |+.+++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 455567899999999999999999999999999865432 2355788999999999999 999999999887 7
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++|+||+ .-+|..++.........++...+..++.||+.||.|||+++ |+||||||.||||+.+|.+||+|||+|
T Consensus 92 l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 92 LYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred EEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchH
Confidence 89999999 56999999986543356888999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
+...... ...+...+|..|.|||++.+. .|+...||||+|||++||+++++.|.+....++...+-........ ..
T Consensus 168 ra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e-~~ 244 (323)
T KOG0594|consen 168 RAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNE-KD 244 (323)
T ss_pred HHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCc-cC
Confidence 8543332 234556799999999999886 7999999999999999999999999987764333222111111000 11
Q ss_pred hhhcc---CC--ccC-----CCCCHHHH---HHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMA---DP--LLE-----GNYPIKGL---YQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~---~~--~l~-----~~~~~~~~---~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
++... +- ... ..+..... .+..+++.+||+.+|.+|.|++.++++
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111 00 000 00111111 377889999999999999999999987
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=332.30 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=205.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|++.+.||.|+||.||++.+..++..+|+|.+..... .....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4689999999999999999999999999999999875422 223568899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+. + |+|+||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999976 45689999999999999999999974 6 99999999999999999999999999864322
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-hhh---------
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-LFK--------- 305 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~--------- 305 (399)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||................. ...
T Consensus 157 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 157 S----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred h----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccC
Confidence 1 12234689999999999888899999999999999999999999976443211100000000 000
Q ss_pred -----------cc---chhhhccCCccC---CCC-CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 -----------DR---RKFTMMADPLLE---GNY-PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 -----------~~---~~~~~~~~~~l~---~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. .....+.+.... ... .......+.+|+.+||+.||++||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 00 000000000000 000 01133568899999999999999999999876
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=322.54 Aligned_cols=256 Identities=29% Similarity=0.436 Sum_probs=212.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
..+|.+.+.||.|+||.||+|.+.. +..+++|.+..........+..|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3568888999999999999999987 888999999877655667789999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||.+.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999863 2456899999999999999999999999 9999999999999999999999999997543322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+..... ..
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~-------------- 219 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI---TA-------------- 219 (261)
T ss_pred c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH---Hh--------------
Confidence 1 1223346778999999988899999999999999999998 89999765532211111 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
......+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 001111233445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=325.54 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=212.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.+|.+.+.||+|+||.||+|... .++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46778899999999999999863 2456789999876655555778999999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC
Q 046609 154 VYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~ 221 (399)
||||+++++|.+++..... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975321 2245899999999999999999999999 999999999999999999
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (399)
++|+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~---~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC---I 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---H
Confidence 99999999875433322222233456788999999999999999999999999999998 9999976554221110 0
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.. ... ...+...+..+.+++.+||+.+|.+||++.+|++.|+++...
T Consensus 239 ----~~---------~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 ----TQ---------GRV-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred ----hC---------CCC-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 00 000 011122345788999999999999999999999999999664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=329.71 Aligned_cols=242 Identities=28% Similarity=0.441 Sum_probs=194.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHc-cCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSM-LSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..+++.||+|.+..... .....+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975321 223345566666664 4799999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999999876 456999999999999999999999999 9999999999999999999999999987532222 2
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... ..... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~------------~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD------SILND------------RP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHcC------------CC
Confidence 2234569999999999998899999999999999999999999998754321111 11000 01
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMS-DVVT 353 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~ 353 (399)
.++......+.+++.+||+.+|.+||++. ++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12223345678899999999999999875 5544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=323.82 Aligned_cols=260 Identities=26% Similarity=0.421 Sum_probs=205.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
.+++|++.+.||+|+||.||+|.+.+ ++..||||.+..... ....++.+|+.+++.++||||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45789999999999999999998643 356799999864322 234568899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeE
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPN------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 224 (399)
.++||||+++|+|.+++...... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999999753211 234678889999999999999999999 999999999999999999999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhh
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
+|||++................++..|+|||++.++.++.++||||||+++|+|++ |..||............ .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~---~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV---M-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H--
Confidence 99999875433322222222345778999999988899999999999999999999 78999765432211100 0
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
... . ...+...+..+.+++.+||+.+|++||++.++++.|+
T Consensus 236 --~~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 --EGG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred --cCC-c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 000 0 0111223457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=340.15 Aligned_cols=254 Identities=26% Similarity=0.290 Sum_probs=200.9
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.|.+.+.||+|+||.||+|.+..++..||||++..... .....+..|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58888999999999999999999999999999975432 223457889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999976 456899999999999999999999999 999999999999999999999999997532110
Q ss_pred CC---------------------------------------------ccccccccccccccccccccCCCCCchhhHHHH
Q 046609 237 DK---------------------------------------------SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSF 271 (399)
Q Consensus 237 ~~---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 271 (399)
.. ........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 000123469999999999988899999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhh--ccccCCCCCCChH
Q 046609 272 GVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAM--CLQEEAGTRPMMS 349 (399)
Q Consensus 272 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~--cl~~dp~~RPs~~ 349 (399)
||++|||++|..||....+.+....+. .... .+...........+.+++.+ |+..+|..||++.
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~------~~~~--------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~ 300 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVI------NWEN--------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGAD 300 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHH------cccc--------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 999999999999998755432111110 0000 00000011233467788877 5566666799999
Q ss_pred HHHHH
Q 046609 350 DVVTA 354 (399)
Q Consensus 350 eil~~ 354 (399)
+++.+
T Consensus 301 ~~l~h 305 (381)
T cd05626 301 DIKAH 305 (381)
T ss_pred HHhcC
Confidence 99876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=335.03 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=217.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCCe-eEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ-RILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~ 155 (399)
++|..+++||+|+||.+++++++..++.+++|++....... .+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57888999999999999999999999999999997655433 3467889999999999999999999998888 99999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
+||+||+|.+.+.... +.-+++..+..++.|++.|+.|||++. |+|||||+.|||++.++.++|.|||+|+....
T Consensus 84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 9999999999998743 567999999999999999999999998 99999999999999999999999999997544
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. .......||+.|+.||++.+.+|+.|+|||||||++|||++-+++|...+.......+ ....
T Consensus 159 ~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki------------~~~~-- 222 (426)
T KOG0589|consen 159 ED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKI------------NRGL-- 222 (426)
T ss_pred ch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHH------------hhcc--
Confidence 43 2445578999999999999999999999999999999999999999986643211111 1111
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+..++.++..++..||+.+|..||++.+++.+
T Consensus 223 ---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 ---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 223466777899999999999999999999999987
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=338.05 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=208.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCC-----CeEEEEEEEccCCC-cchHHHHHHHHHHHccC-CCceeeEEEEEeeCC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGT-----NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~ 149 (399)
..++|.+.++||+|+||.||+|.+... +..||||++..... .....+.+|+.++..+. ||||+++++++.+.+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 346888999999999999999987432 35799999975432 23356889999999996 999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCC---------------------------------------------------------
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPP--------------------------------------------------------- 172 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 172 (399)
..++||||+++|+|.+++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999998865211
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC
Q 046609 173 -----------------------------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD 217 (399)
Q Consensus 173 -----------------------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~ 217 (399)
....+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEe
Confidence 1135788899999999999999999999 99999999999999
Q ss_pred CCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchh
Q 046609 218 QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNL 296 (399)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 296 (399)
.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||........ .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence 999999999999875433322222223456788999999988899999999999999999997 9999976532211 0
Q ss_pred hHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 297 VTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
... .... .....+...+..+.+++.+||+.+|++||++.+|++.|+.+.+
T Consensus 350 ~~~----~~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 YNK----IKSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH----HhcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 000 0000 0011122344578899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=333.78 Aligned_cols=266 Identities=23% Similarity=0.353 Sum_probs=200.2
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeC-----CeeE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG-----DQRI 152 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 152 (399)
+|.+.++||+|+||.||+|.+..++..||||.+.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999999999999999987432 22345688999999999999999999988643 2479
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999999 5789998875 456999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCC-ccccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-h-----
Q 046609 233 GPTGDK-SHVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-L----- 303 (399)
Q Consensus 233 ~~~~~~-~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~----- 303 (399)
...... ........|++.|+|||++.+ ..++.++|||||||++|+|++|++||...........+..... .
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 322221 111233568999999998865 6789999999999999999999999987543221111100000 0
Q ss_pred --hhc---cchhhhcc---CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 --FKD---RRKFTMMA---DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 --~~~---~~~~~~~~---~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ......+. .......+ ......+.+++.+||+.||.+||++++++++
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 00000000 00000000 1123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=337.59 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=199.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|++.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478899999999999999999999999999999975322 22345778999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999976 457999999999999999999999999 99999999999999999999999999875322
Q ss_pred CCCc---------------------------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 046609 236 GDKS---------------------------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282 (399)
Q Consensus 236 ~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 282 (399)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 1100 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccc--cCCCCCCChHHHHHH
Q 046609 283 RVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQ--EEAGTRPMMSDVVTA 354 (399)
Q Consensus 283 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~--~dp~~RPs~~eil~~ 354 (399)
.||....+.+....+. .... .....+ . ......+.+++.+++. .++..||++++|+++
T Consensus 234 ~Pf~~~~~~~~~~~i~------~~~~--~~~~p~----~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQETYKKVM------NWKE--TLIFPP----E--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHHHHHHHH------cCcC--cccCCC----c--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9998755432111110 0000 000011 0 0123356667766443 334456999999887
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=330.62 Aligned_cols=248 Identities=27% Similarity=0.400 Sum_probs=200.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCC-CceeeEEEEEeeCCeeEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSN-PYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~ 155 (399)
+|.+.+.||+|+||.||+|.+..+++.||||++..... .....+..|..++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 57888999999999999999999999999999975421 233557788899998876 56888999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999875 456899999999999999999999999 99999999999999999999999999864222
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ...
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~~--------- 216 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------MEH--------- 216 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HcC---------
Confidence 11 1223456999999999999999999999999999999999999999865432111100 000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM-----SDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 354 (399)
...++......+.+++.+||..||.+||+. .+++++
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 011222344578899999999999999986 566544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=341.07 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=203.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 478899999999999999999999999999999975422 22345778999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999976 456999999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcc------------------------------------ccccccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 046609 236 GDKSH------------------------------------VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEII 279 (399)
Q Consensus 236 ~~~~~------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ell 279 (399)
..... ......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 11000 011246999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC---hHHHHHH
Q 046609 280 TGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM---MSDVVTA 354 (399)
Q Consensus 280 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~ 354 (399)
+|..||....+......+ ....... . ... ....+..+.+++.+|+. +|.+|++ +.+++.+
T Consensus 234 ~G~~Pf~~~~~~~~~~~i------~~~~~~~---~---~~~--~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQETYRKI------INWKETL---Q---FPD--EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHHHHHHHH------HcCCCcc---C---CCC--CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999876542211100 0000000 0 000 11223467889999996 8999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=332.36 Aligned_cols=246 Identities=27% Similarity=0.396 Sum_probs=197.6
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHH---HccCCCceeeEEEEEeeCCeeEEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLML---SMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l---~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
|.+.+.||+|+||.||+|.+..+++.||||.+..... ...+.+..|+.++ ..++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 5678899999999999999999999999999975421 2234456666554 566799999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988854 46999999999999999999999999 9999999999999999999999999986422
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||.......... ......
T Consensus 153 ~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~------~i~~~~------- 217 (324)
T cd05589 153 GF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD------SIVNDE------- 217 (324)
T ss_pred CC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC-------
Confidence 21 122234569999999999999999999999999999999999999998654322111 000100
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
..++...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 012223345788999999999999999 56777654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=324.05 Aligned_cols=250 Identities=34% Similarity=0.545 Sum_probs=196.7
Q ss_pred CCeeccCCcEEEEEEEEC----CCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 84 DNLLGEGGFGRVYRGKLE----GTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+.||.|.||.||+|.+. ..+..|+||.+...... ..+.+.+|+..+++++||||+++++++...+..++|+||+
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 478999999999999987 44678999999654322 3578999999999999999999999999888899999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.++|... ....+++..++.|+.|++.||.|||+.+ ++|+||+++||+++.++.+||+|||++........
T Consensus 84 ~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 84 PGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999883 2467999999999999999999999999 99999999999999999999999999986533333
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
............|+|||.+.+..++.++||||||+++|||++ |+.||....... ..... ....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~~~~----~~~~--------- 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---IIEKL----KQGQ--------- 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HHHHH----HTTE---------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccc----cccc---------
Confidence 333334557789999999988889999999999999999999 789987764322 11111 0000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
....+...+..+.+++.+||+.+|.+||++.+|++.|
T Consensus 223 -~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 -RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0111223345788999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=323.22 Aligned_cols=249 Identities=26% Similarity=0.351 Sum_probs=200.3
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||+|+||+||++.+..+++.||+|.+....... ...+..|+.+++.++||||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999999899999999987543222 24567899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
..++......+..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888654344567999999999999999999999999 99999999999999999999999999875433321 223
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
...|++.|+|||++.+..++.++||||||+++|+|++|+.||............ ... +.... ..++
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~----------~~~~~--~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQR----------ILNDS--VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH--HHh----------hcccC--CCCc
Confidence 356899999999999999999999999999999999999999865432111000 000 00110 1123
Q ss_pred HHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
...+..+.+++.+||+.||.+|| ++++++.+
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 33456788999999999999999 66777654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-44 Score=339.80 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=206.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+..|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 478899999999999999999998999999999975422 23356788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 99999999999976 357999999999999999999999999 99999999999999999999999999975433
Q ss_pred CC---------------------------CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 046609 236 GD---------------------------KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNS 288 (399)
Q Consensus 236 ~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 288 (399)
.. .........||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 001123356899999999999999999999999999999999999999876
Q ss_pred CCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-hHHHHHH
Q 046609 289 RPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-MSDVVTA 354 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~~ 354 (399)
........+ ..... ....+. ....+..+.+++.+||. +|.+||+ +.+++.+
T Consensus 234 ~~~~~~~~i------~~~~~---~~~~p~-----~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 234 TLQETYNKI------INWKE---SLRFPP-----DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred CHHHHHHHH------hccCC---cccCCC-----CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 532211111 00000 000000 01134578899999997 9999999 9999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=320.29 Aligned_cols=258 Identities=29% Similarity=0.432 Sum_probs=204.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCe----EEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQ----DVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.+|.+.+.||+|+||.||+|.+..++. .+++|.+..... ....++..|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 467888999999999999999876665 477777754322 122557778888999999999999998864 45788
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
++||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999976 2356899999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.............++..|+|||.+.++.++.++||||||+++|||++ |..||....+.....+. .... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~-------~~~~---~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL-------EKGE---R 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-------HCCC---c
Confidence 43333223334557788999999988899999999999999999998 99999876543221111 1100 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
... +......+.+++.+||..+|.+||++.++++.|..+..
T Consensus 230 ~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 LAQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 001 11123467789999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=321.97 Aligned_cols=261 Identities=28% Similarity=0.406 Sum_probs=207.4
Q ss_pred CCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
+|++.+.||+|+||.||+|.... ....+++|.+..... .....+.+|+.+++.++||||+++++.+..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998742 235788888865432 223568889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 046609 154 VYEYMPNGSLEDHLLDLPP--------------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASN 213 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~N 213 (399)
++||+.+|+|.+++...+. ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999865321 1235889999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 046609 214 VLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTE 292 (399)
Q Consensus 214 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 292 (399)
|+++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999999875433222222223446778999999988889999999999999999998 999997654332
Q ss_pred cchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 293 EQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
..... . .......+......+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 238 ~~~~~---~--------------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 LFNLL---K--------------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHH---h--------------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 11111 0 001111122334578899999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=335.06 Aligned_cols=243 Identities=27% Similarity=0.358 Sum_probs=198.9
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
+.||+|+||.||++.+..++..||+|++..... .....+..|+.++..++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 469999999999999999999999999975422 22345678999999999999999999999999999999999999
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
+|..++.. ...+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99998875 4568999999999999999999997 68 9999999999999999999999999987422211 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------~~~~------------~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE------------I 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------hcCC------------C
Confidence 223356999999999999999999999999999999999999999765432111111 0000 0
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
.++......+.+++.+||+.||.+|+ ++.+++++
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 11223345788999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=336.79 Aligned_cols=254 Identities=25% Similarity=0.282 Sum_probs=204.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 468889999999999999999999999999999975432 23355778999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999762 357999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYAL------TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.......... .....
T Consensus 155 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~--- 224 (330)
T cd05601 155 NKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNF--- 224 (330)
T ss_pred CCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcC---
Confidence 2221 223356899999999886 4567889999999999999999999998654322111 11000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... +.-.........+.+++.+||+ +|.+||++.+++.+
T Consensus 225 -~~~----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 225 -QRF----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -CCc----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 000 0000011234568889999998 99999999999865
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=336.06 Aligned_cols=263 Identities=18% Similarity=0.203 Sum_probs=201.7
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
...+|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.++||||+++++++......++|+|
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 3468999999999999999999999999999999753 2356789999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
++ +++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 164 ~~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RY-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cC-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 99 5789888865 356899999999999999999999999 999999999999999999999999998643221
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc----hhhHhhhhhhh-------
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ----NLVTWATPLFK------- 305 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~~------- 305 (399)
. ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...........
T Consensus 236 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~ 314 (391)
T PHA03212 236 N-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP 314 (391)
T ss_pred c-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence 1 11223457999999999999999999999999999999999999877543321110 00000000000
Q ss_pred --ccchhhhc---------cCCccCCCC--CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 --DRRKFTMM---------ADPLLEGNY--PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 --~~~~~~~~---------~~~~l~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........ ..+.....+ ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000 000000000 11234578899999999999999999999864
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=330.73 Aligned_cols=264 Identities=26% Similarity=0.389 Sum_probs=206.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEee-CC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVD-GD 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~-~~ 149 (399)
.++|.+.+.||.|+||.||+|...+ +++.||+|++..... ...+.+..|+.++.++ +||||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 3578999999999999999997533 357899999875432 2235677899999999 79999999998864 45
Q ss_pred eeEEEEEecCCCChHHhhccCCCC--------------------------------------------------------
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPN-------------------------------------------------------- 173 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------- 173 (399)
..+++|||+++++|.+++......
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 678999999999999998642210
Q ss_pred -CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcccccccccccccc
Q 046609 174 -RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252 (399)
Q Consensus 174 -~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~ 252 (399)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++................++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 136899999999999999999999999 9999999999999999999999999998643332222223345677899
Q ss_pred ccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHH
Q 046609 253 APEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQAL 331 (399)
Q Consensus 253 aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 331 (399)
|||++.+..++.++|||||||++|+|++ |..||......+. +. ...... .....+......+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~----~~~~~~----------~~~~~~~~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC----RRLKEG----------TRMRAPEYATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH----HHHhcc----------CCCCCCccCCHHHH
Confidence 9999999999999999999999999997 9999976433211 10 000100 00011223345788
Q ss_pred HHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 332 AVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 332 ~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
+++.+||+.+|.+||++.+|+++|+++.+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=315.52 Aligned_cols=262 Identities=20% Similarity=0.299 Sum_probs=212.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||.|++|.||+|....+++.||+|.+..... .....+.+|+.++++++|+||+++++.+.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 578999999999999999999998899999998864322 23456889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998765444567899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... .......... ....
T Consensus 159 ~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~------~~~~ 226 (267)
T cd08224 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEK------CDYP 226 (267)
T ss_pred CCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhhc------CCCC
Confidence 221 122345888999999998888999999999999999999999999754321 1110000000 0000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
+ .........+.+++.+||..+|.+||++.+|++.|+.+.
T Consensus 227 ~----~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 227 P----LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C----CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0 011134557889999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=330.68 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=198.7
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..+++.||+|++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432 2234577899999888 699999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999998865 457999999999999999999999999 999999999999999999999999998642111 11
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc--cchhhHhhhhhhhccchhhhccCCcc
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE--EQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ......+..... ....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~---------~~~~- 221 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI---------LEKQ- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH---------HcCC-
Confidence 2234579999999999999999999999999999999999999997543221 111111111100 0000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCC------hHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPM------MSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~eil~~ 354 (399)
...+......+.+++.+||+.||.+||+ +.+++++
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 0122233457889999999999999997 6677654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=340.13 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=200.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||.|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478899999999999999999999999999999865321 22355788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999976 456899999999999999999999999 99999999999999999999999999863211
Q ss_pred CCCc---------------------------------------------cccccccccccccccccccCCCCCchhhHHH
Q 046609 236 GDKS---------------------------------------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYS 270 (399)
Q Consensus 236 ~~~~---------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvws 270 (399)
.... .......||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 1000 0001246999999999999999999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCC---CC
Q 046609 271 FGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTR---PM 347 (399)
Q Consensus 271 lG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps 347 (399)
|||++|+|++|.+||....+.+....+ ...... +.-+ . .......+.+++.+||. +|.+| |+
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~~---~~~p---~--~~~~s~~~~dli~~lL~-~~~~r~~r~~ 298 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKI------INWRET---LYFP---D--DIHLSVEAEDLIRRLIT-NAENRLGRGG 298 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHH------HccCCc---cCCC---C--CCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence 999999999999999865542211111 000000 0000 0 11233468889999997 66665 59
Q ss_pred hHHHHHH
Q 046609 348 MSDVVTA 354 (399)
Q Consensus 348 ~~eil~~ 354 (399)
+.+++.+
T Consensus 299 ~~~~l~h 305 (377)
T cd05629 299 AHEIKSH 305 (377)
T ss_pred HHHHhcC
Confidence 9998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=325.52 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=210.7
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCC-----CeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeC
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGT-----NQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDG 148 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 148 (399)
...++|.+.+.||+|+||.||++..... ...+|+|.+..... .....+.+|+.++.++ +||||+++++++..+
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 4456788899999999999999987643 37899999875422 2235578899999999 799999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLP------------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
+..+++|||+++|+|..++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999996521 23456899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccch
Q 046609 217 DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQN 295 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 295 (399)
+.++.+||+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||..........
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 245 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK 245 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999986443332222222345678999999988899999999999999999997 999987654322111
Q ss_pred hhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 296 LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
.. .. ......+......+.+|+.+||+.+|++|||+.++++.|+.+.
T Consensus 246 ~~-------~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LL-------KE----------GYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HH-------Hc----------CCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 10 00 0011122334557889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=323.91 Aligned_cols=266 Identities=22% Similarity=0.301 Sum_probs=197.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECC-CCeEEEEEEEccCCCc--chHHHHHHHHHHHcc---CCCceeeEEEEEe-----e
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEG-TNQDVAVKQLDRNGFQ--GNREFLVEVLMLSML---SNPYLVNLVGYCV-----D 147 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~hpnIv~l~~~~~-----~ 147 (399)
.+|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 368899999999999999999854 4688999998754322 223456677776665 6999999999985 3
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
....++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999995 69999987632 345899999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhhc
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKD 306 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~ 306 (399)
|++...... .......|++.|+|||.+.+..++.++|||||||++|+|++|++||......+....+ .........
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999754322 2223456899999999998889999999999999999999999999876543221111 110000000
Q ss_pred cch-hhhccCCccC-------CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 307 RRK-FTMMADPLLE-------GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 307 ~~~-~~~~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
... ...+....+. ..........+.+++.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 000 0000000000 0011123456789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=330.74 Aligned_cols=237 Identities=26% Similarity=0.389 Sum_probs=193.5
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..+++.||||++.... ......+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987532 12334567788888766 699999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GK 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CC
Confidence 999998876 456999999999999999999999999 999999999999999999999999998742211 11
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~------------~ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE------AILNDE------------V 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhcCC------------C
Confidence 2233569999999999998899999999999999999999999998754322111 111110 0
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCCh
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMM 348 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~ 348 (399)
..+......+.+++.+||+.||.+||++
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 1122234578899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=316.86 Aligned_cols=256 Identities=29% Similarity=0.396 Sum_probs=207.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.+.||+|++|.||+|.+.. +..||+|.+.... ...+++.+|+.++++++||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 4578889999999999999999764 5779999987653 3356788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 99999999997632 346899999999999999999999999 9999999999999999999999999997654221
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. .......+..|+|||++.+..++.++||||||+++|+|++ |+.||............ ...
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~--------- 220 (261)
T cd05068 158 YE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV-------DQG--------- 220 (261)
T ss_pred cc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-------HcC---------
Confidence 11 1111223457999999988899999999999999999999 99999865432211100 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 221 -YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 00011223345788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=343.89 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=200.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeC--------C
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--------D 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--------~ 149 (399)
..+|.+.++||+|+||.||+|.+..++..||||++.... ....+|+.+++.++||||+++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 467999999999999999999999899999999986432 2345699999999999999999887432 2
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEeccc
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFG 228 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg 228 (399)
..++||||++ ++|.+++.........+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 141 ~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 4678999996 5787777654344567999999999999999999999999 99999999999998665 69999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh-hhhhhhc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW-ATPLFKD 306 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~ 306 (399)
+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+.. .......
T Consensus 217 la~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9985433221 2234689999999988764 689999999999999999999999987654322111110 0000000
Q ss_pred -----cc-----hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 -----RR-----KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 -----~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. .+.......+...++...+..+.+|+.+||+.||.+|||+.+++.+
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 00 0000011111111223344678999999999999999999999866
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=330.49 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=200.1
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
+|.+.+.||+|+||.||+|.+..++..||||++..... .....+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 57888999999999999999999999999999975432 1223456677777776 5899999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999875 456899999999999999999999999 99999999999999999999999999874321
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+ ...
T Consensus 154 ~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------~~~--------- 216 (323)
T cd05616 154 D--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEH--------- 216 (323)
T ss_pred C--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC---------
Confidence 1 11223456899999999999999999999999999999999999999875432211111 000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM-----SDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 354 (399)
...++......+.+++.+||+.+|.+|++. .+++++
T Consensus 217 ---~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 217 ---NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ---CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 011223344578899999999999999985 565543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=319.57 Aligned_cols=261 Identities=27% Similarity=0.419 Sum_probs=206.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCe----EEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQ----DVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
..+|.+.++||.|+||.||+|.+..++. .||+|.+...... ....+.+|+.++..++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 4578889999999999999999866655 4899998754322 345688899999999999999999999754 578
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 99999999999999976 2356899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..............++..|+|||.+.+..++.++|||||||++|||++ |..||.......... ... ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~----~~---- 227 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD---LLE----KG---- 227 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH---HHH----CC----
Confidence 543222211222335678999999988899999999999999999998 999997654322111 111 00
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.....+...+..+.+++.+||+.||++||++.++++.|+.+....
T Consensus 228 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 228 ------ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred ------CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 000111223457889999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=327.81 Aligned_cols=242 Identities=30% Similarity=0.463 Sum_probs=195.1
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHc-cCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSM-LSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.+..+++.||||.+..... .....+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975421 223445667777775 5899999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999975 356899999999999999999999999 9999999999999999999999999987432221 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+. .. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~------~~--------~~---- 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR------MD--------NP---- 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC--------CC----
Confidence 2233568999999999998899999999999999999999999998654322111110 00 01
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMS-DVVT 353 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~ 353 (399)
.++......+.+++.+||+.||.+||++. +++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11222344678999999999999999997 5644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=315.23 Aligned_cols=253 Identities=28% Similarity=0.350 Sum_probs=206.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-----chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-----GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++|.+.+.||.|++|.||+|....++..||+|.+...... ....+.+|+.++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5788999999999999999999888999999998654221 22457889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999876 356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHV-STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--------------- 219 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI--------------- 219 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH---------------
Confidence 32211111 12345788999999999888999999999999999999999999765332111000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+......+.+++.+||..+|.+||++.+++.+
T Consensus 220 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 220 -ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00001112233445578899999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=317.48 Aligned_cols=256 Identities=25% Similarity=0.360 Sum_probs=206.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.+.||+|++|.||+|.... +..||+|.+.... ...+.+.+|+.+++.++||||+++++.+.+.+..+++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 3578889999999999999999764 6679999986543 2356788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 9999999999762 2456889999999999999999999999 9999999999999999999999999997643322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. ......++..|+|||++.+..++.++||||||+++|+|++ |..||........ ....... ...
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~~~~~----------~~~ 223 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSALQRG----------YRM 223 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHHHHcC----------CCC
Confidence 11 1122345678999999988889999999999999999998 9999976543221 1111000 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
......+..+.+++.+||..+|++||+++++.+.|+++
T Consensus 224 ----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 ----PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred ----CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 01112335688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=339.94 Aligned_cols=253 Identities=24% Similarity=0.260 Sum_probs=199.3
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+|.+.++||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 58889999999999999999999999999999975422 223457889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999976 356899999999999999999999999 999999999999999999999999997532100
Q ss_pred C---------------------------------------------CccccccccccccccccccccCCCCCchhhHHHH
Q 046609 237 D---------------------------------------------KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSF 271 (399)
Q Consensus 237 ~---------------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Dvwsl 271 (399)
. .........||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0000122468999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC---h
Q 046609 272 GVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM---M 348 (399)
Q Consensus 272 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~ 348 (399)
||++|+|++|++||...++.+....+. .. ...+...........+.+++.+++ .+|.+|++ +
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~------~~--------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~ 299 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVI------NW--------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA 299 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHH------cc--------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence 999999999999998765432211110 00 000000001122346677777766 59999997 8
Q ss_pred HHHHHH
Q 046609 349 SDVVTA 354 (399)
Q Consensus 349 ~eil~~ 354 (399)
.+++.+
T Consensus 300 ~ei~~h 305 (382)
T cd05625 300 DEIKAH 305 (382)
T ss_pred HHHhcC
Confidence 887754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=317.19 Aligned_cols=262 Identities=21% Similarity=0.307 Sum_probs=211.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.+|.+.+.||.|++|.||+|....++..+|||.+...... ....+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999999888999999988653322 2356788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754444567899999999999999999999999 99999999999999999999999999875433
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .... .......
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~----------~~~~~~~ 225 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK----------KIEQCDY 225 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHhh----------hhhcCCC
Confidence 221 12234588899999999888899999999999999999999999975432211 1110 0000111
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
+.. .+......+.+++.+||+.+|.+|||+.+|++.++++.
T Consensus 226 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 111 11234457889999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=356.22 Aligned_cols=265 Identities=29% Similarity=0.430 Sum_probs=220.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCC-----eEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTN-----QDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
.+....+.||+|.||.||.|...+.. ..||||.+.... .++..+|.+|..+|+.++|||||+++|++.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 44556789999999999999885433 349999997653 455678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPP---NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
+++|||+||+|..||+..+. ....++....+.++.||+.|+.||++++ +|||||..+|+||+....+||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999998421 1456899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
|+.....+.........-+..|||||.+..+.++.++|||||||++||++| |..||...+..+...... .
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~-------~-- 919 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL-------E-- 919 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH-------h--
Confidence 996555544443333345679999999999999999999999999999999 999999877644322110 0
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.. +-+.|..++..+.+++..||+.+|.+||++..|++.+..+.....
T Consensus 920 ------gg--RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 920 ------GG--RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ------CC--ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 01 223455667788999999999999999999999999888766433
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=316.99 Aligned_cols=258 Identities=27% Similarity=0.409 Sum_probs=203.7
Q ss_pred CCCCCeeccCCcEEEEEEEECC---CCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCe-----
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEG---TNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ----- 150 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~----- 150 (399)
|.+.+.||+|+||.||+|.... ++..||+|.+...... ....+..|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5677899999999999998754 3478999998754322 23568889999999999999999999876554
Q ss_pred -eEEEEEecCCCChHHhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 151 -RILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 151 -~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
.++++||+++|+|..++...+ .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999999986532 12346899999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....... .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~~---~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLRH---G 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc---C
Confidence 99976443322222222335678999999988899999999999999999999 889997644321 1111100 0
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....+......+.+++.+||+.||++||++.+|++.|+++
T Consensus 232 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 -----------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -----------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00112233455789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=328.78 Aligned_cols=242 Identities=28% Similarity=0.442 Sum_probs=194.9
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHc-cCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSM-LSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..++..||+|.+..... ........|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999975421 223445667777765 4899999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--N 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--C
Confidence 999999875 456899999999999999999999999 9999999999999999999999999987432211 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ ... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~------~~~--------~~---- 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI------RVD--------TP---- 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC--------CC----
Confidence 223456999999999999999999999999999999999999999865432111000 000 01
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMS-DVVT 353 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~ 353 (399)
.++......+.+++.+||+.||.+||++. ++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~ 247 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIRG 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 11222345788999999999999999985 5553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=320.23 Aligned_cols=260 Identities=28% Similarity=0.413 Sum_probs=206.0
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
.+++|.+.+.||+|++|.||+|.+.. +...|++|.+...... ....+..|+.+++.++|+||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 34678899999999999999999976 6788999988654322 23568889999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC---CeeE
Q 046609 151 RILVYEYMPNGSLEDHLLDLPP---NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF---NPKL 224 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl 224 (399)
.++||||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976321 1235899999999999999999999999 99999999999998765 5999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhh
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
+|||++.................+..|+|||++.+..++.++|||||||++|+|++ |..||............ .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~---~-- 235 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV---T-- 235 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H--
Confidence 99999976432221111112234568999999988999999999999999999997 99999865443211111 0
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
. ......+...+..+.+++.+||+.+|++||++.+|+++|.
T Consensus 236 --~----------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 --G----------GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred --c----------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 0011122333457889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=329.09 Aligned_cols=243 Identities=26% Similarity=0.382 Sum_probs=197.4
Q ss_pred CeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC----cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 85 NLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF----QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+.||+|+||.||++... .+++.||+|++..... .....+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999863 4678999999875321 2224567899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999976 456889999999999999999999999 9999999999999999999999999987432221
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||........ ....... .
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~~~----------~ 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKILKG----------K 216 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHHcC----------C
Confidence 122335699999999999888899999999999999999999999987543211 1111110 0
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
...+......+.+++.+||+.+|.+|| ++.+++++
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 011223345788999999999999999 78888775
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=339.39 Aligned_cols=254 Identities=24% Similarity=0.262 Sum_probs=201.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 478999999999999999999999999999999865322 22355778999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999976 456899999999999999999999999 99999999999999999999999999753210
Q ss_pred CCC-----------------------------------------ccccccccccccccccccccCCCCCchhhHHHHHHH
Q 046609 236 GDK-----------------------------------------SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVV 274 (399)
Q Consensus 236 ~~~-----------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~i 274 (399)
... ........||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 000 000112469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC---ChHHH
Q 046609 275 FLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP---MMSDV 351 (399)
Q Consensus 275 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP---s~~ei 351 (399)
+|+|++|+.||....+.+....+... .. .+...........+.+++.+|+ .+|.+|+ ++.++
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~----------~~----~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el 298 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINW----------ET----TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI 298 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhcc----------Cc----cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence 99999999999876543221111000 00 0000001122345677888876 5999999 89999
Q ss_pred HHH
Q 046609 352 VTA 354 (399)
Q Consensus 352 l~~ 354 (399)
+.+
T Consensus 299 l~h 301 (376)
T cd05598 299 KAH 301 (376)
T ss_pred hCC
Confidence 876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=330.15 Aligned_cols=243 Identities=26% Similarity=0.398 Sum_probs=197.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..+++.||+|++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999975422 2234566788888765 799999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999998876 456899999999999999999999999 9999999999999999999999999987432221 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||......... ........
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~i~~~~~------------ 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ESILHDDV------------ 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HHHHcCCC------------
Confidence 223456899999999999889999999999999999999999999875532211 11111100
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCC-------ChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRP-------MMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RP-------s~~eil~~ 354 (399)
..+......+.+++.+||+.||.+|| ++.+++++
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11122335788999999999999999 78888765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=337.68 Aligned_cols=256 Identities=21% Similarity=0.266 Sum_probs=204.8
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
...++|.+.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 345689999999999999999999999999999999965321 22344778999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~ 191 (370)
T cd05596 120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceee
Confidence 99999999999999865 35889999999999999999999999 99999999999999999999999999875
Q ss_pred CCCCCCccccccccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTG----QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... ........
T Consensus 192 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~ 264 (370)
T cd05596 192 MDANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKN 264 (370)
T ss_pred ccCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC
Confidence 43221 1122345699999999988653 4788999999999999999999999875432111 11111000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT--RPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 354 (399)
. +.-......+..+.+++.+||+.+|.+ ||++.+++.+
T Consensus 265 ~--------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 S--------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred c--------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0 000001123457889999999999988 9999999876
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=332.32 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=196.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|...+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 4566778999999999999999988999999998654322 235688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 9999986432 3567788899999999999999999 9999999999999999999999999987543221
Q ss_pred CccccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 238 KSHVSTRVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.......|+..|+|||++.. ...+.++|||||||++|+|++|+.||..........+..... ..
T Consensus 223 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~--~~------- 291 (353)
T PLN00034 223 --DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC--MS------- 291 (353)
T ss_pred --ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--cc-------
Confidence 11223468999999998743 234568999999999999999999998443322111111000 00
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ...+......+.+|+.+||+.||.+||++.+|+++
T Consensus 292 -~~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 -QP----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -CC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 11122344578899999999999999999999875
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=314.85 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=202.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+.. +..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 467888999999999999998864 5679999886543 33467888999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+........
T Consensus 82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 999999998752 245899999999999999999999999 99999999999999999999999999875432221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+ .. . ....
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i---~~---~----~~~~--- 221 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI---SR---G----FRLY--- 221 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---HC---C----CCCC---
Confidence 1 1122235668999999988889999999999999999999 89999765432211111 00 0 0000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
.+......+.+++.+||+.+|.+||++.++++.|
T Consensus 222 ----~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ----RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1112234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=328.10 Aligned_cols=243 Identities=28% Similarity=0.424 Sum_probs=198.0
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.+..++..||||++..... .....+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999975421 2334567788888877 699999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999998876 457999999999999999999999999 9999999999999999999999999986422111 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||......... ....... .
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~------~~i~~~~------------~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF------QSILEDE------------V 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcCC------------C
Confidence 223356899999999999999999999999999999999999999765422111 0111000 0
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMM-----SDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 354 (399)
.++......+.+++.+||+.||.+||++ .+++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122334578899999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=324.04 Aligned_cols=275 Identities=23% Similarity=0.369 Sum_probs=213.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCe--EEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQ--DVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+..++. .+++|.+.... ......+.+|+.++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578889999999999999999876665 45777765432 22335688899999999 89999999999999999999
Q ss_pred EEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC
Q 046609 154 VYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~ 221 (399)
||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975321 1236899999999999999999999999 999999999999999999
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (399)
+||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|++ |..||......+.... .
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~ 236 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK---L 236 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH---H
Confidence 999999998632111 11111234667999999988889999999999999999998 9999976543221100 0
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccccccccccCccC
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDSLDSCH 375 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~~ 375 (399)
. . ......+...+..+.+++.+||+.+|++||++.+++..|..+...+.........+...
T Consensus 237 ----~------~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~~~~~~~~ 297 (303)
T cd05088 237 ----P------Q----GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFT 297 (303)
T ss_pred ----h------c----CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhhhhhccCc
Confidence 0 0 00011122234468899999999999999999999999999887776655555554444
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=327.54 Aligned_cols=252 Identities=25% Similarity=0.291 Sum_probs=214.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~l 153 (399)
...|.+.+.||.|.||.||+++.+.+++.+|+|.+.+...... ..+.+|+.+|+++. |||||.++++|++....++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4578888999999999999999999999999999987665443 57899999999998 9999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC----CCCeeEecccC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ----DFNPKLSDFGL 229 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~----~~~~kl~Dfg~ 229 (399)
|||++.||.|.+.+... .+++..+..++.|++.|+.|||+.| |+||||||+|+|+.. ++.+|++|||+
T Consensus 114 vmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 99999999999999873 3999999999999999999999999 999999999999953 35799999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
+..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||...........+.....
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~------- 255 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF------- 255 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------
Confidence 987554 3345567899999999999999999999999999999999999999998765433221111110
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......-......+.++++.+|..||..|+|+.+++++
T Consensus 256 -------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 11122223446688899999999999999999999984
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=316.42 Aligned_cols=256 Identities=22% Similarity=0.294 Sum_probs=205.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
..+|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35799999999999999999999888999999999765444455678899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999875 456899999999999999999999999 9999999999999999999999999987543221
Q ss_pred Ccccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 238 KSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.......++..|+|||.+. ...++.++|||||||++|+|++|+.||....+....... .. ....
T Consensus 161 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~----~~~~ 227 (267)
T cd06646 161 --AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK----SNFQ 227 (267)
T ss_pred --cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec----CCCC
Confidence 1112345888999999874 345788999999999999999999999765432211000 00 0000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
.+... .....+..+.+++.+||+.+|.+||++++|+++|
T Consensus 228 ~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 11111 0122345788999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=327.89 Aligned_cols=250 Identities=24% Similarity=0.360 Sum_probs=197.4
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975422 2234567788888776 799999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999988865 456999999999999999999999999 9999999999999999999999999987422111 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc--chhhHhhhhhhhccchhhhccCCcc
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEE--QNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......||..|+|||++.+..++.++|||||||++|+|++|+.||........ .....+..... ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i---------~~~-- 220 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI---------LEK-- 220 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH---------hcC--
Confidence 22345689999999999999999999999999999999999999964322111 11111111100 000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMM------SDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 354 (399)
....+......+.+++.+||+.||.+||++ .+++++
T Consensus 221 ~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 221 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 011233344578899999999999999984 666554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.18 Aligned_cols=259 Identities=27% Similarity=0.413 Sum_probs=207.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCC-----CeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGT-----NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|..... +..||+|.+..... .....+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 45788899999999999999988643 47899999865432 2335678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEe
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPN------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLS 225 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 225 (399)
++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 9999999999999999753321 234788999999999999999999999 9999999999999999999999
Q ss_pred cccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|||+++...............++..|+|||.+.++.++.++|||||||++|+|++ |..||.............
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~------ 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI------ 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh------
Confidence 9999875433322222233446788999999988889999999999999999998 999997654432111110
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
... ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 236 -~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 00112223557889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.55 Aligned_cols=253 Identities=27% Similarity=0.399 Sum_probs=204.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+|++.++||+|+||.||++.+..++..||+|++...... ....+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999999888999999999754322 22446789999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++|+|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888652 2356899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||............. ... ..
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~--~~~-----------~~ 219 (285)
T cd05605 156 ET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRV-----------KE 219 (285)
T ss_pred Cc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHH--HHh-----------hh
Confidence 21 123468999999999988899999999999999999999999998654321110000 000 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
....++...+..+.+++.+||+.||.+|| ++.+++.+
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 01122334455788999999999999999 88888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=319.50 Aligned_cols=259 Identities=27% Similarity=0.431 Sum_probs=204.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEEC----CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLE----GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++|++.+.||+|+||.||+|... .++..+++|.+..... .....+.+|+.+++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 46778899999999999999852 3467899999875332 223568889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC
Q 046609 154 VYEYMPNGSLEDHLLDLPP-------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF 220 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~ 220 (399)
+|||+++++|.+++..... ....+++..+..++.|++.||.|||+++ ++||||||+||+++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853210 1235788999999999999999999999 99999999999999999
Q ss_pred CeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHh
Q 046609 221 NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTW 299 (399)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 299 (399)
.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||....+.......
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~-- 239 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMV-- 239 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH--
Confidence 999999999976433332222333446778999999988889999999999999999998 99999765432111111
Q ss_pred hhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 300 ATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
. ... .. ..+...+..+.+++.+||+.+|.+||++.+|+++|..
T Consensus 240 -~----~~~------~~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 240 -R----KRQ------LL----PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -H----cCC------cC----CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 0 000 00 1112233578889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=315.75 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=200.7
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCe--EEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeC------Ce
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQ--DVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------DQ 150 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~ 150 (399)
+.+.+.||+|+||.||+|.+..++. .+|+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3466899999999999999876654 68999886542 23345688899999999999999999987532 24
Q ss_pred eEEEEEecCCCChHHhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 151 RILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
.+++|||+++|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++.++|+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999875321 22345899999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
++................+++.|+|||.+.+..++.++||||||+++|+|++ |+.||....... ..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDYL----RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HcC
Confidence 9986543322111222346778999999988899999999999999999999 889997644321 11111 110
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.. ...+......+.+++.+||+.+|.+|||+.+|++.|+.+
T Consensus 231 ~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NR----------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 011123345688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=344.61 Aligned_cols=264 Identities=23% Similarity=0.265 Sum_probs=214.2
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEE-Eee-----
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGY-CVD----- 147 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~-~~~----- 147 (399)
.+...++++.++|.+|||+.||+|.+.+.+..||+|++-.......+.+.+|+.+|++|+ |+|||.+++. ...
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 345567788899999999999999999877999999987766666788999999999997 9999999993 221
Q ss_pred -CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 148 -GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 148 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
.-.++|+||||.||.|-+++...- ...|++.++++|+.|+++|+.+||... ++|||||||-+||||+.+|+.||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 124678999999999999998633 344999999999999999999999775 7799999999999999999999999
Q ss_pred ccCccCCCCCC-Cccc------cccccccccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchh
Q 046609 227 FGLAKLGPTGD-KSHV------STRVMGTYGYCAPEYA---LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL 296 (399)
Q Consensus 227 fg~~~~~~~~~-~~~~------~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 296 (399)
||.+....... .... .....-|+.|.|||.+ .+.+++.|+|||+|||+||-|+....||+......+.
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-- 267 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-- 267 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE--
Confidence 99986422211 1110 0113468999999976 5778999999999999999999999999986543221
Q ss_pred hHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 297 VTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
+....-.-...+...+.+||+.||+.||.+||++-+|++++..++..
T Consensus 268 ------------------ng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 268 ------------------NGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ------------------eccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 11111111246777899999999999999999999999999988764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=329.06 Aligned_cols=253 Identities=25% Similarity=0.349 Sum_probs=200.5
Q ss_pred CCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC----cchHHHHHHHHHHHccC-CCceeeEEEEEeeCCee
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF----QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~ 151 (399)
+|.+.+.||+|+||.||++... .++..||+|++..... ...+.+..|+.++..++ ||||+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999999863 4688999999865321 22345778999999994 89999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999975 456899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........ ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||............ ......
T Consensus 154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~----- 225 (332)
T cd05614 154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILK----- 225 (332)
T ss_pred cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhc-----
Confidence 54332221 22235699999999998765 4788999999999999999999999764432211111 000000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
.++ ..+......+.+++.+||+.||++|| ++.+++++
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011 12223345688999999999999999 67788765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=335.28 Aligned_cols=258 Identities=20% Similarity=0.278 Sum_probs=203.3
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
+....++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 33455789999999999999999999999999999999864321 223457789999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999965 35889999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTG----QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
....... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||......... ......
T Consensus 190 ~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i~~~ 262 (370)
T cd05621 190 MKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKIMDH 262 (370)
T ss_pred eecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHHHhC
Confidence 7543222 1122345699999999998653 3788999999999999999999999865432111 111100
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT--RPMMSDVVTA 354 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 354 (399)
... +...........+.+++.+||..++.+ ||++.+++++
T Consensus 263 ~~~--------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNS--------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred Ccc--------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 000 000001123456778999999865543 8899999887
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=328.88 Aligned_cols=238 Identities=26% Similarity=0.353 Sum_probs=192.1
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHH-HHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVL-MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..+++.||+|++..... .....+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999975422 12234445544 56789999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999999876 457899999999999999999999999 999999999999999999999999998743221 12
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~--------~---- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNILNKP--------L---- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHHcCC--------C----
Confidence 233456999999999999999999999999999999999999999865432110 1111100 0
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMS 349 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 349 (399)
..+......+.+++.+||+.||.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11122345788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=320.55 Aligned_cols=262 Identities=26% Similarity=0.383 Sum_probs=206.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCe--EEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQ--DVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.++||+|+||.||+|....++. .+++|.+.... ....+.+..|+.++.++ +||||+++++++...+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999999876654 46888876422 22335688899999999 799999999999999999999
Q ss_pred EEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 155 YEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
+||+++|+|.+++..... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999965321 1235889999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (399)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~------ 229 (297)
T cd05089 159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE------ 229 (297)
T ss_pred EECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence 99999998632111 11111223567999999988899999999999999999997 999998654322110
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.. ........+...+..+.+++.+||+.+|.+||++++|++.|+.+...+.
T Consensus 230 ~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KL-----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HH-----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 00 0000111122334578899999999999999999999999998887664
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=319.75 Aligned_cols=251 Identities=26% Similarity=0.395 Sum_probs=207.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|.+.+.||.|++|.||+|.+..++..|++|.+..........+.+|+.+++.+.||||+++++.+..+...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57889999999999999999998889999999998766666677889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. ..+++.++..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999864 35889999999999999999999999 99999999999999999999999999875332221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... .... .. ..+.+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~----~~-------~~~~~ 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA----TN-------GTPEL 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHh----cC-------CCCCC
Confidence 122345889999999998888999999999999999999999999765432111 0000 00 00000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+......+.+++.+||..+|.+||++.+|+.+
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1122344578899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=324.45 Aligned_cols=267 Identities=28% Similarity=0.395 Sum_probs=209.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCC-------CeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCC
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGT-------NQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGD 149 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 149 (399)
.+|.+.+.||+|+||.||+|.+.+. ...||+|.+..... .....+.+|+.+++++ +||||+++++++..++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 4688999999999999999986422 24689998875422 2346788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD 217 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~ 217 (399)
..++++||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ |+||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 99999999999999999975321 1235888999999999999999999999 99999999999999
Q ss_pred CCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchh
Q 046609 218 QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNL 296 (399)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 296 (399)
.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||......+....
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~ 248 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999875433222222222334568999999999999999999999999999998 8899976543221111
Q ss_pred hHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccc
Q 046609 297 VTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~ 365 (399)
. ... .....+......+.+++.+||+.+|.+||++.++++.|+.+.......
T Consensus 249 ~-------~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~~~ 300 (334)
T cd05100 249 L-------KEG----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTD 300 (334)
T ss_pred H-------HcC----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcCCC
Confidence 0 000 001112233457889999999999999999999999999998655543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=317.96 Aligned_cols=264 Identities=25% Similarity=0.378 Sum_probs=210.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECC----CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEee-CCe
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEG----TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVD-GDQ 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~ 150 (399)
..++|.+.++||+|+||.||+|.+.. ++..|++|.+..... .....+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 45688899999999999999999865 357899998864422 234557889999999999999999998766 567
Q ss_pred eEEEEEecCCCChHHhhccCCCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPN----RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
.+++++|+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999764322 156899999999999999999999999 99999999999999999999999
Q ss_pred ccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhh
Q 046609 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFK 305 (399)
Q Consensus 227 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~ 305 (399)
||+++...............++..|+|||++.+..++.++||||||+++|++++ |+.||...++.+. ..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHHHHc---
Confidence 999975433332222223446778999999988889999999999999999999 9999987554221 111110
Q ss_pred ccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 306 DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 306 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
.. ....+...+..+.+++.+||..+|++|||+.++++.|+.+..
T Consensus 235 -~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 -GY----------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CC----------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 001112234578899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=318.56 Aligned_cols=258 Identities=28% Similarity=0.435 Sum_probs=206.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.+|...+.||+|+||.||+|... .++..+|+|.+..........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56788899999999999999742 3467899998876555555778999999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 154 VYEYMPNGSLEDHLLDLPP-----------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
+|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999976321 1135889999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (399)
+|+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |.+||......+......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~--- 238 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT--- 238 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH---
Confidence 9999999875433222222222345678999999998999999999999999999998 999997654322111100
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
.. ... ..+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 239 ----~~------~~~----~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 239 ----QG------REL----ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ----cC------ccC----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 000 111223346889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=322.65 Aligned_cols=263 Identities=28% Similarity=0.389 Sum_probs=207.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECC-------CCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCC
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEG-------TNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGD 149 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 149 (399)
.+|.+.+.||+|+||.||+|.+.+ +...+|+|.+..... .....+..|+.+++.+ +||||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 578999999999999999998643 234699999875422 2335678899999999 7999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD 217 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~ 217 (399)
..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999976321 1235899999999999999999999999 99999999999999
Q ss_pred CCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchh
Q 046609 218 QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNL 296 (399)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~ 296 (399)
.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+....
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~ 254 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 254 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 999999999999875433222111222234568999999988899999999999999999998 8899875432211110
Q ss_pred hHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 297 VTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
. .. ......+......+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 255 ~-------~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 255 L-------KE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred H-------Hc----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 0 00 001112233445788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=320.41 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=204.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCC-----CeEEEEEEEccCCCcc-hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGT-----NQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
+|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ...+..|+.++..++||||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 466678999999999999987543 5789999997543322 3557889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC
Q 046609 154 VYEYMPNGSLEDHLLDLP------------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~ 221 (399)
++||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985311 11245888999999999999999999999 999999999999999999
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (399)
+||+|||+++...............+++.|+|||.+.++.++.++||||||+++|||++ |..||......+. ....
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---IEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH
Confidence 99999999876443332222233456789999999988899999999999999999998 8889876543211 1110
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
. ... ....+...+..+.+++..||+.+|.+||++.+|+..|+.
T Consensus 240 ~-------------~~~-~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 240 R-------------NRQ-VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred H-------------cCC-cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 0 000 011223344568899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=320.56 Aligned_cols=260 Identities=25% Similarity=0.359 Sum_probs=206.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEE-----CCCCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 150 (399)
.++|.+.+.||+|+||.||+|.. ..++..||+|.+..... .....+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688899999999999999975 33456899999875432 2235688899999999 79999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.+++|||+++|+|.+++... ....+++.++..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999752 2234899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
................++..|+|||.+.+..++.++|||||||++|+|++ |..||......+. .... ...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~----~~~--- 259 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKL----IKE--- 259 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHH----HHc---
Confidence 75433322222223346778999999999999999999999999999998 9999976543211 0000 000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
......+......+.+++.+||..+|++||++.++++.|+++
T Consensus 260 -------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 -------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 000011122335788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=326.13 Aligned_cols=250 Identities=26% Similarity=0.345 Sum_probs=198.3
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..+++.||+|++..... ...+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999975432 2234577888888888 599999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--GD 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC--CC
Confidence 999998865 456999999999999999999999999 999999999999999999999999998742211 11
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.................... ... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~---------~~~--~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL---------EKP--I 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH---------hCC--C
Confidence 22345699999999999999999999999999999999999999975433222111111111110 000 1
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMM------SDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 354 (399)
..+...+..+.+++.+||+.||.+||++ .+++++
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 1222334567899999999999999985 566554
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=312.25 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=206.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||+|++|.||+|....+++.|++|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777899999999999999999899999999987543 23346688899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999863 2457899999999999999999999999 9999999999999999999999999987543322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......+++.|+|||++.+..++.++|+||||+++|+|++|+.||........ .... .. ..
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~---~~------~~---- 217 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---ILKI---IR------GV---- 217 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHH---Hc------CC----
Confidence 122334688899999999988999999999999999999999999986542111 1000 00 00
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 218 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 218 -FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred -CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 011122344578999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=334.21 Aligned_cols=264 Identities=21% Similarity=0.294 Sum_probs=208.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-C-----CceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-N-----PYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----pnIv~l~~~~~~~~~~~ 152 (399)
.+|.++++||+|+||.|.+|.+..+++.||||+++... .-..+...|+.+|..++ | -|+|+++++|...++.|
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 36788999999999999999999999999999997643 22355677999999997 3 49999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC--CeeEecccCc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF--NPKLSDFGLA 230 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~--~~kl~Dfg~~ 230 (399)
||+|.+ .-+|+++++.. .-.+++...++.|+.||+.||.+||+.+ |||+||||+||||..-+ .+||+|||.|
T Consensus 265 iVfELL-~~NLYellK~n--~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNN--KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeehhh-hhhHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 999999 67999999984 3456999999999999999999999999 99999999999996543 6999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh--------
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-------- 302 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-------- 302 (399)
........ ....+..|.|||++.|.+|+.+.|+||||||++||++|.+.|.+.++.++...+.-...
T Consensus 339 c~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~ 413 (586)
T KOG0667|consen 339 CFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLD 413 (586)
T ss_pred cccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 86433322 34567889999999999999999999999999999999999999876654433211111
Q ss_pred -------hhhc-c--------ch-----------------hhhccCC----ccCCCCCHHHHHHHHHHHhhccccCCCCC
Q 046609 303 -------LFKD-R--------RK-----------------FTMMADP----LLEGNYPIKGLYQALAVAAMCLQEEAGTR 345 (399)
Q Consensus 303 -------~~~~-~--------~~-----------------~~~~~~~----~l~~~~~~~~~~~l~~li~~cl~~dp~~R 345 (399)
.+.. . .. ......| .+...........+.+|+.+||+.||.+|
T Consensus 414 ~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R 493 (586)
T KOG0667|consen 414 TAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAER 493 (586)
T ss_pred hccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhc
Confidence 0100 0 00 0000000 11111222445678999999999999999
Q ss_pred CChHHHHHH
Q 046609 346 PMMSDVVTA 354 (399)
Q Consensus 346 Ps~~eil~~ 354 (399)
+|+.+.+.+
T Consensus 494 ~tp~qal~H 502 (586)
T KOG0667|consen 494 ITPAQALNH 502 (586)
T ss_pred CCHHHHhcC
Confidence 999999876
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=322.35 Aligned_cols=267 Identities=22% Similarity=0.320 Sum_probs=204.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5788999999999999999999988999999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
++ ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LD-KDLKQYMDD---CGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 96 588888865 2446899999999999999999999999 9999999999999999999999999987532222
Q ss_pred CccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-h-------hhccc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-L-------FKDRR 308 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~-------~~~~~ 308 (399)
.......+++.|+|||++.+ ..++.++||||||+++|+|++|++||...+..+....+..... . .....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11223457899999998865 4688999999999999999999999987654332222211100 0 00000
Q ss_pred hhhhccCCccCC----CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEG----NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.....+.... .........+.+++.+||+.||.+|||+.+++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 000000000000 0011234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=316.53 Aligned_cols=273 Identities=25% Similarity=0.341 Sum_probs=204.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEE----CCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee--CCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~ 152 (399)
.+|.+.+.||+|+||.||+|.. ..++..||+|.+........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 5788899999999999999974 45678999999876655555678899999999999999999998753 34688
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+|+||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQK---HRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 99999999999999975 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCcccc-ccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVS-TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.......... ....++..|+|||++.+..++.++||||||+++|||++|..|+................... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM-IVYHLI 236 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccccc-chHHHH
Confidence 5433222111 11223456999999988899999999999999999999887664332110000000000000 000000
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
...........+...+..+.+++.+||+.+|++|||+.+|+..|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00010001111223345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=311.80 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=202.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|.+.+.||+|+||.||+|.+.. +..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 457888999999999999998874 66799999865432 3456888999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 82 ANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred CCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 999999999762 346899999999999999999999999 99999999999999999999999999875432211
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+..... .....
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-------------~~~~~-- 219 (256)
T cd05059 156 T-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-------------SAGYR-- 219 (256)
T ss_pred c-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-------------HcCCc--
Confidence 1 1111224467999999988899999999999999999999 89999865432211100 00000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
...+...+..+.+++.+||..+|++||++.++++.|
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 --LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111222345788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=312.26 Aligned_cols=251 Identities=22% Similarity=0.308 Sum_probs=204.9
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+|.+.+.||.|+||.||++.+..++..+|+|.+.... ....+.+..|+.+++.++||||+++++.+.+++..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999999899999999986432 233466788999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999988652 2456899999999999999999999999 9999999999999999999999999987543222
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||...+.... . ...... . .
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~---~~~~~~--~----~---- 217 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---I---LKVCQG--S----Y---- 217 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---H---HHHhcC--C----C----
Confidence 122335688899999999888899999999999999999999999986443211 0 000000 0 0
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+...+..+.+++.+||+.||.+||++.+|+..
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 218 -KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01122334568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=313.78 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=205.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC---eEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN---QDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|...+.||+|+||.||+|....++ ..+|+|.+.... ......+..|+.++++++||||+++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356788899999999999999986544 379999986542 2234568899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 9999999999999975 2356899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 234 PTGDKSHV-STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 234 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
........ ......+..|+|||++.+..++.++|||||||++|+|++ |+.||......+....+ . ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i---~----~~---- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---N----DG---- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH---h----cC----
Confidence 33221111 111223457999999988889999999999999999997 99999765432111111 0 00
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011222345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=317.43 Aligned_cols=266 Identities=26% Similarity=0.401 Sum_probs=207.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
..++|.+.+.||+|+||.||+|.... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45689999999999999999997642 355799998864432 223457789999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeE
Q 046609 151 RILVYEYMPNGSLEDHLLDLPP------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 224 (399)
.++||||+++|+|.+++..... ....++...+..++.|++.||.|||+++ |+||||||+||+++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999975321 1234567788999999999999999999 999999999999999999999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhh
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
+|||+++...............++..|+|||.+.++.++.++|||||||++|+|++ |..||......+. ....
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~---~~~~--- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV---LKFV--- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH---
Confidence 99999875433322222222345678999999988899999999999999999998 7889976543221 1110
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
. ... . ...+......+.+++.+||+.+|++||++.++++.|++...++
T Consensus 235 ~-~~~---------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 235 M-DGG---------Y-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred H-cCC---------C-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 0 000 0 0111222357889999999999999999999999999875544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=319.13 Aligned_cols=265 Identities=25% Similarity=0.399 Sum_probs=203.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCC--------------CeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGT--------------NQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVG 143 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~--------------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~ 143 (399)
.+|.+.+.||+|+||.||++...++ ...||+|.+...... ....+.+|+.++++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 5789999999999999999987543 235899998754322 2356889999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHhhccCC--------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceE
Q 046609 144 YCVDGDQRILVYEYMPNGSLEDHLLDLP--------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVL 215 (399)
Q Consensus 144 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIl 215 (399)
++...+..++||||+++++|.+++.... .....+++..++.++.|++.||.|||+.+ ++|+||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999986521 01124788999999999999999999999 999999999999
Q ss_pred ECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCccc
Q 046609 216 LDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT--GRRVIDNSRPTEE 293 (399)
Q Consensus 216 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~ 293 (399)
++.++.+||+|||++................++..|+|||.+.++.++.++||||||+++|+|++ |..||........
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~ 241 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV 241 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH
Confidence 99999999999999875433322222233345778999999988899999999999999999988 6677776543221
Q ss_pred chhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 294 QNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
.......+..... .. ....+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 242 ---~~~~~~~~~~~~~--~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 242 ---IENTGEFFRNQGR--QI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHhhhhccc--cc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111110000 00 00111123457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=312.41 Aligned_cols=252 Identities=29% Similarity=0.428 Sum_probs=202.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+.+ +..+|+|.+.... .....+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 467888999999999999998765 4569999987543 23467889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
.+|+|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05113 82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY 155 (256)
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence 999999999762 336899999999999999999999999 99999999999999999999999999875433221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...........+ .... .
T Consensus 156 ~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~~~-------~-- 219 (256)
T cd05113 156 T-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV------SQGL-------R-- 219 (256)
T ss_pred e-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------hcCC-------C--
Confidence 1 1122335678999999988889999999999999999998 99999765432111100 0000 0
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
...+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 220 --~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 --LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0011123457889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=321.16 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=214.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch--HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.=|.+.+.||+|.|+.|-+|++.-+|+.||||++.+...... ..+.+|+..|+.++|||||++|.+..+...+|||+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 347778999999999999999999999999999987655433 458899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE-CCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL-DQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll-~~~~~~kl~Dfg~~~~~~~ 235 (399)
.-.+|+|++|+-. ....+.+..+.+++.||+.|+.|+|... +|||||||+|+++ ..-|-+||+|||++..+..
T Consensus 98 LGD~GDl~DyImK---He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 98 LGDGGDLFDYIMK---HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred ecCCchHHHHHHh---hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 9999999999987 3567999999999999999999999999 9999999999866 6678899999999986655
Q ss_pred CCCccccccccccccccccccccCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTA-KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
+. .....||+..|.|||++.|..|+. +.||||||||||.|++|++||+..+..+.. -+++
T Consensus 172 G~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL----------------TmIm 232 (864)
T KOG4717|consen 172 GK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL----------------TMIM 232 (864)
T ss_pred cc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh----------------hhhh
Confidence 54 334578999999999999999985 689999999999999999999987655432 2222
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
|- .=..|.....+..+||..||..||++|.+.++|+.
T Consensus 233 DC--KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DC--KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred cc--cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 22 12446778889999999999999999999999964
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=319.59 Aligned_cols=264 Identities=26% Similarity=0.380 Sum_probs=209.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC-------CCCeEEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE-------GTNQDVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDG 148 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 148 (399)
..+|.+.+.||+|+||.||+|... ..+..||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457888899999999999999752 234579999986542 23346688999999999 799999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
...++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ |+||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999976321 1245788899999999999999999999 9999999999999
Q ss_pred CCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccch
Q 046609 217 DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQN 295 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 295 (399)
+.++.+||+|||++................++..|+|||++.+..++.++||||||+++|+|++ |..||......+...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~ 250 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHH
Confidence 9999999999999976543332222233446778999999988889999999999999999998 788887653322111
Q ss_pred hhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 296 LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.. .... ....+...+..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 251 ~~-------~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 251 LL-------KEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HH-------HcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 10 0000 0111223445788999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.26 Aligned_cols=242 Identities=26% Similarity=0.387 Sum_probs=196.4
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 155 (399)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 46778999999999999999999999999999975421 22345677888888776 578889999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999875 456999999999999999999999999 99999999999999999999999999874322
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+..... ......
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~------~i~~~~-------- 217 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQ------SIMEHN-------- 217 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC--------
Confidence 11 12233568999999999998899999999999999999999999998754321111 001100
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCCh
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM 348 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 348 (399)
..++......+.+++.+||+.+|.+|++.
T Consensus 218 ----~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 ----VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 11222334578899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=318.04 Aligned_cols=266 Identities=28% Similarity=0.430 Sum_probs=207.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC----------------eEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN----------------QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVN 140 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~ 140 (399)
..+|.+.+.||+|+||.||+|.+...+ ..||+|.+..... .....+.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 357899999999999999999876433 5689999875532 23456888999999999999999
Q ss_pred EEEEEeeCCeeEEEEEecCCCChHHhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 046609 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPP-------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASN 213 (399)
Q Consensus 141 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~N 213 (399)
+++++..++..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.+ |+|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976321 1236899999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCc
Q 046609 214 VLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT--GRRVIDNSRPT 291 (399)
Q Consensus 214 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~ 291 (399)
|+++.++.++|+|||++................++..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999875433332223334456789999999988889999999999999999998 67788654422
Q ss_pred ccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 292 EEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
. ........+.... .......+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 Q---VIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 1111111111100 00000112233457899999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=310.75 Aligned_cols=252 Identities=33% Similarity=0.492 Sum_probs=207.0
Q ss_pred CeeccCCcEEEEEEEECCC---CeEEEEEEEccCCCcc-hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|..... +..|++|.+....... ...+..|+.++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 4699999999999999865 8899999997654433 56788999999999999999999999999999999999999
Q ss_pred CChHHhhccCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 161 GSLEDHLLDLPPN-----RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 161 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
++|.+++...... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999873211 367999999999999999999999999 99999999999999999999999999986554
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
...........++..|+|||.+.+..++.++||||||+++|+|++ |..||............ . .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~----~-------- 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---R----K-------- 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H----c--------
Confidence 432222334557889999999988889999999999999999999 69999876432211100 0 0
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
......+...+..+.+++.+||+.+|.+||++.+++.+|+
T Consensus 223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0011223333568899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=310.53 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=197.8
Q ss_pred eeccCCcEEEEEEEE--CCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 86 LLGEGGFGRVYRGKL--EGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
.||+|+||.||+|.+ ..++..+|+|++...... ..+.+..|+.+++.++||||+++++++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 456789999998654322 2356888999999999999999999886 45678999999999
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccc
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV 241 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 241 (399)
+|.+++.. ...+++..+..++.|++.||.|||+++ |+||||||.||+++.++.+||+|||++...........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999975 346899999999999999999999999 99999999999999999999999999976433322111
Q ss_pred -cccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 242 -STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 242 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+....+ .. ...
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-------~~----------~~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-------ES----------GER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HC----------CCC
Confidence 112234578999999988889999999999999999998 99999875432211111 00 001
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
...+...+..+.+++.+||+.||++||++.+|.+.|++.
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112223445788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=329.79 Aligned_cols=264 Identities=27% Similarity=0.365 Sum_probs=207.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCcc-hHHHHHHHHHHHccC-CCceeeEEEEEeeCC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLS-NPYLVNLVGYCVDGD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~ 149 (399)
..++|.+.+.||+|+||.||+|.+. .++..||+|++....... ...+.+|+.++.++. ||||+++++++...+
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 3346778899999999999999864 345689999997653322 346888999999997 999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCC---------------------------------------------------------
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPP--------------------------------------------------------- 172 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 172 (399)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975321
Q ss_pred -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceE
Q 046609 173 -------------------------------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVL 215 (399)
Q Consensus 173 -------------------------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIl 215 (399)
....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEE
Confidence 1234678888999999999999999998 999999999999
Q ss_pred ECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccc
Q 046609 216 LDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQ 294 (399)
Q Consensus 216 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 294 (399)
++.++.+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999975432222112222356788999999988889999999999999999998 8899876432211
Q ss_pred hhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
.... ... ......+......+.+++.+||..+|.+||++.+|+..|+.+.
T Consensus 351 -~~~~----~~~----------~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FYNA----IKR----------GYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHH----HHc----------CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 0000 000 0011112233457889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.70 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=200.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|....+++.||+|++.... ......+..|+.++..++||||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999999999999999997432 122355778999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999976 456999999999999999999999999 99999999999999999999999999864321
Q ss_pred CCCc---------------------------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC
Q 046609 236 GDKS---------------------------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282 (399)
Q Consensus 236 ~~~~---------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~ 282 (399)
.... .......||+.|+|||++.+..++.++|||||||++|+|++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 1100 0112346999999999999999999999999999999999999
Q ss_pred CCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC---hHHHHHH
Q 046609 283 RVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM---MSDVVTA 354 (399)
Q Consensus 283 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~ 354 (399)
.||....+......+. ..... ....+ .......+.+++.+++ .+|.+|++ +.+++++
T Consensus 234 ~Pf~~~~~~~~~~~i~------~~~~~--~~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQETYRKVM------NWKET--LVFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHHHHHHHHH------cCCCc--eecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 9998765432211110 00000 00000 0112346778888876 49999985 5666655
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=315.69 Aligned_cols=249 Identities=25% Similarity=0.379 Sum_probs=197.0
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||+|+||.||++....+++.||+|.+...... ....+..|+.++++++||||+++++++.++...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999998653221 223456799999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 9888652 2345889999999999999999999999 9999999999999999999999999987543322 122
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
...|+..|+|||++.+..++.++|||||||++|+|++|+.||......... .......... .... ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~----------~~~~-~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EELKRRTLED----------EVKF-EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HHHHHHhhcc----------cccc-cc
Confidence 346899999999998888999999999999999999999999764322111 0000111100 0000 01
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
......+.+++.+||+.||.+||+++++++.+.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 123446889999999999999999987764433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=327.73 Aligned_cols=265 Identities=22% Similarity=0.269 Sum_probs=200.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCC-----
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD----- 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----- 149 (399)
..++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999999899999999986532 233456788999999999999999999986543
Q ss_pred -eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 150 -QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 150 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
..++||||+. ++|...+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 4799999995 567766643 4888999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-H---------
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-T--------- 298 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~--------- 298 (399)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+........ .
T Consensus 169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 98753221 1223346899999999999999999999999999999999999999876532211000 0
Q ss_pred ------hhhhhhhccchhh-----hccCCcc---CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 299 ------WATPLFKDRRKFT-----MMADPLL---EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 299 ------~~~~~~~~~~~~~-----~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
............. ....... ...........+.+|+.+||+.||++|||+.+++.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000000000 0000000 000111223567899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=314.17 Aligned_cols=257 Identities=24% Similarity=0.417 Sum_probs=204.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCe---EEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQ---DVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.+|.+.+.||+|+||.||+|....++. .||||.+.... ......+..|+.++++++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357788999999999999999876554 69999987542 22346788999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999762 356899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCcccccccc---ccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 235 TGDKSHVSTRVM---GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 235 ~~~~~~~~~~~~---g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
............ .+..|+|||.+.+..++.++||||||+++|||++ |..||........ .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~~~------- 227 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIEQD------- 227 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHHcC-------
Confidence 322211111111 2457999999988999999999999999999886 9999976543211 1111100
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....+...+..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus 228 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -------YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00011123345678899999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.69 Aligned_cols=250 Identities=28% Similarity=0.450 Sum_probs=199.9
Q ss_pred CeeccCCcEEEEEEEECCCC---eEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTN---QDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.....+ ..+|+|.+...... ..+.+.+|+.+++.+.||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 46999999999999875544 78999998765442 3456889999999999999999999876 4567999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 999999976 346899999999999999999999999 9999999999999999999999999987543332211
Q ss_pred c-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 241 V-STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 241 ~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||...+.... ....... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~~~----~---------- 215 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLESG----E---------- 215 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHcC----C----------
Confidence 1 111224567999999988899999999999999999998 9999987543221 1111100 0
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
....+...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 00112223457889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=310.83 Aligned_cols=255 Identities=29% Similarity=0.408 Sum_probs=204.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+.++ ..||+|.+..... ....+.+|+.+++.++||||+++++.+.+ ...++||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~ 81 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 81 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEc
Confidence 35789999999999999999988765 4599999975432 34578899999999999999999998754 567999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999752 2345899999999999999999999999 9999999999999999999999999997543332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. ......++..|+|||+..+..++.++||||||+++|+|++ |..||............ .. ...
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~-------~~------~~~- 221 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-------ER------GYR- 221 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH-------hc------CCC-
Confidence 21 1122346678999999988899999999999999999999 88899765432211100 00 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 222 ---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 ---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 011223445788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=314.86 Aligned_cols=269 Identities=28% Similarity=0.372 Sum_probs=204.6
Q ss_pred CCCCCeeccCCcEEEEEEEE----CCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRIL 153 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l 153 (399)
|.+.+.||+|+||+||++.. ..++..||+|.+..... .....+.+|+.+++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 45678899999875432 2345688899999999999999999987653 46789
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
+|||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+||||||+||+++.++.++|+|||++...
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999965 35999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHV-STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ .......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhhhh
Confidence 43322111 1223456679999999888899999999999999999999999875432111 0000000000 0001111
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
..+.......+...+..+.+++.+||+.+|++||++++|++.|+.+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 11111111223344568899999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=310.64 Aligned_cols=254 Identities=29% Similarity=0.422 Sum_probs=203.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.+.||+|++|.||+|.... +..+|+|.+..... ....+.+|+.++++++|||++++++++. ....+++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 3578889999999999999998774 56799999876443 3457889999999999999999999885 4567899999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 9999999999762 2346899999999999999999999999 9999999999999999999999999997543322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.... ...
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~---~~~-------------- 218 (260)
T cd05070 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ---VER-------------- 218 (260)
T ss_pred cc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---HHc--------------
Confidence 11 1112235678999999988899999999999999999999 8999976543221111 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
......+...+..+.+++.+||+.+|++|||+.++++.|++
T Consensus 219 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 219 GYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 00011223344578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.43 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=206.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||.|++|.||+|... ++.||+|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 457888999999999999999876 68899999976643 456788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||.+.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999762 2236899999999999999999999999 9999999999999999999999999997642221
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. ....+..|+|||.+.++.++.++||||||+++|+|++ |..||........ ..... ..
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~~~~~----~~--------- 215 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPHVE----KG--------- 215 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHHHh----cC---------
Confidence 1 2235668999999988889999999999999999997 9999976543211 11000 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....+...+..+.+++.+||..+|.+||++.+++++|+.+
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 216 -YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00111223345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=326.07 Aligned_cols=241 Identities=24% Similarity=0.337 Sum_probs=192.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHH-HHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEV-LMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.+..++..||+|++..... .....+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999975321 1223344444 456788999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 999999976 456888999999999999999999999 999999999999999999999999998743221 11
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++|||||||++|+|++|.+||......+.. ....... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~~~------------~ 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNILNKP------------L 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH------HHHHhCC------------c
Confidence 233456999999999999999999999999999999999999999865432211 1111100 0
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil 352 (399)
..+......+.+++.+||+.+|.+||++.+.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 11223345788999999999999999987433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=331.64 Aligned_cols=262 Identities=21% Similarity=0.268 Sum_probs=205.6
Q ss_pred HHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEee
Q 046609 71 YRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVD 147 (399)
Q Consensus 71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~ 147 (399)
.+++....++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44555667899999999999999999999999999999999864321 223446789999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
++..++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999865 35889999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG----QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
|++....... ........||+.|+|||++.+. .++.++|||||||++|+|++|..||...+.... ....
T Consensus 187 G~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i 259 (371)
T cd05622 187 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKI 259 (371)
T ss_pred CceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHH
Confidence 9997543221 1122345699999999998653 378899999999999999999999986543211 1111
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT--RPMMSDVVTAI 355 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~L 355 (399)
...... +.-.........+.+++.+||..++.+ ||++.+|+++.
T Consensus 260 ~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 260 MNHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred HcCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 110000 000011234456788999999844433 78999998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.06 Aligned_cols=238 Identities=25% Similarity=0.341 Sum_probs=191.4
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHH-HHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVL-MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..+++.||+|++..... .....+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999875322 12233445544 67889999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988865 456899999999999999999999999 999999999999999999999999998742221 12
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+.... . ...... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~---~~i~~~----------~--~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y---DNILHK----------P--L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H---HHHhcC----------C--C
Confidence 22345689999999999988999999999999999999999999987542111 1 111100 0 1
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMS 349 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 349 (399)
..+......+.+++.+||+.+|.+||++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12223445788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=315.38 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=204.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+.|++.+.||.|+||.||+|.+..++..+++|.+..........+..|+.+++.++||||+++++.+..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56889999999999999999999999999999998765555677888999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|..++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 92 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 92 PGGAVDAIMLE---LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 99999888765 2356899999999999999999999999 999999999999999999999999988642221
Q ss_pred cccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 239 SHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
........++..|+|||++. ...++.++|||||||++|+|++|.+||....+... ..... . .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~~~----~-------~ 230 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKIA----K-------S 230 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHHHh----c-------C
Confidence 11223345888999999884 34578899999999999999999999976543211 11000 0 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.. ..+......+.+++.+||+.+|++||++.+++++
T Consensus 231 ~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 231 EPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred CCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00100 1122334578899999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=317.10 Aligned_cols=266 Identities=26% Similarity=0.441 Sum_probs=204.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC----------------CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG----------------TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVN 140 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~ 140 (399)
.++|++.+.||+|+||.||++.+.+ +...+|+|.+..... .....+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 3578999999999999999986432 345799999875432 23467889999999999999999
Q ss_pred EEEEEeeCCeeEEEEEecCCCChHHhhccCCCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 046609 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN-------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASN 213 (399)
Q Consensus 141 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~N 213 (399)
+++++..++..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 999999999999999999999999999763211 234788899999999999999999999 9999999999
Q ss_pred eEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCc
Q 046609 214 VLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT--GRRVIDNSRPT 291 (399)
Q Consensus 214 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~ 291 (399)
|+++.++.++|+|||++................++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999875433322222222345678999999888899999999999999999998 77888765432
Q ss_pred ccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 292 EEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
+. .......+..... ....+ .+...+..+.+++.+||+.||.+||++.+|++.|+
T Consensus 241 ~~---~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QV---IENTGEFFRDQGR--QVYLP-----KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HH---HHHHHHHHhhccc--cccCC-----CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 21 1111111111000 00000 11223357889999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=310.54 Aligned_cols=251 Identities=25% Similarity=0.414 Sum_probs=204.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---------HHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---------REFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---------~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
+|.+...||.|++|.||+|.+..++..+|+|.+........ +.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 47788999999999999999988899999999875433221 457789999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.+++|||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||.+
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999976 356899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCC----ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 231 KLGPTGDK----SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 231 ~~~~~~~~----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........ ........|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~-------- 222 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA---IF-------- 222 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH---HH--------
Confidence 75432111 1111234578899999999888899999999999999999999999986432110 00
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....... ...+......+.+++.+||+.+|.+||++.+|+++
T Consensus 223 --~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 223 --KIGENAS----PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --HHhccCC----CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 0000111 12233345678899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=316.23 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=207.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|.+.+.||.|++|.||+|....++..||+|.+..........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 67999999999999999999998889999999997665555667888999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred CCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 99999999864 35889999999999999999999999 99999999999999999999999999875332221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......+++.|+|||.+.+..++.++||||||+++|+|++|..||...++........ . . ..+.
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~---~---~-------~~~~- 234 (297)
T cd06656 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---T---N-------GTPE- 234 (297)
T ss_pred --CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec---c---C-------CCCC-
Confidence 1223458889999999988889999999999999999999999997654422110000 0 0 0000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+......+.+++.+||+.+|.+||++.+|+++
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 235 -LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01122334567889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=302.59 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=207.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc----h----HHHHHHHHHHHccC-CCceeeEEEEEeeC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG----N----REFLVEVLMLSMLS-NPYLVNLVGYCVDG 148 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----~----~~~~~e~~~l~~l~-hpnIv~l~~~~~~~ 148 (399)
-.+|...+.||.|..++|-++.++.++..+|+|++....... . +.-..|+.||+++. ||+|+.+.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356778899999999999999999999999999986432211 1 33467899999985 99999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
...++|+|.|+.|.|.++|.. .-.+++...++|+.|+++|++|||.++ ||||||||+|||++++.++||+|||
T Consensus 96 sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFG 168 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFG 168 (411)
T ss_pred chhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccc
Confidence 999999999999999999976 567999999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALT------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
.+.....+.. ....||||+|+|||.+.. ..|+...|+|++|+++|.|+.|.+||-...+.-....+.....
T Consensus 169 Fa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGky 245 (411)
T KOG0599|consen 169 FACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKY 245 (411)
T ss_pred eeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhccc
Confidence 9997666653 345789999999998843 4688899999999999999999999986433221111111111
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.| ..|. =.+.+....+||.+||++||.+|.|++|++.+
T Consensus 246 qF---------~spe-----Wadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 246 QF---------RSPE-----WADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred cc---------CCcc-----hhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 11 1111 12345578899999999999999999999875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=314.47 Aligned_cols=251 Identities=24% Similarity=0.373 Sum_probs=202.5
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
|++.+.||.|+||.||+|.+..++..+++|.+..........+.+|+.+++.++||||+++++.+..++..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 56678899999999999999999999999999765544556788899999999999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
++|..++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++....... .
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 999988765 2456999999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred cccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 241 VSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
......++..|+|||++. +..++.++|||||||++|+|++|++||....+.... .... .. ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~~~----~~-------~~ 225 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LKIA----KS-------EP 225 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HHHh----hc-------CC
Confidence 222346889999999874 345788999999999999999999999865432111 0000 00 00
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+.. ..+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 226 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 226 PTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred CCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 1122234578899999999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=317.79 Aligned_cols=266 Identities=22% Similarity=0.281 Sum_probs=205.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||+|+||.||++.+..++..+|+|.+...... ...++.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999999999999999998754222 235588899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
+++++|.+++.. ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 153 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence 999999999976 3568999999999999999999997 47 999999999999999999999999998643222
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc--------
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR-------- 308 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-------- 308 (399)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+...................
T Consensus 154 ----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (308)
T cd06615 154 ----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGH 229 (308)
T ss_pred ----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCC
Confidence 12234688999999998888899999999999999999999999975443221111100000000000
Q ss_pred ------------hhhhccCCccCCCCC-HHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 309 ------------KFTMMADPLLEGNYP-IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 309 ------------~~~~~~~~~l~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
....+... .....+ ......+.+++.+||..+|++||++.+|+.+--
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 289 (308)
T cd06615 230 PPDSPRPMAIFELLDYIVNE-PPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF 289 (308)
T ss_pred CCCccchhhHHHHHHHHhcC-CCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 00000000 000001 113456889999999999999999999987743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=327.67 Aligned_cols=239 Identities=25% Similarity=0.351 Sum_probs=194.7
Q ss_pred CeeccCCcEEEEEEEE---CCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 85 NLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
+.||+|+||.||++.. ..++..||+|++..... .....+..|+.++++++||||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999876 35689999999975432 223456789999999999999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
+|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 9999999965 456899999999999999999999999 9999999999999999999999999987533221
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||........... .....
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~------i~~~~------------ 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM------ILKAK------------ 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHH------HHcCC------------
Confidence 122335689999999999888899999999999999999999999986543211110 00000
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCChHH
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSD 350 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 350 (399)
...+......+.+++.+||+.||.+||++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0112233457889999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=309.48 Aligned_cols=255 Identities=25% Similarity=0.344 Sum_probs=209.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||.|++|.||+|.+..++..+++|.+........+.+.+|+.++++++||||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888999999999999999998888999999998665555678899999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 83 ~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999876 2357999999999999999999999999 9999999999999999999999999987543221
Q ss_pred ccccccccccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 239 SHVSTRVMGTYGYCAPEYALTG---QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.......++..|+|||.+.+. .++.++||||||+++|+|++|..||....+........ . .....
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~---------~~~~~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--K---------SNFPP 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h---------ccCCC
Confidence 122234688899999998766 88999999999999999999999998755332111000 0 00001
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+.+ ......+..+.+++.+||..+|.+||++.+|+.+
T Consensus 224 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111 1233445678999999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=318.52 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=207.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC-------CCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG-------TNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDG 148 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 148 (399)
..+|.+.+.||+|+||.||+|...+ ....+|+|.+..... .....+..|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 3578889999999999999997632 345799999875422 2335678899999999 599999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
+..+++|||+++|+|.+++..... ....+++..+..++.|++.||.|||+++ |+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence 999999999999999999976321 1245899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccch
Q 046609 217 DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQN 295 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 295 (399)
+.++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||......+...
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999975433222111122234567999999988899999999999999999999 889997654322111
Q ss_pred hhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 296 LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.. ... .....+......+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus 248 ~~-------~~~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~ 296 (314)
T cd05099 248 LL-------REG----------HRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA 296 (314)
T ss_pred HH-------HcC----------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence 11 000 00011223345788999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=329.89 Aligned_cols=266 Identities=21% Similarity=0.324 Sum_probs=202.2
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCC-----eeE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD-----QRI 152 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 152 (399)
+|++.+.||+|+||.||+|.+..+++.||||.+.... ....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999998889999999986432 223456889999999999999999999998776 789
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+|+||+. ++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 688888765 457999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh--hhhc---
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP--LFKD--- 306 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~--- 306 (399)
...... .......++..|+|||++.+. .++.++|||||||++|+|++|+.||...++......+..... ....
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 432221 122234578899999988764 578999999999999999999999987665432221111000 0000
Q ss_pred -cchhh-hcc-----CCccC--CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 -RRKFT-MMA-----DPLLE--GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 -~~~~~-~~~-----~~~l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..... .+. .+... ..........+.+|+.+||+.||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 00000 000 00000 01112234578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=326.34 Aligned_cols=239 Identities=25% Similarity=0.339 Sum_probs=192.1
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHH-HHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVL-MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.+..+++.||+|++..... .....+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999965421 22234555554 56778999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999988865 457999999999999999999999999 999999999999999999999999998743221 11
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......|++.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ...... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~~~----~----~---- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNILHK----P----L---- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHHcC----C----c----
Confidence 223456999999999999999999999999999999999999999865432211 111110 0 0
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSD 350 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 350 (399)
..+......+.+++.+||+.+|.+||++.+
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 011123446788999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=316.02 Aligned_cols=252 Identities=27% Similarity=0.408 Sum_probs=203.2
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
|+..++||+|+||.||++.+..+++.||+|.+....... ...+..|+.+++.++|+||+.+++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999999999999999987543222 24467899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999988652 2346899999999999999999999999 9999999999999999999999999987543222
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||.............. ....
T Consensus 157 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~~----------- 219 (285)
T cd05630 157 T---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKE----------- 219 (285)
T ss_pred c---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhhh-----------
Confidence 1 1234689999999999989999999999999999999999999986543211111100 0000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
....++......+.+|+.+||+.||.+||| +.+++++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001112233456889999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=313.42 Aligned_cols=254 Identities=22% Similarity=0.312 Sum_probs=204.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++.+..++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777899999999999999999899999999987654444456788999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. .+.+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-- 159 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc--
Confidence 99999999875 457999999999999999999999999 999999999999999999999999998653221
Q ss_pred cccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 239 SHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
........|+..|+|||++. ...++.++|||||||++|+|++|..||....+......... . ....
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~------~-----~~~~ 228 (267)
T cd06645 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK------S-----NFQP 228 (267)
T ss_pred ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc------c-----CCCC
Confidence 11223356899999999874 45688999999999999999999999976543221111000 0 0001
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+.... ....+..+.+++.+||+.+|++||++.+|+++
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 11111 11123467889999999999999999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=304.25 Aligned_cols=253 Identities=19% Similarity=0.254 Sum_probs=206.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.+.|++.++||+|.|+.|+++.+..+|+.+|+|+++...+ ...+++.+|+.|-+.++||||+++.+.+......|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 4567888999999999999999999999999999875433 34577889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~~~~ 232 (399)
|++.|++|..-+.. ..-.++..+-..+.||++||.|+|.++ |||||+||+|+++.. ..-+||+|||++..
T Consensus 90 e~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred ecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 99999999877765 245788888999999999999999999 999999999999943 34599999999987
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.. ....-....|||.|||||++...+|+..+|||+.||+||-|+.|.+||.+.+.......+ ....-
T Consensus 163 l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I----------~~g~y 229 (355)
T KOG0033|consen 163 VN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI----------KAGAY 229 (355)
T ss_pred eC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH----------hcccc
Confidence 65 223334467999999999999999999999999999999999999999985432111111 11111
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+++ .+-.....+..+|+++||..||.+|.|+.|.+.+
T Consensus 230 d~~~----~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 230 DYPS----PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCCC----cccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 1111 1122344578899999999999999999988754
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.91 Aligned_cols=265 Identities=26% Similarity=0.366 Sum_probs=204.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeEEEEEeeC-C
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNLVGYCVDG-D 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~-~ 149 (399)
.++|.+.+.||+|+||.||+|.+. .+++.||||.+...... ....+.+|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 457999999999999999999853 35688999999754322 235678899999999 689999999988654 4
Q ss_pred eeEEEEEecCCCChHHhhccCCC---------------------------------------------------------
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPP--------------------------------------------------------- 172 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 172 (399)
..+++|||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999865211
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcccccccc
Q 046609 173 ------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM 246 (399)
Q Consensus 173 ------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~ 246 (399)
....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++................
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 0124788889999999999999999999 9999999999999999999999999987543322222222234
Q ss_pred ccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHH
Q 046609 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIK 325 (399)
Q Consensus 247 g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 325 (399)
++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .... ..... . ...+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~~----~~~~~------~----~~~~~~ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRR----LKEGT------R----MRAPDY 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHHH----HhccC------C----CCCCCC
Confidence 5678999999988899999999999999999996 9999976433211 1100 00000 0 001111
Q ss_pred HHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 326 GLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 326 ~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
....+.+++..||+.+|.+||++.+|+++|+.+.+.
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 234688999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=307.92 Aligned_cols=248 Identities=25% Similarity=0.413 Sum_probs=197.0
Q ss_pred eccCCcEEEEEEEEC--CCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||+|+||.||+|.+. +.+..||+|++...... ..+.+.+|+.++++++||||+++++++.. ...++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999774 44567999998754322 23568899999999999999999999864 578999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccc-c
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV-S 242 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~-~ 242 (399)
.+++.. ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++........... .
T Consensus 82 ~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 82 NKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999875 2456899999999999999999999999 99999999999999999999999999975433322111 1
Q ss_pred ccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCC
Q 046609 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321 (399)
Q Consensus 243 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 321 (399)
....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+..... . . .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~----~----------~~~~~ 218 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI---E----Q----------GKRLD 218 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH---H----C----------CCCCC
Confidence 11224578999999988889999999999999999996 99999876542211111 0 0 00111
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 322 YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.+......+.+++.+||..+|++||++.+|++.|+.+
T Consensus 219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2233456788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.91 Aligned_cols=194 Identities=24% Similarity=0.367 Sum_probs=168.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
....+|.+.+.||+|+||.||+|.+..++..||+|+.... ....|+.++++++||||+++++++......++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3456899999999999999999999988999999985432 2346899999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|++ .++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 137 PHY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred Ecc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 999 5689888865 3457999999999999999999999999 99999999999999999999999999874222
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVI 285 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 285 (399)
. .......||..|+|||++.+..++.++|||||||++|+|+++..|+
T Consensus 210 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 210 A---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred C---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 1122356899999999999999999999999999999999855444
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.79 Aligned_cols=255 Identities=28% Similarity=0.418 Sum_probs=204.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.++||.|+||.||+|.... ++.||+|.+..... ....+.+|+.+++.++||||+++++++. .+..+++|||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 4578899999999999999998764 67899999876543 3467889999999999999999999874 4578999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999998752 2456899999999999999999999999 9999999999999999999999999987543222
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||.......... .. .. ...
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~----~~------~~~- 221 (260)
T cd05067 157 Y-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ---NL----ER------GYR- 221 (260)
T ss_pred c-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH----Hc------CCC-
Confidence 1 11222346778999999988889999999999999999998 999998654322111 00 00 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
...+...+..+.+++.+||+.+|++||++++++..|+.+
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 222 ---MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 011222345789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=312.29 Aligned_cols=251 Identities=23% Similarity=0.346 Sum_probs=200.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.++||+|+||.||+|.+..++..||+|.+..... .....+.+|+.++.+++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 367888999999999999999998999999999865422 2335688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999986542 3688899999999999999999999 999999999999999999999999998754322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch-hhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN-LVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 316 (399)
......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ........... ..+
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------~~~ 218 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDE-------DPP 218 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhcc-------CCC
Confidence 1223568999999999998899999999999999999999999997643322110 00000000000 001
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+. .......+.+++.+||+.+|.+||++.+++++
T Consensus 219 ~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 219 VLP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 110 11233468899999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=327.21 Aligned_cols=265 Identities=21% Similarity=0.268 Sum_probs=201.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeC------
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------ 148 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------ 148 (399)
..++|.+.+.||+|+||.||++.+..+++.||||.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 34789999999999999999999988899999999975422 2335677899999999999999999998643
Q ss_pred CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
...++||||++ ++|.+.+.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 35699999995 577777643 4888999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-H---------
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-T--------- 298 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~--------- 298 (399)
+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||...+........ .
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99753222 1223356899999999999989999999999999999999999999875432211100 0
Q ss_pred ------hhhhhhhccchhhhccCCc------c--CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 299 ------WATPLFKDRRKFTMMADPL------L--EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 299 ------~~~~~~~~~~~~~~~~~~~------l--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..............+..+. . ...........+.+|+.+||+.||.+|||+.+++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000000000000000000 0 001112234577899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=308.24 Aligned_cols=251 Identities=27% Similarity=0.379 Sum_probs=207.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||.|++|.||+|.+..++..+++|.+..... ...+.+|+.+++.++||||+++++.+.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999998889999999875532 577899999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999865 2457899999999999999999999999 99999999999999999999999999876433221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......++..|+|||++.+..++.++||||||+++|+|++|+.||....+....... .....+.
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~- 218 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI-------------PNKPPPT- 218 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh-------------ccCCCCC-
Confidence 222345788999999998889999999999999999999999999865443211000 0000000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+......+.+++.+||+.+|++||++.+|+++
T Consensus 219 -~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 -LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11122344578899999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.83 Aligned_cols=248 Identities=27% Similarity=0.435 Sum_probs=201.4
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
++||.|++|.||+|.+.. ++.||+|.+...... ....+.+|+.++++++||||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999999987 899999998765443 346788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
.+++.. ....+++..++.++.+++.||.|||+++ ++||||+|+||+++.++.++|+|||++.............
T Consensus 80 ~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~ 153 (251)
T cd05041 80 LTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG 153 (251)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence 999976 2346889999999999999999999999 9999999999999999999999999987543222211112
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNY 322 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 322 (399)
....+..|+|||.+.++.++.++||||||+++|+|++ |..||....+........ . ......
T Consensus 154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---~--------------~~~~~~ 216 (251)
T cd05041 154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---S--------------GYRMPA 216 (251)
T ss_pred cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---c--------------CCCCCC
Confidence 2234667999999988899999999999999999998 889997765422111110 0 000111
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 323 PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
+...+..+.+++.+||..+|++||++.++++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 2233457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=311.55 Aligned_cols=260 Identities=28% Similarity=0.428 Sum_probs=208.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCe----EEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQ----DVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.+|.+.+.||+|+||.||+|.+..++. .+|+|.+..... .....+.+|+.++..++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999999865543 689998875543 233568889999999999999999999987 78899
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 9999999999999976 2345899999999999999999999998 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.............++..|+|||.+....++.++||||||+++|+|++ |+.||......+...... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-------~~~---- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-------KGE---- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-------CCC----
Confidence 43332222222334568999999988899999999999999999998 999998754322111110 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
....+......+.+++.+||..+|++||++.++++.|+.+....
T Consensus 229 ------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 229 ------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 00111223346888999999999999999999999999986543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=330.89 Aligned_cols=265 Identities=21% Similarity=0.232 Sum_probs=200.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
....|.+.+.||+|+||.||+|.+..++..||||... ...+.+|+.++++++||||+++++++..++..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3567999999999999999999999999999999643 2345689999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
++ .++|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 241 ~~-~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 241 KY-RSDLYTYLGA---RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred cc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99 5799988865 2346999999999999999999999999 999999999999999999999999999764333
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc-----chhhHhhhhhhhccchhh
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEE-----QNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 311 (399)
..........||..|+|||++.+..++.++|||||||++|||++|..|+-....... ..+...+...-.....+.
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 222222345699999999999999999999999999999999998865543221110 011111100000000000
Q ss_pred h---------c-------cCCc-cCCCCC--HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 312 M---------M-------ADPL-LEGNYP--IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 312 ~---------~-------~~~~-l~~~~~--~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. . ..+. ....+. ......+.+|+.+||+.||.+|||+.|++++
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 0 0000 000000 0122467889999999999999999999875
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=315.32 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=205.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|.+.+ ++..||+|.+..... .....+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 4678899999999999999998743 578899999875432 2235688899999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCC------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 046609 152 ILVYEYMPNGSLEDHLLDLP------------------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASN 213 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~------------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~N 213 (399)
+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ ++||||+|+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999997421 11235788999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 046609 214 VLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTE 292 (399)
Q Consensus 214 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 292 (399)
|+++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|+|++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875332222111222335667999999988899999999999999999997 888887654322
Q ss_pred cchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 293 EQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
. .... .... . ...+...+..+.+++.+||+.+|.+||++.|+++.|++
T Consensus 241 ~---~~~~----~~~~---------~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 V---IYYV----RDGN---------V-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H---HHHH----hcCC---------C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1100 0000 0 00112234578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.77 Aligned_cols=254 Identities=27% Similarity=0.376 Sum_probs=202.1
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeC------C
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDG------D 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~------~ 149 (399)
+++.|.+.+.||+|+||.||+|....+++.||+|.+.... .....+..|+.++..+ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4567888899999999999999999999999999987543 3345688899999988 699999999998753 4
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..+++|||+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 678999999999999999762 2346899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCcccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
+....... .......|+..|+|||++. +..++.++|||||||++|+|++|..||....+.......
T Consensus 158 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~------- 228 (272)
T cd06637 158 SAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 228 (272)
T ss_pred ceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-------
Confidence 87532221 1223356899999999885 346888999999999999999999999765432211100
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. . ..+.. .....+..+.+|+.+||..+|.+|||+.+++++
T Consensus 229 ~~-~-----~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 229 PR-N-----PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred hc-C-----CCCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0 00000 111233468899999999999999999999753
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=310.85 Aligned_cols=257 Identities=25% Similarity=0.410 Sum_probs=205.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.+|.+.+.||+|+||.||+|.+..+ +..+|+|.+..... .....+.+|+.++++++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 5788899999999999999987533 34799999865432 2235688899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 999999999999976 2346899999999999999999999999 9999999999999999999999999997644
Q ss_pred CCCCccc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 235 TGDKSHV-STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 235 ~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
....... .....++..|+|||.+.+..++.++||||||+++|++++ |..||......+. ....... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~~----~---- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEEG----Y---- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhCC----C----
Confidence 3221111 111223568999999988899999999999999999886 9999987554221 1111100 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
....+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011122345788999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=313.09 Aligned_cols=253 Identities=28% Similarity=0.448 Sum_probs=203.4
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchH--HHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR--EFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
|++.+.||+|+||+||++....+++.||+|.+......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 45678999999999999999999999999999876543332 2356999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. ...+++..++.++.|++.||.+||+.+ |+|+||||+||+++.++.++|+|||.+... ...
T Consensus 81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL--SEN 151 (260)
T ss_dssp TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES--TST
T ss_pred ccccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc--ccc
Confidence 99999999983 467899999999999999999999999 999999999999999999999999998743 122
Q ss_pred cccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-hhhccchhhhccCC
Q 046609 239 SHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-LFKDRRKFTMMADP 316 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 316 (399)
........++..|+|||++. +..++.++||||||+++|+|++|..||................. .... ..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~------~~-- 223 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPS------SS-- 223 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHH------HT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccc------cc--
Confidence 22334456899999999988 78999999999999999999999999997622111111111000 0000 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+.+++.+||+.||++||++.+++++
T Consensus 224 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 ----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp ----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ----cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000112688999999999999999999999753
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=316.40 Aligned_cols=266 Identities=23% Similarity=0.312 Sum_probs=203.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||.|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 5788999999999999999999988999999998754322 234577899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDD---CGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 699988876 2456899999999999999999999999 9999999999999999999999999987532222
Q ss_pred CccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc---
Q 046609 238 KSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM--- 313 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 313 (399)
.......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+........ ...+..+
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 235 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPT-EETWPGILSN 235 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC-hhhchhhhcc
Confidence 11223457889999998765 4578899999999999999999999987654322111111000000 0000000
Q ss_pred ------cCCccCC----CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ------ADPLLEG----NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ------~~~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.... .........+.+|+.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0010000 0111234567899999999999999999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=315.48 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=207.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|.+.+.||.|++|.||+|.+..+++.|++|.+..........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 56888999999999999999998889999999997665555677889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|..++.. ..+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998865 35899999999999999999999999 99999999999999999999999999875432221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......++..|+|||.+.+..++.++|||||||++|+|++|..||...++....... . .. ..+.+
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~---~---~~-------~~~~~ 235 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---A---TN-------GTPEL 235 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H---hc-------CCccc
Confidence 122345888999999998888999999999999999999999999876543211100 0 00 00001
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+......+.+++.+||..+|.+||++.+|+.+
T Consensus 236 --~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 236 --QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred --CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 1122334568889999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=327.97 Aligned_cols=263 Identities=21% Similarity=0.221 Sum_probs=202.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC--CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG--TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
..+|.+.+.||.|+||.||++...+ ++..||+|.+... ....+|+.++++++||||+++++++......+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 4579999999999999999997643 4678999987543 34567999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|++ +++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++.....
T Consensus 166 e~~-~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKY-KCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 999 5789888844 467999999999999999999999999 99999999999999999999999999975444
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc-c------
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR-R------ 308 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~------ 308 (399)
...........||+.|+|||++.+..++.++|||||||++|+|++|+.||..................+... .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 333333334679999999999999999999999999999999999999998765432111111111000000 0
Q ss_pred ------hhhhccCCccCCCCC-------HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 ------KFTMMADPLLEGNYP-------IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ------~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+... ....+..+. .....++.+++.+||..||++||++.+++.+
T Consensus 318 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000 000000000 1123467889999999999999999999876
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=314.15 Aligned_cols=266 Identities=25% Similarity=0.341 Sum_probs=207.9
Q ss_pred ccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEe-
Q 046609 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCV- 146 (399)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~- 146 (399)
...+.+....++|.+.+.||+|+||.||+|.+..+++.+|+|.+.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334555567789999999999999999999999889999999986532 2235677899999998 6999999999874
Q ss_pred ----eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 147 ----DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 147 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
.++..++||||+++++|.+++.........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 445789999999999999988653334567899999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (399)
+|+|||++....... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+.... .
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~ 239 (286)
T cd06638 164 KLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F 239 (286)
T ss_pred EEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence 999999987543221 12223468999999998753 45788999999999999999999999875432211 0
Q ss_pred HhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
.. .....+.+ ..+......+.+++.+||+.+|++||++.+|+++.
T Consensus 240 ~~-----------~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 240 KI-----------PRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hc-----------cccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 00000000 01112234688999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=314.78 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=206.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||.|++|.||+|.+..++..+|+|.+..........+..|+.+++.++||||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 35688889999999999999999888999999999766545556788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 999999999876 2356999999999999999999999999 9999999999999999999999999886532221
Q ss_pred Ccccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 238 KSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.......++..|+|||.+. +..++.++||||||+++|+|++|+.||....+.... .. ...
T Consensus 158 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~----~~~------- 222 (280)
T cd06611 158 --QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LK----ILK------- 222 (280)
T ss_pred --cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HH----Hhc-------
Confidence 1223356889999999874 345778999999999999999999999875432211 10 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+.+ ..+......+.+++.+||+.+|.+||++.+++++
T Consensus 223 ~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 223 SEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 000111 1122334578899999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=314.41 Aligned_cols=264 Identities=22% Similarity=0.280 Sum_probs=197.1
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHcc---CCCceeeEEEEEee-----CC
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSML---SNPYLVNLVGYCVD-----GD 149 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~-----~~ 149 (399)
+|.+.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 478889999999999999999999999999998754222 223455677766655 69999999999864 34
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..+++|||+. ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5799999996 5898888763 2345899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhhccc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKDRR 308 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~~ 308 (399)
+....... ......++..|+|||++.+..++.++|||||||++|+|++|++||...........+ ........ .
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~--~ 229 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE--D 229 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh--h
Confidence 87543221 122345789999999998889999999999999999999999999765433211111 10000000 0
Q ss_pred hhhhc-------cCCcc---CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMM-------ADPLL---EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~-------~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+... ..+.. ...........+.+++.+||+.||.+|||+.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00000 001111234567899999999999999999999853
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=310.72 Aligned_cols=250 Identities=29% Similarity=0.418 Sum_probs=206.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||.|++|.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999999899999999987543 23345688899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999975 27899999999999999999999999 9999999999999999999999999987644332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......++..|+|||++.+..++.++||||||+++|+|++|..||...++......+ .....+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~-------------~~~~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI-------------PKNNPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh-------------hhcCCCC
Confidence 1223345888999999998888999999999999999999999999865532211000 0001111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+... ..+..+.+++.+||..+|++||++++++.+
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 134568899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=309.83 Aligned_cols=249 Identities=26% Similarity=0.366 Sum_probs=207.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.|+..+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 56777899999999999999998899999999875432 33456888999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06640 85 GGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-
Confidence 99999999864 35889999999999999999999999 9999999999999999999999999987543322
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......++..|+|||++.+..++.++|+||||+++|+|++|..||....+....... ....
T Consensus 156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-----------------~~~~ 217 (277)
T cd06640 156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-----------------PKNN 217 (277)
T ss_pred -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-----------------hcCC
Confidence 1222345788999999998888999999999999999999999999865543211100 0011
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
....+...+..+.+++.+||+.+|.+||++.+++.+-
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 1223445567889999999999999999999998873
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=309.22 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=197.5
Q ss_pred CeeccCCcEEEEEEEECCCCe--EEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQ--DVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|+||.||+|.+..++. .+++|.+.... ......+..|+.++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999977665 46888876432 23345688899999999 799999999999999999999999999
Q ss_pred CChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 161 GSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 161 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
|+|.+++..... ....+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 1235889999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
++...... ........+..|+|||++.+..++.++||||||+++|+|++ |..||......+... .. ..
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~~-~~- 226 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KL-PQ- 226 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH------HH-hC-
Confidence 98532111 11111234567999999988889999999999999999997 999997654321110 00 00
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
......+......+.+++.+||+.+|.+||++.+++..|+.+.
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 ---------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ---------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0000112223346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=344.46 Aligned_cols=266 Identities=21% Similarity=0.288 Sum_probs=208.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.++||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999999999999999999754322 2356889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 156 EYMPNGSLEDHLLDLPP-------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
||++||+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1234567788999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCC----------------ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc
Q 046609 229 LAKLGPTGDK----------------SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292 (399)
Q Consensus 229 ~~~~~~~~~~----------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 292 (399)
++........ ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9975421110 001122469999999999999999999999999999999999999997643321
Q ss_pred cchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHHHHhhhcc
Q 046609 293 EQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-MMSDVVTAIEYLAHSK 362 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~l~~~~ 362 (399)
.... . ....+.... .....+..+.+++.+||+.||++|| +++++++.|+......
T Consensus 239 i~~~-----~---------~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~ 294 (932)
T PRK13184 239 ISYR-----D---------VILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGS 294 (932)
T ss_pred hhhh-----h---------hccChhhcc-ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcC
Confidence 1100 0 000000000 0112334678899999999999995 6788888888776543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=337.42 Aligned_cols=268 Identities=19% Similarity=0.255 Sum_probs=198.7
Q ss_pred HHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC------CceeeEEEEEe
Q 046609 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN------PYLVNLVGYCV 146 (399)
Q Consensus 73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------pnIv~l~~~~~ 146 (399)
++.....+|.+.++||+|+||.||+|.+..+++.||||++.... ........|+.++..++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455688999999999999999999999889999999996432 223345567777766654 56889999887
Q ss_pred eC-CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCC----
Q 046609 147 DG-DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDF---- 220 (399)
Q Consensus 147 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~---- 220 (399)
.+ .+.++|||++ +++|.+++.. ...+++..+..++.||+.||.|||+ .+ ||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 64 5788999988 7899998876 3579999999999999999999997 48 99999999999998765
Q ss_pred ------------CeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 046609 221 ------------NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNS 288 (399)
Q Consensus 221 ------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 288 (399)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|++||...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999875321 1223457999999999999999999999999999999999999999876
Q ss_pred CCcccchhhHhhhhhh-----------------hccchhhhccCCc-----cCCC--CCHHHHHHHHHHHhhccccCCCC
Q 046609 289 RPTEEQNLVTWATPLF-----------------KDRRKFTMMADPL-----LEGN--YPIKGLYQALAVAAMCLQEEAGT 344 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~-----l~~~--~~~~~~~~l~~li~~cl~~dp~~ 344 (399)
+..+....+......+ ..........++. .... ........+.+||.+||+.||.+
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 6443322221111000 0000000000000 0000 00011346789999999999999
Q ss_pred CCChHHHHHH
Q 046609 345 RPMMSDVVTA 354 (399)
Q Consensus 345 RPs~~eil~~ 354 (399)
|||+.+++++
T Consensus 429 R~ta~e~L~H 438 (467)
T PTZ00284 429 RLNARQMTTH 438 (467)
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=306.95 Aligned_cols=249 Identities=29% Similarity=0.415 Sum_probs=200.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEe-eCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV-DGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~ 157 (399)
.+|.+.+.||+|+||.||+|... +..||+|.+... ...+.+.+|+.++++++|+|++++++++. +++..+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 57888999999999999999876 677999998654 23467889999999999999999999754 55678999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 82 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred CCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999762 2345889999999999999999999999 9999999999999999999999999987432221
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
....++..|+|||++.+..++.++|||||||++|+|++ |+.||....... ....... .
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~---~---------- 215 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK---G---------- 215 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc---C----------
Confidence 12335668999999988899999999999999999997 999987543211 1111000 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 216 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 216 -YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 00111223345788999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=310.41 Aligned_cols=249 Identities=25% Similarity=0.368 Sum_probs=215.0
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
|.++.+||+|+||.||+|+++.+|+.+|||.+... ...+++.+|+.++.++..|+||++||.+.....+|+|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 55668999999999999999999999999998754 5568899999999999999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|++.+.++. .+++|+++++..++...+.||+|||... -+|||||..|||++.+|..||+|||.+-...+ ...
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 999999987 4678999999999999999999999999 89999999999999999999999999865322 223
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
....+.||+.|||||++..-.|+.++||||||++..||..|++||.+..|......+ +....|.+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------------PT~PPPTF-- 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------------PTKPPPTF-- 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------------cCCCCCCC--
Confidence 345578999999999999999999999999999999999999999987764321111 11112222
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.-|...+..+.+|++.||-.+|++|-|+..++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 2355667789999999999999999999999887
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=308.77 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=204.0
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++.++.....||+|+||.||+|.+..++..|++|.+..........+.+|+.+++.++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 44556666689999999999999998889999999988765555677899999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKAL--DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~ 232 (399)
||+++++|.+++... ...+ ++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.++|+|||++..
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999762 2334 78889999999999999999999 999999999999976 67999999999875
Q ss_pred CCCCCCccccccccccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTG--QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
...... ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ..+......
T Consensus 159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~----- 228 (268)
T cd06624 159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFK----- 228 (268)
T ss_pred cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhc-----
Confidence 432221 12224578999999988654 378899999999999999999999976432111 000000000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+......+.+++.+||+.+|.+||++.+++.+
T Consensus 229 -------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0112233344578899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=312.75 Aligned_cols=252 Identities=27% Similarity=0.399 Sum_probs=202.1
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
|+..+.||.|+||.||+|.+..+++.||+|.+....... ...+.+|+.+++.++|+||+.+.+.+.+++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999999999999999987543222 23467899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|..++... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999888652 2346999999999999999999999999 9999999999999999999999999986533221
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
......|+..|+|||++.+..++.++|+||||+++|+|++|..||............. ......
T Consensus 157 ---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~~~~~----------- 220 (285)
T cd05632 157 ---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RRVLET----------- 220 (285)
T ss_pred ---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhhhcc-----------
Confidence 1123468999999999988899999999999999999999999998654322111110 000000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
...++......+.+|+.+||+.||.+||+ +.+++.+
T Consensus 221 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 221 -EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 01112233446788999999999999999 6677665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.18 Aligned_cols=256 Identities=22% Similarity=0.248 Sum_probs=199.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||++.+..+++.||+|++.... ......+.+|+.++..++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47889999999999999999999999999999997422 123345788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999975 2456899999999999999999999999 99999999999999999999999999865332
Q ss_pred CCCccccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
... .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||......+.. ..........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~~ 227 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEHF 227 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCcc
Confidence 221 11223468999999998863 45788999999999999999999999865432111 1111100000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCC--CCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAG--TRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~eil~~ 354 (399)
. ..+ .....+..+.+++.+||..+++ .||++.+++++
T Consensus 228 ~--~~~-----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 228 Q--FPP-----DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred c--CCC-----ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 000 0112345677888887765443 37899999887
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=306.01 Aligned_cols=253 Identities=28% Similarity=0.407 Sum_probs=202.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+...||.|++|.||+|.+..+ ..+|+|.+.... .....+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 4688889999999999999998764 459999886543 23456888999999999999999999885 45688999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999762 2345899999999999999999999999 99999999999999999999999999975433221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. ......++..|+|||...+..++.++||||||+++|+|++ |..||....+.+.. ..... . ..
T Consensus 158 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~----~------~~-- 221 (260)
T cd05069 158 T-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL---EQVER----G------YR-- 221 (260)
T ss_pred c-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc----C------CC--
Confidence 1 1122345678999999988899999999999999999999 99999865432211 11000 0 00
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
...+...+..+.+++.+||..+|.+||++.+|++.|+.
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 --MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred --CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 01122344678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=324.48 Aligned_cols=265 Identities=22% Similarity=0.276 Sum_probs=201.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeC------
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------ 148 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------ 148 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3478999999999999999999999899999999997542 22345678899999999999999999987543
Q ss_pred CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
...++||||++ ++|..++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 35799999995 578777743 4788999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh-h-------
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW-A------- 300 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~------- 300 (399)
++...... .......+|..|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. .
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 99753222 122334689999999999999999999999999999999999999987654322111100 0
Q ss_pred --------hhhhhccchhh-----hccCCcc---CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 301 --------TPLFKDRRKFT-----MMADPLL---EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 301 --------~~~~~~~~~~~-----~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........... ......+ ...........+.+|+.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000000000 0000000 000111123578899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=310.48 Aligned_cols=252 Identities=29% Similarity=0.426 Sum_probs=200.0
Q ss_pred CeeccCCcEEEEEEEECCCC------eEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 85 NLLGEGGFGRVYRGKLEGTN------QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+.||+|+||.||+|...... ..+|||.+..... .....+.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 46999999999999886433 6899998865432 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-----CeeEecccC
Q 046609 158 MPNGSLEDHLLDLPP---NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-----NPKLSDFGL 229 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-----~~kl~Dfg~ 229 (399)
+++++|.+++..... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999975321 2245889999999999999999999999 99999999999999887 899999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
+................++..|+|||++.++.++.++||||||+++|+|++ |+.||........ .... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~---~~~~----~~-- 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV---LQHV----TA-- 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH---HHHH----hc--
Confidence 875433322222223345788999999999999999999999999999998 9999975443211 1100 00
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
......+...+..+.+++.+||..+|.+||++.+|++.|+
T Consensus 229 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 229 --------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred --------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 0001112234567889999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=306.01 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=206.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
..++|.+.+.||.|++|.||+|...+ +..+|||.+..... ...++.+|+.++++++||||+++++++......++|||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34688999999999999999999864 57799999876443 34678899999999999999999999999899999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|.+++... ....+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999762 2346899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. ........+..|+|||.+.+..++.++||||||+++|+|++ |+.||........ .......+
T Consensus 157 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~~~~~~~----------- 221 (261)
T cd05034 157 EY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---LEQVERGY----------- 221 (261)
T ss_pred hh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCC-----------
Confidence 11 11112234568999999988889999999999999999998 9999976543211 11100000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
....+...+..+.+++.+||+.+|.+||++.++++.|+.
T Consensus 222 ---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 ---RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 001111224578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=314.62 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=204.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCe----EEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQ----DVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
.++|...+.||+|+||.||+|.+..++. .+|+|.+...... ....+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 3567888999999999999999866665 5788888654322 224678899999999999999999998754 467
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+++||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++..
T Consensus 85 ~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~ 158 (303)
T cd05110 85 LVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (303)
T ss_pred eeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccc
Confidence 89999999999999876 2346899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..............++..|+|||.+.+..++.++||||||+++|+|++ |..||............ ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~-------~~~~~~- 230 (303)
T cd05110 159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL-------EKGERL- 230 (303)
T ss_pred ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------HCCCCC-
Confidence 443322222222345778999999988899999999999999999997 99999765432211111 110000
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
..+......+.+++..||..+|.+||++.++++.|+.+...
T Consensus 231 ---------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 ---------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred ---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00112234788999999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=305.86 Aligned_cols=251 Identities=21% Similarity=0.281 Sum_probs=203.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee-CCeeEEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD-GDQRILVYE 156 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e 156 (399)
+|.+.+.||.|++|.||++.+..+++.||+|.+..... ...+.+.+|+.++++++|||++++++.+.. +...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47888999999999999999988899999999865432 233567889999999999999999998764 446799999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|.+++... ....+++.+++.++.|++.||.+||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999762 2346899999999999999999999999 999999999999999999999999998754322
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......+++.|+|||++.+..++.++||||||+++|+|++|+.||...+.... ....... ..
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~~------~~-- 219 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRIIEG------KL-- 219 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHhc------CC--
Confidence 1 122335688999999999999999999999999999999999999975432111 0000000 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+......+.+++.+||+.+|.+||++.+++.+
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11223344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=311.22 Aligned_cols=272 Identities=26% Similarity=0.375 Sum_probs=207.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEEC----CCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEee--CCee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLE----GTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQR 151 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~ 151 (399)
.+|.+.+.||+|+||.||+|... +++..+|||.+...... ....+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 46778899999999999999864 34789999999765443 35678999999999999999999999877 5678
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
+++|||+++++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999762 335999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCccc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSHV-STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.......... .....++..|+|||.+.+..++.++||||||+++|+|++|..|+............. ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI--AQGQMIVTRL 235 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc--ccccccHHHH
Confidence 6543222111 112335567999999988899999999999999999999999986543221100000 0000000000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
............+...+..+.+++.+||+.+|.+||++.+|+++|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111111223345788999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=312.01 Aligned_cols=247 Identities=27% Similarity=0.393 Sum_probs=203.0
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
|...+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 4556789999999999999988899999999875432 334568899999999999999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
+++|.+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06642 86 GGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc--
Confidence 9999998854 46899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||....+...... .. ....+
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~------~~~~~--- 219 (277)
T cd06642 156 IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL-------IP------KNSPP--- 219 (277)
T ss_pred hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh-------hh------cCCCC---
Confidence 122234578899999999888899999999999999999999999986543221100 00 00011
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+.+++.+||+.+|.+||++.+++.+
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 -TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1222344578899999999999999999999986
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=312.20 Aligned_cols=266 Identities=26% Similarity=0.330 Sum_probs=209.0
Q ss_pred cccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEe
Q 046609 68 IFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCV 146 (399)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~ 146 (399)
.+....+..++++|.+.+.||.|+||.||+|....+++.+|+|.+.... .....+..|+.++..+ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4555666667889999999999999999999999899999999986542 2235677899999988 7999999999987
Q ss_pred eC-----CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC
Q 046609 147 DG-----DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 147 ~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~ 221 (399)
.. +..++||||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 54 3589999999999999988754334567899999999999999999999999 999999999999999999
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-----QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL 296 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 296 (399)
++|+|||++........ ......++..|+|||.+... .++.++|||||||++|+|++|+.||....+....
T Consensus 167 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-- 242 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-- 242 (291)
T ss_pred EEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--
Confidence 99999999875432221 12234588899999987543 3688999999999999999999999875432111
Q ss_pred hHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 297 VTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... . ...+.+ ..+......+.+++.+||+.+|++||++.+++++
T Consensus 243 ~~~~----~-------~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIP----R-------NPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHh----c-------CCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1000 0 000011 1122334578899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=310.07 Aligned_cols=268 Identities=22% Similarity=0.274 Sum_probs=202.2
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|++|.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 47788999999999999999998899999999865432 2235678899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
++ ++|.+++..... +..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 689888876332 356899999999999999999999999 9999999999999999999999999987533221
Q ss_pred CccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchh-hHhhhhh-------hhccc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL-VTWATPL-------FKDRR 308 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~-------~~~~~ 308 (399)
.......+++.|+|||++.+. .++.++||||||+++|+|++|++||........... ....... .....
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhH
Confidence 122233578899999987654 578899999999999999999999986543211100 0000000 00000
Q ss_pred hhhhccCCccC---CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLE---GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........... ..........+.+++.+||+.||.+|||+.+|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000000000 00111234577899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=303.12 Aligned_cols=247 Identities=28% Similarity=0.428 Sum_probs=198.0
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
++||.|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 46999999999999866 5788999998754322 234588899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
.+++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......... ...
T Consensus 80 ~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~ 152 (250)
T cd05085 80 LSFLRK---KKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSG 152 (250)
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-cCC
Confidence 999875 2345889999999999999999999999 999999999999999999999999998753322111 111
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNY 322 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 322 (399)
...++..|+|||++.+..++.++||||||+++|+|++ |..||............ .. . .....
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~~----------~----~~~~~ 215 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---EK----------G----YRMSC 215 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---Hc----------C----CCCCC
Confidence 2234678999999988889999999999999999998 99999865432211100 00 0 00111
Q ss_pred CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 323 PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 323 ~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
+...+..+.+++.+||..+|++||++.++++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 2233457889999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=305.06 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=206.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|+..++||.|+||.||.+....++..+++|.+.... ......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999999999999999987543 23346688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999997632 356899999999999999999999999 9999999999999999999999999987543322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......+....+ .. ..
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~------~~----------~~ 217 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI------VQ----------GN 217 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hc----------CC
Confidence 1 223356899999999998888899999999999999999999999765432211110 00 00
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ..+...+..+.+++.+||..+|.+||++.+++++
T Consensus 218 ~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 218 YT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 00 0112334578899999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=305.92 Aligned_cols=252 Identities=27% Similarity=0.349 Sum_probs=199.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-----cchHHHHHHHHHHHccCCCceeeEEEEEee--CCee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-----QGNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQR 151 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~ 151 (399)
.+|...+.||+|+||.||+|.+..++..|++|.+..... .....+.+|+.+++.++||||+++++++.+ ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478899999999999999999998899999999864422 122457889999999999999999999875 3577
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++++||+++++|.+++.. ...+++...+.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999976 346899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCC-CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGD-KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
...... .........++..|+|||.+.+..++.++|||||||++|+|++|+.||..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~--------------- 219 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF--------------- 219 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH---------------
Confidence 543211 1111223458889999999988889999999999999999999999998653321100
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...........+......+.+++ +||..+|++||++++|+.+
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 220 -KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 00000011222333445666777 6777899999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=310.84 Aligned_cols=264 Identities=24% Similarity=0.365 Sum_probs=203.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEE----CCCCeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeC--Cee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKL----EGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQR 151 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~ 151 (399)
..|.+.+.||+|+||.||++.. ..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 4578889999999999999985 4567889999987543 22335688999999999999999999998775 568
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 9999999999999999652 345899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc--------cchhhHhhhh
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE--------EQNLVTWATP 302 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~--------~~~~~~~~~~ 302 (399)
........ .......++..|+|||.+.+..++.++||||||+++|+|+++..|+....... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 64332221 11223456778999999988889999999999999999999876653211100 0000000000
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
..... .....+...+..+.+|+.+||+.+|++||++.++++.|+.+
T Consensus 238 ~~~~~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEG----------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcC----------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00000 00111223456899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=305.62 Aligned_cols=250 Identities=27% Similarity=0.388 Sum_probs=201.1
Q ss_pred CeeccCCcEEEEEEEECC-CC--eEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEG-TN--QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
++||+|++|.||+|.+.. .+ ..||||.+..... ...+.+.+|+.++++++||||+++++.+.+ ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998854 23 3699999987665 455678999999999999999999999988 889999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999987321 46899999999999999999999999 9999999999999999999999999998654322211
Q ss_pred -ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 241 -VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 241 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+..... .. .. .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~---~~---~~--------~-- 218 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI---DK---EG--------E-- 218 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hh---cC--------C--
Confidence 1123457788999999988899999999999999999998 99999765432211110 00 00 0
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
....+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 00112223457889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=327.75 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=207.7
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHH
Q 046609 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLED 165 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 165 (399)
+||+|+||+||-|++..+...+|||.+........+-+..|+.+.++++|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999999999999999976655555668889999999999999999999999999999999999999999
Q ss_pred hhccCCCCCCCC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCeeEecccCccCCCCCCCcccc
Q 046609 166 HLLDLPPNRKAL--DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAKLGPTGDKSHVS 242 (399)
Q Consensus 166 ~l~~~~~~~~~l--~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~ 242 (399)
+|+. .=+++ +++++-.+..||++||.|||++. |||||||.+|+||+ -.|.+||+|||-++....-+ ...
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence 9987 23556 78889999999999999999999 99999999999996 57899999999998644332 234
Q ss_pred ccccccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 243 TRVMGTYGYCAPEYALTG--QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 243 ~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
..+-||..|||||++..+ .|+.++|||||||++.||.||++||-...... -..+....++. -+
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmyKv------------HP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMYKV------------HP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---Hhhhhhcceec------------CC
Confidence 446699999999999765 58899999999999999999999998765321 11111222222 23
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..|.........||.+|+.++|.+||++.++++-
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 5577888899999999999999999999999863
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=307.40 Aligned_cols=259 Identities=23% Similarity=0.354 Sum_probs=205.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
..+|.+.+.||+|+||.||+|.+... ...|+||...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 35688889999999999999987543 4568999887554 2344678899999999999999999999875 45789
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 84 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 84 VMELAPLGELRSYLQV---NKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEcCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeec
Confidence 9999999999999976 2345899999999999999999999999 999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
...... ......++..|+|||.+....++.++||||||+++|+|++ |..||......+..... ....
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~~~~---- 225 (270)
T cd05056 158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-------ENGE---- 225 (270)
T ss_pred ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------HcCC----
Confidence 333211 1112234568999999988889999999999999999986 99999876532211110 0000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.. ..+...+..+.+++.+|+..+|.+|||+.++++.|+.+...
T Consensus 226 --~~----~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 --RL----PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 00 11222345788999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=305.21 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=206.3
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee--CCeeEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 155 (399)
+|++.+.||.|+||.||+|.+..++..+|+|.+..... ...+.+..|+.+++.++||||+++++.+.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47888999999999999999998899999999875433 223567889999999999999999998754 45679999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH-----ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH-----~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
||+++++|.+++.........+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999765444567999999999999999999999 777 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........ ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....... .......
T Consensus 158 ~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~-------- 224 (265)
T cd08217 158 KILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKE-------- 224 (265)
T ss_pred ccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH---HHHHHhc--------
Confidence 86543321 1223468999999999988889999999999999999999999998754211 1111100
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+......+.+++.+||+.+|.+||++.+|+++
T Consensus 225 ------~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ------GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00112233445688899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=343.43 Aligned_cols=258 Identities=20% Similarity=0.314 Sum_probs=202.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEee--CCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~ 152 (399)
...+|.+.+.||.|+||.||+|.+..++..||+|.+...... ....+..|+.++.+++|||||+++++|.+ ...++
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 346899999999999999999999999999999998754332 34568889999999999999999998854 45689
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeEecCCCCCceEECC----------
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ----PPVIYRDFKASNVLLDQ---------- 218 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~----~~ivH~dikp~NIll~~---------- 218 (399)
|||||+++|+|.++|.........+++..++.|+.||+.||.|||+.+. .+||||||||+||||+.
T Consensus 91 IVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~ 170 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccc
Confidence 9999999999999997644344679999999999999999999998431 23999999999999964
Q ss_pred -------CCCeeEecccCccCCCCCCCccccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 046609 219 -------DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSR 289 (399)
Q Consensus 219 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~ 289 (399)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||+|++|..||....
T Consensus 171 ~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 171 QANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3358999999997543221 2233569999999998864 458899999999999999999999997644
Q ss_pred CcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 290 PTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... +. .. +... +.+. .......+.+||..||+.+|.+||++.+++.+
T Consensus 248 ~~~q--li---~~-lk~~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 248 NFSQ--LI---SE-LKRG--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred cHHH--HH---HH-HhcC--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 3211 11 00 1100 0000 01123578899999999999999999999954
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=322.72 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=208.3
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCee
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~ 151 (399)
.+....|++++.||+||-+.||++...+ ...||+|++.... .....-+.+|+..|.+|+ |.+||+++++-..++.+
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 3446779999999999999999999876 5567777664332 233466899999999996 89999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
||||||= ..+|..+|+.. ...++...++.+..|++.|+.++|.+| |||.||||.|+|+- .|.+||+|||+|.
T Consensus 436 YmvmE~G-d~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~ 507 (677)
T KOG0596|consen 436 YMVMECG-DIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIAN 507 (677)
T ss_pred EEEeecc-cccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhc
Confidence 9999986 56999999872 333444588999999999999999999 99999999999984 5699999999999
Q ss_pred CCCCCCCccccccccccccccccccccCC-----------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTG-----------QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 300 (399)
..............+||+.||+||.+... ..+.++||||||||||+|+.|++||..... .
T Consensus 508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~---- 578 (677)
T KOG0596|consen 508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q---- 578 (677)
T ss_pred ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H----
Confidence 87777777777788999999999988532 266889999999999999999999986321 1
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHH-HHHHHHhhccccCCCCCCChHHHHHH
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLY-QALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~-~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+..+.+|.....++..-.. .++++++.||+.||++||++.++|++
T Consensus 579 ------~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 579 ------IAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ------HHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1345556666554444433222 39999999999999999999999876
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=319.89 Aligned_cols=256 Identities=21% Similarity=0.254 Sum_probs=200.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.++||+|+||.||++.+..+++.+|+|++..... .....+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 478889999999999999999999999999999864321 22234778899999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~---~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 99999999999976 2356899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCcccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.. ........||+.|+|||++. ...++.++|||||||++|+|++|+.||......+... .........
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~ 227 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKERF 227 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCccc
Confidence 21 11223356999999999885 3468889999999999999999999998654322111 111100000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT--RPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 354 (399)
. . + .........+.+++.+||..+++. ||++.+++++
T Consensus 228 ~--~-p----~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q--F-P----AQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c--C-C----CccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 0 011223457788999988654444 6899999877
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=315.57 Aligned_cols=265 Identities=17% Similarity=0.196 Sum_probs=197.3
Q ss_pred CCCeeccC--CcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 83 PDNLLGEG--GFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 83 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+.++||+| +|++||++....+++.||+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 688999999999999999999975432 22345778999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++++||+..........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999652 2345899999999999999999999999 99999999999999999999999986543211110
Q ss_pred -c----cccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc----
Q 046609 239 -S----HVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR---- 307 (399)
Q Consensus 239 -~----~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---- 307 (399)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCcccccccc
Confidence 0 01112346778999999875 46899999999999999999999999764322110 00000000000
Q ss_pred ----ch-------------h---------hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 ----RK-------------F---------TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ----~~-------------~---------~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. . ...................+.+|+.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 0 00000000011122334578899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.60 Aligned_cols=256 Identities=21% Similarity=0.231 Sum_probs=200.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||++.+..+++.||+|.+..... .....+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478899999999999999999999999999999865321 22344778899999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999976 2356899999999999999999999999 99999999999999999999999999875433
Q ss_pred CCCccccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
... .......|++.|+|||++.+ +.++.++|||||||++|+|++|+.||......+... .........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~~~ 227 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEERF 227 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCCcc
Confidence 221 11223569999999998865 568889999999999999999999998654322111 111000000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT--RPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 354 (399)
. ..+ .....+..+.+++.+||..++++ |+++++++++
T Consensus 228 ~--~p~-----~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 Q--FPS-----HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c--CCC-----ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 000 01123457888999999866544 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=308.14 Aligned_cols=267 Identities=25% Similarity=0.330 Sum_probs=204.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|++.+.||+|++|.||+|.+..+++.||+|++..... ...+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468889999999999999999998899999999864422 223557889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++++.|..++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9998888877654 346899999999999999999999999 999999999999999999999999999764333
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH-hhhhhhh-------cc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT-WATPLFK-------DR 307 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~~~-------~~ 307 (399)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+...... ....... ..
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223457889999998876 567889999999999999999999998765432211111 0000000 00
Q ss_pred chhhhccCCccCCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........+......+ ...+..+.+|+.+||+.+|++||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000001111110000 1234578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=304.24 Aligned_cols=252 Identities=27% Similarity=0.322 Sum_probs=201.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-----cchHHHHHHHHHHHccCCCceeeEEEEEeeC--Cee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-----QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQR 151 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~ 151 (399)
++|.+.+.||+|+||.||+|.+..++..||||.+..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 478889999999999999999998999999999864321 1234678899999999999999999998763 467
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
+++|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999875 345889999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........ .......++..|+|||.+.+..++.++||||||+++|+|++|+.||......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~--~------------- 219 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI--F------------- 219 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH--H-------------
Confidence 54321111 1122345888999999998888999999999999999999999999764322110 0
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...........+......+.+++.+|+. +|++||++++|+++
T Consensus 220 -~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 220 -KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 0000011122344555678889999994 99999999999854
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=306.05 Aligned_cols=256 Identities=25% Similarity=0.333 Sum_probs=194.2
Q ss_pred CeeccCCcEEEEEEEEC--CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
+.||+|+||.||+|... .++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 36899999999999864 3456799999876542 23356888999999999999999999999999999999999999
Q ss_pred ChHHhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 162 SLEDHLLDLPP-NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 162 ~L~~~l~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
+|.+++..... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975322 1234677788899999999999999999 9999999999999999999999999987533322222
Q ss_pred ccccccccccccccccccCC-------CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 241 VSTRVMGTYGYCAPEYALTG-------QLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~-------~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
......++..|+|||++.+. .++.++||||||+++|+|++ |..||....+.+... .... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~~~-----~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YTVR-----EQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HHhh-----cccCC
Confidence 22334578889999987542 35789999999999999996 999997654332111 1000 00111
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
...+.+. ......+.+++.+|+ .+|++|||+.+|+..|+
T Consensus 230 ~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1112111 122335778999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=319.56 Aligned_cols=267 Identities=28% Similarity=0.426 Sum_probs=221.0
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch-HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN-REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
..+...+.++||+|-||.|.++...+ +..||||+++.....+. ++|.+|+.+|.+++||||++++++|..++.+++|+
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 34566778999999999999999885 78999999987654444 78999999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+|+..... ..+......+|+.||+.|++||.+.+ +|||||.+.|+|+++++++||+|||.++-...
T Consensus 615 EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999987421 22445566779999999999999999 99999999999999999999999999997777
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT--GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
++.........-+.+|||||.+..+.++.++|||+||+++||+++ ...||....... .+.-....+......
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~--- 763 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQ--- 763 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCcc---
Confidence 777776666778899999999999999999999999999999765 778998765421 222222222222111
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
.....|..++..+.+++.+||..+..+||+++++...|+...
T Consensus 764 ----~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 ----VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ----eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 112235566778999999999999999999999999988654
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=305.64 Aligned_cols=255 Identities=23% Similarity=0.367 Sum_probs=202.8
Q ss_pred CCCCCCeeccCCcEEEEEEEECC-CCeEEEEEEEccCCC----------cchHHHHHHHHHHHc-cCCCceeeEEEEEee
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEG-TNQDVAVKQLDRNGF----------QGNREFLVEVLMLSM-LSNPYLVNLVGYCVD 147 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~ 147 (399)
+|.+.+.||+|+||.||+|.+.. ++..+|+|.+..... ....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999977 678999998853221 122446678887764 789999999999999
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
++..+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999886543445679999999999999999999996 67 99999999999999999999999
Q ss_pred ccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 227 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
||++....... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......... ....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~------~~~~- 227 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLAT------KIVE- 227 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHH------HHhh-
Confidence 99997643322 2234568899999999998889999999999999999999999997654321110 0000
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
....+.. .......+.+++.+||+.||++||++.++..++.
T Consensus 228 -----~~~~~~~----~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 -----AVYEPLP----EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -----ccCCcCC----cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0000100 1122357889999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=303.36 Aligned_cols=252 Identities=28% Similarity=0.444 Sum_probs=193.9
Q ss_pred CeeccCCcEEEEEEEECC---CCeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEe-eCCeeEEEEEecC
Q 046609 85 NLLGEGGFGRVYRGKLEG---TNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCV-DGDQRILVYEYMP 159 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~~~ 159 (399)
+.||+|+||.||+|.+.. ....+|+|.+.... ......+..|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998643 34679999985432 233457788999999999999999999875 4556789999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
+|+|.+++... ...+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999762 344678888999999999999999999 999999999999999999999999998753322111
Q ss_pred --cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 240 --HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 240 --~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.......++..|+|||.+.+..++.++||||||+++|+|++ |.+||....... ..... ... ..+
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~~-------~~~ 221 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQG-------RRL 221 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hcC-------CCC
Confidence 11122345778999999988899999999999999999999 566776543221 11111 000 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
..+...+..+.+++.+||+.+|++||++.+|++.|+.+.
T Consensus 222 ----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 222 ----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 011122346889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=304.26 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=201.3
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
+|.+.+.||.|+||.||+|... ++..+|+|.+...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 4778899999999999999875 5888999998654221 12457889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++...
T Consensus 80 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 80 FMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 9999999999999976 356899999999999999999999999 999999999999999999999999998753
Q ss_pred CCC----CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 234 PTG----DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 234 ~~~----~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
... ..........++..|+|||.+.+..++.++||||||+++|+|++|..||...+......... .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~------~---- 222 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG------A---- 222 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhh------h----
Confidence 211 11111223458899999999988889999999999999999999999998654322110000 0
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
.....+ ..+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 -~~~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 223 -HRGLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -ccCCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000011 122234457889999999999999999999975
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-43 Score=328.58 Aligned_cols=252 Identities=22% Similarity=0.349 Sum_probs=213.8
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
.|.++..||.|+||+||+|..+.++-..|.|++.........++.-|+.||..+.||+||++++.|..++.++++.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 46667889999999999999998888889999987777777889999999999999999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
||-++..+.. -+..|++.++..++.|++.||.|||++. |||||||..|||++.+|.++|+|||.+.. .....
T Consensus 113 GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAK--n~~t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAK--NKSTR 184 (1187)
T ss_pred CchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeeccccccc--chhHH
Confidence 9999998876 3678999999999999999999999999 99999999999999999999999999853 22223
Q ss_pred ccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 240 HVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.....+.|||.|||||+.. ..+|+.++||||||++|.||..+.+|-....+.... .. +..--
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl------lK-------iaKSe 251 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LK-------IAKSE 251 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH------HH-------HhhcC
Confidence 4455688999999999874 468999999999999999999999999887653211 11 11111
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+|.+ -.|......+.+|+.+||..||..||++++++++
T Consensus 252 PPTL--lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 252 PPTL--LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred CCcc--cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1211 1255666788999999999999999999999876
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=304.24 Aligned_cols=240 Identities=23% Similarity=0.350 Sum_probs=190.4
Q ss_pred CeeccCCcEEEEEEEECCC------------CeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 85 NLLGEGGFGRVYRGKLEGT------------NQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
+.||+|+||.||+|..... ...+++|.+..........+..|+.++..++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 3689999999999986422 2358899887654444567888999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC-------eeEe
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN-------PKLS 225 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~-------~kl~ 225 (399)
+||||+++|+|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999988865 2356899999999999999999999999 999999999999987664 8999
Q ss_pred cccCccCCCCCCCcccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCcccchhhHhhhhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEII-TGRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
|||++...... ....++..|+|||.+. +..++.++|||||||++|+|+ +|..||......+.....
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------ 222 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY------ 222 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH------
Confidence 99998643211 1234788899999886 467899999999999999998 588888764432211100
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
.. .. . ........+.+++.+||+.||.+||++.+|++.|
T Consensus 223 -~~--~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 -EG--QC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -hc--Cc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 00 0 0111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=306.78 Aligned_cols=257 Identities=28% Similarity=0.380 Sum_probs=204.7
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCC------
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~------ 149 (399)
.+++|.+.+.||.|++|.||+|.+..++..+++|.+..... ....+.+|+.+++++ .||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 45789999999999999999999988899999999876542 346788999999998 6999999999997644
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||+++++|.+++......+..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCcc
Confidence 489999999999999998764433567999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
+....... .......++..|+|||++.. ..++.++||||||+++|+|++|+.||....+....... .
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~ 231 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI------P 231 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHh------h
Confidence 87533221 22233568899999998753 35778899999999999999999999764432111000 0
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+.+ ..+......+.+++.+||..||.+|||+.+++++
T Consensus 232 -------~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 232 -------RNPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred -------ccCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0001111 1122345578899999999999999999999763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=312.19 Aligned_cols=200 Identities=25% Similarity=0.376 Sum_probs=163.0
Q ss_pred CCeeccCCcEEEEEEEEC--CCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee--CCeeEEEEEecC
Q 046609 84 DNLLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRILVYEYMP 159 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~ 159 (399)
.++||+|+||.||+|.+. .++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...+++|||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~- 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA- 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-
Confidence 368999999999999975 356889999987543 23457789999999999999999999854 45678999998
Q ss_pred CCChHHhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE----CCCCCeeEecccCc
Q 046609 160 NGSLEDHLLDLP-----PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLA 230 (399)
Q Consensus 160 ~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~~ 230 (399)
+++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 568888875321 11235899999999999999999999999 9999999999999 45678999999999
Q ss_pred cCCCCCCC-ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 046609 231 KLGPTGDK-SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSR 289 (399)
Q Consensus 231 ~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~ 289 (399)
........ ........||+.|+|||++.+ ..++.++||||+||++|+|++|++||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 76433221 112233568999999998876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.82 Aligned_cols=256 Identities=25% Similarity=0.368 Sum_probs=202.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc----------chHHHHHHHHHHHccCCCceeeEEEEEeeCC
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ----------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD 149 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 149 (399)
+|.+.+.||.|++|.||+|....+++.+|+|.+...... ..+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477789999999999999999888999999998642211 1134678999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 99999999999999999976 357899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ--LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
+................++..|+|||.+.... ++.++|+||||+++|+|++|..||......... . .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~----~~~~~- 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--F----KLGNK- 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--H----Hhhcc-
Confidence 87543322222223356889999999887654 888999999999999999999999754322110 0 00000
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+.+........+..+.+++.+||..+|.+||++.+|+.+
T Consensus 228 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 -----RSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred -----ccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 001111111222345678899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=321.51 Aligned_cols=242 Identities=24% Similarity=0.291 Sum_probs=189.2
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHcc---CCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSML---SNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
||+|+||.||+|.+..++..||+|++....... ......|..++... .||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999999999999999986532221 22344566666554 699999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||++....... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999999875 457999999999999999999999999 9999999999999999999999999987532221 1
Q ss_pred ccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 241 VSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
......||..|+|||++.+. .++.++|||||||++|+|++|+.||...........+ ..... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~~~--------~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFGKV--------RFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcCCC--------CCC
Confidence 22345699999999988754 5889999999999999999999999765432211111 00000 000
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCC----ChHHHHHH
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRP----MMSDVVTA 354 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RP----s~~eil~~ 354 (399)
.......+.+++.+||+.||.+|| ++.+++++
T Consensus 218 ---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 218 ---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred ---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 011234678899999999999998 46666553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=303.37 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=201.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|++.+.||.|+||.||+|.+.. +..+|+|.+.... .....+..|+.++++++||||+++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468888999999999999998864 6789999886543 23457889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 82 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 82 EHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 99999999875 2346899999999999999999999999 99999999999999999999999999875432211
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......++..|+|||.+.++.++.++||||||+++|+|++ |..||.......... .. .. ......
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~------~~-~~---~~~~~~-- 222 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVE------TI-NA---GFRLYK-- 222 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH------HH-hC---CCCCCC--
Confidence 11112235678999999988899999999999999999998 999997644321110 00 00 000001
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
+......+.+++.+||+.+|++||++.++++.|
T Consensus 223 -----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 -----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred -----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111235788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=309.57 Aligned_cols=268 Identities=24% Similarity=0.337 Sum_probs=205.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+|+.+++.++|+||+++++++..++..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999999889999999986532 2334678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++++.+..+... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9987666655543 355899999999999999999999999 999999999999999999999999998764443
Q ss_pred CCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh--------hhhcc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP--------LFKDR 307 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~ 307 (399)
.. .......++..|+|||++.+. .++.++||||||+++|+|++|++||......+.......... .+...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 32 122335578899999999887 889999999999999999999999986543221111110000 00000
Q ss_pred chhhh--ccCC----ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTM--MADP----LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~--~~~~----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..... ..+. .+...++...+..+.+|+.+||..+|++||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 0000 00011222335788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=303.63 Aligned_cols=255 Identities=24% Similarity=0.365 Sum_probs=204.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.... +..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4678899999999999999998664 5669999887542 234578889999999999999999999887 778999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999763 2456888999999999999999999999 9999999999999999999999999987543322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||......... .... .. ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~----~~------~~- 221 (260)
T cd05073 157 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE----RG------YR- 221 (260)
T ss_pred cc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHh----CC------CC-
Confidence 11 1122345678999999988889999999999999999998 99999865432111 1100 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
...+...+..+.+++.+||+.+|++||++.++.+.|+.+
T Consensus 222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 011123345788999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=319.12 Aligned_cols=263 Identities=22% Similarity=0.308 Sum_probs=198.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeC------
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------ 148 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------ 148 (399)
..++|.+.+.||.|+||.||+|.+..++..||||.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 35789999999999999999999998999999999875422 2335577899999999999999999987543
Q ss_pred CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
...+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 8899888754 46999999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhh---
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPL--- 303 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~--- 303 (399)
++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||............ ......
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPE 238 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 98753321 223468999999999876 57889999999999999999999999765432211100 000000
Q ss_pred -hh----c-cchh----hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 -FK----D-RRKF----TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 -~~----~-~~~~----~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. . .... .......+.. ........+.+|+.+||+.||.+|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 0000 0000000000 000112357899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=302.21 Aligned_cols=252 Identities=33% Similarity=0.492 Sum_probs=203.0
Q ss_pred CCCCCeeccCCcEEEEEEEECCCC----eEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTN----QDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
+++.+.||.|+||.||++.+...+ ..||+|.+...... ....+..|+.++..++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 356789999999999999998766 88999999765433 4567889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997621 122899999999999999999999999 99999999999999999999999999976544
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
...... ....++..|+|||.+.+..++.++||||||+++|+|++ |.+||........ ..... .. .
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~~~~---~~-~------ 221 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LEYLK---KG-Y------ 221 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHh---cC-C------
Confidence 322211 12337789999999988889999999999999999998 8888876432111 11100 00 0
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
....+...+..+.+++.+||..+|.+|||+.++++.|
T Consensus 222 ----~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 ----RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred ----CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0011122445788999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=308.86 Aligned_cols=259 Identities=23% Similarity=0.336 Sum_probs=207.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++.+...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 467788999999999999999998899999999865432 2346788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
+++++|.+++.. .+.+++..+..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999998865 4568999999999999999999997 57 999999999999999999999999998643221
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc-----hhhHhhhhhhhccchhh
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ-----NLVTWATPLFKDRRKFT 311 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-----~~~~~~~~~~~~~~~~~ 311 (399)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||......... ............
T Consensus 158 ~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 228 (284)
T cd06620 158 I----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE----- 228 (284)
T ss_pred c----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-----
Confidence 1 12346899999999998889999999999999999999999999865542111 111111111100
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
..+.+. ....+..+.+++.+||+.||.+||++.+++.+..-+
T Consensus 229 --~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 229 --PPPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred --cCCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 001110 112345788999999999999999999999875443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=303.76 Aligned_cols=243 Identities=26% Similarity=0.335 Sum_probs=206.7
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHH---HHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.-++|..+++||+|.||+|.+++.+.+++.||||++++.-.-..++ -..|-.+|+..+||.+..+...|+..+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478899999999999999999999999999999998765544444 3568889999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+.||.|.-+|.. ...+++...+.+...|+.||.|||+++ ||+||||.+|+|+|.+|++||+|||+++..
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999876 567999999999999999999999999 999999999999999999999999999852
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
-........+||||.|+|||++....|+...|+|.+||++|||++|+.||...+-.....+ +
T Consensus 319 --I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL----------------I 380 (516)
T KOG0690|consen 319 --IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL----------------I 380 (516)
T ss_pred --ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH----------------H
Confidence 2333455668999999999999999999999999999999999999999997654321111 1
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCC
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP 346 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 346 (399)
+-.. -.+|.....+...|+...|..||.+|-
T Consensus 381 l~ed--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 381 LMED--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred Hhhh--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1111 134445555778899999999999995
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=308.17 Aligned_cols=240 Identities=25% Similarity=0.427 Sum_probs=192.1
Q ss_pred CeeccCCcEEEEEEEECCCCe-------EEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQ-------DVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+.||.|+||.||+|.....+. .+++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998865443 4888888655444456788899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC--------eeEecccC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN--------PKLSDFGL 229 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~--------~kl~Dfg~ 229 (399)
+++|+|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKK---NKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 999999999976 2346899999999999999999999999 999999999999987765 69999998
Q ss_pred ccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCcccchhhHhhhhhhhcc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGR-RVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
+..... .....++..|+|||++.+ ..++.++||||||+++|+|++|. +||....+...... ....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~-------~~~~ 221 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF-------YEDR 221 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH-------HHcc
Confidence 864322 122457889999999876 45789999999999999999984 66665443221110 0000
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
...+......+.+++.+||+.+|++|||+++|++.|
T Consensus 222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 112222335788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=308.20 Aligned_cols=261 Identities=26% Similarity=0.348 Sum_probs=205.0
Q ss_pred cHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEee-
Q 046609 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVD- 147 (399)
Q Consensus 70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~- 147 (399)
+..++....+.|.+.+.||.|+||.||+|.+..+++.+|+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 34445556678999999999999999999999899999999986543 2335678889999888 69999999999853
Q ss_pred -----CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 148 -----GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 148 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
.+..+++|||+++|+|.+++.... ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 457899999999999999997632 345889999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCcccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (399)
+|+|||++....... .......|+..|+|||.+. +..++.++|||||||++|+|++|..||....+.......
T Consensus 161 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~ 238 (282)
T cd06636 161 KLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238 (282)
T ss_pred EEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence 999999987432211 1122356889999999875 346888999999999999999999999765432211100
Q ss_pred HhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+.. .....+..+.+++.+||+.||.+||++.+|+++
T Consensus 239 -------------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 239 -------------PRNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -------------hhCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 00001111 111234578899999999999999999999753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=309.49 Aligned_cols=266 Identities=20% Similarity=0.243 Sum_probs=199.1
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|++|.||+|.+..++..||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 477889999999999999999999999999998654322 224577899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+. ++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDS---CNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 95 588888765 2456999999999999999999999999 9999999999999999999999999987543222
Q ss_pred CccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc-hhh-Hhhh-------hhhhcc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ-NLV-TWAT-------PLFKDR 307 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~-~~~~-------~~~~~~ 307 (399)
.......++..|+|||++.+. .++.++|||||||++|+|++|..|+......... ..+ .... +.....
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 112234578899999988764 4789999999999999999998886543321110 000 0000 000000
Q ss_pred chhhhccC--CccC-CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMAD--PLLE-GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~--~~l~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........ .... .......+..+.+++.+||+.||.+|||+++++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000 0000 01112234678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=305.39 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=204.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|.+.+.||.|+||.||+|+.+. ....+++|.+...... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 578889999999999999999753 3467999988754433 3467889999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNR-----KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~-----~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
+||||+++|+|.+++....... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999997633111 26899999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
|++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ..... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~~~~---~- 233 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LNRLQ---A- 233 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HHHHH---c-
Confidence 9986432221 111222346778999999888888999999999999999998 8889975433211 11000 0
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
.. +....+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus 234 -~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 00 000111223457889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=302.10 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=202.8
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-----cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-----QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
+|...+.||+|++|.||+|....++..|++|.+..... ...+.+.+|+.+++.++||||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47778999999999999999988899999999865432 1335688899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
+||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999976 346899999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCccccccccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||....+....... . ....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~--~-----~~~~---- 219 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKI--G-----RSKE---- 219 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHH--H-----hccc----
Confidence 222 223355889999999887766 899999999999999999999999865421111000 0 0000
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+......+.+++.+||+.+|.+||++.+++.+
T Consensus 220 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 -----LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -----CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 011122334578899999999999999999999753
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=302.63 Aligned_cols=251 Identities=19% Similarity=0.300 Sum_probs=204.8
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|++.+.||.|+||.||++....++..||+|.+..... ....++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 47888999999999999999988899999999875422 3345788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999998752 2345889999999999999999999999 9999999999999999999999999987543221
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||......+.. ...... . .
T Consensus 156 --~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~~~~------~-~-- 218 (256)
T cd08218 156 --ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLV------LKIIRG------S-Y-- 218 (256)
T ss_pred --hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHH------HHHhcC------C-C--
Confidence 1122345788999999998888999999999999999999999999764322110 000000 0 0
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+......+.+++.+||+.+|.+||++.+|+++
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 01122344578899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=311.41 Aligned_cols=255 Identities=26% Similarity=0.332 Sum_probs=204.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||.|++|.||+|....+++.||+|.+...... ....+..|+.++..++||||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 3688889999999999999999988999999999765433 3356888999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+.+++|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998752 2457899999999999999999999999 99999999999999999999999999864322
Q ss_pred CCCc---------------------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 046609 236 GDKS---------------------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNS 288 (399)
Q Consensus 236 ~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~ 288 (399)
.... .......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0111245788999999999888999999999999999999999999865
Q ss_pred CCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC----hHHHHHH
Q 046609 289 RPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM----MSDVVTA 354 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~eil~~ 354 (399)
+..... . ... .....-.........+.+++.+||+.+|.+||+ +.+++.+
T Consensus 236 ~~~~~~--~----~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRDETF--S----NIL----------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chHHHH--H----HHh----------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 532111 0 000 000000001114567899999999999999999 6666654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=303.71 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=205.3
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
+|+..+.||+|++|.||+|....+++.||+|.+...... ..+.+..|+.+++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999999888999999998753311 23568889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKL 232 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~ 232 (399)
|+||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||.+..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999976 356899999999999999999999999 99999999999998776 599999999875
Q ss_pred CCCCCC--ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 233 GPTGDK--SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 233 ~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
...... ........++..|+|||.+.+..++.++||||||+++|+|++|+.||..............
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----------- 222 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK----------- 222 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHH-----------
Confidence 433211 1112234588899999999888899999999999999999999999975443211111100
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+......+.+++.+||..+|.+||++.+++.+
T Consensus 223 --~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 223 --IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred --HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 000011123344455688899999999999999999999753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=306.45 Aligned_cols=239 Identities=24% Similarity=0.387 Sum_probs=188.9
Q ss_pred eeccCCcEEEEEEEECC------------------------CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeE
Q 046609 86 LLGEGGFGRVYRGKLEG------------------------TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNL 141 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l 141 (399)
.||+|+||.||+|.... ....|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997531 124588998876544444568889999999999999999
Q ss_pred EEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-
Q 046609 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF- 220 (399)
Q Consensus 142 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~- 220 (399)
++++.+....++||||+++|+|..++.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999865 3456899999999999999999999999 99999999999997654
Q ss_pred ------CeeEecccCccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHH-HcCCCCCCCCCCcc
Q 046609 221 ------NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEI-ITGRRVIDNSRPTE 292 (399)
Q Consensus 221 ------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el-ltg~~pf~~~~~~~ 292 (399)
.++++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|+| ++|+.||....+.+
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999987542211 11346788999998865 5689999999999999998 47999998654432
Q ss_pred cchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 293 EQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
..... .... ..+......+.+++.+||+.+|.+||++.+|++.|
T Consensus 230 ~~~~~-------~~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 KERFY-------EKKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHHH-------Hhcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 11110 0000 01111223688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.54 Aligned_cols=266 Identities=25% Similarity=0.388 Sum_probs=214.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|.+.+.||.|+||.||+|....++..||+|.+..........+.+|+.+++.++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67889999999999999999998888999999987655455567889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999865 35789999999999999999999999 99999999999999999999999998865433221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......+++.|+|||.+.+..++.++||||||+++|+|++|+.||....+........ .. . .+..
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~-~------~~~~ 235 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TN-G------TPEL 235 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cC-C------CCCC
Confidence 2223458889999999988889999999999999999999999998654432111000 00 0 0000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccccccccc
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDS 370 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~~~~~ 370 (399)
..+......+.+++.+||..+|.+||++.+++.+ .-++..+....+++.
T Consensus 236 --~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h-~~~~~~~~~~~~~~~ 284 (293)
T cd06647 236 --QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH-PFLKIAKPLSSLTPL 284 (293)
T ss_pred --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC-HHHhcCcccccccch
Confidence 1122334568899999999999999999999987 334445555555544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=309.69 Aligned_cols=257 Identities=23% Similarity=0.322 Sum_probs=203.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||++.+..++..|++|.+..... .....+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 368889999999999999999999999999999875532 22346778999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++|++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999976 356899999999999999999999999 99999999999999999999999998863211
Q ss_pred CCCc-------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 236 GDKS-------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 236 ~~~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
.... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||....+.+.....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~----- 228 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV----- 228 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----
Confidence 1000 0111245788999999998889999999999999999999999999765432111100
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
.. .....+.. ....+..+.+++.+||+.+|.+||+..++++.|+.
T Consensus 229 -~~-----~~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 -IS-----DDIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred -Hh-----cccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 00 00001111 11234467899999999999999997666655544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=303.38 Aligned_cols=256 Identities=24% Similarity=0.347 Sum_probs=191.0
Q ss_pred CeeccCCcEEEEEEEECC--CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLEG--TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
+.||+|+||.||+|.... ....+++|.+..... .....+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997532 345788888764432 22356788999999999999999999999999999999999999
Q ss_pred ChHHhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 162 SLEDHLLDLPPN-RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 162 ~L~~~l~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
+|.+++...... ....++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999764321 233567888999999999999999999 9999999999999999999999999986432222111
Q ss_pred ccccccccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 241 VSTRVMGTYGYCAPEYALT-------GQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
......++..|+|||++.. ..++.++|||||||++|+|++ |..||....+.+..... .. .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~--~~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV------VR--EQDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hh--ccCcc
Confidence 1222345678999998642 456789999999999999999 78898765432210000 00 00001
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
+..+ ..+......+.+++..|+ .||++||++++|++.|.
T Consensus 230 ~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 230 LPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 122233446677888898 59999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=306.76 Aligned_cols=254 Identities=26% Similarity=0.337 Sum_probs=197.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHH-HHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLM-LSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..... .....+..|+.+ ++..+||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 468889999999999999999999999999999876432 223445556654 566789999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|++ |+|.+++.........+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 788888876444456799999999999999999999987 7 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccC----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALT----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.. ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||....... ..+... ..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~----~~------ 222 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLKQV----VE------ 222 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHHHH----Hh------
Confidence 21 1122457889999998754 456889999999999999999999997533211 000000 00
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+.+. ....+..+.+++.+||..+|.+||++.+|+++
T Consensus 223 -~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 223 -EPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -cCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001110 11234578899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=310.06 Aligned_cols=267 Identities=26% Similarity=0.341 Sum_probs=203.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|++.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 4688889999999999999999888999999998654322 23567889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|..+... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999888887654 345899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh-hhhh-------hhcc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW-ATPL-------FKDR 307 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~-------~~~~ 307 (399)
. .......++..|+|||++.+ ..++.++||||||+++|+|++|++||......+....+.. .... +...
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 12223457889999998865 4578899999999999999999999976543221111110 0000 0000
Q ss_pred chhhhccCCccCC-----CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEG-----NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........+.... ......+..+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000011111100 0011334678899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=331.26 Aligned_cols=260 Identities=24% Similarity=0.421 Sum_probs=218.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCC---eEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTN---QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
+...+.++||.|.||.|++|+.+..+ ..||||.++.... ....+|+.|..||.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 44567799999999999999986544 5799999975433 3346799999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
.|||++|+|+.||+. +.+.+++.+...++..|+.|+.||-+.+ +|||||...||||+.+..+|++|||+++...
T Consensus 709 TEyMENGsLDsFLR~---~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhh---cCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 999999999999998 4566999999999999999999999999 9999999999999999999999999999765
Q ss_pred CCCCcccc-ccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 235 TGDKSHVS-TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 235 ~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
++...... ..-.-+.+|.|||.+....++.++||||||++|||.++ |+.||-++...+..+-+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaI--------------- 847 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAI--------------- 847 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHH---------------
Confidence 54422211 11233579999999999999999999999999999777 99999988765432222
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
....+-..|.+++..|.+|+..||++|-.+||.+.+|+..|+++-..
T Consensus 848 --e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 848 --EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred --HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 11122233667888999999999999999999999999999998554
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=300.77 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=209.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||.|++|.||+|.+..+++.|++|++..... .....+.+|+.++..++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 368888999999999999999999999999999976644 3456788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
+++++|.+++.. ...+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999976 3679999999999999999999999 99 999999999999999999999999998754332
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+........... ....+
T Consensus 154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~----------~~~~~ 221 (264)
T cd06623 154 LDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC----------DGPPP 221 (264)
T ss_pred CCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh----------cCCCC
Confidence 221 123458899999999988899999999999999999999999998765311111111111 00011
Q ss_pred ccCCCCCHH-HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIK-GLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.. .+..+.+++.+||..+|.+||++.+++++
T Consensus 222 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 222 ----SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ----CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11222 45688999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=305.10 Aligned_cols=267 Identities=23% Similarity=0.338 Sum_probs=204.8
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|++|.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 47888999999999999999988899999999876542 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+ +++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998762 356999999999999999999999999 9999999999999999999999999987644332
Q ss_pred CccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhh-------hhhhhccc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWA-------TPLFKDRR 308 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~-------~~~~~~~~ 308 (399)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||............ ... ++.+....
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 112234688999999988654 5688999999999999999998888765432211100 000 00000000
Q ss_pred hhhhccCCccC----CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLE----GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+..+... ..........+.+++.+||+.+|.+||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00010000000 00111234688899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=301.94 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=199.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.. ++..||+|.+.... ....+.+|+.+++.++||||+++++++..+ ..+++|||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4688899999999999999875 47789999986542 345788999999999999999999998764 579999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++++|.+++... ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999763 2346899999999999999999999999 9999999999999999999999999987532221
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.....+..|+|||.+.++.++.++|+||||+++|+|++ |+.||......+..... ...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~---------- 213 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------EKG---------- 213 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hCC----------
Confidence 12234568999999988899999999999999999997 99999876542211111 000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
.....+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 214 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 214 YRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 001112233457889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=301.04 Aligned_cols=259 Identities=28% Similarity=0.391 Sum_probs=208.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|++.+.||.|++|.||+|....++..+++|.+..... .....+.+|+.+++.++|+||+++++.+..++..++++|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 478899999999999999999988899999999875432 2446788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999976221 246899999999999999999999999 9999999999999999999999999987544433
Q ss_pred Ccc--ccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 238 KSH--VSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 238 ~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... ......|+..|+|||++... .++.++|+||||+++|+|++|+.||....+.... ...... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~--~~~~~~-----------~ 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL--MLTLQN-----------D 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH--HHHhcC-----------C
Confidence 221 22334688999999998776 7889999999999999999999999865443211 100000 0
Q ss_pred CCccCCCC-CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNY-PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.+.... ....+..+.+++.+||+.||.+||++.+|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111110 12344678899999999999999999999864
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=300.79 Aligned_cols=250 Identities=22% Similarity=0.346 Sum_probs=203.4
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||+|++|.||++....++..+|+|.+..... .....+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 57888999999999999999988999999999876432 2345688899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~ 236 (399)
+++++|.+++... ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999762 2345899999999999999999999999 99999999999998654 5899999998754332
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+.... .. ..... .
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~---~~~~~--~------- 217 (256)
T cd08220 156 SK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VL---KIMSG--T------- 217 (256)
T ss_pred cc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HH---HHHhc--C-------
Confidence 21 1234588899999999888899999999999999999999999976543211 10 00000 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+......+.+++.+||+.+|.+|||+.+++.+
T Consensus 218 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 --FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred --CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 001122234578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=307.21 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=202.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 368888999999999999999998899999999865422 2235688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
+++++|..++.... ....+++..+..++.|++.||.|||+ .+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999887521 13468999999999999999999996 47 999999999999999999999999998653222
Q ss_pred CCccccccccccccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTG------QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||............
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~------------- 219 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL------------- 219 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH-------------
Confidence 11224578899999988543 3578999999999999999999999764332111110
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+... .....+......+.+++.+||+.+|.+||++.+++.+
T Consensus 220 ~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 220 SAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 001010 0112233455678899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=306.11 Aligned_cols=267 Identities=23% Similarity=0.321 Sum_probs=199.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||.|++|.||+|....+++.||||.+...... ....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 5788999999999999999999888999999998754322 224567899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+. ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.......
T Consensus 85 ~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 96 5999988762 346899999999999999999999999 9999999999999999999999999986432211
Q ss_pred CccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc-ccchhhHhh-hhhhhcc-------
Q 046609 238 KSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT-EEQNLVTWA-TPLFKDR------- 307 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~-~~~~~~~------- 307 (399)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...... +....+... .......
T Consensus 158 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred --ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 11122346788999998865 45889999999999999999999999765421 110000000 0000000
Q ss_pred -----chhhhccCCccCCCC-CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 -----RKFTMMADPLLEGNY-PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 -----~~~~~~~~~~l~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+.... .......+.+++.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000000000000 01112577889999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.16 Aligned_cols=246 Identities=28% Similarity=0.397 Sum_probs=204.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|++|.||++.+..+++.||+|.+..... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 468889999999999999999998899999999865432 22356788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999976 357999999999999999999999999 99999999999999999999999999876433
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ... .
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~--------~ 214 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI------LEG--------K 214 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcC--------C
Confidence 3 22346889999999998888899999999999999999999999865521110000 000 0
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
...+......+.+++.+||..+|.+|| ++++++.+
T Consensus 215 ----~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 ----VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ----ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 011223345788999999999999999 77777654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=311.19 Aligned_cols=249 Identities=24% Similarity=0.323 Sum_probs=202.4
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
|.....||.|+||.||++....++..||||.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 33346799999999999999888999999998765545556788999999999999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++....... .
T Consensus 104 ~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--~ 173 (292)
T cd06658 104 GALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--P 173 (292)
T ss_pred CcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc--c
Confidence 999998854 35899999999999999999999999 9999999999999999999999999987533222 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....+...... ......+.+..
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-------------~~~~~~~~~~~ 240 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-------------IRDNLPPRVKD 240 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------------HHhcCCCcccc
Confidence 12234688999999999888899999999999999999999999986543221110 00011111111
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.......+.+++.+||..||.+|||+.+++++
T Consensus 241 --~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 --SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred --ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11233467889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=302.22 Aligned_cols=247 Identities=26% Similarity=0.378 Sum_probs=202.5
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.++..++||||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 6677899999999999999988899999999865432 233568889999999999999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
+++|.+++.. ..+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-- 155 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-- 155 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch--
Confidence 9999999864 35899999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||....+....... . ....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~------~~~~---- 218 (277)
T cd06641 156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-------P------KNNP---- 218 (277)
T ss_pred hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-------h------cCCC----
Confidence 1122345788999999998888899999999999999999999999764432111000 0 0001
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11222334578899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=303.93 Aligned_cols=261 Identities=25% Similarity=0.316 Sum_probs=204.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 155 (399)
++|...+.||.|++|.||+|.+..++..+|+|.+..... .....+.+|+.+++.++||||+++++++.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 357778999999999999999998899999999875433 2346688999999999999999999998653 4689999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++.........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887654334566899999999999999999999999 99999999999999999999999999865332
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc--ccchhhHhhhhhhhccchhhhc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT--EEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... ....++..|+|||.+.+..++.++||||||+++|+|++|..||...... .......+... .....+
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~ 228 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN-----MPNPEL 228 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc-----CCchhh
Confidence 221 2345788999999998889999999999999999999999999866331 11111111111 000011
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+. . .........+.+++.+||+.+|.+|||+.+|+++
T Consensus 229 ~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 229 KDE-P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred ccC-C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 000 0 0011234578899999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=309.59 Aligned_cols=246 Identities=22% Similarity=0.308 Sum_probs=201.5
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
...||.|+||.||+|.+..++..||+|.+..........+.+|+.++..++||||+++++++..++..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 35799999999999999888999999999765555556788999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
..++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 106 ~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~--~~~~ 175 (297)
T cd06659 106 TDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRK 175 (297)
T ss_pred HHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc--cccc
Confidence 988754 45899999999999999999999999 9999999999999999999999999986433221 1122
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
...++..|+|||++.+..++.++||||||+++|+|++|+.||....+.+..... .. ...+.. ...
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~----------~~~~~~--~~~ 240 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL---RD----------SPPPKL--KNA 240 (297)
T ss_pred ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---hc----------cCCCCc--ccc
Confidence 356889999999998888999999999999999999999999865432211110 00 000000 011
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+.+++.+||+.+|.+||++.+++++
T Consensus 241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 241 HKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1233468889999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=301.82 Aligned_cols=258 Identities=27% Similarity=0.413 Sum_probs=200.8
Q ss_pred CCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCC------
Q 046609 81 FNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 149 (399)
|.+.++||+|+||.||+|.+. .++..||||.+..... ...+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999864 3578999999875432 23456888999999999999999999886532
Q ss_pred eeEEEEEecCCCChHHhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 150 QRILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
..++++||+.+|+|..++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999998875421 12235889999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
|+++...............++..|++||.+.+..++.++||||||+++|+|++ |++||......+. ..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHHc----
Confidence 99886433322222222345678999999988889999999999999999999 8999986543221 111100
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.. .. ..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 231 ~~------~~----~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GN------RL----KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC------cC----CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 00 01122345788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=317.37 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=217.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC----CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE----GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
..+.....++||.|.||.||.|... +..-.||||..+.+.. ...+.|..|..++++++||||++++|+|.+ ...
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~ 465 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM 465 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence 3344556689999999999999863 3345699999987443 445779999999999999999999999976 477
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
|+|||.++.|.|..||+. +...|+......++.||..||.|||+.. +|||||...||||...--+||+|||+++
T Consensus 466 WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 466 WIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred eEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhh
Confidence 999999999999999998 5667999999999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
..........+ ...-+..|||||.+.-..++.++|||.|||++||++. |..||.+....+.-..
T Consensus 540 ~~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------------- 604 (974)
T KOG4257|consen 540 YLEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------------- 604 (974)
T ss_pred hccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE--------------
Confidence 87655544333 4456789999999999999999999999999999987 9999998654332111
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
+...-+...|..++..|..++.+||..+|.+||.+.+|...|..+.....
T Consensus 605 ---iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek 654 (974)
T KOG4257|consen 605 ---IENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEK 654 (974)
T ss_pred ---ecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhh
Confidence 11111223455666788999999999999999999999999999887443
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=299.69 Aligned_cols=253 Identities=26% Similarity=0.398 Sum_probs=203.9
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|++|.||+|....++..|++|.+...... ....+..|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999999888999999999766543 456788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999976 345889999999999999999999999 9999999999999999999999999987644332
Q ss_pred Cccc--cccccccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 238 KSHV--STRVMGTYGYCAPEYALTGQ---LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 238 ~~~~--~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.... .....++..|+|||++.+.. ++.++||||||+++|+|++|+.||...+.... ..+... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~~-~~------- 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHVG-AG------- 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHHh-cC-------
Confidence 2111 11345788999999987766 88999999999999999999999976542111 000000 00
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
..+.+.. .......+.+++.+||+.+|.+||++.+++.
T Consensus 223 -~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 223 -HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred -CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0111100 1112456789999999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=300.82 Aligned_cols=256 Identities=22% Similarity=0.312 Sum_probs=191.8
Q ss_pred CeeccCCcEEEEEEEECCC--CeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLEGT--NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
+.||+|+||.||+|..... ...+++|.+..... .....+.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3599999999999975432 34567777765432 33467889999999999999999999999999999999999999
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccc
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV 241 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 241 (399)
+|.+++.........+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.++|+|||++...........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999864333345677888999999999999999999 99999999999999999999999999864222211122
Q ss_pred cccccccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 242 STRVMGTYGYCAPEYALT-------GQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 242 ~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.....++..|+|||++.. ..++.++||||||+++|+|++ |..||....+.+... .... ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~~--~~~~~~ 229 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVIK--DQQVKL 229 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHh--hccccc
Confidence 233567889999998743 245778999999999999997 577886544321111 0011 111112
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
.++.+.. .....+.+++..|| .+|++||++.+|++.|.
T Consensus 230 ~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222 23346778999999 67999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=299.88 Aligned_cols=238 Identities=25% Similarity=0.418 Sum_probs=191.9
Q ss_pred CeeccCCcEEEEEEEECCCC----------eEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTN----------QDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999997665 35788887654333 5778899999999999999999999988 778999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-------CeeEecc
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-------NPKLSDF 227 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-------~~kl~Df 227 (399)
|||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999862 236899999999999999999999999 99999999999999888 7999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCC--CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhh
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG--QLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|++..... .....++..|+|||++.+. .++.++||||||+++|+|++ |..||......+......
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~------ 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ------ 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh------
Confidence 99875332 1223467789999998776 78999999999999999999 578887764322111110
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
... ..+......+.+++.+||..+|.+||++.+|++.|
T Consensus 221 -~~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 -DQH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred -cCC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 000 00111115788999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=302.01 Aligned_cols=249 Identities=28% Similarity=0.398 Sum_probs=202.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccC---CCceeeEEEEEeeCCeeEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLS---NPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.|...+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++ |||++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 47778999999999999999988899999999875432 33456888999999986 999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999865 36899999999999999999999999 99999999999999999999999999876443
Q ss_pred CCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. .......|+..|+|||.+.++ .++.++||||||+++|+|++|..||............ ....
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------------~~~~ 218 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------------PKSK 218 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------------ccCC
Confidence 32 112234688899999988654 5788999999999999999999999865432211100 0001
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.+... .....+.+++.+||+.||++||++.+++.+
T Consensus 219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 1111111 134578899999999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=308.20 Aligned_cols=199 Identities=24% Similarity=0.376 Sum_probs=162.0
Q ss_pred CeeccCCcEEEEEEEECC--CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee--CCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEG--TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~ 160 (399)
.+||+|+||.||+|.... ++..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~- 83 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE- 83 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-
Confidence 579999999999999753 56789999987543 23467889999999999999999999853 567899999985
Q ss_pred CChHHhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE----CCCCCeeEecccCcc
Q 046609 161 GSLEDHLLDLP-----PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLAK 231 (399)
Q Consensus 161 g~L~~~l~~~~-----~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~~~ 231 (399)
++|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 84 HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 58887775321 12235889999999999999999999999 9999999999999 566789999999998
Q ss_pred CCCCCCCc-cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSR 289 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~ 289 (399)
........ .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 64332211 12233568999999998876 458899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=304.10 Aligned_cols=268 Identities=22% Similarity=0.253 Sum_probs=200.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+++|.+.+.||+|+||.||+|....++..||+|.+....... ...+.+|+.+++.++|+||+++++++.++...++|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 478999999999999999999998889999999987543322 3457789999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+. ++|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++......
T Consensus 84 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 788777754 2345788899999999999999999999 999999999999999999999999998753222
Q ss_pred CCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh--hhhh--------h
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA--TPLF--------K 305 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~--~~~~--------~ 305 (399)
. .......++..|+|||.+.+. .++.++||||||+++|+|++|..||.............+. .... .
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 157 S--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred C--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence 1 112234578899999988754 5788999999999999999999999865432111000000 0000 0
Q ss_pred ccchhhhccC----CccCCC-CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 DRRKFTMMAD----PLLEGN-YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 ~~~~~~~~~~----~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.......... ..+... ........+.+++.+|+..||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000 000000 000123577889999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=307.71 Aligned_cols=271 Identities=21% Similarity=0.290 Sum_probs=202.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECC--CCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEG--TNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRI 152 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~ 152 (399)
+|.+.+.||+|++|.||+|.... ++..||+|.+.... ......+.+|+.++..++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999987 78999999998633 23345678899999999999999999999988 8899
Q ss_pred EEEEecCCCChHHhhccCCCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC----CCCeeEecc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNR-KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ----DFNPKLSDF 227 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~----~~~~kl~Df 227 (399)
+||||++ ++|.+++....... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999995 57777775433222 37899999999999999999999999 999999999999999 999999999
Q ss_pred cCccCCCCCCC-ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch-------hhH
Q 046609 228 GLAKLGPTGDK-SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN-------LVT 298 (399)
Q Consensus 228 g~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-------~~~ 298 (399)
|++........ ........++..|+|||.+.+ ..++.++||||||+++|+|++|++||.......... +..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99876433222 112223467889999998766 458899999999999999999999998765433100 000
Q ss_pred hhhh----------hhhccchhhhccCCccCCCCC---------H--HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 299 WATP----------LFKDRRKFTMMADPLLEGNYP---------I--KGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 299 ~~~~----------~~~~~~~~~~~~~~~l~~~~~---------~--~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... .+..........+......++ . .....+.+++.+||+.||.+|||+.+++.+
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 000000000000000000111 0 234568899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=295.40 Aligned_cols=251 Identities=27% Similarity=0.426 Sum_probs=207.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
+|...+.||.|++|.||++.+..++..+++|++..........+.+|+.+++.++||||+++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 47788999999999999999988899999999987655456788999999999999999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
+++|.+++... ...+++..+..++.|++.||.+||+.+ ++||||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999998762 257899999999999999999999998 99999999999999999999999999876544332
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+......... . .. .+.+.
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~------~~-----~~~~~ 218 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA--T------NG-----PPGLR 218 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH--h------cC-----CCCcC
Confidence 234568899999999988889999999999999999999999998654321111000 0 00 00000
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+......+.+++.+||+.||.+|||+.+++++
T Consensus 219 --~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 219 --NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred --cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 011124578899999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=305.78 Aligned_cols=266 Identities=23% Similarity=0.275 Sum_probs=202.2
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-----chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-----GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
+|.+.+.||.|++|.||+|.+..+++.||||.+...... ....+..|+.+++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477789999999999999999888999999999765432 234567899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+ +|+|.+++... ...+++..++.++.||++||.|||+++ |+|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 99999999762 236999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhhcc-chhh
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKDR-RKFT 311 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~-~~~~ 311 (399)
.... ......++..|+|||.+.+ ..++.++|||||||++|+|++|.+||....+.+..... .......... ....
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVT 231 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcc
Confidence 3221 1222346788999998854 46788999999999999999998888765432211111 0000000000 0000
Q ss_pred hc---cCCccC-----CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 312 MM---ADPLLE-----GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 312 ~~---~~~~l~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ...... ..........+.+++.+||+.+|++|||+.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00 000000 01112335678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=301.41 Aligned_cols=254 Identities=26% Similarity=0.363 Sum_probs=205.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|...+.||.|++|.||+|.+..+++.+|+|.+..... .....+.+|+.+++.++||||+++++.+..++..++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 357778999999999999999998899999999876533 3345688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
+++++|.+++... ...+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999762 2578999999999999999999999 88 999999999999999999999999998643221
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .....++..|+|||.+.+..++.++||||||+++|+|++|..||...+.... ........... ...+
T Consensus 155 ~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~-------~~~~ 222 (265)
T cd06605 155 L----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN-------EPPP 222 (265)
T ss_pred H----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc-------CCCC
Confidence 1 1115688899999999888999999999999999999999999976532111 11111111100 0011
Q ss_pred ccCCCCCHH-HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIK-GLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.. ....+.+++.+||..+|.+||++.+++.+
T Consensus 223 ----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 223 ----RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ----CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 11111 45578899999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=304.64 Aligned_cols=267 Identities=23% Similarity=0.308 Sum_probs=203.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv 154 (399)
++|.+.+.||.|++|.||+|.+..+++.+++|.+....... ...+.+|+.++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888899999999999999999889999999997543322 23567899999999999999999999877 889999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
+||+. ++|.+++... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 85 ~e~~~-~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 5999888762 236899999999999999999999999 9999999999999999999999999987644
Q ss_pred CCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhh-------
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFK------- 305 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~------- 305 (399)
... .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...........+ ........
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 332 112234578899999988654 4688999999999999999999999865533211111 00000000
Q ss_pred cc-----chhhhccCCccCCCCCHH-HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 DR-----RKFTMMADPLLEGNYPIK-GLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 ~~-----~~~~~~~~~~l~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ..........+...++.. ....+.+++.+||+.+|++|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 000000111111222222 35678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=302.54 Aligned_cols=248 Identities=26% Similarity=0.346 Sum_probs=204.8
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+|.+.+.||.|+||.||+|.+..++..||+|.+..... ...+.+.+|+.++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47888999999999999999998899999999975432 234678889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999976 357899999999999999999999999 999999999999999999999999998754332
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.............. ...
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK----QET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHH----hcc----------
Confidence 2 22335588899999999888899999999999999999999999987654311111100 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCCh--HHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM--SDVV 352 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~eil 352 (399)
.....+...+..+.+++.+||+.||.+||++ .+++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112223344688899999999999999999 6554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=302.90 Aligned_cols=249 Identities=23% Similarity=0.326 Sum_probs=203.1
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
|...+.||.|++|.||++....++..+++|.+........+.+.+|+.+++.++||||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999999888999999998765444556688999999999999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
++|.+++.. ..+++..+..++.|++.||.|||+++ |+||||+|+||+++.++.++|+|||.+........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 999999865 45899999999999999999999999 99999999999999999999999998764332211
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...++....... . ....+...
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~---~----------~~~~~~~~- 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI---R----------DNLPPKLK- 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH---H----------hcCCCCCc-
Confidence 122345889999999998888999999999999999999999999765432211111 0 00011111
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+......+.+++.+||+.+|++||++.+++++
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111234578999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=294.84 Aligned_cols=253 Identities=26% Similarity=0.340 Sum_probs=208.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 155 (399)
+|...+.||+|++|.||+|....++..|++|.+..... ...+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 47778999999999999999998899999999876543 3356788999999999999999999999988 8999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 99999999999976 337999999999999999999999999 99999999999999999999999999886544
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...........++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..... ...
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~----------~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYK----------IGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHh----------ccc
Confidence 432212334568899999999988889999999999999999999999998765110 00000 000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.......+......+.+++.+||+.+|++||++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112333345689999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=303.95 Aligned_cols=266 Identities=21% Similarity=0.275 Sum_probs=200.6
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|+..+.||.|++|.||+|.+..++..||||.+...... ....+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999999988999999998654322 235688899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+. ++|..++... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 6899888753 2456899999999999999999999999 9999999999999999999999999987543221
Q ss_pred CccccccccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch-hhHhhhhh-------hhcc-
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN-LVTWATPL-------FKDR- 307 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~-------~~~~- 307 (399)
.......++..|+|||.+.+.. ++.++||||||+++|+|+||+.||.......... ........ ....
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1122234688999999886644 6889999999999999999999997654321110 00000000 0000
Q ss_pred ---chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 ---RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ---~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.......+. .........+.+++.+||+.||.+||++++++.+
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 000000000000 0011233467889999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=319.32 Aligned_cols=245 Identities=30% Similarity=0.408 Sum_probs=206.6
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
|.-++.||.|+||.||.|++..+.+.||||++...+.+ ...++.+|+..|.+++|||++.+-++|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44457899999999999999999999999999866543 346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
| -|+-.+.+.- -.+++.+..+..|..+.+.||.|||+.+ .||||||..|||+++.|.+||+|||.+......
T Consensus 108 C-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred H-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9 5687777766 3568999999999999999999999999 999999999999999999999999998754332
Q ss_pred Ccccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 238 KSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
..++|||.|||||++. .+.|+-++||||||++..||.-.++|+-.++.......+ ...-
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI-------------AQNe 241 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------AQNE 241 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH-------------HhcC
Confidence 3467999999999885 589999999999999999999999998877643322211 1111
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.|.+. ..+.+..+..|+..||+.-|.+|||.++++.+
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 22222 33556678899999999999999999998876
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=300.71 Aligned_cols=254 Identities=26% Similarity=0.394 Sum_probs=207.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++.|.+.+.||.|++|.||+|.+..++..+++|.+..... ....+.+|+.+++.++|+||+++++.+...+..++++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 34678888999999999999999998899999999976543 45678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|.+++... ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~~~~L~~~l~~~---~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQN---FVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999872 137999999999999999999999999 999999999999999999999999988643322
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......++..|+|||.+.+..++.++||||||+++|+|++|..||....+....... . . . .. +
T Consensus 170 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~--~----~--~----~~-~ 234 (286)
T cd06614 170 K--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI--T----T--K----GI-P 234 (286)
T ss_pred h--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--H----h--c----CC-C
Confidence 1 1222345788999999998888999999999999999999999999865442211100 0 0 0 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ..+......+.+++.+||+.+|.+||++.+|+++
T Consensus 235 ~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 235 PL--KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred CC--cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 00 0111234578899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=296.99 Aligned_cols=243 Identities=28% Similarity=0.353 Sum_probs=199.1
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||.|++|.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 7999999999999998899999999975432 2335688899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 999976 345899999999999999999999999 9999999999999999999999999998654332 122
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
...++..|+|||.+.+..++.++|+||||+++|+|++|..||........ .... ..........++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~----------~~~~~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYN----------DILKGNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHH----------HHhccCCCCCCC
Confidence 34578899999998888899999999999999999999999987653111 0000 011001111223
Q ss_pred HHHHHHHHHHHhhccccCCCCCCC-----hHHHHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRPM-----MSDVVT 353 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~ 353 (399)
......+.+++.+||+.+|.+||+ ++++++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 333568899999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=313.65 Aligned_cols=249 Identities=23% Similarity=0.343 Sum_probs=212.7
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch--HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.....|.+.+.||+|.|+.|.+|.+..++..||||++.+...... ..+.+|+.+|+.++|||||+++.+.+....+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 345789999999999999999999999999999999987654333 458899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+.+|.+.+++.. ++.+.+..+..++.|++.|++|||+++ |||||||++|||++.+.++||+|||++..+
T Consensus 133 V~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 9999999999999987 567888999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLT-AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..+ ......+|++.|.|||++.+..|+ +.+|+||+|++||.|+.|..||++..-.+.
T Consensus 206 ~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L------------------- 263 (596)
T KOG0586|consen 206 DYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL------------------- 263 (596)
T ss_pred ccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-------------------
Confidence 533 344557899999999999888774 689999999999999999999997543221
Q ss_pred ccCCccCC--CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEG--NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+..+.. ..+.-...+..++|+++|-.+|.+|+++++|.+.
T Consensus 264 -r~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 264 -RPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred -cchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 1111111 1222334467789999999999999999999765
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=302.96 Aligned_cols=248 Identities=31% Similarity=0.407 Sum_probs=200.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
+.|...+.||+|+||.||+|....+++.||+|.+...... ....+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688889999999999999999888999999998644322 2246788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~---~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEV---HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHH---cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9995 678777754 2346899999999999999999999999 99999999999999999999999999875332
Q ss_pred CCCcccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
. ....++..|+|||++. ...++.++||||||+++|+|++|.+||...+........ ...
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~------~~~------ 229 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQN------ 229 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH------hcC------
Confidence 2 1245788999999874 456888999999999999999999999765432211000 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
..+.+ .+......+.+++.+||+.+|++||++.+|+.+.
T Consensus 230 -~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 230 -DSPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred -CCCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 00111 1122445789999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=295.16 Aligned_cols=253 Identities=22% Similarity=0.349 Sum_probs=209.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|++|.||++.+..++..+++|.+..... .....+..|+.+++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 57788999999999999999998899999999976543 3456688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.........+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999874433577999999999999999999999999 9999999999999999999999999987543332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......|++.|+|||.+.+..++.++|+||+|+++|+|++|..||........ . ..... ...
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~---~~~~~------~~~--- 220 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---A---LKILK------GQY--- 220 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---H---HHHhc------CCC---
Confidence 122334688899999999888899999999999999999999999976542211 1 00000 000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+......+.+++.+||..+|.+||++.+++++
T Consensus 221 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 221 --PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred --CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 11122344578899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=297.85 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=207.6
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|++|.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 47788999999999999999998899999999875432 2335677899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998764434567899999999999999999999999 999999999999999999999999999765433
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..... ...
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-----------------~~~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-----------------QRG 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-----------------hcC
Confidence 122245788999999998889999999999999999999999999865532111000 000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+.....++.+++.+||+.+|++||++.+++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0112233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=298.84 Aligned_cols=268 Identities=23% Similarity=0.292 Sum_probs=202.6
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+|++.+.||.|++|.||+|.+..++..||||.+...... ....+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 578889999999999999999989999999999765432 2356778999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+ ++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 D-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred C-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 7 58988887532 1346899999999999999999999999 9999999999999999999999999987533221
Q ss_pred ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhh-------ccch
Q 046609 239 SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFK-------DRRK 309 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~-------~~~~ 309 (399)
.......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+ ........ ....
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11222457889999998865 45788999999999999999999999876543221111 00000000 0000
Q ss_pred hhhccCCcc---CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLL---EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......... ...........+.+++.+||+.||.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 001112234578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=304.49 Aligned_cols=269 Identities=26% Similarity=0.320 Sum_probs=201.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~ 152 (399)
..++|.+.+.||.|+||.||+|.+..+++.||+|.+....... ...+.+|+.++++++|+||+++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 4578999999999999999999999999999999986543221 23456799999999999999999998755 5689
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+. ++|.+++... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++..
T Consensus 85 lv~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 85 LVMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeee
Confidence 9999995 5898888752 356899999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh-hhh-------
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA-TPL------- 303 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~------- 303 (399)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||...++......+... ...
T Consensus 158 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 158 YGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 443221 1122345788999998865 56789999999999999999999999876543322111110 000
Q ss_pred hhccchhhhccCCccC-CC---CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 FKDRRKFTMMADPLLE-GN---YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~-~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+...........+... .. ........+.+++.+||+.||.+|||+.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000000000000 00 001124567889999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=298.81 Aligned_cols=243 Identities=25% Similarity=0.358 Sum_probs=190.9
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHH---ccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLS---MLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~---~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
+||+|+||.||++.+..+++.+|+|.+....... ...+.+|..+++ ..+||||+.+++.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999889999999986543221 122344443333 3479999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
+|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999999875 456999999999999999999999999 9999999999999999999999999986432221
Q ss_pred cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 240 HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.....|+..|+|||.+.+ ..++.++|||||||++|+|++|..||.............. ....
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~-----------~~~~---- 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----------TLTV---- 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH-----------hhcC----
Confidence 122458999999998864 5688999999999999999999999986543221111100 0001
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
....+...+..+.+++.+||+.||.+|| ++.+++++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 1122333456788999999999999999 59999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=314.26 Aligned_cols=266 Identities=26% Similarity=0.366 Sum_probs=224.0
Q ss_pred HHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
++......+....++||-|.||.||.|.|+...-.||||.++.+. -...+|+.|..+|+.++|||+|+|+++|..+...
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 445555567777899999999999999999888899999997654 4467899999999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
|||.|||..|+|.+||+.. +...++....+.++.||..|++||..++ +|||||...|+||.++..+|++|||+++
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999984 3556788889999999999999999999 9999999999999999999999999999
Q ss_pred CCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
++........ ....-++.|.|||-+....++.++|||+|||+|||+.| |--||.+.+.. ++
T Consensus 414 lMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-----------------qV 475 (1157)
T KOG4278|consen 414 LMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----------------QV 475 (1157)
T ss_pred hhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-----------------HH
Confidence 8654443322 22345778999999999999999999999999999998 88899875532 11
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
-.++....+-+-|..++..+.+|++.||+++|.+||+++||-+.++.+-+.
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 122222223334556677899999999999999999999999999887653
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=296.59 Aligned_cols=251 Identities=19% Similarity=0.334 Sum_probs=202.9
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|+||.||+|....++..+|+|.+..... ...+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 47788999999999999999998899999999875432 3345678899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC-eeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN-PKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~-~kl~Dfg~~~~~~~~ 236 (399)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++. ++|+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999762 2345899999999999999999999999 999999999999998864 699999998754322
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||....... ........ ...
T Consensus 156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~------~~~- 220 (257)
T cd08225 156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQG------YFA- 220 (257)
T ss_pred c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhcc------cCC-
Confidence 2 12223458889999999988889999999999999999999999997543211 11110000 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+.+++.+||..+|.+|||+.+++.+
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1112234578899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=298.17 Aligned_cols=263 Identities=21% Similarity=0.254 Sum_probs=196.6
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccC-CCceeeEEEEEeeC--CeeEEEEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDG--DQRILVYE 156 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~e 156 (399)
|.+.+.||+|+||.||+|....++..||+|.+..... ........|+.++.++. ||||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 5677899999999999999998899999999875422 22234457888888885 99999999999987 88999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++ |+|.+++.. ....+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKG---RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 688888865 2356899999999999999999999999 999999999999999 99999999999754332
Q ss_pred CCcccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh--------hhhcc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP--------LFKDR 307 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--------~~~~~ 307 (399)
... ....++..|+|||.+. ++.++.++|||||||++|+|++|.+||...++.+.......... .+...
T Consensus 153 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07831 153 PPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229 (282)
T ss_pred CCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc
Confidence 211 2245788999999764 45678899999999999999999999987654321111100000 00000
Q ss_pred chhhhccCCccC---CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLE---GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
............ .......+..+.+++.+||+.+|.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 00112345789999999999999999999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.14 Aligned_cols=263 Identities=24% Similarity=0.276 Sum_probs=214.2
Q ss_pred ccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEE
Q 046609 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYC 145 (399)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~ 145 (399)
-...+++...++|.++++||+|+||.|.+++++.+++.||+|++++... .+...|..|..+|..-+.+.|+++...|
T Consensus 65 ~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF 144 (1317)
T KOG0612|consen 65 KKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF 144 (1317)
T ss_pred HHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh
Confidence 3456677778999999999999999999999999999999999987432 3445688899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEe
Q 046609 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLS 225 (399)
Q Consensus 146 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 225 (399)
+++.++|+||||++||+|-.++.. -..+++..++.++..|+.||.-||+.| +|||||||+|||||..|++||+
T Consensus 145 QD~~~LYlVMdY~pGGDlltLlSk----~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLA 217 (1317)
T KOG0612|consen 145 QDERYLYLVMDYMPGGDLLTLLSK----FDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLA 217 (1317)
T ss_pred cCccceEEEEecccCchHHHHHhh----cCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeec
Confidence 999999999999999999999987 237999999999999999999999999 9999999999999999999999
Q ss_pred cccCccCCCCCCCcccccccccccccccccccc----C-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL----T-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 300 (399)
|||.+..... +........+|||.|++||++. + +.|+..+|+||+||++|||+.|..||....-.+ -+
T Consensus 218 DFGsClkm~~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve------TY 290 (1317)
T KOG0612|consen 218 DFGSCLKMDA-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE------TY 290 (1317)
T ss_pred cchhHHhcCC-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH------HH
Confidence 9998875433 2334445578999999999984 3 679999999999999999999999998754332 22
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC---hHHHHHH
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM---MSDVVTA 354 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~eil~~ 354 (399)
..+......+... + ....+..+.+||.+.+ -+|..|-. ++++..+
T Consensus 291 ~KIm~hk~~l~FP-~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 291 GKIMNHKESLSFP-D-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred HHHhchhhhcCCC-c-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 2222221111111 0 1224557778888877 45777877 8888765
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=303.43 Aligned_cols=270 Identities=23% Similarity=0.309 Sum_probs=199.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCC------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 149 (399)
.++|.+.+.||+|+||.||+|....+++.||||.+...... ....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35799999999999999999999999999999998654322 2234567999999999999999999987654
Q ss_pred --eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 150 --QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 150 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
..++||||+. ++|.+++.. ....+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3499999995 588888865 2346899999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCc--cccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 228 GLAKLGPTGDKS--HVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 228 g~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|++......... .......++..|+|||.+.+. .++.++||||||+++|+|++|++||....+......+......+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999754332221 112234578899999987654 47889999999999999999999998765433222222111100
Q ss_pred h-----ccchhhh---ccCC-ccCCC-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 K-----DRRKFTM---MADP-LLEGN-----YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~-----~~~~~~~---~~~~-~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ....... ...+ ..... .+......+.+++.+||..||.+|||+++++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 0000000 0000 00000 000123466789999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=294.25 Aligned_cols=252 Identities=26% Similarity=0.307 Sum_probs=201.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-----CcchHHHHHHHHHHHccCCCceeeEEEEEeeC--Cee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-----FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQR 151 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~ 151 (399)
.+|.+.+.||+|++|.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999999899999999875321 12235678899999999999999999998764 467
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999875 345889999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCCC-ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDK-SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
....... ........++..|+|||.+.+..++.++|+|||||++|+|++|+.||......... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~------------- 219 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI--F------------- 219 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH--H-------------
Confidence 5422111 11112345889999999998888999999999999999999999999864322110 0
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...........+......+.+++.+||+ +|..||++.+++.+
T Consensus 220 -~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 220 -KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0000111122344455678899999999 57999999988754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=301.62 Aligned_cols=252 Identities=29% Similarity=0.396 Sum_probs=201.4
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
|...+.||+|+||.||+|.+..++..+|+|.+...... ....+.+|+.+++.++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 66778999999999999999888999999998754322 234678899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+. |+|.+.+.. ....+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 96 588777754 2456899999999999999999999999 999999999999999999999999988643221
Q ss_pred Ccccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 238 KSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
....++..|+|||++. ++.++.++|||||||++|+|++|..||............ . ..
T Consensus 179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~--~----~~-------- 239 (317)
T cd06635 179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--A----QN-------- 239 (317)
T ss_pred -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH--H----hc--------
Confidence 2245888999999873 457889999999999999999999998764322111100 0 00
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.............+.+++.+||+.+|.+||++.+|+.++..+...
T Consensus 240 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 240 --ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred --cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 000011123345688999999999999999999999887655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=299.43 Aligned_cols=265 Identities=23% Similarity=0.282 Sum_probs=200.6
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
|++.+.||.|++|.||+|.+..++..||+|++...... ....+.+|+.+++.++|||++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56779999999999999999888999999998754322 2356788999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~- 153 (283)
T cd07835 81 -DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPV- 153 (283)
T ss_pred -CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-
Confidence 569999987632 246899999999999999999999999 9999999999999999999999999987533221
Q ss_pred ccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchh-hHhhhhhhh-------ccch
Q 046609 239 SHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL-VTWATPLFK-------DRRK 309 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~~~-------~~~~ 309 (399)
.......++..|+|||++.+. .++.++||||||+++|+|++|++||........... ......... ....
T Consensus 154 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 154 -RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchh
Confidence 111223468899999987654 578899999999999999999999986543221100 000000000 0000
Q ss_pred ----hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 ----FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+........ ..........+.+++.+||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 233 YKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000 01122334578899999999999999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=301.72 Aligned_cols=256 Identities=25% Similarity=0.330 Sum_probs=197.1
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|...+.||+|+||.||++.+..++..||+|.+...... ....+.+|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455668899999999999999999999999998754332 3456788999999996 99999999999999999999999
Q ss_pred cCCCChHHhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 158 MPNGSLEDHLLDL-PPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 158 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
+. ++|.++.... ......+++..+..++.|++.||+|||+. + |+||||||+||+++.++.++|+|||++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 84 5665543221 11235699999999999999999999975 7 99999999999999999999999999865332
Q ss_pred CCCccccccccccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTG---QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.. ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .........
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~------- 225 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQVVK------- 225 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhhcC-------
Confidence 21 11223578899999998765 6899999999999999999999999764310 000000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+.+....+...+..+.+|+.+||+.+|.+|||+.+|+.+
T Consensus 226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001111112223345678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=308.64 Aligned_cols=265 Identities=22% Similarity=0.278 Sum_probs=201.6
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeC------
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------ 148 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------ 148 (399)
...+|.+.+.||+|+||.||+|.+..++..||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3478999999999999999999999899999999986432 23345677899999999999999999998643
Q ss_pred CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
...++||||+. ++|.+.+.. .++...+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 35799999994 688888754 2889999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhh-------
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWA------- 300 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~------- 300 (399)
++....... ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+ ...
T Consensus 164 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 240 (353)
T cd07850 164 LARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF 240 (353)
T ss_pred cceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 997543221 122345788999999999999999999999999999999999999865432111000 000
Q ss_pred --------hhhhhcc-----chhhhccCCcc----CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 301 --------TPLFKDR-----RKFTMMADPLL----EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 301 --------~~~~~~~-----~~~~~~~~~~l----~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....... ..+.......+ ....+......+.+++.+||+.||.+|||+.+++.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000 00001111000 001122335578899999999999999999999876
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=291.70 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=205.6
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|.+.+.||.|++|.||+|.+..+++.|++|.+..... .....+.+|+.++++++|||++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 47788999999999999999998899999999987654 3446788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 999999999976 357999999999999999999999999 9999999999999999999999999997644332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||....+.... .. ....
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~--~~---~~~~------------ 214 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--FR---IVQD------------ 214 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH--HH---Hhcc------------
Confidence 21 23345888999999988878899999999999999999999999865421110 00 0000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
.....+......+.+++.+||..+|++||++.+++.
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 215 DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 001122233457889999999999999999999974
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=299.44 Aligned_cols=268 Identities=21% Similarity=0.263 Sum_probs=199.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccC-CCceeeEEEEEeeCCe-----
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQ----- 150 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~----- 150 (399)
++|.+.+.||.|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 3688899999999999999999989999999998654322 2356788999999995 6999999999987665
Q ss_pred eEEEEEecCCCChHHhhccCCCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEeccc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPN-RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFG 228 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg 228 (399)
.++||||+++ +|.+++...... ...+++..++.++.||+.||.|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 898888653322 456899999999999999999999999 999999999999998 8899999999
Q ss_pred CccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch-hhHhhhhhhhc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN-LVTWATPLFKD 306 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~ 306 (399)
++........ ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+..... ........ .
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP--T 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC--C
Confidence 9875432211 1122346788999998765 467899999999999999999999998654322110 00000000 0
Q ss_pred cchhhhc---c----CCccC----CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 RRKFTMM---A----DPLLE----GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 ~~~~~~~---~----~~~l~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+... . -+... ..........+.+++.+||..||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000000 0 00000 00011244578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=295.98 Aligned_cols=245 Identities=29% Similarity=0.397 Sum_probs=195.4
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||+|+||.||+|....+++.||+|.+..... .....+..|+.+++.++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6999999999999998899999999875432 1234467899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
.+++.... ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 99997622 246899999999999999999999999 999999999999999999999999998754321 1122
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
...++..|+|||.+.+..++.++||||||+++|+|++|+.||............. ..... .....+
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~------------~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK--RRTLE------------MAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH--hcccc------------ccccCC
Confidence 3457889999999988889999999999999999999999997654321111100 00000 011122
Q ss_pred HHHHHHHHHHHhhccccCCCCCC-----ChHHHHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRP-----MMSDVVT 353 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~ 353 (399)
......+.+++.+||+.+|.+|| ++.+++.
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23355788999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=298.46 Aligned_cols=267 Identities=21% Similarity=0.262 Sum_probs=199.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||.|++|.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 478889999999999999999998899999999865432 223567889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~ 235 (399)
|++ ++|.+++... ....+++..++.++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 6888887652 2234678889999999999999999999 999999999999985 55799999999975332
Q ss_pred CCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhhcc------
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFKDR------ 307 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~~~------ 307 (399)
.. .......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||....+.+..... ..........
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 21 11223457889999998865 46789999999999999999999999875443211110 0000000000
Q ss_pred -chhhhc----cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 -RKFTMM----ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 -~~~~~~----~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...... ....+. .........+.+++.+||+.+|.+||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLA-TVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHH-HhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 000000 0111234568899999999999999999999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.64 Aligned_cols=265 Identities=27% Similarity=0.501 Sum_probs=211.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
..+...++||+|+||.||+|.+..++..||||.+...... ...|+.++++++|||||++++++.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4577788999999999999999888999999998643221 234688999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.++++. +++..+..++.|++.||+|||....++|+||||||+||+++.++..++. ||.......
T Consensus 766 ~~g~L~~~l~~-------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 766 EGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCcHHHHHhc-------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 99999999964 8899999999999999999995533449999999999999999888875 665432211
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.....+++.|+|||++.+..++.++|||||||++|||++|+.||..... .......|....+.. .....+.++.+
T Consensus 835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~ 909 (968)
T PLN00113 835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSD-CHLDMWIDPSI 909 (968)
T ss_pred ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCc-cchhheeCccc
Confidence 1123578999999999999999999999999999999999999964332 223344454433322 23444555555
Q ss_pred CC--CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 319 EG--NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 319 ~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.. ..+......+.+++.+||+.+|.+||+|.+|++.|+.+.....
T Consensus 910 ~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~ 956 (968)
T PLN00113 910 RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956 (968)
T ss_pred cCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence 33 2345666788899999999999999999999999998765443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=298.94 Aligned_cols=245 Identities=22% Similarity=0.317 Sum_probs=199.7
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChH
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLE 164 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~ 164 (399)
.+||+|+||.||++....++..||||.+..........+.+|+.+++.++|+||+++++.+..++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 57999999999999999899999999987554445567889999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcccccc
Q 046609 165 DHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR 244 (399)
Q Consensus 165 ~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 244 (399)
+++.. ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc--ccccc
Confidence 98754 35899999999999999999999999 9999999999999999999999999886543221 11233
Q ss_pred ccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCH
Q 046609 245 VMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPI 324 (399)
Q Consensus 245 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 324 (399)
..++..|+|||.+.+..++.++|+||||+++|+|++|..||............ . ....+.+.. ..
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~---~----------~~~~~~~~~--~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R----------DNLPPKLKN--LH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---H----------hhCCcccCC--cc
Confidence 45889999999988888999999999999999999999999864432111100 0 001111100 11
Q ss_pred HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 325 KGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 325 ~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+.+++.+||+.+|.+||++.+++.+
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 223467889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=307.58 Aligned_cols=265 Identities=21% Similarity=0.298 Sum_probs=199.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeC-----Cee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG-----DQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~ 151 (399)
+++|.+.+.||+|++|.||+|.+..+++.||||.+.... ......+..|+.++++++||||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 468999999999999999999999999999999986432 22335678899999999999999999887644 357
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++++||+. ++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 84 YIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 99999995 588887754 46999999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCc-cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc--
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR-- 307 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~-- 307 (399)
........ .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+........ ...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~---~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI---LGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHcCCCCH
Confidence 54332211 11223468899999998754 56889999999999999999999999765432111100 0000000
Q ss_pred chhhhccCC---------ccCCC-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADP---------LLEGN-----YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~---------~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+.+. ..... ........+.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 00000 001224568899999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=292.49 Aligned_cols=243 Identities=24% Similarity=0.303 Sum_probs=190.5
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHH-HHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLM-LSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||.|++|.||+|.+..+++.||+|.+........ ..+..|..+ ....+|||++++++++..++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 569999999999999988899999999875432211 233444443 4456899999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999976 356899999999999999999999999 99999999999999999999999998875322
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
.....++..|+|||.+.+..++.++||||||+++|+|++|..||............ ...... ...
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~~--------~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI------LSRRIN--------WPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcccC--------CCC
Confidence 22345888999999998888899999999999999999999999765432211000 000000 001
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+..+.+++.+||+.+|++||++..+.+.
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 1112334578899999999999999977655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=306.66 Aligned_cols=270 Identities=23% Similarity=0.322 Sum_probs=203.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeC-----Ce
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG-----DQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~ 150 (399)
.++|.+.+.||.|+||.||+|.+..++..||||.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457899999999999999999999999999999986532 22345677899999999999999999987654 34
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++|+||+ +++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCC-CCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 79999999 4789888865 456999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh-hhhhhc--
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA-TPLFKD-- 306 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~-- 306 (399)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...+.......+... ......
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7643322 12223457889999998764 56889999999999999999999999765432111111000 000000
Q ss_pred ----cchhh-------hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--HHHh
Q 046609 307 ----RRKFT-------MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA--IEYL 358 (399)
Q Consensus 307 ----~~~~~-------~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~l 358 (399)
..... ....+... ......+..+.+++.+||+.+|.+|||+.+++++ +..+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 00000000 0111344678899999999999999999999987 5443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=312.52 Aligned_cols=252 Identities=27% Similarity=0.383 Sum_probs=211.3
Q ss_pred CCCCeeccCCcEEEEEEEECC---CCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 82 NPDNLLGEGGFGRVYRGKLEG---TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
...++||+|.||.|++|.|.. +...||||.+...... ...+|.+|+.+|.+|+|||+++|||+..+ ....||||.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 344889999999999999853 3357999999876655 66889999999999999999999999988 678999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
++.|+|.+.|++ .....|.......++.||+.|+.||.+++ +|||||...|+|+-..-.+||+|||+++-.....
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999988 34567889999999999999999999999 9999999999999999899999999999766555
Q ss_pred Cccccc-cccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 238 KSHVST-RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 238 ~~~~~~-~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...... ...-...|+|||.+....++.++|||+|||++|||++ |+.||.+-..... ...+|
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI-----------------L~~iD 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI-----------------LKNID 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH-----------------HHhcc
Confidence 444332 2446779999999999999999999999999999999 8899998664221 11222
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
..-+-..+..++.++.+++..||..+|.+||++..|.+.+-
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 22222346677889999999999999999999999985443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=312.92 Aligned_cols=273 Identities=25% Similarity=0.341 Sum_probs=209.3
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCC------eeEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------QRIL 153 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~~l 153 (399)
|...+.||+|+||.||+|+++.+|..||||.++... ....+...+|+++|++++|||||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 344578999999999999999999999999998643 344566788999999999999999999866544 5689
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE--CCCCC--eeEecccC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL--DQDFN--PKLSDFGL 229 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll--~~~~~--~kl~Dfg~ 229 (399)
+||||.||+|...|.+ +++..+|++.+.+.++.++..||.|||+++ |+||||||.||++ ..+|+ .||+|||.
T Consensus 95 vmEyC~gGsL~~~L~~-PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNS-PENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEeecCCCcHHHHhcC-cccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 9999999999999987 667789999999999999999999999999 9999999999998 34344 79999999
Q ss_pred ccCCCCCCCcccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc--
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD-- 306 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 306 (399)
|+....+. ....+.||..|++||++. .+.|+..+|.|||||++|+.+||..||...........+.|....-+.
T Consensus 171 Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~ 247 (732)
T KOG4250|consen 171 ARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG 247 (732)
T ss_pred cccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence 99654443 556688999999999887 488999999999999999999999999876544221112111110000
Q ss_pred -----------cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC--ChHHHHHHHHHhhhcc
Q 046609 307 -----------RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP--MMSDVVTAIEYLAHSK 362 (399)
Q Consensus 307 -----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~eil~~L~~l~~~~ 362 (399)
+..+...++. ...........+...+..+|..+|.+|. ...+.-..+..+....
T Consensus 248 v~i~~~~~eNgpv~~s~~lP~--p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~ 314 (732)
T KOG4250|consen 248 VAIGAQEEENGPVEWSSTLPQ--PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLK 314 (732)
T ss_pred eeEeeecccCCceeeeccCCC--cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhh
Confidence 0111111111 1222334445666678888999999998 6666666666665533
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=295.46 Aligned_cols=266 Identities=22% Similarity=0.276 Sum_probs=201.2
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeEEEEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRILVYE 156 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e 156 (399)
|.+.+.||.|++|.||+|....+++.+|+|.+.... ......+.+|+.+++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567789999999999999999889999999998653 23345678899999999999999999999988 88999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++ ++|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 996 589888865 2257999999999999999999999999 999999999999999999999999999764433
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh-hhhhhhcc-chhhh-
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW-ATPLFKDR-RKFTM- 312 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~~-~~~~~- 312 (399)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+.. ........ .....
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11222456788999997765 4678999999999999999999999987654321111110 00000000 00000
Q ss_pred ----------ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 ----------MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ----------~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+...+....+..+.+++.+||+.+|.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000111125678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=297.53 Aligned_cols=261 Identities=16% Similarity=0.151 Sum_probs=188.6
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCCcchH-----------HHHHHHHHHHccCCCceeeEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGFQGNR-----------EFLVEVLMLSMLSNPYLVNLV 142 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~-----------~~~~e~~~l~~l~hpnIv~l~ 142 (399)
..++|.+.++||+|+||.||+|.+.++ +..+|+|+.......... ....+...+..+.|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999998876 667777765432211111 112233455667899999999
Q ss_pred EEEeeCC----eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC
Q 046609 143 GYCVDGD----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218 (399)
Q Consensus 143 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~ 218 (399)
+++.... ..+++++++ ..++.+.+.. ....++..+..++.|++.||.|||+.+ |+||||||+|||++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~ 161 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDG 161 (294)
T ss_pred EeeeEecCCceEEEEEEehh-ccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcC
Confidence 9876543 346788877 4467666654 233578889999999999999999999 999999999999999
Q ss_pred CCCeeEecccCccCCCCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc
Q 046609 219 DFNPKLSDFGLAKLGPTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEE 293 (399)
Q Consensus 219 ~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 293 (399)
++.++|+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999754322111 112234699999999999999999999999999999999999999987632211
Q ss_pred chhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 294 QNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
........+ ...+...... ....+..+.+++..|++.+|.+||++.+|++.|
T Consensus 242 --~~~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 --LIHAAKCDF-----IKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred --HHHHhHHHH-----HHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 110000000 0001111000 112235788999999999999999999999876
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=301.21 Aligned_cols=263 Identities=21% Similarity=0.251 Sum_probs=196.1
Q ss_pred CeeccC--CcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEG--GFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
..||.| +||+||++.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 346666 8999999999989999999998754322 235678899999999999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999988632 245899999999999999999999999 9999999999999999999999998653221111000
Q ss_pred -----ccccccccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-h--------h
Q 046609 241 -----VSTRVMGTYGYCAPEYALTG--QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-L--------F 304 (399)
Q Consensus 241 -----~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~--------~ 304 (399)
......++..|+|||++.+. .++.++|||||||++|+|++|..||......... ...... . +
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCcccccc
Confidence 01112345679999998763 5788999999999999999999999875432111 000000 0 0
Q ss_pred h--------cc--------------chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 K--------DR--------------RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~--------~~--------------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. .. ..........+...........+.+|+.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 0 00 00000111112222234466789999999999999999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=306.39 Aligned_cols=269 Identities=20% Similarity=0.273 Sum_probs=203.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEe----eCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCV----DGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~----~~~~~ 151 (399)
..+|.+.+.||.|++|.||+|....++..||+|.+..... .....+.+|+.+++.++||||+++++++. .....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3689999999999999999999999999999999875422 33456778999999999999999998875 33568
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999994 689998865 456999999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCc--cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc--
Q 046609 232 LGPTGDKS--HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD-- 306 (399)
Q Consensus 232 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 306 (399)
........ .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+.........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~ 235 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEV 235 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHh
Confidence 54332211 11223468899999998765 46889999999999999999999999876543221111110000000
Q ss_pred -----cchhhhccCC-ccCCC-----CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 -----RRKFTMMADP-LLEGN-----YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 -----~~~~~~~~~~-~l~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.......... ..... .....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 00001 112235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=293.14 Aligned_cols=243 Identities=25% Similarity=0.351 Sum_probs=191.2
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHH---HHHHccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEV---LMLSMLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~---~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
+||+|+||.||+|.+..+++.||+|.+........ ..+..|. ..++...||||+++++.+...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999988899999999876432211 2233343 34445679999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
||+|..++.. ...+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998865 457999999999999999999999999 9999999999999999999999999987543221
Q ss_pred cccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 240 HVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.....|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||.............. ......
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~-----------~~~~~~-- 216 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-----------TLTMAV-- 216 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHH-----------hhccCC--
Confidence 1234689999999998754 689999999999999999999999987543221111100 000011
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
..+...+..+.+++.+||..+|.+|| ++.+++++
T Consensus 217 --~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 --ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred --CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12222345788999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=303.45 Aligned_cols=276 Identities=23% Similarity=0.315 Sum_probs=204.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC--CCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeC--CeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN--GFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDG--DQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~--~~~~ 152 (399)
.++|.+.+.||.|+||.||+|.+..++..+|+|.+... .......+..|+.++.++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 46788889999999999999999888999999988542 122335577899999999 999999999998643 4689
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+. ++|..++.. ..+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++..
T Consensus 86 lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 9999996 699988865 26889999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCc---cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc--
Q 046609 233 GPTGDKS---HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD-- 306 (399)
Q Consensus 233 ~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 306 (399)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||.....................
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 4433221 12233468899999998754 56788999999999999999999999765433211111000000000
Q ss_pred --------c-chhhhccC---CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--HHHhhhccc
Q 046609 307 --------R-RKFTMMAD---PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA--IEYLAHSKE 363 (399)
Q Consensus 307 --------~-~~~~~~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~l~~~~~ 363 (399)
. ........ .... .........+.+++.+||+.+|.+|||+.+++.+ +..+.....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~~~ 306 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLD-ELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNPSD 306 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchh-hhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccCCC
Confidence 0 00000000 0000 0111134578899999999999999999999976 444444333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=289.66 Aligned_cols=245 Identities=22% Similarity=0.267 Sum_probs=193.1
Q ss_pred hcCCCCCCCee--ccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEE
Q 046609 77 ATTNFNPDNLL--GEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 77 ~~~~~~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l 153 (399)
..++|.+.+.+ |.|+||.||++....++..+|+|.+........ |+.....+ +||||+++++.+...+..++
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 34567777766 999999999999999999999999875432221 22222222 69999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKL 232 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~ 232 (399)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++||||+|+||+++.++ .++|+|||++..
T Consensus 87 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~ 159 (267)
T PHA03390 87 IMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKI 159 (267)
T ss_pred EEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcccee
Confidence 9999999999999976 347999999999999999999999999 99999999999999998 999999999875
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.... ....++..|+|||++.+..++.++||||||+++|+|++|..||........ ....+....
T Consensus 160 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~--------- 223 (267)
T PHA03390 160 IGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ--------- 223 (267)
T ss_pred cCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh---------
Confidence 3221 123588999999999888999999999999999999999999985443221 111111110
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-hHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-MSDVVT 353 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~ 353 (399)
... ...+...+..+.+++.+||+.+|.+||+ ++++++
T Consensus 224 --~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 --QKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred --ccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 000 0112234557889999999999999996 688874
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=281.55 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=200.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++...+..||.|+.|.|++++.+.++...|||.+..... ++.+.++..+.++.+.+ +|+||+.+|+|..+...++.|
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455566789999999999999999999999999976543 34466777887777665 899999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|.| .-.+..+++. ..+++++.-+-++...++.||.||.++.+ |+|||+||+|||+|+.|++||||||++-...+
T Consensus 171 elM-s~C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 171 ELM-STCAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHH-HHHHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeec
Confidence 998 4455666655 35679999999999999999999997765 99999999999999999999999999975433
Q ss_pred CCCcccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.. ..+...|.+.|||||.+. ...|+.++||||||++++||.||+.||..-+-+. .-....+++
T Consensus 245 Sk---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~------ 310 (391)
T KOG0983|consen 245 SK---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNE------ 310 (391)
T ss_pred cc---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhc------
Confidence 32 233356999999999885 3478999999999999999999999999744221 011111111
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..|.+... ...+.++.+|+..||+.|+.+||...+++++
T Consensus 311 -ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 311 -EPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -CCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11222221 1245678899999999999999999999876
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=287.85 Aligned_cols=274 Identities=21% Similarity=0.272 Sum_probs=205.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC----eEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEee-CCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN----QDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVD-GDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~ 150 (399)
-..|+....||+|+||.||+|...+++ +.+|||+++... ..-.....+|+.+++.++||||+.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 356888899999999999999665443 378999997542 2334668899999999999999999999987 778
Q ss_pred eEEEEEecCCCChHHhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC----CCeeEe
Q 046609 151 RILVYEYMPNGSLEDHLLDLPP-NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD----FNPKLS 225 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~----~~~kl~ 225 (399)
.+|++||++. +|.+.++-.+. ....++...+.+|+.||+.|+.|||++- |+||||||.||||..+ |.+||+
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 9999999965 89888875432 2357999999999999999999999998 9999999999999888 899999
Q ss_pred cccCccCCCCCCCcc-ccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch------hh
Q 046609 226 DFGLAKLGPTGDKSH-VSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN------LV 297 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~------~~ 297 (399)
|||+++.+...-... ....++.|..|.|||++.| ..|+++.|||+.|||+.||+|-++.|.+........ ..
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl 258 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQL 258 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHH
Confidence 999999866554333 4455778999999999987 479999999999999999999999998754321111 11
Q ss_pred Hhhhhhh--hccchhhhccC---------CccCCCCCH-----------HHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 298 TWATPLF--KDRRKFTMMAD---------PLLEGNYPI-----------KGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 298 ~~~~~~~--~~~~~~~~~~~---------~~l~~~~~~-----------~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
..+..++ ....+++.+.. ..-...+.. .......+|+.++|..||.+|.|+++.+++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111110 00011111100 000000000 0112377899999999999999999998874
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=292.76 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=197.5
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||.|+||.||++.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999998899999999976543 2345688899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC-----
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK----- 238 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~----- 238 (399)
.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLEN----VGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 999976 346899999999999999999999999 99999999999999999999999999875333211
Q ss_pred -ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 -SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
........++..|+|||...+..++.++||||||+++|+|++|..||....+.+..... ....
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~---------- 217 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI------LNGK---------- 217 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC----------
Confidence 11223345788999999998888999999999999999999999999865532211100 0000
Q ss_pred cCCCCCHH--HHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 318 LEGNYPIK--GLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 318 l~~~~~~~--~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
. ..+.. ....+.+++.+||+.+|.+||++..+.+.|
T Consensus 218 ~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 218 I--EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred c--CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0 01111 245788999999999999999995555443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=300.13 Aligned_cols=256 Identities=28% Similarity=0.391 Sum_probs=212.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
..+.|...++||+|+||.|+-++.+.||+.||.|.+.+.... ...-..+|-.||.+++.+.||.+-.+|++.+.++|
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 346788889999999999999999999999999998754332 22346789999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
|+..|.||+|.-+|.+.. +..+++..+..++.+|+-||++||..+ ||+||+||+|||+|+.|++.|+|+|+|...
T Consensus 263 VLtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei 337 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEI 337 (591)
T ss_pred EEEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEec
Confidence 999999999999998743 468999999999999999999999999 999999999999999999999999999977
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
+.+.... ...||.+|||||++.++.|+...|+|||||+||+|+.|+.||...........+ +-..+
T Consensus 338 ~~g~~~~---~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv-----------drr~~ 403 (591)
T KOG0986|consen 338 PEGKPIR---GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV-----------DRRTL 403 (591)
T ss_pred CCCCccc---cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH-----------HHHHh
Confidence 6665432 347999999999999999999999999999999999999999864432111000 00111
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
-+ ...++...+.++.++....|+.||.+|- .+.+|.++
T Consensus 404 ~~---~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H 446 (591)
T KOG0986|consen 404 ED---PEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH 446 (591)
T ss_pred cc---hhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence 11 1245666777888999999999999996 44566554
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=294.58 Aligned_cols=264 Identities=22% Similarity=0.281 Sum_probs=202.8
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
|.+.+.||.|++|.||+|....+++.+++|.+...... ....+..|+.+++.++||||+++++++.+++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999999888999999998754332 3456788999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+ ++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~-~~l~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 D-TDLYKLIKD---RQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred C-CCHHHHHHh---hcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 6 588888876 2357999999999999999999999999 9999999999999999999999999987644332
Q ss_pred ccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH-hhhhh----hhcc-----
Q 046609 239 SHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT-WATPL----FKDR----- 307 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~-~~~~~----~~~~----- 307 (399)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+...... ..... +...
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112224578889999988776 78999999999999999999999997655422111110 00000 0000
Q ss_pred ---chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 ---RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ---~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........... .......+..+.+++.+||+.||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000 01122345688999999999999999999999853
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=295.46 Aligned_cols=270 Identities=23% Similarity=0.284 Sum_probs=200.7
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCC----
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD---- 149 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~---- 149 (399)
...++|.+.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345789999999999999999999998899999999975432 22345678999999999999999999987655
Q ss_pred ------eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 150 ------QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 150 ------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
..++|+||+++ ++...+.. ....+++..++.++.|++.||.|||+.+ |+|+||+|+||+++.++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999965 77777765 2346899999999999999999999999 99999999999999999999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh-h
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA-T 301 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~ 301 (399)
|+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||............... .
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999976443322 11122346778999998764 45788999999999999999999999865432211111100 0
Q ss_pred hhhh-ccchhhhc-----cC------CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 302 PLFK-DRRKFTMM-----AD------PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 302 ~~~~-~~~~~~~~-----~~------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... ....+... .+ ..+... ....+..+.+++.+||+.+|.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREE-FSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhh-cCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 00000000 00 000000 01124578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=294.62 Aligned_cols=245 Identities=31% Similarity=0.438 Sum_probs=196.5
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
|...+.||+|+||.||+|.+..++..|++|.+...... ....+.+|+.+++.++|||++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999999888999999998754332 224578899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+. |+|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 688887765 2456899999999999999999999999 99999999999999999999999998864221
Q ss_pred Ccccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 238 KSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.....|+..|+|||++. ...++.++||||||+++|+|++|..||............. .. .
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~------~~-------~ 236 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QN-------D 236 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH------hc-------C
Confidence 12345888999999874 4668889999999999999999999998754322111110 00 0
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+... .......+.+++.+||+.+|.+||++.+++.+
T Consensus 237 ~~~~~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 237 SPTLQ---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred CCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01110 11223468889999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=295.55 Aligned_cols=251 Identities=27% Similarity=0.386 Sum_probs=205.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.+.||.|++|.||+|....++..||+|++..... .....+..|+.++.+++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 478889999999999999999998899999999875322 22356788999999998 99999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999976 347999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCc------------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchh
Q 046609 235 TGDKS------------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL 296 (399)
Q Consensus 235 ~~~~~------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~ 296 (399)
..... .......++..|+|||.+.+..++.++||||||+++++|++|+.||........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--- 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT--- 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH---
Confidence 32211 122234578899999998888899999999999999999999999987652110
Q ss_pred hHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh----HHHHHH
Q 046609 297 VTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM----SDVVTA 354 (399)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~eil~~ 354 (399)
. ..... .....+...+..+.+++.+||+.+|.+||++ .+++.+
T Consensus 231 ~---~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 231 F---QKILK------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred H---HHHHh------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 0 00000 1112223335578899999999999999999 777643
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=299.06 Aligned_cols=270 Identities=26% Similarity=0.310 Sum_probs=198.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCC------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 149 (399)
.++|.+.+.||.|++|.||+|.+..+++.+|+|.+....... ...+.+|+.+++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999999899999999986543222 245678999999999999999999875433
Q ss_pred --eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 150 --QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 150 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
..++|+||+. ++|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||+++.++.++|+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4699999995 577777765 2457999999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCcc---------ccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh
Q 046609 228 GLAKLGPTGDKSH---------VSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297 (399)
Q Consensus 228 g~~~~~~~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (399)
|++.......... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...........+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9997543322111 1123456888999998765 45889999999999999999999999865543221111
Q ss_pred Hhh-hhhhh----ccchhhhccCCccCCCCC-------HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 298 TWA-TPLFK----DRRKFTMMADPLLEGNYP-------IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 298 ~~~-~~~~~----~~~~~~~~~~~~l~~~~~-------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ..... .........+.......+ ......+.+++.+||+.+|.+|||+.+++.+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 100 00000 000000000000000000 1122578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=319.58 Aligned_cols=272 Identities=18% Similarity=0.217 Sum_probs=189.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC-eEEEEEEE--------------cc---CCCcchHHHHHHHHHHHccCCCcee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN-QDVAVKQL--------------DR---NGFQGNREFLVEVLMLSMLSNPYLV 139 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~--------------~~---~~~~~~~~~~~e~~~l~~l~hpnIv 139 (399)
..+|.+.+.||+|+||.||++..+... ...++|.+ .+ ........+.+|+.++.+++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999998764322 12222211 00 1111234578899999999999999
Q ss_pred eEEEEEeeCCeeEEEEEecCCCChHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC
Q 046609 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLP-PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218 (399)
Q Consensus 140 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~ 218 (399)
++++++.+.+..++|++++ +++|..++.... ..........++.++.||+.||.|||+++ ||||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECC
Confidence 9999999999999999998 568888775421 11223446678889999999999999999 999999999999999
Q ss_pred CCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCC-CCCCCCCcccchhh
Q 046609 219 DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRR-VIDNSRPTEEQNLV 297 (399)
Q Consensus 219 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~ 297 (399)
++.+||+|||++........ .......||..|+|||++.+..++.++|||||||++|||++|.. |+..........+.
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999976433221 12223569999999999999999999999999999999999874 55443322222221
Q ss_pred Hhhhhh------hhc-cchhhhccCC-cc---CCCC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 298 TWATPL------FKD-RRKFTMMADP-LL---EGNY-----PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 298 ~~~~~~------~~~-~~~~~~~~~~-~l---~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...... +.+ .......++. .. .... ......++.+++.+||+.||.+|||+.|++.+
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 111100 000 0000000000 00 0000 00123457788999999999999999999875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=296.30 Aligned_cols=245 Identities=28% Similarity=0.410 Sum_probs=206.1
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHHHHccC-CCceeeEEEEEeeCCe
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLS-NPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~ 150 (399)
.+...+|+++.+||+|+||+|.+|..+++.+.+|||+++++-.-.. +--+.|-.+|.... -|.++++..+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 3445789999999999999999999999999999999987543222 22345667776664 5789999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
+|+||||+.||+|-.++++ -+.+.+..+..++..|+-||-+||++| |++||||.+||++|.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccc
Confidence 9999999999999999987 456778888999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
+..-.+ ......++||+.|+|||++...+|+.++|+||+||+||||+.|++||++.++.+...
T Consensus 498 KEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~--------------- 560 (683)
T KOG0696|consen 498 KENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ--------------- 560 (683)
T ss_pred cccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------
Confidence 863322 334556899999999999999999999999999999999999999999987654221
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP 346 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 346 (399)
.+.+. +-.+|...+.+..++....|..+|.+|-
T Consensus 561 -aI~eh--nvsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 561 -AIMEH--NVSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -HHHHc--cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence 11111 2356777778889999999999999995
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=301.90 Aligned_cols=267 Identities=22% Similarity=0.285 Sum_probs=204.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCC-----eeE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD-----QRI 152 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 152 (399)
+|.+.+.||.|++|.||+|....+++.||||.+.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788899999999999999998889999999987643 234467889999999999999999999988775 789
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
++|||+. ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999996 589888865 347999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCc-cccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh-c---
Q 046609 233 GPTGDKS-HVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK-D--- 306 (399)
Q Consensus 233 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~-~--- 306 (399)
....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||......+....+........ .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 4433210 112234578899999999877 889999999999999999999999987654322111111000000 0
Q ss_pred ---cchhhhccC---CccC---CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 ---RRKFTMMAD---PLLE---GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 ---~~~~~~~~~---~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.......+. .... ..........+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 000000000 0000 00111234578899999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=298.20 Aligned_cols=267 Identities=21% Similarity=0.256 Sum_probs=199.4
Q ss_pred CCCC-CCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--------------hHHHHHHHHHHHccCCCceeeEEE
Q 046609 79 TNFN-PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--------------NREFLVEVLMLSMLSNPYLVNLVG 143 (399)
Q Consensus 79 ~~~~-~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~hpnIv~l~~ 143 (399)
++|. +.+.||.|+||.||+|.+..+++.||||.+....... ...+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4565 4578999999999999999889999999986543221 124678999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 144 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
++..++..++||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999995 699999865 456899999999999999999999999 99999999999999999999
Q ss_pred EecccCccCCCCCC------------CccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Q 046609 224 LSDFGLAKLGPTGD------------KSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRP 290 (399)
Q Consensus 224 l~Dfg~~~~~~~~~------------~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~ 290 (399)
|+|||++....... .........++..|+|||.+.+. .++.++||||||+++|+|++|.+||...++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999987543111 01111223467889999988764 478899999999999999999999987654
Q ss_pred cccchhh-Hhhhhhhhc----cch------hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 291 TEEQNLV-TWATPLFKD----RRK------FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 291 ~~~~~~~-~~~~~~~~~----~~~------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+....+ ......... ... ......+.+. ......+..+.+++.+||+.+|.+||++++++.+
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 3221111 000000000 000 0000000000 0011224578899999999999999999999864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=290.44 Aligned_cols=252 Identities=23% Similarity=0.316 Sum_probs=199.8
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-----cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-----QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
+|.+.+.||+|+||.||++.+..++..+++|.+..... .....+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999999987776677777653221 2234566789999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
+||+++++|.+++.........+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998754444567999999999999999999999999 999999999999975 579999999987543
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... .......++..|+|||.+.+..++.++|+||||+++|+|++|..||........ . .... ...
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~---~---~~~~-------~~~ 221 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV---V---LRIV-------EGP 221 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---H---HHHH-------cCC
Confidence 222 122234578899999998888889999999999999999999999975332110 0 0000 000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+ ..+...+..+.+++.+||+.+|++||++.+++++
T Consensus 222 ~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 222 TP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 1233445678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=334.46 Aligned_cols=256 Identities=26% Similarity=0.329 Sum_probs=209.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
..+-+|.-..+||.|.||.||.|.+..+|+..|+|.+.... ....+...+|..++..++|||+|++||+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 34567788899999999999999999999999999886432 2333567889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
.||||.+|+|.+.+.. ++..++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|...
T Consensus 1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999976 455677777778899999999999999 999999999999999999999999999754
Q ss_pred CCCCCc--cccccccccccccccccccCC---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 234 PTGDKS--HVSTRVMGTYGYCAPEYALTG---QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 234 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
...... .......||+.|||||++.+. ....+.|||||||++.||+||+.||...+.. ..+.+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne---~aIMy--------- 1452 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE---WAIMY--------- 1452 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch---hHHHh---------
Confidence 433211 112346799999999999753 4566899999999999999999999987642 11111
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
-+.....+..|......-.+|+.+||+.||++|.++.+++++
T Consensus 1453 ----~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1453 ----HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ----HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111222345566667778899999999999999999888765
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=293.17 Aligned_cols=255 Identities=26% Similarity=0.409 Sum_probs=196.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 154 (399)
..++|.+.+.||.|++|.||+|.+..++..||||.+..... .....+..|+.++.+.. ||||+++++++.++...+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999998899999999975432 23345666777666665 99999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
|||+ +++|.+++... ...+++..+..++.|++.||.|||+ .+ |+||||+|+||+++.++.+||+|||++...
T Consensus 93 ~e~~-~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 93 MELM-STCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred eecc-CcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 9998 45777776552 3478999999999999999999997 47 999999999999999999999999998754
Q ss_pred CCCCCccccccccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTG----QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
..... .....++..|+|||.+.+. .++.++||||||+++|+|++|+.||....... ..+. ......
T Consensus 166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~~-- 235 (296)
T cd06618 166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT----KILQEE-- 235 (296)
T ss_pred cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH----HHhcCC--
Confidence 32221 1223478899999988654 37889999999999999999999997532211 0000 000000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
.+... ........+.+++.+||..||.+||++.+++.+-
T Consensus 236 -----~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 236 -----PPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -----CCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 00010 0112345788999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=300.47 Aligned_cols=271 Identities=21% Similarity=0.314 Sum_probs=200.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCC------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 149 (399)
..+|.+.+.||.|+||.||+|.+..+++.||+|.+..... .....+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 3689899999999999999999988899999999875322 22345788999999999999999999987543
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++|+||+. .+|..++. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4689999985 47766652 35899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh-----
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL----- 303 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----- 303 (399)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+....+.
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8753221 122457889999998876 46889999999999999999999999875432211111100000
Q ss_pred ---hhcc--chhhhccCCccCCCC---CHHHHHHHHHHHhhccccCCCCCCChHHHHHH--HHHhhhccc
Q 046609 304 ---FKDR--RKFTMMADPLLEGNY---PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA--IEYLAHSKE 363 (399)
Q Consensus 304 ---~~~~--~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~l~~~~~ 363 (399)
.... ............... .......+.+++.+||+.||.+||++.+++.+ ++.++...+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~ 308 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADE 308 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccccc
Confidence 0000 000000000000000 01234568899999999999999999999965 666554433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=294.30 Aligned_cols=250 Identities=29% Similarity=0.380 Sum_probs=198.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.|...+.||.|++|.||+|.+..++..+|+|.+..... .....+.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 36667889999999999999988899999999864322 223467789999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+. |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 995 688877754 2356899999999999999999999999 999999999999999999999999998653221
Q ss_pred CCcccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
....++..|+|||.+. ...++.++|||||||++|+|++|..||............ .. .
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~--~~-----------~ 229 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQ-----------N 229 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHH--hh-----------c
Confidence 2245788999999874 356788999999999999999999998765432111100 00 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
..+.. ........+.+++.+||+.+|.+||++.+++.+-..+
T Consensus 230 ~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 230 ESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred CCCCc---CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 00100 1123445688999999999999999999998774433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=294.18 Aligned_cols=257 Identities=22% Similarity=0.252 Sum_probs=191.9
Q ss_pred CcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhc
Q 046609 91 GFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLL 168 (399)
Q Consensus 91 ~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~ 168 (399)
++|.||.++...+++.||||++.... ......+..|+.+++.++||||+++++++.+.+..+++|||+++|+|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44556666666689999999997652 2334678899999999999999999999999999999999999999999997
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC-----ccccc
Q 046609 169 DLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK-----SHVST 243 (399)
Q Consensus 169 ~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-----~~~~~ 243 (399)
.. ....+++..+..++.|++.||.|||+++ |+||||||+||+++.++.++|+|||.+........ .....
T Consensus 92 ~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~ 166 (314)
T cd08216 92 TH--FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPK 166 (314)
T ss_pred Hh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccc
Confidence 63 2345899999999999999999999999 99999999999999999999999998864322111 11112
Q ss_pred cccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh----hhhc------cchhh
Q 046609 244 RVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP----LFKD------RRKFT 311 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----~~~~------~~~~~ 311 (399)
...++..|+|||++.+ ..++.++|||||||++|+|++|..||........ ....... .+.. .....
T Consensus 167 ~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (314)
T cd08216 167 SSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPLYEDSMS 244 (314)
T ss_pred cccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhhhcCCcC
Confidence 2456778999998865 3588999999999999999999999987543211 1100000 0000 00000
Q ss_pred h----ccCC----ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 312 M----MADP----LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 312 ~----~~~~----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ..++ .............+.+++.+||+.||++|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 245 QSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0 0000 01112233445678899999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=288.81 Aligned_cols=264 Identities=23% Similarity=0.330 Sum_probs=197.2
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHcc---CCCceeeEEEEEeeCCe-----
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSML---SNPYLVNLVGYCVDGDQ----- 150 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l---~hpnIv~l~~~~~~~~~----- 150 (399)
|.+.+.||.|+||.||+|.+..++..||+|.+....... ...+.+|+.+++++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567789999999999999998889999999997543221 23456677776655 59999999999988776
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.+++|||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 58998887632 235899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhh----
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFK---- 305 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~---- 305 (399)
........ .....++..|+|||.+.+..++.++||||||+++|+|++|++||......+....+ ........
T Consensus 155 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 155 RIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcC
Confidence 76433221 12234788999999999889999999999999999999999999875543211111 00000000
Q ss_pred c-----cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 D-----RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 ~-----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ...+........ ..........+.+++.+||+.||.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSF-KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCcccchhhcccccccch-hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 0 000000000000 11112334677899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=296.00 Aligned_cols=266 Identities=21% Similarity=0.243 Sum_probs=195.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCC--CeEEEEEEEccCCC--cchHHHHHHHHHHHcc-CCCceeeEEEEEeeC----Ce
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGT--NQDVAVKQLDRNGF--QGNREFLVEVLMLSML-SNPYLVNLVGYCVDG----DQ 150 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~----~~ 150 (399)
+|.+.+.||+|+||.||++....+ +..||+|.+..... ...+.+.+|+.+++.+ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 477789999999999999999887 88999999864321 2245678899999999 599999999875432 45
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.+++++|+ +++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++
T Consensus 81 ~~~~~e~~-~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELM-EADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEecc-cCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 78889988 4789998865 457999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCc--cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh---
Q 046609 231 KLGPTGDKS--HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF--- 304 (399)
Q Consensus 231 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 304 (399)
......... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|.+||...+...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 754322211 11223468999999998765 468999999999999999999999998754322111100000000
Q ss_pred -----hccc--h----hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 -----KDRR--K----FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 -----~~~~--~----~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... . ........+. .........+.+|+.+||+.||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFE-SIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchH-hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000 0 0000000000 0011124578899999999999999999999755
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=300.18 Aligned_cols=268 Identities=22% Similarity=0.290 Sum_probs=198.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeC---------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--------- 148 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--------- 148 (399)
..+|.+.+.||.|+||.||+|....++..||+|.+........+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 36889999999999999999999999999999999776555567788999999999999999999776543
Q ss_pred -----CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCe
Q 046609 149 -----DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNP 222 (399)
Q Consensus 149 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~ 222 (399)
...++||||+. ++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999996 689888854 35899999999999999999999999 99999999999997 45678
Q ss_pred eEecccCccCCCCCCCc-cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh
Q 046609 223 KLSDFGLAKLGPTGDKS-HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 300 (399)
+|+|||++......... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+..........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 99999998753222111 11122357889999997654 56888999999999999999999999876543221111100
Q ss_pred hhhhhc--cchh----hh-ccCCccCCCC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 301 TPLFKD--RRKF----TM-MADPLLEGNY-----PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 301 ~~~~~~--~~~~----~~-~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.... .... .. .......... .......+.+++.+||+.||.+|||+.+++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 0000 00 0000000000 11234578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=289.13 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=197.7
Q ss_pred CCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC----cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCee
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF----QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 151 (399)
+|++.+.||.|+||.||+|... .++..||+|.+..... ...+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4778899999999999999874 3688999999875322 2235677899999999 589999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999976 356899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCccccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........ ...........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS--- 227 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc---
Confidence 5433221 11223458899999998865 3467899999999999999999999975432111 11111110000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
. ..++......+.+++.+||+.+|.+|| ++.+++.+
T Consensus 228 -----~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 -----E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred -----C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0 112223445788999999999999997 66777654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=307.47 Aligned_cols=247 Identities=24% Similarity=0.373 Sum_probs=195.2
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC----CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCe--eEEEE
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG----FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ--RILVY 155 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~--~~lv~ 155 (399)
.+..+||+|+|-+||+|.+..+|..||=-.++... ....+.|..|+.+|+.|+||||+++|++|.+... ..+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 34578999999999999999889888754443221 1233679999999999999999999999987765 78899
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCccCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKLGP 234 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~~~ 234 (399)
|.+..|+|..|+++ .+.++...+..|+.||+.||.|||++. |||||||||-+||||++ -|.+||+|+|+|....
T Consensus 123 EL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999988 567888999999999999999999876 78999999999999975 4899999999998633
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. ....+.|||.|||||++ ...|+..+||||||+++.||+|+..||..=.... .+...+..-. .+..+..+-
T Consensus 198 ~s----~aksvIGTPEFMAPEmY-EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGi-KP~sl~kV~ 269 (632)
T KOG0584|consen 198 KS----HAKSVIGTPEFMAPEMY-EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGI-KPAALSKVK 269 (632)
T ss_pred cc----ccceeccCccccChHHH-hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCC-CHHHhhccC
Confidence 22 22337899999999966 4899999999999999999999999998533211 1111111000 001122222
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
| ..+.+||.+||.. ..+|||+.|+|..
T Consensus 270 d------------Pevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 D------------PEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred C------------HHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 2 2677899999999 9999999999865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=293.42 Aligned_cols=265 Identities=21% Similarity=0.305 Sum_probs=200.5
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee-CCeeE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD-GDQRI 152 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~ 152 (399)
..+++|.+.+.||.|+||.||+|.+..++..||+|.+..... .....+..|+.+++.++||||+++++++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 356789999999999999999999999999999999864322 234567889999999999999999999865 56789
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+++||+ +++|..++.. ..+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++..
T Consensus 87 lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 999998 6789888864 45888899999999999999999999 99999999999999999999999999874
Q ss_pred CCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhh-------
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPL------- 303 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~------- 303 (399)
.... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............ ......
T Consensus 158 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 158 QDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred cCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 3221 122357888999998765 57899999999999999999999999765432111100 000000
Q ss_pred hhccchhhhccCCccCCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
............-......+ ......+.+++.+||+.+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00000000000000001111 1234578899999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=290.23 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=199.1
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEec
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
|.+.+.||.|++|.||+|....+++.|+||.+...... ......+|+..+..++ ||||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 56778999999999999999888999999998654322 2234557889999999 999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+|+|.+++.... ...+++..+..++.|++.||.|||+++ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 889999887621 347899999999999999999999999 99999999999999999999999999875432211
Q ss_pred cccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhhhh----cc----c
Q 046609 239 SHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPLFK----DR----R 308 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~~~----~~----~ 308 (399)
.....++..|+|||++. +..++.++|+||||+++|+|++|++||......+..... ........ .. .
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 12245788999999875 456789999999999999999999999766543221110 00000000 00 0
Q ss_pred hhhhc----cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMM----ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~----~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..... ....+ ..........+.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSL-HQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccH-HHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 00000 00000 00111124578899999999999999999999754
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=289.21 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=202.0
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
|...+.||.|++|.||+|....+++.||+|.+.... ......+..|+.+++.++||||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999999899999999997653 223456788999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
. ++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 6 6999999762 246999999999999999999999999 99999999999999999999999999875433221
Q ss_pred ccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh-Hhhhhh-------hhc---
Q 046609 239 SHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV-TWATPL-------FKD--- 306 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~-~~~~~~-------~~~--- 306 (399)
......++..|+|||.+.+. .++.++||||||+++|+|++|++||......+....+ ...... ...
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12223457789999988766 8899999999999999999999999875532211111 000000 000
Q ss_pred -cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 -RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 -~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+........... .......+.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKV-LPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHh-cccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 000000000000001 11124578999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=259.01 Aligned_cols=266 Identities=21% Similarity=0.265 Sum_probs=207.9
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+|...++||+|+||+||+|+...+.+.||+|.++.+.. .......+|+.+++.+.|.|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 35556889999999999999999999999999976433 2336688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
| ..+|..+... -++.++.+.++.++.|++.||.++|+++ +.|||+||.|.+|+.+|.+||+|||+++-+...
T Consensus 83 c-dqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 83 C-DQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred h-hHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 9 5689998876 4678999999999999999999999999 999999999999999999999999999864433
Q ss_pred CccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhcc--chhhhc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDR--RKFTMM 313 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 313 (399)
.........|..|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..++...+-+......+. +.+..+
T Consensus 155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 2333445679999999999875 68889999999999999987 888888877655443333332222111 111111
Q ss_pred cCCccCCCCC---------HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYP---------IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.|-..-+-++ +.....=.+++.+.|.-+|..|.++++.+++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111 1222334678888999999999999988754
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=288.23 Aligned_cols=256 Identities=23% Similarity=0.312 Sum_probs=200.0
Q ss_pred CCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC----cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCee
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF----QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 151 (399)
+|.+.+.||+|++|.||++... .++..||||.+..... ...+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4777899999999999999864 3568899999864322 2235578899999999 599999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999875 356899999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCccccccccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQ--LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........ ......|+..|+|||.+.+.. .+.++||||||+++|+|++|..||........ ...........
T Consensus 154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~--- 227 (288)
T cd05583 154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS--- 227 (288)
T ss_pred cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc---
Confidence 54333211 122345889999999887654 78899999999999999999999975432111 01111111110
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEY 357 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~ 357 (399)
. ...+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 -----~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -----K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -----C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 0 11122234568889999999999999999888776554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=289.71 Aligned_cols=267 Identities=21% Similarity=0.263 Sum_probs=207.9
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC--C----ceeeEEEEEeeCC
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN--P----YLVNLVGYCVDGD 149 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--p----nIv~l~~~~~~~~ 149 (399)
..+++|.+...+|+|+||.|..+.+..++..||||+++.... -.+...-|+.+|.++.+ | -+|++.++|...+
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 347899999999999999999999999999999999865321 12345668999999842 2 4788889999999
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-----------
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ----------- 218 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~----------- 218 (399)
+.|+|+|.+ |.++.++|.. ++-.+++..+++.|+.|+++++.+||+.+ ++|.||||+|||+..
T Consensus 165 hiCivfell-G~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~ 238 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKK 238 (415)
T ss_pred ceEEEEecc-ChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCC
Confidence 999999998 7799999987 34567899999999999999999999999 999999999999831
Q ss_pred ---------CCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 046609 219 ---------DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSR 289 (399)
Q Consensus 219 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 289 (399)
+..++|+|||.+....... ...+.|..|.|||++.+-.++.++||||+||||+|+.+|...|++.+
T Consensus 239 ~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 239 KVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 3458999999998533222 34668999999999999999999999999999999999999999987
Q ss_pred CcccchhhHhhhhhhhccchhhh---------------------------ccCCccC-CCCCHHHHHHHHHHHhhccccC
Q 046609 290 PTEEQNLVTWATPLFKDRRKFTM---------------------------MADPLLE-GNYPIKGLYQALAVAAMCLQEE 341 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~l~-~~~~~~~~~~l~~li~~cl~~d 341 (399)
..+.......+...++..-.... ...|.-. -.....+...|.+|+.+||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 65533333322222211100000 0000000 0112244568999999999999
Q ss_pred CCCCCChHHHHHH
Q 046609 342 AGTRPMMSDVVTA 354 (399)
Q Consensus 342 p~~RPs~~eil~~ 354 (399)
|.+|+|+.|++.+
T Consensus 394 P~~RiTl~EAL~H 406 (415)
T KOG0671|consen 394 PARRITLREALSH 406 (415)
T ss_pred ccccccHHHHhcC
Confidence 9999999999875
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=296.60 Aligned_cols=268 Identities=22% Similarity=0.307 Sum_probs=201.5
Q ss_pred HHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeC-
Q 046609 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG- 148 (399)
Q Consensus 72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~- 148 (399)
.++-...++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~ 89 (345)
T cd07877 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 89 (345)
T ss_pred HHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecc
Confidence 4455567899999999999999999999988899999999875322 2235677899999999999999999988643
Q ss_pred -----CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 149 -----DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 149 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
...+++++++ +++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888887 8899888754 35899999999999999999999999 99999999999999999999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
|+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+.......+.....
T Consensus 161 l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 235 (345)
T cd07877 161 ILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 235 (345)
T ss_pred Eeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999998753221 123457889999998766 5688899999999999999999999976543221111100000
Q ss_pred --------hhhcc--chh----hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 --------LFKDR--RKF----TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 --------~~~~~--~~~----~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+... ... ......... +........+.+++.+||+.||.+||++.+++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 236 TPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 00000 000 000000000 0011234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=298.76 Aligned_cols=214 Identities=26% Similarity=0.330 Sum_probs=185.4
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchH---HHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR---EFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~---~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
...+-|..++.||-|+||.|.++...++...||+|.+++....... .+..|..||..-.++.||+||..|.+.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 3456678889999999999999999999999999999876554433 3567999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||+|++||++-.+|.+ .+.+++..++.++..+..|+++.|..| +|||||||+|||||.+|++||+||||+.-
T Consensus 706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTG 778 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTG 778 (1034)
T ss_pred EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccc
Confidence 99999999999999987 467899999999999999999999999 99999999999999999999999999963
Q ss_pred CCCCCCc---------c-------------------------------ccccccccccccccccccCCCCCchhhHHHHH
Q 046609 233 GPTGDKS---------H-------------------------------VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFG 272 (399)
Q Consensus 233 ~~~~~~~---------~-------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG 272 (399)
+...... . ..-..+||+.|+|||++....|+..+|+||.|
T Consensus 779 fRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~g 858 (1034)
T KOG0608|consen 779 FRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVG 858 (1034)
T ss_pred ceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhh
Confidence 2211100 0 00014699999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCCcccchh
Q 046609 273 VVFLEIITGRRVIDNSRPTEEQNL 296 (399)
Q Consensus 273 ~il~elltg~~pf~~~~~~~~~~~ 296 (399)
||||||+.|++||-...+.+.+..
T Consensus 859 vil~em~~g~~pf~~~tp~~tq~k 882 (1034)
T KOG0608|consen 859 VILYEMLVGQPPFLADTPGETQYK 882 (1034)
T ss_pred HHHHHHhhCCCCccCCCCCcceee
Confidence 999999999999999888776543
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=293.99 Aligned_cols=264 Identities=20% Similarity=0.277 Sum_probs=198.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCC-----
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD----- 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----- 149 (399)
..++|.+.+.||.|+||.||+|.+..++..||||.+...... ....+.+|+.+++.++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 356899999999999999999999989999999998643222 2345788999999999999999999987654
Q ss_pred -eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 150 -QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 150 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
..++||||+ +++|..++.. ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 7899888754 46899999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-----
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP----- 302 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~----- 302 (399)
++...... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.....
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 164 LARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 98753221 122457889999998865 4588899999999999999999999986543211100000000
Q ss_pred ---hhhc--cchhhhccCCccCC---CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 ---LFKD--RRKFTMMADPLLEG---NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ---~~~~--~~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.. .......+...... .........+.+++.+||+.||.+|||+.+++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000 00000000000000 0011233468899999999999999999999853
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=278.15 Aligned_cols=250 Identities=22% Similarity=0.259 Sum_probs=200.6
Q ss_pred cCCCCCC-CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEee----CCee
Q 046609 78 TTNFNPD-NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVD----GDQR 151 (399)
Q Consensus 78 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~----~~~~ 151 (399)
+++|.+. ++||-|-.|.|..+.++.+++.+|+|++.. .....+|+++.-.. .|||||.++++|.+ ...+
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 4566653 689999999999999999999999999854 34566788776655 49999999999864 3456
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEeccc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFG 228 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg 228 (399)
.+|||.++||.|.+.+++. ...++++.++..|+.||..|+.|||+.+ |.||||||+|+|.+. |..+||+|||
T Consensus 135 LiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred EeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 7899999999999999883 4567999999999999999999999999 999999999999964 4569999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc----hhhHhhhhhh
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ----NLVTWATPLF 304 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~----~~~~~~~~~~ 304 (399)
+++.... .......+.|+.|.|||++....|+..+|+||+||++|-|++|.+||......... ..+......|
T Consensus 210 FAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F 286 (400)
T KOG0604|consen 210 FAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF 286 (400)
T ss_pred cccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence 9985322 33445578999999999998889999999999999999999999999876542211 1111111111
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.++. | ...+....++|+.+|+.+|.+|.|+.+++++
T Consensus 287 ---------P~pE----W-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 287 ---------PEPE----W-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred ---------CChh----H-hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1111 1 2456788899999999999999999999766
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=281.06 Aligned_cols=237 Identities=30% Similarity=0.385 Sum_probs=195.1
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
||.|++|.||++.+..+++.+++|.+...... ....+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999888999999998765432 335688899999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 243 (399)
.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSK----EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 999976 346899999999999999999999999 9999999999999999999999999987543322 1223
Q ss_pred cccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 244 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
...++..|+|||.+.+...+.++|+||||+++|+|++|..||...+.... . ...... ....+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~---~~~~~~------------~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---Y---EKILKD------------PLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H---HHHhcC------------CCCCC
Confidence 35578899999999888889999999999999999999999976543110 0 000000 01122
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRPMMSD 350 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RPs~~e 350 (399)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 223457889999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=299.21 Aligned_cols=264 Identities=20% Similarity=0.303 Sum_probs=199.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCe----
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ---- 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~---- 150 (399)
..++|.+.+.||.|++|.||+|.+..++..||||.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3578999999999999999999999889999999986532 2233557789999999999999999988766554
Q ss_pred --eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 151 --RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 151 --~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 89999998 7799998865 46999999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchh-hHhhhhh---
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL-VTWATPL--- 303 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~~~~~~--- 303 (399)
++...... .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||........... .......
T Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred cccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 98754322 222457889999998765 4678899999999999999999999986544221111 0000000
Q ss_pred h----hc--cchhhhccCCccCCCC---CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 F----KD--RRKFTMMADPLLEGNY---PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 ~----~~--~~~~~~~~~~~l~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+ .. ...+...........+ .......+.+++.+||+.+|.+|||+.+|+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 00 0000000000000000 11235678999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=285.31 Aligned_cols=273 Identities=29% Similarity=0.409 Sum_probs=209.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHc--cCCCceeeEEEEEeeCC----ee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSM--LSNPYLVNLVGYCVDGD----QR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~~~~~~~~----~~ 151 (399)
-....+.++||+|.||.||+|... ++.||||++.. .+.+.+.+|-.|... +.|+||+++++.-.... .+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 455667789999999999999987 58999999964 445678888777765 57999999999866555 88
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCceEECCCCCeeEe
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA------QPPVIYRDFKASNVLLDQDFNPKLS 225 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~------~~~ivH~dikp~NIll~~~~~~kl~ 225 (399)
+||++|.+.|+|.+||.. ..++|....+|+..+++||+|||+-- +++|+|||||..||||.+|++..|+
T Consensus 284 wLVt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred eEEeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 999999999999999986 56999999999999999999999653 5789999999999999999999999
Q ss_pred cccCccCCCCCCCccccccccccccccccccccCCC-C-----CchhhHHHHHHHHHHHHcCCCCCCCCC-CcccchhhH
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ-L-----TAKSDVYSFGVVFLEIITGRRVIDNSR-PTEEQNLVT 298 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~-----~~~~DvwslG~il~elltg~~pf~~~~-~~~~~~~~~ 298 (399)
|||+|..+..+.........+||.+|||||++.+.. + -.+.||||+|.+||||++.-.-+.... +..+.-+.
T Consensus 359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe- 437 (534)
T KOG3653|consen 359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE- 437 (534)
T ss_pred ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh-
Confidence 999999887777666666688999999999886532 2 236899999999999999765554211 11111000
Q ss_pred hhhhhhhccchhhhc----cCCccCCCCCH-----HHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccc
Q 046609 299 WATPLFKDRRKFTMM----ADPLLEGNYPI-----KGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~----~~~~l~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~ 364 (399)
..+..++.+..+ +....++.++. .....|.+.+..||+.||+-|-|+.=+.+.+..+...++-
T Consensus 438 ---~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~ 509 (534)
T KOG3653|consen 438 ---AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED 509 (534)
T ss_pred ---HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence 000011111111 11111111111 3346788899999999999999999999999999887763
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=302.92 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=216.2
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEe-----eCC
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCV-----DGD 149 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~-----~~~ 149 (399)
..+.-|.+..+||.|.+|.||+++...+++..|+|+..... ....++..|..+++.+ +|||++.++++|. .++
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 34567888999999999999999999999999999998764 3446677889999887 5999999999986 457
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
.+|||||||.||+..++++... +..+.|..+..|+..++.|+.+||.+. ++|||||-.|||++.++.+||+|||+
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGv 169 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGV 169 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeee
Confidence 8999999999999999999864 678999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
+...... ........||+.|||||++.. ..|+..+|+||||++..||.-|.+|+.++.|.....++
T Consensus 170 SaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I------- 240 (953)
T KOG0587|consen 170 SAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI------- 240 (953)
T ss_pred eeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC-------
Confidence 9753322 233345679999999999853 46888999999999999999999999998875322211
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...|...-.-+.....++.++|..||..|-.+||++.+++++
T Consensus 241 --------pRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 --------PRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --------CCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 223333334467778899999999999999999999999876
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=313.74 Aligned_cols=146 Identities=28% Similarity=0.430 Sum_probs=132.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||.|+||.||+|.+..+++.||||++....... ...+..|+.++..++||||+++++++...+..++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999999899999999997543222 256788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
||+.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999975 346889999999999999999999998 9999999999999999999999999885
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=299.37 Aligned_cols=241 Identities=23% Similarity=0.295 Sum_probs=199.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+..|.+...+|.|+|+.|-.+.+..+++..++|++.... .+..+|+.++... +||||+++.+.+.++.+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 567888889999999999999999999999999998662 2333466555554 69999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE-CCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL-DQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll-~~~~~~kl~Dfg~~~~~~~ 235 (399)
.+.|+-|.+.+.. .+... ..+..|+.+|+.|+.|||++| +|||||||+|||+ +..++++|+|||.+.....
T Consensus 397 ~l~g~ell~ri~~----~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 397 LLDGGELLRRIRS----KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hccccHHHHHHHh----cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999988888876 22233 777889999999999999999 9999999999999 6999999999999986544
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ....+-|..|.|||++....|+.++||||||++||+||+|+.||...... . .+..
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~-----------------ei~~ 524 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--I-----------------EIHT 524 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--H-----------------HHHH
Confidence 3 33356789999999999999999999999999999999999999976543 0 1111
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+.+....+....+|+.+||++||.+||++.++..+
T Consensus 525 ~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 525 RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 111122234555678899999999999999999999765
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=274.35 Aligned_cols=257 Identities=21% Similarity=0.275 Sum_probs=199.7
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
++||+|+|+.|--+....++..||||++.+..-.....+.+|++++.+.+ |+||++++++|+++...|||||-+.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 68999999999999999999999999999887777788999999999996 99999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC---CeeEecccCccCCCCCC---
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF---NPKLSDFGLAKLGPTGD--- 237 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Dfg~~~~~~~~~--- 237 (399)
..+++. ...+++.++..+..+|+.||.|||.+| |.||||||+|||-..-. -+|||||.+..-.....
T Consensus 164 LshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s 236 (463)
T KOG0607|consen 164 LSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS 236 (463)
T ss_pred HHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence 999987 567999999999999999999999999 99999999999986544 38999998875321111
Q ss_pred --Ccccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch---h--hHhhhhhhh
Q 046609 238 --KSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN---L--VTWATPLFK 305 (399)
Q Consensus 238 --~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~---~--~~~~~~~~~ 305 (399)
........+|+..|||||+.. ...|+.++|.|||||+||-||+|.+||.+.-..+--+ . ..-...+|+
T Consensus 237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe 316 (463)
T KOG0607|consen 237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 316 (463)
T ss_pred CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence 111123467999999999763 2368899999999999999999999998764321100 0 000001111
Q ss_pred ccc-hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 306 DRR-KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 306 ~~~-~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
... -.-+..+. + =...+....+++...|..++.+|-++..++.
T Consensus 317 sIQEGkYeFPdk----d-WahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEGKYEFPDK----D-WAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhccCCcCChh----h-hHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 000 00000111 1 1234566778999999999999999988865
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=273.56 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=203.1
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 152 (399)
.-.+|.++++||+|+|++|.+++++.+.+.||+|++++.-. +..+.++.|-.+..+. +||.+|-+..+|+++..++
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf 327 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF 327 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence 45789999999999999999999999999999999976433 3335567777777766 6999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+|.||++||+|--++++ +..|+++.++.+...|..||.|||+.| ||+||||.+|+|+|..|++||+|+|.++.
T Consensus 328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999877766 567999999999999999999999999 99999999999999999999999999985
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc--ccchhhHhhhhhhhccchh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT--EEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~ 310 (399)
.- ........++||+.|+|||++++..|....|+|+||++++||+.|+.||+.-.-. +.......+.-+++...
T Consensus 401 ~l--~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-- 476 (593)
T KOG0695|consen 401 GL--GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-- 476 (593)
T ss_pred CC--CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc--
Confidence 32 2334456689999999999999999999999999999999999999999854321 11111112222222211
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP 346 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 346 (399)
..|...+.....+++..|.+||.+|-
T Consensus 477 ----------riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 ----------RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred ----------cccceeehhhHHHHHHhhcCCcHHhc
Confidence 22333344566788899999999984
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=292.59 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=202.7
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
.++||.|.||+||-|+++.+|+.||||++.+..+.. ..++.+|+.||.+++||.||.+.--|++.+..++|||-+. |
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-G 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-c
Confidence 479999999999999999999999999998755433 3668999999999999999999999999999999999995 5
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC---CCeeEecccCccCCCCCCC
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD---FNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~~~~~~~~~~ 238 (399)
++.+.+.. .+.++|++..-..++.||+.||.|||-++ |+|+||||+|||+... .++||||||.++......
T Consensus 648 DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks- 721 (888)
T KOG4236|consen 648 DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS- 721 (888)
T ss_pred hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh-
Confidence 65555544 35788999999999999999999999999 9999999999999644 469999999999865443
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
....+.||+.|+|||+++++.|+..-|+||.|||+|.-++|..||.....- ...+.-+...+ .+.-
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMy----------Pp~P 787 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMY----------PPNP 787 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccch--hHHhhcccccc----------CCCc
Confidence 334578999999999999999999999999999999999999999875432 12222111111 1111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
=.+.....++||...|++.-.+|-|....+.+
T Consensus 788 ----W~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 788 ----WSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred ----hhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 12334578899999999999999999887765
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=302.40 Aligned_cols=254 Identities=29% Similarity=0.417 Sum_probs=216.1
Q ss_pred CCCeeccCCcEEEEEEEECCC----CeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 83 PDNLLGEGGFGRVYRGKLEGT----NQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
..++||.|+||+||+|.+-.. +.+||||++.... .....++..|+.+|..+.|||++++++++.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 358999999999999998433 4579999986543 345578999999999999999999999998765 8899999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+|++. .+..+.....+.|..||++|+.|||.++ +|||||..+||||..-..+||+|||+++......
T Consensus 779 mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 779 MPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred cccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 999999999998 4567888999999999999999999999 9999999999999999999999999999877666
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.........-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+..++.. ..
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------~g--------- 916 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------KG--------- 916 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------cc---------
Confidence 6555555566789999999999999999999999999999999 999999877655433331 11
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
.+-..|+....++..++.+||..|++.||+++++...+....+
T Consensus 917 -eRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 917 -ERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred -ccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1122355666789999999999999999999999999887765
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=274.60 Aligned_cols=220 Identities=23% Similarity=0.239 Sum_probs=178.7
Q ss_pred CCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhcc
Q 046609 90 GGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLD 169 (399)
Q Consensus 90 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 169 (399)
|.+|.||++.+..+++.||+|.+.... .+..|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999999999999999997542 233455555566799999999999999999999999999999999876
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccc
Q 046609 170 LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249 (399)
Q Consensus 170 ~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~ 249 (399)
...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||.+...... .....++.
T Consensus 79 ----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 ----FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred ----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 345899999999999999999999999 999999999999999999999999987643221 12234567
Q ss_pred cccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHH
Q 046609 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQ 329 (399)
Q Consensus 250 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 329 (399)
.|+|||.+.+..++.++||||+|+++|+|++|+.|+....... .. ......+......
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~----------~~~~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NT----------HTTLNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------cc----------ccccCCcccCCHH
Confidence 8999999988889999999999999999999998876422100 00 0000112223457
Q ss_pred HHHHHhhccccCCCCCCCh
Q 046609 330 ALAVAAMCLQEEAGTRPMM 348 (399)
Q Consensus 330 l~~li~~cl~~dp~~RPs~ 348 (399)
+.+++.+||+.||++||++
T Consensus 205 ~~~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHHHccCCHHHhcCC
Confidence 8889999999999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=277.93 Aligned_cols=258 Identities=24% Similarity=0.324 Sum_probs=199.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.+.+-+..||.|+||+|++..++.+|+..|||.++.... .+.+++..|.+...+- +.||||++||++..++..|+.||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 344445789999999999999999999999999987654 4456788888766655 58999999999999999999999
Q ss_pred ecCCCChHHhhccC-CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDL-PPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
.| ..+|+.+.... .-.+..++++-+-.|....+.||.||-..-. ||||||||+|||++..|.+||||||++-..
T Consensus 144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqL-- 218 (361)
T KOG1006|consen 144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQL-- 218 (361)
T ss_pred HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhH--
Confidence 99 56776654321 1124578999999999999999999986644 999999999999999999999999998632
Q ss_pred CCCcccccccccccccccccccc--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYAL--TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~--~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
..+...+...|...|||||.+. +..|+.+|||||||++|||+.||+.|+...+..-.+ . ..+-.-
T Consensus 219 -v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeq-----l-------~~Vv~g 285 (361)
T KOG1006|consen 219 -VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQ-----L-------CQVVIG 285 (361)
T ss_pred -HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHH-----H-------HHHHcC
Confidence 1223334456889999999885 346999999999999999999999999986542110 0 001111
Q ss_pred cCCccC-CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLE-GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
-.|.+. ..-..+....+..++..||.+|...||...+++++
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 111121 11223466789999999999999999999998765
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=285.75 Aligned_cols=258 Identities=28% Similarity=0.384 Sum_probs=199.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC--CCcch-----HHHHHHHHHHHccCCCceeeEEEEEe-eCC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN--GFQGN-----REFLVEVLMLSMLSNPYLVNLVGYCV-DGD 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~-----~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~ 149 (399)
.++|-.+++||+|||+.||+|.+......||+|+-..+ ...+. +...+|..|.+.|.||.||++|++|. +.+
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 35677889999999999999999888899999986432 22222 33678999999999999999999986 556
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC---CCCCeeEec
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD---QDFNPKLSD 226 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~D 226 (399)
..|-|+|||+|-+|+-||+. ++.+++.+++.|+.||+.||.||.... +||||-||||.|||+. .-|.+||+|
T Consensus 542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITD 616 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITD 616 (775)
T ss_pred cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeee
Confidence 77899999999999999987 677999999999999999999999875 6799999999999994 457899999
Q ss_pred ccCccCCCCCCCcc-----ccccccccccccccccccCC----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh
Q 046609 227 FGLAKLGPTGDKSH-----VSTRVMGTYGYCAPEYALTG----QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297 (399)
Q Consensus 227 fg~~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (399)
||+++......... ......||.+|++||.+--+ .++.++||||+|||+|..+.|+.||..... .+.+.
T Consensus 617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQdIL 694 (775)
T KOG1151|consen 617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQDIL 694 (775)
T ss_pred cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHHHH
Confidence 99999765543332 22336799999999988543 578899999999999999999999986432 22222
Q ss_pred HhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHH
Q 046609 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil 352 (399)
....- +.. ..+..-..| .......+||++||+..-.+|....++.
T Consensus 695 qeNTI-lkA-tEVqFP~KP--------vVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 695 QENTI-LKA-TEVQFPPKP--------VVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhhch-hcc-eeccCCCCC--------ccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 21111 111 111111111 2334678899999999999998887775
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=295.56 Aligned_cols=251 Identities=26% Similarity=0.345 Sum_probs=214.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
-+++..+..||-|+||.|=++..+.....+|+|++++.+.-.. ..+..|-.+|...+.|.||++|-.|.+..+.|++
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 4567777899999999999999887666689999877654333 4477899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
||-|-||.|+..|++ .+.+.......++..+++|++|||.++ ||+|||||+|.+++.+|-+||.|||.++...
T Consensus 499 mEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 499 MEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 999999999999987 577999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.+... -.++||+.|.|||++.++..+.++|.||||+++|||++|.+||...+|....+++-....
T Consensus 572 ~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid------------ 636 (732)
T KOG0614|consen 572 SGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGID------------ 636 (732)
T ss_pred cCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhh------------
Confidence 55444 347899999999999999999999999999999999999999999888655444421111
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
.-.+|........+|+++....+|.+|-. +.+|..+
T Consensus 637 ----~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 ----KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred ----hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 12345556667889999999999999975 6777666
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=311.05 Aligned_cols=252 Identities=24% Similarity=0.360 Sum_probs=187.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeC-------
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------- 148 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------- 148 (399)
-.++|..+.+||+||||.||+++++-+|..||||++.... ......+.+|+..+.+|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3467888899999999999999999999999999997654 22235688899999999999999998765210
Q ss_pred --------------------------------------------------------------------------------
Q 046609 149 -------------------------------------------------------------------------------- 148 (399)
Q Consensus 149 -------------------------------------------------------------------------------- 148 (399)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeeEEEEEecCCCChHHhhccCCCCCCCC-CHHHHHHHHHHHHHHHHH
Q 046609 149 --------------------------------DQRILVYEYMPNGSLEDHLLDLPPNRKAL-DWNTRMKIAHGAARGLEY 195 (399)
Q Consensus 149 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~ql~~~l~~ 195 (399)
..+|+-||||+..+|.+++.+ +... .....|+++.+|++||.|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~----N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRR----NHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHh----cccchhhHHHHHHHHHHHHHHHH
Confidence 012567888877666666665 2222 467899999999999999
Q ss_pred HhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC----------------CCCCccccccccccccccccccccC
Q 046609 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP----------------TGDKSHVSTRVMGTYGYCAPEYALT 259 (399)
Q Consensus 196 LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~----------------~~~~~~~~~~~~g~~~y~aPE~~~~ 259 (399)
+|+.| ||||||||.|||++.++.+||+|||++.... .+......+...||.-|+|||++.+
T Consensus 713 IH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 713 IHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 99999 9999999999999999999999999998511 0111223355789999999998865
Q ss_pred C---CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC--CCCCHHHHHHHHHHH
Q 046609 260 G---QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE--GNYPIKGLYQALAVA 334 (399)
Q Consensus 260 ~---~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~--~~~~~~~~~~l~~li 334 (399)
. .|+.|+|+||||++|+||+. ||.+.=. ++. .+..+.++.+. .++.......-..+|
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--------Ra~-------iL~~LR~g~iP~~~~f~~~~~~~e~slI 851 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--------RAS-------ILTNLRKGSIPEPADFFDPEHPEEASLI 851 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHH--------HHH-------HHHhcccCCCCCCcccccccchHHHHHH
Confidence 4 59999999999999999985 4654211 111 11111111111 112222223445699
Q ss_pred hhccccCCCCCCChHHHHH
Q 046609 335 AMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 335 ~~cl~~dp~~RPs~~eil~ 353 (399)
.++++.||.+|||+.++|.
T Consensus 852 ~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 852 RWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHhcCCCccCCCHHHHhh
Confidence 9999999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=273.67 Aligned_cols=282 Identities=22% Similarity=0.326 Sum_probs=211.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee-------
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD------- 147 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------- 147 (399)
..+.|.-..+||+|.||.||+|+.+++++.||+|++-.... .-.....+|+.+|..+.|+|++.++..|..
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34556667899999999999999999999999987643221 222457889999999999999999888753
Q ss_pred -CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 148 -GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 148 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
....|+||.+|+. +|...|.+ ....++..++.+++.+++.||.|+|... |+|||+||.|+||+.+|.+||+|
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklAD 167 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLAD 167 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeec
Confidence 2347999999954 88888876 3467999999999999999999999999 99999999999999999999999
Q ss_pred ccCccCCCCCCCcc--ccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh---
Q 046609 227 FGLAKLGPTGDKSH--VSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA--- 300 (399)
Q Consensus 227 fg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~--- 300 (399)
||+++.+....... ..++.+.|..|.+||.+.| ..|+++.|||.-||++.||.|+.+.+++........++...
T Consensus 168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs 247 (376)
T KOG0669|consen 168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS 247 (376)
T ss_pred cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence 99997655443332 2345667999999998876 57999999999999999999999999987655444443321
Q ss_pred -----hhhhhccchhhhccCC-ccCCCC--------CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccc
Q 046609 301 -----TPLFKDRRKFTMMADP-LLEGNY--------PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365 (399)
Q Consensus 301 -----~~~~~~~~~~~~~~~~-~l~~~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~ 365 (399)
++...+-+-+..+-.+ ...+.+ +.-......+|+.++|..||.+||.+.+++.+--..+.+-+.+
T Consensus 248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqa 326 (376)
T KOG0669|consen 248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQA 326 (376)
T ss_pred CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchh
Confidence 2222221222222111 111111 1111236788999999999999999999998755544444433
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=301.14 Aligned_cols=267 Identities=29% Similarity=0.420 Sum_probs=212.9
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECC-------CCeEEEEEEEccCCCc-chHHHHHHHHHHHccC-CCceeeEEEE
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEG-------TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLS-NPYLVNLVGY 144 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-hpnIv~l~~~ 144 (399)
..+..++..+.+.||.|.||.|++|...+ ....||||.+...... ..+.+..|+.+++.+. ||||+.++++
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34445556677799999999999997531 1567999998765433 4567899999999885 9999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHhhccCC---C-------CC--CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046609 145 CVDGDQRILVYEYMPNGSLEDHLLDLP---P-------NR--KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKAS 212 (399)
Q Consensus 145 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~ 212 (399)
|...+..++|+||+..|+|.++|+..+ . .. ..++....+.++.||+.|++||++.. +|||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999999854 0 01 24899999999999999999999999 999999999
Q ss_pred ceEECCCCCeeEecccCccCCCCCCCccccccc-cccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCC
Q 046609 213 NVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV-MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRP 290 (399)
Q Consensus 213 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~ 290 (399)
|||+..+..+||+|||+++.............. .-+..|||||.+....|+.++||||||++||||++ |..||.+...
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 999999999999999999865444433322111 13557999999999999999999999999999999 8899987332
Q ss_pred cccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 291 TEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
... +.. .+....+-..|.....++.++++.||+.+|.+||++.++.+.|+...
T Consensus 528 ~~~--l~~--------------~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l 580 (609)
T KOG0200|consen 528 TEE--LLE--------------FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL 580 (609)
T ss_pred HHH--HHH--------------HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence 111 111 11222223345556678889999999999999999999999999853
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=269.89 Aligned_cols=267 Identities=23% Similarity=0.344 Sum_probs=202.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHH--ccCCCceeeEEEEEeeCC----ee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLS--MLSNPYLVNLVGYCVDGD----QR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~--~l~hpnIv~l~~~~~~~~----~~ 151 (399)
.....+.+.||+|.||.||+|.++ |+.||||++... +.....+|.+|.+ .++|+||+.+++.=..++ .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeecccc--CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 467888899999999999999999 688999999753 2345666666665 469999999998854433 57
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-----SAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-----~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
+||.+|.+.|+|++||.. ..++....++++..++.||++||. +|+|+|.|||||..||||..+|..-|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 999999999999999976 579999999999999999999994 4688899999999999999999999999
Q ss_pred ccCccCCCCCCC--ccccccccccccccccccccCC----CCC--chhhHHHHHHHHHHHHcC----------CCCCCCC
Q 046609 227 FGLAKLGPTGDK--SHVSTRVMGTYGYCAPEYALTG----QLT--AKSDVYSFGVVFLEIITG----------RRVIDNS 288 (399)
Q Consensus 227 fg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~----~~~--~~~DvwslG~il~elltg----------~~pf~~~ 288 (399)
+|+|........ .......+||.+|||||++... .+. ..+||||||.++||++-. ++||.+.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 999976444321 2223446799999999988543 222 358999999999998642 4566655
Q ss_pred CCcccchhhHhhhhhhhccchhhhccCCccCCC-CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 289 RPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN-YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
-+.+....... + .....-..|.+.+. ...+.+..+.++++.||..+|.-|-|+-.|.+.|.++...
T Consensus 440 Vp~DPs~eeMr--k-----VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~ 506 (513)
T KOG2052|consen 440 VPSDPSFEEMR--K-----VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS 506 (513)
T ss_pred CCCCCCHHHHh--c-----ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence 44322111000 0 00001111222222 2446677889999999999999999999999999988753
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=262.98 Aligned_cols=238 Identities=31% Similarity=0.405 Sum_probs=194.7
Q ss_pred CcEEEEEEEECCCCeEEEEEEEccCCCcc-hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhcc
Q 046609 91 GFGRVYRGKLEGTNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLD 169 (399)
Q Consensus 91 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 169 (399)
+||.||+|...++++.+++|++....... .+.+..|+..+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999999889999999998765444 67889999999999999999999999999999999999999999999976
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccc
Q 046609 170 LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249 (399)
Q Consensus 170 ~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~ 249 (399)
...+++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++.
T Consensus 81 ----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 ----RGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred ----ccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 223899999999999999999999999 9999999999999999999999999998644332 223355888
Q ss_pred cccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCH-HHHH
Q 046609 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPI-KGLY 328 (399)
Q Consensus 250 ~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~~~ 328 (399)
.|++||.+.+..++.++||||||+++|+|++|..||....... ....... .......... ....
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~~-------------~~~~~~~~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKIG-------------KPKPPFPPPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHh-------------ccCCCCccccccCCH
Confidence 9999999988889999999999999999999999997632211 1111100 0000000000 0345
Q ss_pred HHHHHHhhccccCCCCCCChHHHHH
Q 046609 329 QALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 329 ~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
.+.+++.+||..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 7889999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=290.54 Aligned_cols=266 Identities=18% Similarity=0.197 Sum_probs=171.1
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCC----CeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEE------Ee
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGT----NQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY------CV 146 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~------~~ 146 (399)
..++|.+.+.||+|+||.||+|.+..+ +..||||++..... ......+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 567899999999999999999999888 89999999864321 1111111 1112222222222211 24
Q ss_pred eCCeeEEEEEecCCCChHHhhccCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLPP----------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFK 210 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~~----------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dik 210 (399)
.+...++|+||+.+++|.+++..... .........+..++.|++.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 56678999999999999999875210 0011123456689999999999999999 9999999
Q ss_pred CCceEECC-CCCeeEecccCccCCCCCCCccccccccccccccccccccCC----------------------CCCchhh
Q 046609 211 ASNVLLDQ-DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG----------------------QLTAKSD 267 (399)
Q Consensus 211 p~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~~D 267 (399)
|+|||++. ++.+||+|||++....... ........+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 6899999999997543322 1223346789999999965322 2344679
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCC------CHHHHHHHHHHHhhccccC
Q 046609 268 VYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNY------PIKGLYQALAVAAMCLQEE 341 (399)
Q Consensus 268 vwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~------~~~~~~~l~~li~~cl~~d 341 (399)
||||||+||||+++..|+..... .+.......-.+...+.....+....+. .........+|+.+||+.|
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~----~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLI----QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHH----HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999999999997665442110 0000000000000011111111100000 0001123458999999999
Q ss_pred CCCCCChHHHHHH
Q 046609 342 AGTRPMMSDVVTA 354 (399)
Q Consensus 342 p~~RPs~~eil~~ 354 (399)
|.+|||+.+++++
T Consensus 438 P~kR~ta~e~L~H 450 (566)
T PLN03225 438 GRQRISAKAALAH 450 (566)
T ss_pred cccCCCHHHHhCC
Confidence 9999999999875
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=242.59 Aligned_cols=207 Identities=25% Similarity=0.327 Sum_probs=174.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 154 (399)
..++......||+|++|.|-+.++..+|...|+|.+...- .+..++..+|+.+..+. .+|.+|.+||........++.
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 3344555678999999999999999999999999987432 23446678888877765 589999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
||.+ .-+|..+.+.....+..+++..+-+|+..++.||.|||++-+ ++|||+||+||||+.+|++|+||||++-...
T Consensus 124 ME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~ 200 (282)
T KOG0984|consen 124 MELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISGYLV 200 (282)
T ss_pred HHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccceeeh
Confidence 9999 568888877666668899999999999999999999998754 9999999999999999999999999986432
Q ss_pred CCCCcccccccccccccccccccc----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYAL----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSR 289 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~~DvwslG~il~elltg~~pf~~~~ 289 (399)
+ +...+...|...|+|||.+. ...|+.++||||||+++.||.+++.||....
T Consensus 201 d---SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 201 D---SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred h---hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 2 22233356889999999874 3479999999999999999999999998754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=258.72 Aligned_cols=269 Identities=26% Similarity=0.359 Sum_probs=220.1
Q ss_pred HHHHHhcCCCCCCCeeccCCcEEEEEEEECCCC-----eEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEE
Q 046609 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTN-----QDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYC 145 (399)
Q Consensus 72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~ 145 (399)
.++.+...+++...++-+|.||.||.|+++..+ +.|-+|.+....-+ ....+..|..++..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 445556677888899999999999999876432 34556666543221 224577888899999999999999997
Q ss_pred ee-CCeeEEEEEecCCCChHHhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC
Q 046609 146 VD-GDQRILVYEYMPNGSLEDHLLDL----PPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF 220 (399)
Q Consensus 146 ~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~ 220 (399)
.+ ...+++++.+..-|+|..||+.. +...+.++..+...++.|++.|++|||+++ +||.||..+|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 64 56788999999899999999832 234456788889999999999999999999 99999999999999999
Q ss_pred CeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHh
Q 046609 221 NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTW 299 (399)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~ 299 (399)
++||+|=.+++..-.++..........+..||+||.+.+..|+.++||||||++||||+| |+.|+...+|.+......
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylk- 512 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLK- 512 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHh-
Confidence 999999999997766666665566667889999999999999999999999999999998 999999998876543331
Q ss_pred hhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 300 ATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
+ ..+-..|..++.+|..++..||...|++||+.+++..-|..+..
T Consensus 513 ------d----------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ 557 (563)
T KOG1024|consen 513 ------D----------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT 557 (563)
T ss_pred ------c----------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence 1 11223356677799999999999999999999999999987754
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=257.53 Aligned_cols=267 Identities=22% Similarity=0.324 Sum_probs=204.3
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC--CCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC-----eeE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN--GFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD-----QRI 152 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 152 (399)
+.+..+.||.|+||.||.+.+..+++.||+|++... .....+.+.+|+.+|.-++|.|++..+++..-.. ..|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 456678999999999999999999999999998542 2233467899999999999999999988875433 346
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
++.|.+ ..+|...+.. ...++.+.+.-++.||++||.|||+.+ |.||||||.|.|++.|..+||||||+++.
T Consensus 134 V~TELm-QSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-Hhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 788888 5688877765 567999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh--hhc---
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL--FKD--- 306 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~--~~~--- 306 (399)
-...+.. ..+....|..|.|||++.|. .|+.+.||||.||++.||+..+..|+...|.....++...... .+.
T Consensus 206 ee~d~~~-hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRL-NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhh-hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 4333322 33345578999999999874 7999999999999999999999999998887665554322111 000
Q ss_pred ---cchhhhccCCccCC--------CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 307 ---RRKFTMMADPLLEG--------NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 307 ---~~~~~~~~~~~l~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
.-+...+..+.-.. ..+.......+.++.+++.+||++|.+.++.+.++
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 00001111111001 11223345667788999999999999999887764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=273.35 Aligned_cols=269 Identities=20% Similarity=0.261 Sum_probs=180.7
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC----------------CCCeEEEEEEEccCCCcchHH--------------HHHH
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE----------------GTNQDVAVKQLDRNGFQGNRE--------------FLVE 126 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~e 126 (399)
..++|.+.++||+|+||.||+|... ..+..||||.+........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999752 234679999986543222222 3346
Q ss_pred HHHHHccCCCce-----eeEEEEEee--------CCeeEEEEEecCCCChHHhhccCCC--------------------C
Q 046609 127 VLMLSMLSNPYL-----VNLVGYCVD--------GDQRILVYEYMPNGSLEDHLLDLPP--------------------N 173 (399)
Q Consensus 127 ~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~ 173 (399)
+.++.+++|.++ ++++++|.. ....+|||||+++++|.+++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 667777643 3567999999999999999874211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccc
Q 046609 174 RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253 (399)
Q Consensus 174 ~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~a 253 (399)
...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......... ......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeC
Confidence 123567788999999999999999999 999999999999999999999999998754332211 1112235789999
Q ss_pred cccccCCC--------------------CC--chhhHHHHHHHHHHHHcCCC-CCCCCCCcccchhhHhhhhhhhccchh
Q 046609 254 PEYALTGQ--------------------LT--AKSDVYSFGVVFLEIITGRR-VIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 254 PE~~~~~~--------------------~~--~~~DvwslG~il~elltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
||.+.... ++ .+.||||+||++|+|++|.. ||......... +..+ .. ....+
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~-~~---~~~~~ 453 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQY-DN---DLNRW 453 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhc-cc---hHHHH
Confidence 99875322 11 24799999999999999875 77543211100 0000 00 00000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCC---CCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEA---GTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~eil~~ 354 (399)
.........-...........+|+.++|..+| .+|+|++++++|
T Consensus 454 r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 454 RMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred HhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00000000000111234577889999999766 689999999765
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=265.12 Aligned_cols=198 Identities=24% Similarity=0.347 Sum_probs=173.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch--------HHHHHHHHHHHccC---CCceeeEEEEEee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--------REFLVEVLMLSMLS---NPYLVNLVGYCVD 147 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~--------~~~~~e~~~l~~l~---hpnIv~l~~~~~~ 147 (399)
.+|...+.+|.|+||.|++|.++.+...|+||.+.+...-.. -.+..|+.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 568999999999999999999999999999999876432111 22566999999997 9999999999999
Q ss_pred CCeeEEEEEec-CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 148 GDQRILVYEYM-PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 148 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
++++||+||.. +|.+|.+++.. ...+++.++..|+.|++.|+++||+.+ |||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEee
Confidence 99999999985 45689999976 677999999999999999999999999 99999999999999999999999
Q ss_pred ccCccCCCCCCCccccccccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCC
Q 046609 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT-AKSDVYSFGVVFLEIITGRRVIDN 287 (399)
Q Consensus 227 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~ 287 (399)
||.+.....+. ...++||..|.|||++.|..|- ..-|||++|++||.++....||..
T Consensus 714 fgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 714 FGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 99987644443 3447799999999999988875 468999999999999999998863
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=252.08 Aligned_cols=134 Identities=24% Similarity=0.341 Sum_probs=115.6
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-----C---CceeeEEEEEe--
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-----N---PYLVNLVGYCV-- 146 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---pnIv~l~~~~~-- 146 (399)
...+|.+.++||-|.|++||++.+..+.+.||+|+++... .-.+....||.+|++++ | ..||+|++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 3478999999999999999999999999999999986532 12245678999999874 2 47999999986
Q ss_pred --eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 147 --DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 147 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
.+.++|||+|++ |.+|..++... .-+.++...+..|+.||+.||.|||...+ |||.||||+|||+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 466899999999 88999999873 45789999999999999999999998764 9999999999998
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=263.44 Aligned_cols=276 Identities=20% Similarity=0.225 Sum_probs=210.5
Q ss_pred ccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC------CceeeEE
Q 046609 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN------PYLVNLV 142 (399)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------pnIv~l~ 142 (399)
|.+.-......+|.+....|+|-|++|..|.+...+..||||++..+.. -.+.=+.|+.+|++|+. -|.++++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~ 500 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF 500 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence 3444455667889999999999999999999988889999999987642 23445679999999973 4899999
Q ss_pred EEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-C
Q 046609 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-N 221 (399)
Q Consensus 143 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~ 221 (399)
-.|...+++|||+|-+ ..+|.+.|.... .+-.|....+..++.|+.-||..|-..+ |+|.||||+||||++.- .
T Consensus 501 r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~i 575 (752)
T KOG0670|consen 501 RHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNI 575 (752)
T ss_pred HHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcce
Confidence 9999999999999998 569999998754 3567889999999999999999999988 99999999999998764 5
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
+||||||.|........ +....+..|.|||++.|-+|+...|+||.||+||||.||+..|.+........+..-+.
T Consensus 576 LKLCDfGSA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCccccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 89999999976433221 11224557999999999999999999999999999999999999876543332221111
Q ss_pred hhhhc---------------c--------------c--hhhhccCC------ccC-----CCCCHHHHHHHHHHHhhccc
Q 046609 302 PLFKD---------------R--------------R--KFTMMADP------LLE-----GNYPIKGLYQALAVAAMCLQ 339 (399)
Q Consensus 302 ~~~~~---------------~--------------~--~~~~~~~~------~l~-----~~~~~~~~~~l~~li~~cl~ 339 (399)
..|.. . . .+-..+.| .+. .+-.......|.+|+.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 11100 0 0 00000011 010 11133456788999999999
Q ss_pred cCCCCCCChHHHHHH
Q 046609 340 EEAGTRPMMSDVVTA 354 (399)
Q Consensus 340 ~dp~~RPs~~eil~~ 354 (399)
.||.+|.|..+.|.+
T Consensus 732 LdP~KRit~nqAL~H 746 (752)
T KOG0670|consen 732 LDPEKRITVNQALKH 746 (752)
T ss_pred cChhhcCCHHHHhcC
Confidence 999999999998754
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=240.39 Aligned_cols=253 Identities=20% Similarity=0.319 Sum_probs=190.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEE-EeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGY-CVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~-~~~~~~~~lv~ 155 (399)
.+.|.+.+.||+|.||.+.++.+++++..+++|.+...- ....+|.+|...--.| .|.||+.-|++ |+..+.+++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 357889999999999999999999999999999987653 4567899998765555 48999998876 67778889999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE-C-CCCCeeEecccCccCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL-D-QDFNPKLSDFGLAKLG 233 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll-~-~~~~~kl~Dfg~~~~~ 233 (399)
||++.|+|.+-+.. .++.+.....++.|++.||.|+|+++ +||||||.+|||| + +...+||||||+.+..
T Consensus 102 E~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred ccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999998865 46889999999999999999999999 9999999999999 3 3347999999998642
Q ss_pred CCCCCccccccccccccccccccccC---C--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALT---G--QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~---~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.. .......+..|.|||.... + ...+.+|+|+||+++|.++||..||+.... .......|..-.-....
T Consensus 174 g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~rk~~ 247 (378)
T KOG1345|consen 174 GT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKRKNP 247 (378)
T ss_pred Cc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcccCc
Confidence 22 1222346778999997642 2 457789999999999999999999995433 22222222221111111
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+... ......+..+.++-|..+|++|=...++.++
T Consensus 248 ~~P~~F---------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 248 ALPKKF---------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred cCchhh---------cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 111111 1233467889999999999999555444444
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=275.05 Aligned_cols=248 Identities=27% Similarity=0.371 Sum_probs=188.3
Q ss_pred CCCCCeeccCCcE-EEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEec
Q 046609 81 FNPDNLLGEGGFG-RVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 81 ~~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
|...+++|.|..| .||+|... ++.||||.+-... ..-..+|+..|+..+ |||||++++.-.+....|+..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 3445779999987 58999998 6799999875432 245678999999885 999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---C--CCeeEecccCccCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---D--FNPKLSDFGLAKLG 233 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~--~~~kl~Dfg~~~~~ 233 (399)
..+|.+++...............+.++.|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++..
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56999999873111111122456788999999999999999 999999999999975 3 46899999999876
Q ss_pred CCCCCcc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 234 PTGDKSH-VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITG-RRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 234 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..+.... ......||-+|+|||++....-+.++||+||||++|+.++| .+||...-..+. ++ +.......
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI-------l~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI-------LTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh-------hcCcccee
Confidence 6554332 23456799999999999888888899999999999999985 899997532211 11 11111111
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+. +.. .....+||.+|+.++|..||++.+|+.+
T Consensus 734 ~L~--------~~~-d~eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 HLE--------PLP-DCEAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred eec--------cCc-hHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 110 000 0167789999999999999999999865
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-31 Score=232.56 Aligned_cols=211 Identities=35% Similarity=0.548 Sum_probs=184.5
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHH
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLED 165 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 165 (399)
||.|.+|.||++....+++.+++|++...... ....+.+|+..++.++|++|+++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 68999999999999888999999999865432 34678899999999999999999999999999999999999899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCccCCCCCCCcccccc
Q 046609 166 HLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKLGPTGDKSHVSTR 244 (399)
Q Consensus 166 ~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~ 244 (399)
++... ...+++..++.++.+++.++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus 81 ~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKEN---EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99762 146899999999999999999999999 999999999999999 89999999999875433321 1223
Q ss_pred ccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC
Q 046609 245 VMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323 (399)
Q Consensus 245 ~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 323 (399)
..+...|++||.+... .++.++|+|++|+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999988776 888999999999999999
Q ss_pred HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 324 ~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.+++..|++.+|.+||++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 367789999999999999999999865
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=234.06 Aligned_cols=261 Identities=18% Similarity=0.273 Sum_probs=198.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCC--eeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGD--QRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~--~~~lv 154 (399)
.++|++.+++|+|.++.||.|....+++.++||++++. ..+.+.+|+.||..+. ||||++++++..+.. .+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 57899999999999999999999888999999999753 3467889999999997 999999999987654 56899
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-CCeeEecccCccCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAKLG 233 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~~~~~ 233 (399)
+||+.+.+...+.. .++...++.++.+++.||.|+|+.| |.|||+||.|++||.. -.++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly~-------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHhh-------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999888776664 3888899999999999999999999 9999999999999865 46999999999876
Q ss_pred CCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc-h----------hhHhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ-N----------LVTWAT 301 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~----------~~~~~~ 301 (399)
..+..... ...+..|..||++-. ..|+.+-|+|||||+|..|+..+.||-.......+ - +..+..
T Consensus 184 Hp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 184 HPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN 260 (338)
T ss_pred CCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence 65554332 345677889998864 56888999999999999999999888654332211 1 111111
Q ss_pred h-hhhccchhhhccCCccCCCC--------CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 302 P-LFKDRRKFTMMADPLLEGNY--------PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 302 ~-~~~~~~~~~~~~~~~l~~~~--------~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. .+.-.+.+..++....+..+ ..-...++++|+.+.|..|-.+|||+.|...+
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0 00111222222221111111 00112478899999999999999999998765
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-34 Score=269.92 Aligned_cols=254 Identities=23% Similarity=0.297 Sum_probs=211.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
..+|..+..+|.|+||.||++++..+++..|+|+++...-....-+..|+-+++..+|||||.+++.+...+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 46899999999999999999999999999999999887666666778899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
|.||+|.+..+. .+++++.++..+....+.||.|||+.+ =+|||||-.||+++..|.+|++|||.+-....
T Consensus 94 cgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita-- 164 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA-- 164 (829)
T ss_pred cCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh--
Confidence 999999998876 678999999999999999999999999 89999999999999999999999999865322
Q ss_pred Cccccccccccccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 238 KSHVSTRVMGTYGYCAPEYA---LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.-.....+.||+.|||||+. +.+.|...+|||++|++..|+---++|.....+.....+..-. ..-
T Consensus 165 ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS-----------~~q 233 (829)
T KOG0576|consen 165 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKS-----------GFQ 233 (829)
T ss_pred hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhcc-----------CCC
Confidence 23334557899999999976 4678999999999999999999888887776654322221100 001
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
.+.+++ .......+-+|++.||..+|++||+++.++.
T Consensus 234 pp~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 111211 2233456778999999999999999988765
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=240.64 Aligned_cols=263 Identities=22% Similarity=0.289 Sum_probs=200.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC--CCcchHHHHHHHHHHHccCCCceeeEEEEEeeC------C
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN--GFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------D 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~ 149 (399)
..+|.-+..+|.|.- .|..+.+.-.+.+||+|++... .....+...+|...+..++|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 357888889999998 7778888778999999998644 234457788999999999999999999998643 3
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..|+|||++ .++|...+.. .++=..+.+|+.|++.|++|||+.+ |+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m-~~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchh
Confidence 568999999 6799988863 3666788999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH-----------
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT----------- 298 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~----------- 298 (399)
++.. +.....+....+..|.|||++.+-.|...+||||+||++.||++|+..|.+.+..++...+.
T Consensus 165 ar~e---~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~ 241 (369)
T KOG0665|consen 165 ARTE---DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM 241 (369)
T ss_pred hccc---CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence 9742 22234455678899999999998889999999999999999999999998765433221111
Q ss_pred -----hhhhhhhccc-----hhh-hccCCccCC--CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 299 -----WATPLFKDRR-----KFT-MMADPLLEG--NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 299 -----~~~~~~~~~~-----~~~-~~~~~~l~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
-+.......+ .+. .+.|..... ..+.-....+.+++.+||-.||++|.++.++|.+
T Consensus 242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0111111100 111 111111111 1122334567789999999999999999999876
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=230.32 Aligned_cols=200 Identities=34% Similarity=0.456 Sum_probs=174.5
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
|.+.+.||.|++|.||+|....+++.+++|.+...... ..+.+.+|+..++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 45678999999999999999988899999999876554 56778899999999999999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
+++|.+++.... ..+++..++.++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999997621 12889999999999999999999998 999999999999999999999999998865443211
Q ss_pred cccccccccccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 046609 240 HVSTRVMGTYGYCAPEYA-LTGQLTAKSDVYSFGVVFLEIITGRRVIDN 287 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~~ 287 (399)
......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22334578889999988 667788899999999999999999999976
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=236.52 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=198.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECC---CCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEG---TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~ 152 (399)
..+.|...++||.|+|++||++.+.. ....||+|.+... .....+.+|+++|..+. +.||+++.+++..++...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 34678899999999999999998866 6889999998764 34466889999999986 899999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCcc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAK 231 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~ 231 (399)
+|+||++.....+++.. ++...+..++..++.||.++|.+| ||||||||.|+|.+. -+.-.|+|||++.
T Consensus 112 ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred EEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHH
Confidence 99999999999998876 778899999999999999999999 999999999999974 4667899999997
Q ss_pred CCCC-------------------CCC-----------------------ccccccccccccccccccccC-CCCCchhhH
Q 046609 232 LGPT-------------------GDK-----------------------SHVSTRVMGTYGYCAPEYALT-GQLTAKSDV 268 (399)
Q Consensus 232 ~~~~-------------------~~~-----------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Dv 268 (399)
.... +.. ........||++|.|||++.. ..-++++||
T Consensus 182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi 261 (418)
T KOG1167|consen 182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI 261 (418)
T ss_pred HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence 2000 000 000112469999999999865 567889999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCcccc--hhh--------Hhhhh------hhh---------ccchhhhcc-CCc-----
Q 046609 269 YSFGVVFLEIITGRRVIDNSRPTEEQ--NLV--------TWATP------LFK---------DRRKFTMMA-DPL----- 317 (399)
Q Consensus 269 wslG~il~elltg~~pf~~~~~~~~~--~~~--------~~~~~------~~~---------~~~~~~~~~-~~~----- 317 (399)
||.|+++..+++++.||-....+-.. .+. .-... ++. ....+..+. ...
T Consensus 262 ws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q 341 (418)
T KOG1167|consen 262 WSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQ 341 (418)
T ss_pred eeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccc
Confidence 99999999999999998654322110 000 00000 000 000111110 000
Q ss_pred ---cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 ---LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 ---l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+..+++|+.+||..||.+|.|+++.|++
T Consensus 342 ~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 342 PNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0111222334578999999999999999999999866
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=265.09 Aligned_cols=197 Identities=18% Similarity=0.246 Sum_probs=139.7
Q ss_pred ccCC-CceeeEEEEE-------eeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 046609 132 MLSN-PYLVNLVGYC-------VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203 (399)
Q Consensus 132 ~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ 203 (399)
.++| +||++++++| ......++++||+ +++|.++|.. ....+++..++.++.||+.||.|||+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 3455 5888888877 2334567788987 6799999975 2456999999999999999999999999
Q ss_pred eEecCCCCCceEECCC-------------------CCeeEecccCccCCCCCCC--------------cccccccccccc
Q 046609 204 VIYRDFKASNVLLDQD-------------------FNPKLSDFGLAKLGPTGDK--------------SHVSTRVMGTYG 250 (399)
Q Consensus 204 ivH~dikp~NIll~~~-------------------~~~kl~Dfg~~~~~~~~~~--------------~~~~~~~~g~~~ 250 (399)
|+||||||+||||+.. +.+|++|||+++....... ........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4456666666543111000 000111357889
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHH
Q 046609 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQA 330 (399)
Q Consensus 251 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 330 (399)
|+|||++.+..++.++|||||||+||||++|.+|+...... ...... ...++.. .......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~----------~~~~~~~-----~~~~~~~ 241 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRH----------RVLPPQI-----LLNWPKE 241 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHH----------hhcChhh-----hhcCHHH
Confidence 99999999999999999999999999999998886532110 000000 0011110 0112245
Q ss_pred HHHHhhccccCCCCCCChHHHHHH
Q 046609 331 LAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 331 ~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+++.+||+.+|.+||++.+|+++
T Consensus 242 ~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 242 ASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHhCCCChhhCcChHHHhhc
Confidence 678889999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=207.89 Aligned_cols=169 Identities=21% Similarity=0.165 Sum_probs=127.7
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|.+++.. .+..+++..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEV---RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc---
Confidence 689999975 2456999999999999999999999776 999999999999999 99987543221
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
..|++.|+|||++.+..++.++|||||||++|||++|+.||......... +......... . .+. ..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~~~~~~-------~-~~~-~~ 129 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILLNGMPA-------D-DPR-DR 129 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHHHHhcc-------C-Ccc-cc
Confidence 25889999999999999999999999999999999999999764332110 1111100000 0 000 00
Q ss_pred CCCHHHHH--HHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 321 NYPIKGLY--QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 321 ~~~~~~~~--~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
..+..... .+.+++.+||+.+|.+||++.++++++..+..
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 11122222 58999999999999999999999999887643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-26 Score=216.81 Aligned_cols=264 Identities=20% Similarity=0.229 Sum_probs=200.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCC-eEEEEEEEccCCCcchHHHHHHHHHHHccCC----CceeeEEEEE-eeCCeeEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTN-QDVAVKQLDRNGFQGNREFLVEVLMLSMLSN----PYLVNLVGYC-VDGDQRIL 153 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----pnIv~l~~~~-~~~~~~~l 153 (399)
+|.+.+.||+|+||.||+|.+..++ ..+|+|............+..|..++..+.. +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 7999999999999999999987664 6788888766533333367778888888863 6899999999 57788999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-----CCeeEeccc
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-----FNPKLSDFG 228 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-----~~~kl~Dfg 228 (399)
||+.+ |.+|.++..... .+.++..++..|+.|++.+|++||+.| ++||||||+|+++... -.+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 899999886643 578999999999999999999999999 9999999999999765 358999999
Q ss_pred Ccc--CCCCCCCc-----cc-cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh
Q 046609 229 LAK--LGPTGDKS-----HV-STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 229 ~~~--~~~~~~~~-----~~-~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 300 (399)
+++ ........ .. .....||..|.++..+.+...+.+.|+||++.++.+|+.|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 32222111 11 23356999999999999999999999999999999999999999765543221111100
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.. ...... ..... +..+..+...+-..+...+|....+...|+.+....
T Consensus 253 ~~--------~~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PR--------KLLTDR--FGDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hh--------hhcccc--ccCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 00 000000 01112 234445555566689999999999999988877665
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=196.03 Aligned_cols=209 Identities=22% Similarity=0.302 Sum_probs=176.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC-CceeeEEEEEeeCCeeEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~ 155 (399)
...+|.++++||.|+||.+|+|....+|+.||||.-... ....++..|..+.+.+++ ..|..+..+..+..+-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 457899999999999999999999999999999997654 234567789999999986 78999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC---CCeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD---FNPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~~~~ 232 (399)
+.. |.+|.++..- ....++..+++.++.|++.-++|+|.++ +|||||||+|+|..-+ ..+.|+|||+|+.
T Consensus 91 dLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 998 8899988875 3567999999999999999999999999 9999999999999654 3589999999986
Q ss_pred CCCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 046609 233 GPTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294 (399)
Q Consensus 233 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 294 (399)
+.+.... .......||.+|.+=..+.+..-+.+.|+-|+|.+|.++.-|..||++.......
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~ 230 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK 230 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH
Confidence 4433221 1223466999999988887888888999999999999999999999998765443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=212.59 Aligned_cols=170 Identities=18% Similarity=0.126 Sum_probs=130.9
Q ss_pred HHHHhcCCCCCCCeeccCCcEEEEEEEECC-CCeEEEEEEEccCC-----CcchHHHHHHHHHHHccCCCceeeEEEEEe
Q 046609 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEG-TNQDVAVKQLDRNG-----FQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146 (399)
Q Consensus 73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~ 146 (399)
.......+|.+.+.||+|+||+||+|.+.. ++..+|||++.... ......+.+|+.++++++|+|+++.+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 344556789999999999999999998875 67778999875321 11235588999999999999998533322
Q ss_pred eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCceEECCCCCeeEe
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDF-KASNVLLDQDFNPKLS 225 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~di-kp~NIll~~~~~~kl~ 225 (399)
+..++||||++|++|.. +.. .. ...++.|++.||.|||+.+ |+|||| ||+|||++.++.+||+
T Consensus 91 --~~~~LVmE~~~G~~L~~-~~~----~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHL-ARP----HG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --CCcEEEEEccCCCCHHH-hCc----cc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 45799999999999962 211 11 1467889999999999999 999999 9999999999999999
Q ss_pred cccCccCCCCCCCccc------cccccccccccccccccC
Q 046609 226 DFGLAKLGPTGDKSHV------STRVMGTYGYCAPEYALT 259 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~------~~~~~g~~~y~aPE~~~~ 259 (399)
|||+++.......... .....++..|+|||++..
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999986544321111 134568889999998753
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=197.03 Aligned_cols=208 Identities=24% Similarity=0.336 Sum_probs=178.8
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 154 (399)
+..-+|.+.++||+|.||.++.|...-++++||||.-... ....++..|....+.|. .++|..+|.+..++-+-.||
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 3456899999999999999999999889999999986543 34566778888888886 69999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-----CCeeEecccC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-----FNPKLSDFGL 229 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-----~~~kl~Dfg~ 229 (399)
+|.+ |.+|.++..- .+..++..++..++.|++.-++|+|++. +|.|||||+|+||..- ..+.|+|||+
T Consensus 103 idLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred hhhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence 9998 8899888765 4678999999999999999999999999 9999999999999643 3489999999
Q ss_pred ccCCCCCCCcc-----ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc
Q 046609 230 AKLGPTGDKSH-----VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292 (399)
Q Consensus 230 ~~~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 292 (399)
++.+.+..... ......||.+||+=..+.+..-+.+.|+-|||-+++++|-|..||++.....
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t 243 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT 243 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc
Confidence 99765544321 2234679999999999999999999999999999999999999999876543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-27 Score=234.00 Aligned_cols=255 Identities=20% Similarity=0.239 Sum_probs=193.1
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEcc---CCCcch---HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR---NGFQGN---REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
....++|.|.+|.|+.+......+.++.|.+.. ...... ..+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 456889999999888887765555555555432 111111 11556777888899999988877777666666669
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|||++ +|..++.. ...++...+..++.|++.|+.|+|+.| |.||||||+|++++.+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999976 357899999999999999999999999 99999999999999999999999999987655
Q ss_pred CCCc--cccccccccccccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 236 GDKS--HVSTRVMGTYGYCAPEYALTGQLTAK-SDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
+... ......+|+..|+|||.+.+..|++. .||||.|++++.|++|+.||......+.+............
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~------ 546 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNI------ 546 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccc------
Confidence 5544 56677889999999999999999884 79999999999999999999987665443211000000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
... ....-...+..-..++.++|+++|.+|.|+++|++
T Consensus 547 -~~~--~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 -FEG--PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccC--hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 000 00111122345567999999999999999999974
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-23 Score=197.24 Aligned_cols=261 Identities=30% Similarity=0.400 Sum_probs=198.6
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCC-ceeeEEEEEeeCCeeEEEEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNP-YLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e 156 (399)
|.+...||.|+||.||++.+. ..+++|.+....... ...+.+|+.++..+.|+ +|+++++.+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 566789999999999999988 678999987654433 56788999999999988 79999999987777899999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~ 235 (399)
++.++++.+++...... ..++......++.|++.++.|+|..+ ++||||||+||+++..+ .++++|||.+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 99999999777652111 36899999999999999999999999 99999999999999998 699999999975443
Q ss_pred CCCcc----ccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc-ccchhhHhhhhhhhcc
Q 046609 236 GDKSH----VSTRVMGTYGYCAPEYALT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT-EEQNLVTWATPLFKDR 307 (399)
Q Consensus 236 ~~~~~----~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~-~~~~~~~~~~~~~~~~ 307 (399)
..... ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ........... ..
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE---LP 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHh---cC
Confidence 33221 2355679999999999887 57888999999999999999999997765431 00001110000 00
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. .................+.+++..++..+|..|.+..+....
T Consensus 232 ~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000001111112223567889999999999999999988775
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-26 Score=196.54 Aligned_cols=253 Identities=22% Similarity=0.347 Sum_probs=196.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC--CCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN--GFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++..+..+|.+...|..|+|++.+++ +++|++... .....++|..|.-.|+-+.||||..+++.|....++.++..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq 267 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQ 267 (448)
T ss_pred hhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeee
Confidence 34556678999999999999998644 556776533 23344678999999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++.|+|+..|+.. .+-.++-.++.+++.+++.|+.|||+... -|.---|....++||++.+.+|.- + +.
T Consensus 268 ~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarism-a------d~ 337 (448)
T KOG0195|consen 268 YMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISM-A------DT 337 (448)
T ss_pred eccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheec-c------cc
Confidence 99999999999873 34456778999999999999999998863 244457899999999999887741 0 11
Q ss_pred CCccccccccccccccccccccCCCCC---chhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLT---AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~---~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
............+.|++||.+...+-+ .++|+|||++++|||.|.+.||.+..+.+.--. +
T Consensus 338 kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----------------i 401 (448)
T KOG0195|consen 338 KFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----------------I 401 (448)
T ss_pred eeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----------------h
Confidence 111112223457899999998766543 478999999999999999999999887543211 1
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
.-..++-..|+.....+..++.-|+..||.+||.+..|+-.|+++.
T Consensus 402 aleglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 402 ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1223444556666778889999999999999999999998888753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=183.94 Aligned_cols=172 Identities=12% Similarity=0.121 Sum_probs=132.9
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHH---------HHHHHHHHHccCCCceeeEEEEEe
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---------FLVEVLMLSMLSNPYLVNLVGYCV 146 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~hpnIv~l~~~~~ 146 (399)
...++|.+.++||.|+||.||++.. ++..+|||.+.......... +.+|+..+.++.||+|..+.+++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3468999999999999999999655 35679999997543332222 578899999999999999998866
Q ss_pred eC--------CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC
Q 046609 147 DG--------DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218 (399)
Q Consensus 147 ~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~ 218 (399)
.. +..+|+|||++|.+|.++.. ++. ..+.+++.+|..+|..| ++|||++|+||+++.
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~ 170 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSK 170 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeC
Confidence 43 35789999999999987632 232 24568999999999999 999999999999999
Q ss_pred CCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHH
Q 046609 219 DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEII 279 (399)
Q Consensus 219 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ell 279 (399)
+| ++|+|||........... . .++....|+.++|+|+||+++..+.
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~---d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK---D-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH---H-----------HHHHHhHhcccccccceeEeehHHH
Confidence 98 999999987643211111 0 1344556777899999999987553
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.4e-23 Score=179.11 Aligned_cols=138 Identities=14% Similarity=0.129 Sum_probs=108.4
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--c-------h-----------------HHHHHHHHHHHccCCCc
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--G-------N-----------------REFLVEVLMLSMLSNPY 137 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~hpn 137 (399)
...||+|++|.||+|.+. +|+.||||+++..... . . .....|+.++..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 478999999999999987 7999999999754211 1 0 11234889999998877
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCceEE
Q 046609 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL-HESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 138 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~~~ivH~dikp~NIll 216 (399)
+........ ...+|||||++|+++...... ...++...+..++.|++.+|.+| |+.+ |+||||||+||++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli 151 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLY 151 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEE
Confidence 644333322 223899999988777654332 35689999999999999999999 7889 9999999999999
Q ss_pred CCCCCeeEecccCccC
Q 046609 217 DQDFNPKLSDFGLAKL 232 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~~ 232 (399)
+ ++.++|+|||+|..
T Consensus 152 ~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 152 H-DGKLYIIDVSQSVE 166 (190)
T ss_pred E-CCcEEEEEcccccc
Confidence 8 47899999999974
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.7e-24 Score=204.78 Aligned_cols=226 Identities=25% Similarity=0.346 Sum_probs=181.9
Q ss_pred eeccCCcEEEEEEEE---CCCCeEEEEEEEccCCCcch--HHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEecC
Q 046609 86 LLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~~~~--~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~ 159 (399)
++|.|.||.|+++.. ...+..+|+|.+.+...... .....|..++...+ ||.+|++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 479999999998753 34577899998876543222 12345777888887 9999999999999999999999999
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~ 239 (399)
||.|...+.. ...+.+.....+...++-|++++|+.+ |+|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~----~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSK----EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhcccc----CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 9999988876 345677788888889999999999999 999999999999999999999999999864333222
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccC
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 319 (399)
+||..|||||++. .....+|+||||+++++|+||..||.. +.... ++. ..
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~----------------Il~--~~ 203 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKR----------------ILK--AE 203 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHH----------------Hhh--hc
Confidence 8999999999987 677889999999999999999999997 11111 111 11
Q ss_pred CCCCHHHHHHHHHHHhhccccCCCCCCCh
Q 046609 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMM 348 (399)
Q Consensus 320 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 348 (399)
...|......+.+++..++..+|.+|--.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 23466667788889999999999999755
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-22 Score=172.64 Aligned_cols=140 Identities=16% Similarity=0.142 Sum_probs=111.0
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--------------------------hHHHHHHHHHHHccCCCc
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--------------------------NREFLVEVLMLSMLSNPY 137 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------------------------~~~~~~e~~~l~~l~hpn 137 (399)
...||+|++|.||+|.+. +|+.||||+++...... ...+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 578999999999999987 79999999997642110 112356889999999998
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEE
Q 046609 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 138 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll 216 (399)
+.....+... ..+|||||++|+++...... ...++...+..++.|++.++.++|. .| |+||||||+||++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 7554444333 24899999988765443222 2457888999999999999999999 88 9999999999999
Q ss_pred CCCCCeeEecccCccCCC
Q 046609 217 DQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~ 234 (399)
+ ++.++|+|||++....
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=2e-22 Score=181.76 Aligned_cols=233 Identities=19% Similarity=0.245 Sum_probs=149.1
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccC----------CCceeeEEEEEe--
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLS----------NPYLVNLVGYCV-- 146 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~----------hpnIv~l~~~~~-- 146 (399)
...+.||.|+++.||.+++..+++.+|+|++...... ..+++.+|......+. |-.++..++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3457899999999999999999999999998654322 2344555554443322 212222222221
Q ss_pred -------eC---C-----eeEEEEEecCCCChHHhhcc---CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046609 147 -------DG---D-----QRILVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRD 208 (399)
Q Consensus 147 -------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~d 208 (399)
.. + ..+++|+-+ .++|..++.. .......+....++.+..|++..+++||..| +||+|
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgd 170 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGD 170 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecc
Confidence 11 1 236788877 5688877542 1112233455566778899999999999999 99999
Q ss_pred CCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccC--------CCCCchhhHHHHHHHHHHHHc
Q 046609 209 FKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT--------GQLTAKSDVYSFGVVFLEIIT 280 (399)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~ellt 280 (399)
|+|+|++++.+|.+.|+||+...... ..... ...+..|.|||.... -.++.+.|.|+||+++|.|.+
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g--~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAG--TRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETT--EEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecC--ceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999998776422 11111 235578999996633 257889999999999999999
Q ss_pred CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCC
Q 046609 281 GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTR 345 (399)
Q Consensus 281 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R 345 (399)
|+.||....+...... .+ .... +.+..+..||..+|+.+|.+|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999997654322110 11 1223 666788999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=166.19 Aligned_cols=188 Identities=20% Similarity=0.193 Sum_probs=140.2
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch----HHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEE
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN----REFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.+...|++|+||+|+++.. .+..++.+.+.....-.. ..+.+|+.+|++++ |++|++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3457899999999997765 367788777765543211 24788999999996 5889999886 45699999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCceEECCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDF-KASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~di-kp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|+.|.+|...+.. ....++.|++.+|.++|+.| |+|||| ||+|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999888654321 11347789999999999999 999999 79999999999999999999985443
Q ss_pred CCCc---cc--------cccccccccccccccccC-CCCC-chhhHHHHHHHHHHHHcCCCCCCCCC
Q 046609 236 GDKS---HV--------STRVMGTYGYCAPEYALT-GQLT-AKSDVYSFGVVFLEIITGRRVIDNSR 289 (399)
Q Consensus 236 ~~~~---~~--------~~~~~g~~~y~aPE~~~~-~~~~-~~~DvwslG~il~elltg~~pf~~~~ 289 (399)
.... .. ......++.|++|+...- ...+ ...++++.|.-+|.++|+..+.-...
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 2210 00 011336778888875432 1233 57899999999999999998776544
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.5e-21 Score=166.90 Aligned_cols=136 Identities=16% Similarity=0.222 Sum_probs=107.7
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-----CCCceeeEEEEEeeCC---eeE-
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-----SNPYLVNLVGYCVDGD---QRI- 152 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~hpnIv~l~~~~~~~~---~~~- 152 (399)
.-.+.||+|++|.||. +..+... +||++........+.+.+|+.+++.+ .||||++++++++++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3457899999999995 6555554 79998765545567799999999999 5799999999999874 323
Q ss_pred EEEEe--cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCceEECC----CCCeeEe
Q 046609 153 LVYEY--MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL-EYLHESAQPPVIYRDFKASNVLLDQ----DFNPKLS 225 (399)
Q Consensus 153 lv~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l-~~LH~~~~~~ivH~dikp~NIll~~----~~~~kl~ 225 (399)
+|+|| +.+|+|.+++.+ ..+++. ..++.|++.++ +|||+++ |+||||||+|||++. ++.++|+
T Consensus 82 ~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred EEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEE
Confidence 78999 557999999965 235555 35577888777 9999999 999999999999973 3479999
Q ss_pred cccCc
Q 046609 226 DFGLA 230 (399)
Q Consensus 226 Dfg~~ 230 (399)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 95433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.7e-22 Score=200.59 Aligned_cols=260 Identities=21% Similarity=0.207 Sum_probs=189.5
Q ss_pred HHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC---CCceeeEEEEEee
Q 046609 71 YRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS---NPYLVNLVGYCVD 147 (399)
Q Consensus 71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~ 147 (399)
..+.....+.|.+.+.||+|+||+||+|...+ ++.||+|+-..... .+|.--..++.+|+ -+.|..+..++.-
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34455667888899999999999999999987 99999999765432 22222233444444 3566667777777
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-------CCC
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-------QDF 220 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-------~~~ 220 (399)
.+..+||+||.+.|+|.+++.. .+.+++..++.++.|++..++.||..+ |||+||||+|+||. .+-
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~ 838 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINT----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK 838 (974)
T ss_pred CCcceeeeeccccccHHHhhcc----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence 7888999999999999999974 678999999999999999999999999 99999999999993 234
Q ss_pred CeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh
Q 046609 221 NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 300 (399)
.++|+|||.+.....-.........++|-.+--+|...|.+++..+|.|.|+.+++.||.|+.-=.
T Consensus 839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~-------------- 904 (974)
T KOG1166|consen 839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV-------------- 904 (974)
T ss_pred ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh--------------
Confidence 589999999975433333344555778888999999999999999999999999999999974210
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccc
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~ 364 (399)
.+ .....++..+..-+..+ -.-+|+..+|..|-..=|.+.++...|+.......+
T Consensus 905 ----~~--g~~~~~~~~~~Ry~~~~---~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 905 ----KN--GSSWMVKTNFPRYWKRD---MWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred ----cC--CcceeccccchhhhhHH---HHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 00 00000010011011111 233466666775555558888888888777666554
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-22 Score=202.45 Aligned_cols=246 Identities=22% Similarity=0.236 Sum_probs=181.3
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-Ccch---HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-FQGN---REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++...+.||.+.|=+|.+|++.. |. |+||++-+.. .... .+...|+. ...+++||.+++.-+...+...|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 56777899999999999999875 54 8899985433 2222 33344555 55678999999988888888889999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC--C
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--G 233 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~--~ 233 (399)
+|.. -+|++.|.. +.-+...+.+.|+.|++.||..+|..| |+|||||.+||||+.=+=+.|+||..-+. .
T Consensus 101 qyvk-hnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 101 QYVK-HNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHHh-hhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccC
Confidence 9984 499999876 456788888999999999999999999 99999999999999888899999976542 2
Q ss_pred CCCCCc---cccccccccccccccccccCC----------C-CCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhH
Q 046609 234 PTGDKS---HVSTRVMGTYGYCAPEYALTG----------Q-LTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVT 298 (399)
Q Consensus 234 ~~~~~~---~~~~~~~g~~~y~aPE~~~~~----------~-~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 298 (399)
+..++. .....-..-..|+|||.+-.. . .+++-||||+||++.||++ |++||.-.. +..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence 222222 122223334579999987431 2 6788999999999999998 788887532 111
Q ss_pred hhhh-hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 299 WATP-LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 299 ~~~~-~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+-.. .......+..+.|+ .+..++..|++.||.+|-++++.|+.
T Consensus 247 Yr~~~~~~~e~~Le~Ied~------------~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV------------SLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HhccCccCHHHHHHhCcCc------------cHHHHHHHHHccCchhccCHHHHHHh
Confidence 1111 11111122222222 56789999999999999999999987
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.85 E-value=4.2e-22 Score=199.81 Aligned_cols=210 Identities=26% Similarity=0.383 Sum_probs=151.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
..+|+.++.|..|++|.||+++++.+.+++|+| +++.. .+.+- ++....+|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee------------------
Confidence 478999999999999999999999999999994 43321 11111 33333445544
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
|+-...+.. -+.++... +.+++|||+.+ |+|||+||+|.+|+.-|++|++|||+++......
T Consensus 136 ---gDc~tllk~----~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKN----IGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhccc----CCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 333334433 33455433 77899999999 9999999999999999999999999987422111
Q ss_pred Cc-------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 238 KS-------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 238 ~~-------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
.. .....++||+.|.|||++....|...+|+|++|+|+|+.+.|..||.+..+.+..... +
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~v------i 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------I 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhh------h
Confidence 10 0112368999999999999999999999999999999999999999998776533222 1
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP 346 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP 346 (399)
.+...+.+- ......++.+++.++|+.+|..|-
T Consensus 272 sd~i~wpE~---------dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 SDDIEWPEE---------DEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhhcccccc---------CcCCCHHHHHHHHHHHHhChHhhc
Confidence 121212211 122234678899999999999995
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=185.01 Aligned_cols=219 Identities=26% Similarity=0.392 Sum_probs=166.0
Q ss_pred HHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe-EecC
Q 046609 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV-IYRD 208 (399)
Q Consensus 130 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i-vH~d 208 (399)
|+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.. ....+++.....++.+++.||.|||+.. | .|+.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~ 74 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP---IGYHGA 74 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc---ceeeee
Confidence 3568899999999999999999999999999999999987 3566899999999999999999999776 5 9999
Q ss_pred CCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCC-------CCCchhhHHHHHHHHHHHHcC
Q 046609 209 FKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-------QLTAKSDVYSFGVVFLEIITG 281 (399)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-------~~~~~~DvwslG~il~elltg 281 (399)
++..|+++|....+||+|||+.................-..-|.|||.+.+. ..+.+.||||||++++|+++.
T Consensus 75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence 9999999999999999999998765331111111112244579999988653 246779999999999999999
Q ss_pred CCCCCCCCCcccc-hhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 282 RRVIDNSRPTEEQ-NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 282 ~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
..||......+.. .++..+.. .......|.+.... .....+..++..||..+|.+||++..|-..++.+..
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred cCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 9999985544332 12222111 11111122221110 233368899999999999999999999999887766
Q ss_pred cc
Q 046609 361 SK 362 (399)
Q Consensus 361 ~~ 362 (399)
..
T Consensus 227 ~~ 228 (484)
T KOG1023|consen 227 GG 228 (484)
T ss_pred cc
Confidence 43
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=172.20 Aligned_cols=200 Identities=20% Similarity=0.203 Sum_probs=141.8
Q ss_pred CCCceeeEEEEEee---------------------------CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHH
Q 046609 134 SNPYLVNLVGYCVD---------------------------GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIA 186 (399)
Q Consensus 134 ~hpnIv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 186 (399)
.|||||++..+|.+ +...|+||..+ ..+|..++-. ...+.....-++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999988753 23458999988 4599999965 346777788899
Q ss_pred HHHHHHHHHHhhcCCCCeEecCCCCCceEEC--CC--CCeeEecccCccCCCCC----CCcccccccccccccccccccc
Q 046609 187 HGAARGLEYLHESAQPPVIYRDFKASNVLLD--QD--FNPKLSDFGLAKLGPTG----DKSHVSTRVMGTYGYCAPEYAL 258 (399)
Q Consensus 187 ~ql~~~l~~LH~~~~~~ivH~dikp~NIll~--~~--~~~kl~Dfg~~~~~~~~----~~~~~~~~~~g~~~y~aPE~~~ 258 (399)
.|+++|+.|||.+| |.|||+|.+||||. .| ..+.|+|||++--.... ......-...|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999999 99999999999993 33 34789999987532110 1111122345788899999875
Q ss_pred CCC------CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHH
Q 046609 259 TGQ------LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALA 332 (399)
Q Consensus 259 ~~~------~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~ 332 (399)
.-+ --.++|.|+.|.+.||+++...||......... . ....+..-|.+ +...+..+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~-~-----------r~Yqe~qLPal----p~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD-T-----------RTYQESQLPAL----PSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec-h-----------hhhhhhhCCCC----cccCChHHHH
Confidence 422 124799999999999999999999873321110 0 11111112222 3333446788
Q ss_pred HHhhccccCCCCCCChHHHHHHHHHh
Q 046609 333 VAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 333 li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
++...|+.||.+||+..-....|.-.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~Ls 514 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLNLS 514 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHHHH
Confidence 99999999999999987766665543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=161.51 Aligned_cols=144 Identities=15% Similarity=0.157 Sum_probs=112.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEE-ECCCCeEEEEEEEccCCCcc------------------------hHHHHHHHHHHHc
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGK-LEGTNQDVAVKQLDRNGFQG------------------------NREFLVEVLMLSM 132 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~ 132 (399)
..-|.+.+.||+|++|.||+|. +..+++.||+|++....... ...+..|+.++.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3457888999999999999998 66679999999987542110 0224679999999
Q ss_pred cCCC--ceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046609 133 LSNP--YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFK 210 (399)
Q Consensus 133 l~hp--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dik 210 (399)
+.+. .+.++++. ...++||||++|++|...... ...+....+..++.|++.+|.+||+.+. |+|||||
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dik 176 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLS 176 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCC
Confidence 9753 34444443 235899999998888765533 2345666778999999999999997764 9999999
Q ss_pred CCceEECCCCCeeEecccCccC
Q 046609 211 ASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 211 p~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|+||+++ ++.++|+|||.+..
T Consensus 177 p~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 177 EYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred hhhEEEE-CCCEEEEEChhhhc
Confidence 9999999 88999999999874
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=5.2e-19 Score=156.20 Aligned_cols=134 Identities=22% Similarity=0.314 Sum_probs=112.9
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--------hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--------NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+.||+|++|.||+|.+ .+..+++|+........ ...+.+|+.++..+.|++|+....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 36678999865433211 1346789999999999998887777777788899999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|++|++|.+++... .. .+..++.+++.+|.++|+.+ ++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999998651 12 78889999999999999999 99999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-18 Score=151.43 Aligned_cols=130 Identities=24% Similarity=0.361 Sum_probs=106.1
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--------hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--------NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.||+|++|.||+|.+. +..+++|......... ...+.+|+.++..++|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 4899999999999854 5789999865432211 24467899999999988766555555667778999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
++|++|.+++.. ... .++.+++.+|.+||+.+ ++|+|++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~----~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEE----GND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhh----cHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988754 111 78899999999999999 99999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.6e-18 Score=149.25 Aligned_cols=138 Identities=16% Similarity=0.106 Sum_probs=108.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc----------------------chHHHHHHHHHHHccCC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ----------------------GNREFLVEVLMLSMLSN 135 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h 135 (399)
..-|.+.+.||.|+||.||++... +++.||||++...... .......|+.++..+.|
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~ 92 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYE 92 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHH
Confidence 334778899999999999999876 6899999987643210 01125678888888887
Q ss_pred C--ceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 046609 136 P--YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASN 213 (399)
Q Consensus 136 p--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~N 213 (399)
+ .++..++. ...++||||++|++|...... .....++.+++.++.++|+.+ |+||||+|+|
T Consensus 93 ~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~N 155 (198)
T cd05144 93 EGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFN 155 (198)
T ss_pred cCCCCCceeec----CCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCccc
Confidence 7 45555442 355899999999998765421 234678899999999999999 9999999999
Q ss_pred eEECCCCCeeEecccCccCC
Q 046609 214 VLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 214 Ill~~~~~~kl~Dfg~~~~~ 233 (399)
|+++.++.++|+|||.+...
T Consensus 156 ill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 156 ILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred EEEcCCCcEEEEECCccccC
Confidence 99999999999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.77 E-value=7.7e-20 Score=172.15 Aligned_cols=175 Identities=22% Similarity=0.322 Sum_probs=129.3
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
+.++.|++|...+|.+||...+ .....++...+.++.|++.|++| ++ .+|+|+||.||+...+..+||.|||+
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhh
Confidence 5689999999999999997533 34567888999999999999999 77 99999999999999999999999999
Q ss_pred ccCCCCCC----CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhh
Q 046609 230 AKLGPTGD----KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 230 ~~~~~~~~----~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
........ .....+...||..||+||.+.+..|+.++||||||++|+|++. =..+|....-.
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~t~------------- 469 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIATL------------- 469 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHHhh-------------
Confidence 87543333 1223345679999999999999999999999999999999987 22222211100
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDV 351 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei 351 (399)
. ..-...++|....++|. -..|+.+++.+.|.+||++.++
T Consensus 470 ~--d~r~g~ip~~~~~d~p~-----e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 470 T--DIRDGIIPPEFLQDYPE-----EYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred h--hhhcCCCChHHhhcCcH-----HHHHHHHhcCCCcccCchHHHH
Confidence 0 00011112122223332 2358899999999999944443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.3e-18 Score=170.65 Aligned_cols=137 Identities=25% Similarity=0.376 Sum_probs=111.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--------cchHHHHHHHHHHHccCCCceeeEEEEEeeCC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--------QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 149 (399)
...|...+.||+|+||.||+|.+.+.. +++|+...... .....+.+|+.++..++|++++....++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 445567899999999999999886533 44443221111 11245788999999999999998888877777
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||++|++|.+++. ....++.+++.+|.+||+.+ ++||||||+||++ .++.++|+|||+
T Consensus 410 ~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 8899999999999998884 34678999999999999999 9999999999999 678999999999
Q ss_pred ccC
Q 046609 230 AKL 232 (399)
Q Consensus 230 ~~~ 232 (399)
++.
T Consensus 474 a~~ 476 (535)
T PRK09605 474 GKY 476 (535)
T ss_pred ccc
Confidence 874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-19 Score=180.60 Aligned_cols=258 Identities=22% Similarity=0.271 Sum_probs=193.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC-CCCeEEEEEEEccCC--CcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE-GTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~l 153 (399)
...|.+.+.||+|+|+.|-+.... .....+|+|.+.... .........|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 356778888999999999888763 334556777665543 112233445777777777 9999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCceEECCCC-CeeEecccCcc
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH-ESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAK 231 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~ 231 (399)
+++|..|+++...+.. ......+...+..++.|+..++.|+| ..+ +.|+||||+|.+++..+ .++++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 9999999999888832 12225677788889999999999999 888 99999999999999999 99999999998
Q ss_pred CCCC-CCCccccccccc-cccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 232 LGPT-GDKSHVSTRVMG-TYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 232 ~~~~-~~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
.+.. ..........+| ++.|+|||...+. ...+..|+||.|+++..+++|..|+......... ...|... ..
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~----~~ 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSN----KG 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeeccc----cc
Confidence 7666 333444445678 9999999988774 4566789999999999999999999876654321 1111100 00
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
.. .............+++.+++..+|..|.+.+++..
T Consensus 249 ~~--------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RF--------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred cc--------ccCccccCChhhhhcccccccCCchhccccccccc
Confidence 00 00111122335667888999999999999998853
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.1e-16 Score=138.53 Aligned_cols=134 Identities=19% Similarity=0.172 Sum_probs=97.6
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHH----------------------HHHHHHHHHccCCC--c
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NRE----------------------FLVEVLMLSMLSNP--Y 137 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~----------------------~~~e~~~l~~l~hp--n 137 (399)
.+.||+|+||.||+|.+. ++..||||++....... ... ...|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 478999999999999987 68899999986532211 111 12455556555443 3
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCChHHh-hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceE
Q 046609 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDH-LLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVL 215 (399)
Q Consensus 138 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIl 215 (399)
+.++++. ...++||||++++++... +... ... ..+..++.+++.++.++|. .+ |+|+||+|+||+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nil 147 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNIL 147 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEE
Confidence 4555543 245899999998654322 2110 011 5678899999999999999 88 999999999999
Q ss_pred ECCCCCeeEecccCccC
Q 046609 216 LDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 216 l~~~~~~kl~Dfg~~~~ 232 (399)
++ ++.++|+|||.+..
T Consensus 148 i~-~~~~~liDfg~a~~ 163 (187)
T cd05119 148 VD-DGKVYIIDVPQAVE 163 (187)
T ss_pred EE-CCcEEEEECccccc
Confidence 99 89999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.1e-16 Score=141.63 Aligned_cols=134 Identities=20% Similarity=0.233 Sum_probs=104.6
Q ss_pred Ceec-cCCcEEEEEEEECCCCeEEEEEEEccCCC-------------cchHHHHHHHHHHHccCCCce--eeEEEEEeeC
Q 046609 85 NLLG-EGGFGRVYRGKLEGTNQDVAVKQLDRNGF-------------QGNREFLVEVLMLSMLSNPYL--VNLVGYCVDG 148 (399)
Q Consensus 85 ~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~hpnI--v~l~~~~~~~ 148 (399)
.+|| .|+.|+||.+... +..++||.+..... .....+.+|+.++..+.|++| +..+++....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 5687 8889999998775 67789998854221 122457889999999998775 6777765433
Q ss_pred Ce----eEEEEEecCC-CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 149 DQ----RILVYEYMPN-GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 149 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
.. .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||+.| |+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEE
Confidence 22 3599999997 689888754 245544 3568999999999999 99999999999999999999
Q ss_pred EecccCccC
Q 046609 224 LSDFGLAKL 232 (399)
Q Consensus 224 l~Dfg~~~~ 232 (399)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-16 Score=130.60 Aligned_cols=135 Identities=20% Similarity=0.185 Sum_probs=113.0
Q ss_pred CCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC--CceeeEEEEEeeCCeeEEEEEecCC
Q 046609 83 PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN--PYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.+.||.|.++.||++...+ ..+++|....... ...+..|+.++..++| .++++++.+....+..+++|||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35789999999999999864 6799999865433 4578889999999976 5899999998888889999999988
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+.+..+ +......++.+++.++.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus 78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 776543 4556677889999999999986333499999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1e-15 Score=147.01 Aligned_cols=251 Identities=22% Similarity=0.234 Sum_probs=188.5
Q ss_pred cCCCCCCCeecc--CCcEEEEEEEE--CCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGE--GGFGRVYRGKL--EGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~ 150 (399)
...+.+...+|. |.+|.||.+.. ..+...+|+|.-.... ......-.+|+...+.++ |+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345677889999 99999999988 7778899999844322 233334455777777775 9999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCceEECCC-CCeeEe
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR----GLEYLHESAQPPVIYRDFKASNVLLDQD-FNPKLS 225 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~----~l~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~ 225 (399)
.++-+|++ +.+|..+... ....++...++..+.+... ||..+|+.. ++|-|+||.||++..+ ...+++
T Consensus 193 lfiqtE~~-~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred ceeeeccc-cchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecC
Confidence 99999999 6788888876 3445888899999999999 999999999 9999999999999999 889999
Q ss_pred cccCccCCCCCCCccc---cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 226 DFGLAKLGPTGDKSHV---STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
|||+......+..... .....|...|++||. ..+.++...|+|++|.++.+..+|-.+....-..
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----------- 333 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGKNS----------- 333 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCCCC-----------
Confidence 9999886555543222 223368889999994 5778899999999999999999887665543111
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
.+..+....+..++...-...+...+..+++.+|..|++.+.+..
T Consensus 334 ------~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 ------SWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ------CccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 111111111222222223345556888999999999998877654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.1e-15 Score=136.05 Aligned_cols=205 Identities=24% Similarity=0.301 Sum_probs=144.7
Q ss_pred HHHHHccCCCceeeEEEEEeeCC-----eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC
Q 046609 127 VLMLSMLSNPYLVNLVGYCVDGD-----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201 (399)
Q Consensus 127 ~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~ 201 (399)
...|-++.|.|||++..++.+.. ...++.||+.-|+|..+|++...++..+......+|+.||+.||.|||+..
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~- 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD- 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence 34566677999999999986543 467899999999999999988778888999999999999999999999875
Q ss_pred CCeEecCCCCCceEECCCCCeeEecccCccCCCCC---CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHH
Q 046609 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG---DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEI 278 (399)
Q Consensus 202 ~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el 278 (399)
++|+|+++..+-|++..+|-+|+.- +.-...... ..........+.++|.+||.=.....+.++|||+||+...+|
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 7799999999999999998888742 211100000 000111123467899999976666677789999999999999
Q ss_pred HcCCCCCCCC-CCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 279 ITGRRVIDNS-RPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 279 ltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..|..--... ...+..--+.. .+..+-++. -..++.+|++..|..||+|.+++-+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~---------~i~~len~l------------qr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIAN---------VIIGLENGL------------QRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhh---------heeeccCcc------------ccCcCcccccCCCCCCcchhhhhcC
Confidence 9887432211 11111100000 000111111 1237889999999999999998765
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.54 E-value=8e-14 Score=135.45 Aligned_cols=170 Identities=16% Similarity=0.158 Sum_probs=132.2
Q ss_pred EEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCC
Q 046609 97 RGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA 176 (399)
Q Consensus 97 ~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~ 176 (399)
.|..+.++.+|.|..+............+.+..|+.++||||+++++.++.....|||+|.+ -.|..++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------- 100 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------- 100 (690)
T ss_pred ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------
Confidence 56777788899999987665433455677889999999999999999999999999999998 478888876
Q ss_pred CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcccccccccccccccccc
Q 046609 177 LDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256 (399)
Q Consensus 177 l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~ 256 (399)
+....+...+.||+.||.|||+.+. ++|++|.-+.|+|+..|..||++|-++........ .......-..|..|+.
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~ 176 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEE 176 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhh
Confidence 4467778889999999999986554 99999999999999999999999988754322221 1111122334666665
Q ss_pred ccCCCCCchhhHHHHHHHHHHHHcC
Q 046609 257 ALTGQLTAKSDVYSFGVVFLEIITG 281 (399)
Q Consensus 257 ~~~~~~~~~~DvwslG~il~elltg 281 (399)
+.... -..|.|.|||++++++.|
T Consensus 177 ~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 177 IDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cCccc--cchhhhhHHHHHHHHhCc
Confidence 43222 346999999999999999
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.50 E-value=1.7e-13 Score=133.34 Aligned_cols=141 Identities=23% Similarity=0.195 Sum_probs=96.9
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch----------------------------------------HHH
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN----------------------------------------REF 123 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~ 123 (399)
.+.||.|++|.||+|+.. +|+.||||+.+....... -++
T Consensus 122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 367999999999999987 489999999864311000 013
Q ss_pred HHHHHHHHccC----CCceeeEEEEE-eeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHH-HHHHHh
Q 046609 124 LVEVLMLSMLS----NPYLVNLVGYC-VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR-GLEYLH 197 (399)
Q Consensus 124 ~~e~~~l~~l~----hpnIv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~-~l~~LH 197 (399)
.+|...+.++. |.+-+.+-.++ ...+..+|||||++|++|.++.... ..... ...++.+++. .+..+|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~---~~~~~---~~~ia~~~~~~~l~ql~ 274 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD---EAGLD---RKALAENLARSFLNQVL 274 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH---hcCCC---HHHHHHHHHHHHHHHHH
Confidence 44555555442 32222322222 2244579999999999998876531 11122 3445555655 467889
Q ss_pred hcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 198 ~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
..| ++|+|++|.||+++.++.++|+|||++....
T Consensus 275 ~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 275 RDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred hCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 888 9999999999999999999999999987543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.3e-12 Score=112.14 Aligned_cols=137 Identities=15% Similarity=0.130 Sum_probs=100.1
Q ss_pred CCeeccCCcEEEEEEEECC------CCeEEEEEEEccCC---------------Cc------c-hHH----HHHHHHHHH
Q 046609 84 DNLLGEGGFGRVYRGKLEG------TNQDVAVKQLDRNG---------------FQ------G-NRE----FLVEVLMLS 131 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~---------------~~------~-~~~----~~~e~~~l~ 131 (399)
...||.|-.+.||.|...+ .+..+|||+++... +. + ... ..+|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3679999999999998653 35789999974210 00 1 112 237999999
Q ss_pred ccCC--CceeeEEEEEeeCCeeEEEEEecCCCChHH-hhccCCCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEec
Q 046609 132 MLSN--PYLVNLVGYCVDGDQRILVYEYMPNGSLED-HLLDLPPNRKALDWNTRMKIAHGAARGLEYL-HESAQPPVIYR 207 (399)
Q Consensus 132 ~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~L-H~~~~~~ivH~ 207 (399)
++.. -++..++++ ...+|||||+.+..+.. .+.+ ..++......++.+++.+|..| |..+ |||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 8864 466777765 45689999996543422 2322 2355566778889999999999 8888 9999
Q ss_pred CCCCCceEECCCCCeeEecccCccCC
Q 046609 208 DFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 208 dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||++.||+++ ++.+.|+|||.+...
T Consensus 150 DLs~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 150 DLSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCCHHHEEEE-CCcEEEEECCCceeC
Confidence 9999999997 468999999988643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.5e-13 Score=113.31 Aligned_cols=130 Identities=20% Similarity=0.153 Sum_probs=96.0
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCcee-eEEEEEeeCCeeEEEEEecCCCCh
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV-NLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
+.|+.|.++.||++... +..|++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.++
T Consensus 4 ~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 56899999999999875 67899999765431 223467789999888765544 444443 2345899999999887
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA--QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
... . . ....++.+++.+|..||..+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~--~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 543 1 1 11345678999999999887 12259999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.2e-12 Score=129.09 Aligned_cols=146 Identities=16% Similarity=0.163 Sum_probs=97.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc----------------------------------hH---
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG----------------------------------NR--- 121 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------------~~--- 121 (399)
.+|.. +.||.|++|.||+|+.+++|+.||||+.++.-... .+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34665 78999999999999999889999999997531100 01
Q ss_pred ---HHHHHHHHHHccC----CCceeeEEEEEee-CCeeEEEEEecCCCChHHhh--ccCCCCCCCCCHHHHHHHHHHHHH
Q 046609 122 ---EFLVEVLMLSMLS----NPYLVNLVGYCVD-GDQRILVYEYMPNGSLEDHL--LDLPPNRKALDWNTRMKIAHGAAR 191 (399)
Q Consensus 122 ---~~~~e~~~l~~l~----hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~ql~~ 191 (399)
++.+|...+.++. +.+.+.+-.++.+ .+..+|||||++|+++.+.- .........+....+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 1344554444443 4444444444432 45678999999999997742 22100011233444444444443
Q ss_pred HHHHHhhcCCCCeEecCCCCCceEECCCC----CeeEecccCccCCCC
Q 046609 192 GLEYLHESAQPPVIYRDFKASNVLLDQDF----NPKLSDFGLAKLGPT 235 (399)
Q Consensus 192 ~l~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg~~~~~~~ 235 (399)
..| ++|+|++|.||+++.+| .++++|||++.....
T Consensus 278 ------~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ------RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 467 99999999999999888 999999999875433
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5e-13 Score=128.73 Aligned_cols=251 Identities=20% Similarity=0.203 Sum_probs=177.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC-CCCeEEEEEEEccCCCcchHH--HHHHHHHHHcc-CCCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE-GTNQDVAVKQLDRNGFQGNRE--FLVEVLMLSML-SNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 152 (399)
-..+|..+..||.|.|+.|+....+ .++..|++|.+.+.......+ -..|+.+...+ .|.+++..+..+......+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888899999999999988765 567889999886554333333 24466666555 4889999888888888888
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-CCeeEecccCcc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAK 231 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~~~ 231 (399)
+-.|||+++++...+.- ...+.+...+.+..|++.++.++|+.. ++|+|++|+||++..+ +..++.|||+..
T Consensus 343 ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred CchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence 99999999988766532 345777888999999999999999999 9999999999999886 788999999886
Q ss_pred CCCCCCCcccccccccccccc--ccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 232 LGPTGDKSHVSTRVMGTYGYC--APEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
..... .....+.-+++ +|+......+-.+.|++|||..+.+.++|...-.....
T Consensus 416 ~~~~~-----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~------------------- 471 (524)
T KOG0601|consen 416 RLAFS-----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ------------------- 471 (524)
T ss_pred cccee-----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc-------------------
Confidence 31111 11122333344 45544567888899999999999999998743322111
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
+..+.... ....+... ..+..+...++..++..||.+.++..+......
T Consensus 472 ~~~i~~~~-~p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 472 SLTIRSGD-TPNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred ceeeeccc-ccCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 00000000 00111111 456678888999999999999988776555443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2e-13 Score=138.19 Aligned_cols=250 Identities=21% Similarity=0.196 Sum_probs=177.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
....+.+.+-+-.|.++.++.+.-..++...++|.......-. .+....+-.++-..++|.++.....+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3456777788999999999998887777666666554322111 1222223333333456777776666667778899
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
+++|+.+++|...|+.. +..+..-.+..+..+..++++||+.. +.|+|++|.|+++..+|+.+++|||.....
T Consensus 882 ~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 99999999999999873 35666667777888999999999888 999999999999999999999999833211
Q ss_pred CCC--------CCc---------------------cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCC
Q 046609 234 PTG--------DKS---------------------HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRV 284 (399)
Q Consensus 234 ~~~--------~~~---------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~p 284 (399)
... ... .......+|+.|.+||...+......+|+|++|+++++.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 000 000 011225689999999999999999999999999999999999999
Q ss_pred CCCCCCcccchhhHhhhhhhhccchhhhccCCcc-CCCCCHHHHHHHHHHHhhccccCCCCCCChH
Q 046609 285 IDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL-EGNYPIKGLYQALAVAAMCLQEEAGTRPMMS 349 (399)
Q Consensus 285 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ 349 (399)
|....+.... ..+..... ...-+........+++...+..+|.+|-.+.
T Consensus 1035 ~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9987664321 11111100 0112333444666788888899999997766
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.4e-11 Score=112.15 Aligned_cols=170 Identities=16% Similarity=0.210 Sum_probs=131.8
Q ss_pred cEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEe----eCCeeEEEEEecCC-CChHHh
Q 046609 92 FGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV----DGDQRILVYEYMPN-GSLEDH 166 (399)
Q Consensus 92 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~ 166 (399)
-.+.|++...-+|..|++|+++............-+++++++.|+|||++-++|. .+..++||++|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3578999999899999999995443333333445678999999999999999887 34567999999886 577776
Q ss_pred hccCC-----------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 167 LLDLP-----------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 167 l~~~~-----------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
-.... ..+...++..+|.++.|+..||.++|+.| +.-+-|.|.+|+++++.+++|...|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 23456788999999999999999999999 99999999999999999999998887764322
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRR 283 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~ 283 (399)
.. . |-+.+ -.+-|.=.||.++..|.||..
T Consensus 446 d~--------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DP--------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CC--------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 21 0 10111 235799999999999999964
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=3.2e-11 Score=100.26 Aligned_cols=131 Identities=23% Similarity=0.334 Sum_probs=99.2
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--------hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--------NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
..+++|+.+.++.+.+.+ ..+++|.=.+..... ...-.+|..++.++.--.|...+=+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 468899999999997753 345666422211111 1235678999999887677666666677788899999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|++|..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..++ +.++|||++..
T Consensus 80 ~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888761 1446666777788899999 99999999999998775 99999999874
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.4e-11 Score=99.05 Aligned_cols=143 Identities=21% Similarity=0.273 Sum_probs=106.9
Q ss_pred CCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--------cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 83 PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--------QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.+.+|.+|+.+.|+++.+. |+..+||.=..... -......+|+.+|.++.--.|.-..-++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4678999999999999987 56666775211111 1224467799999988766766666667777788999
Q ss_pred EEecCC-CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC---eeEecccCc
Q 046609 155 YEYMPN-GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN---PKLSDFGLA 230 (399)
Q Consensus 155 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg~~ 230 (399)
|||++| .++.+++..... ..........++..+-+.+.-||.++ |+|+||..+||++..++. +.++|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecch
Confidence 999966 478888876322 22333334778889999999999999 999999999999966553 589999998
Q ss_pred cC
Q 046609 231 KL 232 (399)
Q Consensus 231 ~~ 232 (399)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 74
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.4e-10 Score=104.87 Aligned_cols=266 Identities=17% Similarity=0.184 Sum_probs=164.6
Q ss_pred CCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEE-------eeCCeeEEE
Q 046609 83 PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYC-------VDGDQRILV 154 (399)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~-------~~~~~~~lv 154 (399)
....||+|+.+.+|-.-.- ...+.|++.........+. +..|... .||-+..-+.+= ..+....++
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3477999999999964322 1235688877655444332 2233332 465443312221 112236788
Q ss_pred EEecCCC-ChHHhhcc--CCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 155 YEYMPNG-SLEDHLLD--LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 155 ~e~~~~g-~L~~~l~~--~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
|+.+.|. .+..++.. .++.-....|...++++..++.+...||..| .+-+|++++|+|+++++.+.|.|=..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 8888764 23333321 1234456789999999999999999999999 8999999999999999999999854333
Q ss_pred CCCCCCCcccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCcccc---hhhHhhhh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITG-RRVIDNSRPTEEQ---NLVTWATP 302 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~---~~~~~~~~ 302 (399)
... .........|...|.+||.-. +..-+...|.|.||+++++++.| ++||.+....... ........
T Consensus 166 i~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 221 122233356899999999543 34556789999999999999886 9999875321110 01111111
Q ss_pred hhhccchhhhccCCccCCCCCH-HHHHHHHHHHhhcccc--CCCCCCChHHHHHHHHHhhhc
Q 046609 303 LFKDRRKFTMMADPLLEGNYPI-KGLYQALAVAAMCLQE--EAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~-~~~~~l~~li~~cl~~--dp~~RPs~~eil~~L~~l~~~ 361 (399)
.|....+...-..+.- ..+|. ....++..+..+|+.. ++.-|||++-++..|..+...
T Consensus 243 ~f~ya~~~~~g~~p~P-~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 243 RFAYASDQRRGLKPPP-RSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred eeeechhccCCCCCCC-CCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 1111111111111110 11122 2224666788888874 356899999999999988764
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.4e-11 Score=104.67 Aligned_cols=142 Identities=22% Similarity=0.298 Sum_probs=109.4
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCC--CceeeEEEEEeeCC---eeEEEEEec
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSN--PYLVNLVGYCVDGD---QRILVYEYM 158 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~---~~~lv~e~~ 158 (399)
+.|+.|..+.||++...+ +..+++|....... .....+..|+.++..+.+ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998764 57899999765432 134567889999999876 44677777766542 568999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA-------------------------------------- 200 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-------------------------------------- 200 (399)
+|.++...+.. ..++......++.+++.+|..||+..
T Consensus 83 ~G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 83 DGRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred CCEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 99888775531 34677778888888888888888531
Q ss_pred ---------------CCCeEecCCCCCceEECC--CCCeeEecccCccC
Q 046609 201 ---------------QPPVIYRDFKASNVLLDQ--DFNPKLSDFGLAKL 232 (399)
Q Consensus 201 ---------------~~~ivH~dikp~NIll~~--~~~~kl~Dfg~~~~ 232 (399)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134899999999999998 66789999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.5e-09 Score=93.02 Aligned_cols=124 Identities=23% Similarity=0.278 Sum_probs=80.5
Q ss_pred EEEEEEECCCCeEEEEEEEccCC--C-----------c--------c-----hHHHHHHHHHHHccCCC--ceeeEEEEE
Q 046609 94 RVYRGKLEGTNQDVAVKQLDRNG--F-----------Q--------G-----NREFLVEVLMLSMLSNP--YLVNLVGYC 145 (399)
Q Consensus 94 ~V~~~~~~~~~~~vaiK~~~~~~--~-----------~--------~-----~~~~~~e~~~l~~l~hp--nIv~l~~~~ 145 (399)
.||.|...+ +..+|||+..... + . . .....+|...|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 489998754 7899999984310 0 0 0 12356799999999865 566666553
Q ss_pred eeCCeeEEEEEecC--CCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 146 VDGDQRILVYEYMP--NGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY-LHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 146 ~~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~-LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
..+|||||++ |..+.. |... .++......++.+++..+.. +|..| |+|+||.+.||+++.+ .+
T Consensus 80 ----~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ----TTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred ----CCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence 3479999997 544543 3331 12234456677788885555 57888 9999999999999888 99
Q ss_pred eEecccCccC
Q 046609 223 KLSDFGLAKL 232 (399)
Q Consensus 223 kl~Dfg~~~~ 232 (399)
.|+|||.+..
T Consensus 146 ~iIDf~qav~ 155 (188)
T PF01163_consen 146 YIIDFGQAVD 155 (188)
T ss_dssp EE--GTTEEE
T ss_pred EEEecCccee
Confidence 9999998864
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=3.8e-09 Score=95.88 Aligned_cols=141 Identities=18% Similarity=0.123 Sum_probs=99.8
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-----------hHHHHHHHHHHHccCCCc--eeeEEEEEee----
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-----------NREFLVEVLMLSMLSNPY--LVNLVGYCVD---- 147 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpn--Iv~l~~~~~~---- 147 (399)
+.+-......|+++... |+.|.||......... ...+.+|...+..+..-+ .+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 28 EVFRELEGRRTLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred cEEecCCCceEEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 44444444456677664 6789999775433111 113678888888885433 3344555543
Q ss_pred -CCeeEEEEEecCCC-ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-------
Q 046609 148 -GDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ------- 218 (399)
Q Consensus 148 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~------- 218 (399)
....+||+|++++. +|.+++.... ....+......++.+++..+.-||..| |+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence 23468999999875 7888885421 234566778899999999999999999 999999999999975
Q ss_pred CCCeeEecccCccC
Q 046609 219 DFNPKLSDFGLAKL 232 (399)
Q Consensus 219 ~~~~kl~Dfg~~~~ 232 (399)
++.+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46799999998753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.7e-10 Score=113.01 Aligned_cols=151 Identities=20% Similarity=0.256 Sum_probs=104.3
Q ss_pred HHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc-------ccccccccccccccccccC
Q 046609 187 HGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH-------VSTRVMGTYGYCAPEYALT 259 (399)
Q Consensus 187 ~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~ 259 (399)
.+++.|+.|+|...+ +||++|.|++|.++.++..||+.|+.+.......... ......-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 445599999997654 9999999999999999999999999886433311110 0111234568999999999
Q ss_pred CCCCchhhHHHHHHHHHHHH-cCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhcc
Q 046609 260 GQLTAKSDVYSFGVVFLEII-TGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCL 338 (399)
Q Consensus 260 ~~~~~~~DvwslG~il~ell-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl 338 (399)
...+.++|++|+|+++|.+. .|+.-+..........+. ...+..-...++...+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~--------------~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS--------------RNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh--------------hcccccccccccccCcHHHHHHHHHHh
Confidence 88999999999999999999 566555544322211111 011111111223445557778888899
Q ss_pred ccCCCCCCChHHHHH
Q 046609 339 QEEAGTRPMMSDVVT 353 (399)
Q Consensus 339 ~~dp~~RPs~~eil~ 353 (399)
..++..||++..+..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.1e-08 Score=90.25 Aligned_cols=134 Identities=18% Similarity=0.124 Sum_probs=98.0
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC----------------------cchHHHHHHHHHHHccCCC--
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF----------------------QGNREFLVEVLMLSMLSNP-- 136 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~e~~~l~~l~hp-- 136 (399)
..+...||-|--+.||.|... .+.++|||.-+.... -......+|..+|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456689999999999999987 488899997532100 0112357799999998755
Q ss_pred ceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 137 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
.|.+.+++ +...+|||+++|-.|...- +.......++..|++-+.-+-..| |||+|+++-||++
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV 235 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILV 235 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEE
Confidence 77887775 4558999999886554322 123344455566666666666778 9999999999999
Q ss_pred CCCCCeeEecccCcc
Q 046609 217 DQDFNPKLSDFGLAK 231 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~ 231 (399)
+++|.+.++||--+.
T Consensus 236 ~~dg~~~vIDwPQ~v 250 (304)
T COG0478 236 TEDGDIVVIDWPQAV 250 (304)
T ss_pred ecCCCEEEEeCcccc
Confidence 999999999996554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.85 E-value=4.1e-08 Score=86.14 Aligned_cols=106 Identities=25% Similarity=0.276 Sum_probs=83.6
Q ss_pred hHHHHHHHHHHHccCCC--ceeeEEEEEeeCC----eeEEEEEecCCC-ChHHhhccCCCCCCCCCHHHHHHHHHHHHHH
Q 046609 120 NREFLVEVLMLSMLSNP--YLVNLVGYCVDGD----QRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARG 192 (399)
Q Consensus 120 ~~~~~~e~~~l~~l~hp--nIv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~ 192 (399)
.....+|...+..+..- .+++++++..... ..+||+|++++. +|.+++... ..++......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHH
Confidence 34577888888777643 3455666655422 458999999874 799988762 226677788999999999
Q ss_pred HHHHhhcCCCCeEecCCCCCceEECCCC---CeeEecccCccC
Q 046609 193 LEYLHESAQPPVIYRDFKASNVLLDQDF---NPKLSDFGLAKL 232 (399)
Q Consensus 193 l~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Dfg~~~~ 232 (399)
+.-||..| |+|+|+++.|||++.++ .+.|+||+.++.
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999 99999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.2e-07 Score=81.75 Aligned_cols=139 Identities=14% Similarity=0.095 Sum_probs=103.0
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEEEccCC------CcchHHHHHHHHHHHccCC--CceeeEEEEEee----CCeeEE
Q 046609 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG------FQGNREFLVEVLMLSMLSN--PYLVNLVGYCVD----GDQRIL 153 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~----~~~~~l 153 (399)
--|+||.+.|+.....+ +.+-+|.....- ......|.+|+..+.++.. -.+.+++..... .-..+|
T Consensus 25 N~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~L 102 (216)
T PRK09902 25 NYRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALL 102 (216)
T ss_pred CcCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEE
Confidence 35678999999988764 357788764210 2356789999999999864 235555522211 123589
Q ss_pred EEEecCC-CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC--eeEecccCc
Q 046609 154 VYEYMPN-GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN--PKLSDFGLA 230 (399)
Q Consensus 154 v~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~--~kl~Dfg~~ 230 (399)
|+|-+.| -+|.+++.+. .-.+.+......++.+++..+.-||+.| +.|+|+.+.||+++.++. ++++||--+
T Consensus 103 VTe~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 103 VTEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 9998754 5888888652 1234677788899999999999999999 999999999999986677 999999766
Q ss_pred c
Q 046609 231 K 231 (399)
Q Consensus 231 ~ 231 (399)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.6e-08 Score=97.89 Aligned_cols=142 Identities=19% Similarity=0.186 Sum_probs=93.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---------------------c---------hH----------HHH
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---------------------G---------NR----------EFL 124 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---------------------~---------~~----------~~~ 124 (399)
+.|+.++-|.||+|+... |+.||||+.++.-.. . .+ ++.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 689999999999999986 999999998542100 0 01 133
Q ss_pred HHHHHHHccC-----CCceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc
Q 046609 125 VEVLMLSMLS-----NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199 (399)
Q Consensus 125 ~e~~~l~~l~-----hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~ 199 (399)
+|...+.++. .|+|.-..=+++-.+..+|+|||++|-.+.+...-. ...++...+...+.++. +.-+-..
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~d 284 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHHHhc
Confidence 4555555542 354444333444456779999999999888874321 13344333333222221 2222235
Q ss_pred CCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 200 ~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
| +.|.|.+|.||+++.+|.+.+.|||+......
T Consensus 285 g---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 G---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred C---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 7 99999999999999999999999999875433
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=4.2e-07 Score=79.70 Aligned_cols=150 Identities=17% Similarity=0.152 Sum_probs=102.1
Q ss_pred ccHHHHHHhcCCCCCCCe---eccCCcEEEEEEEECCCCeEEEEEEEccCCCc-------------------chH-----
Q 046609 69 FSYRELCVATTNFNPDNL---LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-------------------GNR----- 121 (399)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~---lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------------------~~~----- 121 (399)
.+...+....++..+... |..|-.+.||+|... ++..+|+|++...... +..
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~-~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~ 113 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETG-DGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA 113 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccC-CCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence 344445555556555554 556777799999874 4788999998542211 111
Q ss_pred HHHHHHHHHHccC--CCceeeEEEEEeeCCeeEEEEEecCCC-ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 046609 122 EFLVEVLMLSMLS--NPYLVNLVGYCVDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198 (399)
Q Consensus 122 ~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~ 198 (399)
...+|+..|.++. +-.+.+.+.+.. -.|||||+... .-.-.|.+ -++.......+..++++.+.-|-.
T Consensus 114 W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkD-----v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 114 WARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKD-----VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCccc-----CCcCchhHHHHHHHHHHHHHHHHH
Confidence 1356788888775 455666666653 37999998443 11112222 223344677788899999998887
Q ss_pred -cCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 199 -SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 199 -~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
.+ +||+||+.-|||+. ++.+.|+|||-+..
T Consensus 185 ~a~---LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 185 EAG---LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred hcC---cccccchhhheEEE-CCeEEEEECccccc
Confidence 67 99999999999999 88999999998864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.65 E-value=7.4e-07 Score=79.22 Aligned_cols=139 Identities=16% Similarity=0.153 Sum_probs=85.1
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC--ceeeEEEEEeeCCeeEEEEEecCCCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP--YLVNLVGYCVDGDQRILVYEYMPNGS 162 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~~~~~~~~~lv~e~~~~g~ 162 (399)
..||.|..+.||+.. +..+++|...... ......+|..++..+..- .+.+++++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 578999999999842 3457788876532 334578899999888643 35777888877788889999998863
Q ss_pred -hHHhh---------------------ccCCCCCCCCCHHHHHHHHH----------HHHHH-HHHHhhc-CCCCeEecC
Q 046609 163 -LEDHL---------------------LDLPPNRKALDWNTRMKIAH----------GAARG-LEYLHES-AQPPVIYRD 208 (399)
Q Consensus 163 -L~~~l---------------------~~~~~~~~~l~~~~~~~i~~----------ql~~~-l~~LH~~-~~~~ivH~d 208 (399)
+...+ +..+.....++.. ...+.. .+... ..+|... ..+.++|+|
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 21111 1110011111100 000000 00011 1122111 123479999
Q ss_pred CCCCceEECCCCCeeEecccCcc
Q 046609 209 FKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.65 E-value=5.3e-07 Score=78.20 Aligned_cols=138 Identities=13% Similarity=0.106 Sum_probs=91.0
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHH---------HHHHHHHHccC---CCceeeEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---------LVEVLMLSMLS---NPYLVNLVG 143 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~---------~~e~~~l~~l~---hpnIv~l~~ 143 (399)
....+|.+.+++.......|.+.... +..+++|..+.......+.+ .+.+..+..+. -.....++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 34578888888888888878776655 57799998865432222221 22333333332 222222222
Q ss_pred E-----EeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC
Q 046609 144 Y-----CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218 (399)
Q Consensus 144 ~-----~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~ 218 (399)
+ +......+|+|||++|..|.+... +++ .+...+.+++.-||..| ++|+|.+|.|++++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~ 170 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSN 170 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEEC
Confidence 2 223345578999999988866542 222 24466778899999999 999999999999986
Q ss_pred CCCeeEecccCcc
Q 046609 219 DFNPKLSDFGLAK 231 (399)
Q Consensus 219 ~~~~kl~Dfg~~~ 231 (399)
+ .++++||+..+
T Consensus 171 ~-~i~iID~~~k~ 182 (229)
T PF06176_consen 171 N-GIRIIDTQGKR 182 (229)
T ss_pred C-cEEEEECcccc
Confidence 5 59999997654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.44 E-value=8.1e-06 Score=70.22 Aligned_cols=103 Identities=28% Similarity=0.283 Sum_probs=80.6
Q ss_pred HHHHHHHHccCC-CceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCC
Q 046609 124 LVEVLMLSMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202 (399)
Q Consensus 124 ~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~ 202 (399)
..|..+++.+++ +++++++|+| ..+++.||...+++...-.... .-..-+|..+.+|+.++++.+++|+.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~-~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLS-QFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccc-cccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 348888888886 6999999999 3478999997665542100000 012368999999999999999999975544
Q ss_pred CeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 203 ~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
.+.-.|++|+|+-++.+|++|++|...+.
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 49999999999999999999999997664
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.6e-08 Score=97.02 Aligned_cols=185 Identities=17% Similarity=0.108 Sum_probs=134.0
Q ss_pred CCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc-eeeEEEEEeeCCeeEEEEEecCCC
Q 046609 83 PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY-LVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
..+-.++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++-++.+...+++++++.++
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~ 319 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTG 319 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCC
Confidence 3456889999999998776544333 5555433 34555889999999999 777777788888899999999776
Q ss_pred -ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 162 -SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 162 -~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
+....... ....+..-+...+...-.++++++|+.. =+|+| ||+..+ +..+..||+.........
T Consensus 320 rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--- 385 (829)
T KOG0576|consen 320 RSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--- 385 (829)
T ss_pred ccccccCCh---hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc---
Confidence 22111111 1122333445556677778899999876 58998 776655 688999999887554443
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDN 287 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 287 (399)
......+++.|+|||+...+.+....|+|++|+-..+|.-|-+|-..
T Consensus 386 ~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 386 KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 33446799999999999999999999999999877777777766543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.38 E-value=2.5e-06 Score=83.78 Aligned_cols=138 Identities=17% Similarity=0.158 Sum_probs=91.4
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-------------------------------------hHHHHHHH
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-------------------------------------NREFLVEV 127 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-------------------------------------~~~~~~e~ 127 (399)
+.||.-+.|.||+|+.++ |+.||||+-++.-... .-+|.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 689999999999999997 9999999975421100 00133444
Q ss_pred HHHHc----cCCCc------eeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 046609 128 LMLSM----LSNPY------LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197 (399)
Q Consensus 128 ~~l~~----l~hpn------Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH 197 (399)
....+ +.|-+ |.+++-.+ ....+|+|||++|..+.+.-.- ....++...+..-+.+...-.-+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf-- 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIF-- 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHH--
Confidence 33333 34544 33333332 3467999999999887765332 12457776665555544332222
Q ss_pred hcCCCCeEecCCCCCceEEC----CCCCeeEecccCccCC
Q 046609 198 ESAQPPVIYRDFKASNVLLD----QDFNPKLSDFGLAKLG 233 (399)
Q Consensus 198 ~~~~~~ivH~dikp~NIll~----~~~~~kl~Dfg~~~~~ 233 (399)
..| ++|+|=+|.||+++ .++.+.+.|||+....
T Consensus 319 ~~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 319 KTG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred hcC---CccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 346 99999999999998 3678999999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=7e-06 Score=74.00 Aligned_cols=140 Identities=20% Similarity=0.172 Sum_probs=84.1
Q ss_pred eccCCc-EEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEecCCCChH
Q 046609 87 LGEGGF-GRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEYMPNGSLE 164 (399)
Q Consensus 87 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~ 164 (399)
|..|.. ..||+.... +..+++|+..... ...+..|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 445555 788998764 3568888875442 345677888888874 444667777777666789999999987776
Q ss_pred Hhh-------------------ccCCCCCCCCCHH--HHHHHHH--------------------HHHHHHHHHhh----c
Q 046609 165 DHL-------------------LDLPPNRKALDWN--TRMKIAH--------------------GAARGLEYLHE----S 199 (399)
Q Consensus 165 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------ql~~~l~~LH~----~ 199 (399)
... +..+....++... ....... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 1111111111100 0000000 01111112211 1
Q ss_pred CCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 200 ~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13449999999999999998778899998765
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.37 E-value=1.4e-05 Score=69.16 Aligned_cols=131 Identities=20% Similarity=0.259 Sum_probs=92.8
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCC----------------CcchHHHHHHHHHHHccC------CCceeeE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG----------------FQGNREFLVEVLMLSMLS------NPYLVNL 141 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------hpnIv~l 141 (399)
...||.|+.=.||.- . .+...+||+..... ....++..+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 468999999999953 3 34557899987654 222355666766555554 7899999
Q ss_pred EEEEeeCCeeEEEEEecCC------CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceE
Q 046609 142 VGYCVDGDQRILVYEYMPN------GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVL 215 (399)
Q Consensus 142 ~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIl 215 (399)
+|+.+++-...+|+|.+.+ -+|.+++.. ..++. .....+. +-..||-+.+ |+.+|++|.||+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEE
Confidence 9999999999999998633 368888854 34655 4444444 4456777777 999999999999
Q ss_pred ECCC--C--CeeEec-ccC
Q 046609 216 LDQD--F--NPKLSD-FGL 229 (399)
Q Consensus 216 l~~~--~--~~kl~D-fg~ 229 (399)
+... + .+.|+| ||.
T Consensus 151 ~~~~~~~~~~lvlIDG~G~ 169 (199)
T PF10707_consen 151 VQRRDSGEFRLVLIDGLGE 169 (199)
T ss_pred EEecCCCceEEEEEeCCCC
Confidence 9532 2 477776 443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.5e-06 Score=75.03 Aligned_cols=143 Identities=22% Similarity=0.234 Sum_probs=82.5
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC--ceeeEEEEEe---eCCeeEEEEEecC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP--YLVNLVGYCV---DGDQRILVYEYMP 159 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~~~---~~~~~~lv~e~~~ 159 (399)
+.|+.|..+.||++...+ ..+++|..... .....+..|..+++.+... .+.+++.... .....+++|++++
T Consensus 3 ~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred ccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 578999999999999875 47899997654 3446677888888887533 3566666443 2335689999999
Q ss_pred CCChHH----------------hh---ccCCCCCCCCCHHHH---------H-----H-------HHHHHHH-HHHHHhh
Q 046609 160 NGSLED----------------HL---LDLPPNRKALDWNTR---------M-----K-------IAHGAAR-GLEYLHE 198 (399)
Q Consensus 160 ~g~L~~----------------~l---~~~~~~~~~l~~~~~---------~-----~-------i~~ql~~-~l~~LH~ 198 (399)
|..+.. .+ +........+..... . . ....+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 887776 11 111111111111100 0 0 0111222 2333332
Q ss_pred c----CCCCeEecCCCCCceEEC-CCCCeeEecccCcc
Q 046609 199 S----AQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAK 231 (399)
Q Consensus 199 ~----~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~~~ 231 (399)
. ....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 1 233499999999999999 66666799998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.6e-06 Score=86.91 Aligned_cols=197 Identities=20% Similarity=0.197 Sum_probs=140.3
Q ss_pred HHHHHHHHHccCCCceeeEEEEEeeCCeeE----EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 046609 123 FLVEVLMLSMLSNPYLVNLVGYCVDGDQRI----LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198 (399)
Q Consensus 123 ~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~----lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~ 198 (399)
...|...+.+..|+|++.++.+........ +..+++..-++...+.. -..++....+.+..++..||.|+|+
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 345677888889999999999876554433 34477777788777765 5678999999999999999999999
Q ss_pred cCCCCeEecCCCCC---ceEECCCCCeeEe--cccCccCCCCCCCccccccccccccccccccccCCCCCch--hhHHHH
Q 046609 199 SAQPPVIYRDFKAS---NVLLDQDFNPKLS--DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK--SDVYSF 271 (399)
Q Consensus 199 ~~~~~ivH~dikp~---NIll~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~--~Dvwsl 271 (399)
.. ..|.-+..+ +.-++..+...++ ||+.+...+...... ....+..+.+||......+..+ .|+|.+
T Consensus 305 ~~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~l 378 (1351)
T KOG1035|consen 305 LS---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCL 378 (1351)
T ss_pred hc---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHH
Confidence 87 777777666 5566777777777 998887654443322 1234566888887766665554 799999
Q ss_pred HHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHH
Q 046609 272 GVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDV 351 (399)
Q Consensus 272 G~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei 351 (399)
|..+..+..|..+-..... +.+.+..... ..+.++..+|+..++++|+++.++
T Consensus 379 gll~~~~~~~~~i~~~~~~-----------------------~~~~l~~~~~----~~~~d~~~~~~~~~~~~Rl~~~~l 431 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKSAV-----------------------PVSLLDVLST----SELLDALPKCLDEDSEERLSALEL 431 (1351)
T ss_pred HHHHhhhhhcCcccccccc-----------------------hhhhhccccc----hhhhhhhhhhcchhhhhccchhhh
Confidence 9999999988643322110 0111111111 145678889999999999999999
Q ss_pred HHHHH
Q 046609 352 VTAIE 356 (399)
Q Consensus 352 l~~L~ 356 (399)
+.+.-
T Consensus 432 l~~~f 436 (1351)
T KOG1035|consen 432 LTHPF 436 (1351)
T ss_pred hhchh
Confidence 98743
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.30 E-value=7.6e-06 Score=68.06 Aligned_cols=129 Identities=19% Similarity=0.198 Sum_probs=92.0
Q ss_pred CCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCC
Q 046609 83 PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGS 162 (399)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 162 (399)
..+.|++|++|.||+|.+. +..+|+|+-..+ .....+..|..+|..+.-.++.+=+..+.. .++.|||+.|-+
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhhhcCcc
Confidence 3478999999999999998 457899987655 345678899999999987776554433322 245599998878
Q ss_pred hHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC-CceEECCCCCeeEecccCccC
Q 046609 163 LEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKA-SNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 163 L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp-~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|.++-.. .+..+ +..+++.---|...| |-|+.|+- ..++|.+++.+.|+||..|..
T Consensus 99 L~~~~~~-------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 99 LGKLEIG-------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hhhhhhc-------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 8766543 12223 334566666677778 99999974 444444555999999998863
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.6e-05 Score=84.13 Aligned_cols=80 Identities=13% Similarity=0.218 Sum_probs=57.6
Q ss_pred CCeeccCCcEEEEEEEECCCC--eEEEEEEEccCCC-cchHHHHHHHHHHHccC-CCce--eeEEEEEeeC---CeeEEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTN--QDVAVKQLDRNGF-QGNREFLVEVLMLSMLS-NPYL--VNLVGYCVDG---DQRILV 154 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-hpnI--v~l~~~~~~~---~~~~lv 154 (399)
.+.|+.|....+|+......+ ..+++|+...... .....+.+|+.+++.+. |++| .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 467899999999998775432 4677887654322 23356889999999986 6654 7788887664 467899
Q ss_pred EEecCCCCh
Q 046609 155 YEYMPNGSL 163 (399)
Q Consensus 155 ~e~~~~g~L 163 (399)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999987543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.15 E-value=2.2e-05 Score=70.32 Aligned_cols=73 Identities=16% Similarity=0.163 Sum_probs=46.0
Q ss_pred CeeccCCcE-EEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC---ceeeEEEEEeeC---CeeEEEEEe
Q 046609 85 NLLGEGGFG-RVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP---YLVNLVGYCVDG---DQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~l~~~~~~~---~~~~lv~e~ 157 (399)
+.|+.|+.. .||+.. ..+++|..... .....+..|..++..+... .+.+++...... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457777766 588752 24777875542 2245788899998887532 344445444332 235889999
Q ss_pred cCCCChH
Q 046609 158 MPNGSLE 164 (399)
Q Consensus 158 ~~~g~L~ 164 (399)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.02 E-value=0.00014 Score=67.45 Aligned_cols=76 Identities=14% Similarity=0.106 Sum_probs=55.8
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC---CceeeEEEEEeeC---CeeEEEEEe
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN---PYLVNLVGYCVDG---DQRILVYEY 157 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---pnIv~l~~~~~~~---~~~~lv~e~ 157 (399)
.+.||.|..+.||.....+ + .+++|.... ......+..|...++.+.. -.+.++++++.++ +..+||||+
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 4679999999999986543 3 466777432 1133578889999988853 4688888887543 568999999
Q ss_pred cCCCCh
Q 046609 158 MPNGSL 163 (399)
Q Consensus 158 ~~~g~L 163 (399)
++|+++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 988765
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.01 E-value=0.00012 Score=65.49 Aligned_cols=74 Identities=16% Similarity=0.134 Sum_probs=47.5
Q ss_pred CeeccCCcEEEEEEEECC-CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc-eeeEEEEEeeCCeeEEEEEecCCCC
Q 046609 85 NLLGEGGFGRVYRGKLEG-TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY-LVNLVGYCVDGDQRILVYEYMPNGS 162 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~~~~g~ 162 (399)
+.|..|-...+|++...+ .+..|++|+...... ..-...+|+.++..+...+ .++++..+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788888999987553 346788998754321 1123346888888885433 344444332 248999998876
Q ss_pred h
Q 046609 163 L 163 (399)
Q Consensus 163 L 163 (399)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.97 E-value=0.00016 Score=65.70 Aligned_cols=140 Identities=16% Similarity=0.036 Sum_probs=78.9
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCce-eeEEEEEeeCCeeEEEEEecCCCChH
Q 046609 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL-VNLVGYCVDGDQRILVYEYMPNGSLE 164 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~L~ 164 (399)
.+..|-.+.+|+... ++..+++|........-.-...+|..+++.+....+ .+++.... .++|+||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 355677788998873 356788887654322211235678888888864333 34444332 36899999887654
Q ss_pred Hh-----------------hccCCCCCCCCCHHH-HHHHHHHH---------HHHHHHHhhc-----CCCCeEecCCCCC
Q 046609 165 DH-----------------LLDLPPNRKALDWNT-RMKIAHGA---------ARGLEYLHES-----AQPPVIYRDFKAS 212 (399)
Q Consensus 165 ~~-----------------l~~~~~~~~~l~~~~-~~~i~~ql---------~~~l~~LH~~-----~~~~ivH~dikp~ 212 (399)
.. ++..+....+++... ...+..++ ...+..+-.. ....++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 21 122211122222221 11111111 1112222111 1234899999999
Q ss_pred ceEECCCCCeeEecccCccC
Q 046609 213 NVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 213 NIll~~~~~~kl~Dfg~~~~ 232 (399)
||++++++ +.|+||..+..
T Consensus 157 Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred cEEEeCCC-CEEEeccccCc
Confidence 99999877 78999988763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00045 Score=66.27 Aligned_cols=76 Identities=18% Similarity=0.195 Sum_probs=53.2
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccC------C-CcchHHHHHHHHHHHccC---CCceeeEEEEEeeCCeeEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN------G-FQGNREFLVEVLMLSMLS---NPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv 154 (399)
+.||.|.+..||++...+.++.++||.-... . ....+....|...|..+. -.++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998754468999985321 1 123355667777777763 2456777776 34567899
Q ss_pred EEecCCCC
Q 046609 155 YEYMPNGS 162 (399)
Q Consensus 155 ~e~~~~g~ 162 (399)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00044 Score=59.49 Aligned_cols=125 Identities=25% Similarity=0.348 Sum_probs=86.3
Q ss_pred CCCCCCCeeccCCc-EEEEEEEECCCCeEEEEEEEccC---C-------Cc-----------chHHHHHHHHHHHccC--
Q 046609 79 TNFNPDNLLGEGGF-GRVYRGKLEGTNQDVAVKQLDRN---G-------FQ-----------GNREFLVEVLMLSMLS-- 134 (399)
Q Consensus 79 ~~~~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~---~-------~~-----------~~~~~~~e~~~l~~l~-- 134 (399)
.+++.++.||.|.. |.||++... |..+|+|.+... . .. -..-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78889999999999 999999987 579999994221 0 00 0123667777777665
Q ss_pred -CCce--eeEEEEEeeC------------------CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 046609 135 -NPYL--VNLVGYCVDG------------------DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193 (399)
Q Consensus 135 -hpnI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l 193 (399)
+.++ |+.+|+..-. ....+|.||++... .++... +.++.+-+
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~~~----~~~~~~dl 177 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQIRD----IPQMLRDL 177 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccchhH----HHHHHHHH
Confidence 4455 8899887321 11246777664422 233333 34566667
Q ss_pred HHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 194 ~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
..+|..| |+-+|+++.|.. .-+|+|||.+
T Consensus 178 ~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 178 KILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 8899999 999999999985 3488899864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.78 E-value=0.00024 Score=65.91 Aligned_cols=143 Identities=17% Similarity=0.153 Sum_probs=83.1
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC--ceeeEEEE------EeeCCeeEEEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP--YLVNLVGY------CVDGDQRILVY 155 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~------~~~~~~~~lv~ 155 (399)
.+.|..|....+|+.... +..+++|+... ........|+.++..+.+. .+.+++.. ...++..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456778888899998654 34688898764 2234566678777777532 24444432 22345668999
Q ss_pred EecCCCChHH----h----------hcc----CCCC---CCCCCHHHHH----------HHHHHHHHHHHHHhhc----C
Q 046609 156 EYMPNGSLED----H----------LLD----LPPN---RKALDWNTRM----------KIAHGAARGLEYLHES----A 200 (399)
Q Consensus 156 e~~~~g~L~~----~----------l~~----~~~~---~~~l~~~~~~----------~i~~ql~~~l~~LH~~----~ 200 (399)
+|++|..+.. . ++. .... .....|.... .....+..++.++... .
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9998876532 0 010 0000 0011111110 0111123334444431 1
Q ss_pred CCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 201 ~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
...++|+|+.|.||+++.++.+.|+||+.+.
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 2349999999999999998777899998775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.65 E-value=3.5e-05 Score=70.21 Aligned_cols=134 Identities=16% Similarity=0.096 Sum_probs=93.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--Cc---------------c-----hHHHHHHHHHHHccCC--
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQ---------------G-----NREFLVEVLMLSMLSN-- 135 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~---------------~-----~~~~~~e~~~l~~l~h-- 135 (399)
=+.+.+.||-|.-+.||.+-+.. |.+.++|.-+... +. . .-...+|+..|+.|..
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 36678999999999999998874 7788888643210 00 0 0124568888888863
Q ss_pred CceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceE
Q 046609 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVL 215 (399)
Q Consensus 136 pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIl 215 (399)
--|.+.+++ +..++|||++.|-+|...-+- .+. ..+...+..-+.-|..+| +||+|.+--||+
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~d~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNim 234 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------EDP---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIM 234 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeec-------CCh---HHHHHHHHHHHHHHHHcC---ceecccchheeE
Confidence 345555554 455899999988887654322 122 233444555566778889 999999999999
Q ss_pred ECCCCCeeEecccCcc
Q 046609 216 LDQDFNPKLSDFGLAK 231 (399)
Q Consensus 216 l~~~~~~kl~Dfg~~~ 231 (399)
|++++.++++||--+.
T Consensus 235 v~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 235 VKDDDKIVVIDFPQMV 250 (465)
T ss_pred EecCCCEEEeechHhh
Confidence 9999999999996443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00055 Score=63.77 Aligned_cols=75 Identities=17% Similarity=0.193 Sum_probs=48.2
Q ss_pred CeeccCCcEEEEEEEECC------CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc-eeeEEEEEeeCCeeEEEEEe
Q 046609 85 NLLGEGGFGRVYRGKLEG------TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY-LVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~ 157 (399)
+.|..|-...+|+..... .++.+++|+..... .......+|..++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 445666677899887653 25788999976543 22245567888888876433 3445555532 368999
Q ss_pred cCCCChH
Q 046609 158 MPNGSLE 164 (399)
Q Consensus 158 ~~~g~L~ 164 (399)
++|.++.
T Consensus 79 i~G~~l~ 85 (302)
T cd05156 79 IPSRTLT 85 (302)
T ss_pred eCCCcCC
Confidence 9887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0012 Score=61.60 Aligned_cols=144 Identities=19% Similarity=0.198 Sum_probs=80.9
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC--ceeeEEEEE------eeCCeeEEEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP--YLVNLVGYC------VDGDQRILVY 155 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~~------~~~~~~~lv~ 155 (399)
.+.++.|....+|+.... +..+++|+..... ....+..|..++..+... .+.+++... ...+..++++
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~ 102 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV 102 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence 466778877899988754 3357889875421 234455667777766432 244444321 2245678999
Q ss_pred EecCCCChHH--------------hhcc----CCCCCC---CC-CHHHHH------------HHHHHHHHHHHHHhh---
Q 046609 156 EYMPNGSLED--------------HLLD----LPPNRK---AL-DWNTRM------------KIAHGAARGLEYLHE--- 198 (399)
Q Consensus 156 e~~~~g~L~~--------------~l~~----~~~~~~---~l-~~~~~~------------~i~~ql~~~l~~LH~--- 198 (399)
+|++|..+.. .++. .+.... .+ .|.... .....+...++++..
T Consensus 103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~ 182 (307)
T TIGR00938 103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP 182 (307)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence 9998854321 0111 000000 00 111000 001122334555532
Q ss_pred -cCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 199 -SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 199 -~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
.-...++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 112349999999999999998877899998775
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.56 E-value=0.00081 Score=62.57 Aligned_cols=138 Identities=16% Similarity=0.146 Sum_probs=96.3
Q ss_pred CCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---------------------cch-----HHHHHHHHHHHccCCC
Q 046609 83 PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---------------------QGN-----REFLVEVLMLSMLSNP 136 (399)
Q Consensus 83 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------------------~~~-----~~~~~e~~~l~~l~hp 136 (399)
+...|..|-.+.||.|...+ |..+|||++...-. .+. -....|+..|.+++..
T Consensus 148 inGCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 44678889999999998764 77799999742110 000 1245688888888766
Q ss_pred ceeeEEEEEeeCCeeEEEEEecCCCCh--HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 046609 137 YLVNLVGYCVDGDQRILVYEYMPNGSL--EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214 (399)
Q Consensus 137 nIv~l~~~~~~~~~~~lv~e~~~~g~L--~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NI 214 (399)
.|...--+... ..+|||+++- .+= .-.|+ .-.++...+..+-.|++.-+.-|..... +||.||.--|+
T Consensus 227 GIP~PePIlLk--~hVLVM~FlG-rdgw~aPkLK-----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~ 296 (520)
T KOG2270|consen 227 GIPCPEPILLK--NHVLVMEFLG-RDGWAAPKLK-----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNL 296 (520)
T ss_pred CCCCCCceeee--cceEeeeecc-CCCCcCcccc-----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhh
Confidence 65443333322 3479999983 321 12232 3457778888888899998888877654 99999999999
Q ss_pred EECCCCCeeEecccCccC
Q 046609 215 LLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 215 ll~~~~~~kl~Dfg~~~~ 232 (399)
|+ .+|.+.|+|-+-+..
T Consensus 297 Ly-hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LY-HDGKLYIIDVSQSVE 313 (520)
T ss_pred eE-ECCEEEEEEcccccc
Confidence 98 566899999887764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.0023 Score=60.12 Aligned_cols=142 Identities=15% Similarity=0.130 Sum_probs=75.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC--ceeeEEE------EEeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP--YLVNLVG------YCVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~------~~~~~~~~~lv~e 156 (399)
+.|+.|....+|+....+ + .+++|++.. .....+..|..++..+... .+.+++. +....+..+++++
T Consensus 28 ~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQ-G-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred chhccccccceEEEEeCC-C-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 557778878899987653 3 688998862 2233444455555555321 1333332 1223456789999
Q ss_pred ecCCCChHH-----------h---hccCCC-------CCCCCCH-HHHH------------HHHHH-HHHHHHHHhhc--
Q 046609 157 YMPNGSLED-----------H---LLDLPP-------NRKALDW-NTRM------------KIAHG-AARGLEYLHES-- 199 (399)
Q Consensus 157 ~~~~g~L~~-----------~---l~~~~~-------~~~~l~~-~~~~------------~i~~q-l~~~l~~LH~~-- 199 (399)
|++|..+.. . ++.... ....+.+ .... ..+.+ +...+..+...
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 998864311 1 111000 0011111 1110 01111 11122222211
Q ss_pred --CCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 200 --AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 200 --~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
-..++||+|+.|.||+++.+...-|+||+.+.
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 12349999999999999976556899999875
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.40 E-value=3.7e-05 Score=82.33 Aligned_cols=204 Identities=12% Similarity=-0.002 Sum_probs=135.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC-eEEEEEEEccCCCcchHHH-----HHHHHHHHccCCCceeeEEEEEee--CC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN-QDVAVKQLDRNGFQGNREF-----LVEVLMLSMLSNPYLVNLVGYCVD--GD 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~-----~~e~~~l~~l~hpnIv~l~~~~~~--~~ 149 (399)
...+++.--+|.|.+ +++.+-... .-+.+++......+..-+- ..|...++...|+++...+.-... ..
T Consensus 1228 ~e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 344444434444433 344442211 1245666654443333332 234445555689988887665543 33
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceEECCCCCeeEecc
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA--QPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
..+.+++|+.+|.+.+.+..-.+....+...-+.....+.+.+..-+|+.. +...+|+++|+-|.+|..+..+++.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 558899999999999998875444455555555555455455556655443 345899999999999999999999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVID 286 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 286 (399)
|+.+.. ...........+++.|+.|++...-.++.++|+|..|+.+|+..-|..+|-
T Consensus 1385 gLdKIk--np~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1385 GLDKIK--NPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred cccccc--CchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 998831 112233344567889999998877788889999999999999988887664
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0039 Score=57.87 Aligned_cols=137 Identities=18% Similarity=0.238 Sum_probs=83.6
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEc-cCCCcchHHHHHHHHHHHccCC--CceeeEEEEEeeCC--eeEEEEEecC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLVEVLMLSMLSN--PYLVNLVGYCVDGD--QRILVYEYMP 159 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~--~~~lv~e~~~ 159 (399)
..+..|.--.+|..... ++.++++.-. ...........+|+.+++.+.- .-+...++.|.++. ..+.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 33433333344444433 6778888221 1122333456678888887753 34556667776665 6799999998
Q ss_pred CCChHHhhccCCCCCCCCCHHHHHHHH-HHHHHHHHHHhhcC--------------------------------------
Q 046609 160 NGSLEDHLLDLPPNRKALDWNTRMKIA-HGAARGLEYLHESA-------------------------------------- 200 (399)
Q Consensus 160 ~g~L~~~l~~~~~~~~~l~~~~~~~i~-~ql~~~l~~LH~~~-------------------------------------- 200 (399)
|..+.+.+... ... ..++ ..+++.|.-||+..
T Consensus 109 Ge~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 109 GEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 86444333220 011 1122 25555555555432
Q ss_pred -----------------CCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 201 -----------------QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 201 -----------------~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
.+.++|+|+.+.|++++.++-+-+.||+++..
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 13699999999999999998899999999875
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0059 Score=57.52 Aligned_cols=73 Identities=16% Similarity=0.144 Sum_probs=46.7
Q ss_pred eeccCCcEEEEEEEECCCCeEEEEEEEcc-------CCCcchHHHHHHHHHHHccC--CCc-eeeEEEEEeeCCeeEEEE
Q 046609 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDR-------NGFQGNREFLVEVLMLSMLS--NPY-LVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~e~~~l~~l~--hpn-Iv~l~~~~~~~~~~~lv~ 155 (399)
.||.|....||++...+.++.|+||.-.. .......+...|...|+... -|. ++++|.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 47999999999999764446899997431 11223344556777776654 354 4444433 344557899
Q ss_pred EecCC
Q 046609 156 EYMPN 160 (399)
Q Consensus 156 e~~~~ 160 (399)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0028 Score=58.28 Aligned_cols=73 Identities=19% Similarity=0.226 Sum_probs=47.8
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC---CCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS---NPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
.+.|+.|....+|... .++..+.||.-.. ....-|..|..-|+.|. --.+++++++....+..+|||||++.
T Consensus 22 ~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~ 96 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM 96 (288)
T ss_dssp EEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred eEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence 3578889999999887 4577899998762 23355778888888884 34688899998888888999999876
Q ss_pred C
Q 046609 161 G 161 (399)
Q Consensus 161 g 161 (399)
+
T Consensus 97 ~ 97 (288)
T PF03881_consen 97 G 97 (288)
T ss_dssp -
T ss_pred C
Confidence 6
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0051 Score=58.36 Aligned_cols=143 Identities=16% Similarity=0.131 Sum_probs=81.0
Q ss_pred CeeccCCcEEEEEEEECC----CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCcee-eEEEEEeeCCeeEEEEEecC
Q 046609 85 NLLGEGGFGRVYRGKLEG----TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV-NLVGYCVDGDQRILVYEYMP 159 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~ 159 (399)
..|..|-...+|++...+ .++.|++|+...... ..-....|..+++.+..-++. ++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 445557778899987532 246788998865432 222236688888888654443 455555332 5899997
Q ss_pred CCChHHh-----------------hccCCCCCC--CCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 046609 160 NGSLEDH-----------------LLDLPPNRK--ALDWNTRMKIAHGA-----------------ARGLEYL----HE- 198 (399)
Q Consensus 160 ~g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~ql-----------------~~~l~~L----H~- 198 (399)
+.+|... ++....... ...+..+..++.++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7666421 111111111 11223333332221 1111111 21
Q ss_pred cCCCCeEecCCCCCceEECC-CCCeeEecccCccC
Q 046609 199 SAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKL 232 (399)
Q Consensus 199 ~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~ 232 (399)
.....++|+|+++.||++++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11234999999999999986 46899999987753
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.0096 Score=57.16 Aligned_cols=73 Identities=12% Similarity=0.064 Sum_probs=49.7
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-------cchHHHHHHHHHHHccC---CCceeeEEEEEeeCCeeEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-------QGNREFLVEVLMLSMLS---NPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~l 153 (399)
.+.||.|....||+.... +..++||.-..... ........|...|+.+. -.++.+++.++. +..++
T Consensus 37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl 112 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI 112 (418)
T ss_pred EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence 467899999999998864 45688998642111 12334444566666554 247888888886 44688
Q ss_pred EEEecCC
Q 046609 154 VYEYMPN 160 (399)
Q Consensus 154 v~e~~~~ 160 (399)
+|||+++
T Consensus 113 vME~L~~ 119 (418)
T PLN02756 113 GMRYLEP 119 (418)
T ss_pred EEeecCC
Confidence 9999976
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0056 Score=56.19 Aligned_cols=31 Identities=26% Similarity=0.444 Sum_probs=25.6
Q ss_pred CCeEecCCCCCceEECCCCC-eeEecccCccC
Q 046609 202 PPVIYRDFKASNVLLDQDFN-PKLSDFGLAKL 232 (399)
Q Consensus 202 ~~ivH~dikp~NIll~~~~~-~kl~Dfg~~~~ 232 (399)
+.++|+|++|.||+++.++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 34899999999999997565 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0047 Score=54.26 Aligned_cols=29 Identities=31% Similarity=0.427 Sum_probs=20.9
Q ss_pred CeEecCCCCCceEE-CCCCCeeEecccCcc
Q 046609 203 PVIYRDFKASNVLL-DQDFNPKLSDFGLAK 231 (399)
Q Consensus 203 ~ivH~dikp~NIll-~~~~~~kl~Dfg~~~ 231 (399)
.++|+|+.|.||++ +.++.++|+||..|.
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence 49999999999999 889999999998775
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.014 Score=55.00 Aligned_cols=143 Identities=15% Similarity=0.173 Sum_probs=79.4
Q ss_pred CeeccCCcEEEEEEEECCC---CeEEEEEEEccCCCcchHHHHHHHHHHHccCCCce-eeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL-VNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.|..|-...+|+....+. +..|++|+...... ..-...+|..+++.+..-++ .++++++.. . +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCC--c--EeehhhcC
Confidence 4455566778898875432 23788998865432 12233568888888875554 345555532 2 58899877
Q ss_pred CChHH-----------------hhccCC--CCCCCCCHHHHHHHHHHH----------------------HHHHHHH---
Q 046609 161 GSLED-----------------HLLDLP--PNRKALDWNTRMKIAHGA----------------------ARGLEYL--- 196 (399)
Q Consensus 161 g~L~~-----------------~l~~~~--~~~~~l~~~~~~~i~~ql----------------------~~~l~~L--- 196 (399)
.+|.. .++... .....-.+..+..++.++ ..-+..+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 66522 011111 011111223322222221 1112211
Q ss_pred h-hcC-CCCeEecCCCCCceEECC-CCCeeEecccCccC
Q 046609 197 H-ESA-QPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKL 232 (399)
Q Consensus 197 H-~~~-~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~ 232 (399)
. ..+ ...++|+|+.+.||++++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 111 224899999999999974 57899999988753
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.013 Score=55.96 Aligned_cols=75 Identities=21% Similarity=0.203 Sum_probs=49.0
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEcc------CCCcchHHHHHHHHHHHccC--CCc-eeeEEEEEeeCCeeEEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR------NGFQGNREFLVEVLMLSMLS--NPY-LVNLVGYCVDGDQRILV 154 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~~~~~e~~~l~~l~--hpn-Iv~l~~~~~~~~~~~lv 154 (399)
.+.||.|.-..||++.+...+..|+||.-.. ...-..++..-|...|+... -|. ++++|.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999853356799997431 11233455666777777664 354 4444443 34455788
Q ss_pred EEecCC
Q 046609 155 YEYMPN 160 (399)
Q Consensus 155 ~e~~~~ 160 (399)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.023 Score=53.06 Aligned_cols=28 Identities=21% Similarity=0.315 Sum_probs=24.6
Q ss_pred CeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 203 ~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
.++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 188 ~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 188 GFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred ceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 4999999999999988 678999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.028 Score=52.54 Aligned_cols=30 Identities=17% Similarity=0.221 Sum_probs=27.2
Q ss_pred CeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 203 ~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
.++|+|+.++|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 499999999999999999999999987763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.0092 Score=55.69 Aligned_cols=73 Identities=21% Similarity=0.223 Sum_probs=57.3
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
..+.|++|++. |++|. .+ ....+.++..|+.+.+..+.-+..+-. +-|||+..+||||+ +|++.|+||
T Consensus 298 ~~y~yl~~kdh-gt~is-~i-------k~~~~~e~lsff~s~~sil~~lekkf~--fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPIS-II-------KADRSEEELSFFWSCISILDILEKKFP--FEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceee-ee-------ecccHHHHHHHHHHHHHHHhhhhhcCC--cccccccccceeee-cCceEEEEe
Confidence 34557788875 55553 22 235678899999998887777776553 89999999999999 999999999
Q ss_pred cCccC
Q 046609 228 GLAKL 232 (399)
Q Consensus 228 g~~~~ 232 (399)
.+++.
T Consensus 366 klsRl 370 (488)
T COG5072 366 KLSRL 370 (488)
T ss_pred eeeec
Confidence 99985
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.024 Score=49.37 Aligned_cols=138 Identities=12% Similarity=0.064 Sum_probs=83.5
Q ss_pred EEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHH
Q 046609 106 DVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK 184 (399)
Q Consensus 106 ~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~ 184 (399)
+..+|++...... ...-+..+..++.+++ .|+++..- +.-.+.+++|+|.... .++ ..
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~~----~N 145 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------INF----SN 145 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cch----hH
Confidence 3566776654444 4455777888887664 56666632 4446679999984311 111 11
Q ss_pred HHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCc
Q 046609 185 IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264 (399)
Q Consensus 185 i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 264 (399)
++.-=+.+|.-.|+.. ...+|||-.|+||+-|..|.+||.|=+.-.. .+..|.--| ....+.
T Consensus 146 ~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~---Y~~lT~ 207 (308)
T PF07387_consen 146 FITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIE---YESLTQ 207 (308)
T ss_pred HHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeee---ccccCh
Confidence 2222246688888443 2399999999999999999999999764321 111222211 234466
Q ss_pred hhhHHHHHHHHHHHHcCC
Q 046609 265 KSDVYSFGVVFLEIITGR 282 (399)
Q Consensus 265 ~~DvwslG~il~elltg~ 282 (399)
++.+-+|=.-++++....
T Consensus 208 ~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 208 EAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred HHHHHHHHHHHHHHHHHH
Confidence 667666666666665543
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.072 Score=50.00 Aligned_cols=142 Identities=23% Similarity=0.328 Sum_probs=80.2
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc------eeeEEEE----EeeCCeeEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY------LVNLVGY----CVDGDQRILV 154 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~l~~~----~~~~~~~~lv 154 (399)
..|.. .-..+|+....+ +. +++|+.+.. ....++..|...+..+.... +..+-|- ........-+
T Consensus 32 ~~l~s-~eN~~f~~~~~~-g~-~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 32 RGLNS-EENSNFRVQTED-GR-YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred ccccc-ccCceEEEEecC-CC-eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 34444 556789888764 33 488998775 44556666777777764221 2222111 1122367889
Q ss_pred EEecCCCChHH-------------------hhccC----CCCCCCCCHHH-------------HHHHHHHHHHHHHHHhh
Q 046609 155 YEYMPNGSLED-------------------HLLDL----PPNRKALDWNT-------------RMKIAHGAARGLEYLHE 198 (399)
Q Consensus 155 ~e~~~~g~L~~-------------------~l~~~----~~~~~~l~~~~-------------~~~i~~ql~~~l~~LH~ 198 (399)
++|++|..+.. ..+.. +.......|.. -.....++...+..+.+
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99998877762 01111 11111222320 01122233344444443
Q ss_pred cC----C---CCeEecCCCCCceEECCCCC-eeEecccCcc
Q 046609 199 SA----Q---PPVIYRDFKASNVLLDQDFN-PKLSDFGLAK 231 (399)
Q Consensus 199 ~~----~---~~ivH~dikp~NIll~~~~~-~kl~Dfg~~~ 231 (399)
.- . ..+||+|+.|+||+++.+.. .-++||+-+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 21 1 22899999999999999885 8899998765
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.09 E-value=0.072 Score=46.75 Aligned_cols=75 Identities=23% Similarity=0.320 Sum_probs=50.2
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC---CCceeeEEEEEeeCCeeEEEEEecCCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS---NPYLVNLVGYCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~g 161 (399)
+.+.-|.--..|...+. ..++.+|.-... ...-|..|+.-|..|. .-.|.+++.+....++.|+||||++-|
T Consensus 22 ~~v~gG~inea~~v~dg--~~~~FvK~n~~~---~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~ 96 (286)
T COG3001 22 EEVSGGDINEAWRLRDG--TDPFFVKCNQRE---QLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG 96 (286)
T ss_pred cccCCccccceeEeecC--CcceEEEecchh---hHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence 44555555555555443 456778864321 2244677777666664 356888899989999999999999876
Q ss_pred ChH
Q 046609 162 SLE 164 (399)
Q Consensus 162 ~L~ 164 (399)
.+.
T Consensus 97 ~~d 99 (286)
T COG3001 97 PLD 99 (286)
T ss_pred CCC
Confidence 664
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.25 Score=47.59 Aligned_cols=75 Identities=13% Similarity=0.217 Sum_probs=44.7
Q ss_pred CeeccCCcEEEEEEEECCCC-eE-----EEEEEEccCCCcchHHHHHHHHHHHccCCCce-eeEEEEEeeCCeeEEEEEe
Q 046609 85 NLLGEGGFGRVYRGKLEGTN-QD-----VAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL-VNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~-~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~ 157 (399)
+.|..|-...+|++...+.. .. |.++..... ....-.-.+|+.+++.+...++ .++++.+.. ++|.||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 45656778899998764321 22 444433221 1111223568889999876554 455565532 699999
Q ss_pred cCCCChH
Q 046609 158 MPNGSLE 164 (399)
Q Consensus 158 ~~~g~L~ 164 (399)
++|-+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9887764
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.12 Score=47.78 Aligned_cols=31 Identities=32% Similarity=0.393 Sum_probs=25.3
Q ss_pred CCeEecCCCCCceEECCC--C---CeeEecccCccC
Q 046609 202 PPVIYRDFKASNVLLDQD--F---NPKLSDFGLAKL 232 (399)
Q Consensus 202 ~~ivH~dikp~NIll~~~--~---~~kl~Dfg~~~~ 232 (399)
..++|||+..+|||+..+ | .+++.||-+++.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 359999999999999654 3 589999987763
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.22 Score=54.27 Aligned_cols=30 Identities=40% Similarity=0.410 Sum_probs=25.4
Q ss_pred CeEecCCCCCceEECCCC--Cee-EecccCccC
Q 046609 203 PVIYRDFKASNVLLDQDF--NPK-LSDFGLAKL 232 (399)
Q Consensus 203 ~ivH~dikp~NIll~~~~--~~k-l~Dfg~~~~ 232 (399)
.+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 204 ~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 204 QVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred ceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 399999999999999875 555 999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.50 E-value=0.34 Score=45.61 Aligned_cols=72 Identities=17% Similarity=0.114 Sum_probs=42.8
Q ss_pred cCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC--ceeeEE---E--EEeeCCeeEEEEEecCCC
Q 046609 89 EGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP--YLVNLV---G--YCVDGDQRILVYEYMPNG 161 (399)
Q Consensus 89 ~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~---~--~~~~~~~~~lv~e~~~~g 161 (399)
.+....||+....+ +..+++|+.+... ....++..|...+..+... .++... + +...++..+.++++++|.
T Consensus 35 ~s~eN~vy~v~~~~-~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~ 112 (325)
T PRK11768 35 NSYENRVYQFGDED-GRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGR 112 (325)
T ss_pred ccccceEEEEecCC-CCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCC
Confidence 44556789887653 5678899886432 2445666777777666421 122211 1 122345678899999776
Q ss_pred C
Q 046609 162 S 162 (399)
Q Consensus 162 ~ 162 (399)
.
T Consensus 113 ~ 113 (325)
T PRK11768 113 A 113 (325)
T ss_pred C
Confidence 4
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.2 Score=49.09 Aligned_cols=75 Identities=12% Similarity=0.084 Sum_probs=45.5
Q ss_pred CCeeccCCcEEEEEEEECCC--------CeEEEEEEEccCCCcchHHHHHHHHHHHccCCCcee-eEEEEEeeCCeeEEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGT--------NQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV-NLVGYCVDGDQRILV 154 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv-~l~~~~~~~~~~~lv 154 (399)
.+.|..|-.-.+|++...+. ++.|.+++.......- -....|..+++.+..-+|- ++++.+. -+.|
T Consensus 110 i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~----gg~I 184 (442)
T PTZ00296 110 VNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS----GGRI 184 (442)
T ss_pred EEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC----CCEE
Confidence 45666677778888875421 4578888876543221 1334577777777644443 3445543 2467
Q ss_pred EEecCCCCh
Q 046609 155 YEYMPNGSL 163 (399)
Q Consensus 155 ~e~~~~g~L 163 (399)
.+|++|-+|
T Consensus 185 ~efi~g~~l 193 (442)
T PTZ00296 185 EEWLYGDPL 193 (442)
T ss_pred EEeeCCccC
Confidence 899987644
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 399 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-61 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-60 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-52 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-52 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-45 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-45 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-44 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-42 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-21 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-20 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-20 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-19 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 5e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 5e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 5e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 6e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 6e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 7e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 7e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 7e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 7e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 8e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 8e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 8e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-19 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-18 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-18 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-18 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-18 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-18 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 4e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-18 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 5e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 6e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 6e-18 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 7e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 7e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 9e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-17 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-17 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-17 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 4e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-17 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-17 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 6e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-17 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 7e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 7e-17 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 8e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-17 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 9e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 9e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-16 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-16 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-16 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-16 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-16 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-16 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-16 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-16 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-16 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-16 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-16 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-16 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-16 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 8e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-15 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-15 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-15 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-15 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-15 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-15 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-15 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-15 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 5e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-15 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-15 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-15 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-14 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-14 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-14 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-14 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-14 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 4e-14 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-14 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-14 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-14 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-14 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-14 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-14 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-14 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-14 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-14 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-14 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-14 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-14 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 9e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 9e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-13 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-13 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-13 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-13 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-13 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-13 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-13 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 5e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 5e-13 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-13 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-13 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-13 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-13 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-13 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-13 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-13 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-13 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-13 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-12 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 3e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-12 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-12 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 6e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 6e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-12 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 8e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-12 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 9e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-11 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-11 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-11 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 6e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-11 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-11 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-11 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-10 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-10 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-10 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 6e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 6e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 7e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 8e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-09 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-09 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 8e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 9e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 9e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 9e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-08 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-08 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-08 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-08 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-08 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-08 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-08 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 9e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 9e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-07 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-07 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 8e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-07 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 8e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 8e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 8e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 8e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 9e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 9e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 9e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 9e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 4e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-06 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 5e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-06 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-06 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 7e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 7e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-05 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-05 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-05 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-05 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-05 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-05 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-05 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-05 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-05 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-05 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-05 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-05 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-05 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-05 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-05 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-05 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-05 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-05 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-05 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-05 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-05 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-05 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-05 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-04 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-04 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-04 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-04 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 3e-04 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 3e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 527 bits (1361), Expect = 0.0
Identities = 112/305 (36%), Positives = 163/305 (53%), Gaps = 20/305 (6%)
Query: 67 KIFSYRELCVATTNFNP------DNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNG 116
FS+ EL T NF+ N +GEGGFG VY+G + VAVK+L D
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN--TTVAVKKLAAMVDITT 70
Query: 117 FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKA 176
+ ++F E+ +++ + LV L+G+ DGD LVY YMPNGSL D L
Sbjct: 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPP 129
Query: 177 LDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236
L W+ R KIA GAA G+ +LHE I+RD K++N+LLD+ F K+SDFGLA+
Sbjct: 130 LSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL 296
++ +++R++GT Y APE L G++T KSD+YSFGVV LEIITG +D R Q L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLL 243
Query: 297 VTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
+ + + + D + + + +VA+ CL E+ RP + V ++
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQ 302
Query: 357 YLAHS 361
+ S
Sbjct: 303 EMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 519 bits (1339), Expect = 0.0
Identities = 118/303 (38%), Positives = 168/303 (55%), Gaps = 5/303 (1%)
Query: 63 NITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE 122
+ +L AT NF+ L+G G FG+VY+G L VA+K+ QG E
Sbjct: 23 PFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEE 81
Query: 123 FLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTR 182
F E+ LS +P+LV+L+G+C + ++ IL+Y+YM NG+L+ HL ++ W R
Sbjct: 82 FETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQR 141
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
++I GAARGL YLH +I+RD K+ N+LLD++F PK++DFG++K G D++H+S
Sbjct: 142 LEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLS 198
Query: 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302
T V GT GY PEY + G+LT KSDVYSFGVV E++ R I S P E NL WA
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVE 258
Query: 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362
+ + DP L + L + A CL + RP M DV+ +EY +
Sbjct: 259 SHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317
Query: 363 EEA 365
E
Sbjct: 318 ESV 320
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 509 bits (1314), Expect = 0.0
Identities = 132/308 (42%), Positives = 188/308 (61%), Gaps = 10/308 (3%)
Query: 52 EELRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQ 111
EE ++ G K FS REL VA+ NF+ N+LG GGFG+VY+G+L VAVK+
Sbjct: 7 EEDPEVHLG----QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKR 61
Query: 112 LDRNGFQGN-REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDL 170
L QG +F EV M+SM + L+ L G+C+ +R+LVY YM NGS+ L +
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 171 PPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230
P ++ LDW R +IA G+ARGL YLH+ P +I+RD KA+N+LLD++F + DFGLA
Sbjct: 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181
Query: 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRP 290
KL D +HV+T V GT G+ APEY TG+ + K+DV+ +GV+ LE+ITG+R D +R
Sbjct: 182 KLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARL 240
Query: 291 TEEQ--NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM 348
+ L+ W L K+++ + D L+GNY + + Q + VA +C Q RP M
Sbjct: 241 ANDDDVMLLDWVKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKM 299
Query: 349 SDVVTAIE 356
S+VV +E
Sbjct: 300 SEVVRMLE 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 1e-89
Identities = 70/314 (22%), Positives = 107/314 (34%), Gaps = 29/314 (9%)
Query: 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVL 128
L + + G FG V++ +L + VAVK Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQS-WQNEYEVY 70
Query: 129 MLSMLSNPYLVNLVGYCVDGD----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK 184
L + + ++ +G G L+ + GSL D L + WN
Sbjct: 71 SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCH 125
Query: 185 IAHGAARGLEYLHESAQ-------PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237
IA ARGL YLHE P + +RD K+ NVLL + ++DFGLA G
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGK 185
Query: 238 KSHVSTRVMGTYGYCAPEYA-----LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292
+ + +GT Y APE + D+Y+ G+V E+ + D
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 293 EQNL--VTWATPLFKDRRKF--TMMADPLLEGNYPIKGLYQALA-VAAMCLQEEAGTRPM 347
P +D ++ P+L + L C +A R
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS 305
Query: 348 MSDVVTAIEYLAHS 361
V I +
Sbjct: 306 AGCVGERITQMQRL 319
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-69
Identities = 73/344 (21%), Positives = 125/344 (36%), Gaps = 46/344 (13%)
Query: 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFL--VE 126
+ E + N L+G G +G VY+G L+ + VAVK + F+
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDE--RPVAVKVFSF---ANRQNFINEKN 57
Query: 127 VLMLSMLSNPYLVNLVGYCVDGD-----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNT 181
+ + ++ + + + + +LV EY PNGSL +L + DW +
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-----SLHTSDWVS 112
Query: 182 RMKIAHGAARGLEYLHES------AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK---- 231
++AH RGL YLH +P + +RD + NVL+ D +SDFGL+
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172
Query: 232 --LGPTGDKSHVSTRVMGTYGYCAPEYA-------LTGQLTAKSDVYSFGVVFLEIITGR 282
L G++ + + +GT Y APE + D+Y+ G+++ EI
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 283 RVIDNSRPTEEQNL----VTWATPLFKDRRKF--TMMADPLLEGNYPIKGLYQALAVAAM 336
+ E + P F+D + P + L +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 337 --CLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDSLDSCHHGR 378
C ++A R + L E + + HH
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMIWER--NKSVSPTAHHHH 334
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-64
Identities = 71/289 (24%), Positives = 131/289 (45%), Gaps = 45/289 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN-------REFLVEVLMLSMLSNPYLV 139
+G+GGFG V++G+L VA+K L +G +EF EV ++S L++P +V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L G + +V E++P G L LLD + W+ ++++ A G+EY+ +
Sbjct: 87 KLYGLMH--NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQ-N 140
Query: 200 AQPPVIYRDFKASNVLLDQ-----DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
PP+++RD ++ N+ L K++DFGL++ H + ++G + + AP
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWMAP 195
Query: 255 EYALTGQL---TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311
E + + T K+D YSF ++ I+TG D + + + R
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMI-REEGLR--- 248
Query: 312 MMADPLLEGNYP--IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358
P + + P ++ + + +C + RP S +V + L
Sbjct: 249 ----PTIPEDCPPRLRNVIE------LCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 4e-64
Identities = 85/279 (30%), Positives = 130/279 (46%), Gaps = 28/279 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGY 144
+G G FG V+R + G DVAVK L F EFL EV ++ L +P +V +G
Sbjct: 45 IGAGSFGTVHRAEWHG--SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+V EY+ GSL L R+ LD R+ +A+ A+G+ YLH + PP+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHK-SGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPI 160
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
++R+ K+ N+L+D+ + K+ DFGL++L + S S GT + APE
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNE 218
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP- 323
KSDVYSFGV+ E+ T ++ N P + V A FK +R + N
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQ----VVAAV-GFKCKR-------LEIPRNLNP 266
Query: 324 -IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361
+ + + C E RP + ++ + L S
Sbjct: 267 QVAAIIE------GCWTNEPWKRPSFATIMDLLRPLIKS 299
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-62
Identities = 80/302 (26%), Positives = 125/302 (41%), Gaps = 38/302 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G G FG V + K +DVA+KQ++ + + F+VE+ LS +++P +V L G C+
Sbjct: 16 VGRGAFGVVCKAKWRA--KDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACL 71
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+ LV EY GSL + L P M ++G+ YLH +I+
Sbjct: 72 N--PVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 207 RDFKASNVLLDQDFN-PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL-TA 264
RD K N+LL K+ DFG A D T G+ + APE G +
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPE-VFEGSNYSE 182
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP--LFKDRRKFTMMADPLLEGNY 322
K DV+S+G++ E+IT R +P +E + + R P L N
Sbjct: 183 KCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHNGTR-------PPLIKNL 229
Query: 323 P--IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDSLDSCHHGRNS 380
P I+ L C ++ RP M ++V + +L A H
Sbjct: 230 PKPIESLMT------RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPG 283
Query: 381 QE 382
++
Sbjct: 284 ED 285
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 4e-61
Identities = 51/204 (25%), Positives = 93/204 (45%), Gaps = 21/204 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGY 144
L E G +++G+ +G D+ VK L + R+F E L + S+P ++ ++G
Sbjct: 18 LNENHSGELWKGRWQG--NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 145 CVD--GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
C L+ +MP GSL + L + +D + +K A ARG+ +LH + +P
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLEP 132
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ- 261
+ + +V++D+D ++S + S S M + APE AL +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVK-------FSFQSPGRMYAPAWVAPE-ALQKKP 184
Query: 262 ---LTAKSDVYSFGVVFLEIITGR 282
+D++SF V+ E++T
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTRE 208
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-60
Identities = 73/316 (23%), Positives = 121/316 (38%), Gaps = 41/316 (12%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN 135
F P +L LG+G FG+ + T + + +K+L R + R FL EV ++ L +
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
P ++ +G + + EY+ G+L + W+ R+ A A G+ Y
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAY 123
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL------------GPTGDKSHVST 243
LH +I+RD + N L+ ++ N ++DFGLA+L
Sbjct: 124 LHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180
Query: 244 RVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302
V+G + APE + G+ K DV+SFG+V EII + P +
Sbjct: 181 TVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL----- 234
Query: 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE-YLAHS 361
+ R F P N P + + C + RP + +E H
Sbjct: 235 ---NVRGFLDRYCP---PNCP-PSFFP---ITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284
Query: 362 KEEACIEDSLDSCHHG 377
+ L+ G
Sbjct: 285 AGHLPLGPQLEQLDRG 300
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-59
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 23/208 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN----REFLVEVLMLSMLSNPYLVNLV 142
+G GGFG+VYR G +VAVK + + E + +ML +P ++ L
Sbjct: 15 IGIGGFGKVYRAFWIG--DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G C+ LV E+ G L L + K + + + A ARG+ YLH+ A
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVL-----SGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 203 PVIYRDFKASNVLLDQDFNP--------KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
P+I+RD K+SN+L+ Q K++DFGLA+ G Y + AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE----WHRTTKMSAAGAYAWMAP 183
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGR 282
E + SDV+S+GV+ E++TG
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-57
Identities = 66/307 (21%), Positives = 124/307 (40%), Gaps = 41/307 (13%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
+G+G +G V+ GK G + VAVK + + RE E+ ++ + ++
Sbjct: 42 VKQIGKGRYGEVWMGKWRG--EKVAVKVFFTTEEASWF--RE--TEIYQTVLMRHENILG 95
Query: 141 LVGYCVDGDQRI----LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+ + G L+ +Y NGSL D+L LD + +K+A+ + GL +L
Sbjct: 96 FIAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHL 150
Query: 197 HESA-----QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTY 249
H +P + +RD K+ N+L+ ++ ++D GLA T + +GT
Sbjct: 151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210
Query: 250 GYCAPEYALTGQLTA-------KSDVYSFGVVFLEIITGRRVIDNSRPTEEQ---NLVTW 299
Y PE L L +D+YSFG++ E+ R + E Q + +
Sbjct: 211 RYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVAR--RCVSGGIVEEYQLPYHDLVP 267
Query: 300 ATPLFKDRRKF--TMMADPLLEGNYPIKGLYQALA-VAAMCLQEEAGTRPMMSDVVTAIE 356
+ P ++D R+ P + + + + C +R V +
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLA 327
Query: 357 YLAHSKE 363
++ S++
Sbjct: 328 KMSESQD 334
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-56
Identities = 77/278 (27%), Positives = 125/278 (44%), Gaps = 27/278 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLVGY 144
+G G FG VY+GK + DVAVK L+ + F EV +L + ++ +GY
Sbjct: 32 IGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
I V ++ SL HL + + + IA ARG++YLH +
Sbjct: 89 STAPQLAI-VTQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE---YALTGQ 261
I+RD K++N+ L +D K+ DFGLA SH ++ G+ + APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 262 LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321
+ +SDVY+FG+V E++TG+ N ++ + R + N
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMV-----GRGSLSPDLSKVRSN 253
Query: 322 YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359
P K + + + A CL+++ RP ++ IE LA
Sbjct: 254 CP-KRMKRLM---AECLKKKRDERPSFPRILAEIEELA 287
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 7e-56
Identities = 59/291 (20%), Positives = 109/291 (37%), Gaps = 44/291 (15%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLV 142
L+G+G FG+VY G+ + +VA++ +D + + F EV+ + +V +
Sbjct: 39 ELIGKGRFGQVYHGRW---HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G C+ ++ +L + D + LD N +IA +G+ YLH
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKL---GPTGDKSHVSTRVMGTYGYCAPE---- 255
++++D K+ NV D + ++DFGL + G + G + APE
Sbjct: 150 GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 256 -----YALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL--VTWATPLFKDRR 308
+ SDV++ G ++ E+ P + Q + W +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHARE------WPFKTQPAEAIIWQM-GTGMKP 261
Query: 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359
L + K + L C E RP + ++ +E L
Sbjct: 262 -------NLSQIGMG-KEISDIL---LFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 9e-54
Identities = 52/227 (22%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFL--VEVLMLSMLSNPYLVNLV 142
+G+G +G V+RG +G ++VAVK + + + E+ ML + ++ +
Sbjct: 14 ECVGKGRYGEVWRGSWQG--ENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFI 68
Query: 143 GYCVDGD----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+ Q L+ Y GSL D+L LD + ++I A GL +LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHI 123
Query: 199 -----SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTYGY 251
+P + +RD K+ N+L+ ++ ++D GLA + T + +GT Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183
Query: 252 CAPE------YALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292
APE + D+++FG+V E+ +
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 2e-53
Identities = 69/304 (22%), Positives = 120/304 (39%), Gaps = 37/304 (12%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFL--VEVLMLSMLSNPYLVNL 141
+G+G FG V+RGK G ++VAVK + R + E+ ML + ++
Sbjct: 47 QESIGKGRFGEVWRGKWRG--EEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGF 101
Query: 142 VGYCVDGDQRI----LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+ + LV +Y +GSL D+L NR + +K+A A GL +LH
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLH 156
Query: 198 ESAQ-----PPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTYG 250
P + +RD K+ N+L+ ++ ++D GLA T +GT
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216
Query: 251 YCAPEYALTGQL-------TAKSDVYSFGVVFLEIITGRRVIDNSRPTEE--QNLVTWAT 301
Y APE L + ++D+Y+ G+VF EI + + +LV +
Sbjct: 217 YMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV-PSD 274
Query: 302 PLFKDRRKF--TMMADPLLEGNYPIKGLYQALA-VAAMCLQEEAGTRPMMSDVVTAIEYL 358
P ++ RK P + + + +A + C R + + L
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 359 AHSK 362
+ +
Sbjct: 335 SQQE 338
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 57/195 (29%), Positives = 89/195 (45%), Gaps = 7/195 (3%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
+G G FG V+ G+L N VAVK + +FL E +L S+P +V L+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+V E + G L L T +++ AA G+EYL I
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAK 265
+RD A N L+ + K+SDFG+++ G + + APE G+ +++
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 266 SDVYSFGVVFLEIIT 280
SDV+SFG++ E +
Sbjct: 296 SDVWSFGILLWETFS 310
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 8e-41
Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 87 LGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
LG+G FG V + + T + VAVK+L + + R+F E+ +L L + +V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 143 GYCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
G C +R L+ EY+P GSL D+L +++ +D ++ +G+EYL
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 134
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYAL 258
I+RD N+L++ + K+ DFGL K+ P DK + G + APE
Sbjct: 135 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEFFKVKEPGESPIFWYAPESLT 190
Query: 259 TGQLTAKSDVYSFGVVFLEIIT 280
+ + SDV+SFGVV E+ T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 8e-41
Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 7/196 (3%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
+ LG G +G VY G + + VAVK L + EFL E ++ + +P LV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
C ++ E+M G+L D+L + NR+ + + +A + +EYL +
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKKN---F 339
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
I+R+ A N L+ ++ K++DFGL++L TGD + APE + +
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 265 KSDVYSFGVVFLEIIT 280
KSDV++FGV+ EI T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-40
Identities = 61/206 (29%), Positives = 105/206 (50%), Gaps = 13/206 (6%)
Query: 84 DNLLGEGGFGRVYRGKL----EGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYL 138
+LG G FG VY+G E VA+K+L + + N+E L E +++ + NP++
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
L+G C+ L+ + MP G L D++ + ++ + + A+G+ YL E
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYL-E 134
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+ +++RD A NVL+ + K++DFGLAKL +K + + + A E L
Sbjct: 135 DRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 259 TGQLTAKSDVYSFGVVFLEIIT-GRR 283
T +SDV+S+GV E++T G +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 87 LGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
LG+G FG V + + T + VAVK+L + + R+F E+ +L L + +V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 143 GYCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
G C +R L+ EY+P GSL D+L +++ +D ++ +G+EYL
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQK---HKERIDHIKLLQYTSQICKGMEYLGTKR 165
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYAL 258
I+RD N+L++ + K+ DFGL K+ P DK + + G + APE
Sbjct: 166 ---YIHRDLATRNILVENENRVKIGDFGLTKVLPQ-DKEYYKVKEPGESPIFWYAPESLT 221
Query: 259 TGQLTAKSDVYSFGVVFLEIIT 280
+ + SDV+SFGVV E+ T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G +G VY G + + VAVK L + EFL E ++ + +P LV L+G C
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
++ E+M G+L D+L + NR+ + + +A + +EYL E I+
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYL-EKKN--FIH 134
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGD-KSHVSTRV----MGTYGYCAPEYALTGQ 261
RD A N L+ ++ K++DFGL++L +H + APE +
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAYNK 188
Query: 262 LTAKSDVYSFGVVFLEIIT-GRR 283
+ KSDV++FGV+ EI T G
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMS 211
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-40
Identities = 66/205 (32%), Positives = 101/205 (49%), Gaps = 21/205 (10%)
Query: 87 LGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
LG+G FG V + + T VAVKQL +G R+F E+ +L L + ++V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 143 GYCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
G ++ LV EY+P+G L D L +R LD + + + +G+EYL
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQR---HRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG-----YCAPE 255
++RD A N+L++ + + K++DFGLAKL P +V G + APE
Sbjct: 148 ---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR----EPGQSPIFWYAPE 200
Query: 256 YALTGQLTAKSDVYSFGVVFLEIIT 280
+ +SDV+SFGVV E+ T
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 60/203 (29%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 87 LGEGGFGRVYRGKL----EGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG+V + + T + VAVK L +G + E+ +L L + +V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 142 VGYCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G C + L+ E++P+GSL+++L N+ ++ ++K A +G++YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSR 145
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYA 257
++RD A NVL++ + K+ DFGL K T DK + + + + APE
Sbjct: 146 Q---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET-DKEYYTVKDDRDSPVFWYAPECL 201
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT 280
+ + SDV+SFGV E++T
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-39
Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 84 DNLLGEGGFGRVYRGKL----EGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYL 138
+LG G FG V++G E V +K + D++G Q + +L + L + ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
V L+G C G LV +Y+P GSL DH+ +R AL + A+G+ YL E
Sbjct: 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+++R+ A NVLL +++DFG+A L P DK + + + A E
Sbjct: 134 HG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 259 TGQLTAKSDVYSFGVVFLEIIT-GRR 283
G+ T +SDV+S+GV E++T G
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-39
Identities = 60/203 (29%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 87 LGEGGFGRVYRGKL----EGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LG G FG VY+G E VA+K+L + + N+E L E +++ + NP++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+G C+ L+ + MP G L D++ + ++ + + A+G+ YL +
Sbjct: 83 LGICL-TSTVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR- 137
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+++RD A NVL+ + K++DFGLAKL +K + + + A E L
Sbjct: 138 --LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 262 LTAKSDVYSFGVVFLEIIT-GRR 283
T +SDV+S+GV E++T G +
Sbjct: 196 YTHQSDVWSYGVTVWELMTFGSK 218
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-38
Identities = 63/201 (31%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G G FG V+ G + VA+K + R G +F+ E ++ LS+P LV L G C+
Sbjct: 16 IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+ LV E+M +G L D+L R T + + G+ YL E A VI+
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYL-EEAC--VIH 127
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYALTGQLT 263
RD A N L+ ++ K+SDFG+ + T GT + +PE + +
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRF----VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 264 AKSDVYSFGVVFLEIIT-GRR 283
+KSDV+SFGV+ E+ + G+
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKI 204
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 2e-38
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 87 LGEGGFGRVYRGKL---EGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
LG+G FG V RG+ G VAVK L + + +F+ EV + L + L+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L G + +V E P GSL D L ++ T + A A G+ YL ES
Sbjct: 86 LYGVVL-TPPMKMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYL-ESK 140
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYA 257
+ I+RD A N+LL K+ DFGL + P D +V + +CAPE
Sbjct: 141 R--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPESL 196
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT-GRR 283
T + SD + FGV E+ T G+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-38
Identities = 64/203 (31%), Positives = 97/203 (47%), Gaps = 24/203 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G+G FG V G G VAVK + + + FL E +++ L + LV L+G V
Sbjct: 201 IGKGEFGDVMLGDYRGN--KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 147 DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ + +V EYM GSL D+L R L + +K + +EYL E +
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL-EGNN--FV 311
Query: 206 YRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV----MGTYGYCAPEYALTGQ 261
+RD A NVL+ +D K+SDFGL K + + ++ APE +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREKK 362
Query: 262 LTAKSDVYSFGVVFLEIIT-GRR 283
+ KSDV+SFG++ EI + GR
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRV 385
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQL-DRNGFQGNREFLV-EVLMLSMLSNPYLVNL 141
D +G G F VY+G T +VA +L DR + R+ E ML L +P +V
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 142 VGYCVDGDQR----ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+ +LV E M +G+L+ +L K + +GL++LH
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLH 146
Query: 198 ESAQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+ PP+I+RD K N+ + + K+ D GLA L ++ + V+GT + APE
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK----RASFAKAVIGTPEFMAPEM 201
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGR 282
+ DVY+FG+ LE+ T
Sbjct: 202 -YEEKYDESVDVYAFGMCMLEMATSE 226
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-38
Identities = 70/206 (33%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQD----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNL 141
LGEG FG+V + TN VAVK L G Q + E+ +L L + +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 142 VGYCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G C D LV EY+P GSL D+L R ++ + A G+ YLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYL-----PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG-----YCAP 254
I+RD A NVLLD D K+ DFGLAK P G + + + G + AP
Sbjct: 154 H---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR----VREDGDSPVFWYAP 206
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIIT 280
E + SDV+SFGV E++T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLT 232
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 6e-38
Identities = 65/201 (32%), Positives = 101/201 (50%), Gaps = 16/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V GK +G DVAVK + + G EF E + LS+P LV G C
Sbjct: 16 LGSGQFGVVKLGKWKG-QYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+V EY+ NG L ++L + K L+ + +++ + G+ +L ES Q I+
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFL-ESHQ--FIH 127
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYALTGQLT 263
RD A N L+D+D K+SDFG+ + +GT + APE + +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYV----LDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 264 AKSDVYSFGVVFLEIIT-GRR 283
+KSDV++FG++ E+ + G+
Sbjct: 184 SKSDVWAFGILMWEVFSLGKM 204
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 9e-38
Identities = 62/201 (30%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V GK G DVA+K + + G EF+ E ++ LS+ LV L G C
Sbjct: 32 LGTGQFGVVKYGKWRGQY-DVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
++ EYM NG L ++L + R +++ +EYL ES Q ++
Sbjct: 90 KQRPIFIITEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYL-ESKQ--FLH 143
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYALTGQLT 263
RD A N L++ K+SDFGL++ T +G+ + PE + + +
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYV----LDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 264 AKSDVYSFGVVFLEIIT-GRR 283
+KSD+++FGV+ EI + G+
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKM 220
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-38
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 27/212 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVN 140
LG+G FG VY G +G +D VA+K ++ R EFL E ++ + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDL------PPNRKALDWNTRMKIAHGAARGLE 194
L+G G +++ E M G L+ +L L P + +++A A G+
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD--KSHVSTRV----MGT 248
YL ++RD A N ++ +DF K+ DFG+ + D + + M
Sbjct: 153 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 207
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+PE G T SDV+SFGVV EI T
Sbjct: 208 ----SPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 87 LGEGGFGRVYRGKLEGTNQ-------DVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
LG+G F ++++G +V +K LD+ + F M+S LS+ +LV
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
G CV GD+ ILV E++ GSL+ +L N+ ++ ++++A A + +L E
Sbjct: 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFL-EE 131
Query: 200 AQPPVIYRDFKASNVLLDQDFNP--------KLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
+I+ + A N+LL ++ + KLSD G++ V+
Sbjct: 132 NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT------------VLPKDIL 177
Query: 252 ------CAPEYALTGQL-TAKSDVYSFGVVFLEIIT-GRR 283
PE + +D +SFG EI + G +
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-37
Identities = 65/205 (31%), Positives = 98/205 (47%), Gaps = 24/205 (11%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
+G+G FG V G G VAVK + +N + FL E +++ L + LV L+G
Sbjct: 27 QTIGKGEFGDVMLGDYRGN--KVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 145 CVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
V+ + +V EYM GSL D+L R L + +K + +EYL E
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYL-EGNN-- 137
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV----MGTYGYCAPEYALT 259
++RD A NVL+ +D K+SDFGL K + + ++ APE
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWT------APEALRE 188
Query: 260 GQLTAKSDVYSFGVVFLEIIT-GRR 283
+ + KSDV+SFG++ EI + GR
Sbjct: 189 KKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQ--DVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNLV 142
LG G FG V +G + DVA+K L + G + E + E ++ L NPY+V L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G C + +LV E G L L+ R+ + + ++ H + G++YL E
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL-EEKN- 130
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYALTG 260
++RD A NVLL K+SDFGL+K D S+ + R G + + APE
Sbjct: 131 -FVHRDLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFR 188
Query: 261 QLTAKSDVYSFGVVFLEIIT-GRR 283
+ +++SDV+S+GV E ++ G++
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQK 212
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQ--DVAVKQL--DRNGFQGNREFLVEVLMLSMLSNPYLVNLV 142
LG G FG V +G + VAVK L + N E L E ++ L NPY+V ++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G C + + +LV E G L +L + + +++ H + G++YL E +
Sbjct: 85 GIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYL-EESN- 137
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY--GYCAPEYALTG 260
++RD A NVLL K+SDFGL+K D+++ + G + + APE
Sbjct: 138 -FVHRDLAARNVLLVTQHYAKISDFGLSKALRA-DENYYKAQTHGKWPVKWYAPECINYY 195
Query: 261 QLTAKSDVYSFGVVFLEIIT-GRR 283
+ ++KSDV+SFGV+ E + G++
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-37
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 84 DNLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLV 139
D ++G+G FG VY G+ A+K L R Q FL E L++ L++P ++
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 140 NLVGYCVDGDQRIL-VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
L+G + + + YM +G L + ++ + ARG+EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYL-- 140
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL----GPTGDKSHVSTRV----MGTYG 250
A+ ++RD A N +LD+ F K++DFGLA+ + H R+
Sbjct: 141 -AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT---- 195
Query: 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
A E T + T KSDV+SFGV+ E++T
Sbjct: 196 --ALESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-37
Identities = 63/196 (32%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
LG+G FG V+ G G VA+K L + G FL E ++ L + LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+ + +V EYM GSL D L K L + +A A G+ Y+
Sbjct: 248 VSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 301
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
++RD +A+N+L+ ++ K++DFGLA+L ++ + APE AL G+ T
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 265 KSDVYSFGVVFLEIIT 280
KSDV+SFG++ E+ T
Sbjct: 361 KSDVWSFGILLTELTT 376
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 7e-37
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 37/228 (16%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNREFLVEVLML 130
++ LGEG FG+V+ + + VAVK L ++F E +L
Sbjct: 12 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71
Query: 131 SMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL------------LDLPPNRKALD 178
+ L + ++V G C DGD I+V+EYM +G L L + L
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 179 WNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD- 237
+ + IA A G+ YL A ++RD N L+ + K+ DFG+++ + D
Sbjct: 132 LSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188
Query: 238 -KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ T + M PE + + T +SDV+SFGV+ EI T
Sbjct: 189 YRVGGHTMLPIRWM------PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-37
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)
Query: 87 LGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNL 141
LGEG FG V G L +GT+ VAVK + + EFL E + S+P ++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 142 VGYCVDGDQRI-----LVYEYMPNGSLEDHLLD--LPPNRKALDWNTRMKIAHGAARGLE 194
+G C++ + ++ +M G L +LL L K + T +K A G+E
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD--KSHVSTRV----MGT 248
YL + ++RD A N +L D ++DFGL+K +GD + ++ +
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI-- 216
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
A E T+KSDV++FGV EI T
Sbjct: 217 ----AIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 28/213 (13%)
Query: 87 LGEGGFGRVYRGKLEGTNQD---VAVKQLDRNGFQGNR--EFLVEVLMLSMLSNPYLVNL 141
LG+G FG V +L+ + VAVK L + + EFL E + +P++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 142 VGYCVDGDQRI------LVYEYMPNGSLEDHLLDLPP--NRKALDWNTRMKIAHGAARGL 193
VG + + ++ +M +G L LL N L T ++ A G+
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD--KSHVSTRV----MG 247
EYL + I+RD A N +L +D ++DFGL++ +GD + ++++ +
Sbjct: 151 EYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWL- 206
Query: 248 TYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
A E T SDV++FGV EI+T
Sbjct: 207 -----ALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 21/208 (10%)
Query: 84 DNLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRN-GFQGNREFLVEVLMLSMLSNPYLV 139
+ ++G G FG VY G L +G AVK L+R +FL E +++ S+P ++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 140 NLVGYCVDGDQRIL-VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+L+G C+ + L V YM +G L + + + + A+G++YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYL-- 144
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC------ 252
A ++RD A N +LD+ F K++DFGLA+ + V G
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE----YYSVHNKTGAKLPVKWM 199
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIIT 280
A E T + T KSDV+SFGV+ E++T
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-36
Identities = 74/286 (25%), Positives = 121/286 (42%), Gaps = 31/286 (10%)
Query: 15 HRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKGKNNITAKIFSYREL 74
R S+ I R + L +I + S + +E L G +I + EL
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN-PEL 75
Query: 75 CVATTNFNPD---------NLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRN-GFQGNR 121
A + ++G G FG VY G L +G AVK L+R
Sbjct: 76 VQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS 135
Query: 122 EFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL-VYEYMPNGSLEDHLLDLPPNRKALDWN 180
+FL E +++ S+P +++L+G C+ + L V YM +G L + + +
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN---ETHNPTVK 192
Query: 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
+ A+G+++L A ++RD A N +LD+ F K++DFGLA+ +
Sbjct: 193 DLIGFGLQVAKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 249
Query: 241 VSTRVMG------TYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
V + A E T + T KSDV+SFGV+ E++T
Sbjct: 250 VHNKTGAKLPVKWM----ALESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-36
Identities = 68/199 (34%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+ G G VAVK L + G FL E ++ L + LV L V
Sbjct: 21 LGAGQFGEVWMGYYNGHT-KVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+ ++ EYM NGSL D L P+ L N + +A A G+ ++ E I+
Sbjct: 78 TQEPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFI-EERN--YIH 132
Query: 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGD-KSHVSTRVMGTYGYCAPEYALTGQLTAK 265
RD +A+N+L+ + K++DFGLA+L + + + + APE G T K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTIK 190
Query: 266 SDVYSFGVVFLEIIT-GRR 283
SDV+SFG++ EI+T GR
Sbjct: 191 SDVWSFGILLTEIVTHGRI 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 2e-36
Identities = 63/196 (32%), Positives = 96/196 (48%), Gaps = 9/196 (4%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
LG+G FG V+ G G VA+K L + G FL E ++ L + LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNG-TTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+ + +V EYM GSL D L K L + +A A G+ Y+
Sbjct: 331 VSE-EPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVERMN---Y 384
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
++RD +A+N+L+ ++ K++DFGLA+L ++ + APE AL G+ T
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 265 KSDVYSFGVVFLEIIT 280
KSDV+SFG++ E+ T
Sbjct: 444 KSDVWSFGILLTELTT 459
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 2e-36
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 87 LGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLV 142
+G G G V G+L + VA+K L + R +FL E ++ +P ++ L
Sbjct: 57 IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G G ++V EYM NGSL+ L + + + G G+ YL
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYL-SDLG- 171
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++RD A NVL+D + K+SDFGL++ L D ++ +T + APE
Sbjct: 172 -YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 262 LTAKSDVYSFGVVFLEIIT-GRR 283
++ SDV+SFGVV E++ G R
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGER 253
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-36
Identities = 50/228 (21%), Positives = 88/228 (38%), Gaps = 23/228 (10%)
Query: 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLS 131
+ + ++ LGEGGF V + A+K++ + Q E E M
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 132 MLSNPYLVNLVGYCVDGDQR----ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAH 187
+ ++P ++ LV YC+ L+ + G+L + + L L + + +
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM- 246
G RGLE +H +RD K +N+LL + P L D G + +
Sbjct: 142 GICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198
Query: 247 ------GTYGYCAPE------YALTGQLTAKSDVYSFGVVFLEIITGR 282
T Y APE + + + ++DV+S G V ++ G
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGE 243
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 36/227 (15%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNREFLVEVLML 130
++ LGEG FG+V+ + + VAVK L ++F E +L
Sbjct: 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97
Query: 131 SMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL-----------LDLPPNRKALDW 179
+ML + ++V G C +G ++V+EYM +G L L L
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 180 NTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD-- 237
+ +A A G+ YL A ++RD N L+ Q K+ DFG+++ + D
Sbjct: 158 GQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214
Query: 238 KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ T + M PE L + T +SDV+SFGVV EI T
Sbjct: 215 RVGGRTMLPIRWM------PPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 4e-36
Identities = 62/203 (30%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 87 LGEGGFGRVYRGKLEGTNQ--DVAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVNLVG 143
LG G FG V +G + DVA+K L E + E ++ L NPY+V L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
C + +LV E G L L+ R+ + + ++ H + G++YL E
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYL-EEKN-- 456
Query: 204 VIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY--CAPEYALTGQ 261
++R+ A NVLL K+SDFGL+K D S+ + R G + APE +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD-SYYTARSAGKWPLKWYAPECINFRK 515
Query: 262 LTAKSDVYSFGVVFLEIIT-GRR 283
+++SDV+S+GV E ++ G++
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQK 538
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-36
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 10/200 (5%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
LG G FG V+ + VAVK + + G FL E ++ L + LV L
Sbjct: 194 KKLGAGQFGEVWMATYNK-HTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+ ++ E+M GSL D L + + A G+ ++ E
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKS--DEGSKQPLPKLIDFSAQIAEGMAFI-EQRN--Y 305
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
I+RD +A+N+L+ K++DFGLA++ ++ + APE G T
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 265 KSDVYSFGVVFLEIIT-GRR 283
KSDV+SFG++ +EI+T GR
Sbjct: 365 KSDVWSFGILLMEIVTYGRI 384
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 87 LGEGGFGRVYRGKLEGTN----QDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVN 140
+G G FG VY+G L+ ++ VA+K L + G+ + +FL E ++ S+ ++
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L G +++ EYM NG+L+ L + + + G A G++YL
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT---YGYCAPEYA 257
++RD A N+L++ + K+SDFGL+++ D + G + APE
Sbjct: 168 ---YVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 258 LTGQLTAKSDVYSFGVVFLEIIT-GRR 283
+ T+ SDV+SFG+V E++T G R
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-35
Identities = 61/217 (28%), Positives = 102/217 (47%), Gaps = 30/217 (13%)
Query: 84 DNLLGEGGFGRVYRGKL--EGTNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSN-PYLV 139
+++GEG FG+V + ++ +G D A+K++ + +R+F E+ +L L + P ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHL------------LDLPPNRKALDWNTRMKIAH 187
NL+G C L EY P+G+L D L L + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV-- 245
ARG++YL Q I+RD A N+L+ +++ K++DFGL++ K R+
Sbjct: 150 DVARGMDYL-SQKQ--FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT-MGRLPV 205
Query: 246 --MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
M A E T SDV+S+GV+ EI++
Sbjct: 206 RWM------AIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-35
Identities = 69/288 (23%), Positives = 112/288 (38%), Gaps = 24/288 (8%)
Query: 3 CFHYCCVAKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKGKN 62
YC + I+ +G R S+ AN + S ++E
Sbjct: 314 IDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDE 373
Query: 63 NITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGF-- 117
T + S R+ + +GEG FG V++G E VA+K +N
Sbjct: 374 EDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSD 432
Query: 118 QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKAL 177
+FL E L + +P++V L+G + + ++ E G L L + +L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV---RKFSL 488
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP--- 234
D + + A+ + L YL ++RD A NVL+ + KL DFGL++
Sbjct: 489 DLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 235 --TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
K + + M APE + T+ SDV+ FGV EI+
Sbjct: 546 YYKASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILM 587
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
LGE FG+VY+G L G VA+K L D+ EF E ++ + L +P +V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHL------------LDLPPNRKALDWNTRMKIAHG 188
L+G +++ Y +G L + L D + AL+ + +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD--KSHVSTRV- 245
A G+EYL S V+++D NVL+ N K+SD GL + D K ++ +
Sbjct: 137 IAAGMEYL-SSHH--VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 246 ---MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
M APE + G+ + SD++S+GVV E+ +
Sbjct: 194 IRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-35
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
LG G FG VY G++ G D VAVK L + Q +FL+E L++S ++ +V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPP---NRKALDWNTRMKIAHGAARGLEYLH 197
+G + R ++ E M G L+ L + P +L + +A A G +YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 156
Query: 198 ESAQPPVIYRDFKASNVLLD---QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY--- 251
+ I+RD A N LL K+ DFG+A+ G
Sbjct: 157 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAMLPV 209
Query: 252 --CAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
PE + G T+K+D +SFGV+ EI +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-34
Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 37/214 (17%)
Query: 87 LGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGNR-EFLVEVLMLSMLSNPYLVNLV 142
LGEG FG VY G +G +VAVK ++ N+ +F+ E +++ L +P++V L+
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G + + ++ E P G L +L N+ +L T + + + + YL ES
Sbjct: 80 GII-EEEPTWIIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYL-ESIN- 133
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY----------- 251
++RD N+L+ KL DFGL+ R + Y
Sbjct: 134 -CVHRDIAVRNILVASPECVKLGDFGLS-------------RYIEDEDYYKASVTRLPIK 179
Query: 252 -CAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRR 283
+PE + T SDV+ F V EI++ G++
Sbjct: 180 WMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-34
Identities = 65/221 (29%), Positives = 101/221 (45%), Gaps = 36/221 (16%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-------VAVKQL-DRNGFQGNREFLVEVLMLSMLSN-PY 137
LGEG FG+V + G ++D VAVK L D + + + E+ M+ M+
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLD------------LPPNRKALDWNTRMKI 185
++NL+G C ++ EY G+L ++L + + + +
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD--KSHVST 243
+ ARG+EYL A I+RD A NVL+ ++ K++DFGLA+ D K +
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 244 RV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
R+ M APE T +SDV+SFGV+ EI T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 57/204 (27%), Positives = 100/204 (49%), Gaps = 14/204 (6%)
Query: 87 LGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNL 141
+G G FG V G+L VA+K L + G+ + R+FL E ++ +P ++ L
Sbjct: 53 VGAGEFGEVCSGRLKLPSKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
G ++V EYM NGSL+ L + + + G A G++YL +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG- 167
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
++RD A N+L++ + K+SDFGL + L + ++ + + +PE
Sbjct: 168 --YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 261 QLTAKSDVYSFGVVFLEIIT-GRR 283
+ T+ SDV+S+G+V E+++ G R
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGER 249
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 39/215 (18%)
Query: 87 LGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNL 141
+GEG FG V++G E VA+K +N +FL E L + +P++V L
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+G + ++ E G L L + +LD + + A+ + L YL
Sbjct: 82 IGVI-TENPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR- 136
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY---------- 251
++RD A NVL+ + KL DFGL+ R M Y
Sbjct: 137 --FVHRDIAARNVLVSSNDCVKLGDFGLS-------------RYMEDSTYYKASKGKLPI 181
Query: 252 --CAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRR 283
APE + T+ SDV+ FGV EI+ G +
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLMLSMLSNPYLVN 140
LG G FG VY G++ G D VAVK L + Q +FL+E L++S ++ +V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPP---NRKALDWNTRMKIAHGAARGLEYLH 197
+G + R ++ E M G L+ L + P +L + +A A G +YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL- 197
Query: 198 ESAQPPVIYRDFKASNVLLD---QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY--- 251
+ I+RD A N LL K+ DFG+A+ G
Sbjct: 198 --EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAMLPV 250
Query: 252 --CAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
PE + G T+K+D +SFGV+ EI +
Sbjct: 251 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 56/203 (27%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV----EVLMLSMLSNPYLVNL 141
LG GG VY + N VA+K + + E L EV S LS+ +V++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAI-FIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+ + D LV EY+ +L +++ L +T + + G+++ H+
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR- 131
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST-RVMGTYGYCAPEYALTG 260
+++RD K N+L+D + K+ DFG+AK + S T V+GT Y +PE A
Sbjct: 132 --IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 261 QLTAKSDVYSFGVVFLEIITGRR 283
+D+YS G+V E++ G
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEP 210
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 9e-34
Identities = 62/231 (26%), Positives = 95/231 (41%), Gaps = 40/231 (17%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLM 129
F D L LG G FG+V G ++ VAVK L + +R + E+ +
Sbjct: 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83
Query: 130 LSMLSN-PYLVNLVGYCVDGDQRILV-YEYMPNGSLEDHL------------LDLPPNRK 175
L + + +VNL+G C ++V E+ G+L +L +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 176 ALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235
L + + A+G+E+L A I+RD A N+LL + K+ DFGLA+
Sbjct: 144 FLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200
Query: 236 GD--KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
R+ M APE T +SDV+SFGV+ EI +
Sbjct: 201 DPDYVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 65/237 (27%), Positives = 100/237 (42%), Gaps = 46/237 (19%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLM 129
F NL LGEG FG+V + VAVK L + R+ L E +
Sbjct: 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL--------------------LD 169
L +++P+++ L G C +L+ EY GSL L
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 170 LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229
P+ +AL + A ++G++YL A+ +++RD A N+L+ + K+SDFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 230 AKLGPTGD--KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
++ D R+ M A E T +SDV+SFGV+ EI+T
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 1e-33
Identities = 60/228 (26%), Positives = 91/228 (39%), Gaps = 37/228 (16%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLM 129
F +NL LG G FG+V G ++ VAVK L + E+ +
Sbjct: 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 130 LSMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTR------ 182
+S L +VNL+G C G +++ EY G L + L +
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAS 162
Query: 183 ----MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD- 237
+ + A+G+ +L A I+RD A NVLL K+ DFGLA+
Sbjct: 163 TRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN 219
Query: 238 -KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ R+ M APE T +SDV+S+G++ EI +
Sbjct: 220 YIVKGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-33
Identities = 65/221 (29%), Positives = 98/221 (44%), Gaps = 36/221 (16%)
Query: 87 LGEGGFGRVYRGKLEG-------TNQDVAVKQL-DRNGFQGNREFLVEVLMLSMLSN-PY 137
LGEG FG+V + G VAVK L D + + + E+ M+ M+
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTR------------MKI 185
++NL+G C ++ EY G+L ++L P ++ +
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD--KSHVST 243
+ ARG+EYL A I+RD A NVL+ ++ K++DFGLA+ D K +
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 244 RV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
R+ M APE T +SDV+SFGV+ EI T
Sbjct: 266 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 63/232 (27%), Positives = 96/232 (41%), Gaps = 41/232 (17%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNR-EFLVEVLM 129
F + L LG G FG+V G + VAVK L + R + E+ +
Sbjct: 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79
Query: 130 LSMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL--------------LDLPPNR 174
LS L N +VNL+G C G +++ EY G L + L + +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 175 KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
ALD + ++ A+G+ +L A I+RD A N+LL K+ DFGLA+
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIK 196
Query: 235 TGD--KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
+ R+ M APE T +SDV+S+G+ E+ +
Sbjct: 197 NDSNYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 61/237 (25%), Positives = 102/237 (43%), Gaps = 46/237 (19%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNR-EFLVEVLM 129
+ +N+ +GEG FGRV++ + G VAVK L + +F E +
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL--------------------LD 169
++ NP +V L+G C G L++EYM G L + L
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 170 LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229
P L ++ IA A G+ YL ++ ++RD N L+ ++ K++DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 230 AKLGPTGD--KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
++ + D K+ + + M PE + T +SDV+++GVV EI +
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-33
Identities = 72/261 (27%), Positives = 106/261 (40%), Gaps = 20/261 (7%)
Query: 28 EAKSLASFANISFKTESSRHRYITEELRKIGKGKNN-ITAKIFSYRELCVATTNFNPDNL 86
+A SLAS A + R E G + + YRE
Sbjct: 9 QAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYRE---EVHWMTHQPR 65
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G G FG V+R K + T AVK++ F+ E++ + LS+P +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGAVR 120
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
+G + E + GSL + L + + A GLEYLH +++
Sbjct: 121 EGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTRR---ILH 173
Query: 207 RDFKASNVLLDQDFNP-KLSDFGLAK-LGPTGDKSHVSTR--VMGTYGYCAPEYALTGQL 262
D KA NVLL D + L DFG A L P G + T + GT + APE +
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 263 TAKSDVYSFGVVFLEIITGRR 283
AK D++S + L ++ G
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCH 254
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV----EVLMLSMLSNPYLVNL 141
+LG GG V+ + ++DVAVK L R + F + E + L++P +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 142 --VGYCVDGDQRILVY---EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
G + L Y EY+ +L D + + +++ A + L +
Sbjct: 78 YDTG-EAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFS 132
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPE 255
H++ +I+RD K +N+++ K+ DFG+A+ + +G+ + V+GT Y +PE
Sbjct: 133 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRR 283
A + A+SDVYS G V E++TG
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 41/232 (17%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-------VAVKQL-DRNGFQGNREFLVEV 127
D L LGEG FG+V + G ++D VAVK L + + + E+
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 128 LMLSMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTR---- 182
M+ M+ ++NL+G C ++ EY G+L ++L P +N
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 183 --------MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
+ A+ ARG+EYL A I+RD A NVL+ +D K++DFGLA+
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 235 TGD--KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
D K + R+ M APE T +SDV+SFGV+ EI T
Sbjct: 243 HIDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 63/237 (26%), Positives = 100/237 (42%), Gaps = 46/237 (19%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEG-----TNQDVAVKQL-DRNGFQGNREFLVEVLM 129
F +NL LG G FG+V G + VAVK L ++ + E+ M
Sbjct: 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 130 LSMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL-------------------LD 169
++ L + +VNL+G C L++EY G L ++L L+
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 170 LPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229
+ L + + A+ A+G+E+L ++RD A NVL+ K+ DFGL
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 230 AKLGPTGD--KSHVSTRV----MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT 280
A+ + + R+ M APE G T KSDV+S+G++ EI +
Sbjct: 219 ARDIMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 49/205 (23%), Positives = 76/205 (37%), Gaps = 19/205 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV----EVLMLSMLSNPYLVNL 141
L+G GG G VY + + VA+K + + F E L P++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLM-SETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+ Q + + L L L P R A+ I L+ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPR-AVA------IVRQIGSALDAAHA 152
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+ +RD K N+L+ D L DFG+A + + +GT Y APE
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFS 208
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRR 283
T ++D+Y+ V E +TG
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSP 233
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 35/231 (15%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY 137
++F +LG+G FG+V + + ++ A+K++ + L EV++L+ L++ Y
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 138 LVNLVGYCVDGDQRI-------------LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK 184
+V ++ + + EY NG+L D + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWR 120
Query: 185 IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL------------ 232
+ L Y+H +I+RD K N+ +D+ N K+ DFGLAK
Sbjct: 121 LFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 233 -GPTGDKSHVSTRVMGTYGYCAPE-YALTGQLTAKSDVYSFGVVFLEIITG 281
G ++++ + GT Y A E TG K D+YS G++F E+I
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 47/235 (20%), Positives = 90/235 (38%), Gaps = 25/235 (10%)
Query: 63 NITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN-- 120
++ + ++ + V ++ +G GG +V++ E Q A+K ++
Sbjct: 12 DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTL 70
Query: 121 REFLVEVLMLSMLS--NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALD 178
+ E+ L+ L + ++ L Y + +V E N L L +K++D
Sbjct: 71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK----KKKSID 125
Query: 179 WNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238
R + +H+ +++ D K +N L+ KL DFG+A
Sbjct: 126 PWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTT 181
Query: 239 SHVSTRVMGTYGYCAPE-----------YALTGQLTAKSDVYSFGVVFLEIITGR 282
S V +GT Y PE +++ KSDV+S G + + G+
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-32
Identities = 47/221 (21%), Positives = 90/221 (40%), Gaps = 35/221 (15%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-----------------EVLM 129
L +G F ++ + N+ A+K+ +++ + R+F E+ +
Sbjct: 39 LNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL-----LDLPPNRKALDWNTRMK 184
++ + N Y + G + D+ ++YEYM N S+ LD +
Sbjct: 97 ITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK-C 155
Query: 185 IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR 244
I Y+H + + +RD K SN+L+D++ KLSDFG ++ +
Sbjct: 156 IIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK---KIKG- 209
Query: 245 VMGTYGYCAPEYALTGQLT---AKSDVYSFGVVFLEIITGR 282
GTY + PE + + + AK D++S G+ +
Sbjct: 210 SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-32
Identities = 48/208 (23%), Positives = 85/208 (40%), Gaps = 10/208 (4%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNP 136
NF + +G G F VYR VA+K++ + + E+ +L L++P
Sbjct: 33 NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
++ ++ ++ +V E G L + ++ + T K LE++
Sbjct: 93 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPE 255
H V++RD K +NV + KL D GL + +H + V GT Y +PE
Sbjct: 153 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH--SLV-GTPYYMSPE 206
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRR 283
KSD++S G + E+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 25/213 (11%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLS--NPYLVN 140
+G GG +V++ E Q A+K ++ + E+ L+ L + ++
Sbjct: 15 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 73
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L Y + +V E N L L +K++D R + +H+
Sbjct: 74 LYDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 128
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE----- 255
+++ D K +N L+ KL DFG+A S V +GT Y PE
Sbjct: 129 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 256 ------YALTGQLTAKSDVYSFGVVFLEIITGR 282
+++ KSDV+S G + + G+
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 54/223 (24%), Positives = 94/223 (42%), Gaps = 32/223 (14%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL 138
+F L+G GGFG+V++ K + +K++ N N + EV L+ L + +
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN----NEKAEREVKALAKLDHVNI 66
Query: 139 VNLVGYCVDGDQRI----------------LVYEYMPNGSLEDHLLDLPPNRKALDWNTR 182
V+ G D + E+ G+LE + + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLA 124
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHV 241
+++ +G++Y+H +I RD K SN+ L K+ DFGL L G +
Sbjct: 125 LELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178
Query: 242 STRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRR 283
TR GT Y +PE ++ Q + D+Y+ G++ E++
Sbjct: 179 -TRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 52/208 (25%), Positives = 79/208 (37%), Gaps = 16/208 (7%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEV-LMLSMLS 134
+F + LG G +G V++ + + + AVK+ F+G ++ L EV +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMS-PFRGPKDRARKLAEVGSHEKVGQ 115
Query: 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
+P V L +G L E SL+ H +L L
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALA 171
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
+LH +++ D K +N+ L KL DFGL T V G Y AP
Sbjct: 172 HLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGDPRYMAP 225
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGR 282
E L G +DV+S G+ LE+
Sbjct: 226 E-LLQGSYGTAADVFSLGLTILEVACNM 252
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 56/207 (27%), Positives = 85/207 (41%), Gaps = 16/207 (7%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR---EFLVEVLMLSMLSNP 136
+F LG+G FG VY + + + +A+K L + + + EV + S L +P
Sbjct: 10 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
++ L GY D + L+ EY P G++ L D A L Y
Sbjct: 70 NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 125
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYGYCAPE 255
H VI+RD K N+LL K++DFG + P + GT Y PE
Sbjct: 126 HSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-----SSRRTDLCGTLDYLPPE 177
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGR 282
K D++S GV+ E + G+
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 10/211 (4%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLV-EVLMLSMLSNPY 137
++ +G G +GR + + + + + K+LD + ++ LV EV +L L +P
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 138 LVNLVGYCVDGDQRIL--VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
+V +D L V EY G L + R+ LD +++ L+
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 196 LHESAQPP--VIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYC 252
H + V++RD K +NV LD N KL DFGLA+ L + T V GT Y
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--TFV-GTPYYM 183
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIITGRR 283
+PE KSD++S G + E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-31
Identities = 52/273 (19%), Positives = 99/273 (36%), Gaps = 26/273 (9%)
Query: 26 YREAKSLASFANISFKTESSRHRYITEELRKIGKGKNNITAKIFSYRE-LCVATTNFNPD 84
+ S S E++ ++ + + G ++ S E + V ++
Sbjct: 2 HHHHHSSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSIL 61
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLS--NPYLVN 140
+G GG +V++ E Q A+K ++ + E+ L+ L + ++
Sbjct: 62 KQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L Y + +V E N L L +K++D R + +H+
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 175
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE----- 255
+++ D K +N L+ KL DFG+A S V +G Y PE
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 256 ------YALTGQLTAKSDVYSFGVVFLEIITGR 282
+++ KSDV+S G + + G+
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-31
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 24/202 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G+G G VY T Q+VA++Q++ + E+L++ NP +VN + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK------IAHGAARGLEYLHESA 200
GD+ +V EY+ GSL D + T M + + LE+LH +
Sbjct: 88 VGDELWVVMEYLAGGSLTD-----------VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
VI+RD K+ N+LL D + KL+DFG A++ P K T V GT + APE
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMV-GTPYWMAPEVVTR 190
Query: 260 GQLTAKSDVYSFGVVFLEIITG 281
K D++S G++ +E+I G
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEG 212
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 45/207 (21%), Positives = 87/207 (42%), Gaps = 11/207 (5%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLV-EVLMLSMLSNPY 137
+ +GEG FG+ K + +K+++ + RE EV +L+ + +P
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V + +V +Y G L + + + L+++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVH 142
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEY 256
+ +++RD K+ N+ L +D +L DFG+A+ L T + + + GT Y +PE
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR--ACI-GTPYYLSPEI 196
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRR 283
KSD+++ G V E+ T +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 1e-30
Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 30/208 (14%)
Query: 86 LLGEGGFGRVYRGK---LEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLVNL 141
+ GG G +Y + G + V +K L +G + + E L+ + +P +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNG--RPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 142 VGYCVDGDQRI-----LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+ D+ +V EY+ SL+ + L + L YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYL 198
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPE 255
H ++Y D K N++L ++ KL D G + G + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG-------YLYGTPGFQAPE 247
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRR 283
T +D+Y+ G +
Sbjct: 248 IV-RTGPTVATDIYTVGRTLAALTLDLP 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 24/202 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+GEG G V + + + + VAVK +D Q EV+++ + +V + +
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK------IAHGAARGLEYLHESA 200
G++ ++ E++ G+L D + R+ + + L YLH
Sbjct: 113 VGEELWVLMEFLQGGALTD-----------IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
VI+RD K+ ++LL D KLSDFG A++ K + V GT + APE
Sbjct: 162 ---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK--SLV-GTPYWMAPEVISR 215
Query: 260 GQLTAKSDVYSFGVVFLEIITG 281
+ D++S G++ +E++ G
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDG 237
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 78/289 (26%), Positives = 120/289 (41%), Gaps = 62/289 (21%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G+G FG V++G T + VA+K +D + E + E+ +LS +PY+ G
Sbjct: 30 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ + ++ EY+ GS D L LD I +GL+YLH I
Sbjct: 90 LKDTKLWIIMEYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KI 141
Query: 206 YRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+RD KA+NVLL + KL+DFG+ +L T K + +GT + APE +
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT---FVGTPFWMAPEVIKQSAYDS 198
Query: 265 KSDVYSFGVVFLEIITGR---------RVI----DNSRPTEEQNLVTWATPLFKDRRKFT 311
K+D++S G+ +E+ G +V+ N+ PT E N + K+ F
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNY----SKPLKE---FV 251
Query: 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
CL +E RP TA E L H
Sbjct: 252 -----------------------EACLNKEPSFRP------TAKELLKH 271
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 75/296 (25%), Positives = 118/296 (39%), Gaps = 57/296 (19%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY 137
F+ LGEG +G VY+ + T Q VA+KQ+ +E + E+ ++ +P+
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPH 85
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V G +V EY GS+ D ++ L L + I +GLEYLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKT--LTEDEIATILQSTLKGLEYLH 142
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEY 256
I+RD KA N+LL+ + + KL+DFG+ +L T K + V+GT + APE
Sbjct: 143 FMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT---VIGTPFWMAPEV 196
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGR---------RV---IDNSRPTEEQNLVTWATPLF 304
+D++S G+ +E+ G+ R I + P + W + F
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW-SDNF 255
Query: 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
D F CL + R TA + L H
Sbjct: 256 TD---FV-----------------------KQCLVKSPEQRA------TATQLLQH 279
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-30
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 21/218 (9%)
Query: 78 TTNFNPDNL-----LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV---EVLM 129
+ D+L LG G +G V + + + Q +AVK++ ++ L+ ++ M
Sbjct: 1 SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
++ P+ V G + E M + SL+ + + + + KIA
Sbjct: 61 RTVDC-PFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGT 248
+ LE+LH VI+RD K SNVL++ K+ DFG+ L K G
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK----DIDAGC 172
Query: 249 YGYCAPE----YALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE + KSD++S G+ +E+ R
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 53/226 (23%), Positives = 101/226 (44%), Gaps = 29/226 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPY 137
T+F P LG GGFG V+ K + + + A+K++ + RE + EV L+ L +P
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 138 LVNLVGYCVDGD---------QRILVY---EYMPNGSLEDHLLDLPPNRKALDWNTRMKI 185
+V ++ + ++ +Y + +L+D ++ + + + + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKD-WMNGRCTIEERERSVCLHI 123
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVS-- 242
A +E+LH +++RD K SN+ D K+ DFGL + ++ V
Sbjct: 124 FLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 243 -------TRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIIT 280
T +GT Y +PE + G + K D++S G++ E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLY 225
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-30
Identities = 54/210 (25%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY 137
+ LG+G FG+VY+ K + T A K ++ + +++VE+ +L+ +PY
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V L+G + ++ E+ P G+++ +L+L + L + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD---RGLTEPQIQVVCRQMLEALNFLH 134
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+I+RD KA NVL+ + + +L+DFG+ AK T K +GT + APE
Sbjct: 135 SKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS---FIGTPYWMAPEV 188
Query: 257 ALTGQLT-----AKSDVYSFGVVFLEIITG 281
+ + K+D++S G+ +E+
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQI 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 23/218 (10%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEV-LMLSMLSNPYLVNLVGY 144
+L EGGF VY + G+ ++ A+K+L N + NR + EV M + +P +V
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 145 CVDGDQR-------ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
G + L+ + G L + L + +R L +T +KI + R ++++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA---KLGPTGDKSHVSTRVM-------G 247
+PP+I+RD K N+LL KL DFG A P S ++
Sbjct: 154 -RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 248 TYGYCAPE-YALTGQL--TAKSDVYSFGVVFLEIITGR 282
T Y PE L K D+++ G + + +
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 51/202 (25%), Positives = 89/202 (44%), Gaps = 11/202 (5%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
+LG+G +G VY G+ +A+K++ + ++ E+ + L + +V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ + E +P GSL LL + T GL+YLH++ ++
Sbjct: 89 SENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IV 144
Query: 206 YRDFKASNVLLDQ-DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE---YALTGQ 261
+RD K NVL++ K+SDFG +K + + GT Y APE G
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIIDKGPRG- 201
Query: 262 LTAKSDVYSFGVVFLEIITGRR 283
+D++S G +E+ TG+
Sbjct: 202 YGKAADIWSLGCTIIEMATGKP 223
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-30
Identities = 55/203 (27%), Positives = 84/203 (41%), Gaps = 20/203 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-----EVLMLSMLSNPYLVN 140
LG+G FG VY + + +A+K L ++ Q +E + E+ + S L +P ++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKS--QLEKEGVEHQLRREIEIQSHLRHPNILR 78
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
+ Y D + L+ E+ P G L L D A L Y HE
Sbjct: 79 MYNYFHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEELADALHYCHERK 134
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYGYCAPEYALT 259
VI+RD K N+L+ K++DFG + P+ R M GT Y PE
Sbjct: 135 ---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIEG 186
Query: 260 GQLTAKSDVYSFGVVFLEIITGR 282
K D++ GV+ E + G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
+G G V + VA+K+++ Q + + L+ E+ +S +P +V+
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN-TRMKIA---HGAARGLEYLHESAQ 201
V D+ LV + + GS+ D + + + IA GLEYLH++ Q
Sbjct: 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ 142
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTR--VMGTYGYCAPEYAL 258
I+RD KA N+LL +D + +++DFG+ A L GD + R +GT + APE
Sbjct: 143 ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVME 199
Query: 259 TGQL-TAKSDVYSFGVVFLEIITGR 282
+ K+D++SFG+ +E+ TG
Sbjct: 200 QVRGYDFKADIWSFGITAIELATGA 224
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 65/224 (29%), Positives = 94/224 (41%), Gaps = 18/224 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYL 138
+ LG GGFG V R + T + VA+KQ + NRE E+ ++ L++P +
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 139 VNLV------GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARG 192
V+ D +L EY G L +L N L + +
Sbjct: 75 VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQ-FENCCGLKEGPIRTLLSDISSA 133
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNP---KLSDFGLAKLGPTGDKSHVSTRVMGTY 249
L YLHE+ +I+RD K N++L K+ D G AK G+ V GT
Sbjct: 134 LRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-GTL 187
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRR-VIDNSRPTE 292
Y APE + T D +SFG + E ITG R + N +P +
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQ 231
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR---EFLVEVLMLSMLSNPYLVNLV 142
LG+GGF + + T + A K + ++ + +E+ + L++ ++V
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G+ D D +V E SL + RKAL G +YLH +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNR-- 161
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
VI+RD K N+ L++D K+ DFGLA K+ G++ V GT Y APE L+ +
Sbjct: 162 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKK 216
Query: 262 L-TAKSDVYSFGVVFLEIITGR 282
+ + DV+S G + ++ G+
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGK 238
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 37/310 (11%), Positives = 80/310 (25%), Gaps = 74/310 (23%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE----------------------- 122
+LG+ + T + V +
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 123 -----FLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM----PNGSLEDHLLDLPPN 173
F+ ++ ++ + D + Y + + LL
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 174 RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233
K+L + R+++ R L LH +++ + +++LDQ L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 254
Query: 234 PTGDKSHVSTRVMGTYGYCAPEYALT-----------GQLTAKSDVYSFGVVFLEIITGR 282
+ + G+ PE +T D ++ G+V I
Sbjct: 255 ----RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 283 RVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEA 342
P + + + +F+ + LLEG L+
Sbjct: 311 ------LPITKDAALGGSEWIFRSCKNIPQPVRALLEG----------------FLRYPK 348
Query: 343 GTRPMMSDVV 352
R + +
Sbjct: 349 EDRLLPLQAM 358
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 35/277 (12%), Positives = 72/277 (25%), Gaps = 57/277 (20%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE----------------------- 122
+LG+ + T + V +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 123 -----FLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV----YEYMPNGSLEDHLLDLPPN 173
F+ ++ ++ + D + + LL
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 174 RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233
K+L + R+++ R L LH +++ + +++LDQ L+ F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLV-- 259
Query: 234 PTGDKSHVSTRVMGTYGYCAPEY----------ALTGQLTAKSDVYSFGVVFLEIITGRR 283
G S G+ PE +T D ++ G+ I
Sbjct: 260 RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD- 314
Query: 284 VIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320
P + + + +F+ + LLEG
Sbjct: 315 -----LPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR---EFLVEVLMLSMLSNPYLVNLV 142
LG+GGF + + T + A K + ++ + +E+ + L++ ++V
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
G+ D D +V E SL + RKAL G +YLH +
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEARYYLRQIVLGCQYLHRNR-- 135
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
VI+RD K N+ L++D K+ DFGLA K+ G++ V GT Y APE L+ +
Sbjct: 136 -VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPE-VLSKK 190
Query: 262 L-TAKSDVYSFGVVFLEIITGR 282
+ + DV+S G + ++ G+
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGK 212
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 5e-29
Identities = 53/311 (17%), Positives = 102/311 (32%), Gaps = 48/311 (15%)
Query: 88 GEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
G V + + T + V V++++ FL E+ + + ++P +V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
+ ++ +V +M GS +D + + ++ I G + L+Y+H +
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDG--MNELAIAYILQGVLKALDYIHHMG---YV 150
Query: 206 YRDFKASNVLLDQDFNPKLSDFG-LAKLGPTGDKSHV----STRVMGTYGYCAPEYALTG 260
+R KAS++L+ D LS + G + V + + +PE
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQN 210
Query: 261 QL--TAKSDVYSFGVVFLEIITGR---------RVI----DNSRPTEEQNLVTWATPLFK 305
AKSD+YS G+ E+ G +++ + + P A L
Sbjct: 211 LQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTM 270
Query: 306 DRRKFTMMADPLLEGNYPIKGLYQALAVA---------------AMCLQEEAGTRPMMSD 350
+ + + + CLQ RP
Sbjct: 271 SPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARP---- 326
Query: 351 VVTAIEYLAHS 361
+A L HS
Sbjct: 327 --SASTLLNHS 335
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYL 138
+ ++LG+G V+RG+ + T A+K + F + + E +L L++ +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 139 VNLVGYCV----DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
V L + + ++L+ E+ P GSL L + P N L + + + G+
Sbjct: 70 VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMN 126
Query: 195 YLHESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
+L E+ +++R+ K N++ D KL+DFG A+ D + GT
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEE 180
Query: 251 YCAPE--------YALTGQLTAKSDVYSFGVVFLEIITGR 282
Y P+ + A D++S GV F TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-28
Identities = 46/270 (17%), Positives = 82/270 (30%), Gaps = 33/270 (12%)
Query: 67 KIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTN-----QDVAVKQLDRNGFQGNR 121
I E + + +LLGEG F +VY N Q +K
Sbjct: 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW--- 109
Query: 122 EFLVEVLMLSMLS---NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL-LDLPPNRKAL 177
EF + ++ L + + + +LV E G+L + + L K +
Sbjct: 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVM 169
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL-----------DQDFNPKLSD 226
+ A +E +H+ +I+ D K N +L D L D
Sbjct: 170 PQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVI 285
G + K + T T G+ E L+ + + D + ++ G
Sbjct: 227 LGQSIDMKLFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT--- 282
Query: 286 DNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315
+ + LF+ M +
Sbjct: 283 --YMKVKNEGGECKPEGLFRRLPHLDMWNE 310
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-28
Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVG-Y 144
LG G G V++ + + +A K + R ++ E+ +L ++PY+V G +
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
DG+ I E+M GSL+ L + K++ +GL YL E + +
Sbjct: 101 YSDGEISI-CMEHMDGGSLDQVLKKAGR----IPEQILGKVSIAVIKGLTYLREKHK--I 153
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
++RD K SN+L++ KL DFG++ +L + S V GT Y +PE +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQGTHYS 208
Query: 264 AKSDVYSFGVVFLEIITGR 282
+SD++S G+ +E+ GR
Sbjct: 209 VQSDIWSMGLSLVEMAVGR 227
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 58/219 (26%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 80 NFNPDNL-----LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM----- 129
+F ++L +G G +G V + + + Q +AVK++ + + ++LM
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV---DEKEQKQLLMDLDVV 74
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNR-KALDWNTRMKIAHG 188
+ PY+V G + E M + S + + + KI
Sbjct: 75 MRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLA 133
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMG 247
+ L +L E+ + +I+RD K SN+LLD+ N KL DFG+ +L + K TR G
Sbjct: 134 TVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK----TRDAG 187
Query: 248 TYGYCAPE----YALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE A +SDV+S G+ E+ TGR
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR---EFLVEVLMLSMLSNPYLVNLV 142
LLG+G F VYR + T +VA+K +D+ EV + L +P ++ L
Sbjct: 18 LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
Y D + LV E NG + +L + K N H G+ YLH
Sbjct: 78 NYFEDSNYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG-- 132
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLA-KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+++RD SN+LL ++ N K++DFGLA +L +K + GT Y +PE T
Sbjct: 133 -ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC---GTPNYISPE-IATRS 187
Query: 262 L-TAKSDVYSFGVVFLEIITGR 282
+SDV+S G +F ++ GR
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR 209
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 26/220 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYL 138
+ ++LG+G V+RG+ + T A+K + F + + E +L L++ +
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 139 VNLVGYCV----DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
V L + + ++L+ E+ P GSL L + P N L + + + G+
Sbjct: 70 VKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEE-PSNAYGLPESEFLIVLRDVVGGMN 126
Query: 195 YLHESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
+L E+ +++R+ K N++ D KL+DFG A+ D + GT
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFVSLY-GTEE 180
Query: 251 YCAPE--------YALTGQLTAKSDVYSFGVVFLEIITGR 282
Y P+ + A D++S GV F TG
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 14/209 (6%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNP 136
F +LG GGFG V+ +++ T + A K+L++ + + + +VE +L+ + +
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 137 YLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWN-TRMKIAHGAARGLE 194
++V+L Y + + LV M G + H+ ++ + A GLE
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGLE 303
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
+LH+ +IYRD K NVLLD D N ++SD GLA G GT G+ AP
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGFMAP 358
Query: 255 EYALTGQLTAKS-DVYSFGVVFLEIITGR 282
E L G+ S D ++ GV E+I R
Sbjct: 359 E-LLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVN----- 140
+G G +G+VY+G+ T Q A+K +D G E E+ ML S+ +
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 141 LVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIA---HGAARGLEYL 196
+ D ++ LV E+ GS+ D + + N +W IA RGL +L
Sbjct: 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHL 145
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-AKLGPTGDKSHVSTRVMGTYGYCAPE 255
H+ VI+RD K NVLL ++ KL DFG+ A+L T + + +GT + APE
Sbjct: 146 HQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT---FIGTPYWMAPE 199
Query: 256 YALTGQLT-----AKSDVYSFGVVFLEIITG 281
+ KSD++S G+ +E+ G
Sbjct: 200 VIACDENPDATYDFKSDLWSLGITAIEMAEG 230
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 70/317 (22%), Positives = 117/317 (36%), Gaps = 49/317 (15%)
Query: 60 GKNNITAKIFSYRELCVATTNFNPDNL-----LGEGGFGRVYRGKLEGTNQDVAVKQLDR 114
G + + K Y + ++L +G G G+V++ + T +AVKQ+ R
Sbjct: 1 GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 115 NGFQGNREFLV---EVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLP 171
+G + + ++ +V++ S PY+V G + + E M E +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDC-PYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ 118
Query: 172 PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL-A 230
+ K+ + L YL E VI+RD K SN+LLD+ KL DFG+
Sbjct: 119 ---GPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISG 173
Query: 231 KLGPTGDKSHVSTRVMGTYGYCAPE-----YALTGQLTAKSDVYSFGVVFLEIITGRRVI 285
+L K R G Y APE ++DV+S G+ +E+ TG+
Sbjct: 174 RLVDDKAK----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229
Query: 286 DNSRPTEEQ--NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAG 343
N + E ++ PL F+ + CL ++
Sbjct: 230 KNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFV----------------KDCLTKDHR 273
Query: 344 TRPMMSDVVTAIEYLAH 360
RP + L H
Sbjct: 274 KRP------KYNKLLEH 284
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 28/216 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN 135
+F +LGEG F V + T+++ A+K L++ + E ++S L +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR---- 191
P+ V L D ++ Y NG L ++ RK R
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI------RKI------GSFDETCTRFYTA 137
Query: 192 ----GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG 247
LEYLH +I+RD K N+LL++D + +++DFG AK+ K + +G
Sbjct: 138 EIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 194
Query: 248 TYGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
T Y +PE LT + KS D+++ G + +++ G
Sbjct: 195 TAQYVSPE-LLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 110 bits (275), Expect = 3e-27
Identities = 27/230 (11%), Positives = 47/230 (20%), Gaps = 41/230 (17%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLV 142
L G V+ + +D A+K E + L
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 143 GYC----------VDGDQRI----------------LVYEYMP--NGSLEDHLLDLPPNR 174
V L+ L L + R
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 175 KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
+ R L +++ F N+ + D L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--K 243
Query: 235 TGDKSHVSTRVMGTYGYCAPEYAL--TGQLTAKSDVYSFGVVFLEIITGR 282
G + S+ Y E+ T T + + G+ +
Sbjct: 244 VGTRGPASS---VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 80 NFNPDNLLGEGGFGR-VYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PY 137
+F P ++LG G G VYRG N+DVAVK++ F EV +L P
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADR---EVQLLRESDEHPN 79
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
++ D + + E +L++++ L+ + + GL +LH
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE---PITLLQQTTSGLAHLH 135
Query: 198 ESAQPPVIYRDFKASNVLL-----DQDFNPKLSDFGLAKLGPTGDKS-HVSTRVMGTYGY 251
+++RD K N+L+ +SDFGL K G S + V GT G+
Sbjct: 136 SLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 252 CAPEY---ALTGQLTAKSDVYSFGVVFLEIITG 281
APE T D++S G VF +I+
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 53/312 (16%), Positives = 101/312 (32%), Gaps = 68/312 (21%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLS 134
TT F+ +G G FG V++ A+K+ + G+ + L EV ++L
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKK-PLAGSVDEQNALREVYAHAVLG 68
Query: 135 N-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
++V + D ++ EY GSL D + + + RGL
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNP-------------------KLSDFGLAKLGP 234
Y+H + +++ D K SN+ + + P K+ D G
Sbjct: 129 RYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR-- 183
Query: 235 TGDKSHVSTRVMGTYGYCAPEYALTGQL--TAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292
S G + A E L K+D+++ + +
Sbjct: 184 ---ISSPQVEE-GDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE---------- 228
Query: 293 EQNLVTWATPLFKDRRKFTMMADPLLEGNYP-IKGLY--QALAVAAMCLQEEAGTRPMMS 349
PL ++ + +G P I + + + + + + RP
Sbjct: 229 ---------PLPRN---GDQWH-EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP--- 272
Query: 350 DVVTAIEYLAHS 361
+A+ + HS
Sbjct: 273 ---SAMALVKHS 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 64/212 (30%), Positives = 95/212 (44%), Gaps = 23/212 (10%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLS 134
F+ +G G FG VY + ++ VA+K++ +G Q N ++ + EV L L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
+P + G + LV EY GS D L ++K L + HGA +GL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD---LLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTR--VMGTYGYC 252
YLH +I+RD KA N+LL + KL DFG A S ++ +GT +
Sbjct: 169 YLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTPYWM 217
Query: 253 APEYALTGQLT---AKSDVYSFGVVFLEIITG 281
APE L K DV+S G+ +E+
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAER 249
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 15/212 (7%)
Query: 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSM 132
V F +LG+GGFG V ++ T + A K+L++ + + L E +L
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 133 LSNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
+++ ++V+L Y + + LV M G L+ H+ + A
Sbjct: 241 VNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAAE-ICC 297
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
GLE LH ++YRD K N+LLD + ++SD GLA P G RV GT GY
Sbjct: 298 GLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK--GRV-GTVGY 351
Query: 252 CAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
APE + + S D ++ G + E+I G+
Sbjct: 352 MAPE-VVKNERYTFSPDWWALGCLLYEMIAGQ 382
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 16/202 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGY 144
LG G +G V + + T+ + A+K + + + + EV +L +L +P ++ L +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
D LV E G L D ++ R + I G+ YLH+ +
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---I 157
Query: 205 IYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++RD K N+LL ++D K+ DFGL+ + K +GT Y APE L +
Sbjct: 158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK---ERLGTAYYIAPE-VLRKK 213
Query: 262 LTAKSDVYSFGVVFLEIITGRR 283
K DV+S GV+ ++ G
Sbjct: 214 YDEKCDVWSIGVILFILLAGYP 235
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 61/246 (24%), Positives = 93/246 (37%), Gaps = 44/246 (17%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV----EVLMLSMLSNPYLVNL 141
LLGEG +G+V T AVK L + + E+ +L L + ++ L
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 142 --VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR-------- 191
V Y + + +V EY G E +LD P + R + A
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEK-------RFPVC--QAHGYFCQLID 120
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
GLEYLH ++++D K N+LL K+S G+A+ G+ +
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177
Query: 252 CAPEYALTGQLT---AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK--D 306
PE G T K D++S GV I TG P E N+ LF+
Sbjct: 178 QPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL------YPFEGDNIYK----LFENIG 226
Query: 307 RRKFTM 312
+ + +
Sbjct: 227 KGSYAI 232
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 17/202 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLVG 143
LG+G FG V K + T Q+ AVK + + + + L EV +L L +P ++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPP 203
+ D LV E G L D ++ RK +I G+ Y+H++
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK--- 146
Query: 204 VIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
+++RD K N+LL +D N ++ DFGL+ K +GT Y APE L G
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMK---DKIGTAYYIAPE-VLHG 202
Query: 261 QLTAKSDVYSFGVVFLEIITGR 282
K DV+S GV+ +++G
Sbjct: 203 TYDEKCDVWSTGVILYILLSGC 224
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 9e-24
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGY 144
LGEG +G V T + VAVK +D E + E+ + ML++ +V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR--------GLEYL 196
+G+ + L EY G L D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMP--EPDAQRFFHQLMAGVVYL 121
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H + +RD K N+LLD+ N K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 257 ALTGQL--TAKSDVYSFGVVFLEIITGR 282
L + DV+S G+V ++ G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 36/228 (15%)
Query: 81 FNPDNLLGEGGFGRV-YRGKLEGTNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYL 138
+ +LG G G V ++G + VAVK++ + E +++L S +P +
Sbjct: 17 VVSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLIDFCDIALME--IKLLTES-DDHPNV 71
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGAARGLEY 195
+ + E N +L+D + N K + + A G+ +
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 196 LHESAQPPVIYRDFKASNVLLD-------------QDFNPKLSDFGLAKLGPTGDKSHVS 242
LH +I+RD K N+L+ ++ +SDFGL K +G S +
Sbjct: 131 LHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 243 TR--VMGTYGYCAPE-------YALTGQLTAKSDVYSFGVVFLEIITG 281
GT G+ APE +LT D++S G VF I++
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-23
Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN- 135
+F+ ++G GGFG VY + T + A+K LD+ + + L E +MLS++S
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 136 --PYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKI-AHGAAR 191
P++V + Y ++ + + M G L HL ++ + M+ A
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEIIL 303
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
GLE++H V+YRD K +N+LLD+ + ++SD GLA K H V GT+GY
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGY 356
Query: 252 CAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
APE G S D +S G + +++ G
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 4e-23
Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGY 144
LGEG +G V T + VAVK +D E + E+ + ML++ +V G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR--------GLEYL 196
+G+ + L EY G L D + + M A+ G+ YL
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP----------DIGMP--EPDAQRFFHQLMAGVVYL 121
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H + +RD K N+LLD+ N K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 122 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE- 177
Query: 257 ALTGQL--TAKSDVYSFGVVFLEIITGR 282
L + DV+S G+V ++ G
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE 205
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-23
Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 11/192 (5%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLVNLVGYC 145
LG G FG V+ + + + +K ++++ Q E E+ +L L +P ++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
D +V E G L + ++ KAL ++ L Y H V+
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VV 146
Query: 206 YRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
++D K N+L K+ DFGLA+L + + + GT Y APE +
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH--STNAA-GTALYMAPE-VFKRDV 202
Query: 263 TAKSDVYSFGVV 274
T K D++S GVV
Sbjct: 203 TFKCDIWSAGVV 214
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-23
Identities = 57/215 (26%), Positives = 99/215 (46%), Gaps = 45/215 (20%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGY 144
+G+G F +V + T ++VA+K +D+ + EV ++ +L++P +V L +
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKL--F 80
Query: 145 CV-DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG-----AAR------ 191
V + ++ + L+ EY G + D+L +AHG AR
Sbjct: 81 EVIETEKTLYLIMEYASGGEVFDYL-----------------VAHGRMKEKEARSKFRQI 123
Query: 192 --GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
++Y H+ +++RD KA N+LLD D N K++DFG + G K G
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAP 177
Query: 250 GYCAPEYALTGQL--TAKSDVYSFGVVFLEIITGR 282
Y APE G+ + DV+S GV+ +++G
Sbjct: 178 PYAAPE-LFQGKKYDGPEVDVWSLGVILYTLVSGS 211
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 65/255 (25%), Positives = 103/255 (40%), Gaps = 46/255 (18%)
Query: 55 RKIGKGKNNI------------TAKIFSYRELCVATTNFNPDNL---------LGEGGFG 93
+GKGK K+F + +L V + P L LG G G
Sbjct: 90 ELVGKGKRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACG 149
Query: 94 RVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--------EVLMLSMLSNPYLVNLVGYC 145
V T + VA++ + + F E+ +L L++P ++ + +
Sbjct: 150 EVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF- 208
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
D + +V E M G L D ++ K L T + ++YLHE+ +I
Sbjct: 209 FDAEDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---II 261
Query: 206 YRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE---YALT 259
+RD K NVLL ++D K++DFG +K+ G+ S + T GT Y APE T
Sbjct: 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLC-GTPTYLAPEVLVSVGT 318
Query: 260 GQLTAKSDVYSFGVV 274
D +S GV+
Sbjct: 319 AGYNRAVDCWSLGVI 333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-------------EVLMLS 131
LG G +G V K + + + A+K + ++ F R E+ +L
Sbjct: 42 RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 132 MLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
L +P ++ L D LV E+ G L + ++ NR D I
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII----NRHKFDECDAANIMKQILS 157
Query: 192 GLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
G+ YLH+ +++RD K N+LL + N K+ DFGL+ K +GT
Sbjct: 158 GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR---DRLGT 211
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRR 283
Y APE L + K DV+S GV+ ++ G
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP 245
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-22
Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 16/202 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGY 144
LG+G FG V + K T Q+ AVK +++ + + EV +L L +P ++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
D +V E G L D ++ RK + +I G+ Y+H+ +
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 205 IYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++RD K N+LL ++D + K+ DFGL+ K +GT Y APE L G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAYYIAPE-VLRGT 198
Query: 262 LTAKSDVYSFGVVFLEIITGRR 283
K DV+S GV+ +++G
Sbjct: 199 YDEKCDVWSAGVILYILLSGTP 220
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 66/210 (31%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN 135
F LLG+G FG+V K + T + A+K L + E L E +L +
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 136 PYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
P+L L Y R+ V EY G L HL R + R A + L+
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGELFFHLSR---ERVFSEDRARFYGAEIVS-ALD 262
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYGYCA 253
YLH ++ V+YRD K N++LD+D + K++DFGL K G + + GT Y A
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA---TMKTFCGTPEYLA 317
Query: 254 PEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
PE L ++ D + GVV E++ GR
Sbjct: 318 PE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 65/251 (25%), Positives = 103/251 (41%), Gaps = 20/251 (7%)
Query: 36 ANISFKTESSRHRYITEELRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRV 95
N + + S + E L K K + K + + F+ LG G FGRV
Sbjct: 1 GNAAAAKKGSEQESVKEFL---AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV 57
Query: 96 YRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152
K + + A+K LD+ ++ L E +L ++ P+LV L D
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKAS 212
+V EY+ G + HL + + + R A EYLH +IYRD K
Sbjct: 118 MVMEYVAGGEMFSHLRR---IGRFSEPHARFYAAQ-IVLTFEYLHSLD---LIYRDLKPE 170
Query: 213 NVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKS-DVYSF 271
N+L+DQ +++DFG AK + + GT APE + + K+ D ++
Sbjct: 171 NLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPE-IILSKGYNKAVDWWAL 224
Query: 272 GVVFLEIITGR 282
GV+ E+ G
Sbjct: 225 GVLIYEMAAGY 235
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-22
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 40/214 (18%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-----EVLMLSMLSNPYLVN 140
LG G FG+V G+ + T VAVK L+R + +V E+ L + +P+++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQ--KIRSLDVVGKIKREIQNLKLFRHPHIIK 75
Query: 141 LVGYCV-DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR------- 191
L Y V +V EY+ G L D++ + R++ AR
Sbjct: 76 L--YQVISTPTDFFMVMEYVSGGELFDYICK----------HGRVEEM--EARRLFQQIL 121
Query: 192 -GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYG 250
++Y H V++RD K NVLLD N K++DFGL+ + G+ S G+
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPN 175
Query: 251 YCAPEYALTGQL--TAKSDVYSFGVVFLEIITGR 282
Y APE ++G+L + D++S GV+ ++ G
Sbjct: 176 YAAPE-VISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-21
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 23/215 (10%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY 137
++ ++G G FG VY+ KL + + VA+K++ Q R E+ ++ L +
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCN 108
Query: 138 LVNLVGY-CVDGDQRI-----LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
+V L + G+++ LV +Y+P ++ ++ L + R
Sbjct: 109 IVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNP-KLSDFGLAKLGPTGDK--SHVSTRVMGT 248
L Y+H S + +RD K N+LLD D KL DFG AK G+ S++ +R
Sbjct: 168 SLAYIH-SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR---- 220
Query: 249 YGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGR 282
Y Y APE T+ DV+S G V E++ G+
Sbjct: 221 Y-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 55/212 (25%), Positives = 93/212 (43%), Gaps = 32/212 (15%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSNPYLVNLV 142
+G+G FG+V + T + A+K +++ E E+ ++ L +P+LVNL
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW 81
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR--------GLE 194
D + +V + + G L HL ++ N K + L+
Sbjct: 82 YSFQDEEDMFMVVDLLLGGDLRYHL------QQ----NVHFKEET--VKLFICELVMALD 129
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
YL +I+RD K N+LLD+ + ++DF +A + P + T + GT Y AP
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAP 183
Query: 255 EYALTGQLTAKS---DVYSFGVVFLEIITGRR 283
E + + S D +S GV E++ GRR
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 3e-21
Identities = 49/191 (25%), Positives = 79/191 (41%), Gaps = 14/191 (7%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G G +G V +GT A K++ + + F E+ ++ L +P ++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
D LV E G L + ++ ++ + +I + Y H+ V +
Sbjct: 77 DNTDIYLVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAH 129
Query: 207 RDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
RD K N L D KL DFGLA G + T+V GT Y +P+ L G
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYVSPQ-VLEGLYG 185
Query: 264 AKSDVYSFGVV 274
+ D +S GV+
Sbjct: 186 PECDEWSAGVM 196
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN 135
+F+ LLG+G FG+V + + T + A+K L + E + E +L +
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 136 PYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGAAR 191
P+L L Y R+ V EY G L HL R R A
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEER------ARFYGAE-IVS 116
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYG 250
LEYLH V+YRD K N++LD+D + K++DFGL K G + + + GT
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---TMKTFCGTPE 170
Query: 251 YCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L ++ D + GVV E++ GR
Sbjct: 171 YLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 51/206 (24%), Positives = 82/206 (39%), Gaps = 20/206 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRN----GFQGNREFLV----EVLMLSMLSNPYL 138
LG G FG V+ + N++V VK + + L E+ +LS + + +
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+ ++ + LV E +G L+ L LD I + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+I+RD K N+++ +DF KL DFG A G + GT YCAPE L
Sbjct: 149 KD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPE-VL 201
Query: 259 TGQL--TAKSDVYSFGVVFLEIITGR 282
G + +++S GV ++
Sbjct: 202 MGNPYRGPELEMWSLGVTLYTLVFEE 227
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 5e-21
Identities = 63/217 (29%), Positives = 103/217 (47%), Gaps = 35/217 (16%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVEVLMLSMLSN 135
+F LG G FGRV+ + + A+K L + ++ E LMLS++++
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR---- 191
P+++ + G D Q ++ +Y+ G L L RK+ + + A+
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL------RKS------QRFPNPVAKFYAA 113
Query: 192 ----GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM- 246
LEYLH +IYRD K N+LLD++ + K++DFG AK P T +
Sbjct: 114 EVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLC 164
Query: 247 GTYGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
GT Y APE ++ + KS D +SFG++ E++ G
Sbjct: 165 GTPDYIAPE-VVSTKPYNKSIDWWSFGILIYEMLAGY 200
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 6e-21
Identities = 52/211 (24%), Positives = 82/211 (38%), Gaps = 28/211 (13%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDR----------NGFQGNREFLVEVLMLSMLSN 135
LLG GGFG VY G N VA+K +++ NG + E V +L
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME--VVLLKKVSSGF 107
Query: 136 PYLVNLVGYCVDGDQRILVYEY-MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
++ L+ + D +L+ E P L D + R AL +
Sbjct: 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT----ERGALQEELARSFFWQVLEAVR 163
Query: 195 YLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
+ H V++RD K N+L+D + KL DFG L + GT Y
Sbjct: 164 HCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFD-GTRVYSP 216
Query: 254 PEYALTGQL--TAKSDVYSFGVVFLEIITGR 282
PE+ + + V+S G++ +++ G
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 55/259 (21%), Positives = 96/259 (37%), Gaps = 40/259 (15%)
Query: 41 KTESSRHRYITEELRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKL 100
+ R + I E L + + +++ + +F ++G G FG V KL
Sbjct: 43 NSPLRREKNILEYLEWAKPFTSKV-------KQMRLHREDFEILKVIGRGAFGEVAVVKL 95
Query: 101 EGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157
+ ++ A+K L++ E F E +L + ++ L D + LV +Y
Sbjct: 96 KNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDY 155
Query: 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR--------GLEYLHESAQPPVIYRDF 209
G L L ++ AR ++ +H+ ++RD
Sbjct: 156 YVGGDLLTLLS-----------KFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDI 201
Query: 210 KASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKS--- 266
K N+L+D + + +L+DFG S V GT Y +PE L K
Sbjct: 202 KPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPE-ILQAMEGGKGRYG 259
Query: 267 ---DVYSFGVVFLEIITGR 282
D +S GV E++ G
Sbjct: 260 PECDWWSLGVCMYEMLYGE 278
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-21
Identities = 55/231 (23%), Positives = 92/231 (39%), Gaps = 47/231 (20%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-------------------- 125
+G+G +G V E N A+K L + F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGP 79
Query: 126 ------EVLMLSMLSNPYLVNLVGYCV----DGDQRILVYEYMPNGSLEDHLLDLPPNRK 175
E+ +L L +P +V L V + D +V+E + G + + P K
Sbjct: 80 IEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEV-----PTLK 132
Query: 176 ALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235
L + +G+EYLH +I+RD K SN+L+ +D + K++DFG++
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNE-FK 188
Query: 236 GDKSHVSTRVMGTYGYCAPEYALTGQLT----AKSDVYSFGVVFLEIITGR 282
G + +S V GT + APE +L+ DV++ GV + G+
Sbjct: 189 GSDALLSNTV-GTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-20
Identities = 52/267 (19%), Positives = 85/267 (31%), Gaps = 64/267 (23%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPY 137
T+F P +G GGFG V+ K + + + A+K++ + RE + EV L+ L +P
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 138 LVNLVGYCVDGDQRILVYEYMPN---GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
+V ++ E D L P A R +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 195 YLHESAQPPVIY------------------------------------------------ 206
L S+ +Y
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 207 --RDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVS---------TRVMGTYGYCAP 254
RD K SN+ D K+ DFGL + ++ V T +GT Y +P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITG 281
E + K D++S G++ E++
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 33/217 (15%)
Query: 87 LGEGGFGRVY--RGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
+G G +G VY + K ++D A+KQ++ G + E+ +L L +P +++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKV 86
Query: 145 CVD-GDQRI-LVYEYMPNGSLEDH----LLDLPPNRKALDWNTRMKIAHGAA------RG 192
+ D+++ L+++Y +H ++ KA ++ + G
Sbjct: 87 FLSHADRKVWLLFDYA------EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNP----KLSDFGLAKL--GPTGDKSHVSTRVM 246
+ YLH + V++RD K +N+L+ + K++D G A+L P + + V+
Sbjct: 141 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 247 GTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
T+ Y APE L T D+++ G +F E++T
Sbjct: 198 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 50/211 (23%), Positives = 84/211 (39%), Gaps = 26/211 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRN--GFQGNREFLV----EVLMLSMLSN---- 135
LLG+GGFG V+ G VA+K + RN V EV +L +
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 136 PYLVNLVGYCVDGDQRILVYEY-MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
P ++ L+ + + +LV E +P L D++ + L ++
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT----EKGPLGEGPSRCFFGQVVAAIQ 153
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNP-KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
+ H V++RD K N+L+D KL DFG L + GT Y
Sbjct: 154 HCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE---PYTDFD-GTRVYSP 206
Query: 254 PEYALTGQL--TAKSDVYSFGVVFLEIITGR 282
PE+ ++ + V+S G++ +++ G
Sbjct: 207 PEW-ISRHQYHALPATVWSLGILLYDMVCGD 236
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 53/245 (21%), Positives = 82/245 (33%), Gaps = 54/245 (22%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-----FLVEVLMLSMLSNPYLVNL 141
+G+G +G V T A+K +++N + EV ++ L +P + L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG------------- 188
D LV E G L D L + +K
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 189 ----------------AAR-------GLEYLHESAQPPVIYRDFKASNVLL--DQDFNPK 223
+ L YLH + +RD K N L ++ F K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIK 210
Query: 224 LSDFGLAKL---GPTGDKSHVSTRVMGTYGYCAPEYALTGQL---TAKSDVYSFGVVFLE 277
L DFGL+K G+ ++T+ GT + APE L K D +S GV+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPE-VLNTTNESYGPKCDAWSAGVLLHL 268
Query: 278 IITGR 282
++ G
Sbjct: 269 LLMGA 273
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 52/257 (20%), Positives = 95/257 (36%), Gaps = 34/257 (13%)
Query: 41 KTESSRHRYITEELRKIGKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKL 100
+E ++ +Y+ + L+ + +E+ + +F ++G G F V K+
Sbjct: 30 ASELAQDKYVADFLQWA-------EPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKM 82
Query: 101 EGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNPYLVNLVGYCVDGDQRI-LVYE 156
+ T Q A+K +++ E F E +L ++ L + + + LV E
Sbjct: 83 KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVME 141
Query: 157 YMPNGSLEDHL----LDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKAS 212
Y G L L +P R +A ++ +H ++RD K
Sbjct: 142 YYVGGDLLTLLSKFGERIPAEM------ARFYLAE-IVMAIDSVHRLG---YVHRDIKPD 191
Query: 213 NVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVY--- 269
N+LLD+ + +L+DFG V GT Y +PE + Y
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPE 250
Query: 270 ----SFGVVFLEIITGR 282
+ GV E+ G+
Sbjct: 251 CDWWALGVFAYEMFYGQ 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-20
Identities = 56/227 (24%), Positives = 91/227 (40%), Gaps = 34/227 (14%)
Query: 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVL 128
R+L + ++ ++G G FG V + + T + A+K L + + F E
Sbjct: 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 121
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG 188
+++ ++P++V L D +V EYMP G L + + + +
Sbjct: 122 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM-------------SNYDVPEK 168
Query: 189 AAR--------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240
AR L+ +H I+RD K N+LLD+ + KL+DFG
Sbjct: 169 WARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKS-----DVYSFGVVFLEIITGR 282
T V GT Y +PE L Q D +S GV E++ G
Sbjct: 226 CDTAV-GTPDYISPE-VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-20
Identities = 45/205 (21%), Positives = 85/205 (41%), Gaps = 40/205 (19%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
+LG G F V+ K T + A+K + ++ + E+ +L + + +V L
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG------AAR-------G 192
LV + + G L D + + G A+
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRI-----------------LERGVYTEKDASLVIQQVLSA 118
Query: 193 LEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
++YLHE+ +++RD K N+L +++ ++DFGL+K+ +++ + + GT
Sbjct: 119 VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM----EQNGIMSTACGTP 171
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVV 274
GY APE + D +S GV+
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVI 196
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-20
Identities = 58/193 (30%), Positives = 91/193 (47%), Gaps = 16/193 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGY 144
LG+G FG V + K T Q+ AVK +++ + + EV +L L +P ++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
D +V E G L D ++ RK + +I G+ Y+H+ +
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---I 142
Query: 205 IYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++RD K N+LL ++D + K+ DFGL+ K + R+ GT Y APE L G
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--MKDRI-GTAYYIAPE-VLRGT 198
Query: 262 LTAKSDVYSFGVV 274
K DV+S GV+
Sbjct: 199 YDEKCDVWSAGVI 211
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 3e-20
Identities = 42/265 (15%), Positives = 78/265 (29%), Gaps = 54/265 (20%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLV 142
G + ++ ++ VA+ +D G + +E L L LS + P + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQP 202
++V E++ GSL++ P A+ A + H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAHRA--- 148
Query: 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
V S V + D G L
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVLA--------------YPATMPDA------- 179
Query: 263 TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNY 322
+ D+ G ++ R P E + + P +D A +E
Sbjct: 180 NPQDDIRGIGASLYALLVNR------WPLPEAGVRSGLAPAERD------TAGQPIEPAD 227
Query: 323 PIKGLYQAL-AVAAMCLQEEAGTRP 346
+ + + AVAA +Q + G R
Sbjct: 228 IDRDIPFQISAVAARSVQGDGGIRS 252
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 36/212 (16%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV---EVLMLSMLSNPYLVNLV 142
LG G FG+V GK E T VAVK L+R + E+ L + +P+++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL- 81
Query: 143 GYCV-DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR--------G 192
Y V I +V EY+ G L D++ N R+ +R G
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYICK----------NGRLDEK--ESRRLFQQILSG 128
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252
++Y H V++RD K NVLLD N K++DFGL+ + G+ S G+ Y
Sbjct: 129 VDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYA 182
Query: 253 APEYALTGQL--TAKSDVYSFGVVFLEIITGR 282
APE ++G+L + D++S GV+ ++ G
Sbjct: 183 APE-VISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 3e-20
Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 26/211 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR--------NGFQGNREFLV-EVLML 130
N+ P +LG G V R + T ++ AVK +D Q RE + EV +L
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 131 SMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
+S P ++ L LV++ M G L D+L + + L KI
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRAL 133
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
+ LH+ +++RD K N+LLD D N KL+DFG + G+K + GT
Sbjct: 134 LEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVC-GTP 187
Query: 250 GYCAPE------YALTGQLTAKSDVYSFGVV 274
Y APE + D++S GV+
Sbjct: 188 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 3e-20
Identities = 58/293 (19%), Positives = 106/293 (36%), Gaps = 54/293 (18%)
Query: 10 AKEKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKGKNNITAKIF 69
+R+ + I+ R+ S ++ K + TE L G +
Sbjct: 28 HLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWA 87
Query: 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV---- 125
+ +E ++P +++G G V R T + AVK ++ + + E L
Sbjct: 88 AAKEF---YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVRE 144
Query: 126 ----EVLMLSMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180
E +L ++ P+++ L+ LV++ M G L D+L
Sbjct: 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL------------- 191
Query: 181 TRMKIAHG------AAR-------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227
+ +LH + +++RD K N+LLD + +LSDF
Sbjct: 192 ----TEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDF 244
Query: 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPE------YALTGQLTAKSDVYSFGVV 274
G + G+K + GT GY APE + D+++ GV+
Sbjct: 245 GFSCHLEPGEK--LRELC-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-20
Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 27/215 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVE--VLMLSML 133
+F +LG+G FG+V+ + + TNQ A+K L ++ + + +VE VL L+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW- 75
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGA 189
+P+L ++ + + V EY+ G L H+ +R A
Sbjct: 76 EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR------ATFYAAE-I 127
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
GL++LH ++YRD K N+LLD+D + K++DFG+ K GD T GT
Sbjct: 128 ILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNTFCGT 181
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L GQ S D +SFGV+ E++ G+
Sbjct: 182 PDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 4e-20
Identities = 59/273 (21%), Positives = 109/273 (39%), Gaps = 29/273 (10%)
Query: 12 EKFHRKSIKKSIKGYREAKSLASFANISFKTESSRHRYITEELRKIGKGKNNITAKIFSY 71
+ + S G+ EAK + S A+++ + R + F +
Sbjct: 22 QSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP------PAPFDH 75
Query: 72 RELCVATTNFN------PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV 125
R + N +LG G FG+V++ + T +A K + G + E
Sbjct: 76 RIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKN 135
Query: 126 EVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN---RKALDWNTR 182
E+ +++ L + L+ L + +LV EY+ G L D ++D N
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT------ 189
Query: 183 MKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL-DQDFNP-KLSDFGLAKLGPTGDKSH 240
+ G+ ++H+ +++ D K N+L ++D K+ DFGLA+ +K
Sbjct: 190 ILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLK 246
Query: 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGV 273
V GT + APE ++ +D++S GV
Sbjct: 247 V---NFGTPEFLAPEVVNYDFVSFPTDMWSVGV 276
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 60/204 (29%), Positives = 99/204 (48%), Gaps = 21/204 (10%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV---EVLMLSMLSNPYLVNLV 142
LGEG FG+V T Q VA+K + R + + + E+ L +L +P+++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL- 74
Query: 143 GYCV-DGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
Y V I +V EY G L D+++ +K + + + +EY H
Sbjct: 75 -YDVITTPTDIVMVIEYA-GGELFDYIV----EKKRMTEDEGRRFFQQIICAIEYCHRHK 128
Query: 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
+++RD K N+LLD + N K++DFGL+ + G+ S G+ Y APE + G
Sbjct: 129 ---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VING 181
Query: 261 QL--TAKSDVYSFGVVFLEIITGR 282
+L + DV+S G+V ++ GR
Sbjct: 182 KLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 6e-20
Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGY 144
+LGEG RV T+Q+ AVK +++ EV ML ++ L+ +
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+ D+ LV+E M GS+ H+ R+ + + A L++LH +
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---I 132
Query: 205 IYRDFKASNVLL---DQDFNPKLSDFGLAK-LGPTGDKSHVSTRVM----GTYGYCAPEY 256
+RD K N+L +Q K+ DF L + GD S +ST + G+ Y APE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE- 191
Query: 257 ALTGQLTA------KSDVYSFGVV 274
+ + D++S GV+
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVI 215
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 27/215 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVE--VLMLSML 133
++F+ ++G+G FG+V + + AVK L + +E + E VL+ ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV- 96
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGA 189
+P+LV L + ++ V +Y+ G L HL R R A
Sbjct: 97 KHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR------ARFYAAE-I 148
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
A L YLH ++YRD K N+LLD + L+DFGL K + +T GT
Sbjct: 149 ASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS---TTSTFCGT 202
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L Q ++ D + G V E++ G
Sbjct: 203 PEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 90.5 bits (224), Expect = 8e-20
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM------LSM 132
T+FN +LG+G FG+V + +GT++ AVK L ++ + + VE M
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDD--VECTMVEKRVLALP 398
Query: 133 LSNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
P+L L C R+ V EY+ G L H+ + + + A A
Sbjct: 399 GKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAE-IAI 453
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GTYG 250
GL +L +IYRD K NV+LD + + K++DFG+ K +T+ GT
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGTPD 507
Query: 251 YCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 508 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 29/214 (13%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLSNP 136
+ + LGEG + VY+GK + T+ VA+K++ G + EV +L L +
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA--PCTAIREVSLLKDLKHA 60
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDH----LLDLPPNRKALDWNTRMKIAHGAARG 192
+V L LV+EY+ D LD N ++ + RG
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYL------DKDLKQYLDDCGNI--INMHNVKLFLFQLLRG 112
Query: 193 LEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTYG 250
L Y H V++RD K N+L+++ KL+DFGLA+ PT + V+ T
Sbjct: 113 LAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLW 165
Query: 251 YCAPEYALTG--QLTAKSDVYSFGVVFLEIITGR 282
Y P+ L G + + D++ G +F E+ TGR
Sbjct: 166 YRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 1e-19
Identities = 58/235 (24%), Positives = 103/235 (43%), Gaps = 24/235 (10%)
Query: 58 GKGKNNITAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF 117
I + + ++G G FG V++ KL +++ VA+K++
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKV----L 73
Query: 118 QGNREFLVEVLMLSMLSNPYLVNLVGY-CVDGDQRI-----LVYEYMPNGSLEDHLLDLP 171
Q R E+ ++ ++ +P +V+L + +GD++ LV EY+P ++
Sbjct: 74 QDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYA 132
Query: 172 PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP-KLSDFGLA 230
++ + + R L Y+H S + +RD K N+LLD KL DFG A
Sbjct: 133 KLKQTMPMLLIKLYMYQLLRSLAYIH-SIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189
Query: 231 KLGPTGDK--SHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGR 282
K+ G+ S++ +R Y Y APE T D++S G V E++ G+
Sbjct: 190 KILIAGEPNVSYICSR----Y-YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 1e-19
Identities = 56/211 (26%), Positives = 94/211 (44%), Gaps = 22/211 (10%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSN 135
+ +GEG +G V++ + T Q VA+K+ D + L E+ ML L +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI--KKIALREIRMLKQLKH 61
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
P LVNL+ + LV+EY + ++ L + + + I + + +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQ---RGVPEHLVKSITWQTLQAVNF 117
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSH-VSTRVMGTYGYC 252
H+ I+RD K N+L+ + KL DFG A+L GP+ V+TR Y
Sbjct: 118 CHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYR 169
Query: 253 APEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
+PE + DV++ G VF E+++G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 40/222 (18%)
Query: 79 TNFNPDNLLGEGGFGRVY---RGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM----LS 131
+ F +LG+G FG+V+ + Q A+K L + + V M L
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR--VRTKMERDILV 81
Query: 132 MLSNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
+++P++V L Y + ++ L+ +++ G L L + +
Sbjct: 82 EVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL------------SKEVMFTEEDV 128
Query: 191 R--------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
+ L++LH +IYRD K N+LLD++ + KL+DFGL+K +K
Sbjct: 129 KFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK---K 182
Query: 243 TRVM-GTYGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
GT Y APE + + +S D +SFGV+ E++TG
Sbjct: 183 AYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGT 223
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 59/220 (26%), Positives = 95/220 (43%), Gaps = 30/220 (13%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLML 130
+ + L+GEG +G V + + + T + VA+K+ D + + E+ +L
Sbjct: 21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMV--KKIAMREIKLL 78
Query: 131 SMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDH----LLDLPPNRKALDWNTRMKIA 186
L + LVNL+ C + LV+E++ DH L+L PN LD+ K
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFV------DHTILDDLELFPN--GLDYQVVQKYL 130
Query: 187 HGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSH-VST 243
G+ + H +I+RD K N+L+ Q KL DFG A+ P V+T
Sbjct: 131 FQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 244 RVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
R Y APE + + DV++ G + E+ G
Sbjct: 188 R-----WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVE--VLMLSML 133
+F+ ++G G + +V +L+ T++ A+K + + + + E V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-S 67
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGA 189
++P+LV L C + R+ V EY+ G L H+ LP R A
Sbjct: 68 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH------ARFYSAE-I 119
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
+ L YLHE +IYRD K NVLLD + + KL+D+G+ K G +T GT
Sbjct: 120 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 173
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L G+ S D ++ GV+ E++ GR
Sbjct: 174 PNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 3e-19
Identities = 52/215 (24%), Positives = 91/215 (42%), Gaps = 28/215 (13%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSN 135
+ +GEG +G V++ K T++ VA+K++ D G L E+ +L L +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV--PSSALREICLLKELKH 60
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPN---GSLEDHLLDLPP-NRKALDWNTRMKIAHGAAR 191
+V L + LV+E+ + DL P K+ + +
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF---LFQLL-----K 112
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTY 249
GL + H V++RD K N+L++++ KL++FGLA+ P S V+ T
Sbjct: 113 GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TL 165
Query: 250 GYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRR 283
Y P+ + D++S G +F E+ R
Sbjct: 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 53/216 (24%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--------EVLMLSMLSNPYL 138
LG G G V T + VA+K + + F E+ +L L++P +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG------AAR- 191
+ + + D + +V E M G L D + + +
Sbjct: 78 IKIKNF-FDAEDYYIVLELMEGGELFDKV-----------------VGNKRLKEATCKLY 119
Query: 192 ------GLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVS 242
++YLHE+ +I+RD K NVLL ++D K++DFG +K+ G+ S +
Sbjct: 120 FYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMR 174
Query: 243 TRVMGTYGYCAPEYALTGQLTA----KSDVYSFGVV 274
T GT Y APE L TA D +S GV+
Sbjct: 175 TLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVI 208
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 66/215 (30%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVE--VLMLSML 133
T+FN +LG+G FG+V + +GT++ AVK L ++ + + +VE VL L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-G 78
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGA 189
P+L L C R+ V EY+ G L H+ A
Sbjct: 79 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH------AVFYAAE-I 130
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
A GL +L +IYRD K NV+LD + + K++DFG+ K +T+ GT
Sbjct: 131 AIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE + Q KS D ++FGV+ E++ G+
Sbjct: 185 PDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 4e-19
Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 19/216 (8%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY 137
F + + G+G FG V GK + T VA+K++ ++ NRE L + L++L +P
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80
Query: 138 LVNL--VGYCVDGDQR-----ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
+V L Y + R +V EY+P+ +L + + A
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAK-LGPTGDKSH-VSTRVMG 247
R + LH + V +RD K NVL++ D KL DFG AK L P+ + +R
Sbjct: 140 RSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR--- 195
Query: 248 TYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGR 282
Y Y APE Q T D++S G +F E++ G
Sbjct: 196 -Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 5e-19
Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 40/222 (18%)
Query: 80 NFNPDNLLGEGGFGRVY---RGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM-----LS 131
F +LG+GG+G+V+ + T + A+K L + L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVL-KKAMIVRNAKDTAHTKAERNILE 76
Query: 132 MLSNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
+ +P++V+L+ Y ++ L+ EY+ G L L A
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL------------EREGIFMEDTA 123
Query: 191 R--------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
L +LH+ +IYRD K N++L+ + KL+DFGL K
Sbjct: 124 CFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT---V 177
Query: 243 TRVM-GTYGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
T GT Y APE L ++ D +S G + +++TG
Sbjct: 178 THTFCGTIEYMAPE-ILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 5e-19
Identities = 55/193 (28%), Positives = 86/193 (44%), Gaps = 18/193 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G G + R + TN + AVK +D++ E +E+ +L +P ++ L
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE--IEI-LLRYGQHPNIITLKDVYD 86
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206
DG +V E M G L D +L +K + + +EYLH V++
Sbjct: 87 DGKYVYVVTELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVH 139
Query: 207 RDFKASNVLL-DQDFNP---KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
RD K SN+L D+ NP ++ DFG AK + + T T + APE L Q
Sbjct: 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL-LMTPC-YTANFVAPE-VLERQG 196
Query: 263 -TAKSDVYSFGVV 274
A D++S GV+
Sbjct: 197 YDAACDIWSLGVL 209
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 27/215 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVE--VLMLSML 133
NF +LG+G FG+V +++ T AVK L ++ + + + E +L L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR- 81
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGA 189
++P+L L C R+ V E++ G L H+ R R A
Sbjct: 82 NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR------ARFYAAE-I 133
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
L +LH+ +IYRD K NVLLD + + KL+DFG+ K G +T GT
Sbjct: 134 ISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV---TTATFCGT 187
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L L + D ++ GV+ E++ G
Sbjct: 188 PDYIAPE-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 7e-19
Identities = 53/210 (25%), Positives = 81/210 (38%), Gaps = 34/210 (16%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGY 144
+G G FG + + T + VAVK ++R E + E++ L +P +V
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEV 84
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR--------GLEYL 196
+ ++ EY G L + + + R AR G+ Y
Sbjct: 85 ILTPTHLAIIMEYASGGELYERICN----------AGRFSED--EARFFFQQLLSGVSYC 132
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
H + +RD K N LLD P K+ DFG +K + + V GT Y AP
Sbjct: 133 HSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAP 186
Query: 255 EYALTGQL--TAKSDVYSFGVVFLEIITGR 282
E L Q +DV+S GV ++ G
Sbjct: 187 E-VLLRQEYDGKIADVWSCGVTLYVMLVGA 215
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 27/215 (12%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF---LVE--VLMLSML 133
+F+ ++G G + +V +L+ T++ A++ + + + + E V +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-S 110
Query: 134 SNPYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLD---LPPNRKALDWNTRMKIAHGA 189
++P+LV L C + R+ V EY+ G L H+ LP R A
Sbjct: 111 NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH------ARFYSAE-I 162
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM-GT 248
+ L YLHE +IYRD K NVLLD + + KL+D+G+ K G +T GT
Sbjct: 163 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCGT 216
Query: 249 YGYCAPEYALTGQLTAKS-DVYSFGVVFLEIITGR 282
Y APE L G+ S D ++ GV+ E++ GR
Sbjct: 217 PNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 7e-19
Identities = 60/225 (26%), Positives = 100/225 (44%), Gaps = 32/225 (14%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGK-LEGTNQDVAVKQL----DRNGF--QGNREFLVEV 127
C A + +GEG +G+V++ + L+ + VA+K++ G RE V V
Sbjct: 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIRE--VAV 64
Query: 128 L-MLSMLSNPYLVNL----VGYCVDGDQRI-LVYEYMPNGSLEDH----LLDLPPNRKAL 177
L L +P +V L D + ++ LV+E++ D LD P +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPG-V 117
Query: 178 DWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237
T + RGL++LH V++RD K N+L+ KL+DFGLA+
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR--IYSF 172
Query: 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
+ +++ V+ T Y APE L D++S G +F E+ +
Sbjct: 173 QMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 51/200 (25%), Positives = 79/200 (39%), Gaps = 21/200 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-----EVLMLSMLSNPYLVNL 141
+G+G F V R T Q AVK +D F + E + ML +P++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR----GLEYLH 197
+ +V+E+M L ++ R + +A R L Y H
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVK----RADAGFVYSEAVASHYMRQILEALRYCH 147
Query: 198 ESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
++ +I+RD K VLL + KL FG+A G+ V+ +GT + AP
Sbjct: 148 DNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAP 202
Query: 255 EYALTGQLTAKSDVYSFGVV 274
E DV+ GV+
Sbjct: 203 EVVKREPYGKPVDVWGCGVI 222
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-19
Identities = 43/193 (22%), Positives = 81/193 (41%), Gaps = 17/193 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+R + T + K ++ E+ +++ L +P L+NL
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPN---RKALDWNTRMKIAHGAARGLEYLHESAQPP 203
D + +L+ E++ G L D + + + A GL+++HE +
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV------INYMRQACEGLKHMHEHS--- 169
Query: 204 VIYRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
+++ D K N++ + K+ DFGLA + V T + APE
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREP 226
Query: 262 LTAKSDVYSFGVV 274
+ +D+++ GV+
Sbjct: 227 VGFYTDMWAIGVL 239
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 9e-19
Identities = 50/192 (26%), Positives = 82/192 (42%), Gaps = 17/192 (8%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
LG G FG V+R T + A K + E+ +S+L +P LVNL
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 147 DGDQRILVYEYMPNGSLEDHLLDLPPN---RKALDWNTRMKIAHGAARGLEYLHESAQPP 203
D ++ +++YE+M G L + + D +A ++ +GL ++HE+
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA------VEYMRQVCKGLCHMHENN--- 275
Query: 204 VIYRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++ D K N++ + KL DFGL V GT + APE A
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKP 332
Query: 262 LTAKSDVYSFGV 273
+ +D++S GV
Sbjct: 333 VGYYTDMWSVGV 344
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 60/223 (26%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGN-----REFLV 125
+AT+ + P +G G +G VY+ + + VA+K + G G RE V
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVRE--V 62
Query: 126 EVL-MLSMLSNPYLVNL----VGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDW 179
+L L +P +V L D + ++ LV+E++ L +L PP L
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPP--PGLPA 119
Query: 180 NTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239
T + RGL++LH + +++RD K N+L+ KL+DFGLA+ +
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR--IYSYQM 174
Query: 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
++ V+ T Y APE L D++S G +F E+ +
Sbjct: 175 ALTPVVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 50/226 (22%), Positives = 92/226 (40%), Gaps = 38/226 (16%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLML 130
+ + LGEG +G VY+ TN+ VA+K++ + G + EV +L
Sbjct: 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV--PGTAIREVSLL 87
Query: 131 SMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
L + ++ L + L++EY ++ DL +K +D N + + +
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA------EN--DL---KKYMDKNPDVSMRVIKS 136
Query: 191 ------RGLEYLHESAQPPVIYRDFKASNVLLDQDFNP-----KLSDFGLAKL--GPTGD 237
G+ + H ++RD K N+LL K+ DFGLA+ P
Sbjct: 137 FLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ 193
Query: 238 KSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
+H ++ T Y PE L + + D++S ++ E++
Sbjct: 194 FTH---EII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-18
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGF--QGNREFLVEVL 128
C + + +G+G FG V++ + T Q VA+K++ ++ GF RE +
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALRE----IK 68
Query: 129 MLSMLSNPYLVNLVGYCVDGDQRI--------LVYEYMPNGSLEDH----LLDLPPNRKA 176
+L +L + +VNL+ C LV+++ +H LL +
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVK-- 120
Query: 177 LDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GP 234
+ ++ GL Y+H + +++RD KA+NVL+ +D KL+DFGLA+
Sbjct: 121 FTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLA 177
Query: 235 TGDKSHVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGR 282
+ + T + T Y PE L D++ G + E+ T
Sbjct: 178 KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 57/215 (26%), Positives = 101/215 (46%), Gaps = 31/215 (14%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSN 135
+ +GEG +G VY+ K + + VA+K++ + G + E+ +L L +
Sbjct: 22 KYQKLEKVGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGI--PSTAIREISLLKELHH 78
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPN---GSLEDHLLDLPP-NRKALDWNTRMKIAHGAAR 191
P +V+L+ LV+E+M L+++ L K + R
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIY---LYQLL-----R 130
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTY 249
G+ + H+ +++RD K N+L++ D KL+DFGLA+ P +H V+ T
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH---EVV-TL 183
Query: 250 GYCAPEYALTG--QLTAKSDVYSFGVVFLEIITGR 282
Y AP+ L G + + D++S G +F E+ITG+
Sbjct: 184 WYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-18
Identities = 49/215 (22%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL----DRNGFQGNREFLVEVLMLSMLSN 135
++ +GEG +G VY+ + + A+K++ + G + E+ +L L +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGI--PSTTIREISILKELKH 59
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPN---GSLEDHLLDLPP-NRKALDWNTRMKIAHGAAR 191
+V L + +LV+E++ L+ L K+ +
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSF---LLQLL-----N 111
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTY 249
G+ Y H+ V++RD K N+L++++ K++DFGLA+ P +H ++ T
Sbjct: 112 GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TL 164
Query: 250 GYCAPEYALTG--QLTAKSDVYSFGVVFLEIITGR 282
Y AP+ L G + + D++S G +F E++ G
Sbjct: 165 WYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-18
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 35/219 (15%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL-------DRNGFQGNREFLVEVLMLSM 132
+ + LGEG F VY+ + + TNQ VA+K++ ++G NR L E+ +L
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQE 68
Query: 133 LSNPYLVNLVGYCVDGDQRILVYEYMPN---GSLEDHLLDL-PPNRKALDWNTRMKIAHG 188
LS+P ++ L+ LV+++M ++D+ L L P + KA M +
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAY---MLMTL--- 122
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSH-VSTRV 245
+GLEYLH+ +++RD K +N+LLD++ KL+DFGLAK P +H V TR
Sbjct: 123 --QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR- 176
Query: 246 MGTYGYCAPEYALTG--QLTAKSDVYSFGVVFLEIITGR 282
Y APE L G D+++ G + E++
Sbjct: 177 ----WYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL---DRNGFQGNREFLVEVLMLSMLSNP 136
F LG G + VY+G + T VA+K++ G + E+ ++ L +
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT--PSTAIREISLMKELKHE 63
Query: 137 YLVNLVGYCVDGDQRILVYEYMPN---GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
+V L ++ LV+E+M N ++ + P + L+ N +GL
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTP--RGLELNLVKYFQWQLLQGL 121
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTYGY 251
+ HE+ +++RD K N+L+++ KL DFGLA+ P S V+ T Y
Sbjct: 122 AFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWY 174
Query: 252 CAPEYALTG--QLTAKSDVYSFGVVFLEIITGR 282
AP+ L G + D++S G + E+ITG+
Sbjct: 175 RAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 2e-18
Identities = 46/220 (20%), Positives = 81/220 (36%), Gaps = 47/220 (21%)
Query: 78 TTNFN----PDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLS 131
+T F+ LG+G F V R + T + A K ++ + E +
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 132 MLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG--- 188
L +P +V L + LV++ + G L + + +A
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-----------------VAREFYS 103
Query: 189 ---AAR-------GLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPT 235
A+ + Y H + +++R+ K N+LL + KL+DFGLA
Sbjct: 104 EADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
Query: 236 GDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVV 274
+ GT GY +PE L + D+++ GV+
Sbjct: 161 SEA--WHGFA-GTPGYLSPE-VLKKDPYSKPVDIWACGVI 196
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 47/198 (23%), Positives = 87/198 (43%), Gaps = 22/198 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLV-EVLMLSMLS-NPYLVNLVG 143
LG G F V + + T Q+ A K L R Q R ++ E+ +L + P ++NL
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR----GLEYLHES 199
+ + IL+ EY G + L + + + + + G+ YLH++
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLP-----ELAEMVSENDVIR-LIKQILEGVYYLHQN 150
Query: 200 AQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+++ D K N+LL + K+ DFG+++ + +MGT Y APE
Sbjct: 151 N---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE---IMGTPEYLAPEI 204
Query: 257 ALTGQLTAKSDVYSFGVV 274
+T +D+++ G++
Sbjct: 205 LNYDPITTATDMWNIGII 222
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 48/193 (24%), Positives = 79/193 (40%), Gaps = 18/193 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYC 145
LGEG F + + +NQ AVK + + ++ E+ L + P +V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
D LV E + G L + + +K I + ++H+ V+
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VV 128
Query: 206 YRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL 262
+RD K N+L + + K+ DFG A+L P ++ + T T Y APE L
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-LKTPC-FTLHYAAPE-LLNQNG 185
Query: 263 -TAKSDVYSFGVV 274
D++S GV+
Sbjct: 186 YDESCDLWSLGVI 198
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 5e-18
Identities = 48/201 (23%), Positives = 84/201 (41%), Gaps = 26/201 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR------EFLVEVLMLSMLSNPYLVN 140
LG G F V + + + T + A K + + + +R E EV +L + +P ++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA---ARGLEYLH 197
L + +L+ E + G L D L +++L + + G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESL---SEEEATSFIKQILDGVNYLH 132
Query: 198 ESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
+ + D K N++L + KL DFGLA G + + GT + A
Sbjct: 133 TKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVA 186
Query: 254 PEYALTGQLTAKSDVYSFGVV 274
PE L ++D++S GV+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVI 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 9e-18
Identities = 44/207 (21%), Positives = 77/207 (37%), Gaps = 43/207 (20%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGY 144
LG+G F V R + T + A K ++ + E + L +P +V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG------AAR------- 191
+ LV++ + G L + + +A A+
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDI-----------------VAREFYSEADASHCIQQILE 139
Query: 192 GLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
+ Y H + +++R+ K N+LL + KL+DFGLA + GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--WHGFA-GT 193
Query: 249 YGYCAPEYALTGQL-TAKSDVYSFGVV 274
GY +PE L + D+++ GV+
Sbjct: 194 PGYLSPE-VLKKDPYSKPVDIWACGVI 219
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 49/202 (24%), Positives = 88/202 (43%), Gaps = 28/202 (13%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR------EFLVEVLMLSMLSNPYLVN 140
LG G F V + + +GT ++ A K + + +R E EV +L + +P ++
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR----GLEYL 196
L + +L+ E + G L D L + +++L T + + G+ YL
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAE----KESL---TEDEATQ-FLKQILDGVHYL 124
Query: 197 HESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252
H + + D K N++L + KL DFG+A G++ + GT +
Sbjct: 125 HSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFGTPEFV 178
Query: 253 APEYALTGQLTAKSDVYSFGVV 274
APE L ++D++S GV+
Sbjct: 179 APEIVNYEPLGLEADMWSIGVI 200
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 38/224 (16%)
Query: 79 TNFNPDNLLGEGGFGRVY---RGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLS 131
NF +LG G +G+V+ + T + A+K L + + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 132 MLSN-PYLVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
+ P+LV L Y + ++ L+ +Y+ G L HL + R
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL------SQR----ERFTEHE-- 160
Query: 190 AR--------GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV 241
+ LE+LH+ +IYRD K N+LLD + + L+DFGL+K +
Sbjct: 161 VQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERA 217
Query: 242 STRVMGTYGYCAPEYALTGQLT--AKS-DVYSFGVVFLEIITGR 282
GT Y AP+ + G + K+ D +S GV+ E++TG
Sbjct: 218 YDFC-GTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 48/198 (24%), Positives = 83/198 (41%), Gaps = 20/198 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR------EFLVEVLMLSMLSNPYLVN 140
LG G F V + + + T + A K + + + +R E EV +L + + ++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA 200
L + +L+ E + G L D L +++L G+ YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK 135
Query: 201 QPPVIYRDFKASNVLL-DQDFNP---KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+ + D K N++L D++ KL DFGLA G + + GT + APE
Sbjct: 136 ---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFGTPEFVAPEI 189
Query: 257 ALTGQLTAKSDVYSFGVV 274
L ++D++S GV+
Sbjct: 190 VNYEPLGLEADMWSIGVI 207
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 3e-17
Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 26/199 (13%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGY 144
+LG G G+V T Q A+K L + + EV S P++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCILDV 90
Query: 145 CVDGDQRI----LVYEYMPNGSLEDHLLDLPPNRKALDWNTRM--KIAHGAARGLEYLHE 198
+ ++ E M G L + + R + R +I +++LH
Sbjct: 91 YENMHHGKRCLLIIMECMEGGELFSRIQE----RGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 199 SAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
+ +RD K N+L ++D KL+DFG AK + T T Y APE
Sbjct: 147 HN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAPE 199
Query: 256 YALTGQLTAKSDVYSFGVV 274
+ D++S GV+
Sbjct: 200 VLGPEKYDKSCDMWSLGVI 218
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 4e-17
Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 41/205 (20%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
LG G VYR K +GT + A+K L + + E+ +L LS+P ++ L
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIF 117
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG------AAR-------G 192
+ LV E + G L D + + G AA
Sbjct: 118 ETPTEISLVLELVTGGELFDRI-----------------VEKGYYSERDAADAVKQILEA 160
Query: 193 LEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
+ YLHE+ +++RD K N+L D K++DFGL+K+ + T GT
Sbjct: 161 VAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL--MKTVC-GTP 214
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVV 274
GYCAPE + D++S G++
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGII 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 5e-17
Identities = 43/207 (20%), Positives = 77/207 (37%), Gaps = 42/207 (20%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGY 144
LG+G F V R Q+ A ++ + E + +L +P +V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG------AAR------- 191
+ L+++ + G L + + +A A+
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDI-----------------VAREYYSEADASHCIQQILE 121
Query: 192 GLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGT 248
+ + H+ V++R+ K N+LL + KL+DFGLA G++ GT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWFGFA-GT 176
Query: 249 YGYCAPEYALTGQL-TAKSDVYSFGVV 274
GY +PE L D+++ GV+
Sbjct: 177 PGYLSPE-VLRKDPYGKPVDLWACGVI 202
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 47/211 (22%), Positives = 78/211 (36%), Gaps = 46/211 (21%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR------EFLVEVLMLSMLSNPYLVN 140
LG G F V + + + T A K + + + +R + EV +L + +P ++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 141 LVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG------AAR--- 191
L + IL+ E + G L D L A
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-----------------AEKESLTEEEATEFLK 121
Query: 192 ----GLEYLHESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLAKLGPTGDKSHVST 243
G+ YLH + + D K N++L K+ DFGLA G++
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN-- 176
Query: 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVV 274
+ GT + APE L ++D++S GV+
Sbjct: 177 -IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-16
Identities = 33/193 (17%), Positives = 79/193 (40%), Gaps = 20/193 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV-EVLMLSMLSNPYLVNLVGYC 145
LG G FG V+R + + K + G ++ + E+ +L++ + +++L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESF 70
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPN---RKALDWNTRMKIAHGAARGLEYLHESAQP 202
++ ++++E++ + + + R+ + H L++LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREI------VSYVHQVCEALQFLHSHN-- 122
Query: 203 PVIYRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG 260
+ + D + N++ + K+ +FG A+ GD + + Y APE
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHD 178
Query: 261 QLTAKSDVYSFGV 273
++ +D++S G
Sbjct: 179 VVSTATDMWSLGT 191
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 51/249 (20%), Positives = 100/249 (40%), Gaps = 55/249 (22%)
Query: 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN 135
++ ++ LG G FG V + + A+K++ ++ NRE + ++ +L +
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDH 59
Query: 136 PYLVNL--VGYCVDGDQRI------------------------------------LVYEY 157
++ L Y ++ ++ EY
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD 217
+P+ +L L + +++ N + R + ++H S + +RD K N+L++
Sbjct: 120 VPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLG--ICHRDIKPQNLLVN 175
Query: 218 -QDFNPKLSDFGLAKLGPTGDK--SHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGV 273
+D KL DFG AK + +++ +R + Y APE L T D++S G
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPELMLGATEYTPSIDLWSIGC 230
Query: 274 VFLEIITGR 282
VF E+I G+
Sbjct: 231 VFGELILGK 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ +G G G V +++VA+K+L FQ N+ E++++ +
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL-SRPFQ-NQTHAKRAYRELVLMKCV 118
Query: 134 SNPYLVNLV-----GYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK-IA 186
++ +++L+ ++ Q + LV E M +L + + RM +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA--------NLCQVIQMELDHERMSYLL 170
Query: 187 HGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS--HVSTR 244
+ G+++LH SA +I+RD K SN+++ D K+ DFGLA+ T +V TR
Sbjct: 171 YQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 227
Query: 245 VMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE L D++S G + E++ +
Sbjct: 228 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 48/198 (24%), Positives = 78/198 (39%), Gaps = 25/198 (12%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYC 145
LG G G+V + + T + A+K L EV + S P++V +V
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVELHWRASQCPHIVRIVDVY 124
Query: 146 VDGDQRI----LVYEYMPNGSLEDHLLDLPPNRKALDWNTRM--KIAHGAARGLEYLHES 199
+ +V E + G L + D R + R +I ++YLH
Sbjct: 125 ENLYAGRKCLLIVMECLDGGELFSRIQD----RGDQAFTEREASEIMKSIGEAIQYLHSI 180
Query: 200 AQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+ +RD K N+L + KL+DFG AK + + ++T T Y APE
Sbjct: 181 N---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYYVAPEV 234
Query: 257 ALTGQLTAKSDVYSFGVV 274
+ D++S GV+
Sbjct: 235 LGPEKYDKSCDMWSLGVI 252
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-15
Identities = 55/218 (25%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ +G G G V ++VA+K+L FQ N+ E++++ +
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQ-NQTHAKRAYRELVLMKCV 81
Query: 134 SNPYLVNLV-----GYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMK-IA 186
++ ++ L+ ++ Q + +V E M +L + + LD + RM +
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVI------QMELD-HERMSYLL 133
Query: 187 HGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS--HVSTR 244
+ G+++LH SA +I+RD K SN+++ D K+ DFGLA+ T +V TR
Sbjct: 134 YQMLCGIKHLH-SAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTR 190
Query: 245 VMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
Y APE L D++S G + E+I G
Sbjct: 191 Y-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 34/126 (26%), Positives = 52/126 (41%), Gaps = 3/126 (2%)
Query: 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214
E +E+ + L + + A+G+E+L A I+RD A N+
Sbjct: 168 VEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNI 224
Query: 215 LLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVV 274
LL + K+ DFGLA+ + APE T +SDV+SFGV+
Sbjct: 225 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 284
Query: 275 FLEIIT 280
EI +
Sbjct: 285 LWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 3e-10
Identities = 28/100 (28%), Positives = 45/100 (45%), Gaps = 13/100 (13%)
Query: 81 FNPDNL-----LGEGGFGRVYRGKLEGTNQD-----VAVKQL-DRNGFQGNREFLVEVLM 129
F D L LG G FG+V G ++ VAVK L + +R + E+ +
Sbjct: 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 78
Query: 130 LSML-SNPYLVNLVGYCVDGDQRILV-YEYMPNGSLEDHL 167
L + + +VNL+G C ++V E+ G+L +L
Sbjct: 79 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 44/224 (19%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ +G G +G V + + + VA+K+L FQ + F E+L+L +
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQ-SEIFAKRAYRELLLLKHM 80
Query: 134 SNPYLVNLV-----GYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAH 187
+ ++ L+ + LV +M DL +K + +K +
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT--------DL---QKIM----GLKFSE 125
Query: 188 G--------AARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239
+GL+Y+H SA V++RD K N+ +++D K+ DFGLA+
Sbjct: 126 EKIQYLVYQMLKGLKYIH-SAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG 182
Query: 240 HVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGR 282
+V TR Y APE L+ D++S G + E++TG+
Sbjct: 183 YVVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 56/218 (25%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ + +G G +G V T VAVK+L FQ + E+ +L +
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQ-SIIHAKRTYRELRLLKHM 85
Query: 134 SNPYLVNLV-----GYCVDGDQRI-LVYEYMPNGSLEDHLLDLPP--NRKALDWNTRMKI 185
+ ++ L+ ++ + LV M DL + L + +
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA--------DLNNIVKCQKLTDDHVQFL 137
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
+ RGL+Y+H SA +I+RD K SN+ +++D K+ DFGLA+ +V+TR
Sbjct: 138 IYQILRGLKYIH-SAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW 194
Query: 246 MGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGR 282
Y APE L D++S G + E++TGR
Sbjct: 195 -----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 51/237 (21%), Positives = 95/237 (40%), Gaps = 65/237 (27%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ + +GEG +G V VA+K++ F+ ++ + L E+ +L
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FE-HQTYCQRTLREIKILLRF 82
Query: 134 SNPYLVNLVG----YCVDGDQRI-LVYEYMP--------NGSLED--------HLLDLPP 172
+ ++ + ++ + + +V + M L + +L
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQIL---- 138
Query: 173 NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232
RGL+Y+H SA V++RD K SN+LL+ + K+ DFGLA++
Sbjct: 139 ------------------RGLKYIH-SAN--VLHRDLKPSNLLLNTTCDLKICDFGLARV 177
Query: 233 GPTGDKS------HVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGR 282
+V+TR Y APE L + T D++S G + E+++ R
Sbjct: 178 ADPDHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 3e-14
Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 37/210 (17%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYC 145
LG G + V+ N+ V VK L + + E+ +L L P ++ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADIV 100
Query: 146 VDGDQR--ILVYEYMPNGSLEDHLLDLPPN------RKALDWNTRMKIAHGAARGLEYLH 197
D R LV+E++ N + L + L + L+Y H
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------------KALDYCH 147
Query: 198 ESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKLGPTGDK--SHVSTRVMGTYGYCAP 254
S +++RD K NV++D + +L D+GLA+ G + V++R + P
Sbjct: 148 -SMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGP 199
Query: 255 EYALTGQLTAKS-DVYSFGVVFLEIITGRR 283
E + Q+ S D++S G + +I +
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 55/218 (25%), Positives = 92/218 (42%), Gaps = 31/218 (14%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ +G G +G V T VA+K+L FQ + F E+ +L +
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQ-SELFAKRAYRELRLLKHM 81
Query: 134 SNPYLVNLV-----GYCVDGDQRI-LVYEYMPNGSLEDHLLDLPP--NRKALDWNTRMKI 185
+ ++ L+ +D LV +M DL + L + +
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--------DLGKLMKHEKLGEDRIQFL 133
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
+ +GL Y+H +A +I+RD K N+ +++D K+ DFGLA+ + +V TR
Sbjct: 134 VYQMLKGLRYIH-AAG--IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW 190
Query: 246 MGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGR 282
Y APE L T D++S G + E+ITG+
Sbjct: 191 -----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 55/244 (22%), Positives = 93/244 (38%), Gaps = 72/244 (29%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+++F +LLGEG +G V + T + VA+K++ F F L E+ +L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKI--EPFD-KPLFALRTLREIKILKHF 66
Query: 134 SNPYLVNLV----GYCVDGDQRI-LVYEYMP--------NGSL-EDH-------LLDLPP 172
+ ++ + + + ++ E M L +DH L
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTL---- 122
Query: 173 NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232
R ++ LH + VI+RD K SN+L++ + + K+ DFGLA++
Sbjct: 123 ------------------RAVKVLH-GSN--VIHRDLKPSNLLINSNCDLKVCDFGLARI 161
Query: 233 GPTGDKS-------------HVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEI 278
V+TR Y APE LT + DV+S G + E+
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216
Query: 279 ITGR 282
R
Sbjct: 217 FLRR 220
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 3e-13
Identities = 47/229 (20%), Positives = 85/229 (37%), Gaps = 42/229 (18%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDR--NGFQGNREF---------LVE 126
+ + + G +G V G ++ VA+K++ + + L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 127 VLMLSMLSNPYLVNL----VGYCVDGDQRI-LVYEYMPNGSLEDHLLDL----PPNRKAL 177
+ +L+ +P ++ L V + ++ LV E M DL R +
Sbjct: 80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT--------DLAQVIHDQRIVI 131
Query: 178 DWNTRMK-IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236
++ + GL LH A V++RD N+LL + + + DF LA+
Sbjct: 132 S-PQHIQYFMYHILLGLHVLH-EAG--VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 237 DKS--HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGR 282
+V+ R Y APE + T D++S G V E+ +
Sbjct: 188 ANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 7e-13
Identities = 64/304 (21%), Positives = 108/304 (35%), Gaps = 92/304 (30%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
N+ +L+G G +G VY + T ++VA+K++ F+ + L E+ +L+ L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFE-DLIDCKRILREITILNRL 82
Query: 134 SNPYLVNLVG----YCVDGDQRI-LVYEYMP---------NGSL-EDH-------LLDLP 171
+ Y++ L + + +V E L E+H LL
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL--- 139
Query: 172 PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231
G ++H + +I+RD K +N LL+QD + K+ DFGLA+
Sbjct: 140 -------------------LGENFIH-ESG--IIHRDLKPANCLLNQDCSVKVCDFGLAR 177
Query: 232 LGPTGDKS-------------------------HVSTRVMGTYGYCAPEYALTGQL-TAK 265
+ + HV TR Y APE L + T
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR-----WYRAPELILLQENYTKS 232
Query: 266 SDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIK 325
D++S G +F E++ + N PLF F + D + +
Sbjct: 233 IDIWSTGCIFAELLNMLQSHINDPTNRF--------PLFPGSSCFPLSPDRNSKKVHEKS 284
Query: 326 GLYQ 329
Q
Sbjct: 285 NRDQ 288
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 8e-13
Identities = 53/269 (19%), Positives = 99/269 (36%), Gaps = 65/269 (24%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ +L+G G +G V + + VA+K++ F+ + L E+ +L+ L
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFE-DLIDCKRILREIAILNRL 109
Query: 134 SNPYLVNLV----GYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHG 188
++ ++V ++ V+ + +V E D +K + H
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIAD--------SDF---KKLFRTPVYLTELHI 158
Query: 189 AA------RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS 242
G++Y+H SA +++RD K +N L++QD + K+ DFGLA+ + +
Sbjct: 159 KTLLYNLLVGVKYVH-SAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
Query: 243 TRVMGTYG-------------------------YCAPEYALTGQL-TAKSDVYSFGVVFL 276
+ Y APE L + T DV+S G +F
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFA 275
Query: 277 EIITGRRVIDNSRPTEEQNLVTWATPLFK 305
E++ + PLF
Sbjct: 276 ELLNMIKENVAYHADRG--------PLFP 296
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-12
Identities = 50/207 (24%), Positives = 82/207 (39%), Gaps = 22/207 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYC 145
+G G FG +Y G ++VA+K + + +E + M+ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCG 74
Query: 146 VDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+GD ++V E + G SLED L + + T + +A +EY+H
Sbjct: 75 AEGDYNVMVMELL--GPSLED-LFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---F 126
Query: 205 IYRDFKASNVLLDQDFNPK---LSDFGLAKL-GPTGDKSHVSTR----VMGTYGYCAPEY 256
I+RD K N L+ + DFGLAK H+ R + GT Y A
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-ASIN 185
Query: 257 ALTG-QLTAKSDVYSFGVVFLEIITGR 282
G + + + D+ S G V + G
Sbjct: 186 THLGIEQSRRDDLESLGYVLMYFNLGS 212
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-12
Identities = 43/151 (28%), Positives = 61/151 (40%), Gaps = 15/151 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G G FG + GK TN+ VA+K + S + + +
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQ-LGSGDGIPQVYYFGP 75
Query: 147 DGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
G +V E + G SLED L DL +R T + IA +EY+H +I
Sbjct: 76 CGKYNAMVLELL--GPSLED-LFDL-CDRT-FSLKTVLMIAIQLISRMEYVHSKN---LI 127
Query: 206 YRDFKASNVLLDQDFNPK-----LSDFGLAK 231
YRD K N L+ + N + DF LAK
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 7e-12
Identities = 54/242 (22%), Positives = 97/242 (40%), Gaps = 66/242 (27%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ + LG GG G V+ ++ VA+K++ + + L E+ ++ L
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI---VLT-DPQSVKHALREIKIIRRL 65
Query: 134 SNPYLVNL-------------VGYCVDGDQRI-LVYEYMP--------NGSL-EDH---- 166
+ +V + + + +V EYM G L E+H
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLF 125
Query: 167 ---LLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNP 222
LL RGL+Y+H SA V++RD K +N+ ++ +D
Sbjct: 126 MYQLL----------------------RGLKYIH-SAN--VLHRDLKPANLFINTEDLVL 160
Query: 223 KLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIIT 280
K+ DFGLA+ + P + + T Y +P L+ T D+++ G +F E++T
Sbjct: 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220
Query: 281 GR 282
G+
Sbjct: 221 GK 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYC 145
+G G FG +Y G TN++VA+K + + + L E + +L + N+ +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 146 VDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
V+GD +LV + + G SLED L + + L T + +A +E++H +
Sbjct: 73 VEGDYNVLVMDLL--GPSLED-LFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---F 124
Query: 205 IYRDFKASNVLLDQDFNPK---LSDFGLAKL-GPTGDKSHVSTR----VMGTYGYCAPEY 256
++RD K N L+ + DFGLAK T H+ R + GT Y A
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-ASVN 183
Query: 257 ALTG-QLTAKSDVYSFGVVFLEIITGR 282
G + + + D+ S G V + + G
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFLRGS 210
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.7 bits (154), Expect = 2e-11
Identities = 48/256 (18%), Positives = 75/256 (29%), Gaps = 68/256 (26%)
Query: 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--------DRNGFQGNREFLVE 126
C+ T +GEG FG V++ + T VA+K + + + + E L E
Sbjct: 16 CLPTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPE 73
Query: 127 VLMLSMLSN---------PYLVNLVG-YCVDG---------------------------- 148
+++ LS + L +CV G
Sbjct: 74 IIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFK 133
Query: 149 -DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYR 207
DQ +V E+ G + + K T I H L S + +R
Sbjct: 134 DDQLFIVLEFEFGGIDLEQM-----RTKLSSLATAKSILHQLTASLAVAEASLR--FEHR 186
Query: 208 DFKASNVLLDQDFNPKLSDFGLAKLG--PTGDKSHV----STRVMGTYGYC------APE 255
D NVLL + KL K P+ + + G E
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDE 246
Query: 256 YALTGQLTAKSDVYSF 271
TG + D+Y
Sbjct: 247 DLFTGDGDYQFDIYRL 262
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 53/209 (25%), Positives = 88/209 (42%), Gaps = 24/209 (11%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYC 145
+GEG FG ++ G NQ VA+K R + E +L+ + N+ +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75
Query: 146 VDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+G +LV + + G SLED LLDL + T A ++ +HE + +
Sbjct: 76 QEGLHNVLVIDLL--GPSLED-LLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---L 127
Query: 205 IYRDFKASNVLLDQDFNPK-----LSDFGLAKL-GPTGDKSHVSTR----VMGTYGYCAP 254
+YRD K N L+ + + + DFG+ K K H+ R + GT Y
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY-MS 186
Query: 255 EYALTG-QLTAKSDVYSFGVVFLEIITGR 282
G + + + D+ + G VF+ + G
Sbjct: 187 INTHLGREQSRRDDLEALGHVFMYFLRGS 215
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-11
Identities = 58/248 (23%), Positives = 100/248 (40%), Gaps = 70/248 (28%)
Query: 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF----LVEVLMLSML 133
+ LG+G +G V++ T + VAVK++ + FQ N E+++L+ L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQ-NSTDAQRTFREIMILTEL 65
Query: 134 SN-PYLVNLVG-YCVDGDQRI-LVYEYMP--------NGSLED-H-------LLDLPPNR 174
S +VNL+ D D+ + LV++YM LE H L+
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQLI------ 119
Query: 175 KALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234
+ ++YLH S +++RD K SN+LL+ + + K++DFGL++
Sbjct: 120 ----------------KVIKYLH-SGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFV 160
Query: 235 TGDKSHVSTRVMGTYG-------------------YCAPEYALTGQL-TAKSDVYSFGVV 274
+ + + Y APE L T D++S G +
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCI 220
Query: 275 FLEIITGR 282
EI+ G+
Sbjct: 221 LGEILCGK 228
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 38/157 (24%), Positives = 60/157 (38%), Gaps = 26/157 (16%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEV-LMLSMLSNPYLVNLVGYC 145
LG G G+V + + T + A+K L + EV L P++V +V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVY 80
Query: 146 VDGDQRI----LVYEYMPNGSLEDHLLDLPPN----RKALDWNTRMKIAHGAARGLEYLH 197
+ +V E + G L + D R+A + I ++YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASE------IMKSIGEAIQYLH 134
Query: 198 ESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAK 231
+ +RD K N+L + KL+DFG AK
Sbjct: 135 SIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 9e-10
Identities = 29/167 (17%), Positives = 57/167 (34%), Gaps = 29/167 (17%)
Query: 87 LGEGGFGRVYRG--------KLEGTNQDVAVKQLDRNGFQGNR----EFLVEVLMLSMLS 134
G +Y Q ++K ++G N + + L ++
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 135 NPYLVNLVG-----YC--VDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIA 186
Y L+ R LV + G SL+ L + L + +++A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVS--PKHVLSERSVLQVA 165
Query: 187 HGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK--LSDFGLAK 231
LE+LHE+ ++ + A N+ +D + + L+ +G A
Sbjct: 166 CRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 47/220 (21%), Positives = 82/220 (37%), Gaps = 36/220 (16%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVG-- 143
LG G F V+ K N VA+K + R E+ +L +++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84
Query: 144 --YCV-----------DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRM--KIAHG 188
+ + +G ++V+E L ++LL L + +I+
Sbjct: 85 ANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 189 AARGLEYLHESAQPPVIYRDFKASNVLLD------QDFNPKLSDFGLAKLGPTGDKSHVS 242
GL+Y+H +I+ D K NVL++ K++D G A H +
Sbjct: 140 LLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYT 193
Query: 243 TRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
+ T Y +PE L +D++S + E+ITG
Sbjct: 194 NSIQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 33/168 (19%), Positives = 61/168 (36%), Gaps = 32/168 (19%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVN----- 140
+G GGFG +Y + A + + +Q N E+ ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 141 ----------LVGY----CVDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKI 185
G R +V E + G L+ + N +T +++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQ--NGT-FKKSTVLQL 156
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK--LSDFGLAK 231
LEY+HE+ ++ D KA+N+LL + L+D+GL+
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 50/219 (22%), Positives = 94/219 (42%), Gaps = 48/219 (21%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS------NPYLV 139
++G+G FG+V + +Q VA+K + RN + +R+ E+ +L L ++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 140 NLVGY-------CVDGDQRILVYEYMPNGSLEDHL-------LDLPPNRKALDWNTRMKI 185
+++ C + +E + + +L + + LP RK
Sbjct: 163 HMLENFTFRNHIC-------MTFELL-SMNLYELIKKNKFQGFSLPLVRK---------F 205
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVST 243
AH + L+ LH++ +I+ D K N+LL Q K+ DFG + +++ +
Sbjct: 206 AHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQS 262
Query: 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR 282
R Y APE L + D++S G + E++TG
Sbjct: 263 RF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 48/206 (23%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP------YL 138
+L+G+G FG+V + + VA+K + +N + +EV +L +++ Y+
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
V+L + + + LV+E + + +L D L + N + + N K A L +L
Sbjct: 119 VHLKRHFMFRNHLCLVFEML-SYNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLA- 174
Query: 199 SAQPPVIYRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+ + +I+ D K N+LL K+ DFG + + + + Y +PE
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPEV 229
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGR 282
L D++S G + +E+ TG
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 48/269 (17%), Positives = 84/269 (31%), Gaps = 74/269 (27%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN--------PYL 138
LG G F V+ + VA+K + ++ L E+ +L + N +
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTETALDEIRLLKSVRNSDPNDPNREMV 103
Query: 139 VNLVGY----CVDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
V L+ V+G +V+E + G L ++ L KI +GL
Sbjct: 104 VQLLDDFKISGVNGTHICMVFEVL--GHHLLKWIIKSNYQG--LPLPCVKKIIQQVLQGL 159
Query: 194 EYLHESAQPPVIYRDFKASNVLL------------------------------------- 216
+YLH + +I+ D K N+LL
Sbjct: 160 DYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217
Query: 217 ------------DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
+ K++D G A + TR Y + E +
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRSLEVLIGSGYNT 272
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEE 293
+D++S + E+ TG + + E
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEY 301
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 34/169 (20%), Positives = 62/169 (36%), Gaps = 31/169 (18%)
Query: 86 LLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQGNREF-----LVEVLMLSMLSN 135
+G+GGFG +Y + G++ VK + E + +
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 136 PYLVNLVG----------YCVDGDQRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMK 184
+ +G R ++ + G L+ + + N K T ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEA--NAKRFSRKTVLQ 156
Query: 185 IAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK--LSDFGLAK 231
++ LEY+HE ++ D KASN+LL+ + L D+GLA
Sbjct: 157 LSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 399 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.27 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.86 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.66 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.64 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.57 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.46 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.04 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.71 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.68 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.55 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.53 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.29 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.52 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.84 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 94.34 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.12 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 93.18 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 83.25 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-60 Score=440.95 Aligned_cols=265 Identities=28% Similarity=0.407 Sum_probs=218.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++|.+.+.||+|+||.||+|.+. .++..||||+++.......++|.+|+.++++++|||||+++++|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46778899999999999999875 3578899999987655556789999999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeE
Q 046609 154 VYEYMPNGSLEDHLLDLP---------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 224 (399)
|||||++|+|.++|+... .....+++..++.|+.|++.||.|||+++ ||||||||+||||+.++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997632 22457999999999999999999999999 999999999999999999999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhh
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
+|||+|+...............||+.|+|||++.++.|+.++|||||||++|||+| |+.||......+....+ .
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---~-- 244 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI---T-- 244 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---H--
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H--
Confidence 99999986444333333344579999999999999999999999999999999999 99999876543221111 1
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.. . ....|...+..+.+|+.+||+.||++|||+.+|++.|+.+....+
T Consensus 245 -~~-~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~p 292 (299)
T 4asz_A 245 -QG-R----------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKASP 292 (299)
T ss_dssp -HT-C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -cC-C----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCC
Confidence 00 0 011233445678899999999999999999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=440.47 Aligned_cols=264 Identities=30% Similarity=0.442 Sum_probs=211.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++|.+.+.||+|+||.||+|.+. .++..||||+++.......++|.+|+.+|++++|||||+++++|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777789999999999999875 3578999999987665566789999999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 154 VYEYMPNGSLEDHLLDLPP-----------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
|||||++|+|.++++.... ...++++.+++.|+.|++.||.|||+.+ ||||||||+||||+.++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 1346999999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (399)
||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||+| |+.||......+....+ .
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i---~ 274 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCI---T 274 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHH---H
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH---H
Confidence 9999999986554444444455679999999999999999999999999999999999 99999876543221111 1
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.. . ....|...+..+.+|+.+||+.||++|||+.+|+++|+.+.+..
T Consensus 275 ---~g-~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 275 ---QG-R----------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp ---HT-C----------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred ---cC-C----------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 00 0 01123334557889999999999999999999999999987653
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-60 Score=436.14 Aligned_cols=262 Identities=23% Similarity=0.305 Sum_probs=221.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.++||+|+||+||+|++..+++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+++..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999997532 233467899999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|||+||+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999986 467999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
..........+||+.|+|||++.+..|+.++|||||||++|+|++|++||...+..+... .......
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------~i~~~~~------- 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFA------KIIKLEY------- 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHTCC-------
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHcCCC-------
Confidence 444444556789999999999999999999999999999999999999998754322111 1111110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccc
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~ 365 (399)
.++...+..+.+|+.+||+.||.+|||++|++.+-.-+.++++..
T Consensus 252 -----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 252 -----DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp -----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred -----CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 122233457889999999999999999999876655455666643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-59 Score=428.68 Aligned_cols=265 Identities=28% Similarity=0.435 Sum_probs=209.0
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
..+++.+.+.||+|+||+||+|++.+ .||||+++.... ...+.|.+|+.++++++|||||++++++.+ +..+||
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 34678888999999999999998764 499999875432 234678999999999999999999998865 568999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
||||+||+|.++|.. ....+++..++.|+.|++.||.|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 110 mEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 110 TQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 999999999999976 3457999999999999999999999999 9999999999999999999999999998655
Q ss_pred CCCCccccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
...........+||+.|||||++.+ +.|+.++|||||||+||||+||+.||............ ...
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~--~~~--------- 252 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM--VGR--------- 252 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHT---------
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHH--Hhc---------
Confidence 4444444455789999999999863 46999999999999999999999999876543211110 000
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
....|.+ ...+...+..+.+|+.+||+.||.+|||+.+|++.|+.++.+.+
T Consensus 253 ~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 253 GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 0111111 12233445678899999999999999999999999999876643
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-59 Score=437.58 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=213.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+.|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+|++++|||||+++++|.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999999999999999998766666677899999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+||+|.+++.. ..+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+......
T Consensus 154 ~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 224 (346)
T 4fih_A 154 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 224 (346)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-
T ss_pred CCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-
Confidence 99999999975 45999999999999999999999999 9999999999999999999999999998643322
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......+||+.|+|||++.+..|+.++|||||||++|||++|++||....+.+....+. . ...+.+
T Consensus 225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~-------~~~~~~ 290 (346)
T 4fih_A 225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------D-------NLPPRL 290 (346)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------H-------SSCCCC
T ss_pred -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------c-------CCCCCC
Confidence 23345789999999999999999999999999999999999999998755432211110 0 001111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 291 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 291 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp --SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1123345678999999999999999999999764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-59 Score=438.53 Aligned_cols=252 Identities=18% Similarity=0.308 Sum_probs=206.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+++.||+|+||+||+|++..+++.||||++...... ..+.+.+|+.++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999999999999999999765433 23568899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
||+||+|.++|... ....+++..++.++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+.....
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999762 2456899999999999999999999999 999999999999999999999999999864321
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+... ...... . +
T Consensus 179 --~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~~~------~-~ 243 (350)
T 4b9d_A 179 --VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------KIISGS------F-P 243 (350)
T ss_dssp --HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHTC------C-C
T ss_pred --cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHcCC------C-C
Confidence 122345679999999999999999999999999999999999999998754322111 111110 0 1
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 244 ----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 244 ----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122344578899999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-58 Score=431.12 Aligned_cols=257 Identities=23% Similarity=0.243 Sum_probs=212.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.+.|.+.++||+|+||.||+|++..+++.||||+++.... ..+|+.+++.++|||||++++++.+++..||||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 3567778899999999999999999999999999976432 24699999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKLGPTG 236 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~ 236 (399)
|+||+|.+++.. .+.+++..++.++.||+.||.|||+++ ||||||||+||||+.+| .+||+|||+|+.....
T Consensus 132 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~ 204 (336)
T 4g3f_A 132 LEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204 (336)
T ss_dssp CTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred cCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence 999999999986 457999999999999999999999999 99999999999999988 6999999999865433
Q ss_pred CCc---cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 237 DKS---HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 237 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... ......+||+.|||||++.+..|+.++|||||||++|||++|++||...........+. .......
T Consensus 205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~~~~-- 276 (336)
T 4g3f_A 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPPPIR-- 276 (336)
T ss_dssp ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCCGGG--
T ss_pred CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCCCch--
Confidence 211 12234679999999999999999999999999999999999999998766543322211 1111111
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
..+...+..+.+|+.+||+.||.+|||+.|++++|......
T Consensus 277 -------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 277 -------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp -------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 12233445788999999999999999999999998876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-59 Score=431.31 Aligned_cols=259 Identities=26% Similarity=0.388 Sum_probs=212.4
Q ss_pred CCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++++.+.||+|+||.||+|.+. .+++.||||++..... ...++|.+|+.++++++|||||+++++|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4566789999999999999874 3568999999975432 334679999999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC
Q 046609 154 VYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~ 221 (399)
|||||++|+|.++|..... ....+++..++.|+.||+.||.|||+++ ||||||||+||||+.++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 9999999999999975321 1346999999999999999999999999 999999999999999999
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~ 300 (399)
+||+|||+++...............||+.|+|||++.++.|+.++|||||||+||||+| |+.||.+....+. ...+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~---~~~i 260 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV---VEMI 260 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH---HHHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH
Confidence 99999999986544433334455679999999999999999999999999999999998 8999987654321 1111
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
. .. .....|...+..+.+|+.+||+.||.+|||+.+|+++|+.+
T Consensus 261 ~----~~----------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 261 R----NR----------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp H----TT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred H----cC----------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 00 01112334456788999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-58 Score=439.20 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=214.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+.|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56999999999999999999999999999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+||+|.+++.. ..+++..+..++.||+.||.|||+++ ||||||||+||||+.+|.+||+|||+|+......
T Consensus 231 ~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 231 EGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp TTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 99999999975 45999999999999999999999999 9999999999999999999999999998643322
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
......+||+.|||||++.+..|+.++|||||||++|||++|++||.+..+......+. . ...+.+
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------~-------~~~~~~ 367 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR------D-------NLPPRL 367 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------H-------SCCCCC
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------c-------CCCCCC
Confidence 23345789999999999999999999999999999999999999998755432211111 0 011111
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+..+.+|+.+||+.||.+|||+.|++++
T Consensus 368 --~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 368 --KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp --SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred --cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1122334578899999999999999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-57 Score=417.21 Aligned_cols=248 Identities=25% Similarity=0.390 Sum_probs=199.6
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEee----CCeeEEEE
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVD----GDQRILVY 155 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 155 (399)
.+.+.||+|+||.||+|.+..++..||+|++...... ..+.+.+|+.++++++|||||+++++|.+ ++..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5567899999999999999999999999999754332 33568999999999999999999999875 34679999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCccCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKLGP 234 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~~~ 234 (399)
|||+||+|.+++.. ...+++..++.++.||+.||.|||+++ ++||||||||+||||+. +|.+||+|||+|+...
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 99999999999986 467999999999999999999999875 34999999999999984 8999999999998532
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
. ......+||+.|||||++.+ .|+.++|||||||++|||+||++||........ +...+.. . ..
T Consensus 184 ~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~~~i~~---~------~~ 247 (290)
T 3fpq_A 184 A----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTS---G------VK 247 (290)
T ss_dssp T----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTT---T------CC
T ss_pred C----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HHHHHHc---C------CC
Confidence 2 22345689999999998864 699999999999999999999999976543211 1111100 0 00
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+. .+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~----~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 PAS----FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGG----GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCC----CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 001 111122368899999999999999999999754
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=414.76 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=195.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|++.+.||+|+||+||+|.+..+++.||||++.+... .....+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 589999999999999999999999999999999976432 22356889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+ +|+|.+++.. .+.+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 7899999976 467999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. .....+||+.|+|||++.+..| +.++|||||||++|+|++|+.||......... ........
T Consensus 165 ~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~------~~i~~~~~------ 229 (275)
T 3hyh_A 165 GN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLF------KNISNGVY------ 229 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHTCC------
T ss_pred CC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHcCCC------
Confidence 22 2334679999999999988876 57999999999999999999999865432111 11111100
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.++...+..+.+|+.+||+.||.+|||++|++++
T Consensus 230 ------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122334578899999999999999999999874
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=429.86 Aligned_cols=274 Identities=24% Similarity=0.339 Sum_probs=222.1
Q ss_pred HHHHHHhcCCCCCCCeeccCCcEEEEEEEECCC-----CeEEEEEEEccCCCc-chHHHHHHHHHHHccCC-CceeeEEE
Q 046609 71 YRELCVATTNFNPDNLLGEGGFGRVYRGKLEGT-----NQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSN-PYLVNLVG 143 (399)
Q Consensus 71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h-pnIv~l~~ 143 (399)
..+..+..++|.+.+.||+|+||.||+|.+.++ ++.||||.+...... ..+.+.+|+.+|.+++| ||||++++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 344555667899999999999999999998653 368999999765433 34668999999999965 99999999
Q ss_pred EEeeC-CeeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046609 144 YCVDG-DQRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFK 210 (399)
Q Consensus 144 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dik 210 (399)
+|.+. +..+||||||++|+|.++|+.... ....+++..+..++.||+.||.|||+++ |||||||
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK 212 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 212 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccC
Confidence 99764 568999999999999999976321 1345899999999999999999999999 9999999
Q ss_pred CCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 046609 211 ASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSR 289 (399)
Q Consensus 211 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 289 (399)
|+|||++.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||....
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987655444444556789999999999999999999999999999999998 999998765
Q ss_pred CcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 290 PTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.... +...+ ... .....|...+..+.+++.+||+.||.+|||+.+|+++|+.+.+...
T Consensus 293 ~~~~--~~~~i----~~g----------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~~ 350 (353)
T 4ase_A 293 IDEE--FCRRL----KEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 350 (353)
T ss_dssp CSHH--HHHHH----HHT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred HHHH--HHHHH----HcC----------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence 4321 11111 110 0112233344578899999999999999999999999999876543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-57 Score=420.20 Aligned_cols=248 Identities=25% Similarity=0.355 Sum_probs=200.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++|++.+.||+|+||+||+|++. .+++.||||++.+... .....+.+|+.++++++|||||++++++.+++..||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999873 4678999999975432 223467889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
|||||+||+|.+++.. .+.+++..+..++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999986 467999999999999999999999999 999999999999999999999999999854
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+....+ .....
T Consensus 177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~~~----- 243 (304)
T 3ubd_A 177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKAKL----- 243 (304)
T ss_dssp ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCC-----
T ss_pred cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcCCC-----
Confidence 3222 2234468999999999999999999999999999999999999999876543221111 11110
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM-----SDVVT 353 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~ 353 (399)
.++...+..+.+|+.+||+.||.+|||+ +|+++
T Consensus 244 -------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 244 -------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp -------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred -------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 1223344578899999999999999985 56654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=409.23 Aligned_cols=273 Identities=22% Similarity=0.314 Sum_probs=201.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHH--HHHHHHHHccCCCceeeEEEEEeeCC----eeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREF--LVEVLMLSMLSNPYLVNLVGYCVDGD----QRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~--~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~ 152 (399)
++|.+.+.||+|+||+||+|.+. ++.||||++.... ...+ ..|+..+.+++|||||++++++.+++ ..+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 45777899999999999999985 7899999997542 2333 34566667889999999999998654 579
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceEECCCCCeeEecc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA-----QPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
||||||++|+|.++|+. ..+++..+..++.|++.||.|||++. .++||||||||+||||+.++++||+||
T Consensus 78 lV~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DF 152 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeC
Confidence 99999999999999976 45999999999999999999999871 123999999999999999999999999
Q ss_pred cCccCCCCCCCc--cccccccccccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh
Q 046609 228 GLAKLGPTGDKS--HVSTRVMGTYGYCAPEYALTG------QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW 299 (399)
Q Consensus 228 g~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 299 (399)
|+|+........ ......+||+.|+|||++.+. .++.++|||||||+||||+||.+||............ .
T Consensus 153 Gla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~-~ 231 (303)
T 3hmm_A 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD-L 231 (303)
T ss_dssp TTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT-T
T ss_pred CCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh-c
Confidence 999764333221 122345799999999998754 4678999999999999999999887654332111000 0
Q ss_pred hhhhhhccchhhhccCCccCCCC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 300 ATPLFKDRRKFTMMADPLLEGNY-----PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.............+....++... +.+....+.+|+.+||+.||.+|||+.+|++.|+++.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred ccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 00000000000111111122222 2345668889999999999999999999999999987653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=401.12 Aligned_cols=253 Identities=22% Similarity=0.325 Sum_probs=190.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCC--------
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD-------- 149 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------- 149 (399)
++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3588899999999999999999999999999999765432 3356889999999999999999999987544
Q ss_pred ----eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEe
Q 046609 150 ----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLS 225 (399)
Q Consensus 150 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 225 (399)
..|+|||||++|+|.+++.... .....++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence 3689999999999999998632 1233566778999999999999999999 9999999999999999999999
Q ss_pred cccCccCCCCCCCcc----------ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch
Q 046609 226 DFGLAKLGPTGDKSH----------VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN 295 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 295 (399)
|||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||.... +.
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~-- 233 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER-- 233 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HH--
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HH--
Confidence 999998654332211 1234579999999999999999999999999999999996 775321 00
Q ss_pred hhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 296 LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....... ....-| .........+.+|+.+||+.||.+|||+.+++++
T Consensus 234 -~~~~~~~-------~~~~~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 234 -VRTLTDV-------RNLKFP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp -HHHHHHH-------HTTCCC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -HHHHHHH-------hcCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0000000 000000 0112223456789999999999999999999763
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=407.29 Aligned_cols=269 Identities=22% Similarity=0.265 Sum_probs=206.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEee------CC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVD------GD 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~ 149 (399)
.++|.+.+.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35799999999999999999999999999999999754332 23568899999999999999999999764 35
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..|||||||. |+|.+++.. .+.+++..+..++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 789999976 567999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCC--CccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 230 AKLGPTGD--KSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 230 ~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
|+...... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..+....+.........
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98643322 12233457899999999998875 5689999999999999999999999876644333222111110000
Q ss_pred c----------chhhhccCCccCCC---CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 R----------RKFTMMADPLLEGN---YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 ~----------~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ........+..... ........+.+|+.+||+.||.+|||+.|++++
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000000000000 001223578899999999999999999999764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-52 Score=393.13 Aligned_cols=200 Identities=24% Similarity=0.366 Sum_probs=172.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||+||+|+++ .+++.||||.+... .....+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l 97 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI 97 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence 468999999999999999999874 46789999998654 3345688999999988 69999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-CCeeEecccCccC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAKL 232 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~~~~ 232 (399)
||||++||+|.+++.. +++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 98 vmE~~~g~~L~~~~~~-------l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 98 AMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEECCCCCCHHHHHTT-------CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeCCCcccHHHHHcC-------CCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999843 899999999999999999999999 9999999999999877 7999999999975
Q ss_pred CCCCCCc--------------------------cccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCC
Q 046609 233 GPTGDKS--------------------------HVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVI 285 (399)
Q Consensus 233 ~~~~~~~--------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf 285 (399)
....... ......+||+.|+|||++.+. .|+.++||||+||++|+|++|+.||
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf 247 (361)
T 4f9c_A 168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247 (361)
T ss_dssp CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence 4332111 112335799999999999775 5899999999999999999999999
Q ss_pred CCCC
Q 046609 286 DNSR 289 (399)
Q Consensus 286 ~~~~ 289 (399)
....
T Consensus 248 ~~~~ 251 (361)
T 4f9c_A 248 YKAS 251 (361)
T ss_dssp SCCS
T ss_pred CCCC
Confidence 7544
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-52 Score=416.64 Aligned_cols=253 Identities=22% Similarity=0.287 Sum_probs=213.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.++.+++.||||++........+.+.+|+.+|+.++|||||+++++|.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999999999999999998766555677899999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC--CCeeEecccCccCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD--FNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~--~~~kl~Dfg~~~~~~~~ 236 (399)
+||+|.++|.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 237 ~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 237 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred CCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 99999999975 3457999999999999999999999999 9999999999999854 89999999999865433
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||.+....+....+. ..... ...
T Consensus 311 ~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~------~~~~~----~~~ 377 (573)
T 3uto_A 311 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SCDWN----MDD 377 (573)
T ss_dssp S---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------TTCCC----CCS
T ss_pred C---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH------hCCCC----CCc
Confidence 2 2334679999999999999999999999999999999999999998765432211111 00000 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+..+.+||.+||+.||.+|||+.|++++
T Consensus 378 ----~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 378 ----SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234578899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-52 Score=413.82 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=204.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHH---HHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLV---EVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~---e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
-++|.+.++||+|+||.||+|++..+++.||||++.+... .....+.+ ++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 3679999999999999999999999999999999975321 11222333 35666778899999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
|||||||+||+|.++|.. .+.+++..++.++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999986 467999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
...... ....+||+.|+|||++.+ ..|+.++|||||||++|||++|++||..........+.. ......
T Consensus 341 ~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~i~~~~--- 410 (689)
T 3v5w_A 341 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MTLTMA--- 410 (689)
T ss_dssp ECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---HHHHCC---
T ss_pred ecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---hhcCCC---
Confidence 654322 234689999999999964 579999999999999999999999998644322111111 111110
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
..++...+..+.+|+.+||+.||.+|++ +++|+++
T Consensus 411 ---------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ---------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ---------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1223334557899999999999999998 6888765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=381.09 Aligned_cols=286 Identities=42% Similarity=0.699 Sum_probs=244.7
Q ss_pred HHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++...+++|.+.+.||+|+||.||+|.+. ++..||||++........+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 34456789999999999999999999975 58899999988766566678999999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccc
Confidence 999999999999999774444456999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..............||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+......+...... ......
T Consensus 189 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 267 (321)
T 2qkw_B 189 GTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-NGQLEQ 267 (321)
T ss_dssp CSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-TTCCCS
T ss_pred cccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-cccHHH
Confidence 4433333333445689999999999889999999999999999999999999998777666666655443322 234555
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
..++.+....+......+.+++.+||+.||.+|||+.+|+++|+.+....+
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~ 318 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQE 318 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSC
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhccc
Confidence 666666667788899999999999999999999999999999999876543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=371.92 Aligned_cols=288 Identities=45% Similarity=0.744 Sum_probs=241.3
Q ss_pred ccccccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEE
Q 046609 65 TAKIFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVG 143 (399)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~ 143 (399)
..+.++..++....++|.+.+.||+|+||.||+|.+. +++.||||++...... ....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 3456889999999999999999999999999999865 5889999998764322 2346889999999999999999999
Q ss_pred EEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---CCCCeEecCCCCCceEECCCC
Q 046609 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES---AQPPVIYRDFKASNVLLDQDF 220 (399)
Q Consensus 144 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~~~~ivH~dikp~NIll~~~~ 220 (399)
++.+.+..++||||+++|+|.+++.........+++..++.++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~ 171 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEF 171 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTC
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCC
Confidence 99999999999999999999999998665666799999999999999999999999 7 99999999999999999
Q ss_pred CeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--CcccchhhH
Q 046609 221 NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSR--PTEEQNLVT 298 (399)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~--~~~~~~~~~ 298 (399)
.+||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.... .........
T Consensus 172 ~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 999999999986543322 22334569999999999988899999999999999999999999996321 112223334
Q ss_pred hhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
+....... .....+.+..+...++......+.+++.+||+.||.+|||+.+|+++|+..
T Consensus 251 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 251 WVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp HHTTTTSS-CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHHHhhc-hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 44333332 455666667777788889999999999999999999999999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=365.36 Aligned_cols=252 Identities=26% Similarity=0.402 Sum_probs=213.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 35899999999999999999999999999999999876666667789999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 999999999976 35999999999999999999999999 9999999999999999999999999987643322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||....+........ .. ..+
T Consensus 171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~------~~-------~~~- 234 (297)
T 3fxz_A 171 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA------TN-------GTP- 234 (297)
T ss_dssp --CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH------HH-------CSC-
T ss_pred --cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC-------CCC-
Confidence 22334579999999999999999999999999999999999999998755322111110 00 000
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011233445578899999999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=367.78 Aligned_cols=264 Identities=24% Similarity=0.371 Sum_probs=217.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|.+........+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 35788889999999999999999999999999999765555567799999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 89 IKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp CTTCBHHHHHHH---CCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred cCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999987 3456999999999999999999999999 9999999999999999999999999997643322
Q ss_pred Ccc------------ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh
Q 046609 238 KSH------------VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305 (399)
Q Consensus 238 ~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (399)
... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....+......... .
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-~---- 237 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-R---- 237 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH-H----
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh-h----
Confidence 211 11145799999999999999999999999999999999999999987554322111100 0
Q ss_pred ccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 306 DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 306 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
...... .+...+..+.+++.+||+.||.+|||+.++++.|+.++...
T Consensus 238 ------~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~ 284 (310)
T 3s95_A 238 ------GFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHL 284 (310)
T ss_dssp ------HHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ------cccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 000000 11122236888999999999999999999999999987643
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=368.09 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=210.1
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999999999999999999765332 335688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999976 456999999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCccccccccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLT-AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...........+ ....
T Consensus 166 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i------~~~~------ 230 (328)
T 3fe3_A 166 VGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERV------LRGK------ 230 (328)
T ss_dssp SSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC------
T ss_pred CCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC------
Confidence 332 23446799999999999888775 7999999999999999999999875532211111 1100
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 231 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 01122334578899999999999999999999764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=370.55 Aligned_cols=264 Identities=26% Similarity=0.371 Sum_probs=216.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC-------CCCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE-------GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDG 148 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 148 (399)
.++|.+.+.||+|+||.||+|.+. .++..||||++..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467888999999999999999874 2456799999976532 2335688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999986431 1245899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccch
Q 046609 217 DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQN 295 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 295 (399)
+.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+...
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~ 316 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986544433333344567889999999999999999999999999999999 999998765332111
Q ss_pred hhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 296 LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.. . . ......+......+.+++.+||+.||.+||++.++++.|+.+...
T Consensus 317 ~~---~----~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 317 LL---K----E----------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp HH---H----T----------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH---h----c----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 11 0 0 001122334455788999999999999999999999999998754
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=366.14 Aligned_cols=274 Identities=24% Similarity=0.299 Sum_probs=211.7
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC----eeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD----QRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~ 152 (399)
..++|.+.++||+|+||.||+|.+. ++.||||++.... ........|+.++.+++||||+++++++.+.. ..+
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 4568999999999999999999886 6899999996542 22344566888899999999999999998754 469
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeEecCCCCCceEECCCCCe
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES----------AQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~----------~~~~ivH~dikp~NIll~~~~~~ 222 (399)
+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+
T Consensus 99 lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~ 170 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTA 170 (322)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCE
T ss_pred EEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeE
Confidence 99999999999999976 3599999999999999999999998 8 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCC-----CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-----QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~ 297 (399)
||+|||++................||+.|+|||++.+. .++.++|||||||++|+|++|+.||............
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 250 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence 99999999765444333333446799999999998763 5567889999999999999999999876543322211
Q ss_pred HhhhhhhhccchhhhccCCccCCCC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 298 TWATPLFKDRRKFTMMADPLLEGNY-----PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......................... .......+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 251 EEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1110000000000011111111111 224456799999999999999999999999999998764
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=363.06 Aligned_cols=255 Identities=26% Similarity=0.349 Sum_probs=207.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 3689999999999999999999999999999999975432 223568899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 86 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 9999999999975 456999999999999999999999999 999999999999999999999999999764433
Q ss_pred CCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
..........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+...
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~------------- 224 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK------------- 224 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHHTT-------------
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHhcc-------------
Confidence 33333345679999999999987776 67899999999999999999999875543211 1111100
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.............+.+|+.+||+.||.+|||+.+++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 225 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00001112334577899999999999999999999754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=352.18 Aligned_cols=286 Identities=38% Similarity=0.599 Sum_probs=231.6
Q ss_pred ccccccHHHHHHhcCCCCCC------CeeccCCcEEEEEEEECCCCeEEEEEEEccCC----CcchHHHHHHHHHHHccC
Q 046609 65 TAKIFSYRELCVATTNFNPD------NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG----FQGNREFLVEVLMLSMLS 134 (399)
Q Consensus 65 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~ 134 (399)
....|++.++..++++|... +.||+|+||.||+|.+. +..||||++.... ....+.+.+|+.++++++
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 88 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence 34568888888888888877 89999999999999874 7889999986532 223466889999999999
Q ss_pred CCceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 046609 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214 (399)
Q Consensus 135 hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NI 214 (399)
||||+++++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Ni 164 (307)
T 2nru_A 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANI 164 (307)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHE
Confidence 9999999999999999999999999999999997532 2456999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 046609 215 LLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294 (399)
Q Consensus 215 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 294 (399)
+++.++.+||+|||++................|++.|+|||++.+ .++.++||||||+++|+|++|.+||.........
T Consensus 165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 243 (307)
T 2nru_A 165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243 (307)
T ss_dssp EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence 999999999999999976544333333344679999999998754 5889999999999999999999999876543221
Q ss_pred hhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
. .+..........+...+++.+ ...+......+.+++.+||+.||.+|||+.+|+++|+.+..
T Consensus 244 ~--~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 L--DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp T--HHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred H--HHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 1 111111122223333444433 34567788899999999999999999999999999998864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=364.86 Aligned_cols=250 Identities=26% Similarity=0.337 Sum_probs=210.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 357889999999999999999999999999999997532 23345688899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||++||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 84 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 999999999999976 457999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... ......
T Consensus 157 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~~~~------- 221 (337)
T 1o6l_A 157 SD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE------LILMEE------- 221 (337)
T ss_dssp CT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCC-------
T ss_pred cC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH------HHHcCC-------
Confidence 22 122344679999999999999999999999999999999999999998654321111 111110
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
..++...+..+.+++.+||+.||.+|| ++.+|+++
T Consensus 222 -----~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 112233445788999999999999999 89999876
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=364.12 Aligned_cols=263 Identities=27% Similarity=0.413 Sum_probs=213.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC---eEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN---QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+..++ ..||||.+..... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 457888999999999999999997544 4599999976432 234568899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 128 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 128 VTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999976 3457999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 234 PTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 234 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
...... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||............ ..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~---~~--------- 269 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV---EE--------- 269 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH---HT---------
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---Hc---------
Confidence 433221 12223446788999999998999999999999999999999 99999875432211111 00
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
......+...+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 270 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 270 -----GYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp -----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred -----CCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 01111233344578899999999999999999999999999876543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-49 Score=376.03 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=215.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
...++|.+.+.||+|+||.||+|.+..+++.||||.+...... ....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 3456788899999999999999999988999999998754222 234678899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRT---EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999976 2346899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
............++..|+|||++.++.++.++|||||||++|||++ |..||............ . .
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~---~----~------- 330 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---E----K------- 330 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH---H----T-------
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----c-------
Confidence 3221111122345778999999998999999999999999999998 99999876543211111 0 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......+...+..+.+++.+||+.||.+|||+.+|++.|+.++..
T Consensus 331 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 331 ---GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 001111223345788999999999999999999999999998754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=370.51 Aligned_cols=275 Identities=24% Similarity=0.333 Sum_probs=221.2
Q ss_pred ccHHHHHHhcCCCCCCCeeccCCcEEEEEEE-----ECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeE
Q 046609 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGK-----LEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNL 141 (399)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l 141 (399)
+.........++|.+.+.||+|+||.||+|. ...+++.||||++...... ..+.+.+|+.++.++ +||||+++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~ 91 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 91 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence 4555666777899999999999999999998 4556789999999764332 235689999999999 78999999
Q ss_pred EEEEeeCCe-eEEEEEecCCCChHHhhccCCCC-----------------------------------------------
Q 046609 142 VGYCVDGDQ-RILVYEYMPNGSLEDHLLDLPPN----------------------------------------------- 173 (399)
Q Consensus 142 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------- 173 (399)
++++.+.+. .++||||+++|+|.+++......
T Consensus 92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (359)
T 3vhe_A 92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK 171 (359)
T ss_dssp EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence 999987654 89999999999999999864321
Q ss_pred ---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 174 ---------------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 174 ---------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 248 (359)
T 3vhe_A 172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 248 (359)
T ss_dssp ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence 122899999999999999999999999 99999999999999999999999999986544444
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
........||+.|+|||++.+..++.++||||||+++|+|++ |..||......... ..... . .
T Consensus 249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~----~------~---- 312 (359)
T 3vhe_A 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK----E------G---- 312 (359)
T ss_dssp CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHH----H------T----
T ss_pred chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHHHH----c------C----
Confidence 444455678999999999999999999999999999999998 99999876543211 10000 0 0
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.....+......+.+++.+||+.||.+|||+.+|+++|+.+....
T Consensus 313 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 357 (359)
T 3vhe_A 313 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357 (359)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence 001112223457889999999999999999999999999987654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=360.83 Aligned_cols=269 Identities=30% Similarity=0.464 Sum_probs=207.5
Q ss_pred HHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCC
Q 046609 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGD 149 (399)
Q Consensus 72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 149 (399)
..+.+...+|.+.+.||+|+||.||+|.+. +..||||++....... .+.+.+|+.++++++||||+++++++.+.+
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 334445678999999999999999999874 7889999997654332 356889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||||+||+++.++.+||+|||+
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 185 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGL 185 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-
T ss_pred ceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCC
Confidence 9999999999999999997621 1123899999999999999999999875 3499999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
+...... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.........
T Consensus 186 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~---------- 253 (309)
T 3p86_A 186 SRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF---------- 253 (309)
T ss_dssp ------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH----------
T ss_pred Ccccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----------
Confidence 9753322 1222345799999999999999999999999999999999999999987654321111100
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.......+...+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 254 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~ 300 (309)
T 3p86_A 254 ------KCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300 (309)
T ss_dssp ------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred ------cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence 00011223334457889999999999999999999999999887653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=357.83 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=208.7
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
|...+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++...+..++||||+++
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 126 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQG 126 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCS
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCC
Confidence 55667999999999999999988999999999876666667889999999999999999999999999999999999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH 240 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 240 (399)
|+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....... .
T Consensus 127 ~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~ 196 (321)
T 2c30_A 127 GALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--P 196 (321)
T ss_dssp CBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--C
T ss_pred CCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--c
Confidence 999999864 46999999999999999999999999 9999999999999999999999999987643322 1
Q ss_pred ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 241 VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 241 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ... ....+.+
T Consensus 197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~---~~~----------~~~~~~~-- 261 (321)
T 2c30_A 197 KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLR----------DSPPPKL-- 261 (321)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HHH----------HSSCCCC--
T ss_pred ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHh----------cCCCCCc--
Confidence 2234579999999999999999999999999999999999999998654322111 000 0011111
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+..+.+++.+||+.||.+|||+.+++++
T Consensus 262 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 262 KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334578899999999999999999999875
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-48 Score=365.85 Aligned_cols=253 Identities=22% Similarity=0.292 Sum_probs=208.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 35789999999999999999999999999999999765432 236788999999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC----CeeEecc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF----NPKLSDF 227 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Df 227 (399)
++||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 91 ~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999975 457999999999999999999999999 99999999999998877 7999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||......+....+. ...
T Consensus 164 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~------~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT------AVS 234 (361)
T ss_dssp SSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------TTC
T ss_pred CCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcC
Confidence 9998654332 2234569999999999999999999999999999999999999998754322111110 000
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+ ++. .....+..+.+|+.+||..||.+|||+.+++++
T Consensus 235 ~~~----~~~----~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YDF----DEE----FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CCC----CHH----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCC----Cch----hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 000 000 011223468899999999999999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=360.95 Aligned_cols=267 Identities=27% Similarity=0.392 Sum_probs=217.7
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCC
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD 149 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 149 (399)
...++|.+.+.||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 99 (314)
T 2ivs_A 20 FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDG 99 (314)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCC
Confidence 34568889999999999999999873 4458899999975432 23366889999999999999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPP--------------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDF 209 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~di 209 (399)
..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+++ |+||||
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~di 176 (314)
T 2ivs_A 100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDL 176 (314)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCC
T ss_pred ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Cccccc
Confidence 99999999999999999987432 1234899999999999999999999999 999999
Q ss_pred CCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 046609 210 KASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNS 288 (399)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 288 (399)
||+||+++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 177 kp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 256 (314)
T 2ivs_A 177 AARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256 (314)
T ss_dssp SGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred chheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999986544433333344567889999999999999999999999999999999 99999876
Q ss_pred CCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 289 RPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.......... . ......+...+..+.+++.+||+.||.+||++.+|+++|+.+...+
T Consensus 257 ~~~~~~~~~~-------~----------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 313 (314)
T 2ivs_A 257 PPERLFNLLK-------T----------GHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVKR 313 (314)
T ss_dssp CGGGHHHHHH-------T----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CHHHHHHHhh-------c----------CCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhhc
Confidence 5432211110 0 0011122334457889999999999999999999999999987643
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=355.10 Aligned_cols=263 Identities=22% Similarity=0.315 Sum_probs=210.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|.+....... .+.+.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 468999999999999999999999999999999986543322 35688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp EECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred EeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 999999999999976 457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .. .....
T Consensus 163 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~----~~~~~------- 228 (294)
T 4eqm_A 163 ETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IK----HIQDS------- 228 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HH----HHSSC-------
T ss_pred cccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HH----Hhhcc-------
Confidence 3221 2223356999999999999999999999999999999999999999875432211 00 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHHHHhhhc
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-MMSDVVTAIEYLAHS 361 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~l~~~ 361 (399)
.+..........+..+.+++.+||+.||.+|| ++.++++.|+.+...
T Consensus 229 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 229 VPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp CCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred CCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 00000011222345788999999999999998 999999998876543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=363.75 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=206.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeE----EEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQD----VAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
.++|.+.+.||+|+||.||+|.+..++.. ||+|.+.... ....+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 35788899999999999999998776654 5777775432 234567899999999999999999999998764 78
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+|+||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHH---STTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence 89999999999999987 3456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..............+|+.|+|||++.+..++.++|||||||++|+|++ |+.||..............
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~------------ 234 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------ 234 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT------------
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHc------------
Confidence 544433333344557889999999999999999999999999999999 9999987654332111110
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
......+......+.+++.+||+.||.+||++.+++++|+.+....
T Consensus 235 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 235 -----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp -----TCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred -----CCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 0111123334457889999999999999999999999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=367.29 Aligned_cols=252 Identities=25% Similarity=0.366 Sum_probs=204.6
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCee
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 151 (399)
...++|.+.++||+|+||.||+|++..+++.||||++.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999999999999999997532 12335577899999988 699999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||++||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++
T Consensus 100 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~ 172 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK 172 (353)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEcccccee
Confidence 999999999999999976 456999999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.... +....
T Consensus 173 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~------i~~~~---- 240 (353)
T 3txo_A 173 EGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA------ILNDE---- 240 (353)
T ss_dssp CSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCC----
T ss_pred ecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH------HHcCC----
Confidence 53222 2233446799999999999988999999999999999999999999987654321111 11110
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHHH
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM------SDVVTA 354 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 354 (399)
..++......+.+++.+||+.||.+||++ .+|+++
T Consensus 241 --------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h 281 (353)
T 3txo_A 241 --------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281 (353)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred --------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence 11222344578899999999999999998 777664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=362.10 Aligned_cols=272 Identities=25% Similarity=0.368 Sum_probs=213.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEE-----CCCCeEEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 149 (399)
..++|.+.+.||+|+||.||+|.+ ..++..||||++.... ......+.+|+.++.++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 446888999999999999999997 3456789999997542 23346789999999999 8999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPN-------------------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFK 210 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dik 210 (399)
..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+.+ |+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCC
Confidence 999999999999999999863211 134899999999999999999999999 9999999
Q ss_pred CCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 046609 211 ASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSR 289 (399)
Q Consensus 211 p~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~ 289 (399)
|+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 9999999999999999999986544333333444567889999999999999999999999999999998 999998765
Q ss_pred CcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccccc
Q 046609 290 PTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACI 367 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~~ 367 (399)
..... ..... . ......+...+..+.+++.+||+.||.+|||+.+|+++|+.+.....+...
T Consensus 280 ~~~~~--~~~~~----~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~ 341 (344)
T 1rjb_A 280 VDANF--YKLIQ----N----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMY 341 (344)
T ss_dssp CSHHH--HHHHH----T----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--------
T ss_pred cHHHH--HHHHh----c----------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHHHHHh
Confidence 43211 11000 0 011112223345788999999999999999999999999999877665544
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=349.86 Aligned_cols=258 Identities=27% Similarity=0.421 Sum_probs=213.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+.. +..||+|++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 86 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence 4578889999999999999999874 7789999997654 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 87 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 999999999976 3456999999999999999999999999 9999999999999999999999999997543221
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
........+++.|+|||++.+..++.++||||||+++|+|++ |+.||............ . . .
T Consensus 161 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~---~---~-------~--- 223 (269)
T 4hcu_A 161 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---S---T-------G--- 223 (269)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H---T-------T---
T ss_pred -cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---h---c-------C---
Confidence 112223456788999999998999999999999999999999 99999875432211111 0 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.....+...+..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 224 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -ccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 01111222345788999999999999999999999999998764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=364.94 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=207.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 152 (399)
..++|.+.++||+|+||.||+|++..+++.||||++.+.... ....+..|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 346799999999999999999999999999999999764322 234578899999877 8999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||++||+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.
T Consensus 130 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999986 457999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch---hhHhhhhhhhccch
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN---LVTWATPLFKDRRK 309 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~~~~~~~~ 309 (399)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ............
T Consensus 203 ~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-- 278 (396)
T 4dc2_A 203 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-- 278 (396)
T ss_dssp CCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC--
T ss_pred cccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc--
Confidence 2222 223345689999999999999999999999999999999999999997543322110 000111111110
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM------SDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 354 (399)
..++...+..+.+|+.+||+.||.+||++ .+|+++
T Consensus 279 ----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H 319 (396)
T 4dc2_A 279 ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 319 (396)
T ss_dssp ----------CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred ----------cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence 12233345578899999999999999996 566554
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=358.61 Aligned_cols=253 Identities=16% Similarity=0.234 Sum_probs=209.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367899999999999999999999999999999997542 3345688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC--CCCeeEecccCccCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ--DFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~--~~~~kl~Dfg~~~~~~~ 235 (399)
+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++.....
T Consensus 83 ~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 83 ISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999976 3356999999999999999999999999 999999999999987 78999999999986543
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+ ....... +
T Consensus 157 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~~~----~ 223 (321)
T 1tki_A 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTF----D 223 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCC----C
T ss_pred CC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------HcCCCCC----C
Confidence 32 223456999999999999888999999999999999999999999875432211111 0000000 0
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ....+..+.+++.+||..||.+|||+.+++++
T Consensus 224 ~~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 224 EEA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 000 01223578899999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=360.07 Aligned_cols=263 Identities=26% Similarity=0.412 Sum_probs=207.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEE----EEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDV----AVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
.++|.+.+.||+|+||.||+|.+..+++.+ |+|.+.... ......+.+|+.+++.++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999998777654 677765432 334577899999999999999999999998765 78
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+|++|+.+|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 93 ~v~~~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 89999999999999987 3456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..............+|+.|+|||++.+..++.++||||||+++|+|++ |..||..............
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~------------ 234 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------ 234 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT------------
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc------------
Confidence 544433333344557889999999999999999999999999999999 9999987654332111110
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~ 364 (399)
......+...+..+.+++.+||+.||.+||++.++++.|+.+......
T Consensus 235 -----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 282 (327)
T 3lzb_A 235 -----GERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDPQR 282 (327)
T ss_dssp -----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSHHH
T ss_pred -----CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCcCc
Confidence 001112233445788999999999999999999999999999865433
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=364.68 Aligned_cols=268 Identities=27% Similarity=0.378 Sum_probs=218.7
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECC-------CCeEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeEEEEEe
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEG-------TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNLVGYCV 146 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~~~~~ 146 (399)
...++|.+.+.||+|+||.||+|.+.+ .+..||||++...... ....+.+|+.+++.+ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 345688899999999999999999743 3367999999765322 236688999999999 8999999999999
Q ss_pred eCCeeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NI 214 (399)
+++..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence 99999999999999999999987431 1246999999999999999999999999 99999999999
Q ss_pred EECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccc
Q 046609 215 LLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEE 293 (399)
Q Consensus 215 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 293 (399)
|++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+.
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~ 302 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 302 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999986544433333444567889999999999999999999999999999999 9999987543221
Q ss_pred chhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 294 QNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
...+ . . ......+......+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 303 ~~~~---~----~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 303 FKLL---K----E----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp HHHH---H----T----------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred HHHH---H----c----------CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 1111 0 0 00111222344578899999999999999999999999999976554
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=370.16 Aligned_cols=266 Identities=27% Similarity=0.392 Sum_probs=212.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEE-----CCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|.+ ..++..||||++..... .....+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 46788899999999999999994 44678899999965422 2335688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCC---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC---CeeEe
Q 046609 152 ILVYEYMPNGSLEDHLLDLP---PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF---NPKLS 225 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~ 225 (399)
++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999998632 12346999999999999999999999999 99999999999999555 49999
Q ss_pred cccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+ ..
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i---~~-- 301 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV---TS-- 301 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HT--
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc--
Confidence 9999974322222222333568899999999999999999999999999999998 99999876532211111 00
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
. .....+...+..+.+++.+||+.||.+||++.+|+++|+.+.....
T Consensus 302 -~-----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~ 348 (367)
T 3l9p_A 302 -G-----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 348 (367)
T ss_dssp -T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -C-----------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence 0 0011122334578899999999999999999999999999877654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=358.41 Aligned_cols=277 Identities=23% Similarity=0.331 Sum_probs=210.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEE----ECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeC--Cee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGK----LEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~ 151 (399)
.++|++.+.||+|+||.||+|. ...+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 4678899999999999999998 4567899999999876555557789999999999999999999998653 568
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999872 345999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........ .......++..|+|||++.+..++.++||||||+++|+|++|..||..................... ...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 241 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIV-FHL 241 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHH-HHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhH-HHH
Confidence 65433221 2223345778899999999999999999999999999999999998753211000000000000000 000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
............+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 000111111122334456889999999999999999999999999998754
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=363.59 Aligned_cols=253 Identities=27% Similarity=0.408 Sum_probs=208.5
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCe
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~ 150 (399)
....++|.+.++||+|+||.||+|++..+++.||||++.... ......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345678999999999999999999999999999999997542 23345677888898876 89999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a 165 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMC 165 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhh
Confidence 9999999999999999976 356999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+ ....
T Consensus 166 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~--- 234 (345)
T 1xjd_A 166 KENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RMDN--- 234 (345)
T ss_dssp BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC---
T ss_pred hhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------HhCC---
Confidence 7533222 2234467999999999999999999999999999999999999999875432211111 1110
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChH-HHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMS-DVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~~ 354 (399)
..++...+..+.+++.+||+.||.+||++. +|+++
T Consensus 235 ---------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 235 ---------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred ---------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 112223445788999999999999999998 66543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=365.53 Aligned_cols=263 Identities=25% Similarity=0.416 Sum_probs=203.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+. .++..||||.+..... .....+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 458999999999999999999876 4577899999975432 234568999999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999976 3456999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCcc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 234 PTGDKSH-VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 234 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||........... ...
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~---i~~--------- 265 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA---VDE--------- 265 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH---HHT---------
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc---------
Confidence 4332111 1122345778999999999999999999999999999998 9999987543221111 100
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
......+...+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus 266 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~ 312 (373)
T 2qol_A 266 -----GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG 312 (373)
T ss_dssp -----TEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCGG
T ss_pred -----CCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCcc
Confidence 00111122344578899999999999999999999999999976543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=358.34 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=210.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeE----EEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQD----VAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
.++|.+.+.||+|+||.||+|.+..++.. ||+|.+.... ......+.+|+.++..++||||+++++++. ++..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 35788899999999999999999877765 7778775432 223356778999999999999999999986 45688
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 91 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp EEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred EEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence 99999999999999976 2357899999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..............++..|+|||++.+..++.++||||||+++|+|++ |+.||................
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---------- 234 (325)
T 3kex_A 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---------- 234 (325)
T ss_dssp SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----------
T ss_pred cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------
Confidence 655544444455678889999999999999999999999999999999 999998765433222211100
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
....+......+.+++.+||+.||.+||++.+++++|+.+....
T Consensus 235 -------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 235 -------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp -------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred -------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 00111112235678999999999999999999999999987643
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=362.93 Aligned_cols=270 Identities=26% Similarity=0.414 Sum_probs=215.8
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEee
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVD 147 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~ 147 (399)
+....++|.+.+.||+|+||.||+|.+.+ +++.||||++...... ....+.+|+.++++++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34456789999999999999999999863 4589999999764322 24568899999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPN--------------------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYR 207 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~ 207 (399)
++..++||||+++|+|.+++...... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 99999999999999999999864221 257999999999999999999999999 9999
Q ss_pred CCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 046609 208 DFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVID 286 (399)
Q Consensus 208 dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~ 286 (399)
||||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999875433222222334568899999999998999999999999999999999 999998
Q ss_pred CCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 287 NSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.....+....+ ... . . ...+...+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus 279 ~~~~~~~~~~~------~~~--~-----~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 279 GMAHEEVIYYV------RDG--N-----I----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TSCHHHHHHHH------HTT--C-----C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCChHHHHHHH------hCC--C-----c----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 75432211100 000 0 0 01122334578899999999999999999999999999876543
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=362.55 Aligned_cols=250 Identities=25% Similarity=0.355 Sum_probs=208.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 57889999999999999999999999999999996532 233467889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+.||+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++.....
T Consensus 95 e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp CCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999986 457999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCccccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................. .
T Consensus 168 ~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~---~------ 235 (384)
T 4fr4_A 168 ET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET---T------ 235 (384)
T ss_dssp TC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH---C------
T ss_pred CC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh---c------
Confidence 22 2344679999999999863 4689999999999999999999999986554332222211111 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-hHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-MSDVVT 353 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~eil~ 353 (399)
...++...+..+.+|+.+||+.||.+||+ +.+|+.
T Consensus 236 ------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 01123334457899999999999999998 666654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=347.13 Aligned_cols=258 Identities=28% Similarity=0.396 Sum_probs=212.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+.+ +..||+|++.... ...+++.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4678889999999999999998874 7789999997654 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHH---HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999976 2346999999999999999999999999 9999999999999999999999999998654332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............. .. ..
T Consensus 159 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~------~~-------~~- 223 (268)
T 3sxs_A 159 YV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS------QG-------HR- 223 (268)
T ss_dssp EE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------TT-------CC-
T ss_pred hh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH------cC-------CC-
Confidence 22 2233456778999999988899999999999999999999 999998655332111110 00 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
...+...+..+.+++.+||+.||.+|||+.+++++|+.++..
T Consensus 224 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 224 ---LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp ---CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred ---CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 011122234788999999999999999999999999988654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=350.57 Aligned_cols=278 Identities=19% Similarity=0.231 Sum_probs=217.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCC--eeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD--QRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~lv 154 (399)
.++|.+.++||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+ ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3578899999999999999999999999999999975432 33466789999999999999999999998765 77999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE----CCCCCeeEecccCc
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLA 230 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~~ 230 (399)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999998632 1234999999999999999999999999 9999999999999 78888999999999
Q ss_pred cCCCCCCCcccccccccccccccccccc--------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc-hhhHhhh
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYAL--------TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ-NLVTWAT 301 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~ 301 (399)
....... ......||+.|+|||++. +..++.++|||||||++|+|++|+.||......... .......
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~ 240 (319)
T 4euu_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (319)
T ss_dssp EECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred eecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence 8644332 223356999999999886 578999999999999999999999999865433221 1111111
Q ss_pred -hhhhc-cchhhhc--------cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 302 -PLFKD-RRKFTMM--------ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 302 -~~~~~-~~~~~~~--------~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
..... ....... .........+......+.+++.+||+.||.+|||+.+++++..+-....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~ 311 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence 00000 0000000 0111123456778889999999999999999999999999988776554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=355.43 Aligned_cols=252 Identities=22% Similarity=0.300 Sum_probs=207.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|.+.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 4588889999999999999999999999999999754322 3467889999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC----CeeEeccc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF----NPKLSDFG 228 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg 228 (399)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 91 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999975 467999999999999999999999999 99999999999999887 79999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+.... .
T Consensus 164 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------~ 234 (326)
T 2y0a_A 164 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN------Y 234 (326)
T ss_dssp TCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTC------C
T ss_pred CCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcC------C
Confidence 998653322 1233569999999999998999999999999999999999999998654322111110000 0
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. .........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 235 ~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 E--------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C--------CCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C--------cCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0000011223468899999999999999999999875
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=350.85 Aligned_cols=252 Identities=21% Similarity=0.286 Sum_probs=199.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--------------------------chHHHHHHHHHH
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--------------------------GNREFLVEVLML 130 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l 130 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 347899999999999999999999999999999999654321 124588999999
Q ss_pred HccCCCceeeEEEEEee--CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 046609 131 SMLSNPYLVNLVGYCVD--GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRD 208 (399)
Q Consensus 131 ~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~d 208 (399)
+.++||||+++++++.+ .+..++||||+++++|.+++. ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~D 162 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRD 162 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCC
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccC
Confidence 99999999999999986 568899999999999988654 356999999999999999999999999 99999
Q ss_pred CCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCC
Q 046609 209 FKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ---LTAKSDVYSFGVVFLEIITGRRVI 285 (399)
Q Consensus 209 ikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf 285 (399)
|||+|||++.++.+||+|||++....... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||
T Consensus 163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 240 (298)
T 2zv2_A 163 IKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240 (298)
T ss_dssp CCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred CCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence 99999999999999999999997643322 1223457999999999987655 477899999999999999999999
Q ss_pred CCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 286 DNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......... ....... ... ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~------~~~~~~~------~~~----~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 241 MDERIMCLH------SKIKSQA------LEF----PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp CCSSHHHHH------HHHHHCC------CCC----CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred CCccHHHHH------HHHhccc------CCC----CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 865422110 1100000 000 0011233578899999999999999999999764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=354.93 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=208.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57888999999999999999999999999999997532 233456788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999986 456999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... .......
T Consensus 159 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~-------- 219 (318)
T 1fot_A 159 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKILNAE-------- 219 (318)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHCC--------
T ss_pred c-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC--------
Confidence 1 23457999999999999999999999999999999999999999875432111 1111110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
..++......+.+++.+||+.||.+|| ++++|+++
T Consensus 220 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 012233445788999999999999999 88999865
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=347.70 Aligned_cols=267 Identities=19% Similarity=0.232 Sum_probs=203.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5788999999999999999999999999999999755432 23668899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++ +|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9965 66666654 2467999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCccccccccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCcc-cchhhHh-hhhhhhc-cchhhh
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITGRRVIDNSRPTE-EQNLVTW-ATPLFKD-RRKFTM 312 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~-~~~~~~~-~~~~~~~-~~~~~~ 312 (399)
........||+.|+|||++.+.. ++.++|||||||++|+|++|..||....... ....+.. ....... ......
T Consensus 155 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp --CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred --cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcc
Confidence 22223456899999999987765 8999999999999999999887754433221 1111100 0000000 000000
Q ss_pred c---------cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 M---------ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~---------~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ................+.+|+.+||+.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0 00000111223445678899999999999999999999754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=353.09 Aligned_cols=265 Identities=21% Similarity=0.214 Sum_probs=215.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.+ +||||+++++++.+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 468999999999999999999999899999999987543 234688899999999 89999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC-----eeEecccCcc
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN-----PKLSDFGLAK 231 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~-----~kl~Dfg~~~ 231 (399)
|+ +++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++.
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999862 457999999999999999999999999 999999999999998887 9999999998
Q ss_pred CCCCCCCcc-----ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 232 LGPTGDKSH-----VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 232 ~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 643332211 123467999999999999999999999999999999999999999986544332222111110000
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
... ..+... .+ .+.+++..||+.||.+||++.+|++.|+.+....
T Consensus 239 -~~~-----~~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~ 283 (330)
T 2izr_A 239 -TPI-----EVLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK 283 (330)
T ss_dssp -SCH-----HHHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -CCH-----HHHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence 000 000111 22 7889999999999999999999999999887654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=369.35 Aligned_cols=254 Identities=18% Similarity=0.234 Sum_probs=207.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++|.+.+.||+|+||.||+|.+..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 45789999999999999999999999999999999765432 2356889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC---CCCCeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD---QDFNPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~~~~ 232 (399)
||++||+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++..
T Consensus 90 E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 90 DLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp CCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999987 456999999999999999999999999 99999999999998 567899999999976
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+. .....
T Consensus 163 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~~~--- 231 (444)
T 3soa_A 163 VEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK------AGAYD--- 231 (444)
T ss_dssp CCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HTCCC---
T ss_pred ecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------hCCCC---
Confidence 44322 22234679999999999999999999999999999999999999998754322111110 00000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+ .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 232 ~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 FPSP-----EWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp CCTT-----TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCcc-----ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000 011234578899999999999999999999875
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=362.84 Aligned_cols=253 Identities=20% Similarity=0.249 Sum_probs=209.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|++..........+.+|+.+++.++||||+++++++.+....++||||+
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~ 130 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 130 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcC
Confidence 57999999999999999999999999999999998665445567889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC--CCCeeEecccCccCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ--DFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~--~~~~kl~Dfg~~~~~~~~ 236 (399)
++|+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||++......
T Consensus 131 ~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 131 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999976 3456999999999999999999999999 999999999999974 577999999999864432
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........+ .....
T Consensus 205 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i------~~~~~-------- 267 (387)
T 1kob_A 205 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRCDW-------- 267 (387)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHCCC--------
T ss_pred c---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC--------
Confidence 2 223356999999999999999999999999999999999999999875432211111 00000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 00111122334578899999999999999999999875
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=357.50 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=207.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999996432 12235688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+ +|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899999876 456999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+
T Consensus 160 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i---------------- 220 (336)
T 3h4j_B 160 DGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV---------------- 220 (336)
T ss_dssp TSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----------------
T ss_pred CCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----------------
Confidence 332 2234579999999999988776 68999999999999999999999865432211100
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ....+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 221 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 221 NSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp CSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred HcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 000 011223344578899999999999999999999765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=353.34 Aligned_cols=268 Identities=24% Similarity=0.341 Sum_probs=218.0
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEE-----CCCCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeC
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDG 148 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 148 (399)
...++|.+.+.||+|+||.||+|.+ ..++..||||++..... ...+.+.+|+.+++++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3446788999999999999999985 45678999999976543 2346688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPP--------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NI 214 (399)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence 999999999999999999986321 1235899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCccc
Q 046609 215 LLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEE 293 (399)
Q Consensus 215 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~ 293 (399)
+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 999999999999999986555443333444567889999999999999999999999999999999 9999987654321
Q ss_pred chhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 294 QNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
. ...... ... ...+...+..+.+++.+||+.||.+|||+.+++++|+++....
T Consensus 257 ~--~~~~~~----------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 257 F--YKMIKE----------GFR----MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp H--HHHHHH----------TCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred H--HHHhcc----------CCC----CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 1 100000 001 1112233457889999999999999999999999999886643
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=349.50 Aligned_cols=266 Identities=18% Similarity=0.209 Sum_probs=215.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.++..+ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 467999999999999999999998899999999986542 335678899999999 79999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC-----eeEecccCcc
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN-----PKLSDFGLAK 231 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~-----~kl~Dfg~~~ 231 (399)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++.
T Consensus 87 ~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 87 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99 9999999986 2446999999999999999999999999 999999999999987776 9999999998
Q ss_pred CCCCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 232 LGPTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 232 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 64433221 1233467999999999999999999999999999999999999999986544332222111110000
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
..... +.. ..+..+.+++.+||+.||.+||++.+|++.|+.+....
T Consensus 240 -~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~ 285 (298)
T 1csn_A 240 -TPLRE-----LCA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 285 (298)
T ss_dssp -SCHHH-----HTT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred -ccHHH-----HHh----hCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence 00000 111 22347889999999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-47 Score=361.84 Aligned_cols=256 Identities=21% Similarity=0.251 Sum_probs=206.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC-----CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG-----FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56889999999999999999999999999999986421 1235678999999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC---eeEecccCc
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN---PKLSDFGLA 230 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg~~ 230 (399)
||||+++|+|.+++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 99999999999888653333456899999999999999999999999 999999999999987655 999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ... ........
T Consensus 181 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~---~i~~~~~~- 250 (351)
T 3c0i_A 181 IQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFE---GIIKGKYK- 250 (351)
T ss_dssp EECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHH---HHHHTCCC-
T ss_pred eEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHH---HHHcCCCC-
Confidence 7644322 2233457999999999999999999999999999999999999999864211 110 00000000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.. ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 251 ---~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 251 ---MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp ---CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ---CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000 01223578899999999999999999999874
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=354.74 Aligned_cols=268 Identities=25% Similarity=0.365 Sum_probs=198.8
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCe---EEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQ---DVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
...++|.+.+.||+|+||.||+|.+..++. .||||++.... ....+.+.+|+.++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 445789999999999999999999876654 89999987542 2344678999999999999999999999987766
Q ss_pred e------EEEEEecCCCChHHhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 151 R------ILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 151 ~------~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
. ++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999999996522 12236999999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (399)
||+|||++................+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+......
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~--- 253 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI--- 253 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh---
Confidence 9999999986544433333334557889999999999999999999999999999999 999998765432211110
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.. .....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 254 ---~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~ 301 (323)
T 3qup_A 254 ---GG-----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301 (323)
T ss_dssp ---TT-----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred ---cC-----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence 00 0011122344578899999999999999999999999999876443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=354.82 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=206.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.+.||+|+||.||+|++..+++.||||++....... ...+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57888999999999999999999999999999997654322 34577899999887 899999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999976 356999999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc---hhhHhhhhhhhccchhh
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ---NLVTWATPLFKDRRKFT 311 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~ 311 (399)
.. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .............
T Consensus 162 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~---- 235 (345)
T 3a8x_A 162 RP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---- 235 (345)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred CC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence 22 12234467999999999999999999999999999999999999999764322111 0000011111110
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh------HHHHHH
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM------SDVVTA 354 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~eil~~ 354 (399)
..++...+..+.+++.+||+.||.+||++ .+++.+
T Consensus 236 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h 276 (345)
T 3a8x_A 236 --------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 276 (345)
T ss_dssp --------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred --------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence 11233345578899999999999999996 566544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=359.56 Aligned_cols=251 Identities=27% Similarity=0.374 Sum_probs=208.1
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~ 152 (399)
..++|.+.++||+|+||.||+|.+..+++.||||++.... ......+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 4578999999999999999999999999999999997542 23345678899999887 7999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++..
T Consensus 98 lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999976 356999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.. ..+....
T Consensus 171 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~~----- 237 (353)
T 2i0e_A 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIMEHN----- 237 (353)
T ss_dssp CCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC-----
T ss_pred cccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHH------HHHHhCC-----
Confidence 3222 12234467999999999999999999999999999999999999999875432211 1111110
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
..++...+..+.+++.+||+.||.+||+ +.+|+++
T Consensus 238 -------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 -------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1122334457889999999999999995 4777655
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=354.12 Aligned_cols=274 Identities=23% Similarity=0.383 Sum_probs=217.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEE--EEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDV--AVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.+.||+|+||.||+|.+..++..+ |+|.+.... ......+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57899999999999999999998778755 999886432 23345688999999999 899999999999999999999
Q ss_pred EEecCCCChHHhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 155 YEYMPNGSLEDHLLDLP------------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999998632 22357999999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~ 301 (399)
||+|||++..... ........+++.|+|||++.+..++.++||||||+++|+|++ |+.||............ .
T Consensus 182 kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~---~ 255 (327)
T 1fvr_A 182 KIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---P 255 (327)
T ss_dssp EECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG---G
T ss_pred EEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh---h
Confidence 9999999874221 112223457889999999988889999999999999999998 99999876532211000 0
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccccccccccCccC
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDSLDSCH 375 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~~~~~~~~~~ 375 (399)
. ......+...+..+.+++.+||+.||.+|||+.++++.|+.+.............+...
T Consensus 256 ---~-----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~~~~~~~~~~ 315 (327)
T 1fvr_A 256 ---Q-----------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFT 315 (327)
T ss_dssp ---G-----------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSCSBCCBCTTCCC
T ss_pred ---c-----------CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhcCccccchhccCC
Confidence 0 00111223344578899999999999999999999999999988876555444444433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=370.00 Aligned_cols=265 Identities=19% Similarity=0.226 Sum_probs=214.0
Q ss_pred cHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEe
Q 046609 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCV 146 (399)
Q Consensus 70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~ 146 (399)
...++....++|.+.++||+|+||.||+|++..+++.||||++..... .....+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 445566677899999999999999999999999999999999965321 22234788999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
+.+..++||||++||+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999976 2457999999999999999999999999 99999999999999999999999
Q ss_pred ccCccCCCCCCCcccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 227 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
||+++...... .......+||+.|+|||++. ...++.++|||||||++|||++|++||...+..+....+.
T Consensus 219 FGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~--- 294 (437)
T 4aw2_A 219 FGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--- 294 (437)
T ss_dssp CTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---
T ss_pred hhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh---
Confidence 99997543322 22233467999999999986 5678999999999999999999999998765432221111
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT--RPMMSDVVTA 354 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 354 (399)
.... ...-+.. ....+..+.+|+.+||..+|++ ||++++++++
T Consensus 295 ---~~~~---~~~~p~~----~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 ---NHKE---RFQFPTQ----VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp ---THHH---HCCCCSS----CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred ---hccc---cccCCcc----cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 0000 0000111 1123457889999999888888 9999999875
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=359.33 Aligned_cols=253 Identities=19% Similarity=0.264 Sum_probs=207.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 35799999999999999999999999999999999765432 3356889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC---CeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF---NPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Dfg~~~~ 232 (399)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++..
T Consensus 108 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 108 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp CCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999976 456999999999999999999999999 99999999999998654 599999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||...+.......+. ......
T Consensus 181 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~------~~~~~~-- 249 (362)
T 2bdw_A 181 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK------AGAYDY-- 249 (362)
T ss_dssp CTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCCCC--
T ss_pred ecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCCCCC--
Confidence 54322 2234579999999999999899999999999999999999999998754322111110 000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ......+..+.+|+.+||+.||.+||++.+++++
T Consensus 250 -~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 -PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp -CT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred -Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0011234578899999999999999999999865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=350.72 Aligned_cols=263 Identities=26% Similarity=0.393 Sum_probs=219.9
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
...++|.+.+.||+|+||.||+|.+..++..||+|.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567888999999999999999999999999999997543 34567889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 999999999999863 2456999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.............
T Consensus 164 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---------------- 226 (288)
T 3kfa_A 164 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---------------- 226 (288)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----------------
T ss_pred Cc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh----------------
Confidence 32 222333557889999999998999999999999999999999 999998765432211110
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.......+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 227 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~ 273 (288)
T 3kfa_A 227 -KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES 273 (288)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00111222334457889999999999999999999999999887654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=347.29 Aligned_cols=259 Identities=25% Similarity=0.388 Sum_probs=210.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
..++|.+.+.||+|+||.||+|.+. ++..||+|++.... ...+++.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 4467888999999999999999887 47789999997654 334678999999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 100 ~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 100 YMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCTTCBHHHHHHC---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred ccCCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 9999999999976 2456999999999999999999999999 999999999999999999999999999754322
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+. ..
T Consensus 174 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-------------~~-- 237 (283)
T 3gen_A 174 E-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-------------QG-- 237 (283)
T ss_dssp H-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-------------TT--
T ss_pred c-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-------------cc--
Confidence 1 111223446788999999998999999999999999999998 999998765432111110 00
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.....+......+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus 238 --~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 238 --LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 01111222235788999999999999999999999999988643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-47 Score=358.18 Aligned_cols=246 Identities=26% Similarity=0.322 Sum_probs=208.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57889999999999999999999999999999996532 233466888999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++.....
T Consensus 121 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999986 356999999999999999999999999 99999999999999999999999999985432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||......... .......
T Consensus 194 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~~-------- 254 (350)
T 1rdq_E 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY------EKIVSGK-------- 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCC--------
T ss_pred C-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH------HHHHcCC--------
Confidence 2 23457999999999999999999999999999999999999999875432211 1111110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
..++...+..+.+++.+||+.||.+||+ +.+|+++
T Consensus 255 ----~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 0122334457889999999999999998 8888765
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=351.46 Aligned_cols=267 Identities=21% Similarity=0.283 Sum_probs=194.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 4689999999999999999999999999999999975432 234678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 157 YMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|++ |+|.+++.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 996 69999886521 22346999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh-----hhcc-
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL-----FKDR- 307 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~~- 307 (399)
... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+...... +...
T Consensus 160 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 237 (317)
T 2pmi_A 160 IPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT 237 (317)
T ss_dssp SCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred CCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence 222 12233568999999999876 46899999999999999999999999876543322111110000 0000
Q ss_pred --ch------------hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 --RK------------FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 --~~------------~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ......+.. .......+.+|+.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 238 KLPKYNPNIQQRPPRDLRQVLQPHT----KEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GCTTCCTTCCCCCCCCSHHHHGGGC----SSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccchhHHHhhcccc----cccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 00 000000111 11234578899999999999999999999754
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.96 Aligned_cols=257 Identities=28% Similarity=0.503 Sum_probs=208.0
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch-------HHHHHHHHHHHccCCCceeeEEEEEeeCC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN-------REFLVEVLMLSMLSNPYLVNLVGYCVDGD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 149 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++........ +.+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 34789999999999999999999998999999999865433221 56889999999999999999999997655
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC-----eeE
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN-----PKL 224 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~-----~kl 224 (399)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ ++|+||||||+||+++.++. +||
T Consensus 97 --~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl 170 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKV 170 (287)
T ss_dssp --EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred --eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEe
Confidence 799999999999998876 3457999999999999999999999875 34999999999999988876 999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccc--cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA--LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
+|||++..... ......||+.|+|||++ ....++.++||||||+++|+|++|+.||..............
T Consensus 171 ~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--- 242 (287)
T 4f0f_A 171 ADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI--- 242 (287)
T ss_dssp CCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH---
T ss_pred CCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH---
Confidence 99999974322 22335699999999988 355678999999999999999999999987654322111100
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.........+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 243 -----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 -----------REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----------HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----------hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 001111122334456789999999999999999999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=359.04 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=198.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999999999999999997643 3346688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC--eeEecccCccCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN--PKLSDFGLAKLGPT 235 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~ 235 (399)
+++|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999976 456999999999999999999999999 999999999999987765 99999999874222
Q ss_pred CCCccccccccccccccccccccCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAK-SDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~-~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............ .......
T Consensus 171 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~--~~~~~~~-------- 237 (361)
T 3uc3_A 171 H---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT--IQRILSV-------- 237 (361)
T ss_dssp -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH--HHHHHTT--------
T ss_pred c---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH--HHHHhcC--------
Confidence 2 12233569999999999988888765 89999999999999999999875543221111 1111100
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 238 --~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 --KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp --CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred --CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 00000011233578899999999999999999999887
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=367.61 Aligned_cols=261 Identities=21% Similarity=0.267 Sum_probs=212.1
Q ss_pred HHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEee
Q 046609 71 YRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVD 147 (399)
Q Consensus 71 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~ 147 (399)
.+++....++|.+.++||+|+||.||+|++..+++.||+|++.+.. ......+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566789999999999999999999999999999999996522 1223457889999999999999999999999
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
.+..++||||++||+|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999975 35899999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ----LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
|++....... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|++||...+.......+
T Consensus 213 G~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------ 285 (410)
T 3v8s_A 213 GTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI------ 285 (410)
T ss_dssp TTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------
T ss_pred ceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH------
Confidence 9997643322 12233567999999999997655 889999999999999999999999875543221111
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCC--CCChHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGT--RPMMSDVVTA 354 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~eil~~ 354 (399)
....... .-+. ....+..+.+|+.+||+.+|.+ ||++.+|+++
T Consensus 286 ~~~~~~~---~~p~-----~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 286 MNHKNSL---TFPD-----DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HTHHHHC---CCCT-----TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred Hhccccc---cCCC-----cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 1100000 0000 0123357889999999999988 9999999876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=350.36 Aligned_cols=267 Identities=21% Similarity=0.283 Sum_probs=203.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++|.+.+.||+|+||.||+|.+.. ++.||+|++...... ....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 4789999999999999999999964 889999999754322 2356889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++ |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 99 e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFME-KDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCS-EEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCC-CCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 9996 588888876 3456999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-hhh----ccch
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-LFK----DRRK 309 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~----~~~~ 309 (399)
.. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+..... ... ....
T Consensus 172 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 249 (311)
T 3niz_A 172 PV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQE 249 (311)
T ss_dssp CC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTT
T ss_pred Cc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhc
Confidence 22 22233568999999999876 5689999999999999999999999987665433222111000 000 0000
Q ss_pred hhhccC---CccCC----CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMAD---PLLEG----NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~---~~l~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...... ..... .........+.+|+.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000000 00000 0011233578899999999999999999999763
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-47 Score=374.25 Aligned_cols=261 Identities=26% Similarity=0.393 Sum_probs=217.4
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
+...+|.+.+.||+|+||.||+|.+..++..||||.+.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 34567888899999999999999999889999999997653 34578999999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 370 (495)
T 1opk_A 296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370 (495)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTT
T ss_pred EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccC
Confidence 999999999999863 2356899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. ........++..|+|||++.+..++.++|||||||++|||++ |..||...........+ .
T Consensus 371 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~---~------------- 433 (495)
T 1opk_A 371 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E------------- 433 (495)
T ss_dssp CC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H-------------
T ss_pred Cc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H-------------
Confidence 22 122223456789999999998999999999999999999999 99999876543211111 0
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
.......+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 434 -~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 434 -KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 011112233444678899999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=342.50 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=198.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC----cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF----QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+. +..||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 467888999999999999999986 78899999865432 223668899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC--------CCCeeEe
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ--------DFNPKLS 225 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~--------~~~~kl~ 225 (399)
||||+++++|.+++.. ..+++..++.++.|++.||.|||+.+..+|+||||||+||+++. ++.+||+
T Consensus 84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 9999999999999854 46999999999999999999999988555889999999999986 7789999
Q ss_pred cccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (399)
|||++....... .....|++.|+|||++.+..++.++||||||+++|+|++|+.||............
T Consensus 159 Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------- 226 (271)
T 3dtc_A 159 DFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV-------- 226 (271)
T ss_dssp CCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH--------
T ss_pred cCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh--------
Confidence 999997543322 12346899999999999999999999999999999999999999875432111100
Q ss_pred ccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 306 DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 306 ~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.........+...+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus 227 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 --------AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------hcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 001111122333445788999999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=346.54 Aligned_cols=266 Identities=19% Similarity=0.262 Sum_probs=201.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|.+ .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence 5788899999999999999998 4688999999975432 223678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|++ ++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 81 HLD-QDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CCS-EEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ecC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 996 499999876 2457999999999999999999999999 999999999999999999999999998753221
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh-hhhhh-ccchhhh-
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA-TPLFK-DRRKFTM- 312 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~-~~~~~~~- 312 (399)
. .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+... ..... .......
T Consensus 154 ~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 1 12233468999999999876 45899999999999999999999999875433221111000 00000 0000000
Q ss_pred -ccCCccC-------CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 -MADPLLE-------GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 -~~~~~l~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..++... .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 01112234578899999999999999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=352.41 Aligned_cols=275 Identities=24% Similarity=0.336 Sum_probs=219.7
Q ss_pred cHHHHHHhcCCCCCCCeeccCCcEEEEEEEE-----CCCCeEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeEE
Q 046609 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKL-----EGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNLV 142 (399)
Q Consensus 70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~ 142 (399)
.........++|.+.+.||+|+||.||+|.+ ..+++.||||++...... ....+.+|+.++.++ +||||++++
T Consensus 18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 97 (316)
T 2xir_A 18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 97 (316)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence 3445555678899999999999999999985 346789999999765332 335688999999999 689999999
Q ss_pred EEEeeCC-eeEEEEEecCCCChHHhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 046609 143 GYCVDGD-QRILVYEYMPNGSLEDHLLDLPPN------------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDF 209 (399)
Q Consensus 143 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~di 209 (399)
+++...+ ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||
T Consensus 98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~di 174 (316)
T 2xir_A 98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174 (316)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccC
Confidence 9988755 489999999999999999874321 123899999999999999999999999 999999
Q ss_pred CCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 046609 210 KASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNS 288 (399)
Q Consensus 210 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~ 288 (399)
||+||+++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||...
T Consensus 175 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 254 (316)
T 2xir_A 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 254 (316)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred ccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999999999999999986544443333445668899999999999999999999999999999998 99999875
Q ss_pred CCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 289 RPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
..... ...... . ... ...+......+.+++.+||+.||.+|||+.+|+++|+.+.....
T Consensus 255 ~~~~~--~~~~~~----~------~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 255 KIDEE--FCRRLK----E------GTR----MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp CCSHH--HHHHHH----H------TCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred chhHH--HHHHhc----c------Ccc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 53221 110000 0 000 01122234578899999999999999999999999999876544
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=364.44 Aligned_cols=256 Identities=28% Similarity=0.393 Sum_probs=211.3
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC-eeEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD-QRILV 154 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-~~~lv 154 (399)
...++|.+.+.||+|+||.||+|.+. +..||||++.... ..+.+.+|+.++++++||||+++++++.+.. ..++|
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 34567888999999999999999986 6799999997653 4577999999999999999999999987665 78999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999862 2334799999999999999999999999 9999999999999999999999999997532
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.. .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+....+ . .
T Consensus 341 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~----~------- 401 (450)
T 1k9a_A 341 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---E----K------- 401 (450)
T ss_dssp -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH---H----T-------
T ss_pred cc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----c-------
Confidence 21 112357889999999999999999999999999999998 99999876543321111 0 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
......+...+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 402 ---~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~ 447 (450)
T 1k9a_A 402 ---GYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447 (450)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence 0011223334567889999999999999999999999999987653
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=354.67 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=193.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 3467999999999999999999999999999999997542 34567889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEecccCccCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFGLAKLG 233 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~~~~~ 233 (399)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||++...
T Consensus 129 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~ 201 (349)
T 2w4o_A 129 LVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIV 201 (349)
T ss_dssp CCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-----
T ss_pred eCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCcccccc
Confidence 9999999999976 456999999999999999999999999 999999999999975 889999999999754
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ... .......
T Consensus 202 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~---~i~~~~~----- 268 (349)
T 2w4o_A 202 EHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MFR---RILNCEY----- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HHH---HHHTTCC-----
T ss_pred Ccc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HHH---HHHhCCC-----
Confidence 322 122345699999999999999999999999999999999999999986543211 110 0000000
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 269 ---~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 269 ---YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00011112334578899999999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=352.25 Aligned_cols=267 Identities=25% Similarity=0.373 Sum_probs=214.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC-------CCCeEEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEee
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE-------GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVD 147 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~ 147 (399)
..++|.+.+.||+|+||.||+|.+. .++..||||++..... .....+.+|+.+++++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 4568889999999999999999975 3567899999975432 2335688999999999 89999999999999
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceE
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPN------------RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVL 215 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIl 215 (399)
.+..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+.+ |+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEE
Confidence 99999999999999999999864321 234899999999999999999999999 999999999999
Q ss_pred ECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccc
Q 046609 216 LDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQ 294 (399)
Q Consensus 216 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 294 (399)
++.++.+||+|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||......+..
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 269 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHH
Confidence 99999999999999986544333333334557889999999988899999999999999999999 99999875432211
Q ss_pred hhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
... .. . . ....+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 270 ~~~---~~---~-------~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 270 KLL---KE---G-------H----RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp HHH---HH---T-------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHH---hc---C-------C----CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 111 00 0 0 011122344578899999999999999999999999999976543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=345.63 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=201.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHc--cCCCceeeEEEEEee----CCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSM--LSNPYLVNLVGYCVD----GDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~~~~~~----~~~~ 151 (399)
.++|.+.+.||+|+||.||+|.+ +++.||||++... ....+..|.+++.. ++||||+++++++.+ ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 46899999999999999999988 4889999999653 33455666666666 789999999998654 3457
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCceEECCCCCee
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH--------ESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEE
Confidence 999999999999999954 46999999999999999999999 888 99999999999999999999
Q ss_pred EecccCccCCCCCCCcc--ccccccccccccccccccCC------CCCchhhHHHHHHHHHHHHcC----------CCCC
Q 046609 224 LSDFGLAKLGPTGDKSH--VSTRVMGTYGYCAPEYALTG------QLTAKSDVYSFGVVFLEIITG----------RRVI 285 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~~pf 285 (399)
|+|||++.......... ......||+.|+|||++.+. .++.++|||||||++|+|++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999997533322211 12234799999999998776 455799999999999999999 7888
Q ss_pred CCCCCcccchhhHhhhhhhhccchhhhccCCcc-CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 286 DNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL-EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
....+........ ........ ..+.+ ....+......+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus 234 ~~~~~~~~~~~~~--~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPSFEDM--RKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCCHHHH--HHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcchhhh--hHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 6654332211110 00000000 01111 1112335667899999999999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=344.81 Aligned_cols=260 Identities=22% Similarity=0.325 Sum_probs=200.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
..++|.+.+.||+|+||.||+|.+..+ +..||+|.+..... .....+.+|+.++++++||||+++++++. ++..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 346788899999999999999998643 45799999875432 23456889999999999999999999985 56789
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 92 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp EEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccc
Confidence 99999999999999986 2446999999999999999999999999 99999999999999999999999999976
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
....... ......+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+. ..
T Consensus 166 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------~~----- 233 (281)
T 1mp8_A 166 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NG----- 233 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TT-----
T ss_pred cCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH------cC-----
Confidence 4332211 1223456789999999998999999999999999999997 999998765432111110 00
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
. ....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 234 --~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 234 --E----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp --C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --C----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 0112233445788999999999999999999999999998654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=355.88 Aligned_cols=267 Identities=24% Similarity=0.348 Sum_probs=215.0
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCe-----EEEEEEEccCCC-cchHHHHHHHHHHHcc-CCCceeeEEEEEeeC
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQ-----DVAVKQLDRNGF-QGNREFLVEVLMLSML-SNPYLVNLVGYCVDG 148 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~~~-~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 148 (399)
...++|.+.+.||+|+||.||+|.+..++. .||+|.+..... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345788999999999999999999876554 799999976532 2345688999999999 899999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPP----------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ 218 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~ 218 (399)
+..++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECC
Confidence 999999999999999999875210 1346899999999999999999999999 999999999999999
Q ss_pred CCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhh
Q 046609 219 DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLV 297 (399)
Q Consensus 219 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~ 297 (399)
++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||......... .
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~ 277 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--Y 277 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--H
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--H
Confidence 99999999999985443333333344567889999999999999999999999999999998 99999875533211 1
Q ss_pred HhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 298 TWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
...... .....+...+..+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus 278 ~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 278 KLVKDG--------------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHHHT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhcC--------------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 100000 00111222345788999999999999999999999999988654
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=348.48 Aligned_cols=267 Identities=20% Similarity=0.291 Sum_probs=204.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.+|.+.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 578999999999999999999988899999999975432 23356889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999998753334567999999999999999999999999 99999999999999999999999999875432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ ....... ....
T Consensus 189 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~----------~~~~ 255 (310)
T 2wqm_A 189 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCKKIE----------QCDY 255 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHHHHH----------TTCS
T ss_pred CC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHHHhh----------cccC
Confidence 22 122335689999999999999999999999999999999999999976432211 1111000 0000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccc
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~ 364 (399)
+.. .....+..+.+++.+||+.||.+|||+.+|++.|+++.....+
T Consensus 256 ~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~ 301 (310)
T 2wqm_A 256 PPL---PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTAS 301 (310)
T ss_dssp CCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred CCC---cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhh
Confidence 000 1122345788999999999999999999999999999876653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=365.33 Aligned_cols=265 Identities=22% Similarity=0.210 Sum_probs=211.9
Q ss_pred ccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEE
Q 046609 69 FSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYC 145 (399)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~ 145 (399)
+...+.....++|.+.++||+|+||.||+|++..+++.||||++.+... .....+.+|..++..++||||+++++++
T Consensus 51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~ 130 (412)
T 2vd5_A 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF 130 (412)
T ss_dssp HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 3445566677899999999999999999999999999999999975321 2234478899999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEe
Q 046609 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLS 225 (399)
Q Consensus 146 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 225 (399)
.+.+..++||||++||+|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.+|++||+
T Consensus 131 ~~~~~~~lVmE~~~gg~L~~~l~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 131 QDENYLYLVMEYYVGGDLLTLLSK---FGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp ECSSEEEEEECCCCSCBHHHHHHH---HSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEEC
T ss_pred eeCCEEEEEEcCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999999976 2346999999999999999999999999 9999999999999999999999
Q ss_pred cccCccCCCCCCCcccccccccccccccccccc-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-------TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 298 (399)
|||++........ ......+||+.|+|||++. +..++.++|||||||++|||++|+.||...+..+....+.
T Consensus 205 DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 283 (412)
T 2vd5_A 205 DFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283 (412)
T ss_dssp CCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred echhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999976433221 1223467999999999987 3578999999999999999999999998755432211111
Q ss_pred hhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCC---CChHHHHHH
Q 046609 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTR---PMMSDVVTA 354 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~eil~~ 354 (399)
.... ....+.. +...+..+.+|+.+||. +|.+| |++++|+++
T Consensus 284 ~~~~---------~~~~p~~----~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 284 HYKE---------HLSLPLV----DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp THHH---------HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred hccc---------CcCCCcc----ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 0000 0001111 12234578899999999 99998 689999765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-46 Score=349.65 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=206.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC----eEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN----QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
.++|.+.+.||+|+||.||+|.+..++ ..||||.+..... .....+.+|+.+++.++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 456777899999999999999886543 4699999975432 23356889999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999976 3457999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 233 GPTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 233 ~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
....... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+... ... ..
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~---~~~----~~--- 266 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMK---AIN----DG--- 266 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH---HHH----TT---
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHH---HHH----CC---
Confidence 4432211 11222346788999999999999999999999999999999 999997654322111 000 00
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.....+...+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus 267 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~ 312 (333)
T 1mqb_A 267 -------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312 (333)
T ss_dssp -------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -------CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence 0011122344578899999999999999999999999999876543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=346.54 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=204.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57889999999999999999999999999999986554322 3557889999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 83 ~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 83 YCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp CCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred eCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999988875 456999999999999999999999999 999999999999999999999999999764322
Q ss_pred CCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh--------hhhhcc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT--------PLFKDR 307 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~--------~~~~~~ 307 (399)
. .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+......... ..+...
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (311)
T 4agu_A 156 S--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred c--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence 2 22234568999999999876 678999999999999999999999998765443222211110 000000
Q ss_pred chhhhccCCccCCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........+......+ ...+..+.+|+.+||+.||.+|||+++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 1111111110000000 1234568899999999999999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=354.10 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=200.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCC--CceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSN--PYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~ 152 (399)
..++|.+.+.||+|+||.||+|.+. ++..||||++...... ..+.+.+|+.++..++| |||+++++++.+++..+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 85 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 85 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence 4567999999999999999999886 5889999999755432 23668899999999986 99999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+|||+ .+|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ ++.+||+|||++..
T Consensus 86 lv~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 86 MVMEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp EEECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred EEEeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99995 58899999987 457999999999999999999999999 99999999999997 67899999999986
Q ss_pred CCCCCCccccccccccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALT-----------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
..............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--------- 227 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------- 227 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---------
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH---------
Confidence 554443333445679999999999864 678999999999999999999999997643211
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
.......++.....++......+.+|+.+||+.||.+|||+.+++++-.
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 228 ------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp ------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred ------HHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1111112222222233333457889999999999999999999998743
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=351.68 Aligned_cols=272 Identities=21% Similarity=0.265 Sum_probs=213.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEe----eCCee
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV----DGDQR 151 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~----~~~~~ 151 (399)
+..++|.+.+.||+|+||.||+|.+..+++.||||++..........+.+|+.+++.++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 34578999999999999999999998899999999997655555677899999999999999999999987 33478
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 9999999999999999864444677999999999999999999999999 9999999999999999999999999987
Q ss_pred CCCCCCCcc-------ccccccccccccccccccCCC---CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 232 LGPTGDKSH-------VSTRVMGTYGYCAPEYALTGQ---LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 232 ~~~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~---~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
......... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......... .....
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~- 260 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-VALAV- 260 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-HHHHH-
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-hhHHh-
Confidence 532211110 012245799999999887554 688999999999999999999999642111100 00000
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccc
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~ 365 (399)
.. ......+...+..+.+++.+||+.||.+||++.+++++|+.+.+..+..
T Consensus 261 ---~~----------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~ 311 (317)
T 2buj_A 261 ---QN----------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ 311 (317)
T ss_dssp ---HC----------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred ---hc----------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence 00 0000111233457889999999999999999999999999987665543
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=340.85 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=212.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF 84 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence 457888899999999999999987 478899999986543 346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 85 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp CTTCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred CCCCcHHHHHhh---CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccc
Confidence 999999999986 2356899999999999999999999999 9999999999999999999999999997543211
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
........++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+ . ..
T Consensus 159 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i---~---~~---------- 221 (267)
T 3t9t_A 159 -YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI---S---TG---------- 221 (267)
T ss_dssp -HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H---TT----------
T ss_pred -ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH---h---cC----------
Confidence 111223457788999999988999999999999999999999 89999875432211100 0 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.....+...+..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus 222 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 222 -FRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -CcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 00111222345788999999999999999999999999998764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=351.16 Aligned_cols=260 Identities=22% Similarity=0.298 Sum_probs=199.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCe----
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ---- 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~---- 150 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 468999999999999999999999899999999997653332 2467889999999999999999999876543
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 4999999999999999976 456999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 231 KLGPTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 231 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+....... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hcCCCC
Confidence 754333221 2223456899999999999999999999999999999999999999875542211100 000000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHH-HHHHHh
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV-TAIEYL 358 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil-~~L~~l 358 (399)
.... . ....+..+.+++.+||+.||.+||++.+++ ..+..+
T Consensus 238 ~~~~----~----~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 PPSA----R----HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CHHH----H----STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Cccc----c----cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0000 0 111334788999999999999999666655 445444
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=355.34 Aligned_cols=271 Identities=17% Similarity=0.185 Sum_probs=208.2
Q ss_pred hcCCCCCCCeeccC--CcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEG--GFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
..++|.+.+.||+| +||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45689999999999 9999999999999999999999765432 2356788999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||.+..
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999999863 2356999999999999999999999999 99999999999999999999999998764
Q ss_pred CCCCCC-----ccccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh
Q 046609 233 GPTGDK-----SHVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305 (399)
Q Consensus 233 ~~~~~~-----~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (399)
...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............ ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~ 255 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK--LNGTVP 255 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--hcCCCC
Confidence 221111 111223468999999999987 67999999999999999999999999875543221110 000000
Q ss_pred ccchhhh---------------------cc---------CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 DRRKFTM---------------------MA---------DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 ~~~~~~~---------------------~~---------~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....... .. ........+......+.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0000000 00 0000011233345678999999999999999999999866
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=354.67 Aligned_cols=278 Identities=26% Similarity=0.339 Sum_probs=214.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEE----ECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEe--eCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGK----LEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV--DGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~--~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|. ...++..||||++........+.+.+|+.++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4678899999999999999999 46678999999998765555567899999999999999999999986 45678
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999762 346999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........ .......+|..|+|||++.+..++.++||||||+++|+|++|..||............ . ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~-~~~~~~~~~~ 253 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-C-ERDVPALSRL 253 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC------CCHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-c-ccccccHHHH
Confidence 65433322 1223355888899999999999999999999999999999999998753321100000 0 0000000011
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
............+...+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 306 (327)
T 3lxl_A 254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR 306 (327)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 11111111222344455688999999999999999999999999998865443
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=339.79 Aligned_cols=254 Identities=26% Similarity=0.356 Sum_probs=207.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence 568889999999999999999998999999999975432 3346788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 87 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 87 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 999999999975 456999999999999999999999999 9999999999999999999999999997543333
Q ss_pred CccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.........|++.|+|||++.+..+ +.++||||||+++|+|++|+.||......... ...+... .
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~-----~-------- 225 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK-----K-------- 225 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHTT-----C--------
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhhc-----c--------
Confidence 2223344678999999999987765 67899999999999999999999875532211 1111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+..+.+++.+||+.||.+|||+.+++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0000112334578899999999999999999999753
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=343.25 Aligned_cols=262 Identities=29% Similarity=0.464 Sum_probs=198.4
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
..++|.+.+.||+|+||.||+|.+.. .||+|++...... ..+.+.+|+.++++++||||+++++++ .....++|
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 22 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred CccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 45789999999999999999998753 4999999755432 235688999999999999999999965 45678999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999975 3467999999999999999999999999 9999999999999999999999999997544
Q ss_pred CCCCcccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
............||+.|+|||++. +..++.++||||||+++|+|++|+.||........ ....... .
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-----~--- 241 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR-----G--- 241 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH-----T---
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc-----c---
Confidence 333333334467999999999886 66789999999999999999999999987554221 1111100 0
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
...+.+ .......+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 242 -~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 242 -SLSPDL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp -SCCCCT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred -ccCcch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 001110 11122344578999999999999999999999999998864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=369.14 Aligned_cols=250 Identities=26% Similarity=0.347 Sum_probs=200.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC---CCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN---GFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999999999999999999753 222335577899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
|||+++|+|..++.. ...+++..++.++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||++...
T Consensus 227 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999976 4579999999999999999999998 88 999999999999999999999999999753
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+ ....
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~------ 365 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LMEE------ 365 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC------
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC------
Confidence 222 22234467999999999999999999999999999999999999999875432211111 1110
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
..++......+.+|+.+||+.||.+|| ++.+++++
T Consensus 366 ------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 012223345788999999999999999 99999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=348.65 Aligned_cols=255 Identities=24% Similarity=0.394 Sum_probs=206.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC-------eEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN-------QDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++........+.+.+|+.++++++||||+++++++.+++.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 357888999999999999999987666 5799999977665666789999999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC--------e
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN--------P 222 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~--------~ 222 (399)
.++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999987 2344999999999999999999999999 999999999999998887 9
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCcccchhhHhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGR-RVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~ 300 (399)
||+|||++..... .....+++.|+|||++.+ ..++.++||||||+++|+|++|. +||...........
T Consensus 161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~---- 230 (289)
T 4fvq_A 161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF---- 230 (289)
T ss_dssp EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----
T ss_pred eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH----
Confidence 9999999864321 123458899999999987 77999999999999999999954 55554332111100
Q ss_pred hhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 301 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
..... ..+...+..+.+++.+||+.||.+|||+.+++++|+.+.++..
T Consensus 231 ---~~~~~------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 231 ---YEDRH------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp ---HHTTC------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred ---hhccC------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 00000 0111112357789999999999999999999999999876544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=347.11 Aligned_cols=267 Identities=27% Similarity=0.382 Sum_probs=204.0
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECC---CCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCC-
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEG---TNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD- 149 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~- 149 (399)
...++|.+.+.||+|+||.||+|.+.. ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345688899999999999999998754 4568999998754332 2356889999999999999999999998765
Q ss_pred ----eeEEEEEecCCCChHHhhccCC--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 150 ----QRILVYEYMPNGSLEDHLLDLP--PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 150 ----~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 3499999999999999985422 23467999999999999999999999999 99999999999999999999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhh
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~ 302 (399)
|+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||............ .
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~---~- 263 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL---L- 263 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---H-
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH---H-
Confidence 999999986544333333334567889999999999999999999999999999999 89999876543211111 0
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.. .....+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus 264 --~~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 264 --HG-----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp --TT-----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred --cC-----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 00 011122334457889999999999999999999999999987643
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=346.95 Aligned_cols=271 Identities=24% Similarity=0.349 Sum_probs=209.4
Q ss_pred CCCCCCCeeccCCcEEEEEEE----ECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeC--Cee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGK----LEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQR 151 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~ 151 (399)
.+|++.+.||+|+||.||+|. ...+++.||||++..... .....+.+|+.+++.++||||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 457888999999999999999 466789999999975432 3346788999999999999999999999876 668
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK---NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 999999999999999965 2456999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh--ccc
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK--DRR 308 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 308 (399)
........ .......+|..|+|||++.+..++.++||||||+++|+|++|..|+...... ......+... ...
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVT 250 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHH
Confidence 65443322 2233456888999999999999999999999999999999999886532110 0000000000 000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
..............+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 001111111112233445568899999999999999999999999999874
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=350.79 Aligned_cols=250 Identities=24% Similarity=0.357 Sum_probs=198.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC----cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF----QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
.++|.+.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 357899999999999999999984 5789999999976432 223457789999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 9999999999999999976 456899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
....... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .......
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~~~--- 237 (327)
T 3a62_A 169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKILKCK--- 237 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHTC---
T ss_pred cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhCC---
Confidence 7432221 1223457999999999999999999999999999999999999999875432211 1111110
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
...+......+.+++.+||+.||.+|| ++.+++++
T Consensus 238 ---------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ---------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ---------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ---------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 012223345788999999999999999 77788765
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=348.66 Aligned_cols=251 Identities=23% Similarity=0.293 Sum_probs=182.1
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEecCCCC
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEYMPNGS 162 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 162 (399)
.+.||+|+||.||+|.+..+++.||||++... ....+.+|+.+++.+. ||||+++++++.++...++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 37899999999999999999999999999653 3456788999999997 9999999999999999999999999999
Q ss_pred hHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC---CeeEecccCccCCCCCCCc
Q 046609 163 LEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF---NPKLSDFGLAKLGPTGDKS 239 (399)
Q Consensus 163 L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~Dfg~~~~~~~~~~~ 239 (399)
|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++.......
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-- 163 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-- 163 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--
Confidence 9999987 467999999999999999999999999 99999999999997765 79999999997543322
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch-hhHhhhhhhhccchhhhccCCcc
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN-LVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......... ............ ...
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~--------~~~ 235 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD--------FSF 235 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC--------CCC
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC--------CCC
Confidence 22334568999999999999999999999999999999999999998755421111 111111110000 000
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 000011234578899999999999999999999643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-46 Score=364.97 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=208.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999975422 2345688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999975 467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .....
T Consensus 168 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~------~i~~~------- 231 (476)
T 2y94_A 168 DGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK------KICDG------- 231 (476)
T ss_dssp TTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH------HHHTT-------
T ss_pred ccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhcC-------
Confidence 332 2234579999999999988776 689999999999999999999998754322111 11000
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ..+......+.+|+.+||+.||.+|||+.+|+++
T Consensus 232 ---~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 ---IF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---Cc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 00 1122233578899999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=341.16 Aligned_cols=263 Identities=26% Similarity=0.392 Sum_probs=212.3
Q ss_pred CCCCCCC-eeccCCcEEEEEEEEC--CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDN-LLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.+ .||+|+||.||+|.+. .++..||||++..... ...+.+.+|+.+++.++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4555665 8999999999999864 4578899999976532 2346688999999999999999999999 55678999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 999999999999975 3456999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 235 TGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 235 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+ . .
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i---~----~------ 228 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---E----Q------ 228 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---H----T------
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---h----c------
Confidence 33221 11223456889999999988899999999999999999998 99999876543211111 0 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccccc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEA 365 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~ 365 (399)
. .....+...+..+.+++.+||+.||.+||++.+++++|+.+..+....
T Consensus 229 ~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~ 277 (287)
T 1u59_A 229 G----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277 (287)
T ss_dssp T----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred C----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence 0 011223344558889999999999999999999999999997765543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=359.13 Aligned_cols=246 Identities=24% Similarity=0.325 Sum_probs=196.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHH-HHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLM-LSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~-l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|.+.++||+|+||.||+|++..++..||||++.+.... ....+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 36799999999999999999999999999999999765432 22345666665 467899999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999976 456899999999999999999999999 999999999999999999999999999752
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+.. ..+....
T Consensus 190 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i~~~~------ 255 (373)
T 2r5t_A 190 IEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNILNKP------ 255 (373)
T ss_dssp BCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------HHHHHSC------
T ss_pred ccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHhcc------
Confidence 221 12234467999999999999999999999999999999999999999865432211 1111110
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSD 350 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e 350 (399)
..++......+.+++.+||+.||.+||++.+
T Consensus 256 ------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 ------LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 0112233457889999999999999999853
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=355.54 Aligned_cols=248 Identities=22% Similarity=0.291 Sum_probs=200.5
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+++|+|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 46799999999999999999999999999876555667899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE--CCCCCeeEecccCccCCCCCCCccc
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL--DQDFNPKLSDFGLAKLGPTGDKSHV 241 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll--~~~~~~kl~Dfg~~~~~~~~~~~~~ 241 (399)
.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++........
T Consensus 174 ~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--- 244 (373)
T 2x4f_A 174 FDRIID---ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--- 244 (373)
T ss_dssp HHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---
T ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---
Confidence 999876 2356999999999999999999999999 9999999999999 6778899999999986543322
Q ss_pred cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCC
Q 046609 242 STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321 (399)
Q Consensus 242 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 321 (399)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+ ...... ....
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i------~~~~~~----~~~~---- 310 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI------LACRWD----LEDE---- 310 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCC----SCSG----
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhccCC----CChh----
Confidence 22346999999999999899999999999999999999999999876532211111 110000 0000
Q ss_pred CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 322 YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 322 ~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........+.+|+.+||+.||.+|||+.+++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011234578899999999999999999999984
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=344.27 Aligned_cols=268 Identities=23% Similarity=0.284 Sum_probs=203.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-----cchHHHHHHHHHHHccC---CCceeeEEEEEeeC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-----QGNREFLVEVLMLSMLS---NPYLVNLVGYCVDG 148 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~ 148 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 46789999999999999999999998999999999864321 12345677877777665 99999999999876
Q ss_pred C-----eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 149 D-----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 149 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
. ..++||||+. |+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+|
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 5 5799999995 69999998732 344999999999999999999999999 99999999999999999999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
|+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||...........+......
T Consensus 161 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99999997543322 223457899999999999999999999999999999999999999876543322111111000
Q ss_pred hhccchhhhc-------cCCccC---CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 FKDRRKFTMM-------ADPLLE---GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 ~~~~~~~~~~-------~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ..+... ..+... ..........+.+|+.+||+.||.+|||+.+++++
T Consensus 238 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 238 PPE-DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCT-TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCh-hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 000 000000 000000 00011234578899999999999999999999754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=344.45 Aligned_cols=260 Identities=26% Similarity=0.404 Sum_probs=208.2
Q ss_pred hcCCCCCCC-eeccCCcEEEEEEEE--CCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 77 ATTNFNPDN-LLGEGGFGRVYRGKL--EGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 77 ~~~~~~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
..++|.+.+ .||+|+||.||+|.+ ..+++.||||++...... ..+.+.+|+.+++.++||||+++++++ ..+..
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 345677777 999999999999954 566789999999765322 246788999999999999999999999 56778
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999987 456999999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCCCcc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 232 LGPTGDKSH-VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 232 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
......... ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||............ . .
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~----~--- 235 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---E----K--- 235 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H----T---
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H----c---
Confidence 654333221 1222446788999999988889999999999999999999 99999876542211111 0 0
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......+...+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 236 -------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 280 (291)
T 1xbb_A 236 -------GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 280 (291)
T ss_dssp -------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred -------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 001112333455788999999999999999999999999988654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=345.92 Aligned_cols=266 Identities=21% Similarity=0.279 Sum_probs=202.2
Q ss_pred CCCCCC-CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPD-NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+.|.+. ++||+|+||.||+|.+..+++.||||++..........+.+|+.++.++ +||||+++++++.+++..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 567774 7899999999999999989999999999876656667899999999885 79999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC---eeEecccCccCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN---PKLSDFGLAKLG 233 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg~~~~~ 233 (399)
|+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||++...
T Consensus 92 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 92 KMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred cCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999976 356999999999999999999999999 999999999999998776 999999998754
Q ss_pred CCCCC-----ccccccccccccccccccccC-----CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh
Q 046609 234 PTGDK-----SHVSTRVMGTYGYCAPEYALT-----GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 234 ~~~~~-----~~~~~~~~g~~~y~aPE~~~~-----~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..................
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 32211 111223469999999999865 56889999999999999999999999876543211100000000
Q ss_pred hhccchhhhccCCccCCCCCH----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 304 FKDRRKFTMMADPLLEGNYPI----KGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... .....+..... .++. ..+..+.+|+.+||+.||.+|||+.+++++
T Consensus 245 ~~~-~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQN-MLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHH-HHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHH-HHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 000 00000000000 1111 123578899999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=342.79 Aligned_cols=268 Identities=19% Similarity=0.267 Sum_probs=209.7
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEE-eeCCeeEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC-VDGDQRILVY 155 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~ 155 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 3578999999999999999999999899999999876543 234578899999999987766665554 6778889999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE---CCCCCeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~~~~ 232 (399)
||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Ecc-CCCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999 9999999985 2456999999999999999999999999 9999999999999 7899999999999986
Q ss_pred CCCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 233 GPTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 233 ~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 236 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH-
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc-
Confidence 4433221 1223457999999999999999999999999999999999999999886654433322221110000
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
... +.+... .+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 237 ~~~-----~~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~ 283 (296)
T 4hgt_A 237 TPI-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp SCH-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred chh-----hhhhcc----CCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence 000 001111 23478899999999999999999999999999876543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-47 Score=353.88 Aligned_cols=272 Identities=25% Similarity=0.368 Sum_probs=217.5
Q ss_pred HHHHHhcCCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEE
Q 046609 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYC 145 (399)
Q Consensus 72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~ 145 (399)
.+.....++|.+.+.||+|+||.||+|.+. .++..||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 344455678999999999999999999876 3578899999975432 2335688999999999999999999999
Q ss_pred eeCCeeEEEEEecCCCChHHhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC
Q 046609 146 VDGDQRILVYEYMPNGSLEDHLLDLP------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD 219 (399)
Q Consensus 146 ~~~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~ 219 (399)
.+.+..++||||+++|+|.+++.... .....+++..++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCC
Confidence 99999999999999999999987521 11245799999999999999999999999 9999999999999999
Q ss_pred CCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhH
Q 046609 220 FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVT 298 (399)
Q Consensus 220 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~ 298 (399)
+.+||+|||++................+|+.|+|||++.+..++.++||||||+++|+|++ |..||............
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~- 253 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV- 253 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH-
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH-
Confidence 9999999999975433322223333457889999999999999999999999999999999 89999875432211110
Q ss_pred hhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
... . ....+...+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 254 -----~~~----------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 254 -----MEG----------G-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp -----HTT----------C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred -----HcC----------C-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 000 0 001122344578899999999999999999999999998866544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=340.03 Aligned_cols=247 Identities=21% Similarity=0.293 Sum_probs=207.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELC 88 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEecc
Confidence 56888999999999999999999999999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE---CCCCCeeEecccCccCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~ 235 (399)
++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 89 TGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 99999999876 456999999999999999999999999 9999999999999 8889999999999976443
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+...... ....
T Consensus 162 ~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~------- 224 (277)
T 3f3z_A 162 GK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR------EGTF------- 224 (277)
T ss_dssp TS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCC-------
T ss_pred cc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCCC-------
Confidence 32 2233569999999998765 49999999999999999999999998754322111110 0000
Q ss_pred CccCCCCCH----HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPI----KGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+. ..+..+.+++.+||+.||.+|||+.+++++
T Consensus 225 -----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 225 -----TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp -----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred -----CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011 123578899999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=339.33 Aligned_cols=253 Identities=19% Similarity=0.258 Sum_probs=207.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 47899999999999999999999999999999999755432 2356788999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC---eeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN---PKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Dfg~~~~ 232 (399)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 85 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 85 DLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998876 456999999999999999999999999 999999999999986655 99999999975
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||............. .....
T Consensus 158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~~~~--- 225 (284)
T 3kk8_A 158 VNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK------AGAYD--- 225 (284)
T ss_dssp CCSSC---BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCCC---
T ss_pred cccCc---cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH------hcccc---
Confidence 43322 2233569999999999999999999999999999999999999998754322111110 00000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 226 ~~~-----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 YPS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp CCT-----TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCc-----hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 0011233468899999999999999999999875
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=356.61 Aligned_cols=253 Identities=22% Similarity=0.297 Sum_probs=199.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccC--CCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLS--NPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~~~l 153 (399)
..+|.+.+.||+|+||.||+|.+.. ++.||||++...... ....+.+|+.++..++ ||||+++++++..++..++
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 3469999999999999999999875 889999999765332 3366889999999996 5999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||| +.+++|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||++...
T Consensus 134 v~E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EEE-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred EEe-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 999 558899999987 357899999999999999999999999 99999999999995 589999999999865
Q ss_pred CCCCCccccccccccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALT-----------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
.............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~---- 275 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S---- 275 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----H----
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----H----
Confidence 44333333345679999999998865 468999999999999999999999997643211 0
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
.+..+.++.....++......+.+|+.+||+.||.+|||+.+++++-
T Consensus 276 ------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 276 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp ------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 01111111111122222245788999999999999999999998763
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=361.18 Aligned_cols=268 Identities=22% Similarity=0.308 Sum_probs=195.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccC-CCceeeEEEEEeeCC--ee
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGD--QR 151 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~--~~ 151 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++..+. ||||+++++++...+ ..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 35789999999999999999999999999999999865322 23456788999999997 999999999997544 68
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||++ |+|..++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 87 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 99999996 699999976 46999999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCC-------------------CccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc
Q 046609 232 LGPTGD-------------------KSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT 291 (399)
Q Consensus 232 ~~~~~~-------------------~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 291 (399)
...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 543211 1112234579999999999876 67999999999999999999999999876543
Q ss_pred ccchhhHhhhhhhhccchhhhcc------------------CCccCCCC------------CHHHHHHHHHHHhhccccC
Q 046609 292 EEQNLVTWATPLFKDRRKFTMMA------------------DPLLEGNY------------PIKGLYQALAVAAMCLQEE 341 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~------------------~~~l~~~~------------~~~~~~~l~~li~~cl~~d 341 (399)
.....+...... ........+. .......+ .......+.+|+.+||+.|
T Consensus 238 ~~~~~i~~~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d 316 (388)
T 3oz6_A 238 NQLERIIGVIDF-PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN 316 (388)
T ss_dssp HHHHHHHHHHCC-CCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred HHHHHHHHhcCC-CCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence 322211100000 0000000000 00000000 0122457889999999999
Q ss_pred CCCCCChHHHHHH
Q 046609 342 AGTRPMMSDVVTA 354 (399)
Q Consensus 342 p~~RPs~~eil~~ 354 (399)
|.+|||+.+++++
T Consensus 317 P~~R~t~~e~l~H 329 (388)
T 3oz6_A 317 PNKRISANDALKH 329 (388)
T ss_dssp GGGSCCHHHHTTS
T ss_pred cccCCCHHHHhCC
Confidence 9999999999765
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=367.63 Aligned_cols=265 Identities=23% Similarity=0.351 Sum_probs=214.7
Q ss_pred HHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 72 RELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 72 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
....+..++|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.+.+|+.++++++||||+++++++. .+..
T Consensus 181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred cceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 3344556788889999999999999999874 7789999997654 44678999999999999999999999986 5678
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 258 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~ 332 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLAR 332 (454)
T ss_dssp EEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence 9999999999999999752 1235889999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+ ...
T Consensus 333 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~~------- 401 (454)
T 1qcf_A 333 VIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---ERG------- 401 (454)
T ss_dssp GBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HHT-------
T ss_pred EcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---HcC-------
Confidence 643221 111223446788999999998999999999999999999999 99999876533211111 000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.....+...+..+.+++.+||+.||.+|||+.+|++.|+.+....
T Consensus 402 -------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 402 -------YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp -------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred -------CCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 001112234457889999999999999999999999999886543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=355.62 Aligned_cols=275 Identities=22% Similarity=0.255 Sum_probs=212.0
Q ss_pred cccHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-----CCceeeEE
Q 046609 68 IFSYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-----NPYLVNLV 142 (399)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----hpnIv~l~ 142 (399)
.+++.......++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.+++.+. ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3455555566789999999999999999999999899999999997432 33455778999999986 99999999
Q ss_pred EEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC----
Q 046609 143 GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---- 218 (399)
Q Consensus 143 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---- 218 (399)
+++...+..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccccc
Confidence 9999999999999999 99999999873 2346999999999999999999999999 999999999999975
Q ss_pred ---------------------CCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHH
Q 046609 219 ---------------------DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLE 277 (399)
Q Consensus 219 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~e 277 (399)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 789999999999753322 223568999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCcccchhhHhhhhhhhccc--------hhhhccCCccCCCC--------------------CHHHHHH
Q 046609 278 IITGRRVIDNSRPTEEQNLVTWATPLFKDRR--------KFTMMADPLLEGNY--------------------PIKGLYQ 329 (399)
Q Consensus 278 lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~~~--------------------~~~~~~~ 329 (399)
|++|+.||......+....+......+.... .............+ .......
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 9999999987654332222111111000000 00000000000000 0011256
Q ss_pred HHHHHhhccccCCCCCCChHHHHHH
Q 046609 330 ALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 330 l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+.+|+.+||+.||.+|||+.+++++
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~h 356 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKH 356 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcC
Confidence 7799999999999999999999753
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=351.86 Aligned_cols=267 Identities=24% Similarity=0.325 Sum_probs=199.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57888999999999999999999999999999997543221 12355799999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
++ |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~- 153 (324)
T 3mtl_A 82 LD-KDLKQYLDD---CGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP- 153 (324)
T ss_dssp CS-EEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-
Confidence 96 699999886 3456999999999999999999999999 999999999999999999999999999753322
Q ss_pred CccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc--------cc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD--------RR 308 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--------~~ 308 (399)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+......... ..
T Consensus 154 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (324)
T 3mtl_A 154 -TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 232 (324)
T ss_dssp ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCH
T ss_pred -ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcch
Confidence 222233568999999999876 57899999999999999999999999876543322221111000000 00
Q ss_pred hhhhccCCccCCC----CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGN----YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~----~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.......+..... ........+.+|+.+||+.||.+|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0000000000000 011234578899999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.30 Aligned_cols=258 Identities=28% Similarity=0.425 Sum_probs=202.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+. ++.||||.+... ...+.+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 56888899999999999999986 688999998643 345678999999999999999999998863 479999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCCCeEecCCCCCceEECCCCC-eeEecccCccCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE---SAQPPVIYRDFKASNVLLDQDFN-PKLSDFGLAKLGP 234 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~~~~ivH~dikp~NIll~~~~~-~kl~Dfg~~~~~~ 234 (399)
++|+|.+++.... ....+++..++.++.|++.||.|||+ ++ |+||||||+||+++.++. +||+|||++....
T Consensus 82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999998632 12347899999999999999999999 66 999999999999998887 7999999987432
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ..+.. . ...
T Consensus 158 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~~--~-------~~~ 221 (307)
T 2eva_A 158 TH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWAV--H-------NGT 221 (307)
T ss_dssp ------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHHH--H-------TTC
T ss_pred cc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHHH--h-------cCC
Confidence 21 12345899999999999999999999999999999999999999865432111 00000 0 000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccccc
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEAC 366 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~ 366 (399)
.+ ..+...+..+.+++.+||+.||.+|||+.++++.|+.+........
T Consensus 222 ~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~ 269 (307)
T 2eva_A 222 RP----PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD 269 (307)
T ss_dssp CC----CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred CC----CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence 11 1122234578899999999999999999999999999987665433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=344.29 Aligned_cols=252 Identities=21% Similarity=0.267 Sum_probs=207.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|.+.+.||+|+||.||+|.+..++..||+|++...... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 4688899999999999999999999999999999754322 2467899999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC----CeeEeccc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF----NPKLSDFG 228 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg 228 (399)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 92 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 99999999999999976 457999999999999999999999999 99999999999999888 79999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+. ....
T Consensus 165 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~------~~~~ 235 (321)
T 2a2a_A 165 LAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT------SVSY 235 (321)
T ss_dssp TCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------TTCC
T ss_pred cceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hccc
Confidence 997644332 1233569999999999999999999999999999999999999998654322111110 0000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. .++.. ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 236 ~----~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 236 D----FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C----CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c----cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00000 01223468899999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=337.20 Aligned_cols=255 Identities=22% Similarity=0.336 Sum_probs=206.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeC--CeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDG--DQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~--~~~~l 153 (399)
.++|.+.+.||+|+||.||+|.+. +..||||++...... ..+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 357888999999999999999986 788999999765432 335688999999999999999999999887 78899
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ ++|+||||||+||+++.++.++|+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 99999999999999872 2336999999999999999999999765 34999999999999999999999998887532
Q ss_pred CCCCCccccccccccccccccccccCCCCCc---hhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTA---KSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
.. ....||+.|+|||++.+..++. ++||||||+++|+|++|+.||............ .
T Consensus 164 ~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~------ 224 (271)
T 3kmu_A 164 QS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV------A------ 224 (271)
T ss_dssp SC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHH------H------
T ss_pred cc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHH------H------
Confidence 11 2245899999999998765544 799999999999999999999865432211000 0
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
........+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 225 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 225 ----LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0011112233344578899999999999999999999999998854
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=355.27 Aligned_cols=254 Identities=20% Similarity=0.231 Sum_probs=195.6
Q ss_pred CCCCCC-CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHH-ccCCCceeeEEEEEee----CCeeE
Q 046609 79 TNFNPD-NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLS-MLSNPYLVNLVGYCVD----GDQRI 152 (399)
Q Consensus 79 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~hpnIv~l~~~~~~----~~~~~ 152 (399)
++|.+. ++||+|+||.||+|.+..+++.||||++.. ...+.+|+.++. ..+||||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456655 689999999999999999999999999863 245677888874 4589999999999875 56789
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEecccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFGL 229 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~ 229 (399)
+||||++||+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999862 2346999999999999999999999999 999999999999987 78999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch-hhHhhhhhhhccc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN-LVTWATPLFKDRR 308 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~ 308 (399)
++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ...... ....
T Consensus 211 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQY 284 (400)
T ss_dssp CEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTCC
T ss_pred ccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCcc
Confidence 98543221 2234678999999999999999999999999999999999999998765433211 111000 0000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
. ...+ .....+..+.+|+.+||+.||.+|||+.+++++-.
T Consensus 285 ~---~~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 285 E---FPNP-----EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp C---CCTT-----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred c---CCCc-----ccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 0000 01123457889999999999999999999998743
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=346.59 Aligned_cols=246 Identities=21% Similarity=0.207 Sum_probs=194.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.++||+|+||.||+|.+..+++.||||++....... ......|+..+..+ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 56889999999999999999999899999999986543322 23345555555554 8999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+ +++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 137 e~~-~~~L~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 137 ELC-GPSLQQHCEA---WGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp ECC-CCBHHHHHHH---HCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred ecc-CCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 999 7799999876 2456999999999999999999999999 99999999999999999999999999875433
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+...... . .+..
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~--------------~~~~ 266 (311)
T 3p1a_A 210 AG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGW-----Q--------------QLRQ 266 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHH-----H--------------HHTT
T ss_pred CC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHH-----H--------------HHhc
Confidence 22 2234569999999998865 7999999999999999999997666532110 0 0000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......++...+..+.+++.+||+.||.+|||+.+++++
T Consensus 267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 000001111234578899999999999999999999863
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=368.99 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=211.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
..++|.+.++||+|+||.||+|.+..+++.||||++.... ......+.+|+.++..++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3567899999999999999999999999999999996532 2234567889999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||++||+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++...
T Consensus 262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceec
Confidence 99999999999999763 2345999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. .....
T Consensus 337 ~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~--~i~~~------- 404 (576)
T 2acx_A 337 PEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER--LVKEV------- 404 (576)
T ss_dssp CTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHH--HHHHC-------
T ss_pred ccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHH--Hhhcc-------
Confidence 4332 22335799999999999999999999999999999999999999987654322111110 00000
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
...++...+..+.+|+.+||+.||.+|| ++.+|+++
T Consensus 405 -----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 -----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred -----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 0122333445788999999999999999 78888765
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=367.22 Aligned_cols=258 Identities=26% Similarity=0.381 Sum_probs=211.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.++||+|+||.||+|++..+++.||||++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 3678889999999999999999999999999999965422 2335688899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||++||+|..++.........+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||++....
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999875444567999999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.... .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... ..........
T Consensus 341 ~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~~~------- 409 (543)
T 3c4z_A 341 AGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLEQA------- 409 (543)
T ss_dssp TTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHHCC-------
T ss_pred CCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhhcc-------
Confidence 3321 2233579999999999999999999999999999999999999998754322111 1111111110
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM-----SDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 354 (399)
..++...+..+.+++.+||+.||.+||++ .+|+.+
T Consensus 410 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 410 -----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp -----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred -----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 12233345578899999999999999975 666543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=349.38 Aligned_cols=253 Identities=21% Similarity=0.301 Sum_probs=198.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCC--------
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD-------- 149 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~-------- 149 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 468889999999999999999998999999999975433 34467899999999999999999999986543
Q ss_pred -------------------------------------------------eeEEEEEecCCCChHHhhccCCCCCCCCCHH
Q 046609 150 -------------------------------------------------QRILVYEYMPNGSLEDHLLDLPPNRKALDWN 180 (399)
Q Consensus 150 -------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~ 180 (399)
..++||||+++|+|.+++.... .....++.
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~ 164 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREHG 164 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-CccchhhH
Confidence 3799999999999999998743 23446777
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc----------ccccccccccc
Q 046609 181 TRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS----------HVSTRVMGTYG 250 (399)
Q Consensus 181 ~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----------~~~~~~~g~~~ 250 (399)
.++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 999999999999999999999999999865443211 12233569999
Q ss_pred ccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHH
Q 046609 251 YCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQA 330 (399)
Q Consensus 251 y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 330 (399)
|+|||++.+..++.++||||||+++|+|++|..|+.... ...... ..... ..........+
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~~~~~----------~~~~~----~~~~~~~~~~~ 302 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RIITDV----------RNLKF----PLLFTQKYPQE 302 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HHHHHH----------HTTCC----CHHHHHHCHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HHHHHh----------hccCC----CcccccCChhH
Confidence 999999999999999999999999999999876543210 000000 00000 01112334567
Q ss_pred HHHHhhccccCCCCCCChHHHHHH
Q 046609 331 LAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 331 ~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+++.+||+.||.+|||+.+++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 889999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=341.69 Aligned_cols=248 Identities=27% Similarity=0.392 Sum_probs=205.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 4678899999999999999999999999999999864321 2245688899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999976 356999999999999999999999999 9999999999999999999999999986432
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+..
T Consensus 161 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--------------- 221 (279)
T 3fdn_A 161 SS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR--------------- 221 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH---------------
T ss_pred cc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh---------------
Confidence 22 22335689999999999999999999999999999999999999986543221111100
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+......+.+|+.+||+.||.+|||+.+++++
T Consensus 222 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 ---VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp ---TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0011222334578899999999999999999999986
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=340.75 Aligned_cols=266 Identities=20% Similarity=0.277 Sum_probs=212.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEE-eeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC-VDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+|+.+++.++|++++..+..+ ...+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 478999999999999999999998899999999987553 235688999999999988766555554 67778899999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE---CCCCCeeEecccCccCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~~~~~ 233 (399)
|+ +++|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||++...
T Consensus 86 ~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 86 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred ec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 99 9999999975 2456999999999999999999999999 9999999999999 48889999999999764
Q ss_pred CCCCCcc-----ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-hhhcc
Q 046609 234 PTGDKSH-----VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-LFKDR 307 (399)
Q Consensus 234 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-~~~~~ 307 (399)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||................. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 4332211 12345799999999999999999999999999999999999999997654433222221111 11000
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
. +.+... .+..+.+++.+||+.||.+|||+.+|++.|+.+.....
T Consensus 239 --~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~ 283 (296)
T 3uzp_A 239 --I-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 283 (296)
T ss_dssp --H-----HHHTTT----SCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred --h-----HHHHhh----CCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence 0 001111 23468899999999999999999999999999876554
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=343.62 Aligned_cols=254 Identities=24% Similarity=0.318 Sum_probs=202.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|.+.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 468889999999999999999999999999999976542 3447788999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE---CCCCCeeEecccCccCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~~~~~~ 234 (399)
+++|+|.+++.........+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998653223467999999999999999999999999 9999999999999 556889999999997543
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||................ ...
T Consensus 179 ~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~------~~~---- 244 (285)
T 3is5_A 179 SDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKE------PNY---- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC------CCC----
T ss_pred Ccc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCC------ccc----
Confidence 322 223456899999999875 678999999999999999999999998754322211111100 000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... .......+.+++.+||+.||.+|||+.+++++
T Consensus 245 -~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 245 -AVE----CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp -CC------CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred -ccc----cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01123468899999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=353.46 Aligned_cols=272 Identities=16% Similarity=0.181 Sum_probs=207.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCC-----CeEEEEEEEccCCCcch-----------HHHHHHHHHHHccCCCceee
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGT-----NQDVAVKQLDRNGFQGN-----------REFLVEVLMLSMLSNPYLVN 140 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~hpnIv~ 140 (399)
..++|.+.+.||+|+||.||+|.+..+ ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 456899999999999999999998764 57899999875432111 12344566777888999999
Q ss_pred EEEEEeeC----CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 141 LVGYCVDG----DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 141 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
+++++... ...++||||+ +++|.+++.. ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEE
Confidence 99998764 4589999999 9999999987 3467999999999999999999999999 9999999999999
Q ss_pred C--CCCCeeEecccCccCCCCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Q 046609 217 D--QDFNPKLSDFGLAKLGPTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSR 289 (399)
Q Consensus 217 ~--~~~~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~ 289 (399)
+ .++.+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999754322111 11133559999999999999999999999999999999999999998643
Q ss_pred CcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 290 PTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.... ........+ ......+.++.+. ....+..+.+++..||+.+|.+||++.+|++.|+.+....
T Consensus 266 ~~~~--~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~ 331 (364)
T 3op5_A 266 KDPK--YVRDSKIRY--RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAI 331 (364)
T ss_dssp TCHH--HHHHHHHHH--HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cCHH--HHHHHHHHh--hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHc
Confidence 3211 111111101 0112222222111 0122347889999999999999999999999999987643
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=339.70 Aligned_cols=251 Identities=28% Similarity=0.398 Sum_probs=187.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 3578899999999999999999988899999999965321 2236688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 999999999999986 3457999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.... ......|++.|+|||++.+..++.++||||||+++|+|++|+.||............ .
T Consensus 164 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~----------------~ 225 (278)
T 3cok_A 164 MPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV----------------V 225 (278)
T ss_dssp ------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----C----------------C
T ss_pred CCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHH----------------h
Confidence 2221 222356899999999999889999999999999999999999999875432211000 0
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 226 ~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 226 LAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp SSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 000 01122334578899999999999999999999753
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=349.59 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=203.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+|+.++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 3568899999999999999999999999999999976532 234578888877 79999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC----CCeeEecccCccC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD----FNPKLSDFGLAKL 232 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~----~~~kl~Dfg~~~~ 232 (399)
|++||+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||+..+ +.+||+|||++..
T Consensus 97 ~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 97 LMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999976 456999999999999999999999999 9999999999998433 3499999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+..... ...
T Consensus 170 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~---~~~----- 239 (342)
T 2qr7_A 170 LRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG---SGK----- 239 (342)
T ss_dssp CBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH---HCC-----
T ss_pred CcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc---cCC-----
Confidence 43322 12234578999999999988889999999999999999999999998643222211111111 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+........+..+.+|+.+||+.||.+||++.+++++
T Consensus 240 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 240 ---FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ---CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ---cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 001111222344578899999999999999999999876
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=342.59 Aligned_cols=262 Identities=22% Similarity=0.338 Sum_probs=208.7
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECC---CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEG---TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
..++|.+.+.||+|+||.||+|.+.. ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.++ ..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCE
Confidence 34678889999999999999998643 345699999876532 3346788999999999999999999998754 568
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 89 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 89 IIMELYPYGELGHYLER---NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp EEEECCTTCBHHHHHHH---HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred EEEecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence 99999999999999976 2456999999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
...... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||............. . .
T Consensus 163 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~----~---- 230 (281)
T 3cc6_A 163 IEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---K----G---- 230 (281)
T ss_dssp C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---H----T----
T ss_pred cccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---c----C----
Confidence 443221 12233457889999999988999999999999999999998 999998654432211110 0 0
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.. ...+...+..+.+++.+||+.||.+||++.+++++|+.+.....
T Consensus 231 --~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 276 (281)
T 3cc6_A 231 --DR----LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQMEK 276 (281)
T ss_dssp --CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred --CC----CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHhhh
Confidence 00 01122234578899999999999999999999999999876544
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=339.75 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=207.1
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCC---eEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee-EEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTN---QDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR-ILV 154 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~-~lv 154 (399)
.|.+.++||+|+||.||+|.+..++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 3455689999999999999975443 3799999975433 2346688999999999999999999999876665 999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+.+|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999976 3467899999999999999999999999 9999999999999999999999999997543
Q ss_pred CCCC--ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 235 TGDK--SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR-RVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 235 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
.... ........+++.|+|||.+.+..++.++||||||+++|+|++|. +||...............
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~----------- 244 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG----------- 244 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT-----------
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC-----------
Confidence 3221 11223356789999999999999999999999999999999954 555544432211111000
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.....+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 245 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~ 290 (298)
T 3pls_A 245 ------RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL 290 (298)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred ------CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence 0011122334578899999999999999999999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=350.16 Aligned_cols=243 Identities=22% Similarity=0.311 Sum_probs=205.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--------chHHHHHHHHHHHccCCCceeeEEEEEeeCC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~ 149 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46799999999999999999999999999999999765321 2235678999999999999999999999999
Q ss_pred eeEEEEEecCCC-ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 150 QRILVYEYMPNG-SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 150 ~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
..++||||+.+| +|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 999999998776 99999976 456999999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.......
T Consensus 176 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------------- 237 (335)
T 3dls_A 176 SAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV--------------- 237 (335)
T ss_dssp TCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT---------------
T ss_pred cceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH---------------
Confidence 998644332 2233569999999999988877 789999999999999999999997532110
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... ..+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 238 ---~~~~------~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 ---EAAI------HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---TTCC------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---hhcc------CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 0111234578899999999999999999999876
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=347.47 Aligned_cols=257 Identities=21% Similarity=0.244 Sum_probs=205.3
Q ss_pred HhcCCCCCC-CeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccC-CCceeeEEEEEeeCCee
Q 046609 76 VATTNFNPD-NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 76 ~~~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~ 151 (399)
...++|.+. +.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.++..+. ||||+++++++.+.+..
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~ 104 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEI 104 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeE
Confidence 334567776 899999999999999999999999999975432 23467889999999985 69999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEeccc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFG 228 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg 228 (399)
++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 105 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg 179 (327)
T 3lm5_A 105 ILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFG 179 (327)
T ss_dssp EEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGG
T ss_pred EEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCc
Confidence 9999999999999998652 3467999999999999999999999999 999999999999988 7899999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
++....... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+...
T Consensus 180 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------- 248 (327)
T 3lm5_A 180 MSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV-------- 248 (327)
T ss_dssp GCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--------
T ss_pred cccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhc--------
Confidence 998643322 223356999999999999999999999999999999999999999875432211111000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...............+.+++.+||+.||.+|||+.+++++
T Consensus 249 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 ------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp ------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred ------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0001111122334578899999999999999999999765
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=352.00 Aligned_cols=262 Identities=22% Similarity=0.208 Sum_probs=203.4
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC-----CCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN-----GFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
...++|.+.+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 23 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 102 (345)
T 3hko_A 23 ELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY 102 (345)
T ss_dssp HHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe
Confidence 4456799999999999999999999999999999998643 22344678899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCC------------------------------------CCCCCHHHHHHHHHHHHHHHH
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPN------------------------------------RKALDWNTRMKIAHGAARGLE 194 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~ql~~~l~ 194 (399)
.++||||+++|+|.+++...... ...+++..++.++.|++.||.
T Consensus 103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 182 (345)
T 3hko_A 103 ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182 (345)
T ss_dssp EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHH
Confidence 99999999999999998631100 122467788999999999999
Q ss_pred HHhhcCCCCeEecCCCCCceEECCCC--CeeEecccCccCCCCCC--CccccccccccccccccccccC--CCCCchhhH
Q 046609 195 YLHESAQPPVIYRDFKASNVLLDQDF--NPKLSDFGLAKLGPTGD--KSHVSTRVMGTYGYCAPEYALT--GQLTAKSDV 268 (399)
Q Consensus 195 ~LH~~~~~~ivH~dikp~NIll~~~~--~~kl~Dfg~~~~~~~~~--~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Dv 268 (399)
|||+.+ |+||||||+||+++.++ .+||+|||++....... .........||+.|+|||++.+ ..++.++||
T Consensus 183 ~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di 259 (345)
T 3hko_A 183 YLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA 259 (345)
T ss_dssp HHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred HHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence 999999 99999999999998776 89999999997532221 1112334569999999999865 688999999
Q ss_pred HHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh
Q 046609 269 YSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM 348 (399)
Q Consensus 269 wslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 348 (399)
||||+++|+|++|+.||......+..... ....... ...........+.+++.+||+.||.+||++
T Consensus 260 wslG~il~el~~g~~pf~~~~~~~~~~~~------~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 325 (345)
T 3hko_A 260 WSAGVLLHLLLMGAVPFPGVNDADTISQV------LNKKLCF--------ENPNYNVLSPLARDLLSNLLNRNVDERFDA 325 (345)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCCT--------TSGGGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred HHHHHHHHHHHHCCCCCCCCChHHHHHHH------Hhccccc--------CCcccccCCHHHHHHHHHHcCCChhHCCCH
Confidence 99999999999999999876533211111 1100000 000011234578899999999999999999
Q ss_pred HHHHHH
Q 046609 349 SDVVTA 354 (399)
Q Consensus 349 ~eil~~ 354 (399)
.+++++
T Consensus 326 ~~~l~h 331 (345)
T 3hko_A 326 MRALQH 331 (345)
T ss_dssp HHHHHS
T ss_pred HHHhcC
Confidence 999875
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=361.58 Aligned_cols=264 Identities=21% Similarity=0.248 Sum_probs=200.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeC------C
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------D 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~ 149 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999999999999999997542 23346688999999999999999999999655 3
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||+.+ +|.+.+.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred eEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 56999999965 67777743 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh--------
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT-------- 301 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~-------- 301 (399)
++..... .......||+.|+|||++.+..|+.++|||||||++|+|++|++||.+.+..+....+....
T Consensus 211 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~ 287 (464)
T 3ttj_A 211 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287 (464)
T ss_dssp C-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9854332 22334679999999999999999999999999999999999999998765432221111000
Q ss_pred --------hhhhcc-----chhhhccCCccCC---CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 302 --------PLFKDR-----RKFTMMADPLLEG---NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 302 --------~~~~~~-----~~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...... ..+.......+.. .........+.+|+.+||+.||.+|||+++++++
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000000 0011225678999999999999999999999876
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=361.81 Aligned_cols=269 Identities=19% Similarity=0.252 Sum_probs=189.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee-----CCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD-----GDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-----~~~ 150 (399)
.++|.+.++||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 4689999999999999999999999999999999965422 234668899999999999999999999943 357
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++||||+ +|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 6799999976 457999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCc-------------------------cccccccccccccccccc-cCCCCCchhhHHHHHHHHHHHHc----
Q 046609 231 KLGPTGDKS-------------------------HVSTRVMGTYGYCAPEYA-LTGQLTAKSDVYSFGVVFLEIIT---- 280 (399)
Q Consensus 231 ~~~~~~~~~-------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~ellt---- 280 (399)
+........ ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~ 283 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE 283 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence 864322111 122345789999999976 46679999999999999999999
Q ss_pred -------CCCCCCCCCCccc-----------------chhhHhhhhhhhcc-------------chhhhccCCccC---C
Q 046609 281 -------GRRVIDNSRPTEE-----------------QNLVTWATPLFKDR-------------RKFTMMADPLLE---G 320 (399)
Q Consensus 281 -------g~~pf~~~~~~~~-----------------~~~~~~~~~~~~~~-------------~~~~~~~~~~l~---~ 320 (399)
|+++|.+...... ......+...+... ............ .
T Consensus 284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (458)
T 3rp9_A 284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA 363 (458)
T ss_dssp TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence 6677765432100 00000000000000 000000000000 0
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+.+|+.+||..||.+|||+++++++
T Consensus 364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H 397 (458)
T 3rp9_A 364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH 397 (458)
T ss_dssp GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 0011234678899999999999999999999875
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=340.15 Aligned_cols=262 Identities=26% Similarity=0.393 Sum_probs=206.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEe-eCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCV-DGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~-~~~~~~l 153 (399)
.+|.+.+.||+|+||.||+|.+..+ ...+|+|.+..... ...+.+.+|+.++++++||||+++++++. .++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 4578889999999999999987533 34689999876432 23466889999999999999999999864 5567899
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999976 3456899999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCc--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 234 PTGDKS--HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 234 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
...... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||............. ..
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------~~---- 248 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QG---- 248 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH------TT----
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh------cC----
Confidence 332211 12233557889999999999999999999999999999999 667777654432211110 00
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
... ..+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 249 ---~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~ 294 (298)
T 3f66_A 249 ---RRL----LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 294 (298)
T ss_dssp ---CCC----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred ---CCC----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 000 1122233478899999999999999999999999999876543
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=348.99 Aligned_cols=266 Identities=27% Similarity=0.396 Sum_probs=207.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEE-----ECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGK-----LEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|. ...++..||||.+..... .....+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 4678899999999999999998 445678999999964422 3345688999999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEe
Q 046609 152 ILVYEYMPNGSLEDHLLDLPP---NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLS 225 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~ 225 (399)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999987431 1245899999999999999999999999 999999999999984 4469999
Q ss_pred cccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|||++................+++.|+|||++.+..++.++||||||+++|+|++ |..||.......... ....
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~---~~~~-- 260 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE---FVTS-- 260 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH---HHHT--
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH---HHhc--
Confidence 9999874332222222334567899999999999999999999999999999998 999998754322111 1100
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
. .....+...+..+.+++.+||+.||.+||++.+|+++|+.+.....
T Consensus 261 -~-----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~~ 307 (327)
T 2yfx_A 261 -G-----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307 (327)
T ss_dssp -T-----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred -C-----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCHH
Confidence 0 0011122334578899999999999999999999999999877554
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=342.09 Aligned_cols=251 Identities=21% Similarity=0.299 Sum_probs=205.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|.+..........+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 88 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLV 88 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcC
Confidence 56888999999999999999999899999999998665445567889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE---CCCCCeeEecccCccCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~~~~~~~ 235 (399)
++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||++.....
T Consensus 89 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 89 SGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred CCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 99999999876 356999999999999999999999999 9999999999999 7889999999999875332
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+ .....
T Consensus 162 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~~------- 224 (304)
T 2jam_A 162 G----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI------KEGYY------- 224 (304)
T ss_dssp B----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHCCC-------
T ss_pred C----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HcCCC-------
Confidence 2 223356899999999999999999999999999999999999999875432111100 00000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+..+.+++.+||+.||.+||++.+++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00111122334578899999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=350.39 Aligned_cols=267 Identities=16% Similarity=0.162 Sum_probs=202.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC---CCeEEEEEEEccCCCc-----------chHHHHHHHHHHHccCCCceeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG---TNQDVAVKQLDRNGFQ-----------GNREFLVEVLMLSMLSNPYLVNLVG 143 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~-----------~~~~~~~e~~~l~~l~hpnIv~l~~ 143 (399)
.++|.+.+.||+|+||.||+|.+.. ++..+|||++...... ....+.+|+.++..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999986 7889999998765321 1133567888999999999999999
Q ss_pred EEee----CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC
Q 046609 144 YCVD----GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD 219 (399)
Q Consensus 144 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~ 219 (399)
++.+ ....++||||+ +++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccC
Confidence 9988 78899999999 9999999986 347999999999999999999999999 9999999999999888
Q ss_pred C--CeeEecccCccCCCCCCC-----ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc
Q 046609 220 F--NPKLSDFGLAKLGPTGDK-----SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292 (399)
Q Consensus 220 ~--~~kl~Dfg~~~~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 292 (399)
+ .+||+|||+++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 999999999975432211 111234579999999999999999999999999999999999999996532221
Q ss_pred cchhhHhhhhhhhcc-chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 293 EQNLVTWATPLFKDR-RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
... ........... ........ ....+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 268 ~~~-~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 268 VAV-QTAKTNLLDELPQSVLKWAP-------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp HHH-HHHHHHHHHTTTHHHHHHSC-------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred HHH-HHHHHhhcccccHHHHhhcc-------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 111 11001100000 00000000 01233478899999999999999999999999987654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=354.18 Aligned_cols=278 Identities=20% Similarity=0.235 Sum_probs=217.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCC--eeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD--QRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~~lv 154 (399)
.++|.+.++||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3578899999999999999999999999999999975432 33466789999999999999999999998765 77999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE----CCCCCeeEecccCc
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL----DQDFNPKLSDFGLA 230 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~Dfg~~ 230 (399)
|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999997632 1234999999999999999999999999 9999999999999 78888999999999
Q ss_pred cCCCCCCCccccccccccccccccccccC--------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc-hhhHhh-
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALT--------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ-NLVTWA- 300 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~- 300 (399)
....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ......
T Consensus 164 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~ 240 (396)
T 4eut_A 164 RELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240 (396)
T ss_dssp EECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred eEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence 7643322 2234569999999998864 56788999999999999999999999765432211 111111
Q ss_pred hhhhhc-cc--------hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 301 TPLFKD-RR--------KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 301 ~~~~~~-~~--------~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
...... .. .+.-..........+......+.+++.+||+.||.+||++.++++.++.+....
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~ 311 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence 000000 00 000000111122455778889999999999999999999999999999987754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=348.90 Aligned_cols=272 Identities=22% Similarity=0.289 Sum_probs=197.7
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEe--------
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCV-------- 146 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~-------- 146 (399)
....+|.+.++||+|+||.||+|.+..+++.||||++..........+.+|+.++.++. ||||+++++++.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34457899999999999999999999899999999987665555677889999999996 999999999994
Q ss_pred eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
.....++||||+ +|+|.+++.... ....+++..++.++.||+.||.|||+.+ ++|+||||||+|||++.++.+||+|
T Consensus 105 ~~~~~~lv~e~~-~g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 105 GQAEFLLLTELC-KGQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SSEEEEEEEECC-SEEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CCceEEEEEEec-CCCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEec
Confidence 344579999999 479999886522 2356999999999999999999999765 3499999999999999999999999
Q ss_pred ccCccCCCCCCCcc----------ccccccccccccccccc---cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCccc
Q 046609 227 FGLAKLGPTGDKSH----------VSTRVMGTYGYCAPEYA---LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEE 293 (399)
Q Consensus 227 fg~~~~~~~~~~~~----------~~~~~~g~~~y~aPE~~---~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~ 293 (399)
||++.......... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 99998654332211 11134589999999988 567789999999999999999999999976443211
Q ss_pred chhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccccccccc
Q 046609 294 QNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIEDS 370 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~~~~~~~ 370 (399)
.. . ...... .......+.+++.+||+.||.+||++.+++++|+.+..........+.
T Consensus 262 ~~----------~------~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~~~ 318 (337)
T 3ll6_A 262 VN----------G------KYSIPP----HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPI 318 (337)
T ss_dssp --------------------CCCCT----TCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTSCC
T ss_pred hc----------C------cccCCc----ccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCccH
Confidence 00 0 000000 111122477899999999999999999999999999876654443333
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=346.44 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=208.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
..+|.+.+.||+|+||.||++.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 3578899999999999999999999999999999975432 2345688899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999876 457999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+... ......
T Consensus 193 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~------- 257 (335)
T 2owb_A 193 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNE------- 257 (335)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTC-------
T ss_pred cCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHhcCC-------
Confidence 222 12233568999999999999999999999999999999999999998654321110 000000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ..+......+.+++.+||+.||.+||++.+++++
T Consensus 258 -~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 -Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp -C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 1122233468889999999999999999999875
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=349.91 Aligned_cols=269 Identities=19% Similarity=0.234 Sum_probs=198.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
...++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+++..++
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 110 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL 110 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence 34568999999999999999999999999999999997543322 3457789999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-----CCCCeeEeccc
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-----QDFNPKLSDFG 228 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-----~~~~~kl~Dfg 228 (399)
||||++ |+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||
T Consensus 111 v~e~~~-~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 111 IFEYAE-NDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEECCS-EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEecCC-CCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 999996 599999987 456999999999999999999999999 99999999999994 45569999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
++...... ........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..........
T Consensus 183 ~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 260 (329)
T 3gbz_A 183 LARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT 260 (329)
T ss_dssp HHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred CccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence 99753322 1222335689999999998774 58999999999999999999999998765432211111000000000
Q ss_pred --------chhhhc----cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 --------RKFTMM----ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 --------~~~~~~----~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+... ....+....+......+.+|+.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000000 00000000011134578899999999999999999999753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=362.91 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=208.4
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.+..++|.+.+.||+|+||.||+|.+.+ +..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv 256 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 256 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEE
Confidence 3445678888999999999999999986 5679999997654 345679999999999999999999999976 678999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 257 ~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 257 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp ECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 9999999999999751 1345899999999999999999999999 9999999999999999999999999998644
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.... .......++..|+|||++.++.++.++||||||+++|+|++ |+.||......+....+ . .
T Consensus 332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~----~------- 396 (452)
T 1fmk_A 332 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E----R------- 396 (452)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H----T-------
T ss_pred CCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----c-------
Confidence 3221 12223457789999999999999999999999999999999 99999876543211111 0 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 397 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 397 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 001112233455788999999999999999999999999987644
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=339.61 Aligned_cols=260 Identities=28% Similarity=0.399 Sum_probs=211.0
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
..++|.+.+.||+|+||.||+|.+.+ +..||||.+.... ...+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e 87 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEe
Confidence 44678889999999999999999874 6789999997653 345778999999999999999999999874 56899999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 99999999999751 1226999999999999999999999999 999999999999999999999999999865433
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||......+.. .... . ...
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~~----~------~~~ 228 (279)
T 1qpc_A 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI---QNLE----R------GYR 228 (279)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH---HHHH----T------TCC
T ss_pred cc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH---HHHh----c------ccC
Confidence 21 12223457789999999988899999999999999999999 99999875432211 1000 0 000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
...+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 229 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 229 ----MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ----CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 1112233457889999999999999999999999999987653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=340.10 Aligned_cols=257 Identities=27% Similarity=0.383 Sum_probs=212.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+.|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 468888999999999999999998999999999976543 3346789999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 102 ~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 102 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 999999999964 46999999999999999999999999 9999999999999999999999999997543322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCc
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (399)
.......|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+ .....+.
T Consensus 174 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~~ 238 (303)
T 3a7i_A 174 --IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-------------PKNNPPT 238 (303)
T ss_dssp --CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHSCCCC
T ss_pred --cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-------------hcCCCCC
Confidence 1223456899999999999999999999999999999999999999865432211110 0001111
Q ss_pred cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 318 l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
+. ...+..+.+++.+||+.||.+|||+.+++++..-.....
T Consensus 239 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 239 LE----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp CC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred Cc----cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 22 223346889999999999999999999998765444433
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=340.46 Aligned_cols=263 Identities=19% Similarity=0.192 Sum_probs=203.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||+|++....... .+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999999899999999997543222 35688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999976 356999999999999999999999999 9999999999999999999999999987543
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ .. .........
T Consensus 186 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~----~~~~~~~~~--- 254 (309)
T 2h34_A 186 DEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---GA----HINQAIPRP--- 254 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---HH----HHHSCCCCG---
T ss_pred cccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---HH----HhccCCCCc---
Confidence 3221 122345689999999999999999999999999999999999999986542211 00 000000000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHHHHhhhccc
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-MMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~l~~~~~ 363 (399)
...+...+..+.+++.+||+.||.+|| ++.++++.|+.+.....
T Consensus 255 -----~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~ 299 (309)
T 2h34_A 255 -----STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD 299 (309)
T ss_dssp -----GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred -----cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence 011122334688999999999999999 99999999988755443
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=340.65 Aligned_cols=264 Identities=22% Similarity=0.335 Sum_probs=204.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc--CCCceeeEEEEEeeC----C
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML--SNPYLVNLVGYCVDG----D 149 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~hpnIv~l~~~~~~~----~ 149 (399)
...++|.+.+.||+|+||.||+|.+. ++.||||++... ....+..|..++... +||||+++++++.+. .
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 108 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT 108 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence 34568999999999999999999986 789999998643 234455566666554 899999999999887 7
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------CCCCeEecCCCCCceEECCCCC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES--------AQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~--------~~~~ivH~dikp~NIll~~~~~ 221 (399)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~ 180 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGT 180 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSC
T ss_pred ceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCC
Confidence 88999999999999999976 3599999999999999999999988 7 999999999999999999
Q ss_pred eeEecccCccCCCCCCCcc--ccccccccccccccccccCCCCCch------hhHHHHHHHHHHHHcC----------CC
Q 046609 222 PKLSDFGLAKLGPTGDKSH--VSTRVMGTYGYCAPEYALTGQLTAK------SDVYSFGVVFLEIITG----------RR 283 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~------~DvwslG~il~elltg----------~~ 283 (399)
+||+|||++.......... ......||+.|+|||++.+..++.. +|||||||++|+|++| +.
T Consensus 181 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~ 260 (337)
T 3mdy_A 181 CCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL 260 (337)
T ss_dssp EEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCC
T ss_pred EEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccc
Confidence 9999999997543322211 1123579999999999987766654 9999999999999999 55
Q ss_pred CCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 284 VIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 284 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
||....+....... ... ...........+ ...+..+.+++.+||+.||.+|||+.+|+++|+.+
T Consensus 261 p~~~~~~~~~~~~~--~~~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 261 PYHDLVPSDPSYED--MRE---------IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTTTSCSSCCHHH--HHH---------HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cHhhhcCCCCchhh--hHH---------HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 55544332211100 000 000111111222 25677899999999999999999999999999999
Q ss_pred hhccc
Q 046609 359 AHSKE 363 (399)
Q Consensus 359 ~~~~~ 363 (399)
.....
T Consensus 330 ~~~~~ 334 (337)
T 3mdy_A 330 SESQD 334 (337)
T ss_dssp HHTTT
T ss_pred Hhhcc
Confidence 87643
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=344.76 Aligned_cols=268 Identities=24% Similarity=0.373 Sum_probs=206.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... .+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357889999999999999999999999999999986543322 345778999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++++|..++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 99999888887765 456999999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh--------hhhhhhc
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW--------ATPLFKD 306 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~--------~~~~~~~ 306 (399)
.. .......|++.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.. ....+..
T Consensus 177 ~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 177 PG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred Cc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 22 222345689999999998775 789999999999999999999999987654322211110 0111111
Q ss_pred cchhhhccCCccCCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 RRKFTMMADPLLEGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+.+....+ ...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11112222222211111 1235678999999999999999999999875
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=347.50 Aligned_cols=249 Identities=29% Similarity=0.388 Sum_probs=203.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
+.|...+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++++++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 34888899999999999999998899999999997653322 256889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+. |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9996 688888864 2457999999999999999999999999 99999999999999999999999999975432
Q ss_pred CCCcccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
. ....||+.|+|||++. ++.++.++|||||||++|+|++|+.||.......... .....
T Consensus 207 ~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~------~~~~~------ 268 (348)
T 1u5q_A 207 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQN------ 268 (348)
T ss_dssp B------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS------
T ss_pred C------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhc------
Confidence 1 2356999999999884 5789999999999999999999999998654322110 00000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
..+... +...+..+.+++.+||+.||.+|||+.+++++..
T Consensus 269 -~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 269 -ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp -CCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred -CCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 011111 1123346889999999999999999999987744
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=336.53 Aligned_cols=259 Identities=21% Similarity=0.320 Sum_probs=207.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 4688899999999999999999999999999998754322 3467899999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC----CeeEeccc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF----NPKLSDFG 228 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg 228 (399)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 85 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999976 456999999999999999999999999 99999999999998877 79999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..||...........+. ....
T Consensus 158 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS------AVNY 228 (283)
T ss_dssp TCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------TTCC
T ss_pred cceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH------hccc
Confidence 997543322 1233568999999999998999999999999999999999999998754322111110 0000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH--HHHhhhc
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA--IEYLAHS 361 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~--L~~l~~~ 361 (399)
. ..+ ......+..+.+++.+||+.||.+||++.+++++ ++.+...
T Consensus 229 ~----~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 229 D----FDE----EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp C----CCH----HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred C----Ccc----hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 0 000 0011223468899999999999999999999984 4554433
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=350.81 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=199.5
Q ss_pred CCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEee-CCeeEEEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVD-GDQRILVY 155 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~ 155 (399)
|.+.+.||+|+||.||+|.+..+ ...||||.+..... .....+.+|+.++++++||||+++++++.+ ++..++||
T Consensus 91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~ 170 (373)
T 3c1x_A 91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 170 (373)
T ss_dssp EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence 55678999999999999987432 34689999865332 334678999999999999999999998754 55789999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 171 e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 171 PYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp ECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 99999999999976 3456899999999999999999999999 99999999999999999999999999975433
Q ss_pred CCCc--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 236 GDKS--HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 236 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |.+||......+....... . .
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~------~-~---- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------G-R---- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT------T-C----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc------C-C----
Confidence 2211 12233457889999999999999999999999999999999 7888877654332111100 0 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
. ...+...+..+.+++.+||+.||.+||++.++++.|+.+.....
T Consensus 314 --~----~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~ 358 (373)
T 3c1x_A 314 --R----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 358 (373)
T ss_dssp --C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --C----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence 0 01122234578899999999999999999999999999977655
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=346.65 Aligned_cols=282 Identities=23% Similarity=0.322 Sum_probs=201.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHH--HHccCCCceeeEEEEEee-----CC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM--LSMLSNPYLVNLVGYCVD-----GD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~--l~~l~hpnIv~l~~~~~~-----~~ 149 (399)
..++|.+.+.||+|+||.||+|.. +++.||||++... ....+..|..+ +..++||||+++++.+.. ..
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 346899999999999999999987 4789999999643 23344444444 445899999999986542 33
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeEecCCCCCceEECCCC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES---------AQPPVIYRDFKASNVLLDQDF 220 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---------~~~~ivH~dikp~NIll~~~~ 220 (399)
..++||||+++|+|.+++.. ...++..++.++.|++.||.|||+. + |+||||||+|||++.++
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~ 157 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDG 157 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTS
T ss_pred eEEEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCC
Confidence 56899999999999999976 3458999999999999999999998 8 99999999999999999
Q ss_pred CeeEecccCccCCCCCCC------ccccccccccccccccccccC-------CCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 046609 221 NPKLSDFGLAKLGPTGDK------SHVSTRVMGTYGYCAPEYALT-------GQLTAKSDVYSFGVVFLEIITGRRVIDN 287 (399)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~elltg~~pf~~ 287 (399)
.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~ 237 (336)
T 3g2f_A 158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP 237 (336)
T ss_dssp CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence 999999999975433211 122234569999999999876 4566789999999999999999766654
Q ss_pred CCCccc-chhhHhhhhhhhccchhh-----hccCCccCCC--CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 288 SRPTEE-QNLVTWATPLFKDRRKFT-----MMADPLLEGN--YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 288 ~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
...... .................. ....+.+... .....+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 238 GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp TSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 332211 111100000000000000 0001111111 12245668999999999999999999999999999999
Q ss_pred hccccccccccc
Q 046609 360 HSKEEACIEDSL 371 (399)
Q Consensus 360 ~~~~~~~~~~~~ 371 (399)
..+.........
T Consensus 318 ~~~~~~~~~~~~ 329 (336)
T 3g2f_A 318 MIWERNKSVSPT 329 (336)
T ss_dssp HCCCC-------
T ss_pred HHHHhcccCCCc
Confidence 888866555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=347.39 Aligned_cols=277 Identities=23% Similarity=0.332 Sum_probs=212.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEE----CCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC--ee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD--QR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~--~~ 151 (399)
.++|.+.+.||+|+||.||+|.. ..+++.||||++........+.+.+|+.+++.++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 45688899999999999999984 5678999999998765555677999999999999999999999987654 78
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999872 356999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCcc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSH-VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
......... ......++..|+|||++.+..++.++||||||+++|+|++|..||.................... ....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 272 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-VFHL 272 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH-HHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh-HHHH
Confidence 654433221 12234577889999999888899999999999999999999998874211000000000000000 0000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
...+........+...+..+.+++.+||+.||.+|||+.+|++.|+.++..
T Consensus 273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~ 323 (326)
T 2w1i_A 273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323 (326)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 001111111112334456789999999999999999999999999998753
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=341.29 Aligned_cols=259 Identities=21% Similarity=0.282 Sum_probs=206.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEe--eCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCV--DGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~--~~~~~~lv 154 (399)
++|.+.+.||+|+||.||+|.+..+++.||+|.+...... ..+.+.+|+.++++++||||+++++++. .....++|
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 85 (279)
T 2w5a_A 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 85 (279)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence 5788899999999999999999999999999999765432 3356889999999999999999999885 46688999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA--QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|||+++++|.+++.........+++..++.++.|++.||.|||+.+ ..+|+||||||+||+++.++.+||+|||++..
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~ 165 (279)
T 2w5a_A 86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165 (279)
T ss_dssp EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence 9999999999999764334456999999999999999999999876 23499999999999999999999999999875
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ .... ...
T Consensus 166 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~i---~~~------ 231 (279)
T 2w5a_A 166 LNHDT--SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AGKI---REG------ 231 (279)
T ss_dssp C---C--HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HHT------
T ss_pred ecccc--ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HHHH---hhc------
Confidence 43221 122335689999999999998999999999999999999999999987643211 1100 000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
..+ ..+...+..+.+++.+||+.||.+||++.+|++++.
T Consensus 232 -~~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 232 -KFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp -CCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred -ccc----cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 001 112234457889999999999999999999987653
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=353.06 Aligned_cols=254 Identities=23% Similarity=0.308 Sum_probs=195.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--------cchHHHHHHHHHHHccCCCceeeEEEEEeeC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--------QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG 148 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~ 148 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence 45789999999999999999999999999999999975421 112347889999999999999999999854
Q ss_pred CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC---CeeEe
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF---NPKLS 225 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~---~~kl~ 225 (399)
+..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+
T Consensus 212 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 212 EDYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SEEEEEEECCTTCBGGGGTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred CceEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 567999999999999999875 467999999999999999999999999 99999999999997544 59999
Q ss_pred cccCccCCCCCCCccccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||......... ......
T Consensus 285 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~--~~~i~~ 359 (419)
T 3i6u_A 285 DFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--KDQITS 359 (419)
T ss_dssp CSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH--HHHHHT
T ss_pred ecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH--HHHHhc
Confidence 99999864332 22334679999999998853 67888999999999999999999999865432211 110000
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ... ..+.. ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 360 ---~--~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 360 ---G--KYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp ---T--CCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ---C--CCC--CCchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 0 000 00000 01123578899999999999999999999865
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=336.89 Aligned_cols=248 Identities=24% Similarity=0.338 Sum_probs=207.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 357888999999999999999999999999999996432 22346688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 93 LEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp ECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999976 356999999999999999999999999 9999999999999999999999999986533
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... .....|++.|+|||++.+..++.++||||||+++|+|++|..||.......... .....
T Consensus 166 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~-------- 227 (284)
T 2vgo_A 166 SLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVNV-------- 227 (284)
T ss_dssp SSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTT--------
T ss_pred ccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhcc--------
Confidence 221 233568999999999999999999999999999999999999998654322111 00000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+ ..++...+..+.+++.+||+.||.+||++.+++++
T Consensus 228 ~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 0 11222334578899999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-45 Score=339.35 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=204.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||.+... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 356799999999999999999999999999999999764 335678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++......
T Consensus 105 ~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999974 2457999999999999999999999999 999999999999999999999999999754322
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......|++.|+|||++.+..++.++||||||+++|+|++|+.||............ .. ...+
T Consensus 179 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~-------~~~~ 243 (314)
T 3com_A 179 M--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI------PT-------NPPP 243 (314)
T ss_dssp B--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HH-------SCCC
T ss_pred c--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hc-------CCCc
Confidence 1 1223356899999999999999999999999999999999999999865432111000 00 0000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 244 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 244 TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 00 1122334578899999999999999999999875
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=338.20 Aligned_cols=248 Identities=18% Similarity=0.222 Sum_probs=200.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 3578889999999999999999998999999999976432 3346688899999998 899999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC---------------
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD--------------- 219 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~--------------- 219 (399)
|||+++|+|.+++.........+++..++.++.|++.||.|||+++ |+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 9999999999999763222356999999999999999999999999 9999999999999844
Q ss_pred ----CCeeEecccCccCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 046609 220 ----FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294 (399)
Q Consensus 220 ----~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 294 (399)
..+||+|||++....... ...||+.|+|||++.+. .++.++||||||+++|+|++|.+|+.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---- 236 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---- 236 (289)
T ss_dssp ---CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred cCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence 479999999987643322 23589999999998765 667899999999999999999987654321
Q ss_pred hhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... .....+ ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 237 -~~~~-----------~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 237 -WHEI-----------RQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -HHHH-----------HTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -HHHH-----------HcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0000 000011 1222334578899999999999999999999764
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=334.55 Aligned_cols=253 Identities=22% Similarity=0.235 Sum_probs=202.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC----CcchHHHHHHHHHHHccCCCceeeEEEEEe--eCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG----FQGNREFLVEVLMLSMLSNPYLVNLVGYCV--DGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~--~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999997542 233467889999999999999999999984 45678
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+.++ |.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 9999999765 77777653 2457999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCccccccccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQ--LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
...............|++.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~i~~~--- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLF------ENIGKG--- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHC---
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHH------HHHhcC---
Confidence 654333333334466999999999887644 477999999999999999999999865422111 110000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ..+......+.+++.+||+.||.+|||+.+++++
T Consensus 229 -----~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 -----SY----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp -----CC----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -----CC----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00 1122334578899999999999999999999976
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=345.36 Aligned_cols=269 Identities=24% Similarity=0.301 Sum_probs=201.3
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-----hHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-----NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++.+.+..
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3468999999999999999999999899999999987533221 24678899999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++ +|..++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 88 ~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp EEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred EEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 999999965 89888876 3456899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh-hhhhhc-cc
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA-TPLFKD-RR 308 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~~-~~ 308 (399)
...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||...........+... ...... -.
T Consensus 161 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 161 SFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp TTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence 643322 223345689999999998754 5899999999999999999999999876533221111000 000000 00
Q ss_pred hhhhccCCcc---CCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLL---EGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l---~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+... ....+ ......+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000000000 00011 2234678999999999999999999999876
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=335.78 Aligned_cols=250 Identities=24% Similarity=0.333 Sum_probs=208.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 3578889999999999999999999999999999975432 2335678899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999876 457999999999999999999999999 9999999999999999999999999997643
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... .......|++.|+|||++.+..++.++||||||+++|+|++|+.||......+... ......
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~------- 231 (294)
T 2rku_A 167 YDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNE------- 231 (294)
T ss_dssp STT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTTC-------
T ss_pred cCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHhhcc-------
Confidence 222 12233568999999999998899999999999999999999999998654321110 000000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+......+.+++.+||+.||.+|||+.+++++
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 -----YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred -----CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 01122334578899999999999999999999876
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=336.45 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=206.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee----------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD---------- 147 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~---------- 147 (399)
..+|.+.+.||+|+||.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 85 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK 85 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence 356888999999999999999999889999999997543 457789999999999999999999864
Q ss_pred ------CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC
Q 046609 148 ------GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN 221 (399)
Q Consensus 148 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~ 221 (399)
....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ---CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred cccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 44579999999999999999752 2356999999999999999999999999 999999999999999999
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
+||+|||++....... ......|++.|+|||++.+..++.++||||||+++|+|++|..|+.... ...
T Consensus 161 ~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~- 228 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFF- 228 (284)
T ss_dssp EEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHH-
T ss_pred EEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHH-
Confidence 9999999987644332 1233468999999999999999999999999999999999998775211 000
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
..+....+.. ..+..+.+++.+||+.||.+|||+.+++++|+.+.....
T Consensus 229 ---------~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 229 ---------TDLRDGIISD----IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp ---------HHHHTTCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred ---------HHhhcccccc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 0111111111 223467889999999999999999999999998876544
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=352.63 Aligned_cols=201 Identities=28% Similarity=0.390 Sum_probs=169.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeC-----Ce
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG-----DQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~ 150 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 4789999999999999999999999999999999975422 2336688999999999999999999999776 57
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++||||+. |+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 899999985 699999976 456999999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCc--------------------cccccccccccccccccc-cCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 046609 231 KLGPTGDKS--------------------HVSTRVMGTYGYCAPEYA-LTGQLTAKSDVYSFGVVFLEIITGRRVID 286 (399)
Q Consensus 231 ~~~~~~~~~--------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~~DvwslG~il~elltg~~pf~ 286 (399)
+........ .......||+.|+|||++ .+..++.++|||||||++|||++|..||.
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 864432211 122456799999999986 56679999999999999999998544443
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=374.80 Aligned_cols=252 Identities=27% Similarity=0.376 Sum_probs=209.8
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCee
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 151 (399)
...++|.+.++||+|+||.||+|.+..+++.||||++.... ......+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 44678999999999999999999999999999999997532 23345678899999887 699999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
+|||||++||+|..++.. ...+++..++.++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++
T Consensus 418 ~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~ 490 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 490 (674)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCE
T ss_pred EEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceee
Confidence 999999999999999986 356999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+... .+....
T Consensus 491 ~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~------~i~~~~---- 558 (674)
T 3pfq_A 491 ENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIMEHN---- 558 (674)
T ss_dssp ECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHSSC----
T ss_pred ccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHH------HHHhCC----
Confidence 532222 22345679999999999999999999999999999999999999998755322111 111110
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCCh-----HHHHHH
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM-----SDVVTA 354 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~eil~~ 354 (399)
..++......+.+|+.+||+.||.+||++ .+|+++
T Consensus 559 --------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 559 --------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp --------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred --------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 12233445678999999999999999998 677654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.21 Aligned_cols=254 Identities=27% Similarity=0.385 Sum_probs=202.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeC-CeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG-DQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+. +..||||.+... ...+.+.+|+.++++++||||+++++++.+. +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 467889999999999999999885 789999998754 3456789999999999999999999997654 47899999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred cCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999762 1223889999999999999999999999 999999999999999999999999998753322
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......... ....
T Consensus 171 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~---~~~~-------------- 228 (278)
T 1byg_A 171 -----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVE-------------- 228 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHT--------------
T ss_pred -----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHh--------------
Confidence 122357889999999998999999999999999999998 99999875432211 1000
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
.......+...+..+.+++.+||+.||.+||++.++++.|+.++...
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~ 275 (278)
T 1byg_A 229 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 275 (278)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence 00111222334457889999999999999999999999999987654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=334.95 Aligned_cols=255 Identities=23% Similarity=0.338 Sum_probs=203.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.+|....+||+|+||.||+|.+..++..||||.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999999999999999998765555677899999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEecccCccCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg~~~~~~~~~ 237 (399)
++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 177 (295)
T 2clq_A 102 PGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177 (295)
T ss_dssp SEEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred CCCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence 9999999998632 2345678999999999999999999999 999999999999987 8999999999997543322
Q ss_pred CccccccccccccccccccccCCC--CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQ--LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~--~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||......... ....... ...
T Consensus 178 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~--------~~~ 244 (295)
T 2clq_A 178 --PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA---MFKVGMF--------KVH 244 (295)
T ss_dssp -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH---HHHHHHH--------CCC
T ss_pred --CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH---HHhhccc--------ccc
Confidence 1223356899999999987643 889999999999999999999999754322110 0000000 011
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+ ..+...+..+.+++.+||+.||.+||++.+++++
T Consensus 245 ~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 245 P----EIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp C----CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred c----cccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 2233344578899999999999999999999754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=367.97 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=202.9
Q ss_pred eeccCCcEEEEEEEEC--CCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCCCC
Q 046609 86 LLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGS 162 (399)
Q Consensus 86 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 162 (399)
.||+|+||.||+|.+. +++..||||++..... ...+.+.+|+.++++++||||+++++++.+ +..++||||+++|+
T Consensus 343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~ 421 (613)
T 2ozo_A 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 421 (613)
T ss_dssp EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence 7999999999999875 3467799999976532 345779999999999999999999999976 56899999999999
Q ss_pred hHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcc-c
Q 046609 163 LEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSH-V 241 (399)
Q Consensus 163 L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~-~ 241 (399)
|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++......... .
T Consensus 422 L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 495 (613)
T 2ozo_A 422 LHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA 495 (613)
T ss_dssp HHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred HHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence 9999976 3456999999999999999999999999 9999999999999999999999999998654332211 1
Q ss_pred cccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCC
Q 046609 242 STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEG 320 (399)
Q Consensus 242 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 320 (399)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. . ....
T Consensus 496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~----------~~~~ 558 (613)
T 2ozo_A 496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE-------Q----------GKRM 558 (613)
T ss_dssp ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH-------T----------TCCC
T ss_pred ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-------c----------CCCC
Confidence 122345689999999999999999999999999999998 999999866533211110 0 0011
Q ss_pred CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 321 NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 321 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
..+...+..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus 559 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 599 (613)
T 2ozo_A 559 ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 599 (613)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 22334456889999999999999999999999999987544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=351.12 Aligned_cols=266 Identities=20% Similarity=0.275 Sum_probs=206.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++..... .....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 3578899999999999999999999999999999976532 233568899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|+++++|.+++.. ...+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++.....
T Consensus 112 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 112 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 184 (360)
T ss_dssp CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred CCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccccc
Confidence 9999999999976 35699999999999999999999986 8 99999999999999999999999999863211
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-------------
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP------------- 302 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~------------- 302 (399)
.......||+.|+|||++.+..++.++||||||+++|+|++|+.||.................
T Consensus 185 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp ----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred ----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence 112335689999999999999999999999999999999999999987553221111000000
Q ss_pred --hh-------hc----cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 --LF-------KD----RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 --~~-------~~----~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+ .. ......+.............+..+.+|+.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00 00 000000000000001111234578899999999999999999999986
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=342.09 Aligned_cols=254 Identities=23% Similarity=0.374 Sum_probs=202.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|.+.+.||+|+||.||+|.+..++..||+|++..........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 46789999999999999999999999999999999876666678899999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 169 (302)
T 2j7t_A 98 CPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK-- 169 (302)
T ss_dssp CTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--
T ss_pred CCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccc--
Confidence 999999999875 2456999999999999999999999999 99999999999999999999999998752110
Q ss_pred Cccccccccccccccccccc-----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 238 KSHVSTRVMGTYGYCAPEYA-----LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~-----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.........|++.|+|||++ .+..++.++||||||+++|+|++|..||......... .......
T Consensus 170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~----- 238 (302)
T 2j7t_A 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSD----- 238 (302)
T ss_dssp HHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC-----
T ss_pred cccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhccC-----
Confidence 01112234689999999988 3677899999999999999999999999875532211 0000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+. ...+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 239 --~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 239 --PPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp --CCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred --Ccc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000 01123334578899999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=353.24 Aligned_cols=268 Identities=21% Similarity=0.254 Sum_probs=201.8
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee--------
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD-------- 147 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-------- 147 (399)
...++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~ 79 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKP 79 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccccc
Confidence 456789999999999999999999999999999999865432 23369999999999999999999844
Q ss_pred ------------------------------CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 046609 148 ------------------------------GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197 (399)
Q Consensus 148 ------------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH 197 (399)
....++||||++ |+|.+.+......+..+++..++.++.||+.||.|||
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 158 (383)
T 3eb0_A 80 PQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH 158 (383)
T ss_dssp ------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 334789999997 5888777643334678999999999999999999999
Q ss_pred hcCCCCeEecCCCCCceEEC-CCCCeeEecccCccCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHH
Q 046609 198 ESAQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVF 275 (399)
Q Consensus 198 ~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il 275 (399)
+.+ |+||||||+|||++ .++.+||+|||++....... ......+|+.|+|||++.+. .++.++|||||||++
T Consensus 159 ~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 159 SLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp TTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 99999999999997 68899999999998543332 22334689999999988765 589999999999999
Q ss_pred HHHHcCCCCCCCCCCcccchhhHhhhh-hh-----hccchhhh-----ccCCccCCCCCHHHHHHHHHHHhhccccCCCC
Q 046609 276 LEIITGRRVIDNSRPTEEQNLVTWATP-LF-----KDRRKFTM-----MADPLLEGNYPIKGLYQALAVAAMCLQEEAGT 344 (399)
Q Consensus 276 ~elltg~~pf~~~~~~~~~~~~~~~~~-~~-----~~~~~~~~-----~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~ 344 (399)
|+|++|++||......+....+..... .. ........ .....+....+...+..+.+|+.+||+.||.+
T Consensus 233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 312 (383)
T 3eb0_A 233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL 312 (383)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence 999999999987654332211110000 00 00000000 00011111123334557899999999999999
Q ss_pred CCChHHHHHH
Q 046609 345 RPMMSDVVTA 354 (399)
Q Consensus 345 RPs~~eil~~ 354 (399)
|||+.+++++
T Consensus 313 R~t~~e~l~h 322 (383)
T 3eb0_A 313 RINPYEAMAH 322 (383)
T ss_dssp SCCHHHHHTS
T ss_pred CCCHHHHhcC
Confidence 9999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=342.06 Aligned_cols=273 Identities=29% Similarity=0.365 Sum_probs=210.4
Q ss_pred CCCCCeeccCCcEEEEEEEE----CCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEee--CCeeEE
Q 046609 81 FNPDNLLGEGGFGRVYRGKL----EGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRIL 153 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~l 153 (399)
|.+.+.||+|+||.||++.+ ..+++.||||++..... .....+.+|+.+++.++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 48889999999999988865 34688999999976532 234568899999999999999999999987 467899
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 113 v~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp EECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccc
Confidence 9999999999999976 34999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
...... .......++..|+|||++.+..++.++||||||+++|+|++|..||........ ....+....... .....
T Consensus 185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~-~~~~~ 262 (318)
T 3lxp_A 185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTV-LRLTE 262 (318)
T ss_dssp CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHH-HHHHH
T ss_pred cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhH-HHHHH
Confidence 443322 223345688899999999998999999999999999999999999975321100 000000000000 01111
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
..........+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 313 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ 313 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence 111111222334455689999999999999999999999999998876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=338.62 Aligned_cols=256 Identities=23% Similarity=0.283 Sum_probs=191.1
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-h-HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-N-REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++....... . ..+..+...++.++||||+++++++.+++..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 3467889999999999999999999899999999997543222 2 2234455567888999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
|||++ |+|.+++.........+++..++.++.|++.||.|||++ + |+||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99996 588887765333456799999999999999999999998 8 999999999999999999999999999754
Q ss_pred CCCCCccccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYA----LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
.... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ..... ...
T Consensus 161 ~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~----~~~--- 229 (290)
T 3fme_A 161 VDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLKQV----VEE--- 229 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHHHH----HHS---
T ss_pred cccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHHHH----hcc---
Confidence 3322 22234699999999996 566789999999999999999999999986432211 01100 000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+. ......+..+.+++.+||+.||.+|||+.+++++
T Consensus 230 ----~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 230 ----PSPQ---LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ----CCCC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ----CCCC---cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 0000 1112234578899999999999999999999874
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=344.37 Aligned_cols=270 Identities=21% Similarity=0.274 Sum_probs=204.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEee--------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVD-------- 147 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-------- 147 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 35799999999999999999999999999999998654332 24567899999999999999999999987
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
.+..++||||+. |+|.+.+.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCE-HDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccC-CCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccc
Confidence 446899999996 588888766 2456999999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCC--ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 228 GLAKLGPTGDK--SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 228 g~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||...........+.......
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 248 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 248 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99976443221 222234568999999998876 468999999999999999999999999765433222221111100
Q ss_pred hc--------cchhhhccCCccCCCCCHH------HHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KD--------RRKFTMMADPLLEGNYPIK------GLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~--------~~~~~~~~~~~l~~~~~~~------~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ......+............ ....+.+|+.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 00 0000000000000000000 12457899999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=360.07 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=204.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 57999999999999999999999999999999986432 2345678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC---CCCCeeEecccCccCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD---QDFNPKLSDFGLAKLG 233 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~~~~~ 233 (399)
|+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||++...
T Consensus 102 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 102 LYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 9999999999876 356999999999999999999999999 99999999999995 5567999999999754
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||......+....+.... +.
T Consensus 175 ~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~--~~-------- 240 (486)
T 3mwu_A 175 QQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGK--YA-------- 240 (486)
T ss_dssp CCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CC--------
T ss_pred CCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CC--------
Confidence 3322 2234569999999998865 59999999999999999999999998755432211111000 00
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+ .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 FD----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp SC----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 00012234578899999999999999999999986
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=361.26 Aligned_cols=252 Identities=23% Similarity=0.322 Sum_probs=203.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-------------cchHHHHHHHHHHHccCCCceeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-------------QGNREFLVEVLMLSMLSNPYLVNLVGY 144 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~hpnIv~l~~~ 144 (399)
.++|.+.+.||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4689999999999999999999999999999999975432 224568899999999999999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC---C
Q 046609 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF---N 221 (399)
Q Consensus 145 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~---~ 221 (399)
+.+....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 9999999999999999999999976 456999999999999999999999999 99999999999998776 6
Q ss_pred eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 222 PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 222 ~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|++|.+||......+....+....
T Consensus 188 ~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 263 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK 263 (504)
T ss_dssp EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred EEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999998654332 223456999999999876 579999999999999999999999998765432211111000
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. .+ +... ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 264 ~------~~----~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 264 Y------YF----DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp C------CC----CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C------CC----Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0 00 0000 01123578899999999999999999999876
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=333.28 Aligned_cols=250 Identities=23% Similarity=0.330 Sum_probs=199.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999999889999999996532 2234578899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999976 356899999999999999999999999 999999999999999999999999999764
Q ss_pred CCCCCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.... ......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||........ .... ....
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~---~~~~----- 227 (276)
T 2h6d_A 162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKKI---RGGV----- 227 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH---HHCC-----
T ss_pred CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHHh---hcCc-----
Confidence 4322 1233468999999999987765 5799999999999999999999986432211 1000 0000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+......+.+++.+||+.||.+|||+.+++++
T Consensus 228 -------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 -------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 01122234578899999999999999999999885
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=369.35 Aligned_cols=251 Identities=27% Similarity=0.412 Sum_probs=201.8
Q ss_pred CeeccCCcEEEEEEEE--CCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKL--EGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.+ ..+++.||||++..... ...+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999955 45678999999976432 234679999999999999999999999965 457899999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC-c
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK-S 239 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~-~ 239 (399)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999976 457999999999999999999999999 99999999999999999999999999986543322 1
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+. . ..
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~-------~----------~~ 589 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-------K----------GE 589 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-------T----------TC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------c----------CC
Confidence 22233457789999999999999999999999999999998 999998765432211110 0 01
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
....+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 590 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 590 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 112233445678999999999999999999999999998754
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=359.73 Aligned_cols=251 Identities=24% Similarity=0.312 Sum_probs=201.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC--CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG--FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||.||+|.+..++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46889999999999999999999999999999997643 2335678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC---CCeeEecccCccCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD---FNPKLSDFGLAKLG 233 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~~~~~ 233 (399)
|+++|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.. +.+||+|||++...
T Consensus 117 ~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~ 189 (494)
T 3lij_A 117 CYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF 189 (494)
T ss_dssp CCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence 9999999998876 456999999999999999999999999 9999999999999764 45999999999764
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.... ......||+.|+|||++. +.++.++|||||||++|+|++|.+||......+....+..... .
T Consensus 190 ~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~----------~ 255 (494)
T 3lij_A 190 ENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKY----------T 255 (494)
T ss_dssp BTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC----------C
T ss_pred CCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC----------C
Confidence 3322 223456999999999875 5799999999999999999999999987654322111110000 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+... ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 FDSPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCSGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCchh----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00000 01233478899999999999999999999876
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=362.07 Aligned_cols=251 Identities=25% Similarity=0.337 Sum_probs=207.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.++||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 568899999999999999999999999999999965432 34567899999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE---CCCCCeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~~~~ 232 (399)
||+.+|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||++..
T Consensus 106 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 106 EVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp CCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred ecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 99999999999976 457999999999999999999999999 9999999999999 5678999999999975
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... ......||+.|+|||++.+ .++.++|||||||++|+|++|.+||......+....+.. ....
T Consensus 179 ~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~------~~~~--- 245 (484)
T 3nyv_A 179 FEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------GKYT--- 245 (484)
T ss_dssp BCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCCC---
T ss_pred ccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc------CCCC---
Confidence 43332 2233569999999998865 799999999999999999999999987654322111110 0000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 246 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 246 -----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0000012334578899999999999999999999876
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=333.35 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=200.8
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee----CCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD----GDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~ 152 (399)
..|.+.+.||+|+||.||+|.+..++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 457778899999999999999999999999999975433 234568899999999999999999999875 45689
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCeeEecccCcc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAK 231 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~~~ 231 (399)
+||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ .+|+||||||+||+++ .++.+||+|||++.
T Consensus 106 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999976 356999999999999999999999875 3499999999999997 78999999999997
Q ss_pred CCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..... ......|++.|+|||++. +.++.++||||||+++|+|++|+.||......... ...... .
T Consensus 181 ~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~---~----- 245 (290)
T 1t4h_A 181 LKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YRRVTS---G----- 245 (290)
T ss_dssp GCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HHHHTT---T-----
T ss_pred ccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HHHHhc---c-----
Confidence 53322 223356999999999776 56999999999999999999999999865432211 100000 0
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... ..+......+.+++.+||+.||.+|||+.+++++
T Consensus 246 -~~~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 246 -VKPA----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -CCCG----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCcc----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 0000 1111222468899999999999999999999754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=349.58 Aligned_cols=261 Identities=16% Similarity=0.166 Sum_probs=210.2
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEE-----ECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC---CCceeeEEEEEe
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGK-----LEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS---NPYLVNLVGYCV 146 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~ 146 (399)
....++|.+.+.||+|+||.||+|. ...+++.||||++... ...++..|+.++..++ |+||+++++++.
T Consensus 61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 3456789999999999999999994 5667899999999754 3456778888888887 899999999999
Q ss_pred eCCeeEEEEEecCCCChHHhhccCCC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-------
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLPP-NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ------- 218 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~------- 218 (399)
..+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC--
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccc
Confidence 99999999999999999999974221 2457999999999999999999999999 999999999999998
Q ss_pred ----CCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc
Q 046609 219 ----DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294 (399)
Q Consensus 219 ----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~ 294 (399)
++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||........
T Consensus 215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~- 293 (365)
T 3e7e_A 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC- 293 (365)
T ss_dssp ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE-
T ss_pred cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce-
Confidence 899999999999653333333344556799999999999999999999999999999999999999965432110
Q ss_pred hhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCC-CChHHHHHHHHHhhhccc
Q 046609 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTR-PMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~eil~~L~~l~~~~~ 363 (399)
. ....+. .+ .....+.+++..||+.+|.+| |++.++.+.|+.+.....
T Consensus 294 --------------~----~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~ 342 (365)
T 3e7e_A 294 --------------K----PEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY 342 (365)
T ss_dssp --------------E----ECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred --------------e----echhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence 0 011111 11 123467789999999999999 688888888888766543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=347.01 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=199.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCC------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 149 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 46799999999999999999999999999999999654322 2356889999999999999999999998663
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999975 45899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc--
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD-- 306 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-- 306 (399)
++..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.........
T Consensus 175 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 249 (367)
T 1cm8_A 175 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249 (367)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9864321 233568999999999877 68999999999999999999999999876543222111110000000
Q ss_pred --------cc----hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 --------RR----KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 --------~~----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. .........+. .........+.+|+.+||+.||.+|||+.+++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 250 VQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhHHHHHHHHhCCCCCCCCHH-HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 00000000000 1122334578899999999999999999999875
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-44 Score=337.99 Aligned_cols=268 Identities=22% Similarity=0.333 Sum_probs=209.2
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHc--cCCCceeeEEEEEeeCC---
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSM--LSNPYLVNLVGYCVDGD--- 149 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~hpnIv~l~~~~~~~~--- 149 (399)
....++|.+.+.||+|+||.||+|.+. ++.||||++... ....+.+|..++.. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 344568999999999999999999984 789999999643 34567788888887 78999999999998876
Q ss_pred -eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCceEECCCC
Q 046609 150 -QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH--------ESAQPPVIYRDFKASNVLLDQDF 220 (399)
Q Consensus 150 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--------~~~~~~ivH~dikp~NIll~~~~ 220 (399)
..++||||+++|+|.+++.. ..+++..++.++.|++.||.||| +.+ |+||||||+||+++.++
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNG 184 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTS
T ss_pred ceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCC
Confidence 78999999999999999976 35899999999999999999999 788 99999999999999999
Q ss_pred CeeEecccCccCCCCCCCcc--ccccccccccccccccccCC------CCCchhhHHHHHHHHHHHHcC----------C
Q 046609 221 NPKLSDFGLAKLGPTGDKSH--VSTRVMGTYGYCAPEYALTG------QLTAKSDVYSFGVVFLEIITG----------R 282 (399)
Q Consensus 221 ~~kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg----------~ 282 (399)
.+||+|||++.......... ......||+.|+|||++.+. .++.++||||||+++|+|++| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 99999999997543332211 22345699999999998765 234689999999999999999 6
Q ss_pred CCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCC-CCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 283 RVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN-YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 283 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.||....+..... ..+..... .....+.+... ........+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus 265 ~p~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~ 337 (342)
T 1b6c_B 265 LPYYDLVPSDPSV-EEMRKVVC------EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 337 (342)
T ss_dssp CTTTTTSCSSCCH-HHHHHHHT------TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred cCccccCcCcccH-HHHHHHHH------HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence 7776654322111 10000000 00011111111 1235667899999999999999999999999999999765
Q ss_pred c
Q 046609 362 K 362 (399)
Q Consensus 362 ~ 362 (399)
.
T Consensus 338 ~ 338 (342)
T 1b6c_B 338 E 338 (342)
T ss_dssp T
T ss_pred h
Confidence 4
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=338.34 Aligned_cols=260 Identities=20% Similarity=0.280 Sum_probs=203.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEee--CCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVD--GDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++... ..+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36789999999999999999999989999999999743 3567889999999997 9999999999987 6678999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKLG 233 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~~ 233 (399)
|||+.+++|.+++.. +++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||++...
T Consensus 112 ~e~~~~~~l~~~~~~-------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGGG-------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHHh-------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 999999999999864 889999999999999999999999 99999999999999777 8999999999764
Q ss_pred CCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh-----hh---
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP-----LF--- 304 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~-----~~--- 304 (399)
..... .....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||......... +...... ..
T Consensus 182 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~ 257 (330)
T 3nsz_A 182 HPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYI 257 (330)
T ss_dssp CTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHH
T ss_pred CCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHH
Confidence 43322 233568999999999877 67899999999999999999999999654432111 0000000 00
Q ss_pred -----hccchhhhccC--------CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 -----KDRRKFTMMAD--------PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 -----~~~~~~~~~~~--------~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.....+..... .......+......+.+|+.+||+.||.+|||+++++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00000000000 011111222345688999999999999999999999764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=354.87 Aligned_cols=265 Identities=20% Similarity=0.260 Sum_probs=213.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC-CceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.++||+|+||.||+|.+..+++.||||++..... ...+..|+.+++.++| ++|..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 4689999999999999999999998999999999875432 3457889999999987 667777777788889999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE---CCCCCeeEecccCccCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL---DQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll---~~~~~~kl~Dfg~~~~~ 233 (399)
|+ +++|.+++.. ....+++..++.|+.||+.||.|||+++ |+||||||+|||| +.++.+||+|||+++..
T Consensus 84 ~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 84 LL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred CC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99 9999999985 2456999999999999999999999999 9999999999999 68899999999999865
Q ss_pred CCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 234 PTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 234 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
...... .......||+.|+|||++.+..++.++|||||||+||+|++|+.||..................... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~-~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVA-T 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHH-S
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccc-c
Confidence 433221 1122467999999999999999999999999999999999999999986654333222211110000 0
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
....+ ... .+..+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 236 ~~~~l-----~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~ 279 (483)
T 3sv0_A 236 SIEAL-----CRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR 279 (483)
T ss_dssp CHHHH-----HTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cHHHH-----hcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence 00010 011 234788999999999999999999999999998653
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=338.15 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=199.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC-CC--eEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG-TN--QDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
.++|.+.+.||+|+||.||+|.+.. ++ ..||||++..... ...+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 4678999999999999999998643 22 3689999875432 33467889999999999999999999998765 8
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHh---ccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccc
Confidence 899999999999999976 2356899999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCcc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 232 LGPTGDKSH-VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 232 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
......... ......++..|+|||++.+..++.++||||||+++|+|++ |+.||...........+ ...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~--- 240 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------DKE--- 240 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTS---
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHH------Hcc---
Confidence 654433221 2233457889999999988889999999999999999999 99999876432211100 000
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
......+...+..+.+++.+||+.||.+|||+.++++.|+.+.....
T Consensus 241 -------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 287 (291)
T 1u46_A 241 -------GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTDM 287 (291)
T ss_dssp -------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred -------CCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccch
Confidence 00011122344578899999999999999999999999998876543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=365.53 Aligned_cols=261 Identities=28% Similarity=0.395 Sum_probs=212.0
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.+..++|.+.+.||+|+||.||+|.+.+ +..||||++.... ...+.+.+|+.++++++||||+++++++.+ +..++|
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred ecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 3445678888999999999999999986 5679999998654 345679999999999999999999999976 678999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 340 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp ECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999751 1345899999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
... ........++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+ . .
T Consensus 415 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i---~----~------- 479 (535)
T 2h8h_A 415 DNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---E----R------- 479 (535)
T ss_dssp CHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH---H----T-------
T ss_pred CCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---H----c-------
Confidence 211 111223446789999999999999999999999999999999 99999876532211111 0 0
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......+...+..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus 480 ---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 480 ---GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 001112233445788999999999999999999999999987543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=344.76 Aligned_cols=264 Identities=22% Similarity=0.265 Sum_probs=197.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCC------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 149 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 4689999999999999999999999999999999975432 23356889999999999999999999997665
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||++ |+|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCC-CCHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeec
Confidence 7899999996 588888853 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh----------
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW---------- 299 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~---------- 299 (399)
+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+..
T Consensus 174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9754322 122345689999999999999999999999999999999999999987653221111100
Q ss_pred ------hhhhhhccc-----hhhhccCCccCC---CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 300 ------ATPLFKDRR-----KFTMMADPLLEG---NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 300 ------~~~~~~~~~-----~~~~~~~~~l~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......... .+.......... .........+.+|+.+||+.||.+|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 000000000 000000000000 0112335688999999999999999999999876
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=342.71 Aligned_cols=257 Identities=27% Similarity=0.374 Sum_probs=202.0
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEee-----
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVD----- 147 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~----- 147 (399)
+....++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 3345678999999999999999999998889999999997543 3456788999999998 79999999999987
Q ss_pred -CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEec
Q 046609 148 -GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSD 226 (399)
Q Consensus 148 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~D 226 (399)
.+..++||||+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEee
Confidence 56789999999999999999863 2356999999999999999999999999 99999999999999999999999
Q ss_pred ccCccCCCCCCCcccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 227 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
||++....... .......|++.|+|||++. +..++.++||||||+++|+|++|..||............
T Consensus 173 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---- 246 (326)
T 2x7f_A 173 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---- 246 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH----
T ss_pred CcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh----
Confidence 99987543221 1223356899999999986 567899999999999999999999999765432211100
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ..+.. .+...+..+.+++.+||..||.+||++.+++++
T Consensus 247 --~~~-------~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 247 --PRN-------PAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp --HHS-------CCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --hcC-------ccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 000 01111 011223478899999999999999999999885
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=353.78 Aligned_cols=245 Identities=16% Similarity=0.145 Sum_probs=191.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccC---CCcchHHHHHHH---HHHHccCCCceeeEE-------EE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN---GFQGNREFLVEV---LMLSMLSNPYLVNLV-------GY 144 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~---~~l~~l~hpnIv~l~-------~~ 144 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++... .....+.+.+|+ .++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788899999999999999999888999999999743 223446788999 455556799999998 77
Q ss_pred EeeCCe-----------------eEEEEEecCCCChHHhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046609 145 CVDGDQ-----------------RILVYEYMPNGSLEDHLLDL---PPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204 (399)
Q Consensus 145 ~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i 204 (399)
+.+.+. .++||||+ +|+|.+++... ......+++..++.++.||+.||.|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665542 78999999 68999999752 111223445888999999999999999999 9
Q ss_pred EecCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCC-----------CCCchhhHHHHHH
Q 046609 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-----------QLTAKSDVYSFGV 273 (399)
Q Consensus 205 vH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~~DvwslG~ 273 (399)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 9999999999999999999999999975221 2234567 999999999877 8999999999999
Q ss_pred HHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 274 VFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 274 il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
++|+|++|+.||............ ... ... .+..+.+|+.+||+.||.+|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~~~~~----------------~~~--~~~----~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGGSEWI----------------FRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHHSSCCC------CCSGGG----------------GSS--CCC----CCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHHCCCCCcccccccchhhh----------------hhh--ccC----CCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999999875543221111 000 012 2347889999999999999999999987
Q ss_pred H
Q 046609 354 A 354 (399)
Q Consensus 354 ~ 354 (399)
+
T Consensus 360 h 360 (377)
T 3byv_A 360 T 360 (377)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=343.95 Aligned_cols=257 Identities=21% Similarity=0.333 Sum_probs=206.3
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--------chHHHHHHHHHHHcc-CCCceeeEEEE
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--------GNREFLVEVLMLSML-SNPYLVNLVGY 144 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l-~hpnIv~l~~~ 144 (399)
.....++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 334456799999999999999999999988999999999754321 124577899999999 79999999999
Q ss_pred EeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeE
Q 046609 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224 (399)
Q Consensus 145 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 224 (399)
+...+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl 241 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL 241 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence 9999999999999999999999976 456999999999999999999999999 999999999999999999999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 298 (399)
+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+
T Consensus 242 ~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i- 317 (365)
T 2y7j_A 242 SDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI- 317 (365)
T ss_dssp CCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-
T ss_pred EecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHH-
Confidence 9999987644332 2234579999999998853 36889999999999999999999999865432111110
Q ss_pred hhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........ .+.. ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 318 -----~~~~~~~~---~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 318 -----MEGQYQFS---SPEW-----DDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -----HHTCCCCC---HHHH-----SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----HhCCCCCC---Cccc-----ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 00000000 0000 0123468899999999999999999999864
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=347.34 Aligned_cols=265 Identities=18% Similarity=0.207 Sum_probs=207.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC--------CCceeeEEEEEe---
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS--------NPYLVNLVGYCV--- 146 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------hpnIv~l~~~~~--- 146 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999999999999999997532 23456888999999885 788999999987
Q ss_pred -eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCC----
Q 046609 147 -DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDF---- 220 (399)
Q Consensus 147 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~---- 220 (399)
+....++||||+ +++|.+++... ....+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~ 188 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR 188 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence 556889999999 67777777652 235699999999999999999999998 8 99999999999999775
Q ss_pred ---------------------------------------------CeeEecccCccCCCCCCCccccccccccccccccc
Q 046609 221 ---------------------------------------------NPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255 (399)
Q Consensus 221 ---------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE 255 (399)
.+||+|||++...... .....||+.|+|||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHH
T ss_pred hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCCh
Confidence 7999999999754322 23346899999999
Q ss_pred cccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh---hhhhhh------------------ccchhhhcc
Q 046609 256 YALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW---ATPLFK------------------DRRKFTMMA 314 (399)
Q Consensus 256 ~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~---~~~~~~------------------~~~~~~~~~ 314 (399)
++.+..++.++|||||||++|+|++|+.||.............. ...... .......+.
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 99999999999999999999999999999987664432211111 000000 000000000
Q ss_pred CCc---------cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPL---------LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~---------l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... -...++......+.+|+.+||+.||.+|||+.+++++
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 000 0113456777889999999999999999999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-45 Score=345.00 Aligned_cols=257 Identities=24% Similarity=0.335 Sum_probs=205.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEEC---CCCeEEEEEEEccCCC----cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF----QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGD 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 149 (399)
.++|.+.+.||+|+||.||+|.+. .+++.||||++..... .....+.+|+.++..+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 367999999999999999999984 4789999999875321 2235567799999999 6999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||+++|+|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999976 356999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+ .......
T Consensus 206 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~--~~~~~~~- 281 (355)
T 1vzo_A 206 SKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKS- 281 (355)
T ss_dssp EEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHC-
T ss_pred CeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH--HHHHhcc-
Confidence 97543222 222334579999999999875 35789999999999999999999999865433221111 1111111
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHHHH
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTAIE 356 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~L~ 356 (399)
. ..++......+.+|+.+||+.||.+|| ++.+++++..
T Consensus 282 -------~----~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~ 324 (355)
T 1vzo_A 282 -------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324 (355)
T ss_dssp -------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -------C----CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence 1 112333445788999999999999999 9999987643
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=332.72 Aligned_cols=252 Identities=24% Similarity=0.295 Sum_probs=205.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---------cchHHHHHHHHHHHccC-CCceeeEEEEEee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---------QGNREFLVEVLMLSMLS-NPYLVNLVGYCVD 147 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~ 147 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999975431 11245778999999996 9999999999999
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
.+..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 9999999999999999999976 456999999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCcccccccccccccccccccc------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL------TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
|++....... ......|++.|+|||++. ...++.++||||||+++|+|++|+.||...........+
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---- 241 (298)
T 1phk_A 169 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI---- 241 (298)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH----
T ss_pred cchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHH----
Confidence 9997644322 223356899999999875 457889999999999999999999999765432111100
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
..... ..........+..+.+++.+||+.||.+|||+.++++
T Consensus 242 --~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 242 --MSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp --HHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred --hcCCc--------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 00000 0000111234457889999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=351.31 Aligned_cols=202 Identities=21% Similarity=0.312 Sum_probs=175.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc------CCCceeeEEEEEeeCCee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML------SNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~hpnIv~l~~~~~~~~~~ 151 (399)
..+|.+.++||+|+||.||+|.+..+++.||||++.... .....+.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 467999999999999999999999999999999997532 2235677788888776 577999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC--eeEecccC
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN--PKLSDFGL 229 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~--~kl~Dfg~ 229 (399)
++||||+. ++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 175 ~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 99999994 7999999873 2345999999999999999999999999 999999999999999987 99999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT 291 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 291 (399)
+...... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||...+..
T Consensus 249 a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 249 SCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp CEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 9753322 22356899999999999999999999999999999999999999876543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=333.78 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=199.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--------cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--------QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 578899999999999999999999999999999975422 12235788999999999999999999997665
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC---eeEecc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN---PKLSDF 227 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Df 227 (399)
.++||||+++++|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+||+++.++. +||+||
T Consensus 89 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999999975 467999999999999999999999999 999999999999987665 999999
Q ss_pred cCccCCCCCCCcccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|++...... .......||+.|+|||++. +..++.++||||||+++|+|++|..||........ +......
T Consensus 162 g~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~-- 234 (322)
T 2ycf_A 162 GHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQITS-- 234 (322)
T ss_dssp TTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHHH--
T ss_pred ccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHHh--
Confidence 999764322 1223456899999999874 56789999999999999999999999986543321 1110000
Q ss_pred hccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... ..+.. ....+..+.+++.+||+.||.+||++.+++++
T Consensus 235 -~~~~----~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 235 -GKYN----FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp -TCCC----CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred -Cccc----cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 0000 00000 01223578899999999999999999999864
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=343.81 Aligned_cols=267 Identities=20% Similarity=0.256 Sum_probs=205.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeC-----Cee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDG-----DQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~ 151 (399)
..+|.+.+.||+|+||.||+|.+..++..||||++...... ....+.+|+.++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999999999999999999754322 236688999999999999999999999765 368
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999995 699999975 45999999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCCCc-cccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|++||......+....+......... ..
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~ 255 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ-ED 255 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH-HH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH-HH
Confidence 64332211 11234579999999998754 55899999999999999999999999876654332222110000000 00
Q ss_pred hhh---------ccCCccCCCC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTM---------MADPLLEGNY-----PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~---------~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... .......... .......+.+|+.+||+.||.+|||+.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 0000000000 11234578899999999999999999999764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-45 Score=344.84 Aligned_cols=268 Identities=17% Similarity=0.205 Sum_probs=209.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC--------CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceee---------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG--------TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVN--------- 140 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~--------- 140 (399)
.++|.+.+.||+|+||.||+|.+.. .++.||||.+... ..+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999987 3789999998754 46788999999999999987
Q ss_pred ------EEEEEee-CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 046609 141 ------LVGYCVD-GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASN 213 (399)
Q Consensus 141 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~N 213 (399)
+++++.. ++..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHH
Confidence 6777766 77889999999 99999999862 1367999999999999999999999999 9999999999
Q ss_pred eEECCCC--CeeEecccCccCCCCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 046609 214 VLLDQDF--NPKLSDFGLAKLGPTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVID 286 (399)
Q Consensus 214 Ill~~~~--~~kl~Dfg~~~~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 286 (399)
||++.++ .+||+|||++......... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999754332111 11133479999999999999999999999999999999999999998
Q ss_pred CCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 287 NSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
...+... ............ ...+..... .....+..+.+++.+||+.||.+||++.+|++.|+.+.....
T Consensus 270 ~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 270 NCLPNTE-DIMKQKQKFVDK---PGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GGTTCHH-HHHHHHHHHHHS---CCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred cCCcCHH-HHHHHHHhccCC---hhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 7643221 111111111111 011111100 001223578899999999999999999999999999876554
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=338.76 Aligned_cols=267 Identities=25% Similarity=0.373 Sum_probs=189.6
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
...++|.+.+.||+|+||.||+|.+..+++.||||.+..... .....+.+|+.++++++||||+++++++...+..++|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 456789999999999999999999988899999999865432 3345678899999999999999999999999999999
Q ss_pred EEecCCCChHHhhccC----CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 155 YEYMPNGSLEDHLLDL----PPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~----~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
|||+++++|.+++... ......+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998641 112456999999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCC---ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 231 KLGPTGDK---SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 231 ~~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........ ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||............ ....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT-----LQND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH-----HTSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHH-----hccC
Confidence 75433221 112233568999999998865 57899999999999999999999999876543211100 0000
Q ss_pred cchhh-hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 RRKFT-MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 ~~~~~-~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..... ...++. ........+.+++.+||+.||.+||++.+++++
T Consensus 244 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 244 PPSLETGVQDKE----MLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp CCCTTC-----C----CCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred CCccccccccch----hhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 00000 001111 112233578899999999999999999999864
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=343.31 Aligned_cols=274 Identities=21% Similarity=0.238 Sum_probs=201.4
Q ss_pred cHHHHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-----------hHHHHHHHHHHHccCCCce
Q 046609 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-----------NREFLVEVLMLSMLSNPYL 138 (399)
Q Consensus 70 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~hpnI 138 (399)
...++....++|.+.+.||+|+||.||+|.+.. +..||||++....... .+.+.+|+.++++++||||
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 345677778999999999999999999999875 8999999986432211 2668899999999999999
Q ss_pred eeEEEEEee-----CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCc
Q 046609 139 VNLVGYCVD-----GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASN 213 (399)
Q Consensus 139 v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~N 213 (399)
+++++++.. ....++||||+. |+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~N 164 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGN 164 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHH
Confidence 999999854 346799999996 688888876 3457999999999999999999999999 9999999999
Q ss_pred eEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcc
Q 046609 214 VLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292 (399)
Q Consensus 214 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~ 292 (399)
|+++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+
T Consensus 165 Il~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 165 ILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp EEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999999999999997432222 2233568999999998876 678999999999999999999999998765332
Q ss_pred cchhhHhhhhhhh-------ccchhhhccCCccCC-------CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 293 EQNLVTWATPLFK-------DRRKFTMMADPLLEG-------NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 293 ~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~-------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+........ ............... .........+.+|+.+||+.||.+|||+.+++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 2111110000000 000000000000000 0111234568899999999999999999999764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=349.10 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=197.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeC------CeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------DQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~~ 152 (399)
.+|.+.++||+|+||.||+|.+..+++.||||++.... ....+|+.+++.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999999899999999986542 2234699999999999999999998532 2367
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-CCeeEecccCcc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAK 231 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-~~~kl~Dfg~~~ 231 (399)
+||||+++ +|.+.+.........+++..++.++.||+.||.|||+.+ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999964 677666532233567999999999999999999999999 9999999999999965 568999999998
Q ss_pred CCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh-hhhhh----
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA-TPLFK---- 305 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~-~~~~~---- 305 (399)
....... .....||+.|+|||++.+. .++.++|||||||++|||++|++||......+....+... .....
T Consensus 206 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~ 282 (420)
T 1j1b_A 206 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 282 (420)
T ss_dssp ECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred hcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6433322 2235689999999998765 7999999999999999999999999876533221111100 00000
Q ss_pred -ccchhhhccCCccCC-----CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 -DRRKFTMMADPLLEG-----NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 -~~~~~~~~~~~~l~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........-+.+.. .++......+.+|+.+||+.||.+||++.+++++
T Consensus 283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 000000000011100 0122334678999999999999999999999875
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=346.72 Aligned_cols=256 Identities=11% Similarity=0.011 Sum_probs=184.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHcc--CCCceeeEE-------EEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSML--SNPYLVNLV-------GYC 145 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l--~hpnIv~l~-------~~~ 145 (399)
..+|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34588899999999999999999999999999999875432 234466775444444 699988865 454
Q ss_pred eeC-----------------CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCC
Q 046609 146 VDG-----------------DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTR------MKIAHGAARGLEYLHESAQP 202 (399)
Q Consensus 146 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~ql~~~l~~LH~~~~~ 202 (399)
... ...++||||++ |+|.+++... +..+++..+ +.++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~-- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSKG-- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence 433 33799999997 8999999862 223455555 778899999999999999
Q ss_pred CeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHc
Q 046609 203 PVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIIT 280 (399)
Q Consensus 203 ~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt 280 (399)
|+||||||+|||++.++.+||+|||++...... .....+|+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp -EEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred -CccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 999999999999999999999999999854211 113457799999999987 689999999999999999999
Q ss_pred CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 281 GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 281 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
|+.||....+........ ...................+..+.+|+.+||+.||.+|||+.+++++
T Consensus 289 g~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SSCSTTBCCTTCTTCCCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCCcCcccccchhh---------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 999998775432111000 00000000011111112345678899999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=336.13 Aligned_cols=267 Identities=21% Similarity=0.291 Sum_probs=198.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEe-----------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV----------- 146 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~----------- 146 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 468999999999999999999999999999999997665455577899999999999999999999873
Q ss_pred ---eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCe
Q 046609 147 ---DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNP 222 (399)
Q Consensus 147 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~ 222 (399)
+....++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeE
Confidence 4467899999996 699999964 46899999999999999999999999 99999999999997 56799
Q ss_pred eEecccCccCCCCCCC-ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhh
Q 046609 223 KLSDFGLAKLGPTGDK-SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~ 300 (399)
||+|||++........ ........++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+...
T Consensus 161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 240 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240 (320)
T ss_dssp EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999986432211 112233457899999998865 68899999999999999999999999876543221111100
Q ss_pred hhhhhccchhhhc------------cCCcc-CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 301 TPLFKDRRKFTMM------------ADPLL-EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 301 ~~~~~~~~~~~~~------------~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.... .....+ ..+.. ........+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 241 IPVVHE-EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp SCCCCH-HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred cCCCch-hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 000000 000000 00000 000011234578899999999999999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=338.83 Aligned_cols=264 Identities=19% Similarity=0.261 Sum_probs=205.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch-----------------HHHHHHHHHHHccCCCceee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN-----------------REFLVEVLMLSMLSNPYLVN 140 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-----------------~~~~~e~~~l~~l~hpnIv~ 140 (399)
.++|.+.+.||+|+||.||+|.+ +++.||||.+........ ..+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 46899999999999999999999 699999999964322111 77899999999999999999
Q ss_pred EEEEEeeCCeeEEEEEecCCCChHHh------hccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCc
Q 046609 141 LVGYCVDGDQRILVYEYMPNGSLEDH------LLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASN 213 (399)
Q Consensus 141 l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~N 213 (399)
+++++.+.+..++||||+++|+|.++ +.. .....+++..++.++.|++.||.|||+ .+ |+||||||+|
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~N 182 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSN 182 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGG
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHh
Confidence 99999999999999999999999998 543 225679999999999999999999999 88 9999999999
Q ss_pred eEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCC-CCCc-hhhHHHHHHHHHHHHcCCCCCCCCCCc
Q 046609 214 VLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTA-KSDVYSFGVVFLEIITGRRVIDNSRPT 291 (399)
Q Consensus 214 Ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~~DvwslG~il~elltg~~pf~~~~~~ 291 (399)
|+++.++.+||+|||++...... ......|+..|+|||++.+. .++. ++||||||+++|+|++|+.||......
T Consensus 183 il~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 258 (348)
T 2pml_X 183 ILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL 258 (348)
T ss_dssp EEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS
T ss_pred EEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH
Confidence 99999999999999999754322 23345699999999999877 6766 999999999999999999999876542
Q ss_pred ccchhhHhhhh-hhhccchhhhccCCcc---CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 292 EEQNLVTWATP-LFKDRRKFTMMADPLL---EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 292 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ....... .............+.. ........+..+.+++.+||+.||.+|||+.+++++
T Consensus 259 ~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 VE--LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HH--HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HH--HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 1111100 0000000000000000 000113344678899999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=333.18 Aligned_cols=265 Identities=20% Similarity=0.254 Sum_probs=206.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEE-CCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC------ceeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKL-EGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP------YLVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp------nIv~l~~~~~~~~~ 150 (399)
.++|.+.+.||+|+||.||+|.+ ..+++.||||++.... .....+.+|+.+++.++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999998 5578999999997532 2345678899999888765 49999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC------------
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ------------ 218 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~------------ 218 (399)
.++||||+ +++|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~ 165 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIK 165 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----
T ss_pred EEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccc
Confidence 99999999 89999999872 2346899999999999999999999999 999999999999987
Q ss_pred -------CCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc
Q 046609 219 -------DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT 291 (399)
Q Consensus 219 -------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 291 (399)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+..
T Consensus 166 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 166 RDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 678999999999753322 22356899999999999999999999999999999999999999876543
Q ss_pred ccchhhHhhhhhhhcc-----c--------------------hhhhccCCcc-CCCCCHHHHHHHHHHHhhccccCCCCC
Q 046609 292 EEQNLVTWATPLFKDR-----R--------------------KFTMMADPLL-EGNYPIKGLYQALAVAAMCLQEEAGTR 345 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~~~l-~~~~~~~~~~~l~~li~~cl~~dp~~R 345 (399)
+...........+... . .......+.. ...........+.+|+.+||+.||.+|
T Consensus 241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence 3222211111100000 0 0000000000 011233456789999999999999999
Q ss_pred CChHHHHHH
Q 046609 346 PMMSDVVTA 354 (399)
Q Consensus 346 Ps~~eil~~ 354 (399)
||+.+++++
T Consensus 321 pt~~ell~h 329 (339)
T 1z57_A 321 ITLREALKH 329 (339)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=339.96 Aligned_cols=274 Identities=22% Similarity=0.261 Sum_probs=194.6
Q ss_pred HHHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCe--
Q 046609 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ-- 150 (399)
Q Consensus 73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~-- 150 (399)
......++|.+.+.||+|+||.||+|.+..++..||||++.... ........++..+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 34455689999999999999999999999999999999986543 223456678888899999999999999965433
Q ss_pred -----eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCceEECC-CCCe
Q 046609 151 -----RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH--ESAQPPVIYRDFKASNVLLDQ-DFNP 222 (399)
Q Consensus 151 -----~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH--~~~~~~ivH~dikp~NIll~~-~~~~ 222 (399)
.++||||+++ +|...+.........+++..++.++.|++.||.||| +.+ |+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcE
Confidence 7899999965 665555432234567999999999999999999999 888 999999999999996 8999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~ 301 (399)
||+|||++........ .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+....
T Consensus 172 kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 248 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVL 248 (360)
T ss_dssp EECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred EEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHc
Confidence 9999999986543322 2335689999999998665 48999999999999999999999998765432221111100
Q ss_pred hhh---------hccchhhhccCC-----ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 302 PLF---------KDRRKFTMMADP-----LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 302 ~~~---------~~~~~~~~~~~~-----~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ............ .............+.+|+.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 249 GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000 000000000000 00011222346689999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=344.30 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=187.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeC------C
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------D 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~ 149 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999999999999999999965432 2346688999999999999999999999754 5
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 679999999 7899988864 46999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh---
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK--- 305 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--- 305 (399)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+........
T Consensus 179 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred ccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9753321 233568999999999876 6889999999999999999999999987654322221111000000
Q ss_pred --c--cchhhhccCCcc-CCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 --D--RRKFTMMADPLL-EGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 --~--~~~~~~~~~~~l-~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ............ ....+ ......+.+|+.+||+.||.+|||+.+++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 0 000000000000 00000 1223568899999999999999999999865
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=331.82 Aligned_cols=257 Identities=22% Similarity=0.296 Sum_probs=199.7
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccC--CCceeeEEEEEeeCC
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLS--NPYLVNLVGYCVDGD 149 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~ 149 (399)
+....++|.+.+.||+|+||.||+|.+.. ++.||||++...... ....+.+|+.++.+++ ||||+++++++.+++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 34456789999999999999999999864 888999999754332 3466889999999997 599999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||| +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++. +.+||+|||+
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccc
Confidence 9999999 458899999986 457899999999999999999999999 999999999999964 8999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-----------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-----------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 298 (399)
+................|++.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~----- 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----- 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----
Confidence 986544333323344569999999998865 4788899999999999999999999976432110
Q ss_pred hhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHH
Q 046609 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAI 355 (399)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L 355 (399)
......++.....++......+.+++.+||+.||.+||++.+++++-
T Consensus 248 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 248 ----------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ----------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ----------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 01111111111122222345788999999999999999999998763
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=346.96 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=195.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCC------eeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------QRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------~~~ 152 (399)
.+|.+.++||+|+||.||+|.+..++. ||+|++..... ...+|+.+++.++||||+++++++.... ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468899999999999999999987655 88888754322 2235999999999999999999996443 378
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCeeEecccCcc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAK 231 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~~~ 231 (399)
+||||+++ ++...+.........+++..++.++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999965 444444322223567999999999999999999999999 99999999999999 79999999999998
Q ss_pred CCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh-----
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK----- 305 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~----- 305 (399)
....... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+....+........
T Consensus 191 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~ 267 (394)
T 4e7w_A 191 ILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267 (394)
T ss_dssp ECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred cccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 6433322 2235689999999998765 589999999999999999999999987654322211111000000
Q ss_pred -ccc-----hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 -DRR-----KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 -~~~-----~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... .+.......+...++...+..+.+|+.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 268 TMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred hhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 000 0000000000011122244578999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=340.17 Aligned_cols=268 Identities=20% Similarity=0.254 Sum_probs=202.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeC-----Cee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDG-----DQR 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~~ 151 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 4689999999999999999999999999999999975432 2235678999999999999999999998754 678
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+. |+|.+++.. ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 99999995 699999875 46999999999999999999999999 9999999999999999999999999997
Q ss_pred CCCCCCCcc--------ccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 232 LGPTGDKSH--------VSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 232 ~~~~~~~~~--------~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|++||...+.......+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 644322111 1223468999999998764 7889999999999999999999999987653221111100000
Q ss_pred hhhccch--------hhhccCC--cc-CC---CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKDRRK--------FTMMADP--LL-EG---NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~~~~--------~~~~~~~--~l-~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....... ....... .. .. ......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0000000 00 00 0011234578899999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=330.16 Aligned_cols=268 Identities=22% Similarity=0.301 Sum_probs=203.6
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC-CCCeEEEEEEEccCCC--cchHHHHHHHHHHHcc---CCCceeeEEEEEe----
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE-GTNQDVAVKQLDRNGF--QGNREFLVEVLMLSML---SNPYLVNLVGYCV---- 146 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~---- 146 (399)
..++|.+.+.||+|+||.||+|.+. .+++.||+|++..... .....+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999995 6789999999865332 2234566777777766 8999999999987
Q ss_pred -eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEe
Q 046609 147 -DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLS 225 (399)
Q Consensus 147 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~ 225 (399)
.....++||||+. |+|.+++.... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999996 69999998732 345999999999999999999999999 9999999999999999999999
Q ss_pred cccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh
Q 046609 226 DFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305 (399)
Q Consensus 226 Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~ 305 (399)
|||++..... ........|++.|+|||++.+..++.++||||||+++|+|++|+.||...........+.......
T Consensus 163 Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~- 238 (326)
T 1blx_A 163 DFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP- 238 (326)
T ss_dssp SCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC-
T ss_pred cCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC-
Confidence 9999975432 122334568999999999999999999999999999999999999998765432211111000000
Q ss_pred ccchhhh-------ccC---CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 DRRKFTM-------MAD---PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 ~~~~~~~-------~~~---~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+.. ... ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0000000 000 000011122344578899999999999999999999753
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=337.81 Aligned_cols=265 Identities=18% Similarity=0.215 Sum_probs=201.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-----------CCceeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-----------NPYLVNLVGYCV 146 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~l~~~~~ 146 (399)
..+|.+.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 468999999999999999999999899999999997532 23456788999888876 899999999988
Q ss_pred eCC----eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEEC----
Q 046609 147 DGD----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLD---- 217 (399)
Q Consensus 147 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~---- 217 (399)
..+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEET
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCC
Confidence 654 789999999 899999998732 35699999999999999999999998 8 99999999999994
Q ss_pred --CCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccch
Q 046609 218 --QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQN 295 (399)
Q Consensus 218 --~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~ 295 (399)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 4457999999999754322 223468999999999999999999999999999999999999998765322111
Q ss_pred hhH---hhhhhhh------------------ccchhhhccCC---------ccCCCCCHHHHHHHHHHHhhccccCCCCC
Q 046609 296 LVT---WATPLFK------------------DRRKFTMMADP---------LLEGNYPIKGLYQALAVAAMCLQEEAGTR 345 (399)
Q Consensus 296 ~~~---~~~~~~~------------------~~~~~~~~~~~---------~l~~~~~~~~~~~l~~li~~cl~~dp~~R 345 (399)
... ....... .......+... .....++......+.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 100 0000000 00000000000 00113456778899999999999999999
Q ss_pred CChHHHHHH
Q 046609 346 PMMSDVVTA 354 (399)
Q Consensus 346 Ps~~eil~~ 354 (399)
||+.+++++
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=327.13 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=194.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee----------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD---------- 147 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~---------- 147 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 356888999999999999999999899999999996432 334668899999999999999999999865
Q ss_pred ---CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeE
Q 046609 148 ---GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224 (399)
Q Consensus 148 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 224 (399)
.+..++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS---ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH---SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred cccCCceEEEEecCCCCCHHHhhhc---cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 3567999999999999999986 2456888999999999999999999999 999999999999999999999
Q ss_pred ecccCccCCCCCCC------------ccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCc
Q 046609 225 SDFGLAKLGPTGDK------------SHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPT 291 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~ 291 (399)
+|||++........ ........|++.|+|||++.+. .++.++||||||+++|+|++ ||.....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~- 233 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME- 233 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH-
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh-
Confidence 99999976432210 1122345689999999998764 78999999999999999998 4442110
Q ss_pred ccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 292 EEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..... ..... ....+...++......+.+++.+||+.||.+|||+.+++++
T Consensus 234 -~~~~~---~~~~~--------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 234 -RVNIL---KKLRS--------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp -HHHHH---HHHHS--------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -HHHHH---Hhccc--------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 00011 00000 01111222334445578899999999999999999999864
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=337.21 Aligned_cols=262 Identities=20% Similarity=0.301 Sum_probs=200.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--hHHHHHHHHHHHccCCCceeeEEEEEeeCCee----
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR---- 151 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~---- 151 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 468999999999999999999999999999999997643322 36688999999999999999999999877765
Q ss_pred --EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 152 --ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 152 --~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
++||||+. ++|.+++.. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 121 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMGM------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCEEEEECCC-EEHHHHTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEEcccc-ccHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999995 688888743 4999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh----
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF---- 304 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---- 304 (399)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+....+.......
T Consensus 191 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 9753222 233568999999999877 689999999999999999999999998765332211111000000
Q ss_pred ----hc--cchhhhccCCccCCC---CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 ----KD--RRKFTMMADPLLEGN---YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ----~~--~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ............... ........+.+|+.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 000000000000000 011234578999999999999999999999764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=335.30 Aligned_cols=263 Identities=21% Similarity=0.336 Sum_probs=202.5
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
..+..++|.+.+.||+|+||.||+|.+.+ .+|+|++..... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 33456789999999999999999999864 499999875432 2235577899999999999999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++++|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||+++ ++.+||+|||++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred EEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999976 3456999999999999999999999999 99999999999998 6799999999987
Q ss_pred CCCCCC---CccccccccccccccccccccC---------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh
Q 046609 232 LGPTGD---KSHVSTRVMGTYGYCAPEYALT---------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW 299 (399)
Q Consensus 232 ~~~~~~---~~~~~~~~~g~~~y~aPE~~~~---------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 299 (399)
...... .........|++.|+|||++.+ ..++.++||||||+++|+|++|+.||............
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-- 255 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-- 255 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH--
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh--
Confidence 532211 1122233568999999998864 45789999999999999999999999875432211100
Q ss_pred hhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 300 ATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
. ....+... ....+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 256 -~----------~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 -G----------TGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp -H----------TTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred -c----------cCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 0 00011111 0112236788999999999999999999999999887654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=325.47 Aligned_cols=252 Identities=25% Similarity=0.321 Sum_probs=203.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++..... .....+.+|+.++++++||||+++++++.+.+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 4679999999999999999999998899999999965432 34567889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC---CCeeEecccCccC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD---FNPKLSDFGLAKL 232 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~---~~~kl~Dfg~~~~ 232 (399)
||+++++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++..
T Consensus 101 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~ 173 (287)
T 2wei_A 101 ELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (287)
T ss_dssp CCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred EccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCccee
Confidence 99999999998876 346999999999999999999999999 9999999999999764 4699999999875
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
...... .....+++.|+|||++.+ .++.++||||||+++|+|++|..||...........+ ......
T Consensus 174 ~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~~--- 240 (287)
T 2wei_A 174 FQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------ETGKYA--- 240 (287)
T ss_dssp BCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCCCC---
T ss_pred ecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcCCCC---
Confidence 433221 223458899999998765 5899999999999999999999999875432211110 000000
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+... ....+..+.+++.+||+.||.+|||+.+++++
T Consensus 241 -~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 -FDLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp -CCSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred -CCchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00000 01223578899999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=331.40 Aligned_cols=259 Identities=23% Similarity=0.313 Sum_probs=183.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHH-HHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVL-MLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~-~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 347889999999999999999999989999999999764322 2344555665 67778999999999999999999999
Q ss_pred EEecCCCChHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 155 YEYMPNGSLEDHLLDLP-PNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|||++ |+|.+++.... .....+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++..
T Consensus 100 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99996 48877775311 1245799999999999999999999998 9 99999999999999999999999999975
Q ss_pred CCCCCCccccccccccccccccccc----cCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYA----LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
..... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||......... ...
T Consensus 176 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~------ 241 (327)
T 3aln_A 176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ-----LTQ------ 241 (327)
T ss_dssp ---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CC------
T ss_pred ccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH-----HHH------
Confidence 43322 12234689999999998 4567899999999999999999999999864321100 000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+.+...........+.+++.+||+.||.+||++.+|+++
T Consensus 242 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 242 -VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp -CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred -HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 000001111111122334578899999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=332.68 Aligned_cols=254 Identities=19% Similarity=0.210 Sum_probs=175.9
Q ss_pred cCCCCCC-CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee----CCeeE
Q 046609 78 TTNFNPD-NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD----GDQRI 152 (399)
Q Consensus 78 ~~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~ 152 (399)
.++|.+. ++||+|+||.||+|.+..+++.||||++... ..........++.+.||||+++++++.. ....+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 4678885 4699999999999999999999999998643 1222223344667789999999999876 45589
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEecccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFGL 229 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~ 229 (399)
+||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 103 lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999863 2357999999999999999999999999 999999999999976 45599999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
+...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.............. .. .
T Consensus 178 ~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~-----~ 246 (336)
T 3fhr_A 178 AKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKR--RI-----R 246 (336)
T ss_dssp CEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred ceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHH--hh-----h
Confidence 9754322 12335689999999999888999999999999999999999999976554321100000 00 0
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ............+..+.+|+.+||+.||.+|||+.+++++
T Consensus 247 ~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 247 LG---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp -------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred cc---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0000001112334578899999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=333.44 Aligned_cols=203 Identities=24% Similarity=0.321 Sum_probs=173.8
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CC-----ceeeEEEEEeeCCe
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NP-----YLVNLVGYCVDGDQ 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hp-----nIv~l~~~~~~~~~ 150 (399)
..++|.+.+.||+|+||.||+|.+..+++.||||++.... .....+..|+.++..++ |+ +|+++++++...+.
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 130 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNH 130 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTE
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCc
Confidence 3578999999999999999999999999999999997432 22355677888888775 44 59999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCCCeEecCCCCCceEEC--CCCCeeEec
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE--SAQPPVIYRDFKASNVLLD--QDFNPKLSD 226 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~--~~~~~ivH~dikp~NIll~--~~~~~kl~D 226 (399)
.++||||+. |+|.+++... ....+++..++.++.|++.||.|||+ .+ |+||||||+|||++ .++.+||+|
T Consensus 131 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D 204 (382)
T 2vx3_A 131 LCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD 204 (382)
T ss_dssp EEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence 999999995 6999999873 23569999999999999999999994 56 99999999999994 578899999
Q ss_pred ccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc
Q 046609 227 FGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT 291 (399)
Q Consensus 227 fg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 291 (399)
||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|++||......
T Consensus 205 FG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~ 264 (382)
T 2vx3_A 205 FGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264 (382)
T ss_dssp CTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999764322 22356899999999999999999999999999999999999999976543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=360.13 Aligned_cols=261 Identities=22% Similarity=0.325 Sum_probs=207.5
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCee
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~ 151 (399)
...++|.+.+.||+|+||.||+|.+..+ +..||||.+..... .....+.+|+.++++++||||+++++++. ++..
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 4456788889999999999999998543 46799999875432 22366889999999999999999999985 4568
Q ss_pred EEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 152 ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 466 ~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQV---RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp EEEEECCTTCBHHHHHHH---TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred EEEEEcCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 999999999999999986 2346999999999999999999999999 9999999999999999999999999998
Q ss_pred CCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 232 LGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 232 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
....... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+ . ..
T Consensus 540 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i---~---~~---- 608 (656)
T 2j0j_A 540 YMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---E---NG---- 608 (656)
T ss_dssp SCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H---HT----
T ss_pred ecCCCcc-eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H---cC----
Confidence 6543322 12223457789999999998999999999999999999997 99999876533211111 0 00
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.. ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 609 ---~~----~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 609 ---ER----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp ---CC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CC----CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 00 112223445788999999999999999999999999988643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=332.76 Aligned_cols=261 Identities=20% Similarity=0.296 Sum_probs=200.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCCe-----
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ----- 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~----- 150 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 36789999999999999999999999999999999764322 23568899999999999999999999987654
Q ss_pred -eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 151 -RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 151 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
.++||||+. ++|.+++.. .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999996 688887743 4999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh----
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF---- 304 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~---- 304 (399)
+...... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+.......
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9753221 223568999999998876 678999999999999999999999998765332211110000000
Q ss_pred ----hcc------chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 ----KDR------RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ----~~~------~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ........+.+ .......+..+.+|+.+||+.||.+|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000 00000000001 11122445688999999999999999999999764
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=330.23 Aligned_cols=265 Identities=19% Similarity=0.236 Sum_probs=203.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC-eEEEEEEEccCCCcchHHHHHHHHHHHccCCCc------eeeEEEEEeeCCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN-QDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY------LVNLVGYCVDGDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn------Iv~l~~~~~~~~~ 150 (399)
.++|.+.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+|+.+++.++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999997766 789999997532 33456788999999887655 9999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE--------------
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL-------------- 216 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll-------------- 216 (399)
.++||||+ +++|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred EEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 99999999 77888887762 2356999999999999999999999999 9999999999999
Q ss_pred -----CCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCc
Q 046609 217 -----DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPT 291 (399)
Q Consensus 217 -----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~ 291 (399)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 245 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR 245 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 56789999999999753322 22356999999999999999999999999999999999999999876543
Q ss_pred ccchhhHhhhhhhhc-----cch--------------------hhhccCCc-cCCCCCHHHHHHHHHHHhhccccCCCCC
Q 046609 292 EEQNLVTWATPLFKD-----RRK--------------------FTMMADPL-LEGNYPIKGLYQALAVAAMCLQEEAGTR 345 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~-----~~~--------------------~~~~~~~~-l~~~~~~~~~~~l~~li~~cl~~dp~~R 345 (399)
............... ... ......+. ............+.+|+.+||+.||.+|
T Consensus 246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 325 (355)
T 2eu9_A 246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR 325 (355)
T ss_dssp HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence 221111111000000 000 00000000 0001123445688999999999999999
Q ss_pred CChHHHHHH
Q 046609 346 PMMSDVVTA 354 (399)
Q Consensus 346 Ps~~eil~~ 354 (399)
||+.+++++
T Consensus 326 pt~~e~l~h 334 (355)
T 2eu9_A 326 ITLAEALLH 334 (355)
T ss_dssp CCHHHHTTS
T ss_pred cCHHHHhcC
Confidence 999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=342.53 Aligned_cols=269 Identities=20% Similarity=0.279 Sum_probs=184.1
Q ss_pred CCCC-CCeeccCCcEEEEEEEEC--CCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee--CCeeEEE
Q 046609 80 NFNP-DNLLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRILV 154 (399)
Q Consensus 80 ~~~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv 154 (399)
.|.+ .++||+|+||.||+|.+. .++..||||++.... ....+.+|+.+++.++||||+++++++.. +...++|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv 98 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL 98 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence 3554 458999999999999976 468899999997543 34568899999999999999999999954 6789999
Q ss_pred EEecCCCChHHhhccCC-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE----CCCCCeeEe
Q 046609 155 YEYMPNGSLEDHLLDLP-----PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL----DQDFNPKLS 225 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~-----~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll----~~~~~~kl~ 225 (399)
|||+. |+|.+++.... .....+++..++.++.||+.||.|||+.+ |+||||||+|||| +.++.+||+
T Consensus 99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99995 68888876311 12235999999999999999999999999 9999999999999 778899999
Q ss_pred cccCccCCCCCCC-ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc------hhh
Q 046609 226 DFGLAKLGPTGDK-SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ------NLV 297 (399)
Q Consensus 226 Dfg~~~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~------~~~ 297 (399)
|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||......... ...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 9999986543221 122334679999999999887 45899999999999999999999999765432100 000
Q ss_pred Hhhhhhhhc--cchhhhc-------------cCCccCC--------CCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 298 TWATPLFKD--RRKFTMM-------------ADPLLEG--------NYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 298 ~~~~~~~~~--~~~~~~~-------------~~~~l~~--------~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
......+.. ...+..+ ....... .........+.+|+.+||+.||.+|||+.+++++
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 0000000 0000000 0000113467899999999999999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=328.60 Aligned_cols=246 Identities=22% Similarity=0.356 Sum_probs=202.2
Q ss_pred HHHhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccC--CCceeeEEEEE
Q 046609 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLS--NPYLVNLVGYC 145 (399)
Q Consensus 74 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--hpnIv~l~~~~ 145 (399)
.....++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++++++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 334467899999999999999999999999999999999754322 2245677999999996 59999999999
Q ss_pred eeCCeeEEEEEecCC-CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCee
Q 046609 146 VDGDQRILVYEYMPN-GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNPK 223 (399)
Q Consensus 146 ~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~k 223 (399)
.+.+..++|||++.+ ++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+|||++ .++.+|
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~k 190 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEE
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEE
Confidence 999999999999976 899999976 457999999999999999999999999 99999999999999 789999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
|+|||++....... .....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||..... .
T Consensus 191 L~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~------ 255 (320)
T 3a99_A 191 LIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I------ 255 (320)
T ss_dssp ECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------
T ss_pred EeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h------
Confidence 99999997643321 223569999999999887766 6789999999999999999999975311 0
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... ... +...+..+.+++.+||+.||.+|||+.+|+++
T Consensus 256 -~~~~--------~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 256 -IRGQ--------VFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp -HHCC--------CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -hccc--------ccc----cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 001 11233478899999999999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.57 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=194.4
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHcc----CCCceeeEEEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSML----SNPYLVNLVGYC 145 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~hpnIv~l~~~~ 145 (399)
...++|.+.+.||+|+||.||+|.+..+++.||||++...... ....+.+|+.++.++ +||||+++++++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 3457899999999999999999999888999999999755332 223356788999888 899999999999
Q ss_pred eeCCeeEEEEEe-cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCee
Q 046609 146 VDGDQRILVYEY-MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNPK 223 (399)
Q Consensus 146 ~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~k 223 (399)
.+.+..++|||+ +.+++|.+++.. ...+++..++.++.|++.||.|||+.+ |+||||||+||+++ .++.+|
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 180 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAK 180 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEE
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEE
Confidence 999999999999 789999999986 456999999999999999999999999 99999999999999 889999
Q ss_pred EecccCccCCCCCCCccccccccccccccccccccCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT-AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
|+|||++....... .....|+..|+|||++.+..+. .++||||||+++|+|++|+.||..... .
T Consensus 181 l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~------ 245 (312)
T 2iwi_A 181 LIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----I------ 245 (312)
T ss_dssp ECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H------
T ss_pred EEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----H------
Confidence 99999997644322 2335689999999998877665 489999999999999999999975211 0
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... ...+......+.+++.+||+.||.+|||+.+++++
T Consensus 246 -~~~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 246 -LEAE------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HHTC------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -hhhc------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 01122334578899999999999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=323.62 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=182.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-h-HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-N-REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~-~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... . ..+..+..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 457888899999999999999999889999999997654322 2 22344455778889999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
||+ ++.+..+... ....+++..++.++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5555555543 245699999999999999999999995 8 9999999999999999999999999987543
Q ss_pred CCCCcccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
... ......|++.|+|||++. +..++.++||||||+++|+|++|+.||........ .. .......
T Consensus 177 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~---~~~~~~~-- 246 (318)
T 2dyl_A 177 DDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VL---TKVLQEE-- 246 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HH---HHHHHSC--
T ss_pred CCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HH---HHHhccC--
Confidence 322 223356899999999984 46788999999999999999999999986432211 11 1111110
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.+.. ....+..+.+++.+||+.||.+||++.+++++
T Consensus 247 -----~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 247 -----PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -----CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -----CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011100 11233478899999999999999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=312.58 Aligned_cols=236 Identities=15% Similarity=0.121 Sum_probs=188.2
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.++.+++||||+++++++.+++..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 367999999999999999999999999999999997654332 26688999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||++|++|.+++.. + .....+..++.|++.||.|||+++ |+||||||+|||++.+|.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------ 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------ 174 (286)
T ss_dssp EECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred EEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------
Confidence 999999999999954 2 356678899999999999999999 9999999999999999999998543
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
|++ .++.++|||||||++|+|++|+.||............. ...........
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~~~~~~-- 226 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQPIEPA-- 226 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSCBCCHH--
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccCCCChh--
Confidence 222 36889999999999999999999999765432110000 00000000000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
......+..+.+++.+||+.||.+| |+.++++.|+.+.....
T Consensus 227 ------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 227 ------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp ------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred ------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0011233468899999999999999 99999999999876554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=332.82 Aligned_cols=254 Identities=22% Similarity=0.258 Sum_probs=187.0
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEEec
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
.|.+.++||+|+||+||.+.. .+++.||||++... ..+.+.+|+.++.++ +||||+++++++.+++..++||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 345568899999999987644 35899999998653 235678899999876 8999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCC---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC-------------CCe
Q 046609 159 PNGSLEDHLLDLPPNRKA---LDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD-------------FNP 222 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~-------------~~~ 222 (399)
. |+|.+++......... .++..++.++.||+.||.|||+.+ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999863221111 133356789999999999999999 9999999999999754 479
Q ss_pred eEecccCccCCCCCCCcc--ccccccccccccccccccC-------CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcc
Q 046609 223 KLSDFGLAKLGPTGDKSH--VSTRVMGTYGYCAPEYALT-------GQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTE 292 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-------~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~ 292 (399)
||+|||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 999999998654432211 1234579999999999865 678999999999999999999 999997644321
Q ss_pred cchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 293 EQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
. ... ... .. .+..........+..+.+++.+||+.||.+|||+.+|+++
T Consensus 248 ~-~i~---~~~----~~-----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 296 (434)
T 2rio_A 248 S-NII---RGI----FS-----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH 296 (434)
T ss_dssp H-HHH---HTC----CC-----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred H-HHh---cCC----CC-----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence 1 111 000 00 0111112244566789999999999999999999999863
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=343.79 Aligned_cols=275 Identities=24% Similarity=0.282 Sum_probs=210.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEee------CCe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVD------GDQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~~ 150 (399)
.++|.+.+.||.|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 3689999999999999999999998999999999875422 234568899999999999999999999765 677
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCC---eeEecc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFN---PKLSDF 227 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~---~kl~Df 227 (399)
.++||||++||+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF 168 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL 168 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence 899999999999999998733 2346899999999999999999999999 999999999999997765 899999
Q ss_pred cCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc-
Q 046609 228 GLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD- 306 (399)
Q Consensus 228 g~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~- 306 (399)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||....... .|.......
T Consensus 169 G~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~ 240 (676)
T 3qa8_A 169 GYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKS 240 (676)
T ss_dssp CCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC---
T ss_pred cccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhccc
Confidence 9998654332 2234579999999999999999999999999999999999999997642110 010000000
Q ss_pred ----------cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHH-----HHHHHHHhhhcccc
Q 046609 307 ----------RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSD-----VVTAIEYLAHSKEE 364 (399)
Q Consensus 307 ----------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e-----il~~L~~l~~~~~~ 364 (399)
....................+..+.+++.+||..||.+|||+.+ +.+.++.+......
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~kil 313 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLL 313 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCCEE
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcccc
Confidence 00000000001112345567789999999999999999999988 56677777766543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.44 Aligned_cols=251 Identities=24% Similarity=0.289 Sum_probs=186.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
..+|.+.++||+|+||.|+.... .+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 34688889999999998664333 3588999999975432 2356799999999 79999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-----CCCeeEecccCcc
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-----DFNPKLSDFGLAK 231 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-----~~~~kl~Dfg~~~ 231 (399)
|+. |+|.+++... ...+++..++.++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||++.
T Consensus 99 ~~~-g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~ 171 (432)
T 3p23_A 99 LCA-ATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171 (432)
T ss_dssp CCS-EEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEE
T ss_pred CCC-CCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEeccccee
Confidence 995 6999999863 334555567889999999999999999 999999999999953 2357899999998
Q ss_pred CCCCCCCc-ccccccccccccccccccc---CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 232 LGPTGDKS-HVSTRVMGTYGYCAPEYAL---TGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 232 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~---~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........ .......||+.|+|||++. +..++.++|||||||++|+|++ |..||........... ...
T Consensus 172 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~-------~~~ 244 (432)
T 3p23_A 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL-------LGA 244 (432)
T ss_dssp CC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH-------TTC
T ss_pred eccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH-------hcc
Confidence 65433211 2233467999999999987 4567889999999999999999 9999965432211000 000
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... .. ..........+.+|+.+||+.||.+|||+.+|+++
T Consensus 245 -~~~-----~~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h 284 (432)
T 3p23_A 245 -CSL-----DC--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284 (432)
T ss_dssp -CCC-----TT--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -CCc-----cc--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence 000 00 01122345567899999999999999999999853
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=308.54 Aligned_cols=228 Identities=20% Similarity=0.258 Sum_probs=181.3
Q ss_pred CCCCCC-CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHH-HccCCCceeeEEEEEee----CCeeE
Q 046609 79 TNFNPD-NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLML-SMLSNPYLVNLVGYCVD----GDQRI 152 (399)
Q Consensus 79 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~hpnIv~l~~~~~~----~~~~~ 152 (399)
++|.+. ++||+|+||.||+|.+..+++.||||++.. ...+.+|+.++ +..+||||+++++++.. ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 456666 789999999999999999999999999864 35677788887 56689999999999987 67789
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEecccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFGL 229 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~ 229 (399)
+||||+++|+|.+++... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999873 2346999999999999999999999999 999999999999998 78899999998
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
+... .+..++.++|||||||++|+|++|+.||............
T Consensus 167 a~~~------------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~------------ 210 (299)
T 3m2w_A 167 AKET------------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM------------ 210 (299)
T ss_dssp CEEC------------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS------------
T ss_pred cccc------------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH------------
Confidence 8532 1345778999999999999999999999765432210000
Q ss_pred hhhccCCccCCCCC----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPLLEGNYP----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~l~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+... ....+ ...+..+.+++.+||+.||.+|||+.+++++
T Consensus 211 ~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 211 KTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0000000 00111 1234578899999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=326.63 Aligned_cols=245 Identities=16% Similarity=0.162 Sum_probs=183.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc---chHHHHHHHHHHHccCC-Cce---------e-----
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ---GNREFLVEVLMLSMLSN-PYL---------V----- 139 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h-pnI---------v----- 139 (399)
..+|...++||+|+||.||+|.+..+++.||||++...... ..+.+.+|+.+++.++| +|. +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 34577778999999999999999999999999998743322 24678899999999976 211 1
Q ss_pred -------eEEEEEee-----CCeeEEEEEecCCCChHHhhccC---CCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 046609 140 -------NLVGYCVD-----GDQRILVYEYMPNGSLEDHLLDL---PPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204 (399)
Q Consensus 140 -------~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~i 204 (399)
.++.++.. ....+++|+++ +++|.+++... ......+++..++.++.|++.||.|||+++ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111111 12356777776 78999988521 123456888999999999999999999999 9
Q ss_pred EecCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccc----------cCCCCCchhhHHHHHHH
Q 046609 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA----------LTGQLTAKSDVYSFGVV 274 (399)
Q Consensus 205 vH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~~DvwslG~i 274 (399)
+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 99999999999999999999999998753221 334567 999999998 55568899999999999
Q ss_pred HHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 275 FLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 275 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
+|+|++|+.||........... +... ...+ +..+.+|+.+||+.||.+||++.+++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~~~----------------~~~~--~~~~----~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGSEW----------------IFRS--CKNI----PQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCSGG----------------GGSS--CCCC----CHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhhHHH----------------HHhh--cccC----CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999987543221110 0110 0112 2578899999999999999998877654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=341.67 Aligned_cols=242 Identities=19% Similarity=0.290 Sum_probs=194.7
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECC-CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe-----
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEG-TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ----- 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~----- 150 (399)
.++|.+.+.||+|+||.||+|.+.. +++.||||++..... .....+.+|+.++.+++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 4789999999999999999999975 689999999865432 233567899999999999999999999987665
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.++||||++|++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999887643 6999999999999999999999999 9999999999999886 9999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
...... ....||+.|+|||++.++. +.++|||||||++|+|++|.+||.........
T Consensus 229 ~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~---------------- 285 (681)
T 2pzi_A 229 SRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP---------------- 285 (681)
T ss_dssp EETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC----------------
T ss_pred hhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc----------------
Confidence 764332 3356999999999887654 88999999999999999999988753211000
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHHHHhhh
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-MMSDVVTAIEYLAH 360 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~l~~ 360 (399)
...........+.+++.+||+.||.+|| +++++...|..+..
T Consensus 286 --------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 328 (681)
T 2pzi_A 286 --------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR 328 (681)
T ss_dssp --------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred --------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence 0000112235688999999999999999 56667666766543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-40 Score=308.61 Aligned_cols=242 Identities=18% Similarity=0.136 Sum_probs=184.4
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--------cchHHHHHHHHHHHccC---------CCceee
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--------QGNREFLVEVLMLSMLS---------NPYLVN 140 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---------hpnIv~ 140 (399)
.++|.+.+.||+|+||.||+|++ +++.||||++..... ...+.+.+|+.+++.++ ||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 45788899999999999999998 479999999976532 22367889999998885 888888
Q ss_pred EEEEEe------------------------------eCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 046609 141 LVGYCV------------------------------DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190 (399)
Q Consensus 141 l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~ 190 (399)
+.+++. +.+..++||||+++|++.+.+.. ..+++..++.++.||+
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence 877643 26789999999999987777743 4689999999999999
Q ss_pred HHHHHHh-hcCCCCeEecCCCCCceEECCCC--------------------CeeEecccCccCCCCCCCccccccccccc
Q 046609 191 RGLEYLH-ESAQPPVIYRDFKASNVLLDQDF--------------------NPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249 (399)
Q Consensus 191 ~~l~~LH-~~~~~~ivH~dikp~NIll~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~ 249 (399)
.||.||| +.+ |+||||||+|||++.++ .+||+|||+++.... ....||+
T Consensus 172 ~aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~ 241 (336)
T 2vuw_A 172 ASLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCD 241 (336)
T ss_dssp HHHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCC
T ss_pred HHHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEee
Confidence 9999999 999 99999999999999887 899999999985432 1346999
Q ss_pred cccccccccCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHH
Q 046609 250 GYCAPEYALTGQLTAKSDVYSFGVV-FLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLY 328 (399)
Q Consensus 250 ~y~aPE~~~~~~~~~~~DvwslG~i-l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 328 (399)
.|+|||++.+.. +.++||||||++ .+++++|..||.... ............ . ..............+.
T Consensus 242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~-----~~~~~~~~~~~~-~----~~~~~~~~~~~~~~s~ 310 (336)
T 2vuw_A 242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL-----WLHYLTDKMLKQ-M----TFKTKCNTPAMKQIKR 310 (336)
T ss_dssp CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH-----HHHHHHHHHHHT-C----CCSSCCCSHHHHHHHH
T ss_pred cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh-----hhhHHHHhhhhh-h----ccCcccchhhhhhcCH
Confidence 999999988666 889999998777 777888998885310 000000000000 0 0001111112345677
Q ss_pred HHHHHHhhccccCCCCCCChHHHH
Q 046609 329 QALAVAAMCLQEEAGTRPMMSDVV 352 (399)
Q Consensus 329 ~l~~li~~cl~~dp~~RPs~~eil 352 (399)
.+.+|+.+||+.| |+.+++
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHH
Confidence 8999999999976 898887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.5e-33 Score=282.76 Aligned_cols=186 Identities=18% Similarity=0.090 Sum_probs=132.7
Q ss_pred eccCCcEEEEEEEECCCCeEEEEEEEccCCC----------cchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEEE
Q 046609 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF----------QGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 87 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++.|++|.+..++....++.+++|.+..... ...+++.+|+.+|+++ .|+||+++++++++++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 5666777666666666788899999975422 1225588999999999 6999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++|++|.++|.. .++++.. .|+.||+.||.|||++| ||||||||+|||++.+|.+||+|||+++....
T Consensus 322 Eyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 322 EKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp ECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred ecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 99999999999987 4567654 48899999999999999 99999999999999999999999999986433
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVI 285 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf 285 (399)
.. ......+||+.|+|||++.+ .+..++|+||+|+++++|.++..++
T Consensus 392 ~~--~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 392 DC--SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CC--ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 22 23344679999999998865 4677899999999998877665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-29 Score=249.89 Aligned_cols=186 Identities=20% Similarity=0.264 Sum_probs=144.8
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc--------hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG--------NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--------~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
...++||+|+||.||+|... +..+++|......... .+.+.+|+.++++++||||+++..++...+..++
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 34578999999999999544 6788999875432221 2347899999999999999965555557778899
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||++|++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++..
T Consensus 417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 9999999999999964 4689999999999999999 999999999999998 9999999999865
Q ss_pred CCCCCcc-----ccccccccccccccccccC--CCCCchhhHHHHHHHHHHHHcCCCCCC
Q 046609 234 PTGDKSH-----VSTRVMGTYGYCAPEYALT--GQLTAKSDVYSFGVVFLEIITGRRVID 286 (399)
Q Consensus 234 ~~~~~~~-----~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~elltg~~pf~ 286 (399)
....... ......||+.|+|||++.. ..|+..+|+|+..+-..+.+.++.+|.
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 4322111 1234679999999999876 678888999999999998888776664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.4e-26 Score=207.51 Aligned_cols=148 Identities=14% Similarity=0.032 Sum_probs=117.9
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------------------chHHHHHHHHHHHccCCCc
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------------------GNREFLVEVLMLSMLSNPY 137 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~hpn 137 (399)
.....|.+.+.||+|+||.||+|.+ .+++.||||.+...... ....+.+|+.++++++|
T Consensus 87 ~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~-- 163 (282)
T 1zar_A 87 RSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG-- 163 (282)
T ss_dssp HTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT--
T ss_pred hCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC--
Confidence 3445566679999999999999999 77999999999643211 23458899999999984
Q ss_pred eeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC
Q 046609 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD 217 (399)
Q Consensus 138 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~ 217 (399)
+++.+++.. +..++||||++||+|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++
T Consensus 164 -~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 -LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp -SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred -CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 555554433 56699999999999988 422 124579999999999999999 99999999999999
Q ss_pred CCCCeeEecccCccCCCCCCCcccccccccccccccccccc
Q 046609 218 QDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258 (399)
Q Consensus 218 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~ 258 (399)
++.+||+|||+++ .+..+.|||++.
T Consensus 228 -~~~vkl~DFG~a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSV---------------EVGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCE---------------ETTSTTHHHHHH
T ss_pred -CCcEEEEECCCCe---------------ECCCCCHHHHHH
Confidence 9999999999986 344578888764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1e-21 Score=177.76 Aligned_cols=136 Identities=15% Similarity=0.072 Sum_probs=106.5
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeE--EEEEEEccCCCcc------------------------hHHHHHHHHHHHccC
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQD--VAVKQLDRNGFQG------------------------NREFLVEVLMLSMLS 134 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~~~~------------------------~~~~~~e~~~l~~l~ 134 (399)
|.+.+.||+|+||.||+|.+..++.. ||||++....... ...+.+|+.++..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998666888 9999975432110 125788999999998
Q ss_pred CCce--eeEEEEEeeCCeeEEEEEecCC-C----ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEe
Q 046609 135 NPYL--VNLVGYCVDGDQRILVYEYMPN-G----SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH-ESAQPPVIY 206 (399)
Q Consensus 135 hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH-~~~~~~ivH 206 (399)
|+++ +.++.. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 8754 444443 356899999942 4 66665433 234567889999999999999 999 999
Q ss_pred cCCCCCceEECCCCCeeEecccCccC
Q 046609 207 RDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 207 ~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|||||+|||++. .++|+|||+|..
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEE
T ss_pred CCCCHHHEEEcC--cEEEEECccccc
Confidence 999999999998 999999999964
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=7.5e-18 Score=158.81 Aligned_cols=136 Identities=11% Similarity=0.099 Sum_probs=100.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--------------chH--------HHHHHHHHHHccCCC
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--------------GNR--------EFLVEVLMLSMLSNP 136 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------~~~--------~~~~e~~~l~~l~hp 136 (399)
.=|.+...||.|++|.||+|.+. +|+.||||+++..... ... ...+|...|.++.+.
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~ 173 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE 173 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence 34888999999999999999986 5899999998532100 000 123466777777655
Q ss_pred cee--eEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 046609 137 YLV--NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214 (399)
Q Consensus 137 nIv--~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NI 214 (399)
++. ..++.. ..+|||||++|++|..+... .....++.|++.+|.+||..| ||||||||.||
T Consensus 174 gv~vp~p~~~~----~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NI 236 (397)
T 4gyi_A 174 GFPVPEPIAQS----RHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNI 236 (397)
T ss_dssp TCSCCCEEEEE----TTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSE
T ss_pred CCCCCeeeecc----CceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHE
Confidence 443 333322 23799999998888655421 123568899999999999999 99999999999
Q ss_pred EECCCCC----------eeEecccCccC
Q 046609 215 LLDQDFN----------PKLSDFGLAKL 232 (399)
Q Consensus 215 ll~~~~~----------~kl~Dfg~~~~ 232 (399)
|++.+|. +.|+||+-+..
T Consensus 237 Ll~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 237 LIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred EEeCCCCcccccccccceEEEEeCCccc
Confidence 9988773 89999987653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=3.1e-13 Score=122.02 Aligned_cols=143 Identities=14% Similarity=0.053 Sum_probs=111.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e 156 (399)
...|.+...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+.++++++.+.+..++|||
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e 90 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence 356777788899999999999754 5789999987532233346888999999885 6778899999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA------------------------------------ 200 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~------------------------------------ 200 (399)
|++|.+|.+.+.. ......++.+++.+|..||+..
T Consensus 91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 9999999876421 1123467889999999999811
Q ss_pred --------------------CCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 201 --------------------QPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 201 --------------------~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
...++|+|++|.||+++.+..+.|+||+.+.
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1339999999999999876566799998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.27 E-value=1e-11 Score=111.59 Aligned_cols=136 Identities=15% Similarity=0.072 Sum_probs=99.1
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc--eeeEEEEEeeCCeeEEEEEe
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY--LVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~ 157 (399)
++.+..+.+.|..+.||++... ++..+++|..... ....+..|+.+++.+.+.+ +.+++++...++..++||||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~ 96 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE 96 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred CCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence 3444333346667999999654 4677999997654 2245778999998886544 56688888888889999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA------------------------------------- 200 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~------------------------------------- 200 (399)
++|.+|. ... .. ...++.+++..|..||+..
T Consensus 97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 9998884 221 11 1356777888888888643
Q ss_pred ------------------CCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 201 ------------------QPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 201 ------------------~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
...++|+|++|.||+++.++.+.|+||+.+.
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999877667799999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=7.3e-11 Score=111.49 Aligned_cols=141 Identities=13% Similarity=0.211 Sum_probs=106.2
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEc--cCCC-cchHHHHHHHHHHHccC--CCceeeEEEEEeeC---CeeEEEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLD--RNGF-QGNREFLVEVLMLSMLS--NPYLVNLVGYCVDG---DQRILVY 155 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~-~~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~---~~~~lv~ 155 (399)
.+.|+.|.++.||++... +..+++|+.. .... .....+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 43 ~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred EEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 467899999999998865 3578888875 3221 22356788999999887 45688899998776 4589999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA----------------------------------- 200 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~----------------------------------- 200 (399)
||++|..+.+.. -..++......++.+++.+|..||...
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999988775422 124788888999999999999999731
Q ss_pred --------------------CCCeEecCCCCCceEECCCCC--eeEecccCccC
Q 046609 201 --------------------QPPVIYRDFKASNVLLDQDFN--PKLSDFGLAKL 232 (399)
Q Consensus 201 --------------------~~~ivH~dikp~NIll~~~~~--~kl~Dfg~~~~ 232 (399)
...++|+|++|.||+++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 134999999999999997754 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=2.7e-11 Score=111.73 Aligned_cols=188 Identities=20% Similarity=0.214 Sum_probs=122.8
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCc--eeeEEEEEeeCC---eeEEEEEe
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPY--LVNLVGYCVDGD---QRILVYEY 157 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpn--Iv~l~~~~~~~~---~~~lv~e~ 157 (399)
.+.++.|....||++. ..+++|+.... .....+.+|..+++.+. +.. +.+++......+ ..|+||++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4669999999999863 45889986532 23456888999998874 332 455555544333 34889999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA------------------------------------- 200 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~------------------------------------- 200 (399)
++|.+|...... .++..+...++.+++..+..||+..
T Consensus 98 i~G~~l~~~~~~------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 98 IKGVPLTPLLLN------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp CCCEECCHHHHH------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cCCeECCccccc------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 999888754322 3778888889999999999998621
Q ss_pred ------------------CCCeEecCCCCCceEECC--CCCeeEecccCccCCCCCCCcccccc------------cccc
Q 046609 201 ------------------QPPVIYRDFKASNVLLDQ--DFNPKLSDFGLAKLGPTGDKSHVSTR------------VMGT 248 (399)
Q Consensus 201 ------------------~~~ivH~dikp~NIll~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~------------~~g~ 248 (399)
.+.++|+|++|.||+++. +..+.|+||+.+.............. ....
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~ 251 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNH 251 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHH
Confidence 134899999999999998 45678999998864221100000000 0000
Q ss_pred ccccc-cccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 046609 249 YGYCA-PEYALTGQLTAKSDVYSFGVVFLEIITGRRVID 286 (399)
Q Consensus 249 ~~y~a-PE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 286 (399)
..... |+... ......+.|++|.++|.+.+|..+|-
T Consensus 252 Y~~~~~~~~~~--r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 252 YKHKDIPTVLE--KYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HTCSCHHHHHH--HHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred cCCCCcHHHHH--HHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 01111 22110 01123689999999999999987664
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.66 E-value=1.5e-07 Score=84.72 Aligned_cols=134 Identities=19% Similarity=0.142 Sum_probs=98.9
Q ss_pred eccCCcE-EEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEEecCCCChH
Q 046609 87 LGEGGFG-RVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYEYMPNGSLE 164 (399)
Q Consensus 87 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~ 164 (399)
+..|..| .||+......+..+++|.-... ....+..|...|+.+. +--+.+++.++.+.+..++|||+++|.++.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~ 108 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAF 108 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcccc
Confidence 4445444 6898887766778999986532 3456788999988875 334778899999999999999999998887
Q ss_pred HhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 046609 165 DHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ------------------------------------------- 201 (399)
Q Consensus 165 ~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~------------------------------------------- 201 (399)
+..... ......+..+++..|..||....
T Consensus 109 ~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 109 QVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 765431 12334566677777777775320
Q ss_pred ------------CCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 202 ------------PPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 202 ------------~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
..++|+|+.+.||+++.++.+-|+||+.+.
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 138999999999999987777799998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.64 E-value=2.4e-07 Score=85.21 Aligned_cols=135 Identities=20% Similarity=0.194 Sum_probs=96.5
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC---ceeeEEEEEe-eCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP---YLVNLVGYCV-DGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~e~~~~ 160 (399)
+.++.|....||+. +..+++|+.... .....+..|..+++.+.+. .+.+++.+.. ..+..++||||++|
T Consensus 25 ~~l~~G~~n~v~~v-----g~~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 25 ESLGEGFRNYAILV-----NGDWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEECSSEEEEEE-----TTTEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eecCCCcceeEEEE-----CCEEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 56888999999988 356888985321 2345688899999998752 3666777764 45567899999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA---------------------------------------- 200 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---------------------------------------- 200 (399)
.+|...... .++......++.++...|..||+..
T Consensus 98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 888764321 2455666666666666666666432
Q ss_pred -----------------CCCeEecCCCCCceEECC---CCCe-eEecccCccC
Q 046609 201 -----------------QPPVIYRDFKASNVLLDQ---DFNP-KLSDFGLAKL 232 (399)
Q Consensus 201 -----------------~~~ivH~dikp~NIll~~---~~~~-kl~Dfg~~~~ 232 (399)
.+.++|+|++|.||+++. ++.+ .|+||+.+..
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 224799999999999987 4554 7999997753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=6.9e-07 Score=83.90 Aligned_cols=81 Identities=6% Similarity=0.011 Sum_probs=56.0
Q ss_pred Cee-ccCCcEEEEEEEEC---C---CCeEEEEEEEccCC---CcchHHHHHHHHHHHccCC---CceeeEEEEEeeC---
Q 046609 85 NLL-GEGGFGRVYRGKLE---G---TNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSN---PYLVNLVGYCVDG--- 148 (399)
Q Consensus 85 ~~l-g~G~~g~V~~~~~~---~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h---pnIv~l~~~~~~~--- 148 (399)
+.| +.|....+|+.... + ++..+++|...... ......+..|+.+++.+.. -.+.+++.++.+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 88888999988653 1 15678888865432 1112457778888888752 3577888887665
Q ss_pred CeeEEEEEecCCCChHH
Q 046609 149 DQRILVYEYMPNGSLED 165 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~ 165 (399)
+..++||||++|.++.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999998877653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3.1e-06 Score=80.72 Aligned_cols=76 Identities=14% Similarity=0.103 Sum_probs=49.6
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-------cchHHHHHHHHHHHccCC--Cc-eeeEEEEEeeCCeeEE
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-------QGNREFLVEVLMLSMLSN--PY-LVNLVGYCVDGDQRIL 153 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--pn-Iv~l~~~~~~~~~~~l 153 (399)
.+.||.|..+.||++....++..++||....... .....+..|..+++.+.. |. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 3679999999999997665567899998653211 123456778888887742 43 4455544 3455689
Q ss_pred EEEecCCC
Q 046609 154 VYEYMPNG 161 (399)
Q Consensus 154 v~e~~~~g 161 (399)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.16 E-value=1.6e-05 Score=73.81 Aligned_cols=141 Identities=16% Similarity=0.295 Sum_probs=78.0
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC--CceeeEEE------EEeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN--PYLVNLVG------YCVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~------~~~~~~~~~lv~e 156 (399)
+.|+.|..+.||++... +..+++|+.... ...+..|..++..+.. -.+.+++. +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEET--TEEEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeC--CCCEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666778899998865 345899998752 2334445555554431 12333332 1234667899999
Q ss_pred ecCCCChH--------------Hhhcc----C--CCCC----CCCCHHH-------------------------------
Q 046609 157 YMPNGSLE--------------DHLLD----L--PPNR----KALDWNT------------------------------- 181 (399)
Q Consensus 157 ~~~~g~L~--------------~~l~~----~--~~~~----~~l~~~~------------------------------- 181 (399)
|++|.++. ..++. . +... ..-.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99886542 11111 1 0000 0011211
Q ss_pred HHHHHHHHHHHHHHHhh--------c--CCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 182 RMKIAHGAARGLEYLHE--------S--AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 182 ~~~i~~ql~~~l~~LH~--------~--~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
...+..++..++.+|+. . ....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 01111223345666653 1 13349999999999999888899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.04 E-value=3.2e-05 Score=71.03 Aligned_cols=139 Identities=16% Similarity=0.178 Sum_probs=91.1
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC---CCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS---NPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
.+.|+.|....+|+.... +..+++|..... ....+..|...|+.+. ...+++++.+....+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 367899999999998753 567889987643 2456788988888874 36788899998888889999999998
Q ss_pred CChHH-----------hhccCCC-C-----------------CCCCCHHHHH---HHH----------------HHHHHH
Q 046609 161 GSLED-----------HLLDLPP-N-----------------RKALDWNTRM---KIA----------------HGAARG 192 (399)
Q Consensus 161 g~L~~-----------~l~~~~~-~-----------------~~~l~~~~~~---~i~----------------~ql~~~ 192 (399)
..+.. .|+.... . ...-+|.... ++. ..++..
T Consensus 116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~ 195 (312)
T 3jr1_A 116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI 195 (312)
T ss_dssp CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence 76521 2222211 0 0011343221 111 112222
Q ss_pred H-HHHhh-cCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 193 L-EYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 193 l-~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
+ ..|.. ...+.++|+|+.+.|++++.++ +.|+||.
T Consensus 196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 2 23432 1245599999999999999887 8898974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.84 E-value=6.1e-05 Score=68.28 Aligned_cols=78 Identities=21% Similarity=0.212 Sum_probs=55.6
Q ss_pred CCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC---CceeeEEEEEeeCCeeEEEEEe
Q 046609 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN---PYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 81 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---pnIv~l~~~~~~~~~~~lv~e~ 157 (399)
..-...+|.|..+.||+....+ |+.|++|+...........+..|...|+.+.. -.+.+++++. ..++||||
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~D-G~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELAD-GTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETT-SCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred eEEEEecCCCCCeEEEEEEECC-CCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 3345779999999999999874 78899998765443334557889999988853 2355555542 34789999
Q ss_pred cCCCCh
Q 046609 158 MPNGSL 163 (399)
Q Consensus 158 ~~~g~L 163 (399)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 977653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=8.1e-05 Score=71.42 Aligned_cols=77 Identities=17% Similarity=0.156 Sum_probs=47.4
Q ss_pred CCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCcccccccc--ccccccccccccCC---CCCchhhHHHHHHHHH
Q 046609 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVM--GTYGYCAPEYALTG---QLTAKSDVYSFGVVFL 276 (399)
Q Consensus 202 ~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~---~~~~~~DvwslG~il~ 276 (399)
+.++|+|++|.|||++.++ +.|+||+.+...... ....... -...|.+|+..... .-....++.+....+|
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 3499999999999998876 999999988642211 1111111 12356676654311 1112345567888888
Q ss_pred HHHcCC
Q 046609 277 EIITGR 282 (399)
Q Consensus 277 elltg~ 282 (399)
+.+.+.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877653
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00025 Score=60.60 Aligned_cols=99 Identities=15% Similarity=0.087 Sum_probs=66.1
Q ss_pred ChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCccc
Q 046609 162 SLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV 241 (399)
Q Consensus 162 ~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 241 (399)
+|.+.|+. .+.+++++++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.+.+.+ +.+.
T Consensus 34 SL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 34 SLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred cHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 78888887 46889999999999999998877622111 12334567999999999998764 1111
Q ss_pred cccccccccccccccccCCCCCchhhHHHHHHHHHHHHcC
Q 046609 242 STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITG 281 (399)
Q Consensus 242 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg 281 (399)
.....+.|||... ...+.+.=|||||+++|.-+--
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDy 132 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDY 132 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTT
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhc
Confidence 1233467888652 4456788999999999998863
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00021 Score=65.17 Aligned_cols=71 Identities=10% Similarity=0.042 Sum_probs=44.8
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCce-eeEEEEEeeCCeeEEEEEec-CCC
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL-VNLVGYCVDGDQRILVYEYM-PNG 161 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~-~~g 161 (399)
.+.|+.|....+|++ ..+++|+....... ......|+.+++.+...++ .++++.. .+.-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 578999999999998 34889988653211 1223457777777653222 4555543 33457899999 665
Q ss_pred Ch
Q 046609 162 SL 163 (399)
Q Consensus 162 ~L 163 (399)
+|
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 54
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00056 Score=66.13 Aligned_cols=75 Identities=11% Similarity=0.038 Sum_probs=48.8
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCce-eeEEEEEeeCCeeEEEEEecCCCC
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL-VNLVGYCVDGDQRILVYEYMPNGS 162 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~ 162 (399)
.+.|+.|-...+|++...+.+..+++|+..... ...-....|..++..+...++ .++++.+. + .+|+||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 346888888999999876545788999885432 111122578888888875444 56777663 2 35999998755
Q ss_pred h
Q 046609 163 L 163 (399)
Q Consensus 163 L 163 (399)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00024 Score=68.32 Aligned_cols=74 Identities=16% Similarity=0.212 Sum_probs=50.3
Q ss_pred CCeeccCCcEEEEEEEECC-------CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc-eeeEEEEEeeCCeeEEEE
Q 046609 84 DNLLGEGGFGRVYRGKLEG-------TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY-LVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~ 155 (399)
.+.|+.|....+|++...+ .+..+++|+.... .....+..|..+++.+...+ ..++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888889999998753 2567899998432 11145667888888875333 3567766542 3899
Q ss_pred EecCCCCh
Q 046609 156 EYMPNGSL 163 (399)
Q Consensus 156 e~~~~g~L 163 (399)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99976444
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.0003 Score=66.28 Aligned_cols=142 Identities=18% Similarity=0.247 Sum_probs=82.5
Q ss_pred CeeccCCcEEEEEEEECC-------CCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEG-------TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+.|..|-...+|++.... ++..+++|+.... ........+|..+++.+. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 567778788899988642 3467889986432 223456678999888875 3333566766643 29999
Q ss_pred ecCCCChHHh-----------------hccCC-CCCCCC--CHHHHHHHHHHHHH-------------------HHHHH-
Q 046609 157 YMPNGSLEDH-----------------LLDLP-PNRKAL--DWNTRMKIAHGAAR-------------------GLEYL- 196 (399)
Q Consensus 157 ~~~~g~L~~~-----------------l~~~~-~~~~~l--~~~~~~~i~~ql~~-------------------~l~~L- 196 (399)
|++|.+|..- |+... ...... -+.++..++.++.. .+..|
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9987655311 11111 111112 23455555544322 12222
Q ss_pred ---hhcC-CCCeEecCCCCCceEECCC----CCeeEecccCcc
Q 046609 197 ---HESA-QPPVIYRDFKASNVLLDQD----FNPKLSDFGLAK 231 (399)
Q Consensus 197 ---H~~~-~~~ivH~dikp~NIll~~~----~~~kl~Dfg~~~ 231 (399)
.... ...++|+|+.+.||+++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 2221 2349999999999999876 789999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00098 Score=61.14 Aligned_cols=143 Identities=14% Similarity=0.127 Sum_probs=76.7
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc--eeeEEEE------EeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY--LVNLVGY------CVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~e 156 (399)
+.|+.|....+|+....+ + .+++|..... .....+..|..++..+...+ +.+++.. ....+..+++++
T Consensus 28 ~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~ 103 (322)
T 2ppq_A 28 KGIAEGVENSNFLLHTTK-D-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 103 (322)
T ss_dssp EEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred eccCCCcccceEEEEeCC-c-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence 457778888999988653 3 6889998753 12234556777776664212 2333321 122456789999
Q ss_pred ecCCCChHH--------------hhc----cCCCCC-CCCC---HHHHHH------------HHHHHHHHHHHHhhc---
Q 046609 157 YMPNGSLED--------------HLL----DLPPNR-KALD---WNTRMK------------IAHGAARGLEYLHES--- 199 (399)
Q Consensus 157 ~~~~g~L~~--------------~l~----~~~~~~-~~l~---~~~~~~------------i~~ql~~~l~~LH~~--- 199 (399)
|++|..+.. .++ ...... .... |..... +...+...+..+...
T Consensus 104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~ 183 (322)
T 2ppq_A 104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 183 (322)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence 998865321 011 111000 0011 111000 001133445555432
Q ss_pred -CCCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 200 -AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 200 -~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
....++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 12349999999999999887666899998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.002 Score=59.35 Aligned_cols=31 Identities=35% Similarity=0.380 Sum_probs=26.7
Q ss_pred CCeEecCCCCCceEECCC----CCeeEecccCccC
Q 046609 202 PPVIYRDFKASNVLLDQD----FNPKLSDFGLAKL 232 (399)
Q Consensus 202 ~~ivH~dikp~NIll~~~----~~~kl~Dfg~~~~ 232 (399)
..++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 349999999999999875 6789999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.0014 Score=60.27 Aligned_cols=143 Identities=17% Similarity=0.114 Sum_probs=79.3
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCC--ceeeEEEE-----EeeCCeeEEEEEe
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNP--YLVNLVGY-----CVDGDQRILVYEY 157 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hp--nIv~l~~~-----~~~~~~~~lv~e~ 157 (399)
..|+ |....||++... +++.+++|...... .....+..|..++..+... .+++++.. ...++..+++|++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 4566 778889987654 35679999986432 2345566788777776422 23444432 1224566889999
Q ss_pred cCCCChH------------------HhhccCCC-CCCCCCHHHH----------------------HHHHHHHHHHHHHH
Q 046609 158 MPNGSLE------------------DHLLDLPP-NRKALDWNTR----------------------MKIAHGAARGLEYL 196 (399)
Q Consensus 158 ~~~g~L~------------------~~l~~~~~-~~~~l~~~~~----------------------~~i~~ql~~~l~~L 196 (399)
++|.++. ........ ....++.... ...+..++..+.-+
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9875432 01111100 0111222111 11122222222222
Q ss_pred hhc-CCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 197 HES-AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 197 H~~-~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
-.. ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 111 223489999999999999 4 899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0013 Score=61.74 Aligned_cols=74 Identities=11% Similarity=0.071 Sum_probs=43.9
Q ss_pred CeeccCCcEEEEEEEECC--------CCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc-eeeEEEEEeeCCeeEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEG--------TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY-LVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~ 155 (399)
..|+.|....+|++...+ .+..+++|+..... ........|..+++.+...+ +.++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567788888999998653 12578888875432 11112356788887775333 44666554 2 27899
Q ss_pred EecCCCCh
Q 046609 156 EYMPNGSL 163 (399)
Q Consensus 156 e~~~~g~L 163 (399)
||++|.++
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987544
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0059 Score=56.53 Aligned_cols=30 Identities=20% Similarity=0.189 Sum_probs=26.7
Q ss_pred CCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 202 ~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence 349999999999999988889999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.074 Score=50.62 Aligned_cols=74 Identities=11% Similarity=0.079 Sum_probs=47.5
Q ss_pred CeeccCCcEEEEEEEECCC-------CeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGT-------NQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+.|..|-...+|+...... +..+++++..... ...-...+|..+++.+. +.-..++++.+. -++|+|
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEEE
Confidence 5677788889999987521 4678899865432 11223456888887775 333455565432 278999
Q ss_pred ecCCCCh
Q 046609 157 YMPNGSL 163 (399)
Q Consensus 157 ~~~~g~L 163 (399)
|++|.+|
T Consensus 151 fI~G~~l 157 (424)
T 3mes_A 151 FIDGEPL 157 (424)
T ss_dssp CCCSEEC
T ss_pred EeCCccC
Confidence 9988654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=94.34 E-value=0.36 Score=41.00 Aligned_cols=118 Identities=12% Similarity=0.150 Sum_probs=80.1
Q ss_pred cCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046609 133 LSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKAS 212 (399)
Q Consensus 133 l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~ 212 (399)
..||+++.. .+-.+++.+.+.++.-+.+.=...++ .++....++++.+|+....+++ . -+|--|.|+
T Consensus 42 ~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik-------~~~~~eKlr~l~ni~~l~~~~~--~---r~tf~L~P~ 108 (215)
T 4ann_A 42 QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK-------SFTKNEKLRYLLNIKNLEEVNR--T---RYTFVLAPD 108 (215)
T ss_dssp SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG-------GSCHHHHHHHHHHGGGGGGGGG--S---SEECCCSGG
T ss_pred ccCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH-------hcCHHHHHHHHHHHHHHHHHhc--C---ceEEEEecc
Confidence 358888876 56666666555555433222222243 3788999999999998774444 2 478899999
Q ss_pred ceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 046609 213 NVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDN 287 (399)
Q Consensus 213 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~ 287 (399)
||+++.++.+++.-.|+... ++|. ..+...=+-.+=+++..+++++..|..
T Consensus 109 NL~f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 99999999999987765332 2222 223334455778899999999877763
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.12 E-value=0.17 Score=47.75 Aligned_cols=28 Identities=25% Similarity=0.350 Sum_probs=24.1
Q ss_pred eEecCCCCCceEE------CCCCCeeEecccCcc
Q 046609 204 VIYRDFKASNVLL------DQDFNPKLSDFGLAK 231 (399)
Q Consensus 204 ivH~dikp~NIll------~~~~~~kl~Dfg~~~ 231 (399)
++|+|+.+.|||+ +++..+.++||-.|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6799999999999 456779999998775
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=93.18 E-value=0.33 Score=41.39 Aligned_cols=116 Identities=11% Similarity=0.101 Sum_probs=79.0
Q ss_pred cCCCceeeEEEEEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCC
Q 046609 133 LSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE-YLHESAQPPVIYRDFKA 211 (399)
Q Consensus 133 l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~-~LH~~~~~~ivH~dikp 211 (399)
..||++ -..+-.+++.+.+.++.-+++.=...++. ++....++++.+|+.... +++ . -+|--|.|
T Consensus 47 ~~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~-------~~~~eKlrll~nl~~L~~~~~~--~---r~tf~l~P 112 (219)
T 4ano_A 47 EVDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK-------TTLLSRIRAAIHLVSKVKHHSA--R---RLIFIVCP 112 (219)
T ss_dssp GSCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT-------SCHHHHHHHHHHHHHHHSSCCS--S---SEECCCCG
T ss_pred ccCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh-------cCHHHHHHHHHHHHHHHHHhhh--C---ceeEEEeC
Confidence 357888 44445667777777766544433444543 788999999999887655 443 3 57889999
Q ss_pred CceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 046609 212 SNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVID 286 (399)
Q Consensus 212 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~ 286 (399)
+||+++.++.++|.-.|+-. -++|.- .+..-=+-++=+++..++.++..|.
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~-------------------~lpP~e-----~~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKE-------------------SLPPDE-----WDDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETT-------------------TBSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCcc-------------------cCCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 99999999999998777643 223321 2222334567788888888877665
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=83.25 E-value=0.13 Score=49.70 Aligned_cols=62 Identities=10% Similarity=0.092 Sum_probs=18.8
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEE------EEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEe
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAV------KQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCV 146 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vai------K~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~ 146 (399)
.+.+.|| ||.||+|.+.....+||+ |....... .....+.+|..+++.++|||+++.+++..
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 4456777 999999999765678888 66543222 22345778888888999999999988764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 399 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-75 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-64 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-63 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-61 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-60 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-60 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-59 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 9e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 5e-55 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 7e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-53 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-47 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 4e-47 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-46 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-46 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 7e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-41 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-37 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-36 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 7e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-32 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 3e-17 | |
| d2pula1 | 392 | d.144.1.6 (A:5-396) Methylthioribose kinase MtnK { | 0.002 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 2e-75
Identities = 77/287 (26%), Positives = 125/287 (43%), Gaps = 27/287 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPY 137
+G G FG VY+GK + DVAVK L+ Q + F EV +L +
Sbjct: 9 QITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
++ +GY Q +V ++ SL HL + + IA A+G++YLH
Sbjct: 66 ILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH 121
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+I+RD K++N+ L +D K+ DFGLA + SH ++ G+ + APE
Sbjct: 122 ---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 258 LT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314
+ +SDVY+FG+V E++TG+ N ++ + L D K
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC 238
Query: 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361
+ A CL+++ RP+ ++ +IE LA S
Sbjct: 239 PK------------AMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 208 bits (529), Expect = 3e-65
Identities = 73/303 (24%), Positives = 131/303 (43%), Gaps = 26/303 (8%)
Query: 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLM 129
+Y + + T+ + LG G +G VY G + + VAVK L + + EFL E +
Sbjct: 8 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAV 66
Query: 130 LSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
+ + +P LV L+G C ++ E+M G+L D+L + NR+ + + +A
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQI 124
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
+ +EYL + I+RD A N L+ ++ K++DFGL++L GD
Sbjct: 125 SSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPI 180
Query: 250 GYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309
+ APE + + KSDV++FGV+ EI T + +++
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------VYE---- 227
Query: 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEACIED 369
+ + P + + C Q RP +++ A E + +E+ I D
Sbjct: 228 ---LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF---QESSISD 281
Query: 370 SLD 372
++
Sbjct: 282 EVE 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-64
Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 11/222 (4%)
Query: 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLS 134
+ +F + LG G G V++ + + +A K + R + E+ +L +
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 135 NPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLE 194
+PY+V G + + E+M GSL+ L + K++ +GL
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLT 118
Query: 195 YLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAP 254
YL E + +++RD K SN+L++ KL DFG++ ++ +GT Y +P
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSP 172
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL 296
E + +SD++S G+ +E+ GR I E + +
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-64
Identities = 73/282 (25%), Positives = 120/282 (42%), Gaps = 25/282 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
+G G FG V+ G VA+K + R G +F+ E ++ LS+P LV
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L G C++ LV+E+M +G L D+L R T + + G+ YL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE- 119
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
VI+RD A N L+ ++ K+SDFG+ + D+ ST + +PE
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSSTGTKFPVKWASPEVFSF 176
Query: 260 GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319
+ ++KSDV+SFGV+ E+ + ++ +R E + +D + P L
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLA 227
Query: 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361
+ C +E RP S ++ + +A S
Sbjct: 228 ST-------HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 6e-64
Identities = 62/297 (20%), Positives = 112/297 (37%), Gaps = 29/297 (9%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCV 146
+G+G FG V+RGK ++VAVK + + E+ ML + ++ +
Sbjct: 11 IGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADN 67
Query: 147 DGD----QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA-- 200
+ Q LV +Y +GSL D+L NR + +K+A A GL +LH
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYL-----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 201 ---QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK--SHVSTRVMGTYGYCAPE 255
+P + +RD K+ N+L+ ++ ++D GLA + +GT Y APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 256 YALT------GQLTAKSDVYSFGVVFLEIITGRRVI----DNSRPTEEQNLVTWATPLFK 305
+ ++D+Y+ G+VF EI + D P + + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 306 DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362
+ + + L + C R + + L+ +
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 1e-63
Identities = 79/287 (27%), Positives = 128/287 (44%), Gaps = 29/287 (10%)
Query: 82 NPDNLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGFQGN-REFLVEVLMLSMLSNPY 137
+ + ++G G FG VY G L +G AVK L+R G +FL E +++ S+P
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 138 LVNLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+++L+G C+ + +V YM +G L + + + A+G+++L
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFL 146
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL--GPTGDKSHVSTRVMGTYGYCAP 254
++RD A N +LD+ F K++DFGLA+ D H T + A
Sbjct: 147 A---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 255 EYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314
E T + T KSDV+SFGV+ E++T P + N L + RR
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRR------ 252
Query: 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361
LL+ Y LY+ V C +A RP S++V+ I + +
Sbjct: 253 --LLQPEYCPDPLYE---VMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-63
Identities = 66/278 (23%), Positives = 112/278 (40%), Gaps = 27/278 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
+ LG G FG V GK DVA+K + + G EF+ E ++ LS+ LV
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L G C ++ EYM NG L ++ L R +++ +EYL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNY---LREMRHRFQTQQLLEMCKDVCEAMEYLE-- 117
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
++RD A N L++ K+SDFGL++ D+ S + PE +
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMY 175
Query: 260 GQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318
+ ++KSD+++FGV+ EI + G+ + +E + L++ +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYT--- 232
Query: 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
+ C E+A RP +++ I
Sbjct: 233 --------------IMYSCWHEKADERPTFKILLSNIL 256
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (516), Expect = 3e-63
Identities = 67/306 (21%), Positives = 122/306 (39%), Gaps = 38/306 (12%)
Query: 69 FSYRELCVATTNFNP---------DNLLGEGGFGRVYRGKLEGTNQD---VAVKQLDRNG 116
F++ + A F + ++G G FG V G L+ + VA+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 117 FQGN-REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRK 175
+ R+FL E ++ +P +++L G +++ E+M NGSL+ L N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---NDG 123
Query: 176 ALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235
+ + G A G++YL ++RD A N+L++ + K+SDFGL++
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 236 GDKSHVSTRV---MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTE 292
T + APE + T+ SDV+S+G+V E+++ RP
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE-----RPYW 235
Query: 293 EQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352
+ + +D R P+ + C Q++ RP +V
Sbjct: 236 DMTNQDVINAIEQDYRL-----------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284
Query: 353 TAIEYL 358
++ +
Sbjct: 285 NTLDKM 290
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 4e-63
Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 25/277 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
LG G FG V+ G G + VAVK L + G FL E ++ L + LV
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L + ++ EYM NGSL D L P+ L N + +A A G+ ++ E
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
I+RD +A+N+L+ + K++DFGLA+L ++ + APE
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTAPEAINY 184
Query: 260 GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319
G T KSDV+SFG++ EI+T R+ E + ++ + M P
Sbjct: 185 GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---------VIQNLERGYRMVRP--- 232
Query: 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
N P + + +C +E RP + + +E
Sbjct: 233 DNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (511), Expect = 1e-62
Identities = 71/315 (22%), Positives = 117/315 (37%), Gaps = 45/315 (14%)
Query: 70 SYRELCVATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQGNR-EF 123
L N +GEG FGRV++ + G VAVK L + +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 124 LVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL---------------- 167
E +++ NP +V L+G C G L++EYM G L + L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 168 ----LDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223
P L ++ IA A G+ YL E ++RD N L+ ++ K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRR 283
++DFGL++ + D + PE + T +SDV+++GVV EI +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240
Query: 284 VIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAG 343
EE + R ++A P N P+ + + +C +
Sbjct: 241 QPYYGMAHEE---------VIYYVRDGNILACP---ENCPL----ELYNLMRLCWSKLPA 284
Query: 344 TRPMMSDVVTAIEYL 358
RP + ++ +
Sbjct: 285 DRPSFCSIHRILQRM 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-62
Identities = 72/313 (23%), Positives = 132/313 (42%), Gaps = 33/313 (10%)
Query: 72 RELCVATTNFNPDNL-LGEGGFGRVYRG--KLEGTNQDVAVKQLDRNGFQGNRE-FLVEV 127
++L + N ++ LG G FG V +G ++ DVA+K L + + + E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 128 LMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAH 187
++ L NPY+V L+G C + +LV E G L L+ R+ + + ++ H
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLH 116
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVM 246
+ G++YL + ++RD A NVLL K+SDFGL+K LG +
Sbjct: 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306
+ APE + +++SDV+S+GV E ++ + +P ++ + +
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPEVMAFIEQG 228
Query: 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEEAC 366
+R P + A+ + C + RP V + +S
Sbjct: 229 KR-------MECPPECPP----ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS----- 272
Query: 367 IEDSLDSCHHGRN 379
+ ++ HH +
Sbjct: 273 LASKVEGHHHHHH 285
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-62
Identities = 57/279 (20%), Positives = 101/279 (36%), Gaps = 25/279 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPY 137
++ +G G +GR + + + + + K+LD + + EV +L L +P
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 138 LVNLVGYCVDGDQRIL--VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
+V +D L V EY G L + R+ LD +++ L+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 196 LHE--SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
H V++RD K +NV LD N KL DFGLA++ + + +GT Y +
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGTPYYMS 182
Query: 254 PEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313
PE KSD++S G + E+ E +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF----------- 231
Query: 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352
+ Y + + L + RP + +++
Sbjct: 232 --RRIPYRYSD----ELNEIITRMLNLKDYHRPSVEEIL 264
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-61
Identities = 73/280 (26%), Positives = 111/280 (39%), Gaps = 31/280 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
+G+G FG V G G VAVK + + + FL E +++ L + LV
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 140 NLVGYCVDGDQRI-LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
L+G V+ + +V EYM GSL D+L R L + +K + +EYL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLE- 120
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
++RD A NVL+ +D K+SDFGL K + S + APE
Sbjct: 121 --GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-----EASSTQDTGKLPVKWTAPEALR 173
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318
+ + KSDV+SFG++ EI + R P L + K +
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYK-------MDA 221
Query: 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358
P V C +A RP + +E++
Sbjct: 222 PDGCPP----AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-61
Identities = 70/298 (23%), Positives = 107/298 (35%), Gaps = 39/298 (13%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQGNRE-FLVEVLMLSML 133
+ LG G FG+V G VAVK L + RE + E+ +LS L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 134 SN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL--------------LDLPPNRKALD 178
N +VNL+G C G +++ EY G L + L + + ALD
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 179 WNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238
+ ++ A+G+ +L I+RD A N+LL K+ DFGLA+
Sbjct: 144 LEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298
V + APE T +SDV+S+G+ E+ + P + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---- 256
Query: 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
F M P + + C + RP +V IE
Sbjct: 257 -----------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 4e-61
Identities = 68/299 (22%), Positives = 113/299 (37%), Gaps = 44/299 (14%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNRE-FLVEVLMLSML 133
N +LG G FG+V G ++ VAVK L RE + E+ M++ L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 134 SN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL-------------------LDLPPN 173
+ +VNL+G C L++EY G L ++L L+ +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 174 RKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233
L + + A+ A+G+E+L ++RD A NVL+ K+ DFGLA+
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEE 293
+ V + APE G T KSDV+S+G++ EI + P +
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 294 QNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352
F + + + P + + C ++ RP ++
Sbjct: 275 N---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-60
Identities = 69/298 (23%), Positives = 126/298 (42%), Gaps = 33/298 (11%)
Query: 78 TTNFNPD-----NLLGEGGFGRVYRGKLEGTNQD----VAVKQLDRNGFQGNR-EFLVEV 127
TT +P ++G G FG VY+G L+ ++ VA+K L + R +FL E
Sbjct: 1 TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60
Query: 128 LMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAH 187
++ S+ ++ L G +++ EYM NG+L+ L + + +
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLR 117
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVM 246
G A G++YL ++RD A N+L++ + K+SDFGL++ L + ++ ++
Sbjct: 118 GIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 247 GTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306
+ APE + T+ SDV+SFG+V E++T E
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------- 221
Query: 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364
+ P+ + C Q+E RP +D+V+ ++ L + +
Sbjct: 222 ---VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS 276
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 2e-60
Identities = 64/274 (23%), Positives = 112/274 (40%), Gaps = 24/274 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLD-RNGFQGNREFLVEVLMLSMLSNPYL 138
+++ LGEG +G V T + VAVK +D + E+ + ML++ +
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
V G+ +G+ + L EY G L D + + + H G+ YLH
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+ +RD K N+LLD+ N K+SDFGLA + ++ + ++ GT Y APE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 259 TGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317
+ DV+S G+V ++ G D + ++ +K+++ + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------WKEKKTYLNPWKKI 232
Query: 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDV 351
LA+ L E R + D+
Sbjct: 233 DS---------APLALLHKILVENPSARITIPDI 257
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-60
Identities = 60/276 (21%), Positives = 110/276 (39%), Gaps = 32/276 (11%)
Query: 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLVNL 141
D +G G F VY+G T +VA +L + + F E ML L +P +V
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 142 VGYCVDGDQR----ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+ +LV E M +G+L+ +L K + +GL++LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYL----KRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 198 ESAQPPVIYRDFKASNVLL-DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
+ PP+I+RD K N+ + + K+ D GLA L ++ + V+GT + APE
Sbjct: 130 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM 184
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316
+ DVY+FG+ LE+ T + + + +
Sbjct: 185 -YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSG 228
Query: 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352
+ ++ + + + C+++ R + D++
Sbjct: 229 VKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 6e-60
Identities = 68/301 (22%), Positives = 123/301 (40%), Gaps = 38/301 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSN- 135
+ +++GEG FG+V + +++ G D A+K++ +R+F E+ +L L +
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLD------------LPPNRKALDWNTRM 183
P ++NL+G C L EY P+G+L D L L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 184 KIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVST 243
A ARG++YL Q I+RD A N+L+ +++ K++DFGL++ K T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KT 184
Query: 244 RVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303
+ A E T SDV+S+GV+ EI++ P L
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEKL 239
Query: 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363
+ R P+ + + C +E+ RP + ++ ++ + ++
Sbjct: 240 PQGYR-----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
Query: 364 E 364
Sbjct: 289 T 289
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 8e-60
Identities = 58/284 (20%), Positives = 115/284 (40%), Gaps = 36/284 (12%)
Query: 80 NFNPD------NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSML 133
+ NP+ LG+G FG+VY+ + + T+ A K +D + +++VE+ +L+
Sbjct: 7 DLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC 66
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
+P +V L+ + ++ E+ G+++ +L+ + L + + L
Sbjct: 67 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDAL 123
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
YLH++ +I+RD KA N+L D + KL+DFG++ + +GT + A
Sbjct: 124 NYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMA 178
Query: 254 PEYALTGQL-----TAKSDVYSFGVVFLEIITGRRVIDNSRPTEE-QNLVTWATPLFKDR 307
PE + K+DV+S G+ +E+ P + P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDV 351
+++ L+ CL++ R S +
Sbjct: 239 SRWSSNFKDFLKK----------------CLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (490), Expect = 3e-59
Identities = 67/278 (24%), Positives = 111/278 (39%), Gaps = 35/278 (12%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPY 137
F+ +G G FG VY + ++ VA+K++ +G Q N ++ + EV L L +P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+ G + LV EY + + + ++K L + HGA +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+I+RD KA N+LL + KL DFG A + + +GT + APE
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVI 183
Query: 258 LT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314
L GQ K DV+S G+ +E+ + + N + ++
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243
Query: 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352
++ CLQ+ RP ++
Sbjct: 244 RNFVDS----------------CLQKIPQDRPTSEVLL 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 6e-59
Identities = 70/278 (25%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 84 DNLLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYLV 139
D LG G FG V +G + + VAVK L E L E ++ L NPY+V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
++G C + + +LV E G L +L + + +++ H + G++YL
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLE-- 124
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+ ++RD A NVLL K+SDFGL+K L + T + APE
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318
+ ++KSDV+SFGV+ E + + +P L K R
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSEVTAMLEKGER-------MGC 231
Query: 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
P + + +C + RP + V +
Sbjct: 232 PAGCPR----EMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 8e-59
Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 25/277 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
+ + LG+G FG V+ G GT + VA+K L + G FL E ++ L + LV
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L + +V EYM GSL D L K L + +A A G+ Y+
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVE-- 130
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
+ ++RD +A+N+L+ ++ K++DFGLA+L ++ + APE AL
Sbjct: 131 -RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPEAALY 188
Query: 260 GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319
G+ T KSDV+SFG++ E+ T RV E L + R + M P
Sbjct: 189 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--------LDQVERGYRMPCPP--- 237
Query: 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
P + C ++E RP + +E
Sbjct: 238 -ECPES----LHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-58
Identities = 68/276 (24%), Positives = 107/276 (38%), Gaps = 32/276 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNP 136
+F LG+G FG VY + + + +A+K L + + + EV + S L +P
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
++ L GY D + L+ EY P G++ L L D A L Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK----FDEQRTATYITELANALSYC 122
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H VI+RD K N+LL K++DFG + P S T + GT Y PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTLDYLPPEM 175
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316
K D++S GV+ E + G+ + + E ++ F D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------VTE 229
Query: 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVV 352
A + + L+ RPM+ +V+
Sbjct: 230 ------------GARDLISRLLKHNPSQRPMLREVL 253
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 9e-58
Identities = 70/291 (24%), Positives = 125/291 (42%), Gaps = 28/291 (9%)
Query: 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQD----VAVKQLDRNGF-QGNREFLVEVLMLSML 133
T F +LG G FG VY+G + VA+K+L + N+E L E +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
NP++ L+G C+ + L+ + MP G L D++ + ++ + + A+G+
Sbjct: 69 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGM 124
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
YL +++RD A NVL+ + K++DFGLAKL +K + + + A
Sbjct: 125 NYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 254 PEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313
E L T +SDV+S+GV E++T +P + ++ L K R
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGS-----KPYDGIPASEISSILEKGER----- 231
Query: 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364
I + C +A +RP +++ +A +
Sbjct: 232 --LPQPPICTI----DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQR 276
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (476), Expect = 2e-57
Identities = 66/268 (24%), Positives = 113/268 (42%), Gaps = 27/268 (10%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGY 144
+G+G G VY T Q+VA++Q++ + E+L++ NP +VN +
Sbjct: 26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 145 CVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+ GD+ +V EY+ GSL D + +D + + LE+LH + V
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 205 IYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTA 264
I+RD K+ N+LL D + KL+DFG + + ++GT + APE
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQ--ITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 265 KSDVYSFGVVFLEIITGRRVIDNSRPTEE-QNLVTWATPLFKDRRKFTMMADPLLEGNYP 323
K D++S G++ +E+I G N P + T TP ++ K + + L
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR--- 252
Query: 324 IKGLYQALAVAAMCLQEEAGTRPMMSDV 351
CL + R ++
Sbjct: 253 -------------CLDMDVEKRGSAKEL 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 5e-55
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 31/293 (10%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQD-----VAVKQLDRNGFQGNR-EFLVEVLMLSML 133
LG+G FG VY G +G +D VA+K ++ R EFL E ++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHL------LDLPPNRKALDWNTRMKIAH 187
+ ++V L+G G +++ E M G L+ +L + P + +++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 188 GAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMG 247
A G+ YL+ + ++RD A N ++ +DF K+ DFG+ + D + +
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 248 TYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307
+ +PE G T SDV+SFGVV EI T E+
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------- 244
Query: 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+M LL+ P + MC Q RP +++++I+
Sbjct: 245 -LRFVMEGGLLD--KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 7e-55
Identities = 60/286 (20%), Positives = 111/286 (38%), Gaps = 32/286 (11%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNP 136
+F +LGEG F V + T+++ A+K L++ E ++S L +P
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+ V L D ++ Y NG L ++ + D LEYL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 124
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H +I+RD K N+LL++D + +++DFG AK+ K + +GT Y +PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316
SD+++ G + +++ G P F+ ++ +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL-------------------PPFRAGNEYLIF-QK 221
Query: 317 LLEGNYPIKGLY--QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+++ Y + +A + L +A R ++ AH
Sbjct: 222 IIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-54
Identities = 70/284 (24%), Positives = 106/284 (37%), Gaps = 29/284 (10%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLE---GTNQDVAVKQLDRNGF---QGNREFLVEVLMLSML 133
+ LG+G FG V RG+ + G VAVK L + + +F+ EV + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 134 SNPYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
+ L+ L G + ++ V E P GSL D L ++ T + A A G+
Sbjct: 69 DHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGM 124
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHV-STRVMGTYGYC 252
YL I+RD A N+LL K+ DFGL + P D +V + +C
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312
APE T + SD + FGV E+ T + P N + K+ +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERLPR 236
Query: 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356
D + V C + RP + +
Sbjct: 237 PEDCPQD----------IYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-53
Identities = 66/299 (22%), Positives = 107/299 (35%), Gaps = 38/299 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQG-NREFLVEV-LMLSM 132
LG G FG+V G T + VAVK L +R + E+ +++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 133 LSNPYLVNLVGYCV-DGDQRILVYEYMPNGSLEDHL------------LDLPPNRKALDW 179
+ +VNL+G C G +++ E+ G+L +L + L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 180 NTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS 239
+ + A+G+E+L I+RD A N+LL + K+ DFGLA+
Sbjct: 134 EHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW 299
+ APE T +SDV+SFGV+ EI + P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEE 245
Query: 300 ATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358
K+ + P + C E RP S++V + L
Sbjct: 246 FCRRLKEGTRMRA----------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-53
Identities = 77/300 (25%), Positives = 121/300 (40%), Gaps = 40/300 (13%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQD-------VAVKQLDRNGFQGN-REFLVEVLMLS 131
LGEG FG+V + G ++D VAVK L + + + + + E+ M+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 132 MLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPN------------RKALD 178
M+ ++NL+G C ++ EY G+L ++L P + L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 179 WNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238
+ A+ ARG+EYL I+RD A NVL+ +D K++DFGLA+ D
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298
+T + APE T +SDV+SFGV+ EI T P EE
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245
Query: 299 WATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358
LFK ++ M + P + + C RP +V ++ +
Sbjct: 246 ----LFKLLKEGHRM-------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-52
Identities = 61/277 (22%), Positives = 107/277 (38%), Gaps = 28/277 (10%)
Query: 86 LLGEGGFGRVYRGKLEGTNQD---VAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLVNL 141
+GEG FG V++G VA+K RE FL E L + +P++V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 142 VGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
+G + + ++ E G L L + +LD + + A+ + L YL
Sbjct: 74 IGVITE-NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLES--- 126
Query: 202 PPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQ 261
++RD A NVL+ + KL DFGL++ + +++ + APE +
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRR 185
Query: 262 LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGN 321
T+ SDV+ FGV EI+ +P + + R + N
Sbjct: 186 FTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER-------LPMPPN 233
Query: 322 YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358
P ++ C + RP +++ + +
Sbjct: 234 CPP----TLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (432), Expect = 3e-50
Identities = 60/283 (21%), Positives = 102/283 (36%), Gaps = 31/283 (10%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
+++ LG G FG V+R T + A K + E+ +S+L +P LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
NL D ++ +++YE+M G L + + D + + ++ +GL ++HE
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 200 AQPPVIYRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
++ D K N++ + KL DFGL V GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVA 197
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317
+ +D++S GV+ +++G E V D + D
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED-- 255
Query: 318 LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
L + TR T + L H
Sbjct: 256 ------------GKDFIRKLLLADPNTRM------TIHQALEH 280
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 169 bits (430), Expect = 7e-50
Identities = 54/277 (19%), Positives = 100/277 (36%), Gaps = 31/277 (11%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
LG G FG V+R + T + K ++ E+ +++ L +P L+NL
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
D + +L+ E++ G L D + + + A GL+++HE ++
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIV 149
Query: 206 YRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
+ D K N++ + K+ DFGLA + T + APE +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPVG 206
Query: 264 AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323
+D+++ GV+ +++G E V F + ++ +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE-------- 258
Query: 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
A LQ+E R T + L H
Sbjct: 259 ------AKDFIKNLLQKEPRKRL------TVHDALEH 283
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 2e-49
Identities = 63/231 (27%), Positives = 106/231 (45%), Gaps = 13/231 (5%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSM-LSN 135
+F +LG+G FG+V+ + + TNQ A+K L ++ + + +VE +LS+ +
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 136 PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEY 195
P+L ++ + V EY+ G L H+ + D + A GL++
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 196 LHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
LH ++YRD K N+LLD+D + K++DFG+ K GD GT Y APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306
L + D +SFGV+ E++ G+ E + + P +
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR 224
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 168 bits (427), Expect = 3e-49
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 18/225 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSN- 135
+F+ ++G GGFG VY + T + A+K LD+ QG L E +MLS++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 136 --PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
P++V + D+ + + M G L HL A GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEIILGL 120
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCA 253
E++H V+YRD K +N+LLD+ + ++SD GLA +GT+GY A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 254 PEYALTGQ-LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV 297
PE G + +D +S G + +++ G + ++ +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 166 bits (422), Expect = 3e-49
Identities = 55/281 (19%), Positives = 103/281 (36%), Gaps = 28/281 (9%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLV 139
++ ++LG G F V + + T + VA+K + + +G E+ +L + +P +V
Sbjct: 11 YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L G L+ + + G L D ++ + ++ ++YLH+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
+ LD+D +SDFGL+K+ D V + GT GY APE
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME---DPGSVLSTACGTPGYVAPEVLAQ 183
Query: 260 GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLE 319
+ D +S GV+ ++ G P ++N + K +F +
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 320 GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
A ++++ R T + L H
Sbjct: 238 D--------SAKDFIRHLMEKDPEKRF------TCEQALQH 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 162 bits (412), Expect = 4e-48
Identities = 69/297 (23%), Positives = 106/297 (35%), Gaps = 46/297 (15%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---------QGNREFLVEVLML 130
N+ P +LG G V R + T ++ AVK +D G + L EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 131 SMLSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGA 189
+S P ++ L LV++ M G L D+L + L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMRAL 119
Query: 190 ARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTY 249
+ LH+ +++RD K N+LLD D N KL+DFG + G+K V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 250 GYCAPEYALTGQL------TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL 303
Y APE + D++S GV+ ++ G + + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
F + + L + R TA E LAH
Sbjct: 234 FGSPEWDDYSDT--------------VKDLVSRFLVVQPQKRY------TAEEALAH 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 161 bits (409), Expect = 1e-47
Identities = 63/285 (22%), Positives = 113/285 (39%), Gaps = 30/285 (10%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPY 137
+ +LG GG V+ + ++DVAVK L + + F E + L++P
Sbjct: 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68
Query: 138 LVNLVGYCVD----GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
+V + G +V EY+ +L D + + +++ A + L
Sbjct: 69 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV----HTEGPMTPKRAIEVIADACQAL 124
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYC 252
+ H+ +I+RD K +N+++ K+ DFG+A+ + +G+ + V+GT Y
Sbjct: 125 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312
+PE A + A+SDVYS G V E++TG P P+ R +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241
Query: 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-MMSDVVTAIE 356
AD AV L + R +++ +
Sbjct: 242 SAD--------------LDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 4e-47
Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 31/292 (10%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-----NREFLVEVLMLSMLSNPYLV 139
+ LGEG F VY+ + + TNQ VA+K++ NR L E+ +L LS+P ++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L+ LV+++M D + + N L + +GLEYLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALT 259
+++RD K +N+LLD++ KL+DFGLAK G + T + T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFG 174
Query: 260 GQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLV--TWATPLFKDRRKFTMMADP 316
++ D+++ G + E++ + ++ + T TP + + D
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 317 LLEGNYPIKGLY--------QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+ ++P L+ L + R TA + L
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI------TATQALKM 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 2e-46
Identities = 45/277 (16%), Positives = 101/277 (36%), Gaps = 32/277 (11%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
LG G FG V+R + + K + G E+ +L++ + +++L
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 146 VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVI 205
++ ++++E++ + + + + L+ + H L++LH +
Sbjct: 71 ESMEELVMIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHS---HNIG 124
Query: 206 YRDFKASNVLLDQDFNP--KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLT 263
+ D + N++ + K+ +FG A+ GD + + Y APE ++
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVVS 181
Query: 264 AKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYP 323
+D++S G + +++G + + A F + + +
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE-------- 233
Query: 324 IKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
A+ L +E +R TA E L H
Sbjct: 234 ------AMDFVDRLLVKERKSRM------TASEALQH 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 159 bits (402), Expect = 4e-46
Identities = 62/231 (26%), Positives = 100/231 (43%), Gaps = 15/231 (6%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNP 136
+F LG G FGRV+ + + A+K L + ++ E LMLS++++P
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+++ + G D Q ++ +Y+ L L + A LEYL
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H +IYRD K N+LLD++ + K++DFG AK P V+ + GT Y APE
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPDYIAPEV 172
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307
T D +SFG++ E++ G +S + + A F
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 223
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 3e-44
Identities = 65/300 (21%), Positives = 118/300 (39%), Gaps = 36/300 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLV 139
++ ++G G FG VY+ KL + + VA+K++ ++ NR E+ ++ L + +V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 140 NLVGYCVDGDQR------ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
L + ++ LV +Y+P ++ L + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV-ARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252
Y+H + +RD K N+LLD D KL DFG AK G+ + + + Y
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIITGRRV------------IDNSRPTEEQNLVTWA 300
T+ DV+S G V E++ G+ + I T + +
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 301 TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
P + + + + A P + P + +A+A+ + L+ R T +E AH
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRP-RTPPEAIALCSRLLEYTPTARL------TPLEACAH 303
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 4e-44
Identities = 62/296 (20%), Positives = 112/296 (37%), Gaps = 26/296 (8%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE-FLVEVLMLSMLSNPYLV 139
+ + +GEG +G V VA+K++ Q + L E+ +L + ++
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
+ + Y+ + L L + L + + RGL+Y+H +
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRGLKYIHSA 128
Query: 200 AQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK-LGPTGDKSHVSTRVMGTYGYCAPEYAL 258
V++RD K SN+LL+ + K+ DFGLA+ P D + T + T Y APE L
Sbjct: 129 ---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 259 TGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA--TPLFKDRRKFTMMAD 315
+ T D++S G + E+++ R + ++ N + +P +D +
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 316 PLLEGNYPIKGLY-----------QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+ P K +AL + L R + LAH
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI------EVEQALAH 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 2e-43
Identities = 54/294 (18%), Positives = 112/294 (38%), Gaps = 26/294 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNREFLVEVLMLSMLSNPY 137
NF +GEG +G VY+ + + T + VA+K++ D + E+ +L L++P
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V L+ ++ LV+E++ + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
V++RD K N+L++ + KL+DFGLA+ + + V+ +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILL 175
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317
+ D++S G +F E++T R + ++ + + + + P
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPD 235
Query: 318 LEGNYPIKGLY-----------QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+ ++P ++ + L + R +A LAH
Sbjct: 236 YKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI------SAKAALAH 283
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-43
Identities = 59/285 (20%), Positives = 102/285 (35%), Gaps = 40/285 (14%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNR------EFLVEVLMLSMLSNPYLV 139
LG G F V + + + T A K + + + +R + EV +L + +P ++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 140 NLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHES 199
L + IL+ E + G L D +++L + G+ YLH
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQILNGVYYLHS- 131
Query: 200 AQPPVIYRDFKASNVLLDQDFNP----KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
+ + D K N++L P K+ DFGLA G++ + GT + APE
Sbjct: 132 --LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPEFVAPE 186
Query: 256 YALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315
L ++D++S GV+ +++G E V+ F+D
Sbjct: 187 IVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDE-------- 238
Query: 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
Y A L ++ R T + L H
Sbjct: 239 ------YFSNTSALAKDFIRRLLVKDPKKRM------TIQDSLQH 271
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 5e-43
Identities = 63/304 (20%), Positives = 109/304 (35%), Gaps = 29/304 (9%)
Query: 74 LCVATTNFNPDNLLGEGGFGRVYRGK-LEGTNQDVAVKQLDRNGFQGN--REFLVEVLML 130
LC A + +GEG +G+V++ + L+ + VA+K++ + + EV +L
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 131 SMLSN---PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDL--PPNRKALDWNTRMKI 185
L P +V L C + ++ L + T +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 186 AHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRV 245
RGL++LH V++RD K N+L+ KL+DFGLA++ T V
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSV 175
Query: 246 MGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK 305
+ T Y APE L D++S G +F E+ + + S ++ + L
Sbjct: 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 235
Query: 306 DRRKFTMMADPLLEGNYPIKGLY---------QALAVAAMCLQEEAGTRPMMSDVVTAIE 356
+ +A P + + CL R +A
Sbjct: 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI------SAYS 289
Query: 357 YLAH 360
L+H
Sbjct: 290 ALSH 293
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (377), Expect = 7e-43
Identities = 51/286 (17%), Positives = 94/286 (32%), Gaps = 28/286 (9%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
+G G FG +Y G ++VA+K + + +E + M+ + + +C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWC 71
Query: 146 -VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPV 204
+GD ++V E + + + T + +A +EY+H
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIHSKN---F 124
Query: 205 IYRDFKASNVL---LDQDFNPKLSDFGLAKL-----GPTGDKSHVSTRVMGTYGYCAPEY 256
I+RD K N L + + DFGLAK + + GT Y +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316
L + + + D+ S G V + G + ++ + K
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY------ERISEKKMSTPIE 238
Query: 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362
+L YP + C +P S + L H +
Sbjct: 239 VLCKGYPS----EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-41
Identities = 57/232 (24%), Positives = 93/232 (40%), Gaps = 26/232 (11%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE------FLVEVLMLSMLSNPY-- 137
LLG GGFG VY G N VA+K ++++ E +EV++L +S+ +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
++ L+ + D +L+ E + R AL + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFIT---ERGALQEELARSFFWQVLEAVRHCH 127
Query: 198 ESAQPPVIYRDFKASNVLLDQD-FNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
V++RD K N+L+D + KL DFG L K V T GT Y PE+
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTDFDGTRVYSPPEW 180
Query: 257 ALTGQLTAKS-DVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307
+ +S V+S G++ +++ G P E + F+ R
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVFFRQR 226
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 144 bits (364), Expect = 5e-41
Identities = 47/294 (15%), Positives = 112/294 (38%), Gaps = 28/294 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNREFLVEVLMLSMLSNPY 137
++ +GEG +G VY+ + + A+K++ ++ + E+ +L L +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V L + +LV+E++ + + L+ T G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+ V++RD K N+L++++ K++DFGLA+ + + ++ +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLM 173
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPL 317
+ + + D++S G +F E++ G + ++ + + + P
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 318 LEGNYPIKGLY-----------QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+ N+ + + + + L+ + R TA + L H
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI------TAKQALEH 281
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 6e-41
Identities = 63/230 (27%), Positives = 91/230 (39%), Gaps = 12/230 (5%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNP 136
+F+ LLG+G FG+V + + T + A+K L + E + E +L +P
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+L L D+ V EY G L HL + LEYL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL 121
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H V+YRD K N++LD+D + K++DFGL K G + + GT Y APE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEV 176
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306
D + GVV E++ GR N L+ F
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR 226
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-40
Identities = 59/314 (18%), Positives = 113/314 (35%), Gaps = 40/314 (12%)
Query: 74 LCVATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLS 131
C + + +G+G FG V++ + T Q VA+K++ + L E+ +L
Sbjct: 5 FCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQ 64
Query: 132 MLSNPYLVNLVGYCVDGDQRI--------LVYEYMPNGSLEDHLLDLPPNRKALDWNTRM 183
+L + +VNL+ C LV+++ + +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIK 120
Query: 184 KIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVS- 242
++ GL Y+H +++RD KA+NVL+ +D KL+DFGLA+ S +
Sbjct: 121 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 177
Query: 243 -TRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA 300
T + T Y PE L + D++ G + E+ T ++ + + L++
Sbjct: 178 YTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 237
Query: 301 --------------TPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP 346
L++ + + AL + L + R
Sbjct: 238 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI 297
Query: 347 MMSDVVTAIEYLAH 360
+ + L H
Sbjct: 298 ------DSDDALNH 305
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-40
Identities = 54/282 (19%), Positives = 94/282 (33%), Gaps = 35/282 (12%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
+LG G G+V + + T + A+K L ++ + RE L P++V +V
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-QDCPKARREV---ELHWRASQCPHIVRIVDVY 74
Query: 146 ----VDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ 201
++V E + G L + D +I ++YLH
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAIQYLHSIN- 131
Query: 202 PPVIYRDFKASNVLLDQDFNP---KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+ +RD K N+L KL+DFG AK + + T Y APE
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPEVLG 186
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318
+ D++S GV+ ++ G P + + + + R
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240
Query: 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+ + L+ E R T E++ H
Sbjct: 241 WSEVSE----EVKMLIRNLLKTEPTQRM------TITEFMNH 272
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (360), Expect = 2e-40
Identities = 47/294 (15%), Positives = 91/294 (30%), Gaps = 30/294 (10%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYL 138
++ +GEG FG ++ G NQ VA+K R + E +L+ +
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGI 63
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
N+ + +G +LV + + L + T A ++ +HE
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 199 SAQPPVIYRDFKASNVLLDQDFNP-----KLSDFGLAKLGPTGDKS-----HVSTRVMGT 248
++YRD K N L+ + + + DFG+ K + GT
Sbjct: 120 K---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 249 YGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308
Y + L + + + D+ + G VF+ + G + + +
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY------ERIGE 230
Query: 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362
K L +P + Y+ P + +
Sbjct: 231 KKQSTPLRELCAGFP-EEFYK---YMHYARNLAFDATPDYDYLQGLFSKVLERL 280
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (341), Expect = 1e-37
Identities = 58/295 (19%), Positives = 106/295 (35%), Gaps = 28/295 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQL--DRNGFQGNREFLVEVLMLSMLSNPY 137
+ +GEG +G V++ K T++ VA+K++ D + L E+ +L L +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+V L + LV+E+ + LD +GL + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
V++RD K N+L++++ KL++FGLA+ + + S V+ +
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ---NLVTWATPLFKDRRKFTMMA 314
+ D++S G +F E+ R + ++Q TP + T +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 315 DPLLEGNYPIKGLY---------QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
D YP + L+ R +A E L H
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI------SAEEALQH 283
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 4e-37
Identities = 59/231 (25%), Positives = 89/231 (38%), Gaps = 15/231 (6%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNRE---FLVEVLMLSMLSNP 136
F+ LG G FGRV K + + A+K LD+ ++ L E +L ++ P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 137 YLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+LV L D +V EY+ G + HL A EYL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEYL 157
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEY 256
H +IYRD K N+L+DQ +++DFG AK + + GT APE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209
Query: 257 ALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307
L+ D ++ GV+ E+ G +P + + F
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH 260
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 7e-36
Identities = 55/295 (18%), Positives = 105/295 (35%), Gaps = 28/295 (9%)
Query: 81 FNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPYL 138
+ +G G +G V T VA+K+L R + E+ +L + + +
Sbjct: 20 YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79
Query: 139 VNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE 198
+ L+ + ++ L + L + + + +GL Y+H
Sbjct: 80 IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 139
Query: 199 SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYAL 258
+I+RD K N+ +++D K+ DFGLA+ S ++ V+ +
Sbjct: 140 ---AGIIHRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEVILN 192
Query: 259 TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318
+ T D++S G + E+ITG+ + S ++ + T + +D
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252
Query: 319 EGNYPIKGLY-------------QALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
+ L A+ + L +A R TA E LAH
Sbjct: 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV------TAGEALAH 301
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 7e-34
Identities = 44/220 (20%), Positives = 85/220 (38%), Gaps = 21/220 (9%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYL 138
++ LG G + V+ N+ V VK L + + E+ +L L P +
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 139 VNLVGYCVDGDQR--ILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYL 196
+ L D R LV+E++ N + + L + + L+Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYC 145
Query: 197 HESAQPPVIYRDFKASNVLLDQDFNP-KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE 255
H +++RD K NV++D + +L D+GLA+ G + + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFKGPE 199
Query: 256 YALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ 294
+ Q+ D++S G + +I + + +Q
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-32
Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 37/293 (12%)
Query: 80 NFNPDNLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGF----QGNREFLVEVLMLSM 132
NF +LG G +G+V+ + T + A+K L + + E +L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 133 LSN-PYLVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
+ P+LV L + L+ +Y+ G L HL R+ +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL----SQRERFTEHEVQIYVGEIVL 140
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
LE+LH+ +IYRD K N+LLD + + L+DFGL+K D++ + GT Y
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEY 196
Query: 252 CAPEYALTGQ--LTAKSDVYSFGVVFLEIITGRR--VIDNSRPTEEQNLVTWATPLFKDR 307
AP+ G D +S GV+ E++TG +D + ++ +
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
Query: 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360
++ + +A L++ L ++ R A E H
Sbjct: 257 QEMSALAKDLIQR----------------LLMKDPKKRLGCGP-RDADEIKEH 292
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 8e-32
Identities = 54/258 (20%), Positives = 102/258 (39%), Gaps = 23/258 (8%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPY 137
+ +G G G V +++VA+K+L R + E++++ +++
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 138 LVNLVGYCV------DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAAR 191
+++L+ + LV E M + + LD + +
Sbjct: 78 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQMLC 130
Query: 192 GLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGY 251
G+++LH +I+RD K SN+++ D K+ DFGLA+ T S + T + T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR---TAGTSFMMTPYVVTRYY 184
Query: 252 CAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWA--TPLFKDRRK 309
APE L D++S G + E++ + + ++ N V TP + +K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244
Query: 310 FTMMADPLLEGNYPIKGL 327
+E GL
Sbjct: 245 LQPTVRNYVENRPKYAGL 262
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-29
Identities = 43/205 (20%), Positives = 80/205 (39%), Gaps = 9/205 (4%)
Query: 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN--REFLVEVLMLSMLSNPY 137
+ + +G G +G V T VAVK+L R + E+ +L + +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 138 LVNLVGYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
++ L+ + L L+ + L + + + RGL+Y+H
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 138
Query: 198 ESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYA 257
+I+RD K SN+ +++D K+ DFGLA+ ++ V +
Sbjct: 139 S---ADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPEIML 191
Query: 258 LTGQLTAKSDVYSFGVVFLEIITGR 282
D++S G + E++TGR
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (277), Expect = 4e-28
Identities = 45/210 (21%), Positives = 77/210 (36%), Gaps = 16/210 (7%)
Query: 86 LLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYC 145
LG G F V+ K N VA+K + + E+ +L +++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 78
Query: 146 VDGDQRILVY--EYMPNGSL----------EDHLLDLPPNRKALDWNTRMKIAHGAARGL 193
+ ++L + PNG L + + +I+ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 194 EYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYC 252
+Y+H + +I+ D K NVL++ D L +A LG T + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 253 APEYALTGQLTAKSDVYSFGVVFLEIITGR 282
+PE L +D++S + E+ITG
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 77.1 bits (189), Expect = 3e-17
Identities = 22/161 (13%), Positives = 44/161 (27%), Gaps = 30/161 (18%)
Query: 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG----------FQGNREFLVEVLMLSMLS 134
L+GEG V+ E + VK G+ F V + +
Sbjct: 6 KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64
Query: 135 NPYLVNLVGYCV----DGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAA 190
L L G V + ++ E + + ++
Sbjct: 65 FRALQKLQGLAVPKVYAWEGNAVLMELIDAK-----------ELYRVRVENPDEVLDMIL 113
Query: 191 RGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231
+ + +++ D NVL+ + + DF +
Sbjct: 114 EEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Score = 37.5 bits (86), Expect = 0.002
Identities = 17/135 (12%), Positives = 40/135 (29%), Gaps = 14/135 (10%)
Query: 87 LGEGGFGRVYRGKLEGTNQDVAVKQL--------DRNGFQGNREFLVEVLMLSMLSNPYL 138
+G+G V+ + ++ + +KQ + +R +E L
Sbjct: 34 IGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRAR-IESSALIRQGEHVP 92
Query: 139 VNLV-GYCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLH 197
+ + D + + V E + + + L + I + L Y
Sbjct: 93 HLVPRVFYSDTEMAVTVMEDLSHLKIARKGL----IEGENYPHLSQHIGEFLGKTLFYSS 148
Query: 198 ESAQPPVIYRDFKAS 212
+ A P + +
Sbjct: 149 DYALEPKVKKQLVKQ 163
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 399 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.13 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.09 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.88 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-58 Score=417.09 Aligned_cols=253 Identities=26% Similarity=0.341 Sum_probs=208.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5799999999999999999999999999999999765432 345688999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999975 567999999999999999999999999 9999999999999999999999999998655444
Q ss_pred CccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|++||............ ... .
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~-~~~--------------~ 222 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-WKE--------------K 222 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH-HHT--------------T
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH-Hhc--------------C
Confidence 4444455789999999999988876 56899999999999999999999865432211110 000 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
..........+..+.+|+.+||+.||.+|||++++++
T Consensus 223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0000111233457889999999999999999999954
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-57 Score=416.58 Aligned_cols=251 Identities=26% Similarity=0.397 Sum_probs=213.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999999999999999998766566678999999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
+||+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.+|.+||+|||+++......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 99999998865 46999999999999999999999999 9999999999999999999999999998654332
Q ss_pred ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 239 SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......||+.|+|||++.+..|+.++|||||||++|+|++|+.||............ .... .+
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~------~~~~-------~~-- 234 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNG-------TP-- 234 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHC-------SC--
T ss_pred -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH------HhCC-------CC--
Confidence 2234467999999999999999999999999999999999999999865432211111 0000 00
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 011233445678899999999999999999999754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-57 Score=409.45 Aligned_cols=264 Identities=29% Similarity=0.454 Sum_probs=207.9
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
..++|.+.+.||+|+||.||+|++++ .||||+++.... ...+.+.+|+.++++++|||||++++++.+ +..++|
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred ccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 34689999999999999999998653 599999875432 334678999999999999999999998764 568999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ....+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+...
T Consensus 82 ~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 999999999999976 3456999999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCccccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
............||+.|+|||++.+ +.|+.++|||||||++|||+||+.||....+....... ....
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~--~~~~-------- 225 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM--VGRG-------- 225 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHH--HHHT--------
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHH--HhcC--------
Confidence 4444444456789999999999864 45899999999999999999999999876543221111 1100
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSK 362 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~ 362 (399)
...+.+ ...+...+..+.+|+.+||+.||.+|||+.+|+++|+.++++-
T Consensus 226 -~~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 226 -YLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -SCCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -CCCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 001111 1112233457889999999999999999999999999988653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=409.42 Aligned_cols=247 Identities=26% Similarity=0.382 Sum_probs=209.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.+.||+|+||.||+|++..+++.||||++.+.. ......+.+|+.+++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 47889999999999999999999999999999986432 233466889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999976 457999999999999999999999999 99999999999999999999999999976443
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+ ....
T Consensus 159 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~-------- 220 (263)
T d2j4za1 159 SR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SRVE-------- 220 (263)
T ss_dssp CC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTTC--------
T ss_pred Cc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH------HcCC--------
Confidence 22 23457999999999999999999999999999999999999999875432211111 0100
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...+...+..+.+|+.+||+.||.+|||+++++++
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 11222344578899999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-57 Score=413.53 Aligned_cols=253 Identities=23% Similarity=0.354 Sum_probs=211.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+.|++.+.||+|+||.||+|++..++..||||++........+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 35888899999999999999999999999999998776666778999999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|..... .
T Consensus 92 ~~g~L~~~~~~---~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~--~ 163 (288)
T d2jfla1 92 AGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--T 163 (288)
T ss_dssp TTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHH--H
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCC--C
Confidence 99999999865 2456999999999999999999999999 99999999999999999999999999864221 1
Q ss_pred cccccccccccccccccccc-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 239 SHVSTRVMGTYGYCAPEYAL-----TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
........||+.|+|||++. +..|+.++|||||||++|+|++|+.||....+.+....+ ....
T Consensus 164 ~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~~~~------ 231 (288)
T d2jfla1 164 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------AKSE------ 231 (288)
T ss_dssp HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------HHSC------
T ss_pred cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcCC------
Confidence 12233467999999999884 456899999999999999999999999876543321111 0000
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+ ....+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 232 -~~--~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 232 -PP--TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -CC--CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -CC--CCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 011233445688999999999999999999999754
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-57 Score=414.02 Aligned_cols=262 Identities=26% Similarity=0.370 Sum_probs=216.4
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
+..++|++.+.||+|+||.||+|.+..+++.||||++.... ...+++.+|+.++++++|||||++++++.+++..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888899999999999999999999999999987653 34577999999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+++|+|.+++... ....+++..++.++.|++.||.|||+++ |+||||||+||||+.++.+||+|||+|+....
T Consensus 93 E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCC
Confidence 999999999999762 3467999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. ........|++.|+|||++.++.|+.++|||||||++|||++|..||....... ...... .
T Consensus 168 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~~~i--------------~ 230 (287)
T d1opja_ 168 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELL--------------E 230 (287)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHH--------------H
T ss_pred CC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHHHHH--------------h
Confidence 32 222334568999999999999999999999999999999999766554332211 111111 0
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
.......+...+..+.+|+.+||+.||.+|||+++|++.|+.+..
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111122233445678999999999999999999999999988754
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-57 Score=413.42 Aligned_cols=257 Identities=22% Similarity=0.310 Sum_probs=199.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEee--CCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVD--GDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~--~~~~~lv 154 (399)
++|++.+.||+|+||.||+|++..+++.||||.+...... ..+.+.+|+.++++++|||||++++++.+ ++..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999999999999999999765433 23568899999999999999999999865 4568999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA--QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
|||+++|+|.+++......+..+++..++.++.||+.||.|||+.+ ..+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999998753334567999999999999999999999865 23499999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... .......||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+....+ ... .
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i------~~~--~--- 230 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------REG--K--- 230 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHT--C---
T ss_pred cccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH------HcC--C---
Confidence 44322 2233467999999999999999999999999999999999999999875432211111 000 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+ ..+...+..+.+|+.+||+.||.+|||+.|++++
T Consensus 231 --~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 231 --FR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp --CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 01 1122344578899999999999999999999753
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-57 Score=412.91 Aligned_cols=261 Identities=23% Similarity=0.300 Sum_probs=214.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|++.+.||+|+||+||+|.+..+++.||||++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 47999999999999999999999999999999997532 233466899999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999876 467999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
...........||+.|+|||++.+..|+.++|||||||++|+|++|+.||...++......+ ....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~~-------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKI------IKLE-------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HTTC--------
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHH------HcCC--------
Confidence 44444445567999999999999999999999999999999999999999875432211111 1110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccc
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~ 364 (399)
..++...+..+.+|+.+||+.||.+|||++|++.+-.-+.+++..
T Consensus 227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~ 271 (288)
T d1uu3a_ 227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred ----CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccC
Confidence 112233445788999999999999999999987765545555543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-56 Score=405.41 Aligned_cols=258 Identities=27% Similarity=0.411 Sum_probs=204.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.+.||+|+||.||+|.+.+ +..||||++.... ...+++.+|+.++++++|||||++++++.+++..++||||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 3578889999999999999999874 6789999997643 4457799999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 82 MEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp CTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred cCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 999999999876 3467899999999999999999999999 9999999999999999999999999998654332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITG-RRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.. ......||+.|+|||++.+..++.++|||||||++|||+|+ .+||......+. .......
T Consensus 156 ~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~------------- 218 (263)
T d1sm2a_ 156 YT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---VEDISTG------------- 218 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH---HHHHHHT-------------
T ss_pred ce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH---HHHHHhc-------------
Confidence 22 22335689999999999999999999999999999999994 666654332211 1111110
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.....+...+..+.+++.+||+.||.+|||+++|+++|++++.+
T Consensus 219 -~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 219 -FRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 00111223345788999999999999999999999999998653
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-56 Score=409.68 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=202.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCe---EEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQ---DVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.++||+|+||+||+|.+..++. .||||.+..... ...+.+.+|+.+|++++|||||++++++.+++..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467778999999999999999876554 688998865433 2346789999999999999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999998876 3457999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCccc---cccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 235 TGDKSHV---STRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 235 ~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |++||......+....+ ..
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i---~~-------- 248 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQ-------- 248 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HT--------
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc--------
Confidence 3322211 122457899999999999999999999999999999998 89999876543211111 00
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
......+...+..+.+|+.+||+.||.+|||+.+|++.|+++.+
T Consensus 249 ------~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 ------DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ------TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 01112233445678899999999999999999999999998755
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-55 Score=395.25 Aligned_cols=255 Identities=25% Similarity=0.404 Sum_probs=214.8
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.+.||+|+||+||+|+++ ++..||||++..... ..+++.+|+.++++++||||+++++++.+++..++||||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 468999999999999999999986 588999999987543 457899999999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|..++.. ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 81 MANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp CTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred cCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 999999999776 3467899999999999999999999999 9999999999999999999999999998654432
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+....+. . .
T Consensus 155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~---~---~---------- 217 (258)
T d1k2pa_ 155 Y-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---Q---G---------- 217 (258)
T ss_dssp C-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---T---T----------
T ss_pred c-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH---h---C----------
Confidence 2 23334669999999999999999999999999999999998 899998765433221111 0 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.....|...+..+.+|+.+||+.||.+|||+++|+++|.++
T Consensus 218 -~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 218 -LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 01112223345788999999999999999999999998653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=411.80 Aligned_cols=259 Identities=25% Similarity=0.381 Sum_probs=209.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCC-----eEEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTN-----QDVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQR 151 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~ 151 (399)
++|.+.++||+|+||+||+|++.+++ ..||+|.+.... ......+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 57888899999999999999986544 369999986543 23346788999999998 899999999999999999
Q ss_pred EEEEEecCCCChHHhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 046609 152 ILVYEYMPNGSLEDHLLDLPP-------------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKAS 212 (399)
Q Consensus 152 ~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~ 212 (399)
++|||||++|+|.++|+.... ....+++..++.++.|++.||.|||+++ ||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchh
Confidence 999999999999999976321 1245899999999999999999999999 999999999
Q ss_pred ceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCc
Q 046609 213 NVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPT 291 (399)
Q Consensus 213 NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~ 291 (399)
|||++.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |++||.+....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544444444445678999999999999999999999999999999998 89999876543
Q ss_pred ccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHH
Q 046609 292 EEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIE 356 (399)
Q Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~ 356 (399)
... .... .. ......+...+..+.+|+.+||+.||.+|||+++|+++|.
T Consensus 274 ~~~--~~~~----~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 274 ANF--YKLI----QN----------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp HHH--HHHH----HT----------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--HHHH----hc----------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 211 1111 10 1111223344567899999999999999999999999985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-56 Score=414.21 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=208.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|.+.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+.+|++++|||||+++++|.+++..++|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 4689999999999999999999999999999999976532 234678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
|++||+|.+++.. .+.+++..++.++.|++.||.|||+ ++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp CCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred cCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999976 4569999999999999999999997 48 99999999999999999999999999975321
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh-hhhhhhc--------
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW-ATPLFKD-------- 306 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~-~~~~~~~-------- 306 (399)
......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+.......... .......
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred ----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence 122346799999999999999999999999999999999999999987553321110000 0000000
Q ss_pred -----------------cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 -----------------RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 -----------------~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....................+..+.+|+.+||+.||.+|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000000000000011224578899999999999999999999985
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-55 Score=408.31 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=194.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
+.|.+.+.||+|+||+||+|++..+++.||||++...... ....+.+|+.++++++|||||++++++.+++..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 5689999999999999999999999999999999765433 235578899999999999999999999999999999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC---CCCCeeEecccCccCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD---QDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~---~~~~~kl~Dfg~~~~~~ 234 (399)
|+||+|.+++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+. .++.+||+|||+++...
T Consensus 89 ~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 89 VSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred cCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 999999999976 467999999999999999999999999 99999999999994 57899999999998543
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... .....+||+.|+|||++.+..|+.++|||||||++|+|++|++||...........+ .....
T Consensus 162 ~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i------~~~~~------ 226 (307)
T d1a06a_ 162 PGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI------LKAEY------ 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HTTCC------
T ss_pred CCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------hccCC------
Confidence 322 223467999999999999999999999999999999999999999875432211111 11000
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+..+.+|+.+||+.||.+|||++|++++
T Consensus 227 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 --EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01111122344578899999999999999999999875
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=397.24 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=198.9
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee----CCeeEEEE
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD----GDQRILVY 155 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 155 (399)
++.+.||+|+||+||+|.+..++..||+|.+..... ...+.+.+|+.++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 556789999999999999999999999999975432 233568899999999999999999999865 45679999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC-CCCCeeEecccCccCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD-QDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~-~~~~~kl~Dfg~~~~~~ 234 (399)
||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ ++|+||||||+|||++ .++.+||+|||+++...
T Consensus 92 E~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 99999999999976 457999999999999999999999865 3499999999999996 57899999999997532
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
.. ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||........ +...... . ..
T Consensus 167 ~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~~~~i~~---~------~~ 230 (270)
T d1t4ha_ 167 AS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IYRRVTS---G------VK 230 (270)
T ss_dssp TT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HHHHHTT---T------CC
T ss_pred CC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--HHHHHHc---C------CC
Confidence 22 2234679999999998764 699999999999999999999999986543221 1111100 0 00
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.+.+ +...+..+.+|+.+||+.||++|||++|++++
T Consensus 231 ~~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 PASF----DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CGGG----GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred Cccc----CccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 0111 11223468899999999999999999999763
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=400.41 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=209.3
Q ss_pred CCCCCCCe-eccCCcEEEEEEEECC--CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNL-LGEGGFGRVYRGKLEG--TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.+. ||+|+||.||+|.++. ++..||||++..... ...+.+.+|+.++++++|||||++++++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 35556664 9999999999998753 456899999976533 234678999999999999999999999975 467999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. .+..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 87 mE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccc
Confidence 999999999999865 3467999999999999999999999999 9999999999999999999999999998654
Q ss_pred CCCCc-cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 235 TGDKS-HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 235 ~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+....+ . .
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i---~----~------ 227 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---E----Q------ 227 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---H----T------
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHH---H----c------
Confidence 43322 22234568999999999999999999999999999999998 99999876543221111 0 0
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
......+...+..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus 228 ----~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 228 ----GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 00112233444678899999999999999999999999887654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.3e-55 Score=411.98 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=212.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||.||+|.+..+++.||||++........+.+.+|+.++++++|||||++++++.+++..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 47999999999999999999999999999999998766556677899999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC--CCCCeeEecccCccCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD--QDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~--~~~~~kl~Dfg~~~~~~~~ 236 (399)
+||+|.+++.. ....+++..++.++.||+.||.|||+++ ||||||||+|||++ .++.+||+|||+++.....
T Consensus 106 ~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 106 SGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 99999999965 3457999999999999999999999999 99999999999995 4678999999999864433
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. .....
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~~~~------- 243 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK------SCDWN------- 243 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTCCC-------
T ss_pred c---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------hCCCC-------
Confidence 2 2334679999999999999999999999999999999999999998754332211110 00000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.........+..+.+|+.+||+.||.+|||+++++++
T Consensus 244 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 -MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp -SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred -CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0011112334578899999999999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-55 Score=398.22 Aligned_cols=257 Identities=27% Similarity=0.388 Sum_probs=208.1
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.+.||+|+||.||+|.++ ++..||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 457888899999999999999987 47889999997653 445779999999999999999999998865 567999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 9999999987652 2345999999999999999999999999 9999999999999999999999999998654332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR-RVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
........||+.|+|||++.++.++.++|||||||++|||+||. +||......+ ....+.. .
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~---~~~~i~~----------~--- 226 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLER----------G--- 226 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT----------T---
T ss_pred -cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh----------c---
Confidence 22233456899999999999999999999999999999999955 5555433221 1111100 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
.....+...+..+.+|+.+||+.||++|||+.+|++.|+.+-+
T Consensus 227 -~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 1111222344578899999999999999999999999987654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-55 Score=396.71 Aligned_cols=249 Identities=27% Similarity=0.422 Sum_probs=201.3
Q ss_pred CeeccCCcEEEEEEEEC--CCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEecCC
Q 046609 85 NLLGEGGFGRVYRGKLE--GTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYMPN 160 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 160 (399)
+.||+|+||.||+|.+. .+++.||||++..... ...+.+.+|+.++++++|||||++++++.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 57999999999999864 3457899999965432 224679999999999999999999999965 457899999999
Q ss_pred CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCCc-
Q 046609 161 GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKS- 239 (399)
Q Consensus 161 g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~- 239 (399)
|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999986 467999999999999999999999999 999999999999999999999999999865443322
Q ss_pred cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCCcc
Q 046609 240 HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADPLL 318 (399)
Q Consensus 240 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 318 (399)
.......||+.|+|||++.+..++.++|||||||++|||++ |++||......+....+ . . ..
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i---~----~----------~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---E----K----------GE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---H----T----------TC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHH---H----c----------CC
Confidence 22334578999999999999999999999999999999998 89999876543211111 1 0 01
Q ss_pred CCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 319 EGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 319 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
....+...+..+.+|+.+||+.||.+|||+++|++.|+..
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1122333456788999999999999999999999988765
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.4e-55 Score=410.87 Aligned_cols=253 Identities=21% Similarity=0.253 Sum_probs=212.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|++.+.||+|+||.||+|.+..+++.||||++..........+.+|+.++++++|||||++++++.+++..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999999999999999999999998765555667889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEEC--CCCCeeEecccCccCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLD--QDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~--~~~~~kl~Dfg~~~~~~~~ 236 (399)
+||+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||||+ .++.+||+|||+|......
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999988865 3456999999999999999999999999 99999999999997 6789999999999865433
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+ ... ..
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~--------~~ 245 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRC--------DW 245 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHC--------CC
T ss_pred C---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC--------CC
Confidence 2 234467999999999999999999999999999999999999999875543221111 000 00
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..........+..+.+|+.+||+.||.+|||+.|++++
T Consensus 246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01111222344578899999999999999999999874
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-55 Score=404.48 Aligned_cols=246 Identities=28% Similarity=0.393 Sum_probs=204.5
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcch---HHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGN---REFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.|+..+.||+|+||+||+|++..+++.||||++........ +.+.+|+.++++++|||||++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 48888999999999999999999999999999976544332 458899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
||.+|+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp CCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred ecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999877665 467999999999999999999999999 99999999999999999999999999985332
Q ss_pred CCccccccccccccccccccccC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALT---GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMM 313 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 313 (399)
.....||+.|+|||++.+ +.|+.++|||||||++|+|++|+.||.......... .....
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~~------- 229 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQN------- 229 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHS-------
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhC-------
Confidence 223569999999999864 468999999999999999999999998654322111 00000
Q ss_pred cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.+. +...+..+.+|+.+||+.||.+|||+++++++
T Consensus 230 ~~~~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 230 ESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp CCCCCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred CCCCCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 011111 11234578899999999999999999999874
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=396.91 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=203.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCC----eEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTN----QDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
+.|++.++||+|+||.||+|.++.++ ..||||++...... ...++.+|+.++++++|||||++++++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 56778899999999999999986544 47999999754333 23568899999999999999999999999999999
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+.+|++.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998876 3467999999999999999999999999 999999999999999999999999999865
Q ss_pred CCCCC-ccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCCCcccchhhHhhhhhhhccchhh
Q 046609 234 PTGDK-SHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVID-NSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 234 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..... ........||+.|+|||++.++.++.++|||||||++|||++|..|+. .....+ ....+.
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~---~~~~i~---------- 227 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKAIN---------- 227 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH----------
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH---HHHHHh----------
Confidence 43322 222334568999999999999999999999999999999999655544 332211 111110
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
...+...+...+..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus 228 ----~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 273 (283)
T d1mqba_ 228 ----DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273 (283)
T ss_dssp ----TTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----ccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence 1111222334456789999999999999999999999999988654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=404.31 Aligned_cols=249 Identities=27% Similarity=0.347 Sum_probs=211.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+.++||+|+||.||+|++..+++.||||++.+.. ......+.+|+.+|++++||||+++++++.+++..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999999999999999997542 233466889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999987 567999999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|++||...+..+....+ ....
T Consensus 158 ~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i------~~~~-------- 221 (337)
T d1o6la_ 158 DG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LMEE-------- 221 (337)
T ss_dssp TT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC--------
T ss_pred CC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH------hcCC--------
Confidence 22 2334467999999999999999999999999999999999999999976543211111 1110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
..+|...+..+.+||.+||+.||.+||+ +.+++++
T Consensus 222 ----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 ----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1123334457889999999999999995 7888774
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=398.84 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=208.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|.+.+.||+|+||+||+|++..+++.||||++.+.... ..+.+.+|+.++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999999999999999999754321 2467899999999999999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC----CeeEeccc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF----NPKLSDFG 228 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~----~~kl~Dfg 228 (399)
+|||||+||+|.+++.. .+.+++..++.++.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999976 457999999999999999999999999 99999999999998776 49999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+. ....
T Consensus 163 ~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------AVNY 233 (293)
T ss_dssp TCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TTCC
T ss_pred hhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH------hcCC
Confidence 998654332 2234569999999999999999999999999999999999999998755332211110 0000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ....+...+..+.+|+.+||+.||.+|||+++++++
T Consensus 234 ~~--------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 234 EF--------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CC--------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CC--------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 000011233578899999999999999999999763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-54 Score=399.17 Aligned_cols=259 Identities=27% Similarity=0.416 Sum_probs=208.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCe----EEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQ----DVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
++|++.++||+|+||+||+|.+..+++ .||+|.+.... ....+++.+|+.++++++|||||++++++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999999987765 58888886432 33457799999999999999999999999875 5678
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
++||+.+|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceec
Confidence 8899999999998876 3567999999999999999999999999 999999999999999999999999999876
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
.............||+.|+|||++.++.++.++|||||||++|||+| |.+||......+....+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~------------- 228 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------- 228 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-------------
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-------------
Confidence 55444444445678999999999999999999999999999999998 8999987654332221110
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......+...+..+.+|+.+||+.||.+|||+.+|+++|..+...
T Consensus 229 ----~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 229 ----GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp ----TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 001122333445788999999999999999999999999988654
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-53 Score=395.66 Aligned_cols=246 Identities=26% Similarity=0.378 Sum_probs=209.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 47889999999999999999999999999999996432 233467889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||++||+|..++.. ...+++..++.++.||+.||.|||+++ |+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999987 567899999999999999999999999 99999999999999999999999999986433
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||...+..+....+ ....
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~-------- 217 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNAE-------- 217 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHCC--------
T ss_pred c-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------HcCC--------
Confidence 2 23467999999999999999999999999999999999999999875543221111 1110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
..++...+..+.+++.+||+.||.+|| |+++++++
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 112223345788999999999999996 89999875
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-53 Score=388.16 Aligned_cols=261 Identities=22% Similarity=0.293 Sum_probs=206.0
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---hHHHHHHHHHHHccCCCceeeEEEEEeeCC----e
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---NREFLVEVLMLSMLSNPYLVNLVGYCVDGD----Q 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~ 150 (399)
.++|.+.+.||+|+||.||+|.+..+++.||||++....... ...+.+|+.+++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999997654332 346889999999999999999999987654 3
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||+++ |+||||||+|||++.++..+|+|||.+
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhh
Confidence 7899999999999999876 467999999999999999999999999 999999999999999999999999988
Q ss_pred cCCCCCC-CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 231 KLGPTGD-KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 231 ~~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
....... .........||+.|+|||++.+..++.++|||||||++|+|+||++||....+.+... ........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------~~~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCCC
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH------HHHhcCCC
Confidence 7543322 2223344679999999999999999999999999999999999999998755432111 11111111
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCC-ChHHHHHHHHHhh
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-MMSDVVTAIEYLA 359 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~eil~~L~~l~ 359 (399)
... . .....+..+.+++.+||+.||.+|| |++++++.|.++.
T Consensus 233 ~~~----~----~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 PPS----A----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CGG----G----TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCc----h----hccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 000 1 1112335788999999999999999 8999999988774
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=394.31 Aligned_cols=268 Identities=25% Similarity=0.339 Sum_probs=204.1
Q ss_pred HHhcCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeEEEEEee
Q 046609 75 CVATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNLVGYCVD 147 (399)
Q Consensus 75 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~ 147 (399)
.+..++|.+.+.||+|+||.||+|.+.. +++.||||++...... ..+.+..|..++.++ +|+||+.+++++.+
T Consensus 9 ei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 9 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc
Confidence 3445689999999999999999999754 3468999998754332 335577788877776 68999999999876
Q ss_pred C-CeeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCce
Q 046609 148 G-DQRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNV 214 (399)
Q Consensus 148 ~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NI 214 (399)
. ...++|||||++|+|.+++..... ....+++..++.++.|++.||.|||+++ ||||||||+||
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NI 165 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNI 165 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccce
Confidence 4 468999999999999999975321 1345899999999999999999999999 99999999999
Q ss_pred EECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCccc
Q 046609 215 LLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITG-RRVIDNSRPTEE 293 (399)
Q Consensus 215 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~ 293 (399)
||+.++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++| .+||........
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~ 245 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 245 (299)
T ss_dssp EECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred eECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence 9999999999999999865554444445557799999999999999999999999999999999986 567876543221
Q ss_pred chhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 294 QNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
+.... ... . ....+...+..+.+++.+||+.||.+|||+.+|+++|+.+.++
T Consensus 246 --~~~~~----~~~------~----~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 246 --FCRRL----KEG------T----RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp --HHHHH----HHT------C----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHHH----hcC------C----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 11110 000 0 1112223345788999999999999999999999999988654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-54 Score=386.98 Aligned_cols=252 Identities=28% Similarity=0.393 Sum_probs=202.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEee-CCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVD-GDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~ 157 (399)
++|.+.+.||+|+||.||+|.++ +..||||+++.. ...+.+.+|+.++++++||||+++++++.+ .+..++||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46778899999999999999986 678999999754 345779999999999999999999999865 4568999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999752 1235899999999999999999999999 999999999999999999999999999853322
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
.....++..|+|||++.++.++.++|||||||++|||+| |++||........ ...+. .
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~~~i~--------------~ 215 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVE--------------K 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HHHHT--------------T
T ss_pred ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHH--------------c
Confidence 223458899999999999999999999999999999998 7888876544321 11111 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......+...+..+.+|+.+||+.||.+|||+.+|+++|+++++.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence 111223334445788999999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.8e-54 Score=395.45 Aligned_cols=267 Identities=25% Similarity=0.415 Sum_probs=215.5
Q ss_pred HHHHhcCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCCcc-hHHHHHHHHHHHccCCCceeeEEEEEe
Q 046609 73 ELCVATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGFQG-NREFLVEVLMLSMLSNPYLVNLVGYCV 146 (399)
Q Consensus 73 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~hpnIv~l~~~~~ 146 (399)
++....++|++.+.||+|+||+||+|++.+ +++.||||++....... .+++.+|+.++++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 344456789999999999999999999753 45789999987543332 456899999999999999999999999
Q ss_pred eCCeeEEEEEecCCCChHHhhccCC--------------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 046609 147 DGDQRILVYEYMPNGSLEDHLLDLP--------------------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIY 206 (399)
Q Consensus 147 ~~~~~~lv~e~~~~g~L~~~l~~~~--------------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH 206 (399)
+.+..+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||+.+ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999997522 12335899999999999999999999999 999
Q ss_pred cCCCCCceEECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCC
Q 046609 207 RDFKASNVLLDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR-RVI 285 (399)
Q Consensus 207 ~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf 285 (399)
|||||+|||++.++.+||+|||+|+...............|++.|+|||++.+..|+.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999997544333333444567899999999999999999999999999999999985 678
Q ss_pred CCCCCcccchhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhh
Q 046609 286 DNSRPTEEQNLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLA 359 (399)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~ 359 (399)
......+....+ . ... ....+...+..+.+|+.+||+.+|.+|||+.+|+++|+++.
T Consensus 244 ~~~~~~e~~~~v---~----~~~----------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEVIYYV---R----DGN----------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHHHHHH---H----TTC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHHHHHH---H----cCC----------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 776543321111 0 000 01123334457889999999999999999999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=388.08 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=201.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCCc-chHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGFQ-GNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRIL 153 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~l 153 (399)
.++|++.+.||+|+||.||+|.+..+ +..||||.+...... ..+.+.+|+.++++++|||||++++++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 35788899999999999999998644 356899988654333 2356899999999999999999999996 467899
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLG 233 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 233 (399)
||||+++|+|.+++.. ....+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheec
Confidence 9999999999998876 3467999999999999999999999999 999999999999999999999999999864
Q ss_pred CCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchhhh
Q 046609 234 PTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKFTM 312 (399)
Q Consensus 234 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (399)
..... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||......+....+. ..
T Consensus 159 ~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-------~~----- 225 (273)
T d1mp8a_ 159 EDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-------NG----- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-------TT-----
T ss_pred cCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cC-----
Confidence 43322 22334568999999999999999999999999999999998 899998876543221111 00
Q ss_pred ccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 313 MADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 313 ~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
.....+...+..+.+|+.+||+.||.+|||+.+|+++|+.+...
T Consensus 226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 00112333445789999999999999999999999999987543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-53 Score=394.11 Aligned_cols=248 Identities=28% Similarity=0.435 Sum_probs=206.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHH-ccCCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLS-MLSNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|.+.+.||+|+||+||+|.+..+++.||||++.+.. ......+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57899999999999999999999999999999997532 233345666776665 68999999999999999999999
Q ss_pred EEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCC
Q 046609 155 YEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGP 234 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~ 234 (399)
|||+++|+|.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999976 457999999999999999999999999 9999999999999999999999999998643
Q ss_pred CCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhcc
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMA 314 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (399)
... .......||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.++......+. ..
T Consensus 155 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~-------- 218 (320)
T d1xjda_ 155 LGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------MD-------- 218 (320)
T ss_dssp CTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC--------
T ss_pred ccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------cC--------
Confidence 322 22344679999999999999999999999999999999999999998765432211111 11
Q ss_pred CCccCCCCCHHHHHHHHHHHhhccccCCCCCCChH-HHHH
Q 046609 315 DPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMS-DVVT 353 (399)
Q Consensus 315 ~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-eil~ 353 (399)
.+ .++...+..+.+|+.+||+.||.+||++. ++++
T Consensus 219 ~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 12223345788999999999999999995 7765
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-53 Score=393.45 Aligned_cols=252 Identities=16% Similarity=0.234 Sum_probs=208.5
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
++|.+.+.||+|+||+||+|.+..+++.||||++.... .....+.+|+.+|+.++|||||++++++.+++..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 67999999999999999999999999999999997653 23356789999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCC--CCeeEecccCccCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQD--FNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~--~~~kl~Dfg~~~~~~~~ 236 (399)
+||+|.+++.. ....+++.+++.++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++......
T Consensus 84 ~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999976 2446999999999999999999999999 9999999999999854 57999999999864333
Q ss_pred CCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||......+....+ ......+....
T Consensus 158 ~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~~~~~~~~~-- 226 (321)
T d1tkia_ 158 D---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEYTFDEEA-- 226 (321)
T ss_dssp C---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCCCCCHHH--
T ss_pred C---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCCCChhh--
Confidence 2 233457899999999999999999999999999999999999999876543211111 11100000000
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....+..+.+|+.+||..||.+|||+.|++++
T Consensus 227 ------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 227 ------FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp ------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 01123468899999999999999999999985
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7.7e-53 Score=383.56 Aligned_cols=252 Identities=24% Similarity=0.303 Sum_probs=208.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc---------hHHHHHHHHHHHccC-CCceeeEEEEEeeC
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG---------NREFLVEVLMLSMLS-NPYLVNLVGYCVDG 148 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---------~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~ 148 (399)
++|++.+.||+|+||+||+|++..+++.||||++....... .+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 68999999999999999999999999999999997654321 135788999999997 99999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEeccc
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFG 228 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg 228 (399)
+..+|||||+++|+|.+++.. ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999976 457999999999999999999999999 9999999999999999999999999
Q ss_pred CccCCCCCCCccccccccccccccccccccC------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhh
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALT------GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATP 302 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~ 302 (399)
+++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||....+......+
T Consensus 156 ~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i----- 227 (277)
T d1phka_ 156 FSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI----- 227 (277)
T ss_dssp TCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-----
T ss_pred heeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHH-----
Confidence 998654432 2234579999999998853 45788999999999999999999999876543221111
Q ss_pred hhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
...... .........+..+.+|+.+||+.||.+|||+++|+++
T Consensus 228 -~~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 -MSGNYQ--------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp -HHTCCC--------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred -HhCCCC--------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111000 0111122445678999999999999999999999654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=387.05 Aligned_cols=258 Identities=28% Similarity=0.392 Sum_probs=203.3
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEe
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 157 (399)
.++|++.+.||+|+||.||+|.++++ ..||||++.... ...+.+.+|+.++++++|||||++++++.+ +..++||||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 35788999999999999999999864 679999997553 445789999999999999999999999965 567899999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGD 237 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~ 237 (399)
+++|+|..++... ....+++..++.++.||+.||.|||+++ |+||||||+||||+.++++||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999998752 2356999999999999999999999999 9999999999999999999999999998654332
Q ss_pred CccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 238 KSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVI-DNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 238 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......||+.|+|||++.++.++.++|||||||++|||++|..|+ ......+. ...+..
T Consensus 168 ~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~---~~~i~~-------------- 229 (285)
T d1fmka3 168 Y-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVER-------------- 229 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT--------------
T ss_pred c-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHH---HHHHHh--------------
Confidence 2 2233456999999999999999999999999999999999965554 44332111 111100
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
......+...+..+.+++.+||+.||++||++.+|++.|+...+.
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 011122333445788999999999999999999999998876543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-52 Score=389.48 Aligned_cols=263 Identities=24% Similarity=0.385 Sum_probs=210.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCe--EEEEEEEccCC-CcchHHHHHHHHHHHcc-CCCceeeEEEEEeeCCeeEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQ--DVAVKQLDRNG-FQGNREFLVEVLMLSML-SNPYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 154 (399)
++|++.++||+|+||.||+|.+.+++. .||||.+.... ....+.+.+|+.++.++ +|||||++++++.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578888999999999999999987776 47778875432 23446789999999998 799999999999999999999
Q ss_pred EEecCCCChHHhhccCC------------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCe
Q 046609 155 YEYMPNGSLEDHLLDLP------------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNP 222 (399)
Q Consensus 155 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~ 222 (399)
|||+++|+|.++|+... .....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997531 23467999999999999999999999999 9999999999999999999
Q ss_pred eEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCC-CCCCCCCCcccchhhHhhh
Q 046609 223 KLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGR-RVIDNSRPTEEQNLVTWAT 301 (399)
Q Consensus 223 kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~-~pf~~~~~~~~~~~~~~~~ 301 (399)
||+|||+++...... ......||..|+|||.+.++.++.++|||||||++|||++|. +||...+..+. ...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~---~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YEKLP 240 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHGG
T ss_pred EEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH---HHHHH
Confidence 999999997533222 222356899999999999999999999999999999999965 67776543221 11110
Q ss_pred hhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhcccc
Q 046609 302 PLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKEE 364 (399)
Q Consensus 302 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~~ 364 (399)
. ......+...+..+.+|+.+||+.||++|||+.+|+++|+++......
T Consensus 241 ~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~~ 289 (309)
T d1fvra_ 241 Q--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289 (309)
T ss_dssp G--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSSC
T ss_pred h--------------cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcCcC
Confidence 0 011122334456889999999999999999999999999999876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.7e-53 Score=396.91 Aligned_cols=246 Identities=26% Similarity=0.322 Sum_probs=208.6
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCC---CcchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNG---FQGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 155 (399)
++|.+++.||+|+||.||+|.+..+++.||||++.... ....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999999999999999996432 233456889999999999999999999999999999999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPT 235 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~ 235 (399)
||+.+|+|..++.. .+.+++..++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 99999999999976 457999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccC
Q 046609 236 GDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMAD 315 (399)
Q Consensus 236 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (399)
. .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...++......+ ....
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~~-------- 254 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI------VSGK-------- 254 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC--------
T ss_pred c-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHH------hcCC--------
Confidence 2 23467999999999999999999999999999999999999999875432211111 1110
Q ss_pred CccCCCCCHHHHHHHHHHHhhccccCCCCCC-----ChHHHHHH
Q 046609 316 PLLEGNYPIKGLYQALAVAAMCLQEEAGTRP-----MMSDVVTA 354 (399)
Q Consensus 316 ~~l~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~eil~~ 354 (399)
...+...+..+.+|+.+||+.||.+|+ |+++++++
T Consensus 255 ----~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 ----VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp ----CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 011223345788999999999999994 89999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-52 Score=396.80 Aligned_cols=250 Identities=24% Similarity=0.349 Sum_probs=203.4
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC---cchHHHHH---HHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF---QGNREFLV---EVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~---e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|.+.++||+|+||.||+|++..+++.||||++..... .....+.+ ++.+++.++|||||++++++.+++..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 579999999999999999999999999999999864321 11223333 466777788999999999999999999
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||++||+|.+++.. ...+++..++.++.||+.||.|||+++ ||||||||+|||++.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999976 467899999999999999999999999 99999999999999999999999999986
Q ss_pred CCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhh
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFT 311 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (399)
..... .....||+.|+|||++.+ ..|+.++|||||||++|+|++|+.||..........+.... ...
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~---~~~----- 224 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LTM----- 224 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHS---SSC-----
T ss_pred cCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc---ccC-----
Confidence 44332 233579999999999864 56899999999999999999999999876543321111110 000
Q ss_pred hccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 312 MMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 312 ~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
....+...+..+.+||.+||+.||.+||| +++++++
T Consensus 225 -------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 01122234457889999999999999999 6888765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=387.93 Aligned_cols=263 Identities=28% Similarity=0.392 Sum_probs=210.6
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCC-------eEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeEEEEEeeC
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTN-------QDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNLVGYCVDG 148 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~ 148 (399)
.++|.+.+.||+|+||.||+|+...++ ..||||++...... ...++.+|...+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 457888899999999999999875543 47999999765432 336688888888888 799999999999999
Q ss_pred CeeEEEEEecCCCChHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEE
Q 046609 149 DQRILVYEYMPNGSLEDHLLDLPP------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLL 216 (399)
Q Consensus 149 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll 216 (399)
+..++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999976321 2356899999999999999999999999 9999999999999
Q ss_pred CCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccch
Q 046609 217 DQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQN 295 (399)
Q Consensus 217 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~ 295 (399)
+.++.+||+|||+++...............+++.|+|||.+.++.|+.++|||||||++|||++ |++||..........
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~ 248 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHH
Confidence 9999999999999986555444444455679999999999999999999999999999999998 789998655432111
Q ss_pred hhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 296 LVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
.+ .. ......+...+..+.+|+.+||+.||.+|||+.+|++.|+++..
T Consensus 249 ~i-------~~----------~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 249 LL-------KE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HH-------HT----------TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH-------Hc----------CCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11 11 01112233344578999999999999999999999999998854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-52 Score=392.04 Aligned_cols=251 Identities=20% Similarity=0.218 Sum_probs=201.2
Q ss_pred CCCCCC-CeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHc-cCCCceeeEEEEEee----CCeeE
Q 046609 79 TNFNPD-NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSM-LSNPYLVNLVGYCVD----GDQRI 152 (399)
Q Consensus 79 ~~~~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~-l~hpnIv~l~~~~~~----~~~~~ 152 (399)
++|.+. ++||+|+||+||+|.+..+++.||||+++. ...+.+|+.++.+ .+|||||+++++|.+ +...|
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 578776 469999999999999999999999999854 3567789988655 489999999999875 46789
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEecccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFGL 229 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~ 229 (399)
+|||||+||+|.+++... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 86 ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999762 2357999999999999999999999999 999999999999975 56799999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
++...... ......||+.|+|||++.+..|+.++|||||||++|+|+||++||.............
T Consensus 161 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~----------- 226 (335)
T d2ozaa1 161 AKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK----------- 226 (335)
T ss_dssp CEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH-----------
Confidence 98654332 2234679999999999999999999999999999999999999998765432211110
Q ss_pred hhhccCCc--cCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 310 FTMMADPL--LEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 310 ~~~~~~~~--l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
..+.... +........+..+.+|+.+||+.||.+|||+.+++++
T Consensus 227 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 0000000 0001112345678999999999999999999999875
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=385.43 Aligned_cols=257 Identities=26% Similarity=0.346 Sum_probs=199.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCC---CeEEEEEEEccCCC---cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNGF---QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~ 152 (399)
++|++.+.||+|+||.||+|.+... ...||||++..... ...+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5788899999999999999987432 34789999875432 223678999999999999999999999976 4678
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
+||||+++|+|.+++.. ....+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhc---ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 99999999999998876 2456999999999999999999999999 99999999999999999999999999987
Q ss_pred CCCCCCcc-ccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccchhhHhhhhhhhccchh
Q 046609 233 GPTGDKSH-VSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQNLVTWATPLFKDRRKF 310 (399)
Q Consensus 233 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (399)
........ ......|+..|+|||++.+..++.++|||||||++|||+| |++||......+....+ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i------~~----- 229 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI------DK----- 229 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HT-----
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHH------Hh-----
Confidence 54443322 2334568889999999999999999999999999999998 89999876543221111 01
Q ss_pred hhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHh
Q 046609 311 TMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYL 358 (399)
Q Consensus 311 ~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l 358 (399)
.......+...+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus 230 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 -----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1111122333445788999999999999999999999998875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-52 Score=384.10 Aligned_cols=262 Identities=23% Similarity=0.260 Sum_probs=198.2
Q ss_pred CCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcc-----hHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEEec
Q 046609 84 DNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQG-----NREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYEYM 158 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 158 (399)
+++||+|+||+||+|.+..+++.||||++....... .+.+.+|+.++++++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999999999999999986543222 245889999999999999999999999999999999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
.++++..+... ...+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 83 ~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~- 154 (299)
T d1ua2a_ 83 ETDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN- 154 (299)
T ss_dssp SEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-
T ss_pred cchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-
Confidence 88776665543 567999999999999999999999999 9999999999999999999999999997644332
Q ss_pred ccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh-hc-cchhhhccC
Q 046609 239 SHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF-KD-RRKFTMMAD 315 (399)
Q Consensus 239 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~ 315 (399)
.......||+.|+|||++.+ ..|+.++|||||||++|+|++|++||......+....+....... .. .........
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 155 -RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233 (299)
T ss_dssp -CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred -ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccch
Confidence 22234579999999998865 468999999999999999999999998765433221111100000 00 000000000
Q ss_pred Ccc---CCCCC-----HHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 316 PLL---EGNYP-----IKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 316 ~~l---~~~~~-----~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ....+ ......+.+|+.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 000 00011 1234578999999999999999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-52 Score=385.49 Aligned_cols=268 Identities=21% Similarity=0.273 Sum_probs=203.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||+||+|.+..+++.||||++..... .....+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 578999999999999999999999999999999965432 234678999999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+.+ ++..++.. .....+++..++.++.|++.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhh--hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 55555543 13567999999999999999999999999 999999999999999999999999999754322
Q ss_pred CCccccccccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc--cchhhhc
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD--RRKFTMM 313 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 313 (399)
........||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+....+......... .......
T Consensus 156 --~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 156 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 22333457999999999877655 578999999999999999999999876533221111000000000 0000000
Q ss_pred ------cCCccCCC---CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 314 ------ADPLLEGN---YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 314 ------~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........ .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000000 011233578899999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-52 Score=385.29 Aligned_cols=265 Identities=24% Similarity=0.344 Sum_probs=216.2
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEEC-----CCCeEEEEEEEccCCCc-chHHHHHHHHHHHcc-CCCceeeEEEEEeeCC
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLE-----GTNQDVAVKQLDRNGFQ-GNREFLVEVLMLSML-SNPYLVNLVGYCVDGD 149 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l-~hpnIv~l~~~~~~~~ 149 (399)
..++|.+.++||+|+||.||+|++. .+++.||||++...... ....+.+|+.+++++ +|||||++++++.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 3467888899999999999999863 45678999999765432 345688999999998 6999999999999999
Q ss_pred eeEEEEEecCCCChHHhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceE
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPP--------------NRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVL 215 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIl 215 (399)
..++||||+++|+|.++++.... ....+++..+..++.||+.||.|||+++ ||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccccccc
Confidence 99999999999999999976321 2346899999999999999999999999 999999999999
Q ss_pred ECCCCCeeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCCcccc
Q 046609 216 LDQDFNPKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIIT-GRRVIDNSRPTEEQ 294 (399)
Q Consensus 216 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~ellt-g~~pf~~~~~~~~~ 294 (399)
++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+| |.+||......+..
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~ 257 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987665555555556789999999999999999999999999999999999 66666665443211
Q ss_pred hhhHhhhhhhhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 295 NLVTWATPLFKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
. ... ........+...+..+.+|+.+||+.||.+|||+++|+++|++...
T Consensus 258 ~--~~i--------------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 258 Y--KMI--------------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp H--HHH--------------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred H--HHH--------------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1 000 0011112223344578999999999999999999999999987643
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=377.72 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=205.3
Q ss_pred CCeeccCCcEEEEEEEECCC---CeEEEEEEEccCC-CcchHHHHHHHHHHHccCCCceeeEEEEEee-CCeeEEEEEec
Q 046609 84 DNLLGEGGFGRVYRGKLEGT---NQDVAVKQLDRNG-FQGNREFLVEVLMLSMLSNPYLVNLVGYCVD-GDQRILVYEYM 158 (399)
Q Consensus 84 ~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~ 158 (399)
.++||+|+||+||+|.+..+ ...||||+++... ....+++.+|+.++++++||||+++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999998653 3469999997532 2334679999999999999999999999875 45889999999
Q ss_pred CCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCCCC
Q 046609 159 PNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTGDK 238 (399)
Q Consensus 159 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~ 238 (399)
++|+|.+++.. ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999886 3556889999999999999999999999 99999999999999999999999999986544332
Q ss_pred c--cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccchhhhccCC
Q 046609 239 S--HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRKFTMMADP 316 (399)
Q Consensus 239 ~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (399)
. .......||+.|+|||.+.++.++.++||||||+++|||++|..||....... ....... .. .
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~---~g-~-------- 251 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL---QG-R-------- 251 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TT-C--------
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH---cC-C--------
Confidence 2 22233568999999999999999999999999999999999877776533211 1111111 00 0
Q ss_pred ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 317 LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 317 ~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
....+...+..+.+|+.+||+.||++||++.||+++|+.+.....
T Consensus 252 --~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~ 296 (311)
T d1r0pa_ 252 --RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI 296 (311)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred --CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhh
Confidence 011122334578899999999999999999999999999987644
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=379.73 Aligned_cols=270 Identities=21% Similarity=0.258 Sum_probs=203.1
Q ss_pred HhcCCCCCCCeeccCCcEEEEEEEECCC-CeEEEEEEEccCCC--cchHHHHHHHHHHHcc---CCCceeeEEEEEee--
Q 046609 76 VATTNFNPDNLLGEGGFGRVYRGKLEGT-NQDVAVKQLDRNGF--QGNREFLVEVLMLSML---SNPYLVNLVGYCVD-- 147 (399)
Q Consensus 76 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~hpnIv~l~~~~~~-- 147 (399)
...++|++++.||+|+||+||+|++..+ ++.||||++..... .....+.+|+.+++.+ +||||++++++|..
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 3457899999999999999999999654 67899999865322 2234566788777665 79999999999853
Q ss_pred ---CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeE
Q 046609 148 ---GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224 (399)
Q Consensus 148 ---~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 224 (399)
....+++|||+.++.+...... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl 157 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKL 157 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEE
T ss_pred cccCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeee
Confidence 3467999999988766555443 3567999999999999999999999999 999999999999999999999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
+|||++.... .........||+.|+|||++.+..|+.++|||||||++|||++|++||...++.+....+.......
T Consensus 158 ~dfg~~~~~~---~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 158 ADFGLARIYS---FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCSCCCCC---GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhhhhhc---ccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 9999987532 2233445679999999999999999999999999999999999999998765433222211110000
Q ss_pred -hc----cchhh-hc---cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 -KD----RRKFT-MM---ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 -~~----~~~~~-~~---~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ..... .. ........+.......+.+|+.+||+.||.+|||+.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000 00 00000011222344578899999999999999999999764
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=373.70 Aligned_cols=241 Identities=23% Similarity=0.385 Sum_probs=199.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------chHHHHHHHHHHHccC--CCceeeEEEEEeeCCe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------GNREFLVEVLMLSMLS--NPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--hpnIv~l~~~~~~~~~ 150 (399)
++|++.++||+|+||.||+|++..+++.||||++...... ....+.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999999999999999999754322 1234678999999987 8999999999999999
Q ss_pred eEEEEEecCC-CChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-CCCeeEeccc
Q 046609 151 RILVYEYMPN-GSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-DFNPKLSDFG 228 (399)
Q Consensus 151 ~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-~~~~kl~Dfg 228 (399)
.++||||+.+ +++.+++.. ...+++..++.++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 9999999976 577788765 467999999999999999999999999 999999999999985 4789999999
Q ss_pred CccCCCCCCCccccccccccccccccccccCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhcc
Q 046609 229 LAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQL-TAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDR 307 (399)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~ 307 (399)
+|...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..... + ....
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~------i------~~~~ 220 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I------IRGQ 220 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------H------HHCC
T ss_pred cceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH------H------hhcc
Confidence 99764332 2234679999999999987766 5678999999999999999999975211 0 0000
Q ss_pred chhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 308 RKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 308 ~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ++...+..+.+|+.+||+.||.+|||++|++++
T Consensus 221 --------~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 --------VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp --------CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --------cC----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 01 112233578899999999999999999999764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-51 Score=380.62 Aligned_cols=267 Identities=25% Similarity=0.371 Sum_probs=215.5
Q ss_pred hcCCCCCCCeeccCCcEEEEEEEECC-----CCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCCe
Q 046609 77 ATTNFNPDNLLGEGGFGRVYRGKLEG-----TNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQ 150 (399)
Q Consensus 77 ~~~~~~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~ 150 (399)
..++|.+.+.||+|+||.||+|.+.+ ++..||||+++.... .....+.+|+.++++++||||+++++++..++.
T Consensus 18 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 34678888999999999999998753 357899999975432 223458899999999999999999999999999
Q ss_pred eEEEEEecCCCChHHhhccCC------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeE
Q 046609 151 RILVYEYMPNGSLEDHLLDLP------PNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKL 224 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl 224 (399)
.++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEE
Confidence 999999999999999886421 12345789999999999999999999999 999999999999999999999
Q ss_pred ecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCCcccchhhHhhhhh
Q 046609 225 SDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITG-RRVIDNSRPTEEQNLVTWATPL 303 (399)
Q Consensus 225 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg-~~pf~~~~~~~~~~~~~~~~~~ 303 (399)
+|||+++...............||+.|+|||.+.++.++.++||||||+++|||+|| .+||......+....+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------ 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------ 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH------
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH------
Confidence 999999865444434444455789999999999999999999999999999999998 5778765433221111
Q ss_pred hhccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhccc
Q 046609 304 FKDRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHSKE 363 (399)
Q Consensus 304 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~~~ 363 (399)
.+.. ....+...+..+.+++.+||+.+|++|||+.+|+++|++..++..
T Consensus 249 ----------~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~ 297 (308)
T d1p4oa_ 249 ----------MEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 297 (308)
T ss_dssp ----------HTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred ----------HhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 0000 011223344579999999999999999999999999988766543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=375.63 Aligned_cols=272 Identities=22% Similarity=0.319 Sum_probs=200.0
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHH--HHHHHHccCCCceeeEEEEEeeCC----eeE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLV--EVLMLSMLSNPYLVNLVGYCVDGD----QRI 152 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~--e~~~l~~l~hpnIv~l~~~~~~~~----~~~ 152 (399)
.+|.+.+.||+|+||.||+|++. ++.||||++.... ...+.. |+..+.+++||||+++++++.+.+ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 45777889999999999999974 7899999996542 233333 455556789999999999998654 578
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCceEECCCCCeeEecc
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA-----QPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~-----~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
+||||+++|+|.++++. ..+++..++.++.|++.||.|||+.. .++|+||||||+||||+.++.+||+||
T Consensus 78 lv~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DF 152 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 152 (303)
T ss_dssp EEEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred EEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEec
Confidence 99999999999999986 35999999999999999999999741 122999999999999999999999999
Q ss_pred cCccCCCCCCCc--cccccccccccccccccccCC------CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh
Q 046609 228 GLAKLGPTGDKS--HVSTRVMGTYGYCAPEYALTG------QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW 299 (399)
Q Consensus 228 g~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~------~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~ 299 (399)
|++......... .......||+.|+|||++.+. .++.++|||||||+||||+||..||..............
T Consensus 153 Gl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~ 232 (303)
T d1vjya_ 153 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 232 (303)
T ss_dssp TTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTS
T ss_pred CccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcc
Confidence 999864433222 123446799999999988654 267789999999999999999988865443221110000
Q ss_pred hhhhhhccchhhhccCCccCCCC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhhc
Q 046609 300 ATPLFKDRRKFTMMADPLLEGNY-----PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAHS 361 (399)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~~ 361 (399)
... ..............++... +......+.+++.+||+.||.+|||+.+|++.|+++...
T Consensus 233 ~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 233 PSD-PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CSS-CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccc-chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 000 0000000111111111111 224556789999999999999999999999999988754
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.3e-50 Score=371.72 Aligned_cols=266 Identities=18% Similarity=0.254 Sum_probs=201.7
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|.+.+.||+|+||+||+|++. +++.||||++..... ...+.+.+|+.++++++||||+++++++.+++..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence 57899999999999999999987 689999999976532 224678999999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
|+.++.+..+... ...+++..++.++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 81 HLDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CCSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred eehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 9977666666544 567999999999999999999999999 999999999999999999999999999754322
Q ss_pred CCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhh-----hhccchh
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPL-----FKDRRKF 310 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~ 310 (399)
. .......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+..+....+...... +......
T Consensus 154 ~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 154 V--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhh
Confidence 2 222334689999999998754 5689999999999999999999999876543221111110000 0000000
Q ss_pred hhc------cCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 311 TMM------ADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 311 ~~~------~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
... ..+..........+..+.+|+.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000 00000011122334578899999999999999999999753
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-49 Score=375.33 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=196.7
Q ss_pred CCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCceeeEEEEEeeC------CeeEE
Q 046609 80 NFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYLVNLVGYCVDG------DQRIL 153 (399)
Q Consensus 80 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~------~~~~l 153 (399)
+|+..++||+|+||+||+|++..+++.||||++..... ...+|+.+|++++||||++++++|... .+.+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 57778999999999999999999999999999976532 234699999999999999999998543 35789
Q ss_pred EEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccC
Q 046609 154 VYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKL 232 (399)
Q Consensus 154 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~ 232 (399)
||||++++ +...+.........+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||++..
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 44444322223567999999999999999999999999 99999999999999775 899999999986
Q ss_pred CCCCCCccccccccccccccccccccC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhh---------h
Q 046609 233 GPTGDKSHVSTRVMGTYGYCAPEYALT-GQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWAT---------P 302 (399)
Q Consensus 233 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~---------~ 302 (399)
...... .....|++.|+|||.+.+ ..++.++|||||||++|||++|++||......+....+.... .
T Consensus 173 ~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 173 LVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp CCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccCCcc---cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence 543332 233569999999998765 578999999999999999999999998765432211111000 0
Q ss_pred hhhc--cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 303 LFKD--RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 303 ~~~~--~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.... ...+................+..+.+|+.+||+.||.+|||+.|++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000 000000000000111122334578899999999999999999999865
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-49 Score=367.22 Aligned_cols=269 Identities=21% Similarity=0.266 Sum_probs=200.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEee--------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVD-------- 147 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~-------- 147 (399)
.++|.+.+.||+|+||+||+|++..+++.||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 4789999999999999999999999999999999865432 334678899999999999999999999865
Q ss_pred CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecc
Q 046609 148 GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDF 227 (399)
Q Consensus 148 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Df 227 (399)
.+..++||||+.++.+..+... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeec
Confidence 3467999999977666544433 567999999999999999999999999 999999999999999999999999
Q ss_pred cCccCCCCCCCc--cccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhh
Q 046609 228 GLAKLGPTGDKS--HVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLF 304 (399)
Q Consensus 228 g~~~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 304 (399)
|++......... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999754432221 222335699999999998765 68999999999999999999999998765443332222111111
Q ss_pred hccchhhhcc--------CCccCCCCCH-------HHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 305 KDRRKFTMMA--------DPLLEGNYPI-------KGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 305 ~~~~~~~~~~--------~~~l~~~~~~-------~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.. ....... .......... .....+.+|+.+||+.||++|||++|++++
T Consensus 242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 242 TP-EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CT-TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred Ch-hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 00 0000000 0000000011 113466789999999999999999999754
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=371.95 Aligned_cols=263 Identities=21% Similarity=0.284 Sum_probs=197.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeCC------
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDGD------ 149 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~------ 149 (399)
.++|.+.+.||+|+||+||+|.+..+++.||||++...... ..+.+.+|+.+|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 46899999999999999999999999999999999754332 2356889999999999999999999998665
Q ss_pred eeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccC
Q 046609 150 QRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGL 229 (399)
Q Consensus 150 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~ 229 (399)
..++||||+ +.+|..++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 6678777754 46999999999999999999999999 99999999999999999999999999
Q ss_pred ccCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhh---
Q 046609 230 AKLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFK--- 305 (399)
Q Consensus 230 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~--- 305 (399)
++..... .....||+.|+|||++.+. .++.++||||+||++|+|++|++||...+................
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 9864322 2345699999999998764 568999999999999999999999987654322211111000000
Q ss_pred -------ccchhhhccCCccC---CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 -------DRRKFTMMADPLLE---GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 -------~~~~~~~~~~~~l~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.............. ..........+.+|+.+||..||.+|||+.|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00000000000000 01112234578899999999999999999999875
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-49 Score=362.49 Aligned_cols=263 Identities=19% Similarity=0.245 Sum_probs=203.9
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCc-eeeEEEEEeeCCeeEEEEEe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPY-LVNLVGYCVDGDQRILVYEY 157 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e~ 157 (399)
++|++.+.||+|+||.||+|++..+++.||||++.... ...++..|+.+++.++|+| |+.+..++.+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 57999999999999999999999999999999987643 2345788999999998765 55566667888899999999
Q ss_pred cCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC---CCCeeEecccCccCCC
Q 046609 158 MPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ---DFNPKLSDFGLAKLGP 234 (399)
Q Consensus 158 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~---~~~~kl~Dfg~~~~~~ 234 (399)
+ +++|...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++. +..+||+|||+|+...
T Consensus 85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 9 6677777665 3567999999999999999999999999 999999999999864 5579999999998654
Q ss_pred CCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccch
Q 046609 235 TGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRRK 309 (399)
Q Consensus 235 ~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 309 (399)
..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..................... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~~ 236 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-TP 236 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-SC
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-CC
Confidence 33221 1233467999999999999999999999999999999999999999876654333222111110000 00
Q ss_pred hhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 310 FTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 310 ~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
. +.+... .+..+.+++.+||+.+|.+||+++++.+.|+.+..
T Consensus 237 ~-----~~~~~~----~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 237 I-----EVLCKG----YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp H-----HHHTTT----SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred h-----hHhccC----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0 011112 23468899999999999999999999998887743
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-48 Score=367.48 Aligned_cols=269 Identities=19% Similarity=0.241 Sum_probs=200.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC-cchHHHHHHHHHHHccCCCceeeEEEEEeeCC----eeE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF-QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGD----QRI 152 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~----~~~ 152 (399)
+++|.+++.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 4679999999999999999999999999999999976432 22356889999999999999999999997653 234
Q ss_pred EEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 153 LVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 153 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||+++ ||||||||+|||++.++.+||+|||++..
T Consensus 87 ~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~ 158 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 158 (345)
T ss_dssp EEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceee
Confidence 55566679999999975 36999999999999999999999999 99999999999999999999999999975
Q ss_pred CCCCCCc-ccccccccccccccccccc-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc--
Q 046609 233 GPTGDKS-HVSTRVMGTYGYCAPEYAL-TGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR-- 308 (399)
Q Consensus 233 ~~~~~~~-~~~~~~~g~~~y~aPE~~~-~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-- 308 (399)
....... .......||+.|+|||++. +..++.++||||+||++|+|++|+.||......+................
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (345)
T d1pmea_ 159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238 (345)
T ss_dssp CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhh
Confidence 4333222 2234467999999999885 45678899999999999999999999987654322221111100000000
Q ss_pred ------hhhhccCCccCCCC-----CHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 309 ------KFTMMADPLLEGNY-----PIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 309 ------~~~~~~~~~l~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
.............. .......+.+|+.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000000000000 11223468899999999999999999999865
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.2e-48 Score=359.49 Aligned_cols=264 Identities=19% Similarity=0.240 Sum_probs=212.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC-CceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN-PYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e 156 (399)
.++|++.+.||+|+||+||+|++..+++.||||++.... ....+.+|+.++..++| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999999999999999986542 33457789999999975 899999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECC-----CCCeeEecccCcc
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQ-----DFNPKLSDFGLAK 231 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~-----~~~~kl~Dfg~~~ 231 (399)
|+ +++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 7899999876 3457999999999999999999999999 999999999999964 5789999999998
Q ss_pred CCCCCCCc-----cccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc
Q 046609 232 LGPTGDKS-----HVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD 306 (399)
Q Consensus 232 ~~~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~ 306 (399)
........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-
Confidence 64432211 223346799999999999999999999999999999999999999987655433222211111000
Q ss_pred cchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHHHHHhhh
Q 046609 307 RRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTAIEYLAH 360 (399)
Q Consensus 307 ~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~L~~l~~ 360 (399)
...... +....| ..+.+++..|+..+|++||+++.+.+.|+++..
T Consensus 234 ~~~~~~-----l~~~~p----~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 234 STPLRE-----LCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp HSCHHH-----HTTTSC----HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCChHH-----hcCCCC----HHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence 000111 112223 468889999999999999999999999888754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=357.46 Aligned_cols=267 Identities=19% Similarity=0.226 Sum_probs=207.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCC--cchHHHHHHHHHHHccCCCceeeEEEEEeeCCeeEEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGF--QGNREFLVEVLMLSMLSNPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 156 (399)
++|++++.||+|+||+||+|.+..+++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 578999999999999999999999999999999965433 234678899999999999999999999999999999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCccCCCCC
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLAKLGPTG 236 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~ 236 (399)
++.+++|..++.. .+.+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.+......
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc----ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999888887765 567899999999999999999999999 999999999999999999999999999865433
Q ss_pred CCccccccccccccccccccccCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCcccc-hhhHhhhhh-hh--------
Q 046609 237 DKSHVSTRVMGTYGYCAPEYALTGQ-LTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQ-NLVTWATPL-FK-------- 305 (399)
Q Consensus 237 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~-~~-------- 305 (399)
.. ......++..|+|||++.+.. ++.++|||||||++|+|++|+.||......... ..+...... ..
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred Cc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhh
Confidence 22 223345788999999887654 689999999999999999999987654432211 111000000 00
Q ss_pred --ccchhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 306 --DRRKFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 306 --~~~~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
........................+.+|+.+||+.||.+|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0000000000111112233445678899999999999999999999653
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4e-48 Score=362.03 Aligned_cols=259 Identities=18% Similarity=0.250 Sum_probs=200.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEee--CCeeEEEE
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVD--GDQRILVY 155 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv~ 155 (399)
++|++.++||+|+||+||+|++..+++.||||++... ..+.+.+|+.+|++++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999999999999999999753 3567889999999996 9999999999974 35689999
Q ss_pred EecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCC-CeeEecccCccCCC
Q 046609 156 EYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDF-NPKLSDFGLAKLGP 234 (399)
Q Consensus 156 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~-~~kl~Dfg~~~~~~ 234 (399)
||+.+++|..+.+ .+++..++.++.||+.||.|||+++ |+||||||+||||+.++ .+||+|||+|....
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHhc-------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceecc
Confidence 9999999876643 4999999999999999999999999 99999999999998655 59999999998644
Q ss_pred CCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchh-hH-hhhh---------
Q 046609 235 TGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNL-VT-WATP--------- 302 (399)
Q Consensus 235 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~-~~-~~~~--------- 302 (399)
... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||........... +. ....
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence 332 22345689999999998765 579999999999999999999999987654321110 00 0000
Q ss_pred -hhhccchhhhccCC--------ccCCCCCHHHHHHHHHHHhhccccCCCCCCChHHHHH
Q 046609 303 -LFKDRRKFTMMADP--------LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVT 353 (399)
Q Consensus 303 -~~~~~~~~~~~~~~--------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~ 353 (399)
.......+...... ............++.+|+.+||+.||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00000011111100 0111112233457889999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=363.97 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=205.3
Q ss_pred CCCCCCCeeccCCcEEEEEEEE---CCCCeEEEEEEEccCCC----cchHHHHHHHHHHHccCC-CceeeEEEEEeeCCe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKL---EGTNQDVAVKQLDRNGF----QGNREFLVEVLMLSMLSN-PYLVNLVGYCVDGDQ 150 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h-pnIv~l~~~~~~~~~ 150 (399)
++|.+.+.||+|+||+||+|.+ +.+++.||||++..... ...+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999987 44689999999875432 233567889999999976 899999999999999
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.+++|||+.+|+|.+++.. ...+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccch
Confidence 9999999999999999986 456889999999999999999999999 999999999999999999999999999
Q ss_pred cCCCCCCCccccccccccccccccccccCC--CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhccc
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTG--QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKDRR 308 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 308 (399)
+....... .......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||...........+.... ...
T Consensus 177 ~~~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~--~~~-- 251 (322)
T d1vzoa_ 177 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKS-- 251 (322)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHH--HHC--
T ss_pred hhhccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc--ccC--
Confidence 76543322 223346799999999998754 47889999999999999999999998776544322221110 000
Q ss_pred hhhhccCCccCCCCCHHHHHHHHHHHhhccccCCCCCCC-----hHHHHHH
Q 046609 309 KFTMMADPLLEGNYPIKGLYQALAVAAMCLQEEAGTRPM-----MSDVVTA 354 (399)
Q Consensus 309 ~~~~~~~~~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~eil~~ 354 (399)
. ...+...+..+.+|+.+||+.||.+||| ++|++++
T Consensus 252 ------~----~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 ------E----PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ------C----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ------C----CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0 1123344568899999999999999995 7888753
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-48 Score=364.04 Aligned_cols=263 Identities=21% Similarity=0.253 Sum_probs=194.2
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEee------CCe
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVD------GDQ 150 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~------~~~ 150 (399)
++|++.++||+|+||+||+|.+..+++.||||++...... ....+.+|+.++++++||||++++++|.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6799999999999999999999999999999999765432 23568899999999999999999999963 468
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred eEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhh
Confidence 8999999965 4555553 34899999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHh---------h-
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTW---------A- 300 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~---------~- 300 (399)
+..... .......+|+.|+|||++.+..++.++||||+||++|+|++|++||...+.......+.. .
T Consensus 167 ~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 167 RTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 754332 233445799999999999999999999999999999999999999987653322111100 0
Q ss_pred ------hhhhhcc-----chhhhccCCc-cC--CCCCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 301 ------TPLFKDR-----RKFTMMADPL-LE--GNYPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 301 ------~~~~~~~-----~~~~~~~~~~-l~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
....... .......... .. .......+..+.+|+.+||+.||.+|||++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000 0000001000 01 11123456788999999999999999999999755
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-47 Score=357.28 Aligned_cols=264 Identities=21% Similarity=0.273 Sum_probs=198.5
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc--chHHHHHHHHHHHccCCCceeeEEEEEeeC-----Ce
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ--GNREFLVEVLMLSMLSNPYLVNLVGYCVDG-----DQ 150 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~hpnIv~l~~~~~~~-----~~ 150 (399)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+.+|+.+|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 46899999999999999999999999999999999765332 335688999999999999999999998643 33
Q ss_pred eEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCeeEecccCc
Q 046609 151 RILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPKLSDFGLA 230 (399)
Q Consensus 151 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~kl~Dfg~~ 230 (399)
.+++++|+.+|+|.+++.. ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchh
Confidence 4666777889999999964 46999999999999999999999999 999999999999999999999999998
Q ss_pred cCCCCCCCccccccccccccccccccccCC-CCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhHhhhhhhhc---
Q 046609 231 KLGPTGDKSHVSTRVMGTYGYCAPEYALTG-QLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVTWATPLFKD--- 306 (399)
Q Consensus 231 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~--- 306 (399)
.... .......|++.|+|||.+.+. .++.++|||||||++|+|++|++||.+.+.......+.........
T Consensus 169 ~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~ 243 (348)
T d2gfsa1 169 RHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 243 (348)
T ss_dssp -CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred cccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence 7432 223345689999999987665 4688999999999999999999999876543222221111000000
Q ss_pred -------cchhhhccCCccCCC---CCHHHHHHHHHHHhhccccCCCCCCChHHHHHH
Q 046609 307 -------RRKFTMMADPLLEGN---YPIKGLYQALAVAAMCLQEEAGTRPMMSDVVTA 354 (399)
Q Consensus 307 -------~~~~~~~~~~~l~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~eil~~ 354 (399)
............... ........+.+|+.+||+.||.+|||+.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000000000000000 011233568899999999999999999999864
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.2e-42 Score=323.74 Aligned_cols=266 Identities=18% Similarity=0.176 Sum_probs=192.1
Q ss_pred CCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-----------CCceeeEEEEEee
Q 046609 79 TNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-----------NPYLVNLVGYCVD 147 (399)
Q Consensus 79 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------hpnIv~l~~~~~~ 147 (399)
.+|++.++||+|+||+||+|++..+++.||||+++... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 45999999999999999999999999999999997653 22356778888888775 5789999988754
Q ss_pred --CCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCceEECCCCC---
Q 046609 148 --GDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHE-SAQPPVIYRDFKASNVLLDQDFN--- 221 (399)
Q Consensus 148 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~-~~~~~ivH~dikp~NIll~~~~~--- 221 (399)
....+++++++..+......... .....+++..+..++.|++.||.|||+ .+ |+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccc
Confidence 45667777776554433332221 235678999999999999999999997 77 999999999999986654
Q ss_pred ---eeEecccCccCCCCCCCccccccccccccccccccccCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCcccchhhH
Q 046609 222 ---PKLSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPEYALTGQLTAKSDVYSFGVVFLEIITGRRVIDNSRPTEEQNLVT 298 (399)
Q Consensus 222 ---~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~elltg~~pf~~~~~~~~~~~~~ 298 (399)
++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.............
T Consensus 168 ~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred cceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 899999998753322 233569999999999999999999999999999999999999998654321111100
Q ss_pred hh---hhhhhc--------cchhhhccC---------C----------ccCCCCCHHHHHHHHHHHhhccccCCCCCCCh
Q 046609 299 WA---TPLFKD--------RRKFTMMAD---------P----------LLEGNYPIKGLYQALAVAAMCLQEEAGTRPMM 348 (399)
Q Consensus 299 ~~---~~~~~~--------~~~~~~~~~---------~----------~l~~~~~~~~~~~l~~li~~cl~~dp~~RPs~ 348 (399)
.. ...+.. ........+ . .............+.+|+.+||+.||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 00 000000 000000000 0 00123355677889999999999999999999
Q ss_pred HHHHHH
Q 046609 349 SDVVTA 354 (399)
Q Consensus 349 ~eil~~ 354 (399)
+|++++
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=3e-25 Score=189.66 Aligned_cols=164 Identities=13% Similarity=0.076 Sum_probs=118.8
Q ss_pred CCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCc------------------chHHHHHHHHHHHccCCCceeeEEE
Q 046609 82 NPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQ------------------GNREFLVEVLMLSMLSNPYLVNLVG 143 (399)
Q Consensus 82 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------------------~~~~~~~e~~~l~~l~hpnIv~l~~ 143 (399)
.+.+.||+|+||.||+|.+. +++.||||+++..... .......|...+.++.|++++..++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 34588999999999999986 5899999987532110 0122456788999999999999887
Q ss_pred EEeeCCeeEEEEEecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCceEECCCCCee
Q 046609 144 YCVDGDQRILVYEYMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQPPVIYRDFKASNVLLDQDFNPK 223 (399)
Q Consensus 144 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~~~ivH~dikp~NIll~~~~~~k 223 (399)
+. ..+++|||+++..+.. ++...+..++.|++.+|.|||+.+ |+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEE
Confidence 64 2379999998765432 233445678999999999999999 9999999999999865 589
Q ss_pred EecccCccCCCCCCCccccccccccccccccc-----cccCCCCCchhhHHHHHHHH
Q 046609 224 LSDFGLAKLGPTGDKSHVSTRVMGTYGYCAPE-----YALTGQLTAKSDVYSFGVVF 275 (399)
Q Consensus 224 l~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~~DvwslG~il 275 (399)
|+|||.|......... .|.... .+....|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999998753322111 111110 02246778899999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=1.5e-08 Score=88.81 Aligned_cols=143 Identities=13% Similarity=0.040 Sum_probs=99.9
Q ss_pred cCCCCCCCeeccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEE
Q 046609 78 TTNFNPDNLLGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 78 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e 156 (399)
.+.|++.+..+.++.+.||+... .+..+++|+...........+..|...+..+. +--+.+++.+..+++..++||+
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~ 90 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS 90 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEE
Confidence 34555555555555678998764 35667889887654444556778888887775 4346788888888899999999
Q ss_pred ecCCCChHHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-----------------------------------
Q 046609 157 YMPNGSLEDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESAQ----------------------------------- 201 (399)
Q Consensus 157 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~~----------------------------------- 201 (399)
+++|.++.+.... .. ....++.+++..+..||+...
T Consensus 91 ~l~G~~~~~~~~~------~~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 91 EADGVLCSEEYED------EQ---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp CCSSEEHHHHTTT------CS---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred ecccccccccccc------cc---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 9998887655432 11 123345566666677775320
Q ss_pred ---------------------CCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 202 ---------------------PPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 202 ---------------------~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
..++|+|+.|.||++++++.+-|+||+.+.
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 138999999999999987667799998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.13 E-value=1.2e-05 Score=69.20 Aligned_cols=129 Identities=18% Similarity=0.104 Sum_probs=85.7
Q ss_pred eccCC-cEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCC--CceeeEEEEEeeCCeeEEEEEecCCCCh
Q 046609 87 LGEGG-FGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSN--PYLVNLVGYCVDGDQRILVYEYMPNGSL 163 (399)
Q Consensus 87 lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L 163 (399)
+..|. .+.||+....+ +..+++|...... ...+..|...++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 18 ~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQG-RPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp CSCTTSSCEEEEEECTT-SCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred cCCcccCCeEEEEEeCC-CCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 44444 36789987654 6668889865443 2346667777776643 3467788888888899999999988665
Q ss_pred HHhhccCCCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------------
Q 046609 164 EDHLLDLPPNRKALDWNTRMKIAHGAARGLEYLHESA------------------------------------------- 200 (399)
Q Consensus 164 ~~~l~~~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~------------------------------------------- 200 (399)
.+.. +... ..+.++...|.-||...
T Consensus 94 ~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred cccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 3311 1111 12234444555555321
Q ss_pred ------------CCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 201 ------------QPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 201 ------------~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
...++|+|+.|.||+++.+..+-|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1138999999999999987667899998764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.09 E-value=7.9e-06 Score=75.47 Aligned_cols=77 Identities=13% Similarity=0.080 Sum_probs=49.1
Q ss_pred CeeccCCcEEEEEEEECCCCeEEEEEEEccC-------CCcchHHHHHHHHHHHccC-C--CceeeEEEEEeeCCeeEEE
Q 046609 85 NLLGEGGFGRVYRGKLEGTNQDVAVKQLDRN-------GFQGNREFLVEVLMLSMLS-N--PYLVNLVGYCVDGDQRILV 154 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~e~~~l~~l~-h--pnIv~l~~~~~~~~~~~lv 154 (399)
+.||.|....||++....+++.++||.-... ..........|...|..+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 4689999999999988777788999975421 1112234556777777663 2 345666654 45566899
Q ss_pred EEecCCCCh
Q 046609 155 YEYMPNGSL 163 (399)
Q Consensus 155 ~e~~~~g~L 163 (399)
||++.+..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EeccCCccc
Confidence 999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.11 E-value=0.0015 Score=59.65 Aligned_cols=73 Identities=16% Similarity=0.238 Sum_probs=50.0
Q ss_pred CeeccCCcEEEEEEEECC-------CCeEEEEEEEccCCCcchHHHHHHHHHHHccC-CCceeeEEEEEeeCCeeEEEEE
Q 046609 85 NLLGEGGFGRVYRGKLEG-------TNQDVAVKQLDRNGFQGNREFLVEVLMLSMLS-NPYLVNLVGYCVDGDQRILVYE 156 (399)
Q Consensus 85 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e 156 (399)
+.|+.|-.-.+|++.... ..+.|.+++.... .......+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 568888888999998753 2356777777532 22344567888888876 4334577777743 68999
Q ss_pred ecCCCCh
Q 046609 157 YMPNGSL 163 (399)
Q Consensus 157 ~~~~g~L 163 (399)
|++|.+|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9977544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.001 Score=59.08 Aligned_cols=139 Identities=17% Similarity=0.095 Sum_probs=77.4
Q ss_pred CCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCce--eeEE-----EEEeeCCeeEEEEEecCCCC
Q 046609 90 GGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL--VNLV-----GYCVDGDQRILVYEYMPNGS 162 (399)
Q Consensus 90 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnI--v~l~-----~~~~~~~~~~lv~e~~~~g~ 162 (399)
+..-.||++... +|..|++|+.+... ....++..|...+..|...++ +..+ ..+..+...+.++++++|..
T Consensus 33 s~EN~vy~v~~~-dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcC-CCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 334689999876 47889999987543 345667788888877653222 1111 11234567788999986543
Q ss_pred hH------------------HhhccCC-CCCCCCCHH----------------------HHHHHHHHHHHHHHHHh-hcC
Q 046609 163 LE------------------DHLLDLP-PNRKALDWN----------------------TRMKIAHGAARGLEYLH-ESA 200 (399)
Q Consensus 163 L~------------------~~l~~~~-~~~~~l~~~----------------------~~~~i~~ql~~~l~~LH-~~~ 200 (399)
+. ....... .....++.. .....+.++...+.-+- +..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 21 1111110 001111111 12223333333333221 111
Q ss_pred CCCeEecCCCCCceEECCCCCeeEecccCccC
Q 046609 201 QPPVIYRDFKASNVLLDQDFNPKLSDFGLAKL 232 (399)
Q Consensus 201 ~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~~ 232 (399)
...+||+|+.+.|||++++ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 3348999999999999743 45889987763
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.88 E-value=0.0019 Score=56.89 Aligned_cols=158 Identities=14% Similarity=0.056 Sum_probs=79.3
Q ss_pred cHHHHHHhcCCCCCCCe-----eccCCcEEEEEEEECCCCeEEEEEEEccCCCcchHHHHHHHHHHHccCCCce--eeEE
Q 046609 70 SYRELCVATTNFNPDNL-----LGEGGFGRVYRGKLEGTNQDVAVKQLDRNGFQGNREFLVEVLMLSMLSNPYL--VNLV 142 (399)
Q Consensus 70 ~~~~~~~~~~~~~~~~~-----lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~hpnI--v~l~ 142 (399)
+..++....++|.+.++ |..|---+.|+....+ + .+++|++.... ...++..|+.++..+...++ ...+
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 34555555566776544 4466667889988764 3 48999986532 23445556666666643221 1111
Q ss_pred E------EEeeCCeeEEEEEecCCCChHH--------------hhc----cCCC-CCCCCCH------------------
Q 046609 143 G------YCVDGDQRILVYEYMPNGSLED--------------HLL----DLPP-NRKALDW------------------ 179 (399)
Q Consensus 143 ~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~----~~~~-~~~~l~~------------------ 179 (399)
. +..-......++.+..+..... .++ .... .......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 1122345566677665543210 000 0000 0000000
Q ss_pred HHHHHHHHHHHHHHHHHhhcC-CCCeEecCCCCCceEECCCCCeeEecccCcc
Q 046609 180 NTRMKIAHGAARGLEYLHESA-QPPVIYRDFKASNVLLDQDFNPKLSDFGLAK 231 (399)
Q Consensus 180 ~~~~~i~~ql~~~l~~LH~~~-~~~ivH~dikp~NIll~~~~~~kl~Dfg~~~ 231 (399)
......+..+...+.-.+... ..++||+|+.++||+++.+...-|+||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 011122222333333333211 2349999999999999988777899999774
|